data_2n9p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n9p _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 120.407 0.146 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.645 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 10.0 m-85 -120.67 165.29 15.27 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 167.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.464 ' CB ' HD22 ' A' ' 40' ' ' LEU . 75.4 t80 -137.22 117.44 13.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.687 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -97.55 120.95 38.86 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -74.69 -15.64 60.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.748 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.6 m -70.78 -37.28 73.34 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.937 0.399 . . . . 0.0 111.147 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.441 ' O ' HG22 ' A' ' 18' ' ' VAL . 90.5 m -89.48 -16.0 31.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.695 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 16' ' ' CYS . 22.7 p 49.64 31.35 4.2 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.256 -171.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 16' ' ' CYS . 98.0 t -141.13 146.91 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.539 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 25.5 tt0 -70.39 149.0 47.75 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.343 0.402 . . . . 0.0 111.235 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.621 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.4 pt -138.12 167.01 22.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.477 -173.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 40.5 t -122.96 96.68 44.67 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 163.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.645 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.88 177.12 0.19 Allowed 'Trans proline' 0 C--N 1.325 -0.691 1 C-N-CA 125.455 4.103 . . . . 0.0 116.426 -170.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.503 ' CB ' HD11 ' A' ' 28' ' ' ILE . 36.7 mtt180 -112.97 51.01 0.85 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 112.818 -1.992 . . . . 0.0 107.565 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.407 HD12 ' CE1' ' A' ' 27' ' ' TYR . 3.1 mm? 3.0 -60.81 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.213 0 CA-C-N 111.507 -2.588 . . . . 0.0 117.555 171.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.444 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 32.6 Cg_exo -37.12 -32.84 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.613 2.209 . . . . 0.0 113.826 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.538 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -118.29 -20.39 8.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.558 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.473 ' C ' HD12 ' A' ' 37' ' ' ILE . 44.1 m-85 65.25 46.66 2.59 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.57 1.176 . . . . 0.0 109.767 -170.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -92.0 163.77 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 113.315 -1.766 . . . . 0.0 109.793 174.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.537 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -94.29 144.49 28.1 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.621 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 68.3 Cg_endo -80.72 -22.43 6.45 Favored 'Trans proline' 0 CA--C 1.5 -1.208 0 C-N-CA 122.711 2.274 . . . . 0.0 108.083 -171.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.508 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 51.6 mtt180 -81.24 -34.76 31.92 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.968 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.4 p -139.27 -8.42 1.31 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.333 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 60.11 25.98 15.32 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.0 m -98.5 133.69 42.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 166.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.03 30.76 2.62 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.007 -172.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 51.8 m-85 -86.58 47.99 1.56 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.498 0.666 . . . . 0.0 109.842 176.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.538 HG21 HD11 ' A' ' 20' ' ' ILE . 9.6 pt -111.33 133.45 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.382 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HB3' HD12 ' C' ' 60' ' ' ILE . 11.5 pt-20 -117.2 141.48 48.23 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -79.29 131.99 36.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.206 0.527 . . . . 0.0 109.848 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.464 HD22 ' CB ' ' A' ' 12' ' ' PHE . 2.5 mt . . . . . 0 C--O 1.25 1.12 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.877 -173.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.506 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 12.2 tpt . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 120.823 0.344 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.735 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -99.19 148.29 24.25 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.467 ' HA ' HG13 ' C' ' 32' ' ' ILE . 30.2 tt0 -98.72 91.58 5.17 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.3 t -78.79 106.11 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.443 -168.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -94.64 140.93 29.21 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.471 HG22 ' HB ' ' C' ' 82' ' ' ILE . 70.7 t -151.68 120.44 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 37.7 mtpt -95.54 159.18 15.12 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 63.3 p . . . . . 0 C--N 1.314 -0.954 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.783 -171.927 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 22.8 m . . . . . 0 C--O 1.232 0.18 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -125.59 152.89 44.51 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.63 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p -99.1 145.42 27.16 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.162 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.464 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 29.0 m-85 -135.88 58.54 1.74 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.654 -175.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.467 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -57.35 122.29 6.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 123.381 1.563 . . . . 0.0 114.362 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -142.94 -165.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 110.677 -2.965 . . . . 0.0 111.39 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -81.57 -179.85 53.13 Favored Glycine 0 C--N 1.312 -0.769 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.123 174.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.735 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -78.78 -23.83 45.04 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-N 117.254 0.527 . . . . 0.0 110.132 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -151.75 23.08 0.69 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -162.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' MET . . . . . 0.478 ' HB2' ' HA3' ' C' ' 34' ' ' GLY . 25.5 ttt -73.6 -68.75 0.48 Allowed 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 111.409 -2.632 . . . . 0.0 110.805 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.447 ' OD1' ' HG2' ' C' ' 37' ' ' MET . 23.6 m120 -126.19 -94.52 0.46 Allowed 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.583 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 82.94 -38.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 O-C-N 124.305 1.003 . . . . 0.0 111.128 -162.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.505 ' HA ' ' CB ' ' C' ' 68' ' ' ASP . 0.0 OUTLIER -78.97 -69.46 0.57 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 122.512 1.148 . . . . 0.0 108.939 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . 0.404 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 20.7 mt-10 -63.08 -27.82 69.66 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.902 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.583 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 2.6 t80 -59.05 -50.34 74.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.328 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.475 ' HE3' ' OG ' ' C' ' 54' ' ' SER . 23.1 mtpp -60.61 -41.27 94.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.988 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -57.73 -38.39 75.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.175 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -70.43 -45.97 64.81 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.209 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.595 ' O ' HG21 ' C' ' 50' ' ' VAL . 17.0 pt -76.78 -10.63 13.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -174.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -43.92 -49.46 8.42 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.63 -38.28 48.28 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.707 -0.397 . . . . 0.0 112.065 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -28.21 69.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.987 0.422 . . . . 0.0 110.996 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.595 HG21 ' O ' ' C' ' 46' ' ' ILE . 34.8 m -109.11 -5.84 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.47 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 46.1 m 68.13 20.65 8.9 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 121.629 0.728 . . . . 0.0 109.768 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.6 mm -122.95 111.2 30.97 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.546 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' C' ' 52' ' ' ILE . 7.1 Cg_exo -70.49 141.6 42.65 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.61 2.207 . . . . 0.0 111.695 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.475 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 42.8 t -50.75 -26.19 5.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.73 -173.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.75 -36.31 67.69 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -94.85 -32.28 13.33 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.741 0.782 . . . . 0.0 109.468 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.468 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 20.8 tt0 -51.92 132.43 32.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.664 -1.607 . . . . 0.0 111.48 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -133.95 113.02 11.73 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.506 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 37.8 mt -84.89 118.38 24.48 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.432 HD12 ' HB3' ' A' ' 38' ' ' GLU . 5.4 mt -117.25 121.17 67.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.664 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -137.85 132.82 33.12 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 59.15 32.87 22.45 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.534 0.521 . . . . 0.0 110.14 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 67.85 4.18 32.47 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.87 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -88.7 142.08 27.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -90.24 89.41 3.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.618 HD23 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -81.14 131.86 35.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -144.67 -177.32 5.44 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.536 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.511 ' HA ' HG11 ' C' ' 39' ' ' VAL . 6.7 p-10 -70.51 -3.22 16.87 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.751 0.821 . . . . 0.0 112.033 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.32 -21.63 62.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -131.85 -142.22 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.196 -0.315 . . . . 0.0 111.442 -169.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -126.64 167.17 16.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.623 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 7.3 mt -70.61 -37.31 73.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.022 0.439 . . . . 0.0 111.758 -175.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' C' ' 35' ' ' ALA . 23.1 tp60 -70.66 -18.65 62.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.521 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -61.61 -29.41 70.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.83 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.618 ' CD1' HD23 ' C' ' 66' ' ' LEU . 36.8 m-85 -103.66 -18.62 14.65 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.65 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.8 t30 59.22 52.6 5.96 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.904 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 35.1 m -95.23 14.98 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -171.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -57.56 99.27 0.1 OUTLIER Glycine 0 CA--C 1.492 -1.381 0 CA-C-O 122.915 1.286 . . . . 0.0 113.789 171.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.94 14.92 47.4 Favored Glycine 0 C--N 1.284 -2.328 0 CA-C-N 111.877 -2.162 . . . . 0.0 114.132 171.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.35 141.19 50.29 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 122.495 -0.414 . . . . 0.0 110.642 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 21.2 m -78.37 123.96 36.02 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-O 121.932 0.872 . . . . 0.0 111.104 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.5 HG23 ' N ' ' C' ' 83' ' ' HIS . 66.3 mt -82.6 168.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.0 172.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.5 ' N ' HG23 ' C' ' 82' ' ' ILE . 62.5 m80 -118.27 115.5 24.86 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 15.0 mt -88.42 148.73 24.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.17 0.51 . . . . 0.0 111.452 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.133 -178.335 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 121.651 0.739 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.556 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 9.0 m-85 -115.88 169.6 9.11 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.513 -1.222 . . . . 0.0 108.39 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.538 ' CB ' HD21 ' A' ' 40' ' ' LEU . 38.4 t80 -142.0 113.62 7.83 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.917 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 31.6 p -83.09 87.67 6.9 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.813 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.528 ' CE1' HG11 ' C' ' 85' ' ' VAL . 30.3 p80 -66.17 -14.72 62.32 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.619 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.754 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 3.0 p -67.08 -49.08 66.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.044 0.449 . . . . 0.0 110.437 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -99.9 -5.61 28.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.626 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m 65.16 55.44 1.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.034 172.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.94 145.36 24.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.501 ' C ' HG23 ' A' ' 20' ' ' ILE . 33.4 tt0 -86.25 138.92 31.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.132 0.492 . . . . 0.0 110.709 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.629 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 6.2 pt -143.49 166.87 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -164.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 46.5 t -120.07 94.81 48.89 Favored Pre-proline 0 N--CA 1.447 -0.578 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 160.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 9.8 Cg_endo -56.73 171.36 1.03 Allowed 'Trans proline' 0 C--N 1.32 -0.965 1 C-N-CA 125.479 4.119 . . . . 0.0 117.186 -167.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.533 ' CB ' HD13 ' A' ' 28' ' ' ILE . 98.3 mtt180 -101.91 47.48 0.9 Allowed 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 112.4 -2.182 . . . . 0.0 107.205 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -8.53 -54.25 0.01 OUTLIER Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 110.467 -3.06 . . . . 0.0 115.606 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 19.2 Cg_exo -35.27 -33.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 123.216 2.611 . . . . 0.0 114.512 173.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.473 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -122.91 -19.01 6.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.121 0.486 . . . . 0.0 111.42 177.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.468 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 90.5 m-85 73.04 53.28 0.13 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.162 -174.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -108.78 164.16 5.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 113.628 -1.624 . . . . 0.0 108.086 177.21 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.414 ' HA ' HD12 ' A' ' 20' ' ' ILE . 27.1 p -94.49 139.12 22.24 Favored Pre-proline 0 N--CA 1.424 -1.733 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.629 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 85.4 Cg_endo -78.63 -25.31 6.67 Favored 'Trans proline' 0 CA--C 1.493 -1.545 0 C-N-CA 123.535 2.823 . . . . 0.0 108.822 -166.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.47 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 52.9 mtt180 -79.68 -28.86 40.67 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.381 -2.19 . . . . 0.0 113.162 -175.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -157.7 9.8 0.18 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.322 -170.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 49.48 64.24 1.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 167.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.507 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -133.3 147.88 51.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.169 169.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -88.46 6.85 83.13 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.49 -0.862 . . . . 0.0 114.089 -170.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.754 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 69.8 m-85 -83.4 59.46 5.07 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.505 -0.409 . . . . 0.0 111.485 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.583 ' CG2' HD11 ' A' ' 20' ' ' ILE . 3.5 pt -112.73 141.56 27.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.07 0.462 . . . . 0.0 111.769 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -129.23 153.71 47.51 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -84.78 143.4 29.14 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.538 HD21 ' CB ' ' A' ' 12' ' ' PHE . 7.9 mt . . . . . 0 C--N 1.311 -1.066 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.899 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.652 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 24.6 ptt? . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 121.086 0.47 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.622 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 0.4 OUTLIER -104.09 133.07 49.65 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 170.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.507 ' HA ' HG13 ' C' ' 32' ' ' ILE . 26.0 mt-10 -80.45 96.56 6.78 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.0 t -81.63 104.64 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.5 -172.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -93.31 141.78 28.05 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.481 HG21 ' HB ' ' C' ' 82' ' ' ILE . 69.5 t -147.84 118.09 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 118.219 0.463 . . . . 0.0 110.781 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.625 ' HG2' ' OG1' ' C' ' 28' ' ' THR . 73.5 mttt -100.09 115.05 28.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.315 -0.934 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.625 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 22.0 m . . . . . 0 C--O 1.233 0.227 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -126.67 154.72 43.69 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.332 -1.304 . . . . 0.0 109.547 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 2.4 p -103.03 141.91 35.01 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.476 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 26.8 m-85 -138.08 59.54 1.65 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.247 0.546 . . . . 0.0 109.991 -173.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.507 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.2 mp -54.88 125.46 9.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 123.04 1.4 . . . . 0.0 114.501 -173.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.6 m -132.7 -169.23 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 111.892 -2.413 . . . . 0.0 111.429 -176.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.68 40.85 1.99 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.239 -0.982 . . . . 0.0 114.323 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' C' ' 17' ' ' LEU . . . 70.07 -28.67 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 168.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' C' ' 36' ' ' GLN . 2.7 pt20 -154.48 24.7 0.46 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -173.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -76.2 -68.11 0.62 Allowed 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 112.51 -2.132 . . . . 0.0 111.046 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.459 ' O ' HG12 ' C' ' 39' ' ' VAL . 10.9 m120 -132.29 -87.51 0.45 Allowed 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.646 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 82.41 -37.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 124.746 1.279 . . . . 0.0 111.372 -166.033 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' C' ' 40' ' ' LYS . 0.0 OUTLIER -77.97 -68.17 0.66 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 122.591 1.186 . . . . 0.0 108.653 178.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.29 -28.0 69.42 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 112.616 -2.084 . . . . 0.0 110.819 173.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.646 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.2 t80 -58.32 -49.52 76.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.89 174.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.512 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 14.9 mtpp -62.97 -41.2 99.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.92 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -61.63 -37.29 83.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.035 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -70.35 -43.2 70.68 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.525 ' O ' HG21 ' C' ' 50' ' ' VAL . 18.2 pt -76.87 -12.13 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.281 -0.262 . . . . 0.0 110.948 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.94 -55.51 3.71 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 -42.82 91.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -21.64 65.64 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.241 0.543 . . . . 0.0 111.276 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.525 HG21 ' O ' ' C' ' 46' ' ' ILE . 27.7 m -112.31 -3.69 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.44 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 32.9 t 65.8 22.42 11.47 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.843 0.83 . . . . 0.0 109.049 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 11.5 mm -131.35 111.76 15.36 Favored Pre-proline 0 N--CA 1.437 -1.095 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.799 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.492 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 7.2 Cg_exo -68.29 151.68 76.3 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.496 2.13 . . . . 0.0 111.445 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.496 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 32.0 t -51.99 -32.65 34.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.572 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.535 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 13.5 pt-20 -66.26 -33.06 74.9 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.815 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.535 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 90.6 mttt -106.56 -1.04 23.4 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.371 0.605 . . . . 0.0 110.518 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.512 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 24.0 tt0 -90.21 123.62 34.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.109 -168.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . 0.468 ' O ' HG21 ' C' ' 85' ' ' VAL . 29.1 mtm105 -121.77 115.4 22.6 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.402 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 53.5 mt -87.94 122.68 31.84 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 122.452 0.301 . . . . 0.0 110.968 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' C' ' 64' ' ' ARG . 8.8 mt -114.63 112.07 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 121.494 -0.754 . . . . 0.0 111.39 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.489 ' CG ' HG12 ' C' ' 77' ' ' VAL . 41.0 t80 -116.62 133.12 56.39 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . 0.468 ' HG2' ' CD2' ' C' ' 61' ' ' TYR . 2.3 pt20 39.55 46.14 1.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.142 0.901 . . . . 0.0 112.153 -174.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.71 5.2 63.61 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.864 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -94.85 141.64 28.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.88 98.39 7.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.175 0.512 . . . . 0.0 109.951 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.534 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.0 OUTLIER -90.26 152.09 21.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.228 -176.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . 0.438 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.8 pt20 -158.14 -166.79 2.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.32 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.556 ' HA ' HG11 ' C' ' 39' ' ' VAL . 5.1 p-10 -62.49 0.54 0.46 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.052 0.941 . . . . 0.0 112.592 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' C' ' 67' ' ' GLN . 21.2 t70 -55.59 -11.65 0.96 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.376 1.071 . . . . 0.0 112.957 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.477 ' HA ' ' CG1' ' C' ' 39' ' ' VAL . 7.8 mtmp? 84.55 167.43 0.09 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.481 1.112 . . . . 0.0 113.429 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 68.29 83.79 0.16 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.053 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.469 ' CD2' HG23 ' C' ' 39' ' ' VAL . 13.6 mt -64.47 -32.19 73.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.513 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -68.83 -29.07 67.33 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.641 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.49 -27.73 67.25 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.534 ' CD1' HD22 ' C' ' 66' ' ' LEU . 30.7 m-85 -82.96 -23.11 33.56 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.5 t30 63.44 36.67 11.2 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.707 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.489 HG12 ' CG ' ' C' ' 61' ' ' TYR . 20.0 m -85.25 26.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.622 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -86.09 102.36 2.68 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-O 122.926 1.292 . . . . 0.0 113.441 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.89 13.26 56.83 Favored Glycine 0 C--N 1.285 -2.29 0 CA-C-N 112.266 -1.967 . . . . 0.0 114.022 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -133.58 152.53 51.91 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 18.4 m -79.11 126.07 38.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.904 0.859 . . . . 0.0 112.62 -175.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.481 ' HB ' HG21 ' C' ' 21' ' ' VAL . 46.2 mt -71.21 161.68 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.339 168.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.432 ' N ' HG21 ' C' ' 82' ' ' ILE . 45.5 m80 -116.01 113.0 22.63 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 171.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.449 ' CD1' HG12 ' C' ' 50' ' ' VAL . 1.6 mt -85.84 157.86 20.11 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.504 -176.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.528 HG11 ' CE1' ' A' ' 14' ' ' HIS . 2.7 t . . . . . 0 C--N 1.32 -0.717 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.447 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 10.9 ptt180 . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.852 0.834 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.518 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 8.6 m-85 -122.43 174.05 7.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.701 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CB ' HD12 ' A' ' 40' ' ' LEU . 79.1 t80 -142.05 121.27 13.04 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.119 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.581 ' HB2' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -100.98 120.29 39.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.812 176.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.508 ' CD2' HG21 ' C' ' 85' ' ' VAL . 62.6 m-70 -74.43 -16.24 60.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.565 -175.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.97 -35.8 72.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.411 ' O ' HG22 ' A' ' 18' ' ' VAL . 88.0 m -91.71 -23.84 19.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.313 0.578 . . . . 0.0 110.319 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER 56.23 31.42 18.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.421 -173.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 16' ' ' CYS . 39.7 t -136.82 148.31 26.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.763 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 32.3 tt0 -67.19 147.34 53.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.895 0.379 . . . . 0.0 111.326 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.579 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 4.2 pt -139.89 168.73 17.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.564 -175.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 94.0 t -126.4 101.29 28.04 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 162.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 6.0 Cg_endo -56.39 174.77 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 125.273 3.982 . . . . 0.0 116.736 -171.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.513 ' CB ' HD12 ' A' ' 28' ' ' ILE . 8.6 mtt180 -107.25 47.2 0.89 Allowed 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.875 175.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 1.6 -61.73 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.941 0 CA-C-N 110.783 -2.917 . . . . 0.0 116.912 175.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.462 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 39.2 Cg_exo -30.24 -34.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 124.017 3.145 . . . . 0.0 114.904 175.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.531 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.86 -19.65 9.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.411 ' C ' HD13 ' A' ' 37' ' ' ILE . 54.7 m-85 68.79 47.62 0.81 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.41 -171.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -101.24 161.47 3.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.237 176.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.9 OUTLIER -97.35 145.54 29.83 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.579 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 83.2 Cg_endo -84.26 -15.61 6.44 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 C-N-CA 122.415 2.077 . . . . 0.0 108.864 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.54 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 60.1 mtt-85 -85.12 -21.37 29.3 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.354 -1.748 . . . . 0.0 114.074 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.2 p -149.03 -7.25 0.37 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 58.22 30.81 19.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.803 0.811 . . . . 0.0 111.207 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.7 m -112.47 139.22 48.23 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.583 172.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.38 53.72 4.69 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.419 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 84.5 m-85 -112.18 46.67 1.13 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.413 0.625 . . . . 0.0 110.011 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' A' ' 13' ' ' CYS . 3.4 pt -112.15 138.54 40.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.41 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HB3' HD11 ' C' ' 60' ' ' ILE . 11.2 pt-20 -117.18 141.92 47.68 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -73.6 142.74 46.55 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.452 HD12 ' CB ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.161 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.412 ' SD ' HD22 ' C' ' 17' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' C' ' 35' ' ' ALA . 0.8 OUTLIER -102.86 131.03 50.05 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 111.456 -172.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.507 ' HA ' HG13 ' C' ' 32' ' ' ILE . 41.9 tt0 -88.01 94.43 9.79 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.61 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 5.6 t -80.75 104.87 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.513 -173.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.69 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 1.0 OUTLIER -94.13 141.87 28.05 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 174.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.514 HG21 ' HB ' ' C' ' 82' ' ' ILE . 78.9 t -150.36 121.32 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.328 0.513 . . . . 0.0 110.585 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 26.2 mtpt -108.36 164.37 12.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.494 0.664 . . . . 0.0 110.669 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 48.7 p . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.663 167.631 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 61.2 m . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -118.95 159.69 23.36 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.869 -1.132 . . . . 0.0 112.215 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 1.4 p -100.66 139.65 36.04 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.947 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.61 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 23.3 m-85 -133.83 55.86 1.88 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.231 -171.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.507 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -54.55 123.11 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 123.38 1.562 . . . . 0.0 113.979 -174.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.436 HG11 ' HD2' ' C' ' 42' ' ' PHE . 11.2 m -126.87 -175.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 110.961 -2.836 . . . . 0.0 111.196 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.65 52.72 0.8 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.512 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.575 ' HA ' HD12 ' C' ' 17' ' ' LEU . . . 71.01 -29.29 0.19 Allowed 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 167.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -162.19 23.83 0.11 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -172.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' MET . . . . . 0.52 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 16.0 tpt -72.2 -69.24 0.41 Allowed 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 111.754 -2.476 . . . . 0.0 111.435 -171.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.52 ' OD1' ' HG3' ' C' ' 37' ' ' MET . 24.8 m120 -129.18 -82.86 0.57 Allowed 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.09 0.472 . . . . 0.0 111.229 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.69 ' O ' ' HD2' ' C' ' 43' ' ' LYS . 0.4 OUTLIER 74.36 -31.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.744 -165.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' C' ' 43' ' ' LYS . 0.1 OUTLIER -84.15 -67.94 0.75 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.489 1.138 . . . . 0.0 109.661 178.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.17 -25.7 61.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.235 170.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.652 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 1.2 t80 -60.74 -48.63 80.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.425 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.69 ' HD2' ' O ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -53.15 -48.92 67.55 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.862 0.839 . . . . 0.0 109.037 173.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -35.47 74.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.887 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -69.16 -50.95 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.098 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.607 ' O ' HG23 ' C' ' 50' ' ' VAL . 25.5 pt -78.88 -12.44 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.85 -59.3 1.46 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.14 75.34 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.269 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -34.51 72.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.887 0.375 . . . . 0.0 111.113 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.607 HG23 ' O ' ' C' ' 46' ' ' ILE . 27.8 m -100.39 -3.01 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.228 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 26.4 t 69.16 19.75 7.83 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 121.752 0.787 . . . . 0.0 109.287 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.3 mm -128.36 117.67 20.17 Favored Pre-proline 0 N--CA 1.442 -0.836 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.627 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.436 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.0 Cg_exo -65.52 149.37 87.75 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.924 1.749 . . . . 0.0 113.149 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.464 ' CB ' ' HB3' ' C' ' 43' ' ' LYS . 2.2 p -53.37 -29.94 37.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.463 -1.698 . . . . 0.0 113.375 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.499 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.8 pt-20 -82.07 -7.47 59.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.65 -176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.499 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 96.0 mttt -125.13 -31.31 3.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.567 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.604 ' OE1' ' HG3' ' C' ' 43' ' ' LYS . 3.3 pt20 -62.6 136.92 58.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.304 0.573 . . . . 0.0 111.185 -174.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -121.49 129.93 53.24 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.798 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.527 ' CD1' ' HZ1' ' C' ' 43' ' ' LYS . 4.2 mp -91.18 134.57 34.43 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 37' ' ' ILE . 6.3 mt -126.76 115.06 40.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.334 0.588 . . . . 0.0 112.001 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -124.11 116.59 23.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.518 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 61.02 34.87 19.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.494 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.16 -7.39 60.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.483 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -85.39 127.62 34.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -86.11 91.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.084 0.469 . . . . 0.0 110.227 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.668 HD22 ' CD1' ' C' ' 75' ' ' TYR . 1.6 mt -73.24 136.54 44.65 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . 0.452 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 8.5 pt20 -149.89 -168.31 3.07 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.275 -171.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.517 ' HA ' HG12 ' C' ' 39' ' ' VAL . 6.8 p-10 -66.42 -0.43 2.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.064 0.946 . . . . 0.0 112.629 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . 0.452 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 9.2 t70 -69.07 2.46 2.74 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.734 0.813 . . . . 0.0 112.62 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.402 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.8 mtpt 72.74 -177.37 0.19 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.155 175.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 70.58 66.84 0.19 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.979 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.51 ' HA ' ' CD2' ' C' ' 75' ' ' TYR . 6.6 mt -64.12 -41.84 97.08 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.549 -175.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . 0.456 ' HB3' ' HB2' ' C' ' 35' ' ' ALA . 3.7 pt20 -71.13 -18.27 62.53 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -70.07 -27.69 64.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.668 ' CD1' HD22 ' C' ' 66' ' ' LEU . 22.5 m-85 -74.17 -24.22 59.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 t30 64.09 36.49 9.7 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 123.392 1.568 . . . . 0.0 107.403 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.44 ' CG1' HG22 ' C' ' 19' ' ' VAL . 0.5 OUTLIER -96.41 0.79 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.059 -161.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.563 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -70.41 102.27 1.0 Allowed Glycine 0 N--CA 1.432 -1.591 0 CA-C-O 122.723 1.18 . . . . 0.0 112.824 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.68 13.84 26.83 Favored Glycine 0 C--N 1.283 -2.413 0 CA-C-N 112.24 -1.98 . . . . 0.0 114.325 173.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -124.78 154.36 41.06 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.69 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 2.8 m -85.28 131.02 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.093 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.514 ' HB ' HG21 ' C' ' 21' ' ' VAL . 56.5 mt -83.96 160.56 3.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.246 172.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.437 ' N ' HG23 ' C' ' 82' ' ' ILE . 67.4 m170 -109.22 112.49 24.68 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 166.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.15 153.66 19.4 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.426 -0.91 . . . . 0.0 108.618 172.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 14' ' ' HIS . 17.3 m . . . . . 0 C--N 1.308 -1.221 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.208 -174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.462 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 94.5 mtt180 . . . . . 0 C--O 1.224 -0.264 0 CA-C-O 120.688 0.28 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.663 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 14.2 m-85 -115.15 149.45 37.61 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.952 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CB ' HD22 ' A' ' 40' ' ' LEU . 71.7 t80 -124.73 120.01 30.57 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.72 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -96.22 121.09 37.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -73.22 -20.22 60.92 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.388 -173.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -71.15 -30.86 66.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.851 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.422 ' O ' HG22 ' A' ' 18' ' ' VAL . 53.4 m -90.94 -18.42 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.475 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.8 p 51.49 30.28 6.18 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.888 0.742 . . . . 0.0 110.843 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 16' ' ' CYS . 73.9 t -144.73 145.71 20.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HG2' ' N ' ' A' ' 20' ' ' ILE . 26.3 tt0 -74.96 151.98 38.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.109 0.481 . . . . 0.0 111.779 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.558 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.7 pt -138.24 168.51 19.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.958 -171.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.46 109.98 36.12 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 159.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.663 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 18.1 Cg_endo -69.94 174.92 8.96 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 124.45 3.433 . . . . 0.0 115.736 -166.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.49 ' CB ' HD11 ' A' ' 28' ' ' ILE . 75.9 mtt180 -106.64 47.69 0.87 Allowed 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.856 -1.975 . . . . 0.0 106.768 174.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -8.34 -55.9 0.01 OUTLIER Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 110.673 -2.967 . . . . 0.0 116.517 174.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.444 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 45.8 Cg_exo -34.13 -35.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 123.255 2.637 . . . . 0.0 114.34 175.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.522 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.19 -19.34 10.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.319 0.58 . . . . 0.0 111.839 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.417 ' C ' HD13 ' A' ' 37' ' ' ILE . 86.8 m-85 68.41 55.3 0.51 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.991 -169.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.522 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -109.63 163.1 6.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.561 175.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -95.19 146.32 31.12 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.558 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 52.8 Cg_endo -82.82 -21.88 4.65 Favored 'Trans proline' 0 CA--C 1.504 -0.993 0 C-N-CA 123.202 2.601 . . . . 0.0 108.47 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.584 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.4 mtt-85 -79.29 -29.06 42.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.835 -1.984 . . . . 0.0 113.377 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.0 p -147.9 -3.84 0.51 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.69 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 14.7 tt0 60.15 40.51 18.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.067 0.461 . . . . 0.0 111.832 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.4 p -112.59 155.82 23.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.87 44.13 2.09 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.798 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 86.6 m-85 -109.13 47.5 0.92 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.293 0.568 . . . . 0.0 110.158 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.588 ' O ' HG22 ' C' ' 60' ' ' ILE . 5.7 pt -111.86 147.43 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.272 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.489 ' HB2' HG23 ' C' ' 65' ' ' VAL . 12.6 pt-20 -135.57 147.17 48.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.594 0.235 . . . . 0.0 110.804 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.26 144.81 55.72 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.534 HD22 ' CB ' ' A' ' 12' ' ' PHE . 13.5 mt . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.028 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.457 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 50.2 ttm . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.628 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 0.9 OUTLIER -101.45 132.12 47.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.491 ' HA ' HG13 ' C' ' 32' ' ' ILE . 30.6 mt-10 -83.87 94.72 8.28 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.534 HG13 ' CZ ' ' C' ' 42' ' ' PHE . 5.4 t -79.23 92.65 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.098 -172.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 1.5 mp -85.24 133.16 34.18 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.509 HG22 ' HB ' ' C' ' 82' ' ' ILE . 71.1 t -141.58 116.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 40.7 mtpt -88.29 153.58 21.09 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 C--N 1.309 -1.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.397 -178.292 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 39.1 m . . . . . 0 C--O 1.233 0.185 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -118.48 149.55 41.09 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.376 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -106.52 141.94 36.99 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.178 0.513 . . . . 0.0 111.777 -174.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.463 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 35.9 m-85 -130.9 60.18 1.66 Allowed 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.722 -174.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.491 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -56.58 121.32 4.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 123.338 1.542 . . . . 0.0 114.48 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.87 -166.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 111.038 -2.801 . . . . 0.0 111.57 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -95.62 -170.82 35.89 Favored Glycine 0 C--N 1.312 -0.758 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.396 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.865 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . -103.9 83.24 2.09 Favored 'General case' 0 CA--C 1.477 -1.855 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.865 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 23.7 mt-30 108.6 15.88 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 O-C-N 126.599 2.437 . . . . 0.0 107.795 170.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -76.79 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.063 -2.335 . . . . 0.0 111.528 171.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.469 ' CG ' ' HB2' ' C' ' 41' ' ' GLU . 13.0 m120 -123.55 -98.5 0.43 Allowed 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.587 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 84.22 -35.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 123.931 0.892 . . . . 0.0 110.648 -162.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.518 ' HA ' ' CB ' ' C' ' 68' ' ' ASP . 0.0 OUTLIER -81.43 -69.53 0.6 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.3 1.048 . . . . 0.0 108.959 177.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . 0.469 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 43.3 mt-10 -61.12 -28.95 69.47 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.012 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.587 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.1 t80 -61.1 -51.61 68.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.406 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 52.3 mtpt -58.5 -45.53 88.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.445 0.641 . . . . 0.0 110.358 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -59.79 -34.83 73.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.207 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -70.12 -47.76 60.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.789 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.566 ' O ' HG23 ' C' ' 50' ' ' VAL . 24.2 pt -75.04 -16.96 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.971 -0.104 . . . . 0.0 111.133 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.66 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -39.92 -61.0 0.91 Allowed 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -176.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.4 77.48 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.371 -0.532 . . . . 0.0 112.376 -173.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -26.73 68.46 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.181 0.515 . . . . 0.0 110.832 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.566 HG23 ' O ' ' C' ' 46' ' ' ILE . 22.2 m -104.66 -0.77 10.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.849 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 55.1 p 66.16 20.27 11.14 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.766 0.826 . . . . 0.0 109.842 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.66 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.7 mm -128.82 112.59 18.88 Favored Pre-proline 0 N--CA 1.437 -1.123 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.073 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.462 ' HA ' ' HB3' ' C' ' 47' ' ' ALA . 3.9 Cg_exo -69.29 146.78 64.22 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.471 2.114 . . . . 0.0 111.284 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.431 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 44.2 t -51.95 -25.97 9.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.347 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.402 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.5 pt-20 -79.51 -24.52 42.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.706 0.288 . . . . 0.0 111.342 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.402 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 48.2 mtpt -106.79 -16.27 14.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.854 0.359 . . . . 0.0 110.363 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.51 ' OE1' HD13 ' C' ' 46' ' ' ILE . 0.0 OUTLIER -87.25 148.86 24.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.726 -174.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -139.03 132.25 29.84 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.587 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 52.7 mt -90.67 109.68 20.85 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 37' ' ' ILE . 10.3 mt -106.39 113.73 43.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.263 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.577 ' OH ' ' HD3' ' C' ' 80' ' ' LYS . 50.3 t80 -118.03 127.82 54.17 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . 0.452 ' HG2' ' CD2' ' C' ' 61' ' ' TYR . 3.5 pt20 40.98 46.77 2.5 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.028 0.931 . . . . 0.0 112.244 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.28 5.87 78.26 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.686 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -99.4 134.88 41.62 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 38' ' ' GLU . 2.1 t -88.96 90.07 3.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.078 0.466 . . . . 0.0 109.746 -177.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.57 HD21 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -73.91 132.14 42.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -144.83 173.01 12.23 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.201 -171.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.518 ' HA ' HG11 ' C' ' 39' ' ' VAL . 5.9 p-10 -70.73 -2.86 16.01 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.896 0.879 . . . . 0.0 113.06 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.25 -15.63 49.53 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.179 -0.326 . . . . 0.0 111.609 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.488 ' HB3' ' OE1' ' C' ' 74' ' ' GLU . 4.0 mtpm? -122.44 -151.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.52 -169.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.482 ' HB2' ' HG3' ' C' ' 74' ' ' GLU . 97.7 mttt -125.25 151.14 46.33 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.838 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . . . . . . . . . 35.5 mt -57.32 -53.11 61.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . 0.549 ' CB ' ' HG3' ' C' ' 36' ' ' GLN . 53.2 tt0 -71.54 -14.4 62.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.565 -170.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . 0.488 ' OE1' ' HB3' ' C' ' 70' ' ' LYS . 46.2 mt-10 -63.09 -29.24 70.65 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.57 ' CD1' HD21 ' C' ' 66' ' ' LEU . 60.5 m-85 -93.91 -21.24 19.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.2 t30 52.87 52.16 14.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.588 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.413 HG21 HD11 ' C' ' 82' ' ' ILE . 29.9 m -93.27 19.85 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.307 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.628 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -75.18 102.39 1.45 Allowed Glycine 0 CA--C 1.482 -2.01 0 CA-C-O 122.483 1.046 . . . . 0.0 111.713 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.12 14.97 46.65 Favored Glycine 0 C--N 1.281 -2.481 0 CA-C-N 112.562 -1.819 . . . . 0.0 112.107 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . 0.577 ' HD3' ' OH ' ' C' ' 61' ' ' TYR . 81.2 mttt -123.46 142.33 51.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 16.3 m -82.35 133.91 28.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.907 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.509 ' HB ' HG22 ' C' ' 21' ' ' VAL . 29.1 mt -92.56 170.19 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.265 175.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.474 ' N ' HG22 ' C' ' 82' ' ' ILE . 70.5 m80 -118.56 114.49 22.88 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.79 141.45 28.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.383 0.611 . . . . 0.0 111.743 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.671 -178.191 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 10' ' ' ARG . 10.6 ptt180 . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 121.471 0.653 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.678 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 14.3 m-85 -120.17 167.24 12.44 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.449 ' CB ' HD12 ' A' ' 40' ' ' LEU . 65.7 t80 -140.35 114.56 9.15 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.446 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.531 ' HB2' HG23 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -95.44 114.97 26.79 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.567 174.27 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -69.9 -18.09 63.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.118 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.511 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 43.9 t -68.66 -35.44 77.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.081 0.467 . . . . 0.0 110.708 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.434 ' O ' HG22 ' A' ' 18' ' ' VAL . 92.6 m -95.16 -15.26 23.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.817 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 16' ' ' CYS . 32.5 p 51.57 29.87 5.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.237 1.015 . . . . 0.0 111.582 -173.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 16' ' ' CYS . 97.2 t -139.39 147.25 24.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.761 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.651 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 31.4 tt0 -67.48 149.15 50.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.17 0.509 . . . . 0.0 111.092 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.651 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.5 pt -138.68 167.36 21.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.856 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.481 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 19.4 t -122.64 96.23 45.79 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 164.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.678 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 9.5 Cg_endo -58.36 176.48 0.39 Allowed 'Trans proline' 0 C--N 1.325 -0.697 1 C-N-CA 125.349 4.033 . . . . 0.0 117.776 -167.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' C ' ' HD2' ' A' ' 25' ' ' PRO . 40.2 mtt180 -112.25 51.42 0.81 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.764 -2.471 . . . . 0.0 106.848 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -7.32 -53.73 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.911 0 CA-C-N 111.705 -2.498 . . . . 0.0 115.965 172.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.532 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 24.1 Cg_exo -31.17 -39.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.398 2.732 . . . . 0.0 114.204 174.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.536 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -120.03 -16.64 8.57 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.296 0.57 . . . . 0.0 111.342 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 66.3 m-85 70.87 52.26 0.29 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.018 -1.447 . . . . 0.0 109.728 -169.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.536 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -106.38 162.26 5.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.165 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -98.23 149.2 35.49 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.237 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.651 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 62.2 Cg_endo -83.88 -18.73 5.28 Favored 'Trans proline' 0 CA--C 1.501 -1.135 0 C-N-CA 123.117 2.545 . . . . 0.0 108.59 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.506 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 56.0 mtt180 -88.58 -11.89 44.25 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.07 -1.877 . . . . 0.0 114.192 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 p -156.77 -11.43 0.09 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 61.16 29.48 18.83 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.558 0.694 . . . . 0.0 111.171 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.5 m -107.18 142.94 36.1 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -79.55 38.07 2.08 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.507 -175.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 50.9 m-85 -93.49 39.93 1.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.744 0.307 . . . . 0.0 111.054 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.634 HG22 ' CD1' ' A' ' 20' ' ' ILE . 6.1 pt -109.87 141.51 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.505 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.2 pt-20 -117.37 144.16 45.23 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 169.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -79.72 129.5 34.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.909 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 47.0 tpp . . . . . 0 C--O 1.234 0.281 0 CA-C-O 120.975 0.417 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.745 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -91.69 146.55 23.68 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.501 ' HA ' HG13 ' C' ' 32' ' ' ILE . 15.1 mt-10 -95.04 91.48 6.37 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 169.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.584 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 4.9 t -78.38 105.21 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.2 -170.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.5 OUTLIER -96.25 142.58 28.23 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 175.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.517 HG23 ' HB ' ' C' ' 82' ' ' ILE . 54.7 t -148.05 124.53 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.899 0.381 . . . . 0.0 110.628 -173.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.507 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 43.0 mtpt -105.06 141.3 36.87 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.547 176.34 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.443 ' OG1' ' HE3' ' C' ' 22' ' ' LYS . 51.0 m . . . . . 0 C--O 1.236 0.344 0 CA-C-O 120.601 0.239 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -127.36 155.83 42.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.814 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.526 HG22 ' CD2' ' C' ' 20' ' ' LEU . 11.8 p -95.49 142.01 28.35 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 121.382 0.611 . . . . 0.0 112.223 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.584 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 25.6 m-85 -132.72 56.17 1.86 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.224 -174.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -56.87 121.17 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 123.353 1.549 . . . . 0.0 114.412 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.7 m -140.43 -163.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 110.777 -2.919 . . . . 0.0 111.307 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.51 165.48 19.24 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.154 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.745 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -68.43 -16.2 63.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.637 0.732 . . . . 0.0 112.16 -175.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -158.8 25.33 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -167.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 51.0 ttm -79.47 -72.64 0.38 Allowed 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 111.699 -2.501 . . . . 0.0 110.928 -176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.535 ' O ' HG12 ' C' ' 39' ' ' VAL . 12.3 m120 -125.51 -99.51 0.4 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.649 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 83.88 -29.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 C-N-CA 125.161 1.385 . . . . 0.0 111.502 -162.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.74 -68.13 0.74 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.346 1.07 . . . . 0.0 109.122 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.55 -30.34 69.71 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.949 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.649 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 7.0 t80 -58.34 -51.08 71.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.848 174.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.625 ' HB3' ' OE1' ' C' ' 57' ' ' GLN . 47.8 mtpt -61.24 -47.01 88.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.109 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -56.53 -36.8 69.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.892 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -70.6 -43.79 68.62 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.636 ' O ' HG22 ' C' ' 50' ' ' VAL . 22.1 pt -77.77 -8.51 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -175.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.66 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.03 -56.83 1.77 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.74 -36.79 50.37 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.272 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -33.06 71.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.018 0.437 . . . . 0.0 110.9 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.636 HG22 ' O ' ' C' ' 46' ' ' ILE . 34.5 m -105.38 -2.63 9.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.885 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 59.6 p 64.78 21.23 12.33 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 122.003 0.906 . . . . 0.0 109.298 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.752 HG23 ' CG ' ' C' ' 57' ' ' GLN . 7.2 mm -122.63 117.21 28.98 Favored Pre-proline 0 N--CA 1.439 -0.976 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.302 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.577 ' O ' ' HG3' ' C' ' 57' ' ' GLN . 4.6 Cg_exo -71.76 150.16 55.62 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.961 1.774 . . . . 0.0 112.226 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.639 ' HA ' ' OE1' ' C' ' 57' ' ' GLN . 0.9 OUTLIER -52.12 -25.17 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.096 -176.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.436 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.4 pt-20 -74.67 -26.91 60.17 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.207 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.436 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 47.9 mttm -105.66 -25.01 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.688 0.28 . . . . 0.0 111.526 -173.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.752 ' CG ' HG23 ' C' ' 52' ' ' ILE . 88.9 mt-30 -56.55 126.17 25.39 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.895 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -122.95 110.14 15.01 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 1.1 mm? -87.11 112.48 21.96 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 37' ' ' ILE . 6.7 mt -110.33 120.61 61.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 121.809 -0.557 . . . . 0.0 111.024 175.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -128.75 134.61 48.48 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 41.97 42.38 2.29 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.987 0.804 . . . . 0.0 111.732 -173.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.98 4.02 61.62 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.593 -0.731 . . . . 0.0 113.608 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -96.15 130.82 43.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.3 99.22 9.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.297 0.57 . . . . 0.0 110.451 -175.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -86.16 154.66 21.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.054 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -165.91 -169.77 1.59 Allowed 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.958 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.549 ' HA ' HG11 ' C' ' 39' ' ' VAL . 5.1 p-10 -64.94 -1.4 2.0 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.902 0.881 . . . . 0.0 113.123 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.97 -7.2 3.52 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.449 ' HA ' HG12 ' C' ' 39' ' ' VAL . 47.8 mttp 88.22 170.57 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.48 1.112 . . . . 0.0 111.827 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.49 ' HB3' ' HG2' ' C' ' 74' ' ' GLU . 13.5 mmmm 71.45 79.52 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.617 177.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.526 ' HA ' ' CD2' ' C' ' 75' ' ' TYR . 37.2 mt -68.82 -29.22 67.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.849 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -68.52 -27.17 65.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.401 . . . . 0.0 111.364 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' C' ' 71' ' ' LYS . 58.8 mm-40 -63.48 -27.12 69.06 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.526 ' CD2' ' HA ' ' C' ' 72' ' ' LEU . 7.8 m-85 -90.17 -23.07 21.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 55.31 46.79 22.82 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.198 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.434 HG11 HD11 ' C' ' 82' ' ' ILE . 33.1 m -93.66 4.36 7.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 119.957 -0.697 . . . . 0.0 112.862 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -56.22 100.37 0.1 Allowed Glycine 0 CA--C 1.491 -1.435 0 CA-C-O 122.918 1.288 . . . . 0.0 113.68 171.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.47 14.8 49.42 Favored Glycine 0 C--N 1.289 -2.076 0 CA-C-N 111.367 -2.417 . . . . 0.0 113.534 173.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -124.37 139.91 53.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.545 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 22.2 m -80.08 126.48 39.39 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.748 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.517 ' HB ' HG23 ' C' ' 21' ' ' VAL . 60.9 mt -83.11 167.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.452 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.492 ' N ' HG23 ' C' ' 82' ' ' ILE . 42.9 m80 -114.42 114.63 26.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 171.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.419 HD12 ' H ' ' C' ' 85' ' ' VAL . 15.8 tp -97.23 133.01 42.43 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.203 0.525 . . . . 0.0 110.135 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.419 ' H ' HD12 ' C' ' 84' ' ' LEU . 25.2 m . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.367 -177.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 121.19 0.519 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.728 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.9 m-85 -124.93 151.96 44.73 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 172.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -124.04 118.29 26.64 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.262 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.493 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -96.37 117.67 31.32 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.048 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.727 ' CG ' HG12 ' C' ' 85' ' ' VAL . 12.6 p80 -75.07 -10.68 59.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.89 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.435 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 49.7 t -71.97 -37.52 69.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.159 0.505 . . . . 0.0 109.727 175.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.3 m -91.0 -27.94 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.182 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.86 32.05 21.39 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.267 -171.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.56 144.45 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -71.83 146.5 47.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.234 0.54 . . . . 0.0 111.093 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.598 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 4.5 pt -134.04 166.71 28.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.266 -171.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -118.44 110.22 39.4 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 158.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.728 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 12.1 Cg_endo -69.28 176.16 6.77 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.441 3.427 . . . . 0.0 114.777 -170.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.646 ' HB2' HG13 ' A' ' 28' ' ' ILE . 40.7 mtt180 -107.02 47.77 0.87 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 113.532 -1.667 . . . . 0.0 106.707 175.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.589 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 1.6 mm? 0.82 -62.62 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.147 0 CA-C-N 111.032 -2.804 . . . . 0.0 117.107 174.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -35.21 -35.04 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.949 2.433 . . . . 0.0 113.611 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.551 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -112.76 -22.84 10.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.631 -177.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.473 ' C ' HD13 ' A' ' 37' ' ' ILE . 22.5 m-85 68.48 45.25 1.16 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.026 0.917 . . . . 0.0 110.528 -170.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.646 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -97.53 162.01 2.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.517 172.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.4 t -97.08 146.07 30.69 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.598 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 66.9 Cg_endo -79.84 -23.15 7.04 Favored 'Trans proline' 0 CA--C 1.498 -1.315 0 C-N-CA 122.582 2.188 . . . . 0.0 107.785 -174.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.587 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 91.2 mtt-85 -79.21 -35.34 41.84 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 112.683 -2.053 . . . . 0.0 113.556 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.2 p -135.76 -7.74 2.15 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.582 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 11.3 tt0 56.95 31.08 19.17 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.507 0.67 . . . . 0.0 111.511 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.3 m -110.72 145.97 37.11 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.321 170.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.6 52.99 4.81 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.372 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 72.2 m-85 -109.0 43.86 1.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.551 -0.382 . . . . 0.0 110.684 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.557 ' O ' HG21 ' C' ' 60' ' ' ILE . 11.7 pt -114.31 139.96 37.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.255 -175.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.06 155.52 30.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.36 127.84 39.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.381 0.61 . . . . 0.0 110.747 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.007 -170.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 73.7 mtm . . . . . 0 N--CA 1.463 0.225 0 CA-C-O 121.15 0.5 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.792 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -98.58 149.05 23.17 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 172.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.501 ' HA ' HG13 ' C' ' 32' ' ' ILE . 34.2 tt0 -102.17 87.92 3.19 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' C' ' 30' ' ' THR . 2.4 t -77.41 127.05 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.025 -167.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.624 ' CB ' HG11 ' C' ' 81' ' ' VAL . 1.0 OUTLIER -113.05 147.91 36.25 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 170.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.535 HG21 ' HB ' ' C' ' 82' ' ' ILE . 66.0 t -153.83 114.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -171.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 38.7 mtpt -99.96 172.1 7.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.371 0.605 . . . . 0.0 110.28 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.814 172.25 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 53.8 m . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -120.49 158.58 26.96 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.15 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 4.2 p -104.26 147.67 27.22 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.517 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 42.1 m-85 -140.96 63.82 1.44 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.487 0.66 . . . . 0.0 110.314 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.4 mp -54.88 125.4 9.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 123.215 1.483 . . . . 0.0 114.458 -174.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.4 m -131.81 -170.47 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 111.507 -2.588 . . . . 0.0 111.927 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -113.17 40.27 2.57 Favored Glycine 0 C--N 1.317 -0.498 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.706 -175.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.792 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . 68.9 -50.43 0.59 Allowed 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 124.224 1.01 . . . . 0.0 113.529 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -130.72 23.44 5.03 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 2.1 ttt -66.16 -72.27 0.17 Allowed 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.93 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.599 ' O ' ' HD2' ' C' ' 40' ' ' LYS . 17.9 m120 -129.04 -91.1 0.48 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.598 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.5 OUTLIER 85.19 -40.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 O-C-N 124.5 1.125 . . . . 0.0 110.814 -164.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.599 ' HD2' ' O ' ' C' ' 38' ' ' ASN . 0.0 OUTLIER -74.14 -69.48 0.44 Allowed 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 122.449 1.118 . . . . 0.0 108.594 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.08 -26.52 68.59 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.186 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.598 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 5.8 t80 -59.2 -52.65 64.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.753 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.521 ' HD3' ' HB3' ' C' ' 68' ' ' ASP . 7.1 ptmm? -68.58 -38.73 80.94 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.355 0.598 . . . . 0.0 110.974 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' C' ' 54' ' ' SER . 1.3 tm-20 -54.56 -41.52 69.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.138 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -69.67 -51.57 33.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.53 ' O ' HG21 ' C' ' 50' ' ' VAL . 22.5 pt -70.69 -10.01 13.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.341 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.61 -36.63 0.61 Allowed 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.45 -50.57 11.43 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.944 -0.473 . . . . 0.0 111.938 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -28.41 69.47 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.23 0.538 . . . . 0.0 110.79 -176.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.53 HG21 ' O ' ' C' ' 46' ' ' ILE . 6.7 m -96.34 -11.46 8.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.542 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 18.6 m 68.36 19.79 8.82 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 121.55 0.69 . . . . 0.0 109.91 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 3.6 mm -129.35 118.21 19.07 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.856 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -67.29 148.5 80.2 Favored 'Trans proline' 0 CA--C 1.514 -0.475 0 C-N-CA 122.27 1.98 . . . . 0.0 111.147 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.446 ' OG ' ' HG3' ' C' ' 43' ' ' LYS . 41.8 t -51.19 -33.26 26.66 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.155 0.285 . . . . 0.0 111.748 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 8.5 pt-20 -66.42 -30.19 70.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.782 0.325 . . . . 0.0 111.441 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.448 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 55.7 mtpt -101.11 -23.79 14.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.071 0.462 . . . . 0.0 110.281 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.455 ' HA ' HG21 ' C' ' 52' ' ' ILE . 7.1 tt0 -76.19 119.44 20.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.058 -172.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -113.91 123.08 48.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.277 170.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.647 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 19.4 mt -89.79 113.87 25.49 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.557 HG21 ' O ' ' A' ' 37' ' ' ILE . 9.2 mt -108.36 126.44 65.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 121.289 -0.882 . . . . 0.0 111.424 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.498 ' CZ ' ' HB3' ' C' ' 80' ' ' LYS . 31.0 t80 -139.12 127.26 22.52 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 169.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 60.67 35.84 19.7 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.547 0.529 . . . . 0.0 110.549 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 71.33 2.28 47.77 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.596 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -89.0 137.86 31.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.87 88.92 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -76.46 128.11 34.16 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -147.33 177.01 9.56 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.905 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.579 ' CB ' ' HA ' ' C' ' 40' ' ' LYS . 4.0 p-10 -65.69 -1.85 3.11 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.105 0.962 . . . . 0.0 113.469 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -81.48 -13.37 58.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -131.32 -154.44 0.63 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.912 -0.493 . . . . 0.0 112.053 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.82 -179.67 3.93 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.701 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 2.9 mt -86.27 -34.09 20.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.025 0.44 . . . . 0.0 110.809 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.92 -23.72 66.01 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.403 0.681 . . . . 0.0 111.183 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -59.39 -28.81 67.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.655 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.627 ' CD1' HD23 ' C' ' 66' ' ' LEU . 34.0 m-85 -105.16 -16.05 14.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.114 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 55.83 52.49 10.68 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.996 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.408 HG12 HD13 ' C' ' 82' ' ' ILE . 28.2 m -93.08 16.6 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.559 -174.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.62 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -64.41 101.47 0.51 Allowed Glycine 0 CA--C 1.481 -2.033 0 CA-C-O 122.774 1.208 . . . . 0.0 112.785 172.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.34 15.13 56.19 Favored Glycine 0 C--N 1.283 -2.378 0 CA-C-N 111.868 -2.166 . . . . 0.0 112.599 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . 0.498 ' HB3' ' CZ ' ' C' ' 61' ' ' TYR . 73.1 mmtt -116.37 145.32 43.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 118.85 -0.595 . . . . 0.0 109.638 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.624 HG11 ' CB ' ' C' ' 20' ' ' LEU . 3.1 m -86.7 130.17 37.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.379 173.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.535 ' HB ' HG21 ' C' ' 21' ' ' VAL . 56.3 mt -88.48 169.17 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.869 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.481 ' N ' HG23 ' C' ' 82' ' ' ILE . 58.4 m80 -112.45 121.94 46.27 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.414 ' HG ' ' CG1' ' C' ' 21' ' ' VAL . 20.6 mt -78.32 152.71 32.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.971 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.727 HG12 ' CG ' ' A' ' 14' ' ' HIS . 5.7 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.773 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.296 0 CA-C-O 121.897 0.856 . . . . 0.0 110.637 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.59 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 5.5 m-85 -118.45 169.8 9.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.264 175.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.508 ' CB ' HD12 ' A' ' 40' ' ' LEU . 61.9 t80 -138.43 116.11 11.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.595 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -96.36 114.61 26.31 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.808 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.551 ' CD2' HG11 ' C' ' 85' ' ' VAL . 8.9 p80 -73.16 -8.69 56.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.702 0.286 . . . . 0.0 111.406 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.613 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 42.6 t -72.6 -32.7 66.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.359 0.6 . . . . 0.0 110.182 173.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.5 m -99.46 -25.9 14.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.391 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER 58.21 31.04 20.3 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.384 -171.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.65 144.75 34.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.5 tt0 -64.28 148.34 50.43 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.158 0.286 . . . . 0.0 110.745 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.655 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.2 pt -140.42 166.98 18.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.51 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.52 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 74.9 t -125.6 97.32 36.61 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 164.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 6.5 Cg_endo -55.94 174.91 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 125.06 3.84 . . . . 0.0 115.798 -171.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.454 ' HB2' HG13 ' A' ' 28' ' ' ILE . 5.3 mtt180 -108.62 49.85 0.8 Allowed 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.156 -1.838 . . . . 0.0 106.937 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.3 mm? 3.92 -61.98 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 110.952 -2.84 . . . . 0.0 117.049 171.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 15.8 Cg_exo -36.96 -33.44 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.69 2.26 . . . . 0.0 113.908 176.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.506 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.93 -22.38 9.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.326 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.494 ' C ' HD12 ' A' ' 37' ' ' ILE . 70.6 m-85 65.28 54.13 1.22 Allowed 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.171 0.986 . . . . 0.0 110.228 -169.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.506 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -104.93 161.13 4.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.985 176.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.516 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.7 t -96.28 145.84 30.26 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.655 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 81.7 Cg_endo -82.55 -20.52 5.69 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.702 2.268 . . . . 0.0 108.279 -174.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.488 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 18.2 mtt180 -89.37 -15.3 33.65 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 112.952 -1.931 . . . . 0.0 114.694 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.8 p -151.53 -8.09 0.23 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 10.1 tt0 60.79 25.2 15.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 111.586 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 m -103.36 141.89 35.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 169.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.59 30.87 2.49 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.268 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.525 ' HD2' ' NE2' ' A' ' 14' ' ' HIS . 35.8 m-85 -89.39 52.6 2.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.597 0.713 . . . . 0.0 110.146 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 13' ' ' CYS . 5.6 pt -122.6 134.17 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.598 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' C' ' 60' ' ' ILE . 11.4 pt-20 -119.75 144.03 47.48 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -75.81 138.49 41.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.508 HD12 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.666 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.541 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 1.2 mt -109.12 134.76 51.28 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.427 0.632 . . . . 0.0 110.543 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.491 ' HA ' ' CG1' ' C' ' 32' ' ' ILE . 36.9 mt-10 -89.77 93.33 9.4 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.278 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.594 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 2.7 t -77.41 124.11 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -171.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.624 ' C ' ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -109.28 146.53 34.13 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 171.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.523 HG23 ' HB ' ' C' ' 82' ' ' ILE . 36.4 t -151.07 125.07 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -172.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.563 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 72.2 mttt -110.93 110.98 21.8 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.171 0.51 . . . . 0.0 110.789 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.425 0 CA-C-O 121.614 0.721 . . . . 0.0 110.289 164.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.503 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 71.8 m . . . . . 0 C--O 1.235 0.299 0 CA-C-O 120.958 0.409 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -135.28 159.04 42.8 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.223 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 8.5 p -96.23 148.55 22.61 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.837 -174.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.594 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 34.3 m-85 -140.21 63.05 1.49 Allowed 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.135 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.491 ' CG1' ' HA ' ' C' ' 18' ' ' GLU . 2.7 mp -59.92 120.18 5.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 123.445 1.593 . . . . 0.0 113.838 -175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.422 HG12 ' HD2' ' C' ' 42' ' ' PHE . 15.5 m -138.12 -172.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 111.016 -2.811 . . . . 0.0 111.565 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.69 175.86 34.51 Favored Glycine 0 C--N 1.308 -0.973 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.954 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.714 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . -90.55 50.17 1.79 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -169.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.714 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 1.5 mt-30 139.21 2.22 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 O-C-N 125.189 1.555 . . . . 0.0 109.42 -171.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 22.9 tpp -44.95 -70.49 0.1 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.769 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.432 ' CG ' ' HB2' ' C' ' 41' ' ' GLU . 26.9 m-80 -136.98 -99.09 0.2 Allowed 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 174.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.622 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 94.72 -29.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 125.151 1.532 . . . . 0.0 110.293 -162.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.603 ' HE2' ' O ' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -79.91 -71.11 0.47 Allowed 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.485 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . 0.432 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 40.4 mt-10 -63.01 -28.06 69.84 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.851 174.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.622 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 4.7 t80 -58.51 -54.36 47.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.739 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.532 ' HD3' ' HB3' ' C' ' 68' ' ' ASP . 8.9 ptmm? -69.6 -37.19 76.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.483 0.659 . . . . 0.0 111.209 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.407 ' HA ' ' HB3' ' C' ' 54' ' ' SER . 1.2 tm-20 -56.07 -44.18 78.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.225 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -69.77 -39.04 76.91 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.535 ' O ' HG22 ' C' ' 50' ' ' VAL . 20.0 pt -83.1 -6.61 10.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -173.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -38.1 -57.48 1.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.97 -36.05 69.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.073 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -20.51 66.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.861 0.362 . . . . 0.0 111.455 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.535 HG22 ' O ' ' C' ' 46' ' ' ILE . 14.6 m -111.76 -6.36 11.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.429 176.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 35.7 m 70.33 21.14 5.86 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.705 0.628 . . . . 0.0 109.475 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.3 mm -126.03 112.96 24.23 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.131 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.421 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.1 Cg_exo -70.94 145.52 50.56 Favored 'Trans proline' 0 CA--C 1.506 -0.876 0 C-N-CA 122.452 2.101 . . . . 0.0 110.784 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.478 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 1.9 p -54.79 -24.72 23.97 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 123.725 0.64 . . . . 0.0 112.647 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.12 -33.79 61.61 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.947 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -98.02 -11.04 23.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.361 0.601 . . . . 0.0 109.503 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.487 ' OE1' HD13 ' C' ' 46' ' ' ILE . 9.3 tt0 -82.99 119.59 24.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.105 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' C' ' 58' ' ' ARG . 22.2 mtm180 -127.66 126.92 42.85 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 171.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.707 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 22.8 mt -84.85 108.04 17.31 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.443 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.545 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.3 mt -99.95 118.35 46.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.39 173.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -132.37 125.99 32.17 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 171.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 58.37 36.37 25.44 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.209 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 76.63 0.9 69.43 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.489 175.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 16.9 mmm180 -98.13 141.49 30.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.72 95.15 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 120.937 0.399 . . . . 0.0 110.399 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -82.96 138.91 33.62 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -147.37 -176.08 5.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.928 0.394 . . . . 0.0 111.446 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.532 ' HB3' ' HD3' ' C' ' 43' ' ' LYS . 2.8 p-10 -69.49 -3.58 15.22 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.593 1.157 . . . . 0.0 113.337 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -75.8 -19.83 58.67 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.603 ' O ' ' HE2' ' C' ' 40' ' ' LYS . 39.5 mtmt -130.56 -147.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -170.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -120.35 153.18 36.83 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.795 -174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -58.01 -50.73 72.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 7.3 tp60 -68.3 -22.42 64.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.909 0.385 . . . . 0.0 111.444 -174.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -60.72 -28.89 69.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.273 0.559 . . . . 0.0 109.947 175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.469 ' CD1' HD23 ' C' ' 66' ' ' LEU . 39.5 m-85 -93.72 -19.81 20.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.398 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 t30 59.75 38.5 21.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.41 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 29.3 m -88.73 22.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.541 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -73.98 103.35 1.45 Allowed Glycine 0 N--CA 1.428 -1.876 0 CA-C-O 122.786 1.215 . . . . 0.0 112.787 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.51 12.98 46.14 Favored Glycine 0 C--N 1.284 -2.311 0 CA-C-N 112.185 -2.007 . . . . 0.0 115.157 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -128.37 148.27 50.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.273 0.536 . . . . 0.0 110.561 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.624 ' HA ' ' C ' ' C' ' 20' ' ' LEU . 18.4 m -78.54 120.91 30.43 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-O 122.007 0.908 . . . . 0.0 111.599 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' C' ' 21' ' ' VAL . 28.1 mt -76.7 166.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.003 173.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.462 ' N ' HG22 ' C' ' 82' ' ' ILE . 52.7 m170 -118.32 116.21 26.28 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.702 -0.624 . . . . 0.0 109.98 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' C' ' 84' ' ' LEU . 11.4 mt -90.81 157.82 17.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.551 HG11 ' CD2' ' A' ' 14' ' ' HIS . 2.4 m . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.987 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 19.5 mtm180 . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 121.402 0.62 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.552 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 14.7 m-85 -125.22 167.39 14.92 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CB ' HD11 ' A' ' 40' ' ' LEU . 53.4 t80 -144.58 121.22 11.13 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.116 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.3 p -91.29 91.89 8.38 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.259 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -56.25 -41.77 76.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.367 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.2 t -55.3 -49.43 72.17 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.427 0.455 . . . . 0.0 112.196 -174.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.54 5.35 44.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.6 0.714 . . . . 0.0 111.559 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.4 p 53.32 58.31 5.36 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.058 1.343 . . . . 0.0 114.266 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -142.77 146.27 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 174.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 28.7 tt0 -89.18 139.42 30.5 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.537 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.654 HD12 ' CG2' ' A' ' 37' ' ' ILE . 7.0 pt -143.9 168.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -163.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.452 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 42.2 t -118.99 100.78 50.59 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 114.332 -1.304 . . . . 0.0 107.536 161.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.686 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . 1.2 Cg_endo -53.09 177.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.853 1 C-N-CA 126.078 4.519 . . . . 0.0 118.669 -168.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.577 ' HB3' HD12 ' A' ' 28' ' ' ILE . 62.9 mtt180 -117.94 50.81 1.11 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 111.34 -2.663 . . . . 0.0 107.388 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' A' ' 27' ' ' TYR . 2.6 mm? -8.71 -57.87 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 127.703 2.401 . . . . 0.0 117.325 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -32.98 -34.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 123.513 2.809 . . . . 0.0 114.378 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.538 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -124.42 -18.48 5.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.536 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.515 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 49.3 m-85 69.98 42.98 0.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.189 -171.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -91.33 165.19 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.119 174.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.468 ' CB ' HD13 ' A' ' 20' ' ' ILE . 25.2 p -95.49 144.06 27.18 Favored Pre-proline 0 N--CA 1.432 -1.338 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.622 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 44.1 Cg_endo -83.25 -22.55 3.96 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 123.278 2.652 . . . . 0.0 109.151 -168.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.508 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 60.0 mtt180 -81.96 -24.83 35.3 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 112.689 -2.051 . . . . 0.0 113.054 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.08 11.23 0.07 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 49.63 66.86 1.0 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.28 145.77 43.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.452 167.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -85.63 33.68 3.44 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.47 -174.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -108.95 52.03 0.72 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.133 0.492 . . . . 0.0 111.068 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.686 ' CD1' ' HB3' ' A' ' 22' ' ' PRO . 3.7 pt -111.58 138.86 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.77 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -116.39 147.71 41.37 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -80.25 122.46 26.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.852 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.599 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 41.6 tpp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.383 0.611 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.725 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -102.09 145.97 28.58 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.455 ' HA ' HG13 ' C' ' 32' ' ' ILE . 43.2 tt0 -97.91 91.88 5.55 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 170.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' C' ' 30' ' ' THR . 4.5 t -76.82 98.68 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.099 -170.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 1.4 mt -87.28 132.97 33.75 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 88.0 t -145.05 120.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.158 0.504 . . . . 0.0 110.322 -173.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.718 ' HG2' ' OG1' ' C' ' 28' ' ' THR . 44.4 mtpt -92.1 144.27 25.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' THR . . . . . 0.417 HG21 ' HB2' ' C' ' 84' ' ' LEU . 18.6 p . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.718 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 19.9 m . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -121.07 150.14 41.65 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.94 0.4 . . . . 0.0 110.885 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.8 p -99.56 144.82 28.2 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.241 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.457 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 34.2 m-85 -132.58 60.18 1.7 Allowed 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.614 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.455 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.5 mp -57.96 118.85 2.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 123.06 1.41 . . . . 0.0 114.367 -173.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.456 HG11 ' HD2' ' C' ' 42' ' ' PHE . 16.6 m -138.36 170.51 16.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 111.625 -2.534 . . . . 0.0 112.593 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' C' ' 36' ' ' GLN . . . -84.88 50.33 4.38 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.08 -1.418 . . . . 0.0 114.188 -168.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.725 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . 65.39 -48.2 0.37 Allowed 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 124.255 1.022 . . . . 0.0 113.482 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.434 ' HA ' ' HB3' ' C' ' 71' ' ' LYS . 3.9 pt20 -139.82 26.04 2.31 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -164.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -59.64 -70.99 0.14 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 111.63 -2.532 . . . . 0.0 111.019 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.431 ' O ' ' HB ' ' C' ' 39' ' ' VAL . 13.5 m-80 -144.23 -92.02 0.11 Allowed 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.671 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 96.44 -29.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 O-C-N 125.702 1.876 . . . . 0.0 110.891 -166.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' C' ' 70' ' ' LYS . 0.9 OUTLIER -80.44 -71.39 0.46 Allowed 'General case' 0 N--CA 1.423 -1.813 0 CA-C-O 122.158 0.98 . . . . 0.0 108.859 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.89 -26.59 68.67 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 113.754 -1.567 . . . . 0.0 111.239 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.671 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.6 OUTLIER -59.37 -51.6 69.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.984 174.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.524 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 17.7 mtpp -63.51 -42.06 98.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.96 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -56.14 -37.0 68.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.282 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -69.76 -47.35 63.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.807 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.641 ' O ' HG22 ' C' ' 50' ' ' VAL . 7.4 pt -74.45 -11.46 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.994 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.5 -58.39 2.27 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.64 -37.53 67.96 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.845 -175.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -36.66 83.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.102 0.477 . . . . 0.0 110.648 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.641 HG22 ' O ' ' C' ' 46' ' ' ILE . 24.5 m -98.68 -1.71 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.946 177.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p 60.66 26.58 16.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.014 0.911 . . . . 0.0 109.533 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.3 mm -128.59 113.74 19.36 Favored Pre-proline 0 N--CA 1.434 -1.269 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.099 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 3.7 Cg_exo -69.98 143.65 50.43 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.131 1.888 . . . . 0.0 111.525 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.499 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 35.3 t -51.58 -24.72 5.71 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.331 1.02 . . . . 0.0 112.286 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.6 pt-20 -72.41 -43.71 63.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.604 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.413 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 96.6 mttt -88.2 -29.13 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.856 0.836 . . . . 0.0 109.382 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.524 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 19.3 tt0 -57.62 131.61 50.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.401 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -136.38 123.76 22.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.876 175.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.476 ' HB3' HG23 ' C' ' 82' ' ' ILE . 46.4 mt -86.73 104.36 16.05 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.098 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.565 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.0 mt -101.94 116.98 46.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.884 -0.51 . . . . 0.0 111.251 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -127.2 113.89 16.94 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 173.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 60.96 43.08 11.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.24 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 72.99 -4.58 22.81 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.142 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -88.32 125.39 34.66 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -87.92 88.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.283 0.564 . . . . 0.0 109.816 -176.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.626 HD21 ' CD1' ' C' ' 75' ' ' TYR . 0.5 OUTLIER -68.55 133.69 48.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -142.65 -176.92 5.06 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.641 -170.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.498 ' HA ' HG13 ' C' ' 39' ' ' VAL . 11.4 p-10 -71.88 -0.61 11.76 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.22 1.008 . . . . 0.0 112.627 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -79.89 -21.93 43.42 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.431 ' O ' ' HE3' ' C' ' 40' ' ' LYS . 68.7 mttt -123.93 -148.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -167.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.434 ' HB3' ' HA ' ' C' ' 36' ' ' GLN . 0.0 OUTLIER -127.17 163.58 23.54 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.694 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 2.9 mm? -66.25 -36.99 84.45 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 118.482 0.583 . . . . 0.0 111.167 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' C' ' 35' ' ' ALA . 35.0 tt0 -70.66 -18.15 62.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.858 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . 0.406 ' HG3' ' HB3' ' C' ' 70' ' ' LYS . 16.9 mm-40 -64.72 -28.84 69.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.464 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.626 ' CD1' HD21 ' C' ' 66' ' ' LEU . 17.8 m-85 -95.54 -22.52 17.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.867 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 t30 63.77 52.35 2.2 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 123.038 1.399 . . . . 0.0 107.76 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.69 -0.86 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 CA-C-N 112.78 -2.009 . . . . 0.0 112.705 -162.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.512 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -47.3 102.45 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.403 0 CA-C-O 122.904 1.28 . . . . 0.0 114.37 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.18 14.29 56.23 Favored Glycine 0 C--N 1.287 -2.188 0 CA-C-N 111.725 -2.237 . . . . 0.0 114.265 170.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -117.23 142.43 47.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.809 0.305 . . . . 0.0 110.25 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.628 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 15.6 m -79.34 124.13 37.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.676 0.751 . . . . 0.0 112.596 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' C' ' 59' ' ' LEU . 25.5 mt -86.87 168.71 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.487 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.442 ' N ' HG22 ' C' ' 82' ' ' ILE . 46.2 m-70 -119.3 115.65 24.6 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 121.965 -0.459 . . . . 0.0 110.168 174.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.417 ' HB2' HG21 ' C' ' 23' ' ' THR . 11.3 mt -91.52 144.64 25.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.103 0.478 . . . . 0.0 111.235 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.837 -176.815 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.545 ' HG2' HD11 ' A' ' 40' ' ' LEU . 38.5 ttt180 . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.929 0.395 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.528 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 8.6 m-85 -117.93 141.21 48.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.955 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.427 ' CB ' HD23 ' A' ' 40' ' ' LEU . 74.4 t80 -112.61 115.69 29.0 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.436 170.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.617 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -91.11 118.99 30.88 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.094 174.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -80.38 -7.89 59.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.263 -174.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 7.9 t -72.04 -51.52 21.32 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.911 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' HG21 ' A' ' 18' ' ' VAL . 26.9 p -100.94 2.97 41.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.312 0.577 . . . . 0.0 110.324 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p 54.4 45.43 27.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.812 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 16' ' ' CYS . 21.7 t -141.61 147.89 21.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.626 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.58 142.1 42.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.561 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.655 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 4.9 pt -133.17 167.05 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.703 0.763 . . . . 0.0 112.916 -170.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.9 t -117.79 108.31 42.99 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.303 160.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.528 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 19.1 Cg_endo -70.19 176.14 7.5 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 124.404 3.402 . . . . 0.0 116.552 -166.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.486 ' HB3' HD11 ' A' ' 28' ' ' ILE . 62.6 mtt180 -114.05 49.17 1.02 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 112.924 -1.944 . . . . 0.0 107.802 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 27' ' ' TYR . 2.6 mm? -0.44 -61.74 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.124 0 CA-C-N 111.308 -2.678 . . . . 0.0 117.763 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -32.38 -36.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.377 2.718 . . . . 0.0 114.397 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.514 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.98 -19.76 9.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.786 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.411 ' CE1' HD12 ' A' ' 24' ' ' LEU . 56.4 m-85 66.91 46.23 1.67 Allowed 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.227 -169.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.514 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -92.09 164.04 2.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 113.82 -1.537 . . . . 0.0 110.341 174.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.428 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.8 OUTLIER -96.41 144.11 27.28 Favored Pre-proline 0 C--N 1.306 -1.303 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.015 177.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.655 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 47.5 Cg_endo -84.87 -15.91 5.57 Favored 'Trans proline' 0 CA--C 1.5 -1.212 0 C-N-CA 123.55 2.833 . . . . 0.0 108.627 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.47 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 85.7 mtt-85 -91.21 -14.18 31.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.177 -1.829 . . . . 0.0 114.0 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.4 p -163.33 3.77 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 55.41 36.91 28.09 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.542 0.687 . . . . 0.0 112.162 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.432 ' HB3' ' CD2' ' A' ' 36' ' ' PHE . 16.7 m -116.81 136.43 52.96 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.493 172.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.67 28.26 2.46 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.086 -0.578 . . . . 0.0 113.925 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 80.0 m-85 -86.57 44.24 1.14 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.087 0.47 . . . . 0.0 109.799 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.625 ' O ' HG21 ' C' ' 60' ' ' ILE . 19.6 pt -110.86 132.79 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.104 -176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.513 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.9 pt-20 -121.7 139.81 53.09 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -76.35 128.64 35.25 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.545 HD11 ' HG2' ' A' ' 10' ' ' ARG . 13.0 mt . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.319 -167.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.426 ' SD ' ' HB3' ' C' ' 35' ' ' ALA . 26.1 ttt . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.743 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -102.08 140.43 36.36 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.786 -179.061 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.509 ' HA ' HG13 ' C' ' 32' ' ' ILE . 4.6 mt-10 -97.21 90.75 5.23 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.966 174.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 24.4 t -78.61 76.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 123.31 1.529 . . . . 0.0 111.019 -169.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 4.3 mt -69.98 140.37 52.94 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.539 HG21 ' HB ' ' C' ' 82' ' ' ILE . 47.4 t -153.44 115.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.986 0.422 . . . . 0.0 110.131 -169.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.515 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 34.8 mtpt -98.9 125.44 44.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.317 -0.827 0 CA-C-O 121.031 0.443 . . . . 0.0 111.467 177.45 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 97.5 m . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 120.761 0.315 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -128.09 150.06 50.13 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.094 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' C' ' 20' ' ' LEU . 0.2 OUTLIER -97.09 139.94 32.34 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.626 -176.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.616 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 38.0 m-85 -127.0 67.67 1.27 Allowed 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.613 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -58.78 120.63 4.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 123.384 1.564 . . . . 0.0 114.189 -174.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.41 HG21 ' CE2' ' C' ' 42' ' ' PHE . 17.8 m -136.99 -170.3 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 110.94 -2.846 . . . . 0.0 110.812 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.435 ' O ' HD22 ' C' ' 17' ' ' LEU . . . -88.93 176.74 44.32 Favored Glycine 0 C--N 1.307 -1.06 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.773 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.743 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -68.73 -17.66 64.09 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 117.818 0.809 . . . . 0.0 112.286 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -163.73 27.07 0.08 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -55.58 -76.53 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 112.019 -2.355 . . . . 0.0 111.219 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.582 ' O ' HG13 ' C' ' 39' ' ' VAL . 83.8 m-20 -128.79 -84.9 0.57 Allowed 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.355 174.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.66 ' O ' ' HD2' ' C' ' 43' ' ' LYS . 0.3 OUTLIER 88.12 -28.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 125.594 1.809 . . . . 0.0 111.646 -167.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -72.6 0.5 Allowed 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.013 0.911 . . . . 0.0 109.402 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.2 -27.86 67.5 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.368 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.505 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.6 OUTLIER -62.25 -50.32 72.21 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.35 174.53 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.66 ' HD2' ' O ' ' C' ' 39' ' ' VAL . 0.0 OUTLIER -58.37 -43.16 88.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.089 0.471 . . . . 0.0 110.756 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -57.03 -34.24 68.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.523 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -70.9 -44.51 66.09 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.677 ' O ' HG23 ' C' ' 50' ' ' VAL . 21.5 pt -77.98 -16.77 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.835 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.06 -49.61 2.56 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.06 -42.49 60.12 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.797 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -16.6 63.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.925 0.393 . . . . 0.0 110.976 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.677 HG23 ' O ' ' C' ' 46' ' ' ILE . 29.0 m -112.06 -9.1 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.891 176.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t 70.62 19.79 5.98 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.768 0.794 . . . . 0.0 109.283 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.7 mm -128.48 110.03 19.23 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.873 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' C' ' 47' ' ' ALA . 6.4 Cg_exo -68.37 146.82 70.09 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.173 1.915 . . . . 0.0 111.09 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -54.91 -25.7 30.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.898 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.427 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.7 pt-20 -75.31 -18.01 60.13 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 111.082 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.427 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 98.7 mttt -120.29 -0.95 10.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.401 . . . . 0.0 110.773 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.672 ' OE1' HD13 ' C' ' 46' ' ' ILE . 0.0 OUTLIER -93.1 126.18 38.07 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.335 -175.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -122.35 123.6 41.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.05 173.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.572 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 2.1 mm? -92.25 104.49 16.85 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.734 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.625 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.6 mt -101.64 122.93 54.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.893 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.455 ' OH ' ' HD3' ' C' ' 80' ' ' LYS . 29.5 t80 -135.24 131.94 37.24 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 171.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 48.44 38.78 11.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.033 -172.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.88 6.4 63.58 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.848 -0.615 . . . . 0.0 113.169 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -98.16 133.52 42.49 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.17 94.45 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.265 0.555 . . . . 0.0 110.471 -176.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.3 OUTLIER -82.66 156.1 24.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . 0.458 ' HA ' HD23 ' C' ' 59' ' ' LEU . 16.4 pt20 -169.97 -169.12 0.83 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.601 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.553 ' HA ' HG12 ' C' ' 39' ' ' VAL . 7.3 p-10 -62.41 -0.02 0.52 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.771 0.828 . . . . 0.0 112.228 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' C' ' 67' ' ' GLN . 28.9 t70 -63.38 -4.33 2.6 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.016 0.926 . . . . 0.0 112.782 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.455 ' HA ' HG13 ' C' ' 39' ' ' VAL . 51.5 mtmt 83.55 167.89 0.1 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 169.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.432 ' HB3' ' HG3' ' C' ' 74' ' ' GLU . 13.9 mptt 67.35 79.12 0.23 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.939 -178.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 20.8 mt -62.27 -33.23 74.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.648 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -69.36 -19.03 63.84 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 122.696 0.399 . . . . 0.0 112.005 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . 0.432 ' HG3' ' HB3' ' C' ' 71' ' ' LYS . 32.1 mt-10 -73.05 -27.85 61.98 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.51 ' CD1' HD21 ' C' ' 66' ' ' LEU . 15.7 m-85 -87.97 -21.99 24.54 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.4 t30 58.89 40.37 22.73 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.709 174.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.481 HG13 HD11 ' C' ' 82' ' ' ILE . 17.4 m -87.92 10.22 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.84 -171.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -60.91 99.48 0.2 Allowed Glycine 0 CA--C 1.488 -1.6 0 CA-C-O 122.785 1.214 . . . . 0.0 113.226 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . 0.423 ' C ' HD12 ' C' ' 20' ' ' LEU . . . 94.35 15.25 48.17 Favored Glycine 0 C--N 1.284 -2.357 0 CA-C-N 112.091 -2.055 . . . . 0.0 114.132 172.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . 0.455 ' HD3' ' OH ' ' C' ' 61' ' ' TYR . 55.2 mttm -126.75 140.47 52.36 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 33.9 m -75.83 134.02 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.854 0.835 . . . . 0.0 110.732 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.562 HG23 ' HB3' ' C' ' 59' ' ' LEU . 59.4 mt -89.78 169.8 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.969 172.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.536 ' N ' HG22 ' C' ' 82' ' ' ILE . 56.8 m80 -115.95 112.38 21.77 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.461 HD12 ' N ' ' C' ' 85' ' ' VAL . 13.7 tp -97.83 130.63 44.74 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 121.218 0.533 . . . . 0.0 110.296 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.461 ' N ' HD12 ' C' ' 84' ' ' LEU . 30.6 m . . . . . 0 C--N 1.311 -1.102 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.978 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 C--O 1.233 0.216 0 CA-C-O 121.483 0.659 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.6 m-85 -115.42 166.2 12.14 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.141 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.507 ' CB ' HD12 ' A' ' 40' ' ' LEU . 39.0 t80 -140.64 119.44 12.53 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.317 178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB2' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -95.9 107.12 19.35 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.782 177.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.605 ' ND1' HG22 ' C' ' 85' ' ' VAL . 17.9 p80 -62.23 -15.73 48.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.808 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.467 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 7.0 t -71.71 -31.12 66.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.645 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.1 m -98.65 -26.14 14.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.156 0.503 . . . . 0.0 110.607 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.37 28.55 15.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.345 -171.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.68 143.53 40.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 36.9 tt0 -71.82 148.39 46.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.11 0.481 . . . . 0.0 110.831 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.67 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.6 pt -138.68 167.04 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.719 -170.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.495 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 20.9 t -123.36 96.85 43.46 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 163.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.685 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 9.2 Cg_endo -56.0 176.16 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.872 1 C-N-CA 125.328 4.018 . . . . 0.0 116.529 -170.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.688 ' HB2' HG13 ' A' ' 28' ' ' ILE . 24.5 mtt180 -110.25 49.82 0.83 Allowed 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 112.488 -2.142 . . . . 0.0 107.692 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -0.75 -58.25 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 CA-C-N 111.21 -2.723 . . . . 0.0 117.047 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.412 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 18.6 Cg_exo -37.15 -31.19 0.12 Allowed 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.88 2.387 . . . . 0.0 114.074 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.533 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -123.69 -19.88 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.357 0.599 . . . . 0.0 111.765 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.482 ' C ' HD11 ' A' ' 37' ' ' ILE . 47.0 m-85 67.34 45.49 1.61 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.28 -171.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.688 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.4 OUTLIER -92.43 160.45 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.723 173.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -96.0 144.64 28.18 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.67 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 96.8 Cg_endo -79.52 -21.55 8.66 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 122.672 2.248 . . . . 0.0 108.049 -172.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.1 mtt-85 -79.92 -37.79 33.87 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 112.561 -2.109 . . . . 0.0 113.567 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.0 p -133.75 -6.92 2.81 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.463 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 59.32 30.91 20.71 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.509 0.671 . . . . 0.0 111.661 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 m -111.48 144.24 41.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.467 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.23 41.06 2.6 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.109 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -96.04 46.02 1.08 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.106 0.479 . . . . 0.0 109.934 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.584 HG22 HD11 ' A' ' 20' ' ' ILE . 3.5 pt -113.31 134.63 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.796 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.481 ' HB3' HD12 ' C' ' 60' ' ' ILE . 0.7 OUTLIER -119.14 141.69 48.6 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -79.9 137.27 36.86 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.507 HD12 ' CB ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.455 -175.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.532 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 26.5 ptt? . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.187 0.518 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.539 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 1.9 mt -105.04 132.15 51.64 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.516 ' HA ' ' CG1' ' C' ' 32' ' ' ILE . 49.3 mt-10 -81.51 94.39 6.86 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 9.4 t -80.67 116.53 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.925 -171.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.539 ' CD2' HG23 ' C' ' 30' ' ' THR . 0.8 OUTLIER -107.5 144.9 33.8 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 175.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' C' ' 28' ' ' THR . 3.5 m -137.02 147.64 26.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.566 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 37.0 mtpt -120.29 123.64 43.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--N 1.315 -0.93 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.789 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 71.7 m . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 121.017 0.437 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -133.11 153.42 51.54 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.425 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.539 HG23 ' CD2' ' C' ' 20' ' ' LEU . 16.3 p -100.11 151.4 21.44 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -170.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.555 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 26.8 m-85 -141.43 55.56 1.52 Allowed 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.246 -175.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.516 ' CG1' ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -60.95 120.84 7.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 123.407 1.575 . . . . 0.0 113.801 -174.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.6 m -138.03 -168.76 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 110.729 -2.942 . . . . 0.0 111.446 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -76.94 -158.96 9.39 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.052 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . -110.13 23.64 14.06 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 120.9 0.381 . . . . 0.0 111.371 -177.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 7.5 tt0 166.19 -17.47 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.418 -163.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -41.25 -64.86 0.5 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.48 1.113 . . . . 0.0 112.262 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.472 ' O ' HG11 ' C' ' 39' ' ' VAL . 66.1 m-20 -131.0 -95.01 0.37 Allowed 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.632 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 86.0 -30.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 O-C-N 125.041 1.463 . . . . 0.0 110.819 -162.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.79 -70.28 0.55 Allowed 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.228 1.013 . . . . 0.0 109.095 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . 0.433 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 43.7 mt-10 -62.03 -26.66 68.37 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.393 173.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.72 ' O ' HG21 ' C' ' 46' ' ' ILE . 0.2 OUTLIER -56.82 -53.71 54.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.255 172.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.454 ' N ' ' HD1' ' C' ' 42' ' ' PHE . 18.8 mtpp -61.79 -41.89 98.32 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.521 0.677 . . . . 0.0 110.721 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -58.46 -40.28 82.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.662 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -69.92 -44.82 68.87 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.027 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.72 HG21 ' O ' ' C' ' 42' ' ' PHE . 4.3 pt -75.22 -13.23 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.792 -0.185 . . . . 0.0 111.225 -172.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -43.49 -45.64 6.52 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.33 -43.09 34.23 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.892 -0.505 . . . . 0.0 111.804 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -20.28 63.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.516 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.649 HG21 ' O ' ' C' ' 46' ' ' ILE . 31.5 m -112.07 -6.68 11.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t 68.85 19.72 8.23 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.724 0.773 . . . . 0.0 109.018 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 8.6 mm -125.71 112.42 25.06 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.385 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 4.7 Cg_exo -69.73 146.31 59.97 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.138 1.892 . . . . 0.0 111.494 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.3 p -53.0 -24.82 10.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.476 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.27 -32.37 55.56 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.36 0.412 . . . . 0.0 111.894 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -97.92 -19.93 17.77 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 109.847 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' C' ' 53' ' ' PRO . 25.8 tt0 -66.52 123.26 19.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.92 -170.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 43.5 mtp85 -124.93 115.4 20.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.204 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 51.6 mt -86.96 111.41 20.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.979 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 38' ' ' GLU . 5.6 mt -109.93 113.63 44.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 O-C-N 121.568 -0.707 . . . . 0.0 112.01 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' C' ' 66' ' ' LEU . 21.1 t80 -129.38 126.89 39.86 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 60.5 34.17 20.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.022 0.439 . . . . 0.0 110.379 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.99 5.44 40.09 Favored Glycine 0 N--CA 1.453 -0.211 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.899 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -87.43 133.4 33.74 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.97 87.6 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.261 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.597 ' HB3' ' CD2' ' C' ' 75' ' ' TYR . 0.8 OUTLIER -68.28 141.63 55.81 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -155.4 -168.97 3.0 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.684 -0.406 . . . . 0.0 109.955 -173.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.541 ' HA ' HG13 ' C' ' 39' ' ' VAL . 8.9 p-10 -67.43 0.24 3.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.608 0.763 . . . . 0.0 112.577 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.17 -4.02 3.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.521 0.729 . . . . 0.0 112.846 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.43 ' HA ' HG11 ' C' ' 39' ' ' VAL . 49.2 mttp 81.95 177.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.951 0.9 . . . . 0.0 111.865 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.407 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 65.5 mttm 74.66 75.12 0.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.145 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.01 -45.39 85.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.292 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -69.55 -25.84 64.2 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . 0.407 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 69.3 mm-40 -67.46 -24.71 65.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.575 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.597 ' CD2' ' HB3' ' C' ' 66' ' ' LEU . 6.9 m-30 -86.42 -10.21 54.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.447 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 1.3 m120 47.89 35.33 4.75 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.328 1.051 . . . . 0.0 113.471 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.449 HG21 HG23 ' C' ' 19' ' ' VAL . 16.5 m -90.55 16.19 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -175.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.539 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -73.18 102.78 1.29 Allowed Glycine 0 N--CA 1.431 -1.658 0 CA-C-O 122.792 1.218 . . . . 0.0 112.082 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.21 14.59 62.01 Favored Glycine 0 C--N 1.283 -2.401 0 CA-C-N 112.052 -2.074 . . . . 0.0 113.045 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -124.23 147.5 48.01 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.566 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 34.0 m -84.13 124.26 39.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 121.971 0.891 . . . . 0.0 112.313 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.449 HG22 ' N ' ' C' ' 83' ' ' HIS . 74.0 mt -77.77 171.6 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.433 173.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.449 ' N ' HG22 ' C' ' 82' ' ' ILE . 45.5 m80 -118.85 119.52 34.62 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.465 -0.772 . . . . 0.0 109.775 170.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.46 HD11 ' H ' ' C' ' 85' ' ' VAL . 25.9 tp -100.59 145.14 28.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -171.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.605 HG22 ' ND1' ' A' ' 14' ' ' HIS . 2.8 p . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.481 0.658 . . . . 0.0 109.973 171.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.585 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 16.7 ptp180 . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 122.353 1.073 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.682 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 8.4 m-85 -116.79 164.59 14.43 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.819 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.588 ' CB ' HD21 ' A' ' 40' ' ' LEU . 54.5 t80 -138.98 112.58 8.3 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.572 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -91.9 110.52 21.87 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.468 ' CG ' HG11 ' C' ' 85' ' ' VAL . 9.8 p80 -69.15 -17.98 63.89 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -169.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 13.5 p -73.33 -39.11 65.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.255 174.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.7 m -78.19 -29.68 48.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.321 0.581 . . . . 0.0 110.646 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER 58.58 28.8 17.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.694 -176.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.54 146.23 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.682 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.1 tt0 -70.06 144.53 52.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.231 0.538 . . . . 0.0 111.034 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.628 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.2 pt -132.08 167.91 25.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.77 -175.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 14.1 t -125.28 95.01 42.17 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 164.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.557 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 3.5 Cg_endo -54.28 175.85 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.842 1 C-N-CA 125.423 4.082 . . . . 0.0 116.973 -169.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.665 ' HB2' HG13 ' A' ' 28' ' ' ILE . 37.8 mtt180 -107.5 48.32 0.85 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 112.565 -2.107 . . . . 0.0 107.023 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 0.79 -61.71 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.116 0 CA-C-N 110.811 -2.904 . . . . 0.0 117.253 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -32.18 -36.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 123.553 2.835 . . . . 0.0 113.819 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.511 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -115.68 -22.62 9.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.181 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.561 ' C ' HD11 ' A' ' 37' ' ' ILE . 58.4 m-85 68.1 58.6 0.46 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.406 1.098 . . . . 0.0 110.32 -168.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.665 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -110.71 162.57 8.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.304 176.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.5 t -96.16 146.61 31.61 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.628 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 67.6 Cg_endo -81.6 -22.3 5.6 Favored 'Trans proline' 0 CA--C 1.5 -1.224 0 C-N-CA 122.606 2.204 . . . . 0.0 108.031 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.538 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 68.5 mtt-85 -81.7 -25.14 35.73 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 112.892 -1.958 . . . . 0.0 113.752 -177.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.6 p -146.23 -7.25 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.637 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 60.35 32.35 20.65 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.744 0.783 . . . . 0.0 111.033 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.1 m -113.19 146.39 39.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.744 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.57 37.64 2.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.14 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 87.8 m-85 -92.34 38.77 1.01 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.255 0.55 . . . . 0.0 110.041 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.59 HG22 ' CD1' ' A' ' 20' ' ' ILE . 7.1 pt -110.94 133.67 55.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.614 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.5 pt-20 -121.95 136.15 54.91 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 172.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.26 135.9 40.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.219 0.533 . . . . 0.0 109.692 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.588 HD21 ' CB ' ' A' ' 12' ' ' PHE . 8.7 mt . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.328 -171.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.737 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -104.08 147.87 26.91 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.294 0.569 . . . . 0.0 109.524 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.452 ' HA ' ' CG1' ' C' ' 32' ' ' ILE . 4.5 mt-10 -106.86 83.55 1.86 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' C' ' 30' ' ' THR . 4.2 t -72.06 143.63 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.441 -166.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.755 ' HB3' ' CG1' ' C' ' 81' ' ' VAL . 7.9 mt -128.65 156.71 43.0 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.77 ' O ' ' HA ' ' C' ' 28' ' ' THR . 21.5 m -145.36 152.89 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.619 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 35.7 mtpt -138.24 110.44 7.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.952 0.501 . . . . 0.0 109.983 173.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 120.869 0.366 . . . . 0.0 111.072 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 51.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' C' ' 20' ' ' LEU . 83.8 mtt180 -130.71 168.18 17.6 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.77 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 2.1 p -108.52 148.32 30.43 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.551 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 40.6 m-85 -139.73 65.07 1.44 Allowed 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.44 0.638 . . . . 0.0 110.365 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.452 ' CG1' ' HA ' ' C' ' 18' ' ' GLU . 2.5 mp -55.23 118.45 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 123.214 1.483 . . . . 0.0 113.776 -176.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.94 -171.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 111.347 -2.661 . . . . 0.0 111.209 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.08 157.18 20.07 Favored Glycine 0 C--N 1.307 -1.082 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.144 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.737 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -63.42 -18.78 64.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -172.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -147.74 22.47 1.13 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -75.53 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.224 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.612 ' O ' HG13 ' C' ' 39' ' ' VAL . 8.1 m120 -128.74 -91.94 0.47 Allowed 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.612 HG13 ' O ' ' C' ' 38' ' ' ASN . 0.3 OUTLIER 82.04 -28.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.035 1.459 . . . . 0.0 112.12 -166.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.632 ' O ' ' HG2' ' C' ' 43' ' ' LYS . 0.0 OUTLIER -80.77 -68.96 0.64 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.557 1.17 . . . . 0.0 108.78 174.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.53 -29.62 70.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.476 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.607 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -62.18 -53.21 58.57 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.184 175.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.636 ' HB2' ' OE1' ' C' ' 57' ' ' GLN . 3.3 ptmt -67.3 -34.1 76.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.192 0.52 . . . . 0.0 110.136 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.499 ' HA ' ' HB3' ' C' ' 54' ' ' SER . 16.7 tt0 -59.46 -37.01 77.07 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.657 175.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -69.98 -40.73 75.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.925 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.609 ' O ' HG22 ' C' ' 50' ' ' VAL . 18.4 pt -81.46 -7.64 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -174.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.24 -59.76 1.44 Allowed 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.24 -34.54 70.86 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.849 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -28.22 69.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.609 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.4 m -106.16 -2.75 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 29.0 m 69.53 19.61 7.42 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.536 0.684 . . . . 0.0 109.586 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.6 mm -127.65 117.12 21.08 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.165 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' C' ' 47' ' ' ALA . 5.0 Cg_exo -68.75 149.8 73.45 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.636 1.558 . . . . 0.0 111.751 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.499 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 29.6 p -53.88 -25.72 21.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.254 -176.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -79.68 -13.6 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -116.24 -33.04 5.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.636 ' OE1' ' HB2' ' C' ' 43' ' ' LYS . 8.7 pt20 -65.33 129.61 40.35 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.985 0.898 . . . . 0.0 111.997 -173.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' C' ' 84' ' ' LEU . 38.5 mmt180 -115.51 116.06 27.55 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.761 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.699 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 11.7 mt -84.23 106.01 15.52 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.346 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.521 HG21 ' O ' ' A' ' 37' ' ' ILE . 26.6 mt -99.1 118.53 45.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.534 -0.729 . . . . 0.0 111.69 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.452 ' OH ' ' HG2' ' C' ' 80' ' ' LYS . 64.5 t80 -135.19 130.2 34.95 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' C' ' 61' ' ' TYR . 48.1 mt-30 61.8 33.62 17.65 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.053 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 68.3 4.58 37.8 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.43 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -99.17 133.41 43.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.99 88.68 2.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.314 0.578 . . . . 0.0 110.013 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.1 OUTLIER -67.93 155.18 40.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.162 178.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . 0.44 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.5 pt20 -161.95 -167.19 1.6 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.686 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.579 ' HA ' HG12 ' C' ' 39' ' ' VAL . 1.5 p-10 -58.81 -2.48 0.23 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.041 0.936 . . . . 0.0 112.893 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' C' ' 67' ' ' GLN . 27.8 t70 -62.25 -9.12 6.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.574 0.75 . . . . 0.0 112.573 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' C' ' 69' ' ' ASP . 37.5 mtmm 78.81 174.9 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.758 0.823 . . . . 0.0 112.41 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.47 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 32.6 mtmm 78.6 71.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 124.209 0.943 . . . . 0.0 111.362 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 3.5 mm? -62.19 -44.14 97.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' C' ' 35' ' ' ALA . 2.3 pt20 -66.02 -19.47 65.87 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . 0.47 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 36.7 mm-40 -70.52 -28.39 64.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.563 ' CD1' HD23 ' C' ' 66' ' ' LEU . 18.9 m-85 -87.29 -23.51 24.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 60.59 43.66 12.48 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.905 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.406 HG23 HG21 ' C' ' 19' ' ' VAL . 19.6 m -91.3 -8.06 10.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.658 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -50.03 100.34 0.04 OUTLIER Glycine 0 CA--C 1.493 -1.305 0 CA-C-O 122.914 1.286 . . . . 0.0 113.944 168.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.93 10.38 49.54 Favored Glycine 0 C--N 1.29 -1.993 0 CA-C-N 111.629 -2.286 . . . . 0.0 114.725 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . 0.558 ' C ' ' HB2' ' C' ' 20' ' ' LEU . 0.0 OUTLIER -132.47 148.18 52.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.524 0.662 . . . . 0.0 111.118 -178.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.755 ' CG1' ' HB3' ' C' ' 20' ' ' LEU . 35.6 m -80.52 122.04 35.01 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-O 121.741 0.781 . . . . 0.0 111.934 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.463 HG23 ' HB3' ' C' ' 59' ' ' LEU . 77.6 mt -80.18 160.46 4.15 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.828 174.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.438 ' N ' HG22 ' C' ' 82' ' ' ILE . 54.8 m80 -117.71 114.73 23.77 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 121.657 -0.652 . . . . 0.0 109.989 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' C' ' 58' ' ' ARG . 8.0 mp -90.49 157.34 17.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.468 HG11 ' CG ' ' A' ' 14' ' ' HIS . 4.1 t . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.618 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.338 0.59 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.57 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 6.7 m-85 -116.3 166.41 12.08 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.982 171.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.538 ' CB ' HD11 ' A' ' 40' ' ' LEU . 60.6 t80 -139.48 123.74 18.01 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.446 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.55 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -98.02 101.05 12.43 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.589 ' HD2' ' OE1' ' A' ' 38' ' ' GLU . 11.9 p80 -52.91 -24.95 10.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.27 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -67.5 -46.76 71.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.769 0.319 . . . . 0.0 110.443 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.0 m -74.58 -28.24 60.83 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.497 0.665 . . . . 0.0 109.852 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.68 29.6 17.56 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.02 -170.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.03 144.39 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 37.5 tt0 -73.67 148.67 42.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.124 0.488 . . . . 0.0 110.844 -175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 37' ' ' ILE . 6.2 pt -139.01 168.38 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.265 -172.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.493 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 47.2 t -122.74 101.3 39.8 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 160.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.548 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 11.1 Cg_endo -54.36 175.32 0.14 Allowed 'Trans proline' 0 C--N 1.328 -0.502 1 C-N-CA 125.582 4.188 . . . . 0.0 116.215 -171.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.552 ' CB ' HD13 ' A' ' 28' ' ' ILE . 29.8 mtt180 -101.82 45.69 0.96 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 112.587 -2.097 . . . . 0.0 107.096 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -1.98 -59.03 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.861 0 CA-C-N 110.41 -3.086 . . . . 0.0 117.654 175.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.29 44.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.268 1.978 . . . . 0.0 112.857 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' HB3' HG12 ' A' ' 28' ' ' ILE . 4.8 t70 177.68 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.942 0.897 . . . . 0.0 109.653 -174.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 70.69 58.13 0.22 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.328 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.552 HD13 ' CB ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -114.76 163.52 11.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 113.307 -1.77 . . . . 0.0 108.833 175.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 2.1 t -95.88 144.42 27.79 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 79.6 Cg_endo -81.09 -22.89 5.69 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 C-N-CA 122.807 2.338 . . . . 0.0 108.182 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.501 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 50.2 mtt180 -89.09 -6.31 57.17 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.835 -1.984 . . . . 0.0 114.485 -176.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.7 p -156.06 -14.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 171.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 61.25 22.59 12.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.364 0.602 . . . . 0.0 111.709 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.9 m -96.13 141.55 29.37 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 166.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.56 51.82 4.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.007 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.501 ' HB3' ' CE1' ' A' ' 14' ' ' HIS . 39.8 m-85 -107.88 45.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.588 HG21 HD12 ' A' ' 20' ' ' ILE . 5.9 pt -113.66 143.87 22.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.922 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.589 ' OE1' ' HD2' ' A' ' 14' ' ' HIS . 1.4 pm0 -120.65 149.53 42.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 165.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -81.27 133.82 35.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.62 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.538 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.425 -0.797 . . . . 0.0 110.409 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.507 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 22.9 mmt . . . . . 0 N--CA 1.465 0.325 0 CA-C-O 121.149 0.499 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.554 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 0.4 OUTLIER -102.18 138.07 39.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.686 178.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.521 ' HG2' HG12 ' C' ' 32' ' ' ILE . 10.3 mt-10 -85.08 98.55 10.49 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.565 0.698 . . . . 0.0 109.287 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' C' ' 30' ' ' THR . 17.1 t -79.5 83.64 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 122.482 1.134 . . . . 0.0 110.904 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.569 ' HB3' ' CG1' ' C' ' 81' ' ' VAL . 12.3 mt -75.66 142.58 42.52 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.472 HG22 ' HB ' ' C' ' 82' ' ' ILE . 82.0 t -156.18 125.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 121.952 0.101 . . . . 0.0 110.889 -171.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.622 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 0.1 OUTLIER -111.97 162.82 14.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.152 0.501 . . . . 0.0 110.901 -178.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' THR . . . . . 0.529 HG23 ' O ' ' C' ' 84' ' ' LEU . 11.3 p . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.836 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 43.9 m . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.909 0.862 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -126.15 151.06 47.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.337 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -99.9 143.41 30.15 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.129 0.49 . . . . 0.0 111.301 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.498 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 29.2 m-85 -126.5 62.82 1.28 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 123.578 0.751 . . . . 0.0 109.766 -175.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.521 HG12 ' HG2' ' C' ' 18' ' ' GLU . 2.9 mp -57.02 121.98 5.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 123.114 1.435 . . . . 0.0 114.745 -172.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.453 ' CG2' ' HG ' ' C' ' 72' ' ' LEU . 16.7 m -141.81 167.01 16.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 111.267 -2.697 . . . . 0.0 112.523 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -96.57 52.16 1.53 Allowed Glycine 0 C--N 1.306 -1.089 0 CA-C-N 114.549 -1.205 . . . . 0.0 114.595 -168.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.536 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.61 -44.67 0.52 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 171.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -132.1 26.61 4.56 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -75.37 0.07 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.87 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -146.58 -79.3 0.16 Allowed 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.665 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 90.56 -29.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 125.375 1.672 . . . . 0.0 111.438 -167.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.468 ' HD2' ' HG2' ' C' ' 70' ' ' LYS . 0.1 OUTLIER -84.24 -70.35 0.58 Allowed 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 122.202 1.001 . . . . 0.0 109.14 177.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.04 -26.57 67.72 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.632 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.665 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -56.14 -50.14 71.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.162 171.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.619 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 43.6 mttp -64.59 -42.32 95.68 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.219 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -56.0 -36.73 68.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.572 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -70.11 -46.71 64.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.755 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.588 HG22 ' O ' ' C' ' 42' ' ' PHE . 8.5 pt -78.1 -13.79 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.792 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.98 -51.2 3.28 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.25 -45.47 69.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -28.07 64.83 Favored 'General case' 0 N--CA 1.424 -1.734 0 C-N-CA 122.868 0.467 . . . . 0.0 112.164 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' C' ' 84' ' ' LEU . 27.6 m -106.41 -3.81 9.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.18 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 82.6 p 63.35 23.7 13.87 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 122.054 0.93 . . . . 0.0 109.54 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.1 mm -131.63 120.44 17.71 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.244 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -67.73 152.8 77.29 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.034 1.823 . . . . 0.0 112.588 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 29.9 t -50.06 -40.89 46.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.358 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.495 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 15.7 pt-20 -67.12 -17.85 65.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.839 -177.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.495 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 67.7 mttm -121.09 -0.91 9.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -173.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.619 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 9.3 pt20 -96.07 142.26 28.49 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.626 -0.829 . . . . 0.0 112.863 -175.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . 0.47 ' O ' HD23 ' C' ' 84' ' ' LEU . 98.0 mtt180 -114.94 121.85 44.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.266 173.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 9.0 mp -92.07 107.3 19.11 Favored 'General case' 0 C--O 1.207 -1.164 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 37' ' ' ILE . 2.8 mt -105.2 106.37 20.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 120.973 0.416 . . . . 0.0 111.114 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -117.62 114.63 23.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.75 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 56.99 41.14 28.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.033 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.7 -15.47 36.34 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.205 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 tpm_? -81.06 126.87 31.97 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.504 -0.409 . . . . 0.0 110.208 -176.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . 0.438 HG21 ' HB2' ' A' ' 38' ' ' GLU . 15.8 t -83.48 90.28 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.973 0.416 . . . . 0.0 109.943 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.6 OUTLIER -75.6 134.14 40.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . 0.5 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 6.9 pt20 -135.22 -168.57 2.21 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.161 -171.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.58 ' HA ' HG12 ' C' ' 39' ' ' VAL . 5.7 p-10 -71.13 2.37 4.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.529 0.732 . . . . 0.0 112.296 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . 0.5 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 19.4 t70 -61.11 1.52 0.17 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.455 1.102 . . . . 0.0 113.146 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.468 ' HG2' ' HD2' ' C' ' 40' ' ' LYS . 47.4 mtmt 83.44 158.44 0.12 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 168.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 72.2 95.18 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.749 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.453 ' HG ' ' CG2' ' C' ' 33' ' ' VAL . 3.6 mm? -62.58 -36.8 83.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.81 177.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.95 -19.16 64.16 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -175.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.48 -27.87 63.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.53 ' CD1' HD21 ' C' ' 66' ' ' LEU . 25.4 m-85 -87.78 -22.36 24.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.731 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.1 t30 61.18 40.63 14.49 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.781 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.407 HG23 HD13 ' C' ' 82' ' ' ILE . 26.4 m -92.43 27.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.743 -175.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.554 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.03 101.74 1.61 Allowed Glycine 0 N--CA 1.433 -1.558 0 CA-C-O 122.744 1.191 . . . . 0.0 112.733 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.28 13.7 50.99 Favored Glycine 0 C--N 1.283 -2.366 0 CA-C-N 112.21 -1.995 . . . . 0.0 114.108 172.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -127.01 147.61 50.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.622 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 3.0 m -79.03 127.44 39.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.605 0.717 . . . . 0.0 112.636 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.472 ' HB ' HG22 ' C' ' 21' ' ' VAL . 27.0 mt -88.71 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.301 171.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.445 ' N ' HG23 ' C' ' 82' ' ' ILE . 86.0 t60 -109.82 133.33 53.27 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 121.821 -0.55 . . . . 0.0 110.094 166.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.529 ' O ' HG23 ' C' ' 23' ' ' THR . 5.8 mt -108.8 138.34 45.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.805 0.812 . . . . 0.0 112.244 170.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.367 177.695 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 3.0 mpt_? . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.93 0.395 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.622 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 12.3 m-85 -118.04 165.9 13.19 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.326 0.584 . . . . 0.0 109.521 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CB ' HD11 ' A' ' 40' ' ' LEU . 74.1 t80 -140.29 118.85 12.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.569 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -98.7 128.55 45.0 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -83.97 -21.32 31.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -167.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 32.0 p -72.36 -31.72 65.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 118.479 0.581 . . . . 0.0 110.016 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.404 ' C ' ' HG ' ' A' ' 17' ' ' SER . 94.5 m -85.64 -20.5 29.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.525 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.404 ' HG ' ' C ' ' A' ' 16' ' ' CYS . 24.8 p 51.22 32.23 7.84 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.116 0.966 . . . . 0.0 112.375 -175.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.426 HG23 HH11 ' A' ' 31' ' ' ARG . 2.8 m -141.42 157.2 21.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.494 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 32.8 tt0 -79.01 145.23 34.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.076 0.465 . . . . 0.0 111.196 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.642 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.3 pt -134.07 167.17 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.21 -173.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 45.3 t -122.76 94.34 47.58 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 163.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.622 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.65 175.35 0.29 Allowed 'Trans proline' 0 C--N 1.325 -0.709 1 C-N-CA 125.537 4.158 . . . . 0.0 116.522 -168.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.618 ' HB2' HG13 ' A' ' 28' ' ' ILE . 36.8 mtt180 -105.74 46.94 0.89 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.702 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -1.46 -60.92 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.932 0 CA-C-N 110.582 -3.008 . . . . 0.0 116.575 174.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.439 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 63.2 Cg_exo -33.58 -31.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.469 2.78 . . . . 0.0 114.55 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.537 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -122.13 -19.08 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.358 0.599 . . . . 0.0 111.745 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.472 ' C ' HD13 ' A' ' 37' ' ' ILE . 50.5 m-85 68.01 58.94 0.46 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.615 -171.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.618 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -111.81 161.38 10.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 113.328 -1.76 . . . . 0.0 108.966 178.299 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.486 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -95.92 146.38 31.22 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.642 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 83.9 Cg_endo -81.32 -21.03 6.71 Favored 'Trans proline' 0 CA--C 1.5 -1.188 0 C-N-CA 122.668 2.245 . . . . 0.0 108.238 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.478 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 84.5 mtt180 -86.79 -15.1 40.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.032 -1.894 . . . . 0.0 114.398 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 31.1 p -151.58 -10.69 0.21 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 175.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 60.42 33.6 20.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.559 0.695 . . . . 0.0 111.217 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 m -113.91 146.32 40.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.47 33.15 3.25 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.826 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 97.9 m-85 -87.88 43.45 1.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.2 0.524 . . . . 0.0 110.649 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.578 HG21 ' CD1' ' A' ' 20' ' ' ILE . 4.6 pt -111.24 135.37 50.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.8 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -117.03 145.01 43.96 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -77.12 135.87 38.59 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.465 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.787 -174.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.565 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 45.7 ttm . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 121.024 0.44 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.565 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 1.2 mt -105.55 137.98 42.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.51 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.461 ' HA ' HG13 ' C' ' 32' ' ' ILE . 32.5 tt0 -84.36 96.75 9.15 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.2 t -78.62 104.62 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.189 -172.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.593 ' C ' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -93.41 145.11 24.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.486 HG23 ' HB ' ' C' ' 82' ' ' ILE . 68.6 t -151.9 121.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 117.921 0.328 . . . . 0.0 110.957 -171.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.563 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 36.8 mtpt -103.51 122.19 44.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.117 -179.223 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.524 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 18.4 m . . . . . 0 C--O 1.232 0.18 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -122.49 153.44 39.17 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.65 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p -101.41 141.29 34.5 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-O 121.219 0.533 . . . . 0.0 112.251 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.494 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 29.4 m-85 -133.81 57.71 1.8 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.663 0.744 . . . . 0.0 109.758 -174.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.461 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.8 mp -57.24 119.19 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 123.362 1.553 . . . . 0.0 114.353 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 17.3 m -143.66 -168.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 110.915 -2.857 . . . . 0.0 111.627 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -96.4 159.11 21.76 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.054 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.534 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -59.65 -31.17 69.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.21 0.529 . . . . 0.0 112.187 -175.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.32 31.7 2.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.486 0.66 . . . . 0.0 109.258 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -74.33 0.14 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.026 -176.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.582 ' O ' HG13 ' C' ' 39' ' ' VAL . 8.5 m120 -128.82 -90.71 0.49 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.661 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 81.83 -30.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 124.794 1.309 . . . . 0.0 111.9 -165.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.491 ' HD2' ' HG2' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -80.23 -69.48 0.59 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 122.286 1.041 . . . . 0.0 108.516 176.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.17 -29.26 69.68 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 113.445 -1.707 . . . . 0.0 111.003 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.661 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.9 t80 -60.64 -53.49 56.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.523 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.648 ' HB2' ' OE1' ' C' ' 57' ' ' GLN . 0.0 OUTLIER -69.82 -33.64 72.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.99 0.424 . . . . 0.0 110.928 -179.444 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -38.64 87.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.718 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -69.65 -48.59 59.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.194 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.583 ' O ' HG22 ' C' ' 50' ' ' VAL . 17.3 pt -70.49 -12.12 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -173.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.29 -56.28 2.47 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.54 -44.3 87.28 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -25.27 65.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.338 0.59 . . . . 0.0 111.087 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.583 HG22 ' O ' ' C' ' 46' ' ' ILE . 30.9 m -110.48 -3.31 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.334 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 60.6 p 64.67 22.08 12.53 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.796 0.807 . . . . 0.0 109.49 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.7 mm -127.66 115.46 20.97 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.274 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 4.6 Cg_exo -73.97 147.02 38.13 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 121.936 1.758 . . . . 0.0 111.306 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -52.55 -24.85 8.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.765 0.826 . . . . 0.0 112.96 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 8.9 pt-20 -68.68 -41.74 78.81 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.677 0.275 . . . . 0.0 111.493 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.497 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 27.4 mtpp -96.2 -25.08 15.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.574 0.702 . . . . 0.0 109.686 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.648 ' OE1' ' HB2' ' C' ' 43' ' ' LYS . 17.8 tt0 -61.1 118.57 6.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.287 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -123.16 119.11 29.27 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.02 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 6.4 mt -84.79 116.29 23.19 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 37' ' ' ILE . 3.3 mt -114.89 122.04 68.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.831 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -136.32 132.72 36.04 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 57.46 35.39 25.83 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.104 0.478 . . . . 0.0 110.753 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.03 4.93 37.74 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.529 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -91.73 140.08 30.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.71 90.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.481 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -83.03 144.06 30.18 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.144 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -156.89 -167.4 2.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.522 -175.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.567 ' HA ' HG12 ' C' ' 39' ' ' VAL . 6.8 p-10 -60.78 0.22 0.23 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.969 1.308 . . . . 0.0 113.368 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 34.0 t70 -60.55 -10.69 5.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.506 0.722 . . . . 0.0 112.421 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.491 ' HG2' ' HD2' ' C' ' 40' ' ' LYS . 57.1 mtmt 88.33 -175.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.149 0.98 . . . . 0.0 112.615 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.422 ' HG2' ' C ' ' C' ' 70' ' ' LYS . 16.5 pttp 47.52 84.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.62 1.2 . . . . 0.0 113.06 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.46 HD22 HG22 ' C' ' 39' ' ' VAL . 35.2 mt -64.94 -32.22 73.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.608 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' C' ' 35' ' ' ALA . 10.3 pt20 -67.26 -18.4 65.2 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.01 -28.7 66.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.547 ' CD1' HD23 ' C' ' 66' ' ' LEU . 25.1 m-85 -86.96 -22.48 25.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.621 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.7 t30 62.09 37.11 14.88 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.001 174.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -88.92 18.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.053 0.454 . . . . 0.0 111.754 -174.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.565 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -73.95 102.81 1.37 Allowed Glycine 0 N--CA 1.427 -1.928 0 CA-C-O 122.779 1.211 . . . . 0.0 111.873 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.36 15.25 60.69 Favored Glycine 0 C--N 1.283 -2.364 0 CA-C-N 112.021 -2.09 . . . . 0.0 112.618 176.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -119.72 145.5 46.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.593 ' HA ' ' C ' ' C' ' 20' ' ' LEU . 34.3 m -83.07 123.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-O 122.111 0.957 . . . . 0.0 111.152 175.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.517 HG23 ' N ' ' C' ' 83' ' ' HIS . 57.6 mt -79.07 170.35 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.094 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.517 ' N ' HG23 ' C' ' 82' ' ' ILE . 44.6 m80 -118.26 116.89 27.69 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 mt -90.63 141.82 28.39 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.257 0.551 . . . . 0.0 111.521 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.431 ' CG2' HD12 ' C' ' 60' ' ' ILE . 31.9 m . . . . . 0 C--N 1.314 -0.953 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.677 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 . . . . . 0 CA--C 1.511 -0.527 0 CA-C-O 121.47 0.652 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.6 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 17.9 m-85 -116.2 162.59 17.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 171.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CB ' HD13 ' A' ' 40' ' ' LEU . 55.3 t80 -141.01 116.63 10.24 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.394 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.511 ' HB2' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -93.83 114.55 26.81 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.565 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.422 ' CG ' HG12 ' C' ' 85' ' ' VAL . 19.0 p80 -69.23 -12.81 61.99 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.878 -176.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 38.9 m -71.57 -39.26 70.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 110.705 173.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.1 m -88.35 -27.58 21.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 110.813 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.53 28.48 17.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.696 -170.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.446 HG13 ' CZ ' ' A' ' 31' ' ' ARG . 97.5 t -131.34 144.53 37.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.445 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 25.8 tt0 -74.93 145.83 42.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 110.453 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.652 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.9 pt -135.7 167.84 24.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.343 -170.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.481 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 61.3 t -124.59 95.69 42.39 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 164.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.8 176.31 0.23 Allowed 'Trans proline' 0 C--N 1.325 -0.681 1 C-N-CA 125.386 4.057 . . . . 0.0 116.216 -173.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.56 ' HB2' HG13 ' A' ' 28' ' ' ILE . 7.8 mtt180 -112.43 52.19 0.78 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 112.711 -2.041 . . . . 0.0 107.155 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 4.04 -61.4 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.016 0 CA-C-N 111.06 -2.791 . . . . 0.0 117.221 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 13.1 Cg_exo -34.12 -37.42 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.899 2.399 . . . . 0.0 113.701 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.09 -23.75 9.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.848 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.566 ' C ' HD12 ' A' ' 37' ' ' ILE . 60.4 m-85 65.18 57.41 0.94 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.304 1.049 . . . . 0.0 109.303 -168.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.56 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.4 OUTLIER -105.7 162.61 4.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.521 176.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.5 t -94.62 145.01 28.87 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 70.3 Cg_endo -83.78 -20.33 4.61 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.938 2.425 . . . . 0.0 108.688 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.482 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 12.5 mtp180 -89.02 -7.91 55.03 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.016 -1.902 . . . . 0.0 114.014 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.4 p -162.66 -8.4 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 15.7 tt0 62.31 28.17 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.137 0.494 . . . . 0.0 112.213 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.1 p -99.58 150.86 21.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.8 25.77 7.2 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.711 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.454 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 75.7 m-85 -89.48 48.99 1.67 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.105 0.479 . . . . 0.0 110.551 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.587 HG23 ' CD1' ' A' ' 20' ' ' ILE . 3.5 pt -110.73 138.56 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.485 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.458 ' HB2' HG23 ' C' ' 65' ' ' VAL . 7.2 pt-20 -123.19 137.67 54.83 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -68.24 140.62 56.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.59 HD13 ' CB ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.499 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.55 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 63.8 ttp . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.631 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 1.2 mt -106.25 131.39 53.54 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.066 173.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.514 ' HA ' HG13 ' C' ' 32' ' ' ILE . 33.9 tt0 -82.5 96.24 7.96 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.624 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 2.5 t -80.45 124.57 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -173.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.4 OUTLIER -110.45 145.62 37.33 Favored 'General case' 0 N--CA 1.417 -2.075 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 171.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.586 HG22 ' HB ' ' C' ' 82' ' ' ILE . 55.4 t -148.38 126.75 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 117.905 0.321 . . . . 0.0 110.404 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.529 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 42.4 mtmt -111.9 127.13 55.75 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.34 0.59 . . . . 0.0 110.029 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 C--N 1.307 -1.282 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.414 172.37 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 97.3 m . . . . . 0 C--O 1.237 0.416 0 CA-C-O 120.781 0.324 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -122.56 151.81 41.02 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.951 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 3.5 p -99.14 140.2 33.67 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.624 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 24.9 m-85 -136.52 60.78 1.66 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.841 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.514 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.6 mp -57.71 128.88 18.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 122.898 1.332 . . . . 0.0 114.304 -172.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.614 HG11 ' CD2' ' C' ' 42' ' ' PHE . 15.3 m -122.78 -169.88 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 112.053 -2.34 . . . . 0.0 111.546 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -125.57 33.34 3.63 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.17 -175.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.661 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . 65.72 18.36 11.15 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 167.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.661 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 10.1 tt0 157.61 -11.85 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.82 0.819 . . . . 0.0 109.163 -166.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.8 tpt -45.4 -73.68 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.844 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.474 ' O ' HG12 ' C' ' 39' ' ' VAL . 77.9 m-20 -141.25 -88.57 0.16 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.554 ' HA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 92.84 -30.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 125.297 1.623 . . . . 0.0 111.274 -164.624 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -66.9 0.78 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 122.393 1.092 . . . . 0.0 108.873 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -61.76 -28.24 69.3 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 113.065 -1.88 . . . . 0.0 111.706 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.614 ' CD2' HG11 ' C' ' 33' ' ' VAL . 0.1 OUTLIER -57.27 -52.87 63.6 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 171.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.429 ' HA ' HG12 ' C' ' 46' ' ' ILE . 24.2 mtpp -67.01 -41.37 86.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.092 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -60.09 -34.71 73.83 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.044 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.6 -48.2 60.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.621 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.63 ' O ' HG21 ' C' ' 50' ' ' VAL . 20.6 pt -74.86 -10.42 13.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.307 -175.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -46.67 -40.64 13.52 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.04 -45.91 19.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -34.13 73.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.104 0.478 . . . . 0.0 110.765 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.63 HG21 ' O ' ' C' ' 46' ' ' ILE . 30.1 m -99.88 -8.12 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.158 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 31.5 m 68.8 20.14 8.15 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.837 0.827 . . . . 0.0 109.775 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.2 mm -123.29 110.98 30.41 Favored Pre-proline 0 N--CA 1.44 -0.935 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.72 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.39 143.11 68.61 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 122.622 2.214 . . . . 0.0 111.902 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' SER . . . . . 0.422 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 35.2 t -51.13 -28.31 10.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.843 -172.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.29 -30.96 60.54 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.877 0.37 . . . . 0.0 111.541 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -95.19 -28.83 14.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.827 0.823 . . . . 0.0 109.206 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.423 HE22 HG13 ' C' ' 46' ' ' ILE . 17.1 tt0 -63.67 122.64 16.85 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.124 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . 0.423 ' O ' HG22 ' C' ' 85' ' ' VAL . 72.6 mtp85 -120.97 123.76 43.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.756 -0.202 . . . . 0.0 110.462 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -90.95 124.06 34.92 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.503 HG21 ' O ' ' A' ' 37' ' ' ILE . 4.6 mt -118.29 125.75 74.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 O-C-N 121.622 -0.674 . . . . 0.0 111.595 172.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.456 ' CD2' HG12 ' C' ' 77' ' ' VAL . 55.1 t80 -138.64 131.87 30.05 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 46.23 40.39 7.43 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.104 0.478 . . . . 0.0 111.357 -170.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.91 5.73 58.39 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.923 -0.58 . . . . 0.0 113.617 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.582 ' HD3' ' N ' ' C' ' 65' ' ' VAL . 0.0 OUTLIER -99.22 131.26 45.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . 0.582 ' N ' ' HD3' ' C' ' 64' ' ' ARG . 2.0 t -82.41 90.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.113 0.482 . . . . 0.0 110.391 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.572 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.4 OUTLIER -71.78 148.1 46.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -158.31 -169.81 2.9 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.835 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.539 ' HA ' HG11 ' C' ' 39' ' ' VAL . 6.7 p-10 -67.04 -2.39 5.37 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.663 0.785 . . . . 0.0 112.233 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 20.9 t70 -68.73 -2.74 9.99 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.082 0.553 . . . . 0.0 111.802 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.454 ' HA ' ' CG1' ' C' ' 39' ' ' VAL . 53.5 mtmt 75.9 -162.47 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.685 178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' C' ' 70' ' ' LYS . 48.5 mttp 77.51 57.18 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.831 0.707 . . . . 0.0 109.659 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.557 HD11 ' H ' ' C' ' 36' ' ' GLN . 22.0 mt -61.72 -56.36 20.46 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.827 -174.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -72.64 -15.86 61.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.073 0.464 . . . . 0.0 111.461 -176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -73.14 -28.93 62.52 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.051 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.572 ' CD1' HD22 ' C' ' 66' ' ' LEU . 24.0 m-85 -75.31 -25.38 57.81 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 61.51 26.39 16.13 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.382 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' C' ' 61' ' ' TYR . 31.3 m -83.04 21.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.902 -175.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.631 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.54 98.97 1.43 Allowed Glycine 0 N--CA 1.431 -1.675 0 CA-C-O 122.418 1.01 . . . . 0.0 111.985 177.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.23 14.14 39.84 Favored Glycine 0 C--N 1.285 -2.262 0 CA-C-N 112.382 -1.909 . . . . 0.0 114.541 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -128.68 147.32 50.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 16.6 m -80.19 125.78 39.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-O 121.881 0.848 . . . . 0.0 111.637 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.586 ' HB ' HG22 ' C' ' 21' ' ' VAL . 57.5 mt -80.25 171.17 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.8 173.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.507 ' N ' HG23 ' C' ' 82' ' ' ILE . 37.6 m80 -118.22 122.01 41.91 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 122.012 -0.43 . . . . 0.0 109.924 174.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mt -85.75 156.86 20.44 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.423 HG22 ' O ' ' C' ' 58' ' ' ARG . 8.0 t . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.417 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 121.229 0.538 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.634 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 17.0 m-85 -118.21 164.27 15.42 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.636 0.731 . . . . 0.0 110.752 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.645 ' CB ' HD13 ' A' ' 40' ' ' LEU . 54.9 t80 -140.92 120.28 13.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.877 178.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -98.57 121.37 40.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.222 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.627 ' CE1' ' HB ' ' C' ' 85' ' ' VAL . 8.9 p80 -76.69 -23.44 53.18 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 24.6 p -71.09 -38.15 72.41 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.272 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.6 m -74.85 -34.81 62.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.084 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.75 32.01 21.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.161 -172.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.5 t -131.65 144.12 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 38.7 tt0 -74.33 143.28 45.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.116 0.484 . . . . 0.0 110.885 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.656 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 4.0 pt -131.86 168.32 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.216 -169.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.423 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 57.7 t -123.53 98.29 40.95 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 162.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.579 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 6.8 Cg_endo -57.3 175.12 0.39 Allowed 'Trans proline' 0 C--N 1.326 -0.613 1 C-N-CA 125.302 4.001 . . . . 0.0 116.675 -169.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.653 ' HB2' HG13 ' A' ' 28' ' ' ILE . 26.0 mtt180 -107.68 47.38 0.89 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 112.629 -2.078 . . . . 0.0 107.183 176.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -0.07 -61.27 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 110.718 -2.947 . . . . 0.0 116.993 174.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.448 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 31.2 Cg_exo -30.96 -38.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 123.591 2.861 . . . . 0.0 114.176 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.515 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.48 -18.05 11.59 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.705 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.472 ' C ' HD11 ' A' ' 37' ' ' ILE . 62.8 m-85 67.11 45.93 1.62 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.04 -172.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.653 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -94.07 161.61 2.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.653 174.622 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.648 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -96.61 145.73 30.08 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.656 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 78.7 Cg_endo -80.46 -20.27 8.33 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 122.861 2.374 . . . . 0.0 108.089 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.648 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.1 mtt-85 -80.19 -34.77 37.19 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 112.658 -2.065 . . . . 0.0 113.712 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.8 p -137.59 -8.74 1.67 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 61.29 35.42 18.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.474 0.654 . . . . 0.0 111.061 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 m -113.09 146.36 39.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.545 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.55 45.86 3.57 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.741 -177.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 57.9 m-85 -102.4 44.38 1.02 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.961 0.41 . . . . 0.0 110.268 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.576 HG22 ' HB2' ' A' ' 13' ' ' CYS . 5.8 pt -115.27 139.21 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.191 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -123.86 145.67 48.93 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.34 131.36 39.13 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.645 HD13 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.857 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 50.9 mtm . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 121.014 0.435 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.592 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 3.7 mt -98.58 132.71 43.77 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.509 ' HA ' HG13 ' C' ' 32' ' ' ILE . 25.6 tt0 -82.23 93.92 7.2 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.617 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 3.1 t -77.06 104.85 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.06 -172.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.614 ' CB ' HG12 ' C' ' 81' ' ' VAL . 1.1 mt -92.76 142.27 27.53 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.56 HG21 ' HB ' ' C' ' 82' ' ' ILE . 59.4 t -147.95 128.92 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -174.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.582 ' CD ' HG21 ' C' ' 81' ' ' VAL . 79.2 mttt -114.24 159.81 19.73 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.361 0.601 . . . . 0.0 109.804 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 C--N 1.308 -1.229 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.99 172.33 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.452 ' OG1' ' HE2' ' C' ' 22' ' ' LYS . 53.7 m . . . . . 0 C--O 1.231 0.123 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -123.33 161.93 23.71 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.795 -177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.5 p -103.69 143.44 32.78 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.468 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.617 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 27.6 m-85 -137.14 59.0 1.7 Allowed 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.271 -174.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -57.92 124.26 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 123.352 1.548 . . . . 0.0 113.872 -174.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' C' ' 16' ' ' MET . 17.2 m -135.27 -165.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 111.104 -2.771 . . . . 0.0 111.324 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.04 -161.76 37.32 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.741 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' C' ' 72' ' ' LEU . . . -100.91 -12.86 18.62 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.577 0.703 . . . . 0.0 111.296 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -166.95 26.57 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -172.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 18.3 ttt -71.95 -73.05 0.2 Allowed 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 111.816 -2.447 . . . . 0.0 110.941 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.618 ' O ' HG11 ' C' ' 39' ' ' VAL . 70.5 m-20 -131.11 -98.18 0.32 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 178.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.618 HG11 ' O ' ' C' ' 38' ' ' ASN . 0.3 OUTLIER 86.7 -16.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 125.341 1.651 . . . . 0.0 111.731 -167.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' C' ' 43' ' ' LYS . 0.1 OUTLIER -88.69 -70.79 0.63 Allowed 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.048 0.928 . . . . 0.0 108.965 171.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.12 -29.4 70.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.099 173.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.602 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -62.08 -54.43 41.41 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.438 175.314 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' C' ' 40' ' ' LYS . 20.0 ptmt -68.25 -33.66 74.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -42.66 82.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.103 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -68.71 -43.26 76.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.439 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.593 ' O ' HG21 ' C' ' 50' ' ' VAL . 16.1 pt -78.35 -10.75 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -172.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.2 -61.02 0.95 Allowed 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.75 86.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -32.82 71.15 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.055 0.455 . . . . 0.0 111.049 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.593 HG21 ' O ' ' C' ' 46' ' ' ILE . 24.3 m -103.63 -3.36 9.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.453 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 48.2 t 69.58 20.04 7.2 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.65 0.738 . . . . 0.0 109.318 178.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.2 mm -123.38 110.67 30.41 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.174 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 6.0 Cg_exo -72.8 146.03 41.95 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.371 2.047 . . . . 0.0 111.299 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -54.49 -24.62 21.27 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.608 0.763 . . . . 0.0 112.285 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -73.6 -26.3 60.74 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -107.66 -26.41 10.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 109.981 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.527 ' OE1' HD13 ' C' ' 46' ' ' ILE . 9.9 tt0 -57.96 118.3 5.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.9 -173.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -122.37 118.0 27.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.314 172.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 5.2 mp -84.7 117.87 24.06 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 37' ' ' ILE . 7.0 mt -115.12 118.12 57.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.169 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -132.39 128.15 36.97 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 58.68 38.83 24.95 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.508 0.505 . . . . 0.0 110.627 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.79 4.17 13.15 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.258 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -89.18 133.98 34.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.14 89.68 2.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.3 OUTLIER -75.04 130.57 39.54 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -143.11 -172.72 3.74 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.511 -170.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.537 ' HA ' HG13 ' C' ' 39' ' ' VAL . 4.4 p-10 -64.3 -3.06 2.52 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.44 0.696 . . . . 0.0 112.145 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 33.7 t70 -68.35 -4.94 16.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.072 0.549 . . . . 0.0 112.293 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' C' ' 69' ' ' ASP . 35.8 mtmm 74.44 -158.21 0.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.375 0.67 . . . . 0.0 110.939 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.527 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 54.3 mttp 71.91 54.08 0.19 Allowed 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.552 0.532 . . . . 0.0 110.692 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.565 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 60.1 mt -63.43 -44.28 95.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.181 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . 0.432 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 9.3 pt20 -70.08 -20.44 63.21 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.742 0.306 . . . . 0.0 111.466 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . 0.527 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 28.0 mm-40 -71.1 -28.01 64.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.555 ' CD1' HD21 ' C' ' 66' ' ' LEU . 19.3 m-85 -83.7 -24.72 31.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 57.66 37.85 27.48 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.807 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -87.31 20.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.539 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.592 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.69 99.93 1.53 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-O 122.767 1.204 . . . . 0.0 112.322 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.88 14.34 43.34 Favored Glycine 0 C--N 1.284 -2.307 0 CA-C-N 112.223 -1.989 . . . . 0.0 113.72 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -124.33 147.49 48.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.614 HG12 ' CB ' ' C' ' 20' ' ' LEU . 4.5 m -82.05 128.53 38.64 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-O 122.055 0.931 . . . . 0.0 111.43 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.56 ' HB ' HG21 ' C' ' 21' ' ' VAL . 54.3 mt -86.9 168.44 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.122 175.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.452 ' N ' HG23 ' C' ' 82' ' ' ILE . 40.7 m80 -117.42 115.03 24.4 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.889 -0.507 . . . . 0.0 110.162 175.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.411 HD12 HG22 ' C' ' 50' ' ' VAL . 13.4 mt -90.67 157.36 17.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.291 0.567 . . . . 0.0 112.379 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.627 ' HB ' ' CE1' ' A' ' 14' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.917 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 5.9 m-85 -116.74 167.53 11.01 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.041 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.544 ' CB ' HD11 ' A' ' 40' ' ' LEU . 48.8 t80 -140.87 114.39 8.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.28 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.593 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -93.49 118.02 30.81 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.51 177.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.429 ' HE2' ' CD1' ' C' ' 60' ' ' ILE . 1.1 p80 -76.68 -20.49 56.56 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.544 -171.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.593 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 16.1 p -72.91 -31.61 64.76 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.82 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.2 m -83.43 -30.61 27.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.189 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.02 28.29 16.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.409 -171.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.88 144.76 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 34.7 tt0 -71.23 146.66 48.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.512 -175.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.694 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 2.6 pt -138.62 166.61 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.847 -172.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.477 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 99.1 t -124.08 97.86 39.97 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 163.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.574 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 5.6 Cg_endo -57.24 173.76 0.59 Allowed 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 124.912 3.741 . . . . 0.0 116.571 -170.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HB2' HG13 ' A' ' 28' ' ' ILE . 15.2 mtt85 -107.35 47.33 0.89 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 112.489 -2.142 . . . . 0.0 107.59 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.506 HD23 ' CE1' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -6.28 -53.69 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 171.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -35.09 -36.16 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.561 2.174 . . . . 0.0 113.428 171.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.483 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.09 -17.56 10.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.352 177.398 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.506 ' CE1' HD23 ' A' ' 24' ' ' LEU . 74.7 m-85 69.68 50.99 0.47 Allowed 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.603 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.483 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -104.81 159.85 5.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.615 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.494 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 t -95.5 144.56 28.02 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.694 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 87.2 Cg_endo -81.24 -17.48 9.09 Favored 'Trans proline' 0 CA--C 1.5 -1.179 0 C-N-CA 122.761 2.308 . . . . 0.0 108.24 -173.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.48 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 60.5 mtt-85 -91.57 -13.81 31.37 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 112.937 -1.938 . . . . 0.0 114.617 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.0 p -153.16 -9.48 0.16 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 60.95 29.18 18.86 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.381 0.61 . . . . 0.0 110.91 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.2 m -109.24 146.97 33.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.487 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.21 28.95 4.46 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.772 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.413 ' HB3' ' CE1' ' A' ' 14' ' ' HIS . 63.0 m-85 -85.86 47.64 1.48 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.568 -0.372 . . . . 0.0 110.462 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 13' ' ' CYS . 5.7 pt -115.58 139.0 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.516 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -123.42 148.28 46.29 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -80.52 134.24 35.92 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.434 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.544 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.808 -174.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.565 ' H ' ' HA2' ' C' ' 34' ' ' GLY . 1.9 mpt? . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.586 HD12 ' HA ' ' C' ' 35' ' ' ALA . 0.7 OUTLIER -104.71 135.62 45.76 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.643 -171.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.485 ' HA ' HG13 ' C' ' 32' ' ' ILE . 36.4 tt0 -88.91 94.27 9.88 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.675 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.3 t -79.48 128.29 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -172.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.519 ' CB ' HG11 ' C' ' 81' ' ' VAL . 0.8 OUTLIER -114.21 150.14 34.74 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' C' ' 28' ' ' THR . 18.5 m -135.32 150.91 29.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.602 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 36.7 mtpt -125.72 96.38 4.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.712 0.291 . . . . 0.0 110.297 174.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' THR . . . . . 0.459 HG23 ' O ' ' C' ' 84' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.316 -0.891 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 171.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 78.7 m . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -136.24 154.56 50.88 Favored 'General case' 0 C--O 1.223 -0.333 0 O-C-N 122.288 -0.258 . . . . 0.0 110.31 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.518 HG22 ' CD2' ' C' ' 20' ' ' LEU . 4.1 p -108.79 147.34 32.19 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -171.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.675 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 31.0 m-85 -140.16 65.14 1.43 Allowed 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 123.292 0.637 . . . . 0.0 111.289 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.485 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.7 mp -59.56 122.17 9.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 123.073 1.415 . . . . 0.0 113.81 -175.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.532 HG12 ' CD2' ' C' ' 42' ' ' PHE . 15.8 m -130.74 -173.71 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 111.723 -2.49 . . . . 0.0 111.461 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.565 ' HA2' ' H ' ' C' ' 16' ' ' MET . . . -120.48 45.61 1.21 Allowed Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.146 -1.026 . . . . 0.0 114.464 -173.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.586 ' HA ' HD12 ' C' ' 17' ' ' LEU . . . 68.16 -36.24 0.3 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 169.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -144.8 20.71 1.64 Allowed 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -172.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 2.0 ttt -66.72 -69.38 0.31 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 112.196 -2.274 . . . . 0.0 110.332 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -142.42 -101.02 0.13 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.655 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.603 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 101.37 -27.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 125.516 1.76 . . . . 0.0 110.189 -165.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' C' ' 40' ' ' LYS . 0.0 OUTLIER -83.99 -71.14 0.52 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 122.127 0.965 . . . . 0.0 109.056 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.11 -27.22 69.24 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.721 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.71 ' O ' HG23 ' C' ' 46' ' ' ILE . 6.3 t80 -58.95 -52.44 65.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.566 173.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 51.3 mtpt -61.55 -42.75 99.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.028 0.442 . . . . 0.0 110.642 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -55.6 -40.92 72.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.361 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -68.98 -47.01 66.63 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.971 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.71 HG23 ' O ' ' C' ' 42' ' ' PHE . 4.1 pt -76.01 -13.06 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.415 -173.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.2 -60.6 1.2 Allowed 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.01 93.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.745 0.307 . . . . 0.0 111.699 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -17.69 64.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.475 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.544 HG21 ' O ' ' C' ' 46' ' ' ILE . 17.8 m -113.33 -6.63 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 33.6 t 69.55 22.18 6.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.648 0.737 . . . . 0.0 109.192 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.1 mm -130.06 117.04 17.99 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.635 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.461 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 5.5 Cg_exo -74.99 148.32 35.15 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.962 1.774 . . . . 0.0 111.12 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -55.12 -25.91 34.82 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.153 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.5 pt-20 -68.54 -24.65 64.66 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.653 0.263 . . . . 0.0 111.623 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.464 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 95.8 mttt -115.64 -17.76 11.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.446 0.641 . . . . 0.0 110.427 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.429 ' HA ' HG22 ' C' ' 52' ' ' ILE . 23.0 tt0 -66.28 119.35 11.39 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.596 -170.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -114.54 113.66 24.72 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.651 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.743 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 47.7 mt -82.62 105.27 13.53 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.512 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.1 mt -102.13 103.62 15.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.611 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -118.6 132.51 56.19 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.628 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 40.64 45.55 2.04 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.985 0.803 . . . . 0.0 111.705 -171.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.95 -6.28 20.83 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.654 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -87.03 129.71 34.78 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 t -87.38 89.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.081 0.467 . . . . 0.0 109.905 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.743 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.1 OUTLIER -76.96 155.84 32.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.103 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . 0.44 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.7 pt20 -160.16 -169.31 2.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.286 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.527 ' HA ' HG11 ' C' ' 39' ' ' VAL . 1.8 p-10 -61.6 1.34 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.251 1.42 . . . . 0.0 113.116 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' C' ' 67' ' ' GLN . 13.4 t70 -65.29 9.85 0.1 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.155 0.982 . . . . 0.0 113.103 -178.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' C' ' 68' ' ' ASP . 51.4 mttp 84.18 159.69 0.11 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.449 1.1 . . . . 0.0 113.648 170.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.4 ' HB3' ' HG2' ' C' ' 74' ' ' GLU . 95.3 mttt 67.89 89.56 0.1 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.123 -1.399 . . . . 0.0 113.005 173.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.433 HD13 ' CG2' ' C' ' 33' ' ' VAL . 11.3 mt -63.9 -36.1 82.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.559 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -66.89 -24.46 66.11 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . 0.4 ' HG2' ' HB3' ' C' ' 71' ' ' LYS . 26.1 mm-40 -62.19 -27.78 69.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.241 0.543 . . . . 0.0 109.623 176.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.534 ' CD1' HD21 ' C' ' 66' ' ' LEU . 17.8 m-85 -94.01 -12.24 29.07 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.781 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 3.8 m120 47.83 45.29 18.57 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.417 1.087 . . . . 0.0 113.366 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 29.5 m -86.68 19.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -74.35 102.41 1.37 Allowed Glycine 0 N--CA 1.429 -1.789 0 CA-C-O 122.989 1.327 . . . . 0.0 112.976 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.26 13.73 53.33 Favored Glycine 0 C--N 1.283 -2.394 0 CA-C-N 111.967 -2.116 . . . . 0.0 114.002 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -127.84 154.7 45.15 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.66 -0.318 . . . . 0.0 110.247 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.602 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 35.0 m -87.03 122.93 39.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.818 0.818 . . . . 0.0 112.157 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . . . . . . . . . 62.3 mt -86.7 135.26 25.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.512 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.404 ' O ' ' HB ' ' C' ' 60' ' ' ILE . 69.5 m80 -93.93 114.62 26.86 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.459 ' O ' HG23 ' C' ' 23' ' ' THR . 2.7 pp -127.37 157.13 40.78 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 118.786 -1.166 . . . . 0.0 113.517 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.533 -178.416 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.602 0.239 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.476 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 8.2 m-85 -117.99 165.21 13.99 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.34 0.59 . . . . 0.0 109.809 171.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.457 ' CB ' HD11 ' A' ' 40' ' ' LEU . 50.1 t80 -140.26 115.15 9.62 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.491 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.571 ' HB2' HG22 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -93.88 108.1 19.92 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -64.88 -15.4 61.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.652 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.5 t -72.34 -36.8 68.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.887 0.375 . . . . 0.0 110.478 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.461 ' HB3' HG23 ' A' ' 18' ' ' VAL . 66.0 m -88.77 -23.89 22.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.423 0.63 . . . . 0.0 110.594 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.07 30.61 20.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.272 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.461 HG23 ' HB3' ' A' ' 16' ' ' CYS . 2.6 m -138.38 162.95 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.694 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -83.42 145.24 29.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.608 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.5 pt -137.21 168.42 21.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.094 -171.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 45.9 t -125.14 99.58 34.09 Favored Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 162.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 12.9 Cg_endo -55.37 175.24 0.19 Allowed 'Trans proline' 0 C--N 1.328 -0.538 1 C-N-CA 125.306 4.004 . . . . 0.0 116.257 -173.17 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HB2' HG13 ' A' ' 28' ' ' ILE . 26.0 mtt180 -109.15 48.99 0.84 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.86 -1.973 . . . . 0.0 106.888 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 27' ' ' TYR . 1.8 mm? 3.05 -61.47 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.362 0 CA-C-N 111.09 -2.777 . . . . 0.0 117.334 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -34.86 -34.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 123.103 2.535 . . . . 0.0 114.42 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.53 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.84 -21.83 9.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.937 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.507 ' C ' HD12 ' A' ' 37' ' ' ILE . 77.3 m-85 65.57 57.6 0.86 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.148 0.975 . . . . 0.0 109.795 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -109.19 163.01 6.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 113.492 -1.686 . . . . 0.0 109.542 176.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 1.4 t -95.92 146.15 30.81 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.608 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 86.8 Cg_endo -83.32 -20.29 5.02 Favored 'Trans proline' 0 CA--C 1.501 -1.15 0 C-N-CA 122.607 2.205 . . . . 0.0 108.85 -175.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.469 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 63.3 mtt180 -86.16 -14.07 45.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.259 -1.791 . . . . 0.0 114.104 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 p -152.36 -14.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 8.4 tt0 62.72 36.59 13.25 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.028 0.531 . . . . 0.0 112.161 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 98.2 p -108.44 154.18 22.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 166.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.46 33.91 3.79 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.801 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.26 47.79 1.21 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.369 . . . . 0.0 111.045 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.571 HG21 HD13 ' A' ' 20' ' ' ILE . 3.6 pt -114.03 139.55 39.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.779 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.454 ' HB3' ' CD1' ' C' ' 60' ' ' ILE . 13.1 pt-20 -117.83 143.41 46.31 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -79.13 139.17 38.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.07 0.462 . . . . 0.0 109.836 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.457 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.933 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.102 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.501 ' H ' ' HA2' ' C' ' 34' ' ' GLY . 94.1 mmm . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.589 HD13 ' HA ' ' C' ' 35' ' ' ALA . 0.6 OUTLIER -99.95 127.46 46.14 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.859 -171.029 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.522 ' HA ' HG13 ' C' ' 32' ' ' ILE . 40.5 tt0 -84.59 92.64 8.19 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.644 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.8 t -76.96 126.24 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.956 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -174.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.611 ' HB2' ' CG1' ' C' ' 81' ' ' VAL . 0.2 OUTLIER -114.21 155.02 26.87 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 170.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.898 ' O ' ' HA ' ' C' ' 28' ' ' THR . 15.7 m -140.82 155.35 22.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.542 ' HG3' ' CG2' ' C' ' 81' ' ' VAL . 45.0 mtmt -134.35 114.18 12.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 169.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.637 176.349 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.898 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 95.0 m . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.516 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -133.93 170.44 15.62 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.205 -0.31 . . . . 0.0 110.674 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.53 HG23 ' CD2' ' C' ' 20' ' ' LEU . 2.6 p -112.09 145.21 40.15 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.644 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 29.5 m-85 -140.85 65.93 1.39 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.177 0.513 . . . . 0.0 110.895 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.522 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -60.32 121.7 8.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 123.384 1.564 . . . . 0.0 114.117 -174.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.549 HG13 ' CD2' ' C' ' 42' ' ' PHE . 10.9 m -125.08 -174.17 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 111.036 -2.802 . . . . 0.0 111.348 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.501 ' HA2' ' H ' ' C' ' 16' ' ' MET . . . -126.78 45.6 1.14 Allowed Glycine 0 C--N 1.317 -0.497 0 C-N-CA 119.78 -1.2 . . . . 0.0 114.119 -173.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.589 ' HA ' HD13 ' C' ' 17' ' ' LEU . . . 69.81 -26.29 0.15 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 169.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -163.33 25.51 0.09 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' MET . . . . . 0.521 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 31.7 tpp -77.14 -68.75 0.58 Allowed 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 112.15 -2.295 . . . . 0.0 109.659 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.574 ' O ' ' HB ' ' C' ' 39' ' ' VAL . 18.2 m120 -142.69 -157.1 0.74 Allowed 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.587 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 2.8 p 159.68 -16.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -70.48 0.6 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.248 -1.796 . . . . 0.0 108.24 169.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -62.68 -32.74 73.86 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.207 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.587 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -57.92 -51.69 68.57 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 173.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' C' ' 43' ' ' LYS . 31.3 mtpt -64.11 -39.3 93.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.99 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -56.6 -36.23 69.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.159 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -69.01 -39.79 79.08 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 122.911 0.484 . . . . 0.0 111.342 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.61 HD12 ' OE1' ' C' ' 57' ' ' GLN . 5.7 pt -84.55 -13.15 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.118 -175.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.32 -55.01 2.86 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.02 87.22 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -31.85 71.71 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.295 0.569 . . . . 0.0 110.868 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.541 HG22 ' O ' ' C' ' 46' ' ' ILE . 29.9 m -102.66 -2.06 9.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.033 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 84.3 p 63.12 23.55 13.99 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.812 0.815 . . . . 0.0 109.461 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.6 mm -130.45 115.29 17.2 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.781 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.48 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 4.5 Cg_exo -69.54 147.09 63.52 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.369 2.046 . . . . 0.0 111.061 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -51.37 -25.73 6.56 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.769 0.668 . . . . 0.0 112.059 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.48 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 10.2 pt-20 -70.75 -36.13 72.99 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.631 0.253 . . . . 0.0 111.568 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.43 -27.54 14.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.376 0.607 . . . . 0.0 110.363 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.61 ' OE1' HD12 ' C' ' 46' ' ' ILE . 6.0 tt0 -68.36 136.44 53.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.239 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . 0.428 ' HB2' ' CG2' ' C' ' 85' ' ' VAL . 47.2 mtm180 -137.48 137.37 38.62 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.33 172.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' C' ' 66' ' ' LEU . 38.6 mt -96.28 123.61 39.98 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.957 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 37' ' ' ILE . 9.9 mt -112.84 122.29 66.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 119.227 0.921 . . . . 0.0 111.374 169.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.647 ' CD2' HG11 ' C' ' 77' ' ' VAL . 36.3 t80 -128.36 119.12 24.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.615 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 58.36 37.4 25.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.117 0.484 . . . . 0.0 110.414 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.46 -4.95 65.78 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.747 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' C' ' 64' ' ' ARG . 2.5 tpm_? -92.43 126.0 37.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.35 90.74 3.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.371 0.605 . . . . 0.0 110.559 -174.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' C' ' 75' ' ' TYR . 0.1 OUTLIER -72.6 154.59 40.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.738 -178.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -152.44 -170.47 3.65 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.214 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.456 ' HA ' HG12 ' C' ' 39' ' ' VAL . 7.8 p-10 -69.64 -2.37 11.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.174 0.589 . . . . 0.0 112.125 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 18.4 t70 -62.91 -9.98 11.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.442 ' HA ' ' CG1' ' C' ' 39' ' ' VAL . 52.9 mtmt 77.53 -175.51 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.739 0.815 . . . . 0.0 111.888 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.446 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 35.5 mmtp 75.09 69.02 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.634 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 30.7 mt -66.89 -39.75 87.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.563 -176.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -67.81 -19.87 65.12 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 120.793 0.33 . . . . 0.0 111.521 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . 0.446 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 17.0 mm-40 -71.05 -27.08 63.39 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.449 ' CD1' HD21 ' C' ' 66' ' ' LEU . 25.2 m-85 -88.28 -25.11 22.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 61.7 t30 60.07 34.24 21.31 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.07 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.647 HG11 ' CD2' ' C' ' 61' ' ' TYR . 17.5 m -83.67 11.92 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -174.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.546 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -71.24 100.81 0.9 Allowed Glycine 0 N--CA 1.431 -1.661 0 CA-C-O 122.634 1.13 . . . . 0.0 113.298 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.5 13.41 28.28 Favored Glycine 0 C--N 1.285 -2.268 0 CA-C-N 112.123 -2.039 . . . . 0.0 115.804 170.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -136.04 148.56 48.41 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.68 0.74 . . . . 0.0 110.507 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.611 ' CG1' ' HB2' ' C' ' 20' ' ' LEU . 27.2 m -74.48 118.94 20.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 CA-C-O 121.97 0.89 . . . . 0.0 112.502 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.423 HG21 ' N ' ' C' ' 83' ' ' HIS . 84.8 mt -70.76 160.6 5.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.514 173.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.423 ' N ' HG21 ' C' ' 82' ' ' ILE . 66.0 m-70 -115.56 117.65 30.93 Favored 'General case' 0 C--N 1.319 -0.761 0 O-C-N 121.338 -0.851 . . . . 0.0 109.564 173.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.43 ' CD1' ' HB ' ' C' ' 21' ' ' VAL . 10.2 mp -85.29 160.94 19.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.238 0.542 . . . . 0.0 111.699 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.428 ' CG2' ' HB2' ' C' ' 58' ' ' ARG . 5.6 m . . . . . 0 C--N 1.324 -0.522 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.423 ' HG2' HD13 ' A' ' 40' ' ' LEU . 43.4 ttm180 . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.283 0.563 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.508 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 6.3 m-85 -116.62 148.69 40.72 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.875 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.484 ' CB ' HD21 ' A' ' 40' ' ' LEU . 37.9 t80 -118.17 116.12 26.18 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.455 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.566 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -92.53 131.73 37.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.509 ' CD2' HG23 ' C' ' 85' ' ' VAL . 72.6 m-70 -85.8 -27.33 25.23 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -169.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 30.7 p -71.36 -30.63 66.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.319 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.416 ' O ' HG22 ' A' ' 18' ' ' VAL . 84.9 m -83.42 -33.01 25.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.091 0.472 . . . . 0.0 110.211 172.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.0 34.28 24.09 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.114 -173.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 16' ' ' CYS . 18.9 t -138.89 145.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.26 146.36 45.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.18 0.514 . . . . 0.0 112.003 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.615 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 2.3 pt -136.14 167.42 24.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.624 -172.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.63 111.39 31.41 Favored Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 159.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.508 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 22.2 Cg_endo -69.04 175.84 6.99 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 124.372 3.381 . . . . 0.0 115.687 -167.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 13.8 mtt180 -108.77 48.86 0.84 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.859 -1.973 . . . . 0.0 106.798 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -1.05 -58.66 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.057 0 CA-C-N 110.964 -2.835 . . . . 0.0 117.056 171.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.434 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 20.0 Cg_exo -37.98 -33.98 0.29 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.706 2.271 . . . . 0.0 113.774 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.521 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.49 -21.0 10.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.777 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' C ' HD12 ' A' ' 37' ' ' ILE . 80.3 m-85 65.49 56.27 0.97 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.356 1.074 . . . . 0.0 109.878 -169.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -109.59 162.85 7.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.38 -1.737 . . . . 0.0 109.606 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.5 t -97.46 147.53 33.12 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.615 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 65.6 Cg_endo -82.56 -19.82 6.08 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.851 2.367 . . . . 0.0 108.046 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.628 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 94.9 mtt-85 -82.69 -24.55 33.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 113.007 -1.906 . . . . 0.0 114.114 -178.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.432 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 28.6 p -147.2 -12.21 0.42 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 8.1 tt0 62.27 29.2 17.33 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.329 0.585 . . . . 0.0 111.02 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 m -106.26 146.76 29.94 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 170.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.27 44.47 3.29 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.572 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 95.4 m-85 -103.95 45.03 0.98 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.52 0.676 . . . . 0.0 109.851 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.566 ' CG2' ' HB2' ' A' ' 13' ' ' CYS . 10.7 pt -113.41 138.76 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.943 -176.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.489 ' HB3' HD12 ' C' ' 60' ' ' ILE . 13.4 pt-20 -129.57 143.85 51.01 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -79.5 133.39 36.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.024 0.44 . . . . 0.0 110.314 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.484 HD21 ' CB ' ' A' ' 12' ' ' PHE . 8.2 mt . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.708 -170.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 92.3 mmm . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 121.175 0.512 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.557 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 5.2 mt -90.37 137.73 32.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.093 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.517 ' HA ' HG13 ' C' ' 32' ' ' ILE . 41.4 tt0 -88.79 89.56 8.04 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.61 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 7.9 t -74.79 97.29 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.978 -173.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.652 ' HB3' ' CG1' ' C' ' 81' ' ' VAL . 4.4 mt -88.89 153.14 21.28 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' C' ' 28' ' ' THR . 33.9 m -144.81 147.55 18.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.343 0.257 . . . . 0.0 110.402 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.617 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 79.8 mttt -131.17 120.41 23.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' THR . . . . . 0.405 HG22 ' O ' ' C' ' 84' ' ' LEU . 3.3 p . . . . . 0 C--N 1.315 -0.898 0 CA-C-O 120.811 0.339 . . . . 0.0 111.09 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.717 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 53.5 m . . . . . 0 C--O 1.235 0.315 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -131.57 172.36 12.32 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.148 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.441 HG21 ' HG ' ' C' ' 20' ' ' LEU . 1.6 p -115.04 151.58 33.98 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.61 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 28.4 m-85 -137.46 58.64 1.7 Allowed 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 124.141 0.977 . . . . 0.0 109.812 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.517 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.4 mp -58.71 123.27 10.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 123.443 1.592 . . . . 0.0 114.38 -172.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' C' ' 16' ' ' MET . 10.7 m -124.66 -170.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 110.79 -2.913 . . . . 0.0 111.635 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.94 45.42 1.21 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.725 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.703 ' O ' ' HB3' ' C' ' 36' ' ' GLN . . . 68.06 17.12 9.51 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 165.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.703 ' HB3' ' O ' ' C' ' 35' ' ' ALA . 3.0 pt20 158.94 -9.08 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.292 0.568 . . . . 0.0 109.718 -162.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.2 tpt -39.83 -66.61 0.29 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.855 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.467 ' O ' HG13 ' C' ' 39' ' ' VAL . 26.2 m-80 -148.6 -88.52 0.08 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.684 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 89.29 -27.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 O-C-N 125.393 1.683 . . . . 0.0 111.559 -167.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -70.9 0.52 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.246 1.022 . . . . 0.0 108.873 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.46 -27.06 69.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.052 173.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.684 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.4 OUTLIER -56.74 -52.29 65.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.364 173.614 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 54.7 mtpt -61.02 -43.75 98.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.42 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -54.8 -39.19 68.2 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.306 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -70.23 -43.73 70.0 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.066 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.645 HG22 ' O ' ' C' ' 42' ' ' PHE . 3.9 pt -79.1 -11.66 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 120.458 0.17 . . . . 0.0 110.945 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.24 -55.48 3.29 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.793 0.683 . . . . 0.0 112.675 -177.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.31 -39.45 74.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -27.96 69.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.053 0.454 . . . . 0.0 111.0 -176.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.568 HG22 ' O ' ' C' ' 46' ' ' ILE . 28.9 m -108.27 -0.9 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.445 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 84.3 p 63.48 23.63 13.75 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.868 0.842 . . . . 0.0 109.464 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.0 mm -128.7 114.13 19.23 Favored Pre-proline 0 N--CA 1.439 -1.007 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.721 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.2 145.99 39.94 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.688 2.259 . . . . 0.0 111.929 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 41.1 t -53.08 -25.56 13.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.647 -174.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.496 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.6 pt-20 -70.76 -27.44 63.94 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.726 0.298 . . . . 0.0 111.474 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.496 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 92.8 mttt -109.0 -22.43 12.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.504 0.668 . . . . 0.0 109.936 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.408 ' HA ' ' CG2' ' C' ' 52' ' ' ILE . 23.6 tt0 -65.03 122.85 17.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.158 -169.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -127.41 115.55 19.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.982 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' C' ' 66' ' ' LEU . 5.3 mp -86.04 105.6 16.6 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.531 HG22 ' O ' ' A' ' 37' ' ' ILE . 13.4 mt -99.61 110.98 27.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 121.268 0.556 . . . . 0.0 111.811 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.484 ' CD2' HG12 ' C' ' 77' ' ' VAL . 50.0 t80 -122.12 121.02 35.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.261 173.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 60.31 39.32 19.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.983 0.421 . . . . 0.0 110.752 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.44 -1.45 27.73 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.679 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 6.2 mmp_? -88.73 140.46 29.42 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.44 87.87 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 0.0 110.611 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' C' ' 59' ' ' LEU . 6.1 mp -65.31 122.55 17.38 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.812 173.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . 0.401 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 19.1 pt20 -144.19 -170.21 3.3 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.23 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.532 ' HA ' HG12 ' C' ' 39' ' ' VAL . 2.2 p-10 -66.67 0.35 2.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.285 1.034 . . . . 0.0 112.599 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . 0.401 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 12.7 t70 -62.85 -2.68 1.25 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.516 0.726 . . . . 0.0 112.679 -177.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.419 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.1 mtmp? 81.71 172.06 0.12 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.12 0.968 . . . . 0.0 112.977 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.467 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 42.1 mtmt 71.0 86.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.937 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.491 ' HB2' ' N ' ' C' ' 36' ' ' GLN . 41.8 mt -71.68 -49.62 37.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.382 -176.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . 0.474 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 29.8 pt20 -67.91 -17.08 64.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . 0.467 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 7.0 mm-40 -63.67 -28.82 70.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.579 ' CD1' ' HG ' ' C' ' 66' ' ' LEU . 42.1 m-85 -85.11 -23.28 28.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.256 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.1 t30 59.72 30.04 19.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.377 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . 0.484 HG12 ' CD2' ' C' ' 61' ' ' TYR . 18.0 m -85.21 25.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -175.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.557 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -76.33 100.4 1.4 Allowed Glycine 0 N--CA 1.431 -1.65 0 CA-C-O 122.552 1.085 . . . . 0.0 111.929 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.95 13.23 34.63 Favored Glycine 0 C--N 1.284 -2.318 0 CA-C-N 112.364 -1.918 . . . . 0.0 114.278 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . 0.427 ' C ' ' HB2' ' C' ' 20' ' ' LEU . 8.2 mptt -126.19 144.19 50.86 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.142 0.471 . . . . 0.0 110.113 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.652 ' CG1' ' HB3' ' C' ' 20' ' ' LEU . 35.2 m -80.22 125.5 39.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.809 0.814 . . . . 0.0 111.524 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.517 HG21 ' HB3' ' C' ' 59' ' ' LEU . 42.6 mt -84.99 171.43 1.17 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.813 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -118.48 113.97 22.14 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 121.759 -0.588 . . . . 0.0 110.131 174.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.445 HD13 ' HB ' ' C' ' 21' ' ' VAL . 8.6 mp -103.32 139.41 38.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.058 0.456 . . . . 0.0 110.756 178.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.509 HG23 ' CD2' ' A' ' 14' ' ' HIS . 7.1 m . . . . . 0 C--N 1.322 -0.625 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.734 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.591 0.234 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.566 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.1 m-85 -117.92 145.39 44.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 169.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CB ' HD13 ' A' ' 40' ' ' LEU . 60.8 t80 -119.21 122.04 41.07 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.349 172.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.64 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -99.28 130.0 45.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.744 177.434 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -85.11 -26.57 26.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.446 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 26.4 p -70.33 -45.47 66.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.425 -174.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.464 ' C ' ' HG ' ' A' ' 17' ' ' SER . 18.6 p -95.05 -0.88 53.24 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.918 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.464 ' HG ' ' C ' ' A' ' 16' ' ' CYS . 35.9 p 50.5 43.18 27.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.586 1.155 . . . . 0.0 113.739 175.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 16' ' ' CYS . 32.1 t -133.3 144.69 35.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.8 148.27 40.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.58 ' CD1' HG21 ' A' ' 37' ' ' ILE . 4.1 pt -140.35 167.57 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.657 0.741 . . . . 0.0 112.93 -167.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.44 106.85 39.67 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 159.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.566 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 25.6 Cg_endo -68.74 175.64 6.97 Favored 'Trans proline' 0 C--N 1.32 -0.921 0 C-N-CA 124.688 3.592 . . . . 0.0 116.546 -166.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.489 ' CB ' HD12 ' A' ' 28' ' ' ILE . 83.7 mtt180 -108.87 48.48 0.86 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 112.65 -2.068 . . . . 0.0 107.434 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -3.28 -59.53 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.85 0 CA-C-N 110.854 -2.885 . . . . 0.0 117.479 173.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 26.8 Cg_exo -37.25 -37.01 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 122.59 2.194 . . . . 0.0 113.53 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.509 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -112.22 -21.49 11.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.704 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 42.2 m-85 68.99 57.41 0.39 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.259 1.028 . . . . 0.0 110.057 -170.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.509 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -111.49 163.79 8.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.159 176.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.452 ' SG ' HG23 ' A' ' 20' ' ' ILE . 1.5 t -95.72 142.4 24.53 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.545 ' HD3' HD11 ' A' ' 20' ' ' ILE . 91.9 Cg_endo -83.35 -18.82 5.75 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.074 1.85 . . . . 0.0 108.577 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.52 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 58.2 mtt180 -95.47 15.96 18.25 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.241 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 31' ' ' ARG . 14.3 p 175.64 -11.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.405 0.441 . . . . 0.0 111.901 172.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 10.4 tt0 63.95 29.71 14.35 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.197 0.522 . . . . 0.0 112.124 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -99.7 148.29 24.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.48 168.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.24 21.98 21.82 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.892 -175.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 74.9 m-85 -86.32 47.73 1.51 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.709 0.29 . . . . 0.0 110.985 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.64 ' CG2' ' HB2' ' A' ' 13' ' ' CYS . 6.6 pt -110.31 131.59 60.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.191 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -118.63 145.94 45.05 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -78.79 143.43 36.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.24 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.414 HD13 ' CB ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.148 -173.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.523 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 13.4 tmm? . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.764 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -106.3 142.76 35.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 172.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.489 ' HA ' HG13 ' C' ' 32' ' ' ILE . 38.8 tt0 -92.78 91.45 7.48 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 173.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' C' ' 30' ' ' THR . 2.9 t -76.2 103.1 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.757 -169.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -92.31 133.96 35.36 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.329 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.485 HG21 ' HB ' ' C' ' 82' ' ' ILE . 52.1 t -142.38 121.13 8.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -175.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.524 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 41.9 mtpt -95.7 154.09 17.39 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 50.9 p . . . . . 0 C--N 1.306 -1.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.662 -177.486 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 53.1 m . . . . . 0 C--O 1.233 0.211 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -129.22 151.45 49.88 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.629 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 4.2 p -104.87 144.12 32.21 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.537 ' HB2' HG11 ' C' ' 19' ' ' VAL . 35.8 m-85 -139.09 62.36 1.54 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.82 0.819 . . . . 0.0 110.147 -174.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.489 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.2 mp -60.25 122.75 11.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 123.221 1.486 . . . . 0.0 114.901 -173.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' C' ' 16' ' ' MET . 19.5 m -140.35 -166.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 111.116 -2.765 . . . . 0.0 112.377 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -80.33 177.84 54.16 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.79 174.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.764 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -79.8 -15.07 58.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.372 0.606 . . . . 0.0 111.476 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -161.93 27.75 0.12 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' MET . . . . . 0.442 ' HB2' ' HA3' ' C' ' 34' ' ' GLY . 4.5 ttp -57.69 -75.95 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.394 -174.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.453 ' O ' HG12 ' C' ' 39' ' ' VAL . 11.7 m120 -121.97 -82.33 0.65 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 120.903 0.383 . . . . 0.0 111.401 -177.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.666 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 78.31 -25.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 O-C-N 124.95 1.406 . . . . 0.0 113.068 -173.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.15 -68.87 0.71 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 122.35 1.071 . . . . 0.0 109.075 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -57.77 -32.67 67.72 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.028 -1.896 . . . . 0.0 110.221 171.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.666 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -63.33 -50.46 69.93 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.999 176.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . 0.686 ' HG3' ' OE1' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -59.11 -48.34 81.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.824 0.345 . . . . 0.0 110.278 176.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -57.31 -33.05 67.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.438 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -69.72 -51.12 37.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.284 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.693 HD13 ' OE1' ' C' ' 57' ' ' GLN . 17.7 pt -74.97 -14.31 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.525 -177.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.36 -57.09 2.27 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 124.165 0.916 . . . . 0.0 113.293 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.12 87.44 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -57.4 -43.73 83.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.484 0.659 . . . . 0.0 110.485 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.607 HG23 ' O ' ' C' ' 46' ' ' ILE . 27.1 m -88.16 -6.25 10.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.286 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m 67.87 21.1 9.14 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 121.62 0.724 . . . . 0.0 109.409 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.5 mm -129.67 111.81 17.6 Favored Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.325 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.449 ' HA ' ' HB2' ' C' ' 47' ' ' ALA . 5.0 Cg_exo -71.39 147.83 53.45 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.84 2.36 . . . . 0.0 111.554 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 37.9 t -51.15 -25.2 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.021 0.928 . . . . 0.0 112.81 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.458 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.5 pt-20 -78.14 -21.28 50.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 111.685 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.458 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 46.0 mtpt -112.9 -15.36 12.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.481 . . . . 0.0 110.195 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.693 ' OE1' HD13 ' C' ' 46' ' ' ILE . 9.6 tt0 -75.8 122.71 24.48 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.163 -174.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -121.73 124.2 43.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.743 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.519 HD11 ' HZ1' ' C' ' 43' ' ' LYS . 87.1 mt -88.29 118.23 27.75 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 37' ' ' ILE . 5.7 mt -114.27 113.12 42.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.047 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -126.15 121.73 33.66 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 59.95 38.39 20.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.792 -177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.03 -4.85 36.33 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.013 -0.54 . . . . 0.0 113.532 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -88.04 130.61 34.93 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.63 88.92 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.059 0.456 . . . . 0.0 109.848 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.522 HD23 ' CD1' ' C' ' 75' ' ' TYR . 0.3 OUTLIER -74.02 142.79 45.73 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -155.16 -168.65 2.93 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.042 -171.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.578 ' HA ' HG11 ' C' ' 39' ' ' VAL . 4.7 p-10 -60.78 -1.85 0.46 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.087 0.955 . . . . 0.0 113.421 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -68.53 -3.29 11.09 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.181 0.592 . . . . 0.0 112.165 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 57.6 mttp 76.63 -165.45 0.06 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.862 0.865 . . . . 0.0 110.623 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 mttt 68.69 55.85 0.46 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.463 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 31.1 mt -61.78 -33.04 73.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -71.72 -18.18 62.16 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 120.746 0.308 . . . . 0.0 111.575 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -76.44 -26.8 55.82 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.522 ' CD1' HD23 ' C' ' 66' ' ' LEU . 16.2 m-85 -82.63 -24.03 34.0 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 58.5 t30 62.88 41.52 8.6 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.596 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.26 -5.25 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-N 112.955 -1.929 . . . . 0.0 112.748 -158.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.639 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -52.58 104.92 0.2 Allowed Glycine 0 CA--C 1.487 -1.666 0 CA-C-O 123.329 1.516 . . . . 0.0 113.769 173.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.97 14.21 59.58 Favored Glycine 0 C--N 1.287 -2.194 0 CA-C-N 111.388 -2.406 . . . . 0.0 113.961 168.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -121.49 138.95 54.07 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 13.1 m -74.76 127.81 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 122.191 0.996 . . . . 0.0 111.46 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.485 ' HB ' HG21 ' C' ' 21' ' ' VAL . 12.6 mt -86.25 167.86 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.838 174.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.418 ' N ' HG21 ' C' ' 82' ' ' ILE . 65.2 m80 -118.92 115.3 24.08 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 19.5 tp -92.45 132.79 36.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.276 0.56 . . . . 0.0 111.914 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 m . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.342 177.635 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.441 ' HB3' HD13 ' A' ' 40' ' ' LEU . 77.6 mtp180 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 120.895 0.378 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.8 m-85 -116.25 144.82 43.72 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.412 173.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.509 ' CB ' HD23 ' A' ' 40' ' ' LEU . 53.8 t80 -114.24 121.59 44.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.762 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -98.43 119.52 37.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 174.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -76.88 -13.33 60.0 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.468 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 36.3 t -70.89 -42.04 70.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.353 0.597 . . . . 0.0 110.581 175.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -85.21 -27.03 26.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.581 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 1.6 m 58.09 29.5 17.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.214 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.37 144.25 34.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -74.82 147.64 40.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.177 0.513 . . . . 0.0 111.267 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.605 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 4.6 pt -133.36 169.7 21.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.841 -169.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.37 108.64 35.61 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 158.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.685 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 15.0 Cg_endo -69.06 177.49 5.05 Favored 'Trans proline' 0 C--N 1.328 -0.53 0 C-N-CA 125.181 3.921 . . . . 0.0 115.315 -170.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.588 ' HB2' HG13 ' A' ' 28' ' ' ILE . 8.2 mtt180 -112.57 50.46 0.87 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.592 174.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.481 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -0.3 -60.23 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 CA-C-N 111.334 -2.667 . . . . 0.0 116.365 172.316 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 24' ' ' LEU . 27.7 Cg_exo -34.79 -36.4 0.12 Allowed 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 123.045 2.497 . . . . 0.0 114.386 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.513 ' CB ' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -110.35 -22.92 11.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.72 178.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.443 ' C ' HD13 ' A' ' 37' ' ' ILE . 64.9 m-85 66.24 49.26 1.51 Allowed 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.642 -168.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.588 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -98.17 162.18 2.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.07 174.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.542 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.8 t -97.63 147.1 32.53 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.605 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 66.6 Cg_endo -80.93 -22.84 5.9 Favored 'Trans proline' 0 CA--C 1.499 -1.261 0 C-N-CA 122.897 2.398 . . . . 0.0 108.21 -174.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.516 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 80.1 mtt-85 -81.66 -30.02 32.9 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 112.819 -1.991 . . . . 0.0 113.776 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.4 p -141.6 -7.02 0.99 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.429 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 17.6 tt0 59.47 27.37 16.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.552 0.691 . . . . 0.0 111.219 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -107.71 143.02 36.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.369 171.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.37 33.24 2.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.899 -0.667 . . . . 0.0 114.012 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 41.1 m-85 -89.54 45.08 1.25 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.101 0.477 . . . . 0.0 110.423 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.536 ' O ' ' HA2' ' C' ' 63' ' ' GLY . 10.4 pt -112.32 132.48 60.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.227 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB3' HD12 ' C' ' 60' ' ' ILE . 7.5 pt-20 -120.08 136.23 54.66 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.95 137.57 39.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.971 0.415 . . . . 0.0 110.094 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.509 HD23 ' CB ' ' A' ' 12' ' ' PHE . 10.4 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.363 -172.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 45.5 ttm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.266 0.555 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' LEU . . . . . 0.632 ' HB3' ' HA2' ' C' ' 78' ' ' GLY . 0.0 OUTLIER -108.69 142.53 39.07 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.104 176.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . 0.517 ' HA ' HG13 ' C' ' 32' ' ' ILE . 37.8 mt-10 -85.04 94.69 8.89 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.5 t -77.9 111.46 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.613 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.4 mt -100.02 146.97 26.12 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' C' ' 28' ' ' THR . 9.4 m -137.32 153.9 29.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' LYS . . . . . 0.522 ' HG3' ' CG2' ' C' ' 81' ' ' VAL . 41.0 mtmt -125.77 133.18 52.14 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.314 -0.944 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.121 -172.418 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 25.5 m . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -131.21 157.55 42.91 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.442 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' THR . . . . . 0.535 HG22 ' CD2' ' C' ' 20' ' ' LEU . 16.8 p -103.76 149.11 25.32 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -172.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' PHE . . . . . 0.613 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 27.6 m-85 -140.36 63.11 1.48 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.376 -177.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . 0.517 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -59.17 122.69 9.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 122.973 1.368 . . . . 0.0 114.154 -174.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.647 HG12 ' CD1' ' C' ' 42' ' ' PHE . 13.9 m -135.74 -168.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 111.498 -2.592 . . . . 0.0 112.107 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.47 38.72 2.56 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.457 -0.878 . . . . 0.0 114.423 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . 71.09 16.99 6.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 163.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.71 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 9.7 tt0 153.43 -7.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.787 0.803 . . . . 0.0 108.933 -166.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' MET . . . . . 0.483 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 35.8 tpp -47.94 -66.52 0.39 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.296 173.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.483 ' OD1' ' HG3' ' C' ' 37' ' ' MET . 18.3 m120 -139.99 -162.68 1.38 Allowed 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 168.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.604 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 8.1 p 173.72 -19.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.485 ' HE2' ' HE2' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -83.05 -70.65 0.54 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.123 173.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -62.77 -32.45 73.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.531 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.647 ' CD1' HG12 ' C' ' 33' ' ' VAL . 5.9 t80 -59.05 -52.17 66.89 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.625 175.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -68.04 -35.67 78.64 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.638 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -56.39 -40.43 74.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.026 0.441 . . . . 0.0 111.133 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -69.56 -41.15 76.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.742 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' ILE . . . . . 0.614 ' O ' HG21 ' C' ' 50' ' ' VAL . 6.2 pt -76.59 -16.62 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -176.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -39.17 -59.57 1.0 Allowed 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.81 95.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -23.57 67.32 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.177 0.513 . . . . 0.0 111.097 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . 0.62 HG22 ' OE1' ' C' ' 57' ' ' GLN . 26.7 m -108.91 -5.93 10.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.096 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t 69.17 19.63 7.86 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.558 0.694 . . . . 0.0 109.637 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 3.4 mm -129.26 118.4 19.22 Favored Pre-proline 0 N--CA 1.444 -0.761 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.726 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' PRO . . . . . 0.427 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 5.1 Cg_exo -70.1 146.67 58.75 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.121 1.88 . . . . 0.0 111.188 177.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 8.7 t -53.48 -26.18 19.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.009 -176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.7 pt-20 -71.63 -32.45 67.96 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.899 0.38 . . . . 0.0 110.998 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.448 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 57.4 mtpt -99.45 -24.42 14.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.36 0.6 . . . . 0.0 110.123 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.62 ' OE1' HG22 ' C' ' 50' ' ' VAL . 6.2 tt0 -69.2 122.64 19.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.728 -173.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -112.02 122.63 48.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.674 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . 0.521 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 95.3 mt -88.46 110.75 21.1 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 38' ' ' GLU . 10.2 mt -108.64 113.88 45.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.95 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -133.54 132.54 41.05 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 59.11 34.21 23.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.401 -173.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 67.83 2.31 22.58 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.777 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -91.16 136.48 33.06 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -90.64 89.18 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.43 0.633 . . . . 0.0 109.563 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.547 HD21 ' CD1' ' C' ' 75' ' ' TYR . 0.3 OUTLIER -73.67 140.94 46.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.918 178.577 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -153.53 -169.31 3.26 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.561 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' ASP . . . . . 0.484 ' HA ' HG12 ' C' ' 39' ' ' VAL . 7.4 p-10 -65.56 -0.43 2.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.268 0.627 . . . . 0.0 112.161 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 38.4 t70 -58.32 -10.9 2.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.296 1.038 . . . . 0.0 113.367 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.485 ' HE2' ' HE2' ' C' ' 40' ' ' LYS . 89.5 mttt 85.6 175.16 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.285 1.034 . . . . 0.0 113.226 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 64.74 86.02 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.916 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.611 ' HB2' ' C ' ' C' ' 35' ' ' ALA . 57.9 mt -75.42 -34.15 60.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.41 -19.3 65.76 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 120.699 0.285 . . . . 0.0 111.636 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -68.8 -28.41 66.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' TYR . . . . . 0.547 ' CD1' HD21 ' C' ' 66' ' ' LEU . 20.9 m-85 -85.85 -23.26 27.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.1 t30 61.07 36.52 18.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.848 -1.524 . . . . 0.0 110.852 171.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.04 25.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.711 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -72.14 95.14 0.65 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-O 122.203 0.89 . . . . 0.0 113.074 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.64 14.77 45.73 Favored Glycine 0 C--N 1.305 -1.179 0 CA-C-N 113.341 -1.429 . . . . 0.0 113.508 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -119.01 149.82 40.99 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.052 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 10.5 m -82.68 124.07 39.04 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-O 122.299 1.047 . . . . 0.0 111.177 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' ILE . . . . . 0.497 HG21 ' N ' ' C' ' 83' ' ' HIS . 68.2 mt -81.95 167.3 2.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.925 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' HIS . . . . . 0.497 ' N ' HG21 ' C' ' 82' ' ' ILE . 54.8 m80 -118.71 115.11 23.82 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -113.94 151.47 32.24 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.051 -1.059 . . . . 0.0 112.562 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.415 0 CA-C-N 113.174 -1.83 . . . . 0.0 110.352 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 18.4 m -54.91 -41.49 71.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.324 0.583 . . . . 0.0 109.72 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 ttm -95.89 123.89 39.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.064 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 5' ' ' SER . . . 66.48 90.38 0.09 Allowed 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.869 0.731 . . . . 0.0 111.013 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.24 114.23 5.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.225 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.61 22.61 9.99 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.008 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 2' ' ' ALA . 23.2 t -118.72 113.46 36.25 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.44 96.46 1.04 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.726 2.284 . . . . 0.0 111.966 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -88.21 131.47 42.49 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.561 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -87.6 22.7 0.87 Allowed 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 123.242 2.628 . . . . 0.0 114.019 -168.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.75 -4.96 86.98 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -121.12 92.2 3.7 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.861 -0.2 . . . . 0.0 110.707 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.645 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 10.0 m-85 -120.67 165.29 15.27 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 167.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.464 ' CB ' HD22 ' A' ' 40' ' ' LEU . 75.4 t80 -137.22 117.44 13.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.687 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -97.55 120.95 38.86 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -74.69 -15.64 60.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.748 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.6 m -70.78 -37.28 73.34 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.937 0.399 . . . . 0.0 111.147 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.441 ' O ' HG22 ' A' ' 18' ' ' VAL . 90.5 m -89.48 -16.0 31.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.695 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 16' ' ' CYS . 22.7 p 49.64 31.35 4.2 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.256 -171.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 16' ' ' CYS . 98.0 t -141.13 146.91 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.539 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 25.5 tt0 -70.39 149.0 47.75 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.343 0.402 . . . . 0.0 111.235 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.621 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.4 pt -138.12 167.01 22.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.477 -173.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 40.5 t -122.96 96.68 44.67 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 163.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.645 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.88 177.12 0.19 Allowed 'Trans proline' 0 C--N 1.325 -0.691 1 C-N-CA 125.455 4.103 . . . . 0.0 116.426 -170.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.503 ' CB ' HD11 ' A' ' 28' ' ' ILE . 36.7 mtt180 -112.97 51.01 0.85 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 112.818 -1.992 . . . . 0.0 107.565 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.407 HD12 ' CE1' ' A' ' 27' ' ' TYR . 3.1 mm? 3.0 -60.81 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.213 0 CA-C-N 111.507 -2.588 . . . . 0.0 117.555 171.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.444 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 32.6 Cg_exo -37.12 -32.84 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.613 2.209 . . . . 0.0 113.826 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.538 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -118.29 -20.39 8.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.558 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.473 ' C ' HD12 ' A' ' 37' ' ' ILE . 44.1 m-85 65.25 46.66 2.59 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.57 1.176 . . . . 0.0 109.767 -170.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -92.0 163.77 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 113.315 -1.766 . . . . 0.0 109.793 174.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.537 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -94.29 144.49 28.1 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.621 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 68.3 Cg_endo -80.72 -22.43 6.45 Favored 'Trans proline' 0 CA--C 1.5 -1.208 0 C-N-CA 122.711 2.274 . . . . 0.0 108.083 -171.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.508 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 51.6 mtt180 -81.24 -34.76 31.92 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.968 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.4 p -139.27 -8.42 1.31 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.333 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 60.11 25.98 15.32 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.0 m -98.5 133.69 42.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 166.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.03 30.76 2.62 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.007 -172.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 51.8 m-85 -86.58 47.99 1.56 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.498 0.666 . . . . 0.0 109.842 176.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.538 HG21 HD11 ' A' ' 20' ' ' ILE . 9.6 pt -111.33 133.45 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.382 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HB3' HD12 ' C' ' 60' ' ' ILE . 11.5 pt-20 -117.2 141.48 48.23 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -79.29 131.99 36.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.206 0.527 . . . . 0.0 109.848 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.464 HD22 ' CB ' ' A' ' 12' ' ' PHE . 2.5 mt . . . . . 0 C--O 1.25 1.12 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.877 -173.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.16 107.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.743 0.652 . . . . 0.0 111.762 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 38.7 m80 65.14 46.26 2.78 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.823 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -83.88 -59.04 2.54 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 38.7 t60 51.13 54.09 11.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.512 0.672 . . . . 0.0 111.53 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -145.91 76.73 1.47 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 52.9 m80 67.5 87.94 0.12 Allowed 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 124.064 0.853 . . . . 0.0 108.915 -171.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -56.63 -29.35 62.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.563 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.7 148.85 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.886 0.85 . . . . 0.0 110.353 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -158.15 -40.47 0.06 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.088 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -69.76 -68.43 0.41 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.321 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.98 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.75 0.656 . . . . 0.0 111.559 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.21 -29.07 54.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.294 0.568 . . . . 0.0 109.986 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . 0.457 ' HA ' ' HB1' ' C' ' 35' ' ' ALA . 51.4 mtpt -72.69 -174.99 1.55 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.703 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.506 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 12.2 tpt 69.12 96.86 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.463 0.477 . . . . 0.0 110.335 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.735 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -99.19 148.29 24.25 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.467 ' HA ' HG13 ' C' ' 32' ' ' ILE . 30.2 tt0 -98.72 91.58 5.17 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.3 t -78.79 106.11 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.443 -168.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -94.64 140.93 29.21 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.471 HG22 ' HB ' ' C' ' 82' ' ' ILE . 70.7 t -151.68 120.44 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 37.7 mtpt -95.54 159.18 15.12 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 63.3 p -106.89 -42.23 4.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.783 -171.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.78 -46.57 0.06 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.731 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -178.07 -48.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.154 0.502 . . . . 0.0 110.158 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -62.53 -40.4 96.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.85 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -108.12 176.07 5.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.521 1.153 . . . . 0.0 113.637 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 22.8 m -176.68 102.88 0.06 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.146 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -125.59 152.89 44.51 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.63 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p -99.1 145.42 27.16 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.162 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.464 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 29.0 m-85 -135.88 58.54 1.74 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.654 -175.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.467 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -57.35 122.29 6.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 123.381 1.563 . . . . 0.0 114.362 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -142.94 -165.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 110.677 -2.965 . . . . 0.0 111.39 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -81.57 -179.85 53.13 Favored Glycine 0 C--N 1.312 -0.769 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.123 174.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.735 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -78.78 -23.83 45.04 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-N 117.254 0.527 . . . . 0.0 110.132 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -151.75 23.08 0.69 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -162.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' MET . . . . . 0.478 ' HB2' ' HA3' ' C' ' 34' ' ' GLY . 25.5 ttt -73.6 -68.75 0.48 Allowed 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 111.409 -2.632 . . . . 0.0 110.805 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.447 ' OD1' ' HG2' ' C' ' 37' ' ' MET . 23.6 m120 -126.19 -94.52 0.46 Allowed 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.583 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 82.94 -38.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 O-C-N 124.305 1.003 . . . . 0.0 111.128 -162.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.505 ' HA ' ' CB ' ' C' ' 68' ' ' ASP . 0.0 OUTLIER -78.97 -69.46 0.57 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 122.512 1.148 . . . . 0.0 108.939 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . 0.404 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 20.7 mt-10 -63.08 -27.82 69.66 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.902 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.583 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 2.6 t80 -59.05 -50.34 74.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.328 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.475 ' HE3' ' OG ' ' C' ' 54' ' ' SER . 23.1 mtpp -60.61 -41.27 94.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.988 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -57.73 -38.39 75.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.175 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -70.43 -45.97 64.81 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.209 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.595 ' O ' HG21 ' C' ' 50' ' ' VAL . 17.0 pt -76.78 -10.63 13.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -174.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -43.92 -49.46 8.42 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.63 -38.28 48.28 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.707 -0.397 . . . . 0.0 112.065 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -28.21 69.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.987 0.422 . . . . 0.0 110.996 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.595 HG21 ' O ' ' C' ' 46' ' ' ILE . 34.8 m -109.11 -5.84 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.47 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 46.1 m 68.13 20.65 8.9 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 121.629 0.728 . . . . 0.0 109.768 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.6 mm -122.95 111.2 30.97 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.546 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' C' ' 52' ' ' ILE . 7.1 Cg_exo -70.49 141.6 42.65 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.61 2.207 . . . . 0.0 111.695 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.475 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 42.8 t -50.75 -26.19 5.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.73 -173.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.75 -36.31 67.69 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -94.85 -32.28 13.33 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.741 0.782 . . . . 0.0 109.468 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.468 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 20.8 tt0 -51.92 132.43 32.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.664 -1.607 . . . . 0.0 111.48 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -133.95 113.02 11.73 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.506 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 37.8 mt -84.89 118.38 24.48 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.432 HD12 ' HB3' ' A' ' 38' ' ' GLU . 5.4 mt -117.25 121.17 67.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.664 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -137.85 132.82 33.12 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 59.15 32.87 22.45 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.534 0.521 . . . . 0.0 110.14 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 67.85 4.18 32.47 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.87 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -88.7 142.08 27.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -90.24 89.41 3.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.618 HD23 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -81.14 131.86 35.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -144.67 -177.32 5.44 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.536 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.511 ' HA ' HG11 ' C' ' 39' ' ' VAL . 6.7 p-10 -70.51 -3.22 16.87 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.751 0.821 . . . . 0.0 112.033 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.32 -21.63 62.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -131.85 -142.22 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.196 -0.315 . . . . 0.0 111.442 -169.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -126.64 167.17 16.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.623 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 7.3 mt -70.61 -37.31 73.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.022 0.439 . . . . 0.0 111.758 -175.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' C' ' 35' ' ' ALA . 23.1 tp60 -70.66 -18.65 62.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.521 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -61.61 -29.41 70.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.83 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.618 ' CD1' HD23 ' C' ' 66' ' ' LEU . 36.8 m-85 -103.66 -18.62 14.65 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.65 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.8 t30 59.22 52.6 5.96 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.904 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 35.1 m -95.23 14.98 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -171.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -57.56 99.27 0.1 OUTLIER Glycine 0 CA--C 1.492 -1.381 0 CA-C-O 122.915 1.286 . . . . 0.0 113.789 171.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.94 14.92 47.4 Favored Glycine 0 C--N 1.284 -2.328 0 CA-C-N 111.877 -2.162 . . . . 0.0 114.132 171.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.35 141.19 50.29 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 122.495 -0.414 . . . . 0.0 110.642 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 21.2 m -78.37 123.96 36.02 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-O 121.932 0.872 . . . . 0.0 111.104 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.5 HG23 ' N ' ' C' ' 83' ' ' HIS . 66.3 mt -82.6 168.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.0 172.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.5 ' N ' HG23 ' C' ' 82' ' ' ILE . 62.5 m80 -118.27 115.5 24.86 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 15.0 mt -88.42 148.73 24.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.17 0.51 . . . . 0.0 111.452 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.6 164.56 15.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.133 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.12 124.48 45.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.398 177.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -98.81 175.35 5.99 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.185 0.517 . . . . 0.0 111.251 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.77 148.97 95.12 Favored Pre-proline 0 N--CA 1.443 -0.793 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -55.74 135.46 69.62 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.939 1.759 . . . . 0.0 111.639 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -94.13 49.25 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.134 2.556 . . . . 0.0 112.227 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -74.41 -27.49 60.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.387 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 11.6 t -80.16 -20.16 45.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.381 0.61 . . . . 0.0 109.822 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -87.91 -30.6 19.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.044 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 48.8 tp -119.4 90.0 41.52 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.642 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.71 153.05 64.8 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.591 2.194 . . . . 0.0 111.294 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 46.3 t 65.63 88.35 0.11 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.341 0.591 . . . . 0.0 110.516 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.33 46.4 2.82 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.527 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.51 -59.38 1.95 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.759 0.314 . . . . 0.0 110.246 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 69.8 m -69.53 107.69 3.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.738 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 33.0 m 59.15 42.78 18.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.831 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.93 0 CA-C-O 119.195 -0.781 . . . . 0.0 111.471 -179.457 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.0 t -163.3 141.72 8.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.912 0.387 . . . . 0.0 110.798 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt -144.2 108.2 4.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.924 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.82 56.9 1.79 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.266 0.555 . . . . 0.0 110.714 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -83.7 61.61 6.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.742 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.79 87.56 5.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.34 -175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 t 66.32 96.22 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.845 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.72 83.8 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 123.031 2.487 . . . . 0.0 112.308 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -80.02 -45.08 1.48 Allowed Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -87.33 52.81 2.49 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 122.021 1.814 . . . . 0.0 111.593 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 21' ' ' VAL . . . 159.5 110.29 0.27 Allowed Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.742 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -139.4 86.03 2.09 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.443 -0.878 . . . . 0.0 109.547 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.556 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 9.0 m-85 -115.88 169.6 9.11 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.513 -1.222 . . . . 0.0 108.39 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.538 ' CB ' HD21 ' A' ' 40' ' ' LEU . 38.4 t80 -142.0 113.62 7.83 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.917 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 31.6 p -83.09 87.67 6.9 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.813 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.528 ' CE1' HG11 ' C' ' 85' ' ' VAL . 30.3 p80 -66.17 -14.72 62.32 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.619 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.754 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 3.0 p -67.08 -49.08 66.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.044 0.449 . . . . 0.0 110.437 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -99.9 -5.61 28.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.626 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m 65.16 55.44 1.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.034 172.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.94 145.36 24.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.501 ' C ' HG23 ' A' ' 20' ' ' ILE . 33.4 tt0 -86.25 138.92 31.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.132 0.492 . . . . 0.0 110.709 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.629 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 6.2 pt -143.49 166.87 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -164.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 9' ' ' GLY . 46.5 t -120.07 94.81 48.89 Favored Pre-proline 0 N--CA 1.447 -0.578 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 160.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 9.8 Cg_endo -56.73 171.36 1.03 Allowed 'Trans proline' 0 C--N 1.32 -0.965 1 C-N-CA 125.479 4.119 . . . . 0.0 117.186 -167.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.533 ' CB ' HD13 ' A' ' 28' ' ' ILE . 98.3 mtt180 -101.91 47.48 0.9 Allowed 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 112.4 -2.182 . . . . 0.0 107.205 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -8.53 -54.25 0.01 OUTLIER Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 110.467 -3.06 . . . . 0.0 115.606 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 19.2 Cg_exo -35.27 -33.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 123.216 2.611 . . . . 0.0 114.512 173.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.473 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -122.91 -19.01 6.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.121 0.486 . . . . 0.0 111.42 177.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.468 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 90.5 m-85 73.04 53.28 0.13 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.162 -174.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -108.78 164.16 5.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 113.628 -1.624 . . . . 0.0 108.086 177.21 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.414 ' HA ' HD12 ' A' ' 20' ' ' ILE . 27.1 p -94.49 139.12 22.24 Favored Pre-proline 0 N--CA 1.424 -1.733 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.629 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 85.4 Cg_endo -78.63 -25.31 6.67 Favored 'Trans proline' 0 CA--C 1.493 -1.545 0 C-N-CA 123.535 2.823 . . . . 0.0 108.822 -166.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.47 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 52.9 mtt180 -79.68 -28.86 40.67 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.381 -2.19 . . . . 0.0 113.162 -175.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -157.7 9.8 0.18 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.322 -170.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 49.48 64.24 1.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 167.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.507 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -133.3 147.88 51.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.169 169.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -88.46 6.85 83.13 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.49 -0.862 . . . . 0.0 114.089 -170.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.754 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 69.8 m-85 -83.4 59.46 5.07 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.505 -0.409 . . . . 0.0 111.485 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.583 ' CG2' HD11 ' A' ' 20' ' ' ILE . 3.5 pt -112.73 141.56 27.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.07 0.462 . . . . 0.0 111.769 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -129.23 153.71 47.51 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -84.78 143.4 29.14 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.538 HD21 ' CB ' ' A' ' 12' ' ' PHE . 7.9 mt . . . . . 0 C--N 1.311 -1.066 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.899 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.495 0.188 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.34 41.19 31.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.554 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -99.17 21.02 12.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.468 0.651 . . . . 0.0 110.144 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' C' ' 6' ' ' HIS . 6.5 p-80 -93.05 60.9 3.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.074 171.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' C' ' 5' ' ' HIS . 44.9 m80 67.72 95.33 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.191 -167.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -77.32 66.09 3.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.769 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -83.93 141.32 31.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.42 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 61.56 83.89 0.14 Allowed 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.503 0.502 . . . . 0.0 110.615 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.99 147.55 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.362 0.601 . . . . 0.0 110.551 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -145.51 45.47 1.3 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.239 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -98.3 20.5 12.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.292 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.06 146.17 53.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.261 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.44 -10.63 59.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.501 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 48.6 mttm 46.64 -170.62 0.01 OUTLIER 'General case' 0 C--N 1.339 0.117 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.652 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 24.6 ptt? -171.79 111.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.193 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.622 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 0.4 OUTLIER -104.09 133.07 49.65 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 170.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.507 ' HA ' HG13 ' C' ' 32' ' ' ILE . 26.0 mt-10 -80.45 96.56 6.78 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.0 t -81.63 104.64 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.5 -172.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -93.31 141.78 28.05 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.481 HG21 ' HB ' ' C' ' 82' ' ' ILE . 69.5 t -147.84 118.09 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 118.219 0.463 . . . . 0.0 110.781 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.625 ' HG2' ' OG1' ' C' ' 28' ' ' THR . 73.5 mttt -100.09 115.05 28.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.55 -173.24 2.5 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 32.3 mt -82.11 -60.3 2.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.433 0.635 . . . . 0.0 111.021 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -91.01 -18.53 24.46 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.883 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -103.33 -40.33 6.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.798 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 67.25 -177.36 0.2 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.74 0.816 . . . . 0.0 112.564 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.625 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 22.0 m -38.69 101.34 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.591 -175.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -126.67 154.72 43.69 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.332 -1.304 . . . . 0.0 109.547 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 2.4 p -103.03 141.91 35.01 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.476 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 26.8 m-85 -138.08 59.54 1.65 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.247 0.546 . . . . 0.0 109.991 -173.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.507 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.2 mp -54.88 125.46 9.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 123.04 1.4 . . . . 0.0 114.501 -173.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.6 m -132.7 -169.23 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 111.892 -2.413 . . . . 0.0 111.429 -176.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.68 40.85 1.99 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.239 -0.982 . . . . 0.0 114.323 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' C' ' 17' ' ' LEU . . . 70.07 -28.67 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 168.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' C' ' 36' ' ' GLN . 2.7 pt20 -154.48 24.7 0.46 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -173.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -76.2 -68.11 0.62 Allowed 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 112.51 -2.132 . . . . 0.0 111.046 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.459 ' O ' HG12 ' C' ' 39' ' ' VAL . 10.9 m120 -132.29 -87.51 0.45 Allowed 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.646 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 82.41 -37.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 124.746 1.279 . . . . 0.0 111.372 -166.033 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' C' ' 40' ' ' LYS . 0.0 OUTLIER -77.97 -68.17 0.66 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 122.591 1.186 . . . . 0.0 108.653 178.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.29 -28.0 69.42 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 112.616 -2.084 . . . . 0.0 110.819 173.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.646 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.2 t80 -58.32 -49.52 76.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.89 174.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.512 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 14.9 mtpp -62.97 -41.2 99.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.92 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -61.63 -37.29 83.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.035 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -70.35 -43.2 70.68 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.525 ' O ' HG21 ' C' ' 50' ' ' VAL . 18.2 pt -76.87 -12.13 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.281 -0.262 . . . . 0.0 110.948 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.94 -55.51 3.71 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 -42.82 91.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -21.64 65.64 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.241 0.543 . . . . 0.0 111.276 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.525 HG21 ' O ' ' C' ' 46' ' ' ILE . 27.7 m -112.31 -3.69 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.44 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 32.9 t 65.8 22.42 11.47 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.843 0.83 . . . . 0.0 109.049 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 11.5 mm -131.35 111.76 15.36 Favored Pre-proline 0 N--CA 1.437 -1.095 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.799 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.492 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 7.2 Cg_exo -68.29 151.68 76.3 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.496 2.13 . . . . 0.0 111.445 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.496 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 32.0 t -51.99 -32.65 34.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.572 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.535 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 13.5 pt-20 -66.26 -33.06 74.9 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.815 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.535 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 90.6 mttt -106.56 -1.04 23.4 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.371 0.605 . . . . 0.0 110.518 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.512 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 24.0 tt0 -90.21 123.62 34.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.109 -168.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . 0.468 ' O ' HG21 ' C' ' 85' ' ' VAL . 29.1 mtm105 -121.77 115.4 22.6 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.402 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 53.5 mt -87.94 122.68 31.84 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 122.452 0.301 . . . . 0.0 110.968 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' C' ' 64' ' ' ARG . 8.8 mt -114.63 112.07 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 121.494 -0.754 . . . . 0.0 111.39 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.489 ' CG ' HG12 ' C' ' 77' ' ' VAL . 41.0 t80 -116.62 133.12 56.39 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . 0.468 ' HG2' ' CD2' ' C' ' 61' ' ' TYR . 2.3 pt20 39.55 46.14 1.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.142 0.901 . . . . 0.0 112.153 -174.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.71 5.2 63.61 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.864 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -94.85 141.64 28.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.88 98.39 7.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.175 0.512 . . . . 0.0 109.951 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.534 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.0 OUTLIER -90.26 152.09 21.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.228 -176.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . 0.438 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.8 pt20 -158.14 -166.79 2.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.32 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.556 ' HA ' HG11 ' C' ' 39' ' ' VAL . 5.1 p-10 -62.49 0.54 0.46 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.052 0.941 . . . . 0.0 112.592 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' C' ' 67' ' ' GLN . 21.2 t70 -55.59 -11.65 0.96 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.376 1.071 . . . . 0.0 112.957 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.477 ' HA ' ' CG1' ' C' ' 39' ' ' VAL . 7.8 mtmp? 84.55 167.43 0.09 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.481 1.112 . . . . 0.0 113.429 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 68.29 83.79 0.16 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.053 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.469 ' CD2' HG23 ' C' ' 39' ' ' VAL . 13.6 mt -64.47 -32.19 73.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.513 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -68.83 -29.07 67.33 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.641 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.49 -27.73 67.25 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.534 ' CD1' HD22 ' C' ' 66' ' ' LEU . 30.7 m-85 -82.96 -23.11 33.56 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.5 t30 63.44 36.67 11.2 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.707 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.489 HG12 ' CG ' ' C' ' 61' ' ' TYR . 20.0 m -85.25 26.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.622 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -86.09 102.36 2.68 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-O 122.926 1.292 . . . . 0.0 113.441 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.89 13.26 56.83 Favored Glycine 0 C--N 1.285 -2.29 0 CA-C-N 112.266 -1.967 . . . . 0.0 114.022 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -133.58 152.53 51.91 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 18.4 m -79.11 126.07 38.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.904 0.859 . . . . 0.0 112.62 -175.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.481 ' HB ' HG21 ' C' ' 21' ' ' VAL . 46.2 mt -71.21 161.68 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.339 168.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.432 ' N ' HG21 ' C' ' 82' ' ' ILE . 45.5 m80 -116.01 113.0 22.63 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 171.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.449 ' CD1' HG12 ' C' ' 50' ' ' VAL . 1.6 mt -85.84 157.86 20.11 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.504 -176.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.528 HG11 ' CE1' ' A' ' 14' ' ' HIS . 2.7 t -114.65 147.83 17.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 174.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -126.41 122.43 35.28 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.501 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -93.01 176.73 6.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.828 0.347 . . . . 0.0 111.69 -171.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.37 154.59 42.01 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.89 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.8 149.59 40.59 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.605 2.203 . . . . 0.0 111.381 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.61 135.61 39.53 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.625 2.217 . . . . 0.0 112.325 -173.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -68.35 -25.5 65.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.395 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 6.4 t 35.97 65.32 0.44 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 124.577 1.173 . . . . 0.0 113.303 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -66.32 -46.94 75.15 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.21 113.79 60.98 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.537 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.49 140.4 93.11 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.678 2.252 . . . . 0.0 112.407 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 32.5 t -58.79 125.78 24.91 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.366 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.08 -23.89 2.41 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.67 40.55 2.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.126 0.489 . . . . 0.0 110.916 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 15.9 t -78.49 -20.26 51.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.486 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 68.8 p -74.64 110.24 8.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.539 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.348 -1.251 . . . . 0.0 111.704 178.535 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.8 t -74.43 118.92 17.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.859 0.361 . . . . 0.0 110.202 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.51 89.98 1.89 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.44 18.79 7.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.214 0.53 . . . . 0.0 110.276 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -96.75 141.85 29.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.002 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.84 -24.91 40.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.083 0.468 . . . . 0.0 110.073 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -152.41 74.5 7.35 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.124 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.64 -43.6 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.141 1.894 . . . . 0.0 111.834 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -169.08 136.53 1.55 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.707 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -95.54 57.24 0.19 Allowed 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 123.763 2.975 . . . . 0.0 111.799 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.23 16.27 0.29 Allowed Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.76 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.447 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 10.9 ptt180 -71.37 106.21 3.81 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.852 0.834 . . . . 0.0 110.907 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.518 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 8.6 m-85 -122.43 174.05 7.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.701 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CB ' HD12 ' A' ' 40' ' ' LEU . 79.1 t80 -142.05 121.27 13.04 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.119 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.581 ' HB2' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -100.98 120.29 39.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.812 176.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.508 ' CD2' HG21 ' C' ' 85' ' ' VAL . 62.6 m-70 -74.43 -16.24 60.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.565 -175.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.97 -35.8 72.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.411 ' O ' HG22 ' A' ' 18' ' ' VAL . 88.0 m -91.71 -23.84 19.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.313 0.578 . . . . 0.0 110.319 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER 56.23 31.42 18.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.421 -173.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 16' ' ' CYS . 39.7 t -136.82 148.31 26.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.763 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 32.3 tt0 -67.19 147.34 53.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.895 0.379 . . . . 0.0 111.326 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.579 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 4.2 pt -139.89 168.73 17.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.564 -175.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 94.0 t -126.4 101.29 28.04 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 162.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 6.0 Cg_endo -56.39 174.77 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 125.273 3.982 . . . . 0.0 116.736 -171.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.513 ' CB ' HD12 ' A' ' 28' ' ' ILE . 8.6 mtt180 -107.25 47.2 0.89 Allowed 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.875 175.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 1.6 -61.73 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.941 0 CA-C-N 110.783 -2.917 . . . . 0.0 116.912 175.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 39.2 Cg_exo -30.24 -34.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 124.017 3.145 . . . . 0.0 114.904 175.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.531 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.86 -19.65 9.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.411 ' C ' HD13 ' A' ' 37' ' ' ILE . 54.7 m-85 68.79 47.62 0.81 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.41 -171.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -101.24 161.47 3.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.237 176.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.9 OUTLIER -97.35 145.54 29.83 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.579 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 83.2 Cg_endo -84.26 -15.61 6.44 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 C-N-CA 122.415 2.077 . . . . 0.0 108.864 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.54 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 60.1 mtt-85 -85.12 -21.37 29.3 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.354 -1.748 . . . . 0.0 114.074 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.2 p -149.03 -7.25 0.37 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 58.22 30.81 19.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.803 0.811 . . . . 0.0 111.207 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.7 m -112.47 139.22 48.23 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.583 172.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.38 53.72 4.69 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.419 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.685 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 84.5 m-85 -112.18 46.67 1.13 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.413 0.625 . . . . 0.0 110.011 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' A' ' 13' ' ' CYS . 3.4 pt -112.15 138.54 40.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.41 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HB3' HD11 ' C' ' 60' ' ' ILE . 11.2 pt-20 -117.18 141.92 47.68 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -73.6 142.74 46.55 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.452 HD12 ' CB ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.161 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 111.547 0.202 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.53 7.91 2.16 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.738 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -154.78 37.39 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.359 0.6 . . . . 0.0 110.8 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -111.88 -61.8 1.66 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -78.97 93.13 5.03 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -76.18 101.84 5.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.452 0.644 . . . . 0.0 111.704 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -80.16 56.42 2.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -148.98 88.34 1.59 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.93 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.87 150.9 3.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.945 0.403 . . . . 0.0 110.659 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -117.15 41.39 2.78 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 122.192 0.996 . . . . 0.0 108.662 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.27 166.46 13.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.388 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 16.8 t70 81.96 -16.4 0.62 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.645 0.778 . . . . 0.0 111.464 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.22 -55.23 11.2 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 71.1 mttt 46.22 -175.27 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.412 ' SD ' HD22 ' C' ' 17' ' ' LEU . 0.0 OUTLIER -171.97 -52.02 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.18 -178.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' C' ' 35' ' ' ALA . 0.8 OUTLIER -102.86 131.03 50.05 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 111.456 -172.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.507 ' HA ' HG13 ' C' ' 32' ' ' ILE . 41.9 tt0 -88.01 94.43 9.79 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.61 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 5.6 t -80.75 104.87 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.513 -173.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.69 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 1.0 OUTLIER -94.13 141.87 28.05 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 174.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.514 HG21 ' HB ' ' C' ' 82' ' ' ILE . 78.9 t -150.36 121.32 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.328 0.513 . . . . 0.0 110.585 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 26.2 mtpt -108.36 164.37 12.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.494 0.664 . . . . 0.0 110.669 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 48.7 p -103.95 -162.73 0.92 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.663 167.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.685 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 4.0 mm? -43.53 -42.51 5.01 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 22.6 t70 177.88 -28.57 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.731 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 12.9 p -54.26 -35.08 62.14 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.724 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -138.67 173.82 11.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.628 1.204 . . . . 0.0 113.325 -172.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 61.2 m -172.82 94.89 0.12 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.322 -2.217 . . . . 0.0 106.589 176.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -118.95 159.69 23.36 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.869 -1.132 . . . . 0.0 112.215 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 1.4 p -100.66 139.65 36.04 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.947 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.61 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 23.3 m-85 -133.83 55.86 1.88 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.231 -171.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.507 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -54.55 123.11 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 123.38 1.562 . . . . 0.0 113.979 -174.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.436 HG11 ' HD2' ' C' ' 42' ' ' PHE . 11.2 m -126.87 -175.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 110.961 -2.836 . . . . 0.0 111.196 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.65 52.72 0.8 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.512 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.575 ' HA ' HD12 ' C' ' 17' ' ' LEU . . . 71.01 -29.29 0.19 Allowed 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 167.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -162.19 23.83 0.11 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -172.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' MET . . . . . 0.52 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 16.0 tpt -72.2 -69.24 0.41 Allowed 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 111.754 -2.476 . . . . 0.0 111.435 -171.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.52 ' OD1' ' HG3' ' C' ' 37' ' ' MET . 24.8 m120 -129.18 -82.86 0.57 Allowed 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.09 0.472 . . . . 0.0 111.229 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.69 ' O ' ' HD2' ' C' ' 43' ' ' LYS . 0.4 OUTLIER 74.36 -31.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.744 -165.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' C' ' 43' ' ' LYS . 0.1 OUTLIER -84.15 -67.94 0.75 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.489 1.138 . . . . 0.0 109.661 178.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.17 -25.7 61.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.235 170.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.652 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 1.2 t80 -60.74 -48.63 80.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.425 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.69 ' HD2' ' O ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -53.15 -48.92 67.55 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.862 0.839 . . . . 0.0 109.037 173.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -35.47 74.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.887 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -69.16 -50.95 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.098 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.607 ' O ' HG23 ' C' ' 50' ' ' VAL . 25.5 pt -78.88 -12.44 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.85 -59.3 1.46 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.14 75.34 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.269 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -34.51 72.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.887 0.375 . . . . 0.0 111.113 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.607 HG23 ' O ' ' C' ' 46' ' ' ILE . 27.8 m -100.39 -3.01 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.228 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 26.4 t 69.16 19.75 7.83 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 121.752 0.787 . . . . 0.0 109.287 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.3 mm -128.36 117.67 20.17 Favored Pre-proline 0 N--CA 1.442 -0.836 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.627 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.436 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.0 Cg_exo -65.52 149.37 87.75 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.924 1.749 . . . . 0.0 113.149 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.464 ' CB ' ' HB3' ' C' ' 43' ' ' LYS . 2.2 p -53.37 -29.94 37.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.463 -1.698 . . . . 0.0 113.375 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.499 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.8 pt-20 -82.07 -7.47 59.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.65 -176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.499 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 96.0 mttt -125.13 -31.31 3.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.567 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.604 ' OE1' ' HG3' ' C' ' 43' ' ' LYS . 3.3 pt20 -62.6 136.92 58.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.304 0.573 . . . . 0.0 111.185 -174.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -121.49 129.93 53.24 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.798 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.527 ' CD1' ' HZ1' ' C' ' 43' ' ' LYS . 4.2 mp -91.18 134.57 34.43 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 37' ' ' ILE . 6.3 mt -126.76 115.06 40.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.334 0.588 . . . . 0.0 112.001 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -124.11 116.59 23.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.518 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 61.02 34.87 19.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.494 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.16 -7.39 60.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.483 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -85.39 127.62 34.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -86.11 91.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.084 0.469 . . . . 0.0 110.227 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.668 HD22 ' CD1' ' C' ' 75' ' ' TYR . 1.6 mt -73.24 136.54 44.65 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . 0.452 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 8.5 pt20 -149.89 -168.31 3.07 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.275 -171.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.517 ' HA ' HG12 ' C' ' 39' ' ' VAL . 6.8 p-10 -66.42 -0.43 2.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.064 0.946 . . . . 0.0 112.629 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . 0.452 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 9.2 t70 -69.07 2.46 2.74 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.734 0.813 . . . . 0.0 112.62 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.402 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.8 mtpt 72.74 -177.37 0.19 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.155 175.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 70.58 66.84 0.19 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.979 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.51 ' HA ' ' CD2' ' C' ' 75' ' ' TYR . 6.6 mt -64.12 -41.84 97.08 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.549 -175.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . 0.456 ' HB3' ' HB2' ' C' ' 35' ' ' ALA . 3.7 pt20 -71.13 -18.27 62.53 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -70.07 -27.69 64.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.668 ' CD1' HD22 ' C' ' 66' ' ' LEU . 22.5 m-85 -74.17 -24.22 59.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 t30 64.09 36.49 9.7 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 123.392 1.568 . . . . 0.0 107.403 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.44 ' CG1' HG22 ' C' ' 19' ' ' VAL . 0.5 OUTLIER -96.41 0.79 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.059 -161.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.563 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -70.41 102.27 1.0 Allowed Glycine 0 N--CA 1.432 -1.591 0 CA-C-O 122.723 1.18 . . . . 0.0 112.824 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.68 13.84 26.83 Favored Glycine 0 C--N 1.283 -2.413 0 CA-C-N 112.24 -1.98 . . . . 0.0 114.325 173.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -124.78 154.36 41.06 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.69 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 2.8 m -85.28 131.02 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.093 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.514 ' HB ' HG21 ' C' ' 21' ' ' VAL . 56.5 mt -83.96 160.56 3.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.246 172.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.437 ' N ' HG23 ' C' ' 82' ' ' ILE . 67.4 m170 -109.22 112.49 24.68 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 166.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.15 153.66 19.4 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.426 -0.91 . . . . 0.0 108.618 172.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 14' ' ' HIS . 17.3 m -127.52 -178.65 2.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.208 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . 0.531 ' HG2' ' H ' ' C' ' 87' ' ' ARG . 25.9 tt0 -77.17 175.71 9.41 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.283 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . 0.531 ' H ' ' HG2' ' C' ' 86' ' ' GLU . 5.0 mtm180 -63.6 166.3 7.03 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.549 0.69 . . . . 0.0 111.058 -175.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.407 ' HB1' ' HD2' ' C' ' 89' ' ' PRO . . . -68.47 171.45 5.97 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.051 176.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . 0.407 ' HD2' ' HB1' ' C' ' 88' ' ' ALA . 75.6 Cg_exo -53.31 150.63 25.31 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.068 1.845 . . . . 0.0 112.212 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.42 59.14 4.66 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.125 2.55 . . . . 0.0 112.825 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' C' ' 89' ' ' PRO . 2.4 pt20 -76.83 -16.55 59.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.782 177.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t 38.04 52.66 1.57 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.095 0.958 . . . . 0.0 112.661 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -70.36 -53.93 14.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.019 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 95.5 mt -134.59 93.5 18.37 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.97 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.65 -23.8 48.77 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.422 2.081 . . . . 0.0 112.181 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 20.3 t -164.33 148.06 9.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.32 35.12 1.85 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.058 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.59 80.87 1.84 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.19 0.519 . . . . 0.0 110.32 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 11.4 t -107.63 -146.37 0.4 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.635 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 24.9 m 65.79 87.13 0.12 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.488 0.661 . . . . 0.0 110.942 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 179.355 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 2.7 p -98.13 -14.06 20.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 110.581 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm -86.27 71.66 10.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.8 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.12 125.63 32.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.8 150.52 20.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.023 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.46 66.77 9.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.04 0.448 . . . . 0.0 110.335 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -101.35 114.05 65.76 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.928 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.66 143.74 69.33 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.353 2.036 . . . . 0.0 111.936 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.401 ' O ' ' HE1' ' A' ' 11' ' ' TYR . 24.5 m-70 -72.49 -43.96 9.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.54 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.73 101.85 0.81 Allowed 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 122.071 1.847 . . . . 0.0 112.543 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.03 -112.69 0.97 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.012 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.462 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 94.5 mtt180 -79.28 87.81 4.96 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.938 -0.631 . . . . 0.0 110.779 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.663 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 14.2 m-85 -115.15 149.45 37.61 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.952 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CB ' HD22 ' A' ' 40' ' ' LEU . 71.7 t80 -124.73 120.01 30.57 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.72 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -96.22 121.09 37.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -73.22 -20.22 60.92 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.388 -173.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -71.15 -30.86 66.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.851 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.422 ' O ' HG22 ' A' ' 18' ' ' VAL . 53.4 m -90.94 -18.42 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.475 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.8 p 51.49 30.28 6.18 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.888 0.742 . . . . 0.0 110.843 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 16' ' ' CYS . 73.9 t -144.73 145.71 20.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HG2' ' N ' ' A' ' 20' ' ' ILE . 26.3 tt0 -74.96 151.98 38.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.109 0.481 . . . . 0.0 111.779 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.558 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.7 pt -138.24 168.51 19.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.958 -171.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.46 109.98 36.12 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 159.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.663 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 18.1 Cg_endo -69.94 174.92 8.96 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 124.45 3.433 . . . . 0.0 115.736 -166.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.49 ' CB ' HD11 ' A' ' 28' ' ' ILE . 75.9 mtt180 -106.64 47.69 0.87 Allowed 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.856 -1.975 . . . . 0.0 106.768 174.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -8.34 -55.9 0.01 OUTLIER Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 110.673 -2.967 . . . . 0.0 116.517 174.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.444 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 45.8 Cg_exo -34.13 -35.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 123.255 2.637 . . . . 0.0 114.34 175.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.522 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.19 -19.34 10.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.319 0.58 . . . . 0.0 111.839 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.417 ' C ' HD13 ' A' ' 37' ' ' ILE . 86.8 m-85 68.41 55.3 0.51 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.991 -169.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.522 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -109.63 163.1 6.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.561 175.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -95.19 146.32 31.12 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.558 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 52.8 Cg_endo -82.82 -21.88 4.65 Favored 'Trans proline' 0 CA--C 1.504 -0.993 0 C-N-CA 123.202 2.601 . . . . 0.0 108.47 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.584 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.4 mtt-85 -79.29 -29.06 42.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.835 -1.984 . . . . 0.0 113.377 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.0 p -147.9 -3.84 0.51 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.69 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 14.7 tt0 60.15 40.51 18.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.067 0.461 . . . . 0.0 111.832 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.4 p -112.59 155.82 23.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.87 44.13 2.09 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.798 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 86.6 m-85 -109.13 47.5 0.92 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.293 0.568 . . . . 0.0 110.158 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.588 ' O ' HG22 ' C' ' 60' ' ' ILE . 5.7 pt -111.86 147.43 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.272 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.489 ' HB2' HG23 ' C' ' 65' ' ' VAL . 12.6 pt-20 -135.57 147.17 48.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.594 0.235 . . . . 0.0 110.804 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.26 144.81 55.72 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.534 HD22 ' CB ' ' A' ' 12' ' ' PHE . 13.5 mt . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.028 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.863 0.363 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.28 7.97 38.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.702 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -97.07 -13.6 22.11 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.121 -0.231 . . . . 0.0 110.994 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -76.73 69.39 3.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.859 0.361 . . . . 0.0 111.827 -176.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -148.11 138.41 22.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.39 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 5.9 t60 53.5 62.6 2.56 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.652 0.595 . . . . 0.0 111.631 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -118.75 -51.18 2.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 62.4 t60 56.22 78.0 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.805 0.691 . . . . 0.0 110.527 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' C' ' 12' ' ' ASP . 31.0 m -94.77 169.93 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.955 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 19.4 t70 76.92 -39.51 0.34 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.055 0.942 . . . . 0.0 110.694 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' C' ' 10' ' ' VAL . 22.2 t70 -122.86 112.85 18.36 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.219 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 36.2 t70 58.14 58.98 3.26 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.891 0.853 . . . . 0.0 110.01 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -70.46 -28.6 65.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.39 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -56.31 143.11 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.457 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 50.2 ttm -166.66 112.1 0.79 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.312 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.628 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 0.9 OUTLIER -101.45 132.12 47.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.491 ' HA ' HG13 ' C' ' 32' ' ' ILE . 30.6 mt-10 -83.87 94.72 8.28 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.534 HG13 ' CZ ' ' C' ' 42' ' ' PHE . 5.4 t -79.23 92.65 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.098 -172.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 1.5 mp -85.24 133.16 34.18 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.509 HG22 ' HB ' ' C' ' 82' ' ' ILE . 71.1 t -141.58 116.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 40.7 mtpt -88.29 153.58 21.09 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p -118.86 171.59 8.12 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.397 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 8.5 mt -68.08 -7.34 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.788 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -85.16 8.87 16.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.71 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 16.9 m 71.86 13.27 6.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.641 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.52 -177.73 4.5 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.409 0.623 . . . . 0.0 110.756 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 39.1 m -141.27 113.44 7.98 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.519 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -118.48 149.55 41.09 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.376 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -106.52 141.94 36.99 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.178 0.513 . . . . 0.0 111.777 -174.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.463 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 35.9 m-85 -130.9 60.18 1.66 Allowed 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.722 -174.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.491 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -56.58 121.32 4.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 123.338 1.542 . . . . 0.0 114.48 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.87 -166.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 111.038 -2.801 . . . . 0.0 111.57 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -95.62 -170.82 35.89 Favored Glycine 0 C--N 1.312 -0.758 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.396 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.865 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . -103.9 83.24 2.09 Favored 'General case' 0 CA--C 1.477 -1.855 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.865 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 23.7 mt-30 108.6 15.88 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 O-C-N 126.599 2.437 . . . . 0.0 107.795 170.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -76.79 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.063 -2.335 . . . . 0.0 111.528 171.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.469 ' CG ' ' HB2' ' C' ' 41' ' ' GLU . 13.0 m120 -123.55 -98.5 0.43 Allowed 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.587 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 84.22 -35.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 123.931 0.892 . . . . 0.0 110.648 -162.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.518 ' HA ' ' CB ' ' C' ' 68' ' ' ASP . 0.0 OUTLIER -81.43 -69.53 0.6 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.3 1.048 . . . . 0.0 108.959 177.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . 0.469 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 43.3 mt-10 -61.12 -28.95 69.47 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.012 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.587 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.1 t80 -61.1 -51.61 68.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.406 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 52.3 mtpt -58.5 -45.53 88.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.445 0.641 . . . . 0.0 110.358 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -59.79 -34.83 73.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.207 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -70.12 -47.76 60.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.789 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.566 ' O ' HG23 ' C' ' 50' ' ' VAL . 24.2 pt -75.04 -16.96 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.971 -0.104 . . . . 0.0 111.133 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.66 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -39.92 -61.0 0.91 Allowed 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -176.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.4 77.48 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.371 -0.532 . . . . 0.0 112.376 -173.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -26.73 68.46 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.181 0.515 . . . . 0.0 110.832 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.566 HG23 ' O ' ' C' ' 46' ' ' ILE . 22.2 m -104.66 -0.77 10.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.849 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 55.1 p 66.16 20.27 11.14 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.766 0.826 . . . . 0.0 109.842 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.66 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.7 mm -128.82 112.59 18.88 Favored Pre-proline 0 N--CA 1.437 -1.123 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.073 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.462 ' HA ' ' HB3' ' C' ' 47' ' ' ALA . 3.9 Cg_exo -69.29 146.78 64.22 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.471 2.114 . . . . 0.0 111.284 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.431 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 44.2 t -51.95 -25.97 9.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.347 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.402 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.5 pt-20 -79.51 -24.52 42.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.706 0.288 . . . . 0.0 111.342 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' C' ' 87' ' ' ARG . 48.2 mtpt -106.79 -16.27 14.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.854 0.359 . . . . 0.0 110.363 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.51 ' OE1' HD13 ' C' ' 46' ' ' ILE . 0.0 OUTLIER -87.25 148.86 24.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.726 -174.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -139.03 132.25 29.84 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.587 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 52.7 mt -90.67 109.68 20.85 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 37' ' ' ILE . 10.3 mt -106.39 113.73 43.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.263 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.577 ' OH ' ' HD3' ' C' ' 80' ' ' LYS . 50.3 t80 -118.03 127.82 54.17 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . 0.452 ' HG2' ' CD2' ' C' ' 61' ' ' TYR . 3.5 pt20 40.98 46.77 2.5 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.028 0.931 . . . . 0.0 112.244 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.28 5.87 78.26 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.686 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -99.4 134.88 41.62 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 38' ' ' GLU . 2.1 t -88.96 90.07 3.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.078 0.466 . . . . 0.0 109.746 -177.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.57 HD21 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -73.91 132.14 42.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -144.83 173.01 12.23 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.201 -171.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.518 ' HA ' HG11 ' C' ' 39' ' ' VAL . 5.9 p-10 -70.73 -2.86 16.01 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.896 0.879 . . . . 0.0 113.06 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.25 -15.63 49.53 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.179 -0.326 . . . . 0.0 111.609 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.488 ' HB3' ' OE1' ' C' ' 74' ' ' GLU . 4.0 mtpm? -122.44 -151.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.52 -169.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.482 ' HB2' ' HG3' ' C' ' 74' ' ' GLU . 97.7 mttt -125.25 151.14 46.33 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.838 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . . . . . . . . . 35.5 mt -57.32 -53.11 61.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . 0.549 ' CB ' ' HG3' ' C' ' 36' ' ' GLN . 53.2 tt0 -71.54 -14.4 62.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.565 -170.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . 0.488 ' OE1' ' HB3' ' C' ' 70' ' ' LYS . 46.2 mt-10 -63.09 -29.24 70.65 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.57 ' CD1' HD21 ' C' ' 66' ' ' LEU . 60.5 m-85 -93.91 -21.24 19.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.2 t30 52.87 52.16 14.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.588 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.413 HG21 HD11 ' C' ' 82' ' ' ILE . 29.9 m -93.27 19.85 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.307 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.628 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -75.18 102.39 1.45 Allowed Glycine 0 CA--C 1.482 -2.01 0 CA-C-O 122.483 1.046 . . . . 0.0 111.713 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.12 14.97 46.65 Favored Glycine 0 C--N 1.281 -2.481 0 CA-C-N 112.562 -1.819 . . . . 0.0 112.107 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . 0.577 ' HD3' ' OH ' ' C' ' 61' ' ' TYR . 81.2 mttt -123.46 142.33 51.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 16.3 m -82.35 133.91 28.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.907 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.509 ' HB ' HG22 ' C' ' 21' ' ' VAL . 29.1 mt -92.56 170.19 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.265 175.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.474 ' N ' HG22 ' C' ' 82' ' ' ILE . 70.5 m80 -118.56 114.49 22.88 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.79 141.45 28.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.383 0.611 . . . . 0.0 111.743 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m -151.83 170.78 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.671 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . 0.433 ' HB2' HD13 ' C' ' 52' ' ' ILE . 32.4 tt0 -110.8 148.37 32.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.374 175.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . 0.503 ' HG3' ' O ' ' C' ' 56' ' ' LYS . 63.8 mtm180 -63.76 166.55 6.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.905 0.859 . . . . 0.0 110.983 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' C' ' 89' ' ' PRO . . . -73.26 172.5 7.94 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.568 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' C' ' 91' ' ' GLN . 75.2 Cg_exo -54.39 150.79 32.38 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.767 1.644 . . . . 0.0 111.386 174.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.35 30.36 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.956 2.438 . . . . 0.0 113.289 -174.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' C' ' 89' ' ' PRO . 7.2 pt20 -80.61 -26.35 37.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.189 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -82.58 83.52 7.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.943 0.877 . . . . 0.0 110.726 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -146.09 87.05 1.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.071 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 1.5 pt? -124.95 110.88 27.24 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.125 0.488 . . . . 0.0 111.033 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.06 -25.92 82.09 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 123.046 2.497 . . . . 0.0 112.283 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 7.9 p -86.88 28.2 0.92 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.81 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.92 -52.91 6.06 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.844 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 51.96 72.5 0.38 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.9 0.48 . . . . 0.0 111.732 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 39.6 t -75.54 93.1 2.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.093 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 9.3 t 60.64 71.39 0.57 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.655 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.671 -1.072 . . . . 0.0 111.59 178.733 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 111.709 -0.557 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 4.8 p -133.24 153.06 51.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.544 0.211 . . . . 0.0 110.725 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tmm? 71.11 87.78 0.11 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.56 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.47 -37.6 10.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.204 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -87.9 151.32 22.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.015 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.72 11.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 t 56.44 78.86 0.36 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.21 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -71.31 79.37 1.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.78 2.32 . . . . 0.0 111.962 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 42.3 m-70 64.91 88.71 0.11 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.233 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 7' ' ' HIS . 18.6 Cg_endo -51.25 112.89 0.9 Allowed 'Trans proline' 0 N--CA 1.444 -1.408 0 C-N-CA 124.442 3.428 . . . . 0.0 114.482 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.64 -117.86 1.79 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 172.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 10' ' ' ARG . 10.6 ptt180 -167.79 101.1 0.47 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.471 0.653 . . . . 0.0 111.082 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.678 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 14.3 m-85 -120.17 167.24 12.44 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.449 ' CB ' HD12 ' A' ' 40' ' ' LEU . 65.7 t80 -140.35 114.56 9.15 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.446 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.531 ' HB2' HG23 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -95.44 114.97 26.79 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.567 174.27 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -69.9 -18.09 63.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.118 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.511 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 43.9 t -68.66 -35.44 77.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.081 0.467 . . . . 0.0 110.708 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.434 ' O ' HG22 ' A' ' 18' ' ' VAL . 92.6 m -95.16 -15.26 23.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.817 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 16' ' ' CYS . 32.5 p 51.57 29.87 5.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.237 1.015 . . . . 0.0 111.582 -173.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 16' ' ' CYS . 97.2 t -139.39 147.25 24.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.761 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.651 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 31.4 tt0 -67.48 149.15 50.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.17 0.509 . . . . 0.0 111.092 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.651 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.5 pt -138.68 167.36 21.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.856 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.481 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 19.4 t -122.64 96.23 45.79 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 164.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.678 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 9.5 Cg_endo -58.36 176.48 0.39 Allowed 'Trans proline' 0 C--N 1.325 -0.697 1 C-N-CA 125.349 4.033 . . . . 0.0 117.776 -167.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' C ' ' HD2' ' A' ' 25' ' ' PRO . 40.2 mtt180 -112.25 51.42 0.81 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.764 -2.471 . . . . 0.0 106.848 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -7.32 -53.73 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.911 0 CA-C-N 111.705 -2.498 . . . . 0.0 115.965 172.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.532 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 24.1 Cg_exo -31.17 -39.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.398 2.732 . . . . 0.0 114.204 174.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.536 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -120.03 -16.64 8.57 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.296 0.57 . . . . 0.0 111.342 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 66.3 m-85 70.87 52.26 0.29 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.018 -1.447 . . . . 0.0 109.728 -169.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.536 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -106.38 162.26 5.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.165 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -98.23 149.2 35.49 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.237 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.651 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 62.2 Cg_endo -83.88 -18.73 5.28 Favored 'Trans proline' 0 CA--C 1.501 -1.135 0 C-N-CA 123.117 2.545 . . . . 0.0 108.59 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.506 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 56.0 mtt180 -88.58 -11.89 44.25 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.07 -1.877 . . . . 0.0 114.192 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 p -156.77 -11.43 0.09 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 61.16 29.48 18.83 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.558 0.694 . . . . 0.0 111.171 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.5 m -107.18 142.94 36.1 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -79.55 38.07 2.08 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.507 -175.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 50.9 m-85 -93.49 39.93 1.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.744 0.307 . . . . 0.0 111.054 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.634 HG22 ' CD1' ' A' ' 20' ' ' ILE . 6.1 pt -109.87 141.51 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.505 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.2 pt-20 -117.37 144.16 45.23 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 169.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -79.72 129.5 34.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.514 ' HG ' ' OE1' ' C' ' 91' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.909 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.811 0.338 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.08 136.26 33.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.628 0.252 . . . . 0.0 110.713 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -119.48 123.25 43.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.483 . . . . 0.0 110.121 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -65.33 -36.6 84.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.586 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -151.59 -69.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.599 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -133.49 50.7 2.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.957 0.408 . . . . 0.0 110.965 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 83.3 t60 48.85 58.54 5.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.682 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -126.32 90.46 3.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.267 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.33 146.89 11.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.12 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -100.74 -29.3 12.35 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.471 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -104.67 -93.55 0.35 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.398 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 t70 56.0 -154.04 0.33 Allowed 'General case' 0 C--O 1.235 0.316 0 O-C-N 123.604 0.565 . . . . 0.0 110.059 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -86.71 -3.14 59.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.045 0.45 . . . . 0.0 110.463 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -56.8 166.95 0.85 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.925 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 47.0 tpp 61.24 89.53 0.08 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.906 -177.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.745 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -91.69 146.55 23.68 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.501 ' HA ' HG13 ' C' ' 32' ' ' ILE . 15.1 mt-10 -95.04 91.48 6.37 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 169.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.584 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 4.9 t -78.38 105.21 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.2 -170.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.5 OUTLIER -96.25 142.58 28.23 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 175.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.517 HG23 ' HB ' ' C' ' 82' ' ' ILE . 54.7 t -148.05 124.53 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.899 0.381 . . . . 0.0 110.628 -173.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.507 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 43.0 mtpt -105.06 141.3 36.87 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 36.3 p -112.02 -179.88 3.81 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.547 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.41 -15.45 62.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.195 0.522 . . . . 0.0 110.854 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -81.48 0.08 39.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.828 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 69.6 m 61.52 22.62 13.04 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.691 0.758 . . . . 0.0 111.573 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -55.67 -56.68 17.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.779 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.443 ' OG1' ' HE3' ' C' ' 22' ' ' LYS . 51.0 m 54.37 94.33 0.02 OUTLIER 'General case' 0 C--O 1.236 0.344 0 O-C-N 124.284 0.99 . . . . 0.0 110.765 -173.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -127.36 155.83 42.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.814 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.526 HG22 ' CD2' ' C' ' 20' ' ' LEU . 11.8 p -95.49 142.01 28.35 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 121.382 0.611 . . . . 0.0 112.223 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.584 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 25.6 m-85 -132.72 56.17 1.86 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.224 -174.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -56.87 121.17 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 123.353 1.549 . . . . 0.0 114.412 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.7 m -140.43 -163.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 110.777 -2.919 . . . . 0.0 111.307 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.51 165.48 19.24 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.154 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.745 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -68.43 -16.2 63.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.637 0.732 . . . . 0.0 112.16 -175.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -158.8 25.33 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -167.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 51.0 ttm -79.47 -72.64 0.38 Allowed 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 111.699 -2.501 . . . . 0.0 110.928 -176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.535 ' O ' HG12 ' C' ' 39' ' ' VAL . 12.3 m120 -125.51 -99.51 0.4 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.649 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 83.88 -29.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 C-N-CA 125.161 1.385 . . . . 0.0 111.502 -162.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.74 -68.13 0.74 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.346 1.07 . . . . 0.0 109.122 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.55 -30.34 69.71 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.949 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.649 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 7.0 t80 -58.34 -51.08 71.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.848 174.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.625 ' HB3' ' OE1' ' C' ' 57' ' ' GLN . 47.8 mtpt -61.24 -47.01 88.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.109 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -56.53 -36.8 69.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.892 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -70.6 -43.79 68.62 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.636 ' O ' HG22 ' C' ' 50' ' ' VAL . 22.1 pt -77.77 -8.51 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -175.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.66 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.03 -56.83 1.77 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.74 -36.79 50.37 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.272 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -33.06 71.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.018 0.437 . . . . 0.0 110.9 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.636 HG22 ' O ' ' C' ' 46' ' ' ILE . 34.5 m -105.38 -2.63 9.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.885 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 59.6 p 64.78 21.23 12.33 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 122.003 0.906 . . . . 0.0 109.298 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.752 HG23 ' CG ' ' C' ' 57' ' ' GLN . 7.2 mm -122.63 117.21 28.98 Favored Pre-proline 0 N--CA 1.439 -0.976 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.302 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.577 ' O ' ' HG3' ' C' ' 57' ' ' GLN . 4.6 Cg_exo -71.76 150.16 55.62 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.961 1.774 . . . . 0.0 112.226 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.639 ' HA ' ' OE1' ' C' ' 57' ' ' GLN . 0.9 OUTLIER -52.12 -25.17 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.096 -176.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.436 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.4 pt-20 -74.67 -26.91 60.17 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.207 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.436 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 47.9 mttm -105.66 -25.01 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.688 0.28 . . . . 0.0 111.526 -173.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.752 ' CG ' HG23 ' C' ' 52' ' ' ILE . 88.9 mt-30 -56.55 126.17 25.39 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.895 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -122.95 110.14 15.01 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 1.1 mm? -87.11 112.48 21.96 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 37' ' ' ILE . 6.7 mt -110.33 120.61 61.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 121.809 -0.557 . . . . 0.0 111.024 175.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -128.75 134.61 48.48 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 41.97 42.38 2.29 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.987 0.804 . . . . 0.0 111.732 -173.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.98 4.02 61.62 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.593 -0.731 . . . . 0.0 113.608 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -96.15 130.82 43.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.3 99.22 9.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.297 0.57 . . . . 0.0 110.451 -175.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -86.16 154.66 21.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.054 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -165.91 -169.77 1.59 Allowed 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.958 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.549 ' HA ' HG11 ' C' ' 39' ' ' VAL . 5.1 p-10 -64.94 -1.4 2.0 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.902 0.881 . . . . 0.0 113.123 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.97 -7.2 3.52 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.449 ' HA ' HG12 ' C' ' 39' ' ' VAL . 47.8 mttp 88.22 170.57 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.48 1.112 . . . . 0.0 111.827 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.49 ' HB3' ' HG2' ' C' ' 74' ' ' GLU . 13.5 mmmm 71.45 79.52 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.617 177.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.526 ' HA ' ' CD2' ' C' ' 75' ' ' TYR . 37.2 mt -68.82 -29.22 67.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.849 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -68.52 -27.17 65.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.401 . . . . 0.0 111.364 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' C' ' 71' ' ' LYS . 58.8 mm-40 -63.48 -27.12 69.06 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.526 ' CD2' ' HA ' ' C' ' 72' ' ' LEU . 7.8 m-85 -90.17 -23.07 21.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 55.31 46.79 22.82 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.198 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.434 HG11 HD11 ' C' ' 82' ' ' ILE . 33.1 m -93.66 4.36 7.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 119.957 -0.697 . . . . 0.0 112.862 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -56.22 100.37 0.1 Allowed Glycine 0 CA--C 1.491 -1.435 0 CA-C-O 122.918 1.288 . . . . 0.0 113.68 171.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.47 14.8 49.42 Favored Glycine 0 C--N 1.289 -2.076 0 CA-C-N 111.367 -2.417 . . . . 0.0 113.534 173.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -124.37 139.91 53.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.545 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 22.2 m -80.08 126.48 39.39 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.748 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.517 ' HB ' HG23 ' C' ' 21' ' ' VAL . 60.9 mt -83.11 167.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.452 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.492 ' N ' HG23 ' C' ' 82' ' ' ILE . 42.9 m80 -114.42 114.63 26.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 171.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.419 HD12 ' H ' ' C' ' 85' ' ' VAL . 15.8 tp -97.23 133.01 42.43 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.203 0.525 . . . . 0.0 110.135 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.419 ' H ' HD12 ' C' ' 84' ' ' LEU . 25.2 m -129.14 172.38 15.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.367 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -70.95 179.94 2.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.879 173.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' C' ' 87' ' ' ARG . 43.0 mtm180 -60.47 165.23 3.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.991 0.901 . . . . 0.0 110.781 -175.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.26 146.22 32.31 Favored Pre-proline 0 N--CA 1.425 -1.684 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.56 -175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.55 160.14 37.38 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.242 2.628 . . . . 0.0 111.058 174.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.12 87.36 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.654 2.236 . . . . 0.0 111.746 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . 0.514 ' OE1' ' HG ' ' A' ' 40' ' ' LEU . 16.9 pt20 -124.39 7.71 8.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.752 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 6.0 t -64.29 102.35 0.51 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.04 0.924 . . . . 0.0 110.823 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -109.66 10.43 24.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.898 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . 0.47 HD22 ' O ' ' C' ' 98' ' ' ALA . 42.2 tp -127.66 76.11 77.31 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.787 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -88.28 161.12 6.95 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.602 2.201 . . . . 0.0 113.093 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t 60.61 68.56 0.75 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.355 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.05 -141.09 39.0 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.232 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . 0.47 ' O ' HD22 ' C' ' 94' ' ' LEU . . . 64.13 13.99 8.24 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.028 0.531 . . . . 0.0 111.969 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -85.52 67.17 10.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.499 0.666 . . . . 0.0 109.411 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 16.2 m -136.85 171.26 14.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.349 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.923 -0.932 . . . . 0.0 111.57 177.732 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.966 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 18.0 m -76.63 147.04 37.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 62.26 84.73 0.13 Allowed 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.547 0.529 . . . . 0.0 110.524 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.28 129.8 36.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.964 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -90.08 69.28 7.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.407 0.622 . . . . 0.0 109.628 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.37 -29.29 37.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.462 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.8 t -83.25 142.22 43.64 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.634 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.07 63.94 2.58 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.9 2.4 . . . . 0.0 112.678 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.9 m80 71.5 135.59 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 123.427 0.691 . . . . 0.0 111.188 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HA ' HG13 ' A' ' 21' ' ' VAL . 84.7 Cg_endo -74.32 116.16 4.54 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.058 2.506 . . . . 0.0 113.568 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.88 -116.17 4.15 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -167.48 98.43 0.49 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.19 0.519 . . . . 0.0 111.735 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.728 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.9 m-85 -124.93 151.96 44.73 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 172.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -124.04 118.29 26.64 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.262 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.493 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -96.37 117.67 31.32 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.048 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.727 ' CG ' HG12 ' C' ' 85' ' ' VAL . 12.6 p80 -75.07 -10.68 59.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.89 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.435 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 49.7 t -71.97 -37.52 69.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.159 0.505 . . . . 0.0 109.727 175.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.3 m -91.0 -27.94 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.182 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.86 32.05 21.39 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.267 -171.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.56 144.45 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -71.83 146.5 47.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.234 0.54 . . . . 0.0 111.093 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.598 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 4.5 pt -134.04 166.71 28.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.266 -171.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 8' ' ' PRO . 48.3 t -118.44 110.22 39.4 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 158.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.728 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 12.1 Cg_endo -69.28 176.16 6.77 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.441 3.427 . . . . 0.0 114.777 -170.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.646 ' HB2' HG13 ' A' ' 28' ' ' ILE . 40.7 mtt180 -107.02 47.77 0.87 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 113.532 -1.667 . . . . 0.0 106.707 175.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.589 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 1.6 mm? 0.82 -62.62 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.147 0 CA-C-N 111.032 -2.804 . . . . 0.0 117.107 174.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -35.21 -35.04 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.949 2.433 . . . . 0.0 113.611 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.551 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -112.76 -22.84 10.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.631 -177.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.473 ' C ' HD13 ' A' ' 37' ' ' ILE . 22.5 m-85 68.48 45.25 1.16 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.026 0.917 . . . . 0.0 110.528 -170.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.646 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -97.53 162.01 2.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.517 172.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.4 t -97.08 146.07 30.69 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.598 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 66.9 Cg_endo -79.84 -23.15 7.04 Favored 'Trans proline' 0 CA--C 1.498 -1.315 0 C-N-CA 122.582 2.188 . . . . 0.0 107.785 -174.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.587 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 91.2 mtt-85 -79.21 -35.34 41.84 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 112.683 -2.053 . . . . 0.0 113.556 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.2 p -135.76 -7.74 2.15 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.582 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 11.3 tt0 56.95 31.08 19.17 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.507 0.67 . . . . 0.0 111.511 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.3 m -110.72 145.97 37.11 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.321 170.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.6 52.99 4.81 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.372 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 72.2 m-85 -109.0 43.86 1.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.551 -0.382 . . . . 0.0 110.684 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.557 ' O ' HG21 ' C' ' 60' ' ' ILE . 11.7 pt -114.31 139.96 37.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.255 -175.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.06 155.52 30.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.36 127.84 39.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.381 0.61 . . . . 0.0 110.747 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.007 -170.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.2 54.66 0.83 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.876 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 64.41 -91.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 174.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -93.3 82.66 4.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.168 0.508 . . . . 0.0 109.971 -177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -85.89 -4.38 59.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.67 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -79.75 59.26 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.786 0.803 . . . . 0.0 110.257 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -128.88 43.17 3.19 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.623 -1.172 . . . . 0.0 107.942 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -75.92 76.7 2.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.634 -174.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.532 HG23 ' H ' ' C' ' 12' ' ' ASP . 5.0 p -87.86 154.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.7 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . 0.467 ' OD2' ' HE2' ' C' ' 15' ' ' LYS . 5.0 m-20 -120.43 36.57 4.52 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.713 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . 0.532 ' H ' HG23 ' C' ' 10' ' ' VAL . 13.8 m-20 45.3 -102.68 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.016 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -130.72 16.34 5.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.03 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.95 -45.48 81.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.428 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . 0.467 ' HE2' ' OD2' ' C' ' 11' ' ' ASP . 67.3 mttm -59.87 161.47 6.45 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.962 175.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 73.7 mtm 66.32 96.73 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.198 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.792 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -98.58 149.05 23.17 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 172.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.501 ' HA ' HG13 ' C' ' 32' ' ' ILE . 34.2 tt0 -102.17 87.92 3.19 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' C' ' 30' ' ' THR . 2.4 t -77.41 127.05 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.025 -167.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.624 ' CB ' HG11 ' C' ' 81' ' ' VAL . 1.0 OUTLIER -113.05 147.91 36.25 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 170.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.535 HG21 ' HB ' ' C' ' 82' ' ' ILE . 66.0 t -153.83 114.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -171.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 38.7 mtpt -99.96 172.1 7.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.371 0.605 . . . . 0.0 110.28 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 6.1 p -116.35 -171.53 2.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.814 172.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 4.3 mm? -42.06 -41.25 2.52 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -177.0 -29.83 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.061 -168.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 17.4 m -47.8 -82.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.827 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -128.13 177.54 6.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -171.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 53.8 m -135.02 111.87 10.13 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.0 -1.909 . . . . 0.0 107.253 170.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -120.49 158.58 26.96 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.15 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 4.2 p -104.26 147.67 27.22 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.517 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 42.1 m-85 -140.96 63.82 1.44 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.487 0.66 . . . . 0.0 110.314 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.4 mp -54.88 125.4 9.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 123.215 1.483 . . . . 0.0 114.458 -174.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.4 m -131.81 -170.47 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 111.507 -2.588 . . . . 0.0 111.927 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -113.17 40.27 2.57 Favored Glycine 0 C--N 1.317 -0.498 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.706 -175.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.792 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . 68.9 -50.43 0.59 Allowed 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 124.224 1.01 . . . . 0.0 113.529 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -130.72 23.44 5.03 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 2.1 ttt -66.16 -72.27 0.17 Allowed 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.93 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.599 ' O ' ' HD2' ' C' ' 40' ' ' LYS . 17.9 m120 -129.04 -91.1 0.48 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.598 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.5 OUTLIER 85.19 -40.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 O-C-N 124.5 1.125 . . . . 0.0 110.814 -164.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.599 ' HD2' ' O ' ' C' ' 38' ' ' ASN . 0.0 OUTLIER -74.14 -69.48 0.44 Allowed 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 122.449 1.118 . . . . 0.0 108.594 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.08 -26.52 68.59 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.186 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.598 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 5.8 t80 -59.2 -52.65 64.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.753 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.521 ' HD3' ' HB3' ' C' ' 68' ' ' ASP . 7.1 ptmm? -68.58 -38.73 80.94 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.355 0.598 . . . . 0.0 110.974 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' C' ' 54' ' ' SER . 1.3 tm-20 -54.56 -41.52 69.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.138 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -69.67 -51.57 33.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.53 ' O ' HG21 ' C' ' 50' ' ' VAL . 22.5 pt -70.69 -10.01 13.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.341 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.61 -36.63 0.61 Allowed 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.45 -50.57 11.43 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.944 -0.473 . . . . 0.0 111.938 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -28.41 69.47 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.23 0.538 . . . . 0.0 110.79 -176.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.53 HG21 ' O ' ' C' ' 46' ' ' ILE . 6.7 m -96.34 -11.46 8.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.542 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 18.6 m 68.36 19.79 8.82 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 121.55 0.69 . . . . 0.0 109.91 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 3.6 mm -129.35 118.21 19.07 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.856 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -67.29 148.5 80.2 Favored 'Trans proline' 0 CA--C 1.514 -0.475 0 C-N-CA 122.27 1.98 . . . . 0.0 111.147 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.446 ' OG ' ' HG3' ' C' ' 43' ' ' LYS . 41.8 t -51.19 -33.26 26.66 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.155 0.285 . . . . 0.0 111.748 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 8.5 pt-20 -66.42 -30.19 70.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.782 0.325 . . . . 0.0 111.441 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.448 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 55.7 mtpt -101.11 -23.79 14.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.071 0.462 . . . . 0.0 110.281 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.455 ' HA ' HG21 ' C' ' 52' ' ' ILE . 7.1 tt0 -76.19 119.44 20.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.058 -172.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -113.91 123.08 48.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.277 170.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.647 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 19.4 mt -89.79 113.87 25.49 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.557 HG21 ' O ' ' A' ' 37' ' ' ILE . 9.2 mt -108.36 126.44 65.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 121.289 -0.882 . . . . 0.0 111.424 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.498 ' CZ ' ' HB3' ' C' ' 80' ' ' LYS . 31.0 t80 -139.12 127.26 22.52 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 169.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 60.67 35.84 19.7 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.547 0.529 . . . . 0.0 110.549 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 71.33 2.28 47.77 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.596 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -89.0 137.86 31.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.87 88.92 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -76.46 128.11 34.16 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -147.33 177.01 9.56 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.905 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.579 ' CB ' ' HA ' ' C' ' 40' ' ' LYS . 4.0 p-10 -65.69 -1.85 3.11 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.105 0.962 . . . . 0.0 113.469 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -81.48 -13.37 58.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -131.32 -154.44 0.63 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.912 -0.493 . . . . 0.0 112.053 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.82 -179.67 3.93 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.701 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 2.9 mt -86.27 -34.09 20.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.025 0.44 . . . . 0.0 110.809 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.92 -23.72 66.01 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.403 0.681 . . . . 0.0 111.183 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -59.39 -28.81 67.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.655 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.627 ' CD1' HD23 ' C' ' 66' ' ' LEU . 34.0 m-85 -105.16 -16.05 14.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.114 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 55.83 52.49 10.68 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.996 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.408 HG12 HD13 ' C' ' 82' ' ' ILE . 28.2 m -93.08 16.6 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.559 -174.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.62 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -64.41 101.47 0.51 Allowed Glycine 0 CA--C 1.481 -2.033 0 CA-C-O 122.774 1.208 . . . . 0.0 112.785 172.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.34 15.13 56.19 Favored Glycine 0 C--N 1.283 -2.378 0 CA-C-N 111.868 -2.166 . . . . 0.0 112.599 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . 0.498 ' HB3' ' CZ ' ' C' ' 61' ' ' TYR . 73.1 mmtt -116.37 145.32 43.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 118.85 -0.595 . . . . 0.0 109.638 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.624 HG11 ' CB ' ' C' ' 20' ' ' LEU . 3.1 m -86.7 130.17 37.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.379 173.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.535 ' HB ' HG21 ' C' ' 21' ' ' VAL . 56.3 mt -88.48 169.17 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.869 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.481 ' N ' HG23 ' C' ' 82' ' ' ILE . 58.4 m80 -112.45 121.94 46.27 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.414 ' HG ' ' CG1' ' C' ' 21' ' ' VAL . 20.6 mt -78.32 152.71 32.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.971 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.727 HG12 ' CG ' ' A' ' 14' ' ' HIS . 5.7 t -143.45 159.51 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.773 -172.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . 0.512 ' O ' HG13 ' C' ' 85' ' ' VAL . 1.5 pm0 -93.17 175.02 6.93 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.403 170.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.34 150.89 45.3 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.219 1.009 . . . . 0.0 111.604 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.72 156.03 55.89 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 113.373 -1.74 . . . . 0.0 111.489 -173.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.4 155.06 32.1 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.741 2.294 . . . . 0.0 111.114 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.9 37.47 0.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.685 2.257 . . . . 0.0 113.668 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -6.88 47.48 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.094 -0.378 . . . . 0.0 110.285 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.0 t -66.38 -4.2 7.6 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.964 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -65.48 -18.51 65.37 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 121.301 0.572 . . . . 0.0 110.087 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 tp -126.12 130.81 23.87 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.162 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.75 103.34 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.316 2.011 . . . . 0.0 111.73 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 30.5 t -68.72 99.37 1.01 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.683 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.32 -118.12 9.04 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.523 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.01 15.68 14.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.548 0.213 . . . . 0.0 111.554 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -66.61 97.64 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.747 0.308 . . . . 0.0 110.455 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 13.3 t 62.38 34.79 15.38 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.103 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.274 -1.292 . . . . 0.0 111.544 179.809 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 42.0 m -86.29 123.56 31.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.792 0.33 . . . . 0.0 110.61 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 tpp -159.31 -59.73 0.07 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.874 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.98 114.12 11.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.562 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 61.95 25.15 15.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.887 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.37 77.62 0.93 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.298 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 m -66.68 116.4 34.33 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.796 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -64.31 -28.12 63.55 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.708 2.272 . . . . 0.0 112.83 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -134.95 127.23 18.17 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.661 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -81.51 37.54 0.69 Allowed 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.409 2.74 . . . . 0.0 112.597 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.52 72.17 0.37 Allowed Glycine 0 CA--C 1.487 -1.689 0 CA-C-O 122.54 1.078 . . . . 0.0 111.518 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -72.03 109.27 5.73 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 112.222 -1.989 . . . . 0.0 110.637 -178.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.59 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 5.5 m-85 -118.45 169.8 9.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.264 175.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.508 ' CB ' HD12 ' A' ' 40' ' ' LEU . 61.9 t80 -138.43 116.11 11.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.595 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -96.36 114.61 26.31 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.808 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.551 ' CD2' HG11 ' C' ' 85' ' ' VAL . 8.9 p80 -73.16 -8.69 56.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.702 0.286 . . . . 0.0 111.406 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.613 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 42.6 t -72.6 -32.7 66.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.359 0.6 . . . . 0.0 110.182 173.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.5 m -99.46 -25.9 14.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.391 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER 58.21 31.04 20.3 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.384 -171.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.65 144.75 34.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.5 tt0 -64.28 148.34 50.43 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.158 0.286 . . . . 0.0 110.745 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.655 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.2 pt -140.42 166.98 18.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.51 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.52 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 74.9 t -125.6 97.32 36.61 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 164.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.59 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 6.5 Cg_endo -55.94 174.91 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 125.06 3.84 . . . . 0.0 115.798 -171.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.454 ' HB2' HG13 ' A' ' 28' ' ' ILE . 5.3 mtt180 -108.62 49.85 0.8 Allowed 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.156 -1.838 . . . . 0.0 106.937 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.3 mm? 3.92 -61.98 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 110.952 -2.84 . . . . 0.0 117.049 171.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 15.8 Cg_exo -36.96 -33.44 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.69 2.26 . . . . 0.0 113.908 176.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.506 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.93 -22.38 9.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.326 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.494 ' C ' HD12 ' A' ' 37' ' ' ILE . 70.6 m-85 65.28 54.13 1.22 Allowed 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.171 0.986 . . . . 0.0 110.228 -169.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.506 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -104.93 161.13 4.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.985 176.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.516 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.7 t -96.28 145.84 30.26 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.655 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 81.7 Cg_endo -82.55 -20.52 5.69 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.702 2.268 . . . . 0.0 108.279 -174.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.488 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 18.2 mtt180 -89.37 -15.3 33.65 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 112.952 -1.931 . . . . 0.0 114.694 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.8 p -151.53 -8.09 0.23 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 10.1 tt0 60.79 25.2 15.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 111.586 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 m -103.36 141.89 35.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 169.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.59 30.87 2.49 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.268 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.583 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 35.8 m-85 -89.39 52.6 2.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.597 0.713 . . . . 0.0 110.146 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 13' ' ' CYS . 5.6 pt -122.6 134.17 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.598 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' C' ' 60' ' ' ILE . 11.4 pt-20 -119.75 144.03 47.48 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -75.81 138.49 41.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.508 HD12 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.666 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 48.3 ttp . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.609 0.242 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' C' ' 4' ' ' HIS . . . -101.39 -34.19 9.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' C' ' 3' ' ' ALA . 14.5 m80 70.81 -67.84 0.23 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.439 0.696 . . . . 0.0 111.765 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -115.35 176.16 5.19 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -63.87 -37.58 87.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 19.52 -85.98 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 O-C-N 125.578 1.798 . . . . 0.0 113.9 172.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -144.97 96.19 2.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.422 . . . . 0.0 110.516 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -75.6 94.46 3.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.72 149.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 122.228 1.014 . . . . 0.0 113.223 -169.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -136.65 -63.74 0.61 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.545 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' C' ' 14' ' ' ASP . 38.4 t70 70.76 127.02 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 124.093 0.871 . . . . 0.0 112.43 169.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.29 59.8 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.578 0.704 . . . . 0.0 110.241 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . 0.42 ' HB2' ' OD2' ' C' ' 12' ' ' ASP . 30.2 t70 -85.38 -16.58 39.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.975 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . 0.498 ' HD3' ' O ' ' C' ' 32' ' ' ILE . 37.3 mttm -71.36 172.39 9.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.169 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ttt -140.89 -36.44 0.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.541 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 1.2 mt -109.12 134.76 51.28 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.427 0.632 . . . . 0.0 110.543 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.491 ' HA ' ' CG1' ' C' ' 32' ' ' ILE . 36.9 mt-10 -89.77 93.33 9.4 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.278 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.594 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 2.7 t -77.41 124.11 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -171.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.624 ' C ' ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -109.28 146.53 34.13 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 171.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.523 HG23 ' HB ' ' C' ' 82' ' ' ILE . 36.4 t -151.07 125.07 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -172.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.563 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 72.2 mttt -110.93 110.98 21.8 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.171 0.51 . . . . 0.0 110.789 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.8 87.93 6.33 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.614 0.721 . . . . 0.0 110.289 164.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER 62.61 18.81 10.84 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.679 176.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 37.0 t70 76.87 -16.49 0.63 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.363 -1.744 . . . . 0.0 111.2 170.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.425 ' H ' ' C ' ' C' ' 24' ' ' LEU . 37.6 m -62.91 -30.39 71.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.03 176.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . 0.43 ' OE1' ' HA ' ' C' ' 50' ' ' VAL . 73.8 mt-30 -102.13 -72.0 0.7 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.503 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 71.8 m 53.63 95.2 0.02 OUTLIER 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.15 0.58 . . . . 0.0 111.412 -171.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -135.28 159.04 42.8 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.223 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 8.5 p -96.23 148.55 22.61 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.837 -174.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.594 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 34.3 m-85 -140.21 63.05 1.49 Allowed 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.135 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.498 ' O ' ' HD3' ' C' ' 15' ' ' LYS . 2.7 mp -59.92 120.18 5.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 123.445 1.593 . . . . 0.0 113.838 -175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.422 HG12 ' HD2' ' C' ' 42' ' ' PHE . 15.5 m -138.12 -172.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 111.016 -2.811 . . . . 0.0 111.565 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.69 175.86 34.51 Favored Glycine 0 C--N 1.308 -0.973 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.954 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.714 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . -90.55 50.17 1.79 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -169.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.714 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 1.5 mt-30 139.21 2.22 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 O-C-N 125.189 1.555 . . . . 0.0 109.42 -171.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 22.9 tpp -44.95 -70.49 0.1 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.769 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.432 ' CG ' ' HB2' ' C' ' 41' ' ' GLU . 26.9 m-80 -136.98 -99.09 0.2 Allowed 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 174.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.622 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 94.72 -29.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 125.151 1.532 . . . . 0.0 110.293 -162.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.603 ' HE2' ' O ' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -79.91 -71.11 0.47 Allowed 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.485 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . 0.432 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 40.4 mt-10 -63.01 -28.06 69.84 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.851 174.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.622 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 4.7 t80 -58.51 -54.36 47.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.739 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.532 ' HD3' ' HB3' ' C' ' 68' ' ' ASP . 8.9 ptmm? -69.6 -37.19 76.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.483 0.659 . . . . 0.0 111.209 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.407 ' HA ' ' HB3' ' C' ' 54' ' ' SER . 1.2 tm-20 -56.07 -44.18 78.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.225 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -69.77 -39.04 76.91 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.535 ' O ' HG22 ' C' ' 50' ' ' VAL . 20.0 pt -83.1 -6.61 10.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -173.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -38.1 -57.48 1.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.97 -36.05 69.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.073 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -20.51 66.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.861 0.362 . . . . 0.0 111.455 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.535 HG22 ' O ' ' C' ' 46' ' ' ILE . 14.6 m -111.76 -6.36 11.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.429 176.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 35.7 m 70.33 21.14 5.86 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.705 0.628 . . . . 0.0 109.475 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.3 mm -126.03 112.96 24.23 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.131 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.421 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.1 Cg_exo -70.94 145.52 50.56 Favored 'Trans proline' 0 CA--C 1.506 -0.876 0 C-N-CA 122.452 2.101 . . . . 0.0 110.784 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.478 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 1.9 p -54.79 -24.72 23.97 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 123.725 0.64 . . . . 0.0 112.647 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.12 -33.79 61.61 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.947 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -98.02 -11.04 23.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.361 0.601 . . . . 0.0 109.503 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.487 ' OE1' HD13 ' C' ' 46' ' ' ILE . 9.3 tt0 -82.99 119.59 24.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.105 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' C' ' 58' ' ' ARG . 22.2 mtm180 -127.66 126.92 42.85 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 171.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.707 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 22.8 mt -84.85 108.04 17.31 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.443 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.545 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.3 mt -99.95 118.35 46.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.39 173.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -132.37 125.99 32.17 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 171.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 58.37 36.37 25.44 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.209 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 76.63 0.9 69.43 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.489 175.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 16.9 mmm180 -98.13 141.49 30.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.72 95.15 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 120.937 0.399 . . . . 0.0 110.399 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -82.96 138.91 33.62 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -147.37 -176.08 5.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.928 0.394 . . . . 0.0 111.446 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.532 ' HB3' ' HD3' ' C' ' 43' ' ' LYS . 2.8 p-10 -69.49 -3.58 15.22 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.593 1.157 . . . . 0.0 113.337 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -75.8 -19.83 58.67 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.603 ' O ' ' HE2' ' C' ' 40' ' ' LYS . 39.5 mtmt -130.56 -147.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -170.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -120.35 153.18 36.83 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.795 -174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -58.01 -50.73 72.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 7.3 tp60 -68.3 -22.42 64.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.909 0.385 . . . . 0.0 111.444 -174.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -60.72 -28.89 69.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.273 0.559 . . . . 0.0 109.947 175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.469 ' CD1' HD23 ' C' ' 66' ' ' LEU . 39.5 m-85 -93.72 -19.81 20.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.398 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 t30 59.75 38.5 21.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.41 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 29.3 m -88.73 22.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.541 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -73.98 103.35 1.45 Allowed Glycine 0 N--CA 1.428 -1.876 0 CA-C-O 122.786 1.215 . . . . 0.0 112.787 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.51 12.98 46.14 Favored Glycine 0 C--N 1.284 -2.311 0 CA-C-N 112.185 -2.007 . . . . 0.0 115.157 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -128.37 148.27 50.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.273 0.536 . . . . 0.0 110.561 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.624 ' HA ' ' C ' ' C' ' 20' ' ' LEU . 18.4 m -78.54 120.91 30.43 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-O 122.007 0.908 . . . . 0.0 111.599 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' C' ' 21' ' ' VAL . 28.1 mt -76.7 166.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.003 173.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.462 ' N ' HG22 ' C' ' 82' ' ' ILE . 52.7 m170 -118.32 116.21 26.28 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.702 -0.624 . . . . 0.0 109.98 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' C' ' 84' ' ' LEU . 11.4 mt -90.81 157.82 17.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.551 HG11 ' CD2' ' A' ' 14' ' ' HIS . 2.4 m -131.49 161.38 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.987 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -128.07 122.68 32.72 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 167.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -74.53 171.79 13.16 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.136 0.493 . . . . 0.0 110.059 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -126.24 136.89 29.2 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.42 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' C' ' 88' ' ' ALA . 39.3 Cg_exo -63.11 137.42 61.58 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 123.286 2.657 . . . . 0.0 112.328 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 89' ' ' PRO . 5.2 Cg_exo -77.82 19.52 0.77 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.961 2.441 . . . . 0.0 112.718 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -96.87 -18.95 19.2 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.168 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.409 ' O ' HG21 ' C' ' 92' ' ' THR . 10.2 t -141.43 108.19 5.38 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.611 0.72 . . . . 0.0 110.319 171.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -88.31 -23.15 23.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.763 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.4 136.33 64.67 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.428 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -62.25 118.64 5.54 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.747 2.298 . . . . 0.0 111.773 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 22.9 t -153.87 99.21 2.26 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.977 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.88 8.68 66.93 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.845 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.9 77.2 1.7 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.031 0.443 . . . . 0.0 110.824 -177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 45.8 m -121.46 2.73 10.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 57.2 m -94.41 37.41 1.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 110.627 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.42 -1.211 . . . . 0.0 111.184 178.702 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 4.2 p -76.8 115.73 16.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.757 0.313 . . . . 0.0 110.79 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -156.29 -36.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.716 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.07 106.28 8.27 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.04 -39.42 4.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.658 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.41 -37.89 88.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.264 0.554 . . . . 0.0 110.498 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.2 m -145.2 80.47 11.05 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.592 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.62 -47.43 16.33 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.23 2.62 . . . . 0.0 114.562 -174.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.561 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 38.3 m80 -86.19 -66.41 0.19 Allowed Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -173.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 7' ' ' HIS . 22.3 Cg_endo -84.16 0.66 9.13 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.44 2.093 . . . . 0.0 112.724 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.68 1.99 62.05 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.75 -174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 19.5 mtm180 -97.89 86.68 3.81 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.402 0.62 . . . . 0.0 110.941 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.552 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 14.7 m-85 -125.22 167.39 14.92 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CB ' HD11 ' A' ' 40' ' ' LEU . 53.4 t80 -144.58 121.22 11.13 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.116 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.3 p -91.29 91.89 8.38 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.259 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -56.25 -41.77 76.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.367 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.2 t -55.3 -49.43 72.17 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.427 0.455 . . . . 0.0 112.196 -174.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.54 5.35 44.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.6 0.714 . . . . 0.0 111.559 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.4 p 53.32 58.31 5.36 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.058 1.343 . . . . 0.0 114.266 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -142.77 146.27 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 174.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 28.7 tt0 -89.18 139.42 30.5 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.537 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.654 HD12 ' CG2' ' A' ' 37' ' ' ILE . 7.0 pt -143.9 168.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -163.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.452 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 42.2 t -118.99 100.78 50.59 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 114.332 -1.304 . . . . 0.0 107.536 161.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.686 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . 1.2 Cg_endo -53.09 177.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.853 1 C-N-CA 126.078 4.519 . . . . 0.0 118.669 -168.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.577 ' HB3' HD12 ' A' ' 28' ' ' ILE . 62.9 mtt180 -117.94 50.81 1.11 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 111.34 -2.663 . . . . 0.0 107.388 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.425 HD12 ' CE1' ' A' ' 27' ' ' TYR . 2.6 mm? -8.71 -57.87 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 127.703 2.401 . . . . 0.0 117.325 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -32.98 -34.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 123.513 2.809 . . . . 0.0 114.378 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.538 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -124.42 -18.48 5.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.536 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.515 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 49.3 m-85 69.98 42.98 0.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.189 -171.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -91.33 165.19 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.119 174.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.468 ' CB ' HD13 ' A' ' 20' ' ' ILE . 25.2 p -95.49 144.06 27.18 Favored Pre-proline 0 N--CA 1.432 -1.338 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.622 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 44.1 Cg_endo -83.25 -22.55 3.96 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 123.278 2.652 . . . . 0.0 109.151 -168.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.508 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 60.0 mtt180 -81.96 -24.83 35.3 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 112.689 -2.051 . . . . 0.0 113.054 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.08 11.23 0.07 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 49.63 66.86 1.0 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.28 145.77 43.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.452 167.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -85.63 33.68 3.44 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.47 -174.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -108.95 52.03 0.72 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.133 0.492 . . . . 0.0 111.068 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.686 ' CD1' ' HB3' ' A' ' 22' ' ' PRO . 3.7 pt -111.58 138.86 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.77 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -116.39 147.71 41.37 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -80.25 122.46 26.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.852 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.599 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.35 -82.29 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 O-C-N 124.03 0.831 . . . . 0.0 111.395 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 56.04 78.66 0.19 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.363 0.601 . . . . 0.0 110.509 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -82.46 136.81 34.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.435 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -91.92 27.19 2.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.527 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -143.46 114.56 7.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.159 0.504 . . . . 0.0 109.816 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -122.75 -174.88 3.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.76 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -73.64 93.31 2.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.87 166.59 4.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.753 -174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -146.75 71.52 1.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.707 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' C' ' 15' ' ' LYS . 41.8 m-20 -79.8 62.65 4.11 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.677 -175.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -99.75 -52.29 3.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.041 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.07 -33.77 13.25 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.429 0.633 . . . . 0.0 109.322 171.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . 0.512 ' HA ' ' HB1' ' C' ' 35' ' ' ALA . 61.9 mttm -70.34 176.82 3.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.261 176.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 41.6 tpp 62.75 95.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.687 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.725 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -102.09 145.97 28.58 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.455 ' HA ' HG13 ' C' ' 32' ' ' ILE . 43.2 tt0 -97.91 91.88 5.55 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 170.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' C' ' 30' ' ' THR . 4.5 t -76.82 98.68 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.099 -170.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 1.4 mt -87.28 132.97 33.75 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 88.0 t -145.05 120.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.158 0.504 . . . . 0.0 110.322 -173.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.718 ' HG2' ' OG1' ' C' ' 28' ' ' THR . 44.4 mtpt -92.1 144.27 25.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' THR . . . . . 0.417 HG21 ' HB2' ' C' ' 84' ' ' LEU . 18.6 p -120.06 114.32 21.82 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' C' ' 25' ' ' ASP . 0.4 OUTLIER 62.7 -47.89 0.19 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 177.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' C' ' 24' ' ' LEU . 31.1 t70 167.38 -27.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.428 0.691 . . . . 0.0 109.511 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -58.3 -72.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.216 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -131.77 -177.65 4.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.768 0.794 . . . . 0.0 112.171 -169.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.718 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 19.9 m -133.59 117.21 16.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.742 -1.572 . . . . 0.0 108.803 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -121.07 150.14 41.65 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.94 0.4 . . . . 0.0 110.885 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.8 p -99.56 144.82 28.2 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.241 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.457 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 34.2 m-85 -132.58 60.18 1.7 Allowed 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.614 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.455 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.5 mp -57.96 118.85 2.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 123.06 1.41 . . . . 0.0 114.367 -173.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.456 HG11 ' HD2' ' C' ' 42' ' ' PHE . 16.6 m -138.36 170.51 16.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 111.625 -2.534 . . . . 0.0 112.593 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' C' ' 36' ' ' GLN . . . -84.88 50.33 4.38 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.08 -1.418 . . . . 0.0 114.188 -168.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.725 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . 65.39 -48.2 0.37 Allowed 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 124.255 1.022 . . . . 0.0 113.482 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.434 ' HA ' ' HB3' ' C' ' 71' ' ' LYS . 3.9 pt20 -139.82 26.04 2.31 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -164.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -59.64 -70.99 0.14 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 111.63 -2.532 . . . . 0.0 111.019 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.431 ' O ' ' HB ' ' C' ' 39' ' ' VAL . 13.5 m-80 -144.23 -92.02 0.11 Allowed 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.671 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 96.44 -29.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 O-C-N 125.702 1.876 . . . . 0.0 110.891 -166.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' C' ' 70' ' ' LYS . 0.9 OUTLIER -80.44 -71.39 0.46 Allowed 'General case' 0 N--CA 1.423 -1.813 0 CA-C-O 122.158 0.98 . . . . 0.0 108.859 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.89 -26.59 68.67 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 113.754 -1.567 . . . . 0.0 111.239 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.671 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.6 OUTLIER -59.37 -51.6 69.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.984 174.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.524 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 17.7 mtpp -63.51 -42.06 98.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.96 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -56.14 -37.0 68.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.282 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -69.76 -47.35 63.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.807 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.641 ' O ' HG22 ' C' ' 50' ' ' VAL . 7.4 pt -74.45 -11.46 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.994 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.5 -58.39 2.27 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.64 -37.53 67.96 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.845 -175.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -36.66 83.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.102 0.477 . . . . 0.0 110.648 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.641 HG22 ' O ' ' C' ' 46' ' ' ILE . 24.5 m -98.68 -1.71 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.946 177.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p 60.66 26.58 16.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.014 0.911 . . . . 0.0 109.533 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.3 mm -128.59 113.74 19.36 Favored Pre-proline 0 N--CA 1.434 -1.269 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.099 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 3.7 Cg_exo -69.98 143.65 50.43 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.131 1.888 . . . . 0.0 111.525 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.499 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 35.3 t -51.58 -24.72 5.71 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.331 1.02 . . . . 0.0 112.286 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.6 pt-20 -72.41 -43.71 63.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.604 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.413 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 96.6 mttt -88.2 -29.13 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.856 0.836 . . . . 0.0 109.382 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.524 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 19.3 tt0 -57.62 131.61 50.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.401 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -136.38 123.76 22.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.876 175.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.476 ' HB3' HG23 ' C' ' 82' ' ' ILE . 46.4 mt -86.73 104.36 16.05 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.098 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.565 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.0 mt -101.94 116.98 46.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.884 -0.51 . . . . 0.0 111.251 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -127.2 113.89 16.94 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 173.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 60.96 43.08 11.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.24 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 72.99 -4.58 22.81 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.142 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -88.32 125.39 34.66 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -87.92 88.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.283 0.564 . . . . 0.0 109.816 -176.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.626 HD21 ' CD1' ' C' ' 75' ' ' TYR . 0.5 OUTLIER -68.55 133.69 48.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -142.65 -176.92 5.06 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.641 -170.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.498 ' HA ' HG13 ' C' ' 39' ' ' VAL . 11.4 p-10 -71.88 -0.61 11.76 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.22 1.008 . . . . 0.0 112.627 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -79.89 -21.93 43.42 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.431 ' O ' ' HE3' ' C' ' 40' ' ' LYS . 68.7 mttt -123.93 -148.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -167.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.434 ' HB3' ' HA ' ' C' ' 36' ' ' GLN . 0.0 OUTLIER -127.17 163.58 23.54 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.694 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 2.9 mm? -66.25 -36.99 84.45 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 118.482 0.583 . . . . 0.0 111.167 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' C' ' 35' ' ' ALA . 35.0 tt0 -70.66 -18.15 62.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.858 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . 0.406 ' HG3' ' HB3' ' C' ' 70' ' ' LYS . 16.9 mm-40 -64.72 -28.84 69.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.464 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.626 ' CD1' HD21 ' C' ' 66' ' ' LEU . 17.8 m-85 -95.54 -22.52 17.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.867 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 t30 63.77 52.35 2.2 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 123.038 1.399 . . . . 0.0 107.76 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.69 -0.86 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 CA-C-N 112.78 -2.009 . . . . 0.0 112.705 -162.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.512 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -47.3 102.45 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.403 0 CA-C-O 122.904 1.28 . . . . 0.0 114.37 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.18 14.29 56.23 Favored Glycine 0 C--N 1.287 -2.188 0 CA-C-N 111.725 -2.237 . . . . 0.0 114.265 170.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -117.23 142.43 47.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.809 0.305 . . . . 0.0 110.25 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.628 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 15.6 m -79.34 124.13 37.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.676 0.751 . . . . 0.0 112.596 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' C' ' 59' ' ' LEU . 25.5 mt -86.87 168.71 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.487 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.442 ' N ' HG22 ' C' ' 82' ' ' ILE . 46.2 m-70 -119.3 115.65 24.6 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 121.965 -0.459 . . . . 0.0 110.168 174.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.417 ' HB2' HG21 ' C' ' 23' ' ' THR . 11.3 mt -91.52 144.64 25.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.103 0.478 . . . . 0.0 111.235 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 31.0 m -142.05 169.39 13.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.837 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.76 150.03 32.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.137 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -71.35 177.2 4.05 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.291 0.567 . . . . 0.0 111.633 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.27 168.7 2.09 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.375 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.55 158.39 8.0 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.198 1.932 . . . . 0.0 112.062 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.45 60.49 3.37 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.212 2.608 . . . . 0.0 113.393 -172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -89.89 -3.34 58.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.811 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -84.82 131.17 34.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.86 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 71.23 -42.8 0.54 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.827 0.851 . . . . 0.0 111.528 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -90.01 116.66 66.9 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.78 110.4 1.45 Allowed 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.404 2.07 . . . . 0.0 112.754 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 23.2 t -76.91 145.81 38.0 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.46 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.64 81.97 1.44 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.272 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 58.6 47.47 13.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.884 0.373 . . . . 0.0 110.576 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 77.9 p 50.65 29.66 4.32 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.918 0.887 . . . . 0.0 112.053 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 15.9 m 60.2 29.03 18.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.995 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.905 -0.942 . . . . 0.0 112.386 177.545 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.7 t -132.31 85.65 2.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.05 0.452 . . . . 0.0 109.872 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -81.48 107.75 14.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.614 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.87 -16.64 37.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.581 0.705 . . . . 0.0 109.639 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.97 -172.07 3.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.148 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.34 58.61 5.06 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 123.604 0.565 . . . . 0.0 110.521 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m 65.72 75.44 0.34 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.126 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.81 -0.92 10.29 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.764 2.31 . . . . 0.0 112.76 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -122.45 128.87 25.29 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.728 0.299 . . . . 0.0 111.066 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.06 50.49 3.13 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.347 2.698 . . . . 0.0 112.553 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.95 3.1 25.72 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.669 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.545 ' HG2' HD11 ' A' ' 40' ' ' LEU . 38.5 ttt180 -114.74 83.4 1.89 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.071 -0.564 . . . . 0.0 110.809 -177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.528 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 8.6 m-85 -117.93 141.21 48.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.955 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.427 ' CB ' HD23 ' A' ' 40' ' ' LEU . 74.4 t80 -112.61 115.69 29.0 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.436 170.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.617 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -91.11 118.99 30.88 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.094 174.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -80.38 -7.89 59.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.263 -174.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 7.9 t -72.04 -51.52 21.32 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.911 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' HG21 ' A' ' 18' ' ' VAL . 26.9 p -100.94 2.97 41.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.312 0.577 . . . . 0.0 110.324 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p 54.4 45.43 27.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.812 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 16' ' ' CYS . 21.7 t -141.61 147.89 21.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.626 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.58 142.1 42.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.561 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.655 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 4.9 pt -133.17 167.05 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.703 0.763 . . . . 0.0 112.916 -170.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.9 t -117.79 108.31 42.99 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.303 160.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.528 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 19.1 Cg_endo -70.19 176.14 7.5 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 124.404 3.402 . . . . 0.0 116.552 -166.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.486 ' HB3' HD11 ' A' ' 28' ' ' ILE . 62.6 mtt180 -114.05 49.17 1.02 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 112.924 -1.944 . . . . 0.0 107.802 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 27' ' ' TYR . 2.6 mm? -0.44 -61.74 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.124 0 CA-C-N 111.308 -2.678 . . . . 0.0 117.763 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -32.38 -36.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.377 2.718 . . . . 0.0 114.397 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.514 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.98 -19.76 9.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.786 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.411 ' CE1' HD12 ' A' ' 24' ' ' LEU . 56.4 m-85 66.91 46.23 1.67 Allowed 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.227 -169.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.514 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -92.09 164.04 2.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 113.82 -1.537 . . . . 0.0 110.341 174.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.428 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.8 OUTLIER -96.41 144.11 27.28 Favored Pre-proline 0 C--N 1.306 -1.303 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.015 177.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.655 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 47.5 Cg_endo -84.87 -15.91 5.57 Favored 'Trans proline' 0 CA--C 1.5 -1.212 0 C-N-CA 123.55 2.833 . . . . 0.0 108.627 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.47 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 85.7 mtt-85 -91.21 -14.18 31.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.177 -1.829 . . . . 0.0 114.0 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.4 p -163.33 3.77 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 55.41 36.91 28.09 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.542 0.687 . . . . 0.0 112.162 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.432 ' HB3' ' CD2' ' A' ' 36' ' ' PHE . 16.7 m -116.81 136.43 52.96 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.493 172.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.67 28.26 2.46 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.086 -0.578 . . . . 0.0 113.925 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 80.0 m-85 -86.57 44.24 1.14 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.087 0.47 . . . . 0.0 109.799 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.625 ' O ' HG21 ' C' ' 60' ' ' ILE . 19.6 pt -110.86 132.79 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.104 -176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.513 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.9 pt-20 -121.7 139.81 53.09 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -76.35 128.64 35.25 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.545 HD11 ' HG2' ' A' ' 10' ' ' ARG . 13.0 mt . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.319 -167.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.43 91.62 4.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.724 0.297 . . . . 0.0 110.682 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 60.34 -161.81 0.27 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.741 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 60.11 46.42 10.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.413 0.625 . . . . 0.0 109.338 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -86.44 14.93 5.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.935 -169.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -56.5 -44.15 80.4 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -120.51 115.82 24.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.042 172.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -86.36 164.41 17.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.15 140.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.149 0.5 . . . . 0.0 110.737 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -124.24 -19.14 5.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.499 0.666 . . . . 0.0 109.419 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -87.07 51.1 2.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.429 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -142.28 155.43 45.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.083 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.43 -26.19 60.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.434 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' C' ' 33' ' ' VAL . 40.9 mttm -82.33 178.16 8.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.739 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.426 ' SD ' ' HB3' ' C' ' 35' ' ' ALA . 26.1 ttt -149.1 -36.57 0.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -175.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.743 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -102.08 140.43 36.36 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.786 -179.061 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.509 ' HA ' HG13 ' C' ' 32' ' ' ILE . 4.6 mt-10 -97.21 90.75 5.23 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.966 174.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 24.4 t -78.61 76.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 123.31 1.529 . . . . 0.0 111.019 -169.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 4.3 mt -69.98 140.37 52.94 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.539 HG21 ' HB ' ' C' ' 82' ' ' ILE . 47.4 t -153.44 115.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.986 0.422 . . . . 0.0 110.131 -169.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.515 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 34.8 mtpt -98.9 125.44 44.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' THR . . . . . 0.557 ' O ' HD21 ' C' ' 24' ' ' LEU . 5.7 p -81.97 -60.66 2.15 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.031 0.443 . . . . 0.0 111.467 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.557 HD21 ' O ' ' C' ' 23' ' ' THR . 1.7 mm? -140.17 26.42 2.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.02 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 11.5 t70 84.23 -35.22 0.06 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.082 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 6.1 m -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.758 0.314 . . . . 0.0 111.19 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -92.09 -76.85 0.45 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 97.5 m 56.67 93.39 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.761 0.315 . . . . 0.0 110.638 -170.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -128.09 150.06 50.13 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.094 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' C' ' 20' ' ' LEU . 0.2 OUTLIER -97.09 139.94 32.34 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.626 -176.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.616 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 38.0 m-85 -127.0 67.67 1.27 Allowed 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.613 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -58.78 120.63 4.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 123.384 1.564 . . . . 0.0 114.189 -174.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' C' ' 15' ' ' LYS . 17.8 m -136.99 -170.3 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 110.94 -2.846 . . . . 0.0 110.812 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.435 ' O ' HD22 ' C' ' 17' ' ' LEU . . . -88.93 176.74 44.32 Favored Glycine 0 C--N 1.307 -1.06 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.773 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.743 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -68.73 -17.66 64.09 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 117.818 0.809 . . . . 0.0 112.286 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -163.73 27.07 0.08 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -55.58 -76.53 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 112.019 -2.355 . . . . 0.0 111.219 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.582 ' O ' HG13 ' C' ' 39' ' ' VAL . 83.8 m-20 -128.79 -84.9 0.57 Allowed 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.355 174.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.66 ' O ' ' HD2' ' C' ' 43' ' ' LYS . 0.3 OUTLIER 88.12 -28.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 125.594 1.809 . . . . 0.0 111.646 -167.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -72.6 0.5 Allowed 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.013 0.911 . . . . 0.0 109.402 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.2 -27.86 67.5 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.368 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.505 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.6 OUTLIER -62.25 -50.32 72.21 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.35 174.53 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.66 ' HD2' ' O ' ' C' ' 39' ' ' VAL . 0.0 OUTLIER -58.37 -43.16 88.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.089 0.471 . . . . 0.0 110.756 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -57.03 -34.24 68.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.523 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -70.9 -44.51 66.09 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.677 ' O ' HG23 ' C' ' 50' ' ' VAL . 21.5 pt -77.98 -16.77 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.835 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.06 -49.61 2.56 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.06 -42.49 60.12 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.797 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -16.6 63.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.925 0.393 . . . . 0.0 110.976 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.677 HG23 ' O ' ' C' ' 46' ' ' ILE . 29.0 m -112.06 -9.1 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.891 176.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t 70.62 19.79 5.98 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.768 0.794 . . . . 0.0 109.283 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.7 mm -128.48 110.03 19.23 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.873 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' C' ' 47' ' ' ALA . 6.4 Cg_exo -68.37 146.82 70.09 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.173 1.915 . . . . 0.0 111.09 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -54.91 -25.7 30.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.898 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.427 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.7 pt-20 -75.31 -18.01 60.13 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 111.082 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.617 ' O ' ' HG3' ' C' ' 87' ' ' ARG . 98.7 mttt -120.29 -0.95 10.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.401 . . . . 0.0 110.773 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.672 ' OE1' HD13 ' C' ' 46' ' ' ILE . 0.0 OUTLIER -93.1 126.18 38.07 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.335 -175.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . 0.459 ' CD ' ' HG2' ' C' ' 87' ' ' ARG . 66.5 mtp85 -122.35 123.6 41.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.05 173.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.572 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 2.1 mm? -92.25 104.49 16.85 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.734 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.625 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.6 mt -101.64 122.93 54.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.893 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.455 ' OH ' ' HD3' ' C' ' 80' ' ' LYS . 29.5 t80 -135.24 131.94 37.24 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 171.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 48.44 38.78 11.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.033 -172.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.88 6.4 63.58 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.848 -0.615 . . . . 0.0 113.169 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -98.16 133.52 42.49 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.17 94.45 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.265 0.555 . . . . 0.0 110.471 -176.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.3 OUTLIER -82.66 156.1 24.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . 0.458 ' HA ' HD23 ' C' ' 59' ' ' LEU . 16.4 pt20 -169.97 -169.12 0.83 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.601 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.553 ' HA ' HG12 ' C' ' 39' ' ' VAL . 7.3 p-10 -62.41 -0.02 0.52 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.771 0.828 . . . . 0.0 112.228 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' C' ' 67' ' ' GLN . 28.9 t70 -63.38 -4.33 2.6 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.016 0.926 . . . . 0.0 112.782 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.455 ' HA ' HG13 ' C' ' 39' ' ' VAL . 51.5 mtmt 83.55 167.89 0.1 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 169.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.432 ' HB3' ' HG3' ' C' ' 74' ' ' GLU . 13.9 mptt 67.35 79.12 0.23 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.939 -178.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 20.8 mt -62.27 -33.23 74.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.648 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -69.36 -19.03 63.84 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 122.696 0.399 . . . . 0.0 112.005 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . 0.432 ' HG3' ' HB3' ' C' ' 71' ' ' LYS . 32.1 mt-10 -73.05 -27.85 61.98 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.51 ' CD1' HD21 ' C' ' 66' ' ' LEU . 15.7 m-85 -87.97 -21.99 24.54 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.4 t30 58.89 40.37 22.73 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.709 174.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.481 HG13 HD11 ' C' ' 82' ' ' ILE . 17.4 m -87.92 10.22 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.84 -171.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -60.91 99.48 0.2 Allowed Glycine 0 CA--C 1.488 -1.6 0 CA-C-O 122.785 1.214 . . . . 0.0 113.226 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . 0.423 ' C ' HD12 ' C' ' 20' ' ' LEU . . . 94.35 15.25 48.17 Favored Glycine 0 C--N 1.284 -2.357 0 CA-C-N 112.091 -2.055 . . . . 0.0 114.132 172.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . 0.455 ' HD3' ' OH ' ' C' ' 61' ' ' TYR . 55.2 mttm -126.75 140.47 52.36 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 33.9 m -75.83 134.02 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.854 0.835 . . . . 0.0 110.732 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.562 HG23 ' HB3' ' C' ' 59' ' ' LEU . 59.4 mt -89.78 169.8 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.969 172.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.536 ' N ' HG22 ' C' ' 82' ' ' ILE . 56.8 m80 -115.95 112.38 21.77 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.461 HD12 ' N ' ' C' ' 85' ' ' VAL . 13.7 tp -97.83 130.63 44.74 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 121.218 0.533 . . . . 0.0 110.296 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.461 ' N ' HD12 ' C' ' 84' ' ' LEU . 30.6 m -131.38 151.81 36.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.978 -176.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . 0.44 ' HB3' HD12 ' C' ' 52' ' ' ILE . 3.2 pt-20 -87.96 143.81 26.89 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.324 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . 0.617 ' HG3' ' O ' ' C' ' 56' ' ' LYS . 54.2 mtt180 -80.76 166.12 21.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.641 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.7 144.44 97.87 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.895 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.9 155.7 62.56 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.101 2.534 . . . . 0.0 112.346 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.08 50.08 2.11 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.906 2.404 . . . . 0.0 113.15 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -100.59 -49.56 4.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.2 t -129.45 150.21 50.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.945 170.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 54.7 t60 60.32 54.85 3.77 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.643 0.735 . . . . 0.0 109.467 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . 0.501 ' H ' HD23 ' C' ' 94' ' ' LEU . 1.3 pt? -109.38 115.58 56.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.231 -175.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.96 -29.55 11.93 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.475 2.117 . . . . 0.0 111.659 176.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 22.6 t -67.44 117.41 9.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.842 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.55 -78.58 1.85 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.517 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 64.29 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.442 0.697 . . . . 0.0 112.174 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 9.7 t 63.48 91.42 0.07 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.392 0.615 . . . . 0.0 110.323 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 8.4 m -87.67 62.2 6.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.136 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.72 -1.044 . . . . 0.0 112.094 177.663 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 112.131 -0.388 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 12.9 p -77.44 95.92 4.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.046 0.45 . . . . 0.0 110.721 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm -160.17 -54.5 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.821 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.12 115.13 4.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.17 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.36 77.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.483 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 66.72 -73.33 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.93 0.769 . . . . 0.0 111.034 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.1 m -151.32 82.04 5.9 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.61 57.59 6.44 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.949 2.433 . . . . 0.0 113.172 -175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.421 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 27.5 t-80 -166.49 -51.57 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.603 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 7' ' ' HIS . 97.1 Cg_endo -95.69 125.12 0.33 Allowed 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 122.497 2.132 . . . . 0.0 111.923 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.566 ' HA3' HG11 ' A' ' 21' ' ' VAL . . . 114.28 5.37 21.37 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 119.506 -1.33 . . . . 0.0 112.289 -176.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -70.96 81.68 0.66 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.483 0.659 . . . . 0.0 110.237 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.6 m-85 -115.42 166.2 12.14 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.141 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.507 ' CB ' HD12 ' A' ' 40' ' ' LEU . 39.0 t80 -140.64 119.44 12.53 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.317 178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB2' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -95.9 107.12 19.35 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.782 177.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.605 ' ND1' HG22 ' C' ' 85' ' ' VAL . 17.9 p80 -62.23 -15.73 48.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.808 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 7.0 t -71.71 -31.12 66.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.645 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.1 m -98.65 -26.14 14.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.156 0.503 . . . . 0.0 110.607 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.37 28.55 15.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.345 -171.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.68 143.53 40.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 36.9 tt0 -71.82 148.39 46.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.11 0.481 . . . . 0.0 110.831 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.67 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.6 pt -138.68 167.04 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.719 -170.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.566 HG11 ' HA3' ' A' ' 9' ' ' GLY . 20.9 t -123.36 96.85 43.46 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 163.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.685 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 9.2 Cg_endo -56.0 176.16 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.872 1 C-N-CA 125.328 4.018 . . . . 0.0 116.529 -170.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.688 ' HB2' HG13 ' A' ' 28' ' ' ILE . 24.5 mtt180 -110.25 49.82 0.83 Allowed 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 112.488 -2.142 . . . . 0.0 107.692 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -0.75 -58.25 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 CA-C-N 111.21 -2.723 . . . . 0.0 117.047 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.412 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 18.6 Cg_exo -37.15 -31.19 0.12 Allowed 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.88 2.387 . . . . 0.0 114.074 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.533 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -123.69 -19.88 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.357 0.599 . . . . 0.0 111.765 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.482 ' C ' HD11 ' A' ' 37' ' ' ILE . 47.0 m-85 67.34 45.49 1.61 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.28 -171.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.688 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.4 OUTLIER -92.43 160.45 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.723 173.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -96.0 144.64 28.18 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.67 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 96.8 Cg_endo -79.52 -21.55 8.66 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 122.672 2.248 . . . . 0.0 108.049 -172.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.1 mtt-85 -79.92 -37.79 33.87 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 112.561 -2.109 . . . . 0.0 113.567 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.0 p -133.75 -6.92 2.81 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.463 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 59.32 30.91 20.71 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.509 0.671 . . . . 0.0 111.661 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 m -111.48 144.24 41.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.467 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.23 41.06 2.6 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.109 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.668 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 60.5 m-85 -96.04 46.02 1.08 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.106 0.479 . . . . 0.0 109.934 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.584 HG22 HD11 ' A' ' 20' ' ' ILE . 3.5 pt -113.31 134.63 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.796 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.481 ' HB3' HD12 ' C' ' 60' ' ' ILE . 0.7 OUTLIER -119.14 141.69 48.6 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -79.9 137.27 36.86 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.507 HD12 ' CB ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.455 -175.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.931 0.396 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.79 121.84 3.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.69 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.01 75.09 6.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.354 0.597 . . . . 0.0 110.531 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 t60 54.77 49.07 18.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.257 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -109.39 15.33 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.424 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 19.3 m80 -96.63 110.97 23.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.043 0.449 . . . . 0.0 110.641 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -145.5 -172.96 3.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -83.11 -47.66 11.4 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.24 142.41 42.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.442 171.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -104.95 -22.85 13.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.04 0.448 . . . . 0.0 110.028 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -83.47 78.17 9.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.655 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -81.51 74.42 8.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.68 0.753 . . . . 0.0 110.613 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.2 -2.7 49.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.764 174.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -68.03 150.79 48.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.173 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.532 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 26.5 ptt? -163.35 122.47 2.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.187 0.518 . . . . 0.0 111.401 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.539 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 1.9 mt -105.04 132.15 51.64 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.516 ' HA ' ' CG1' ' C' ' 32' ' ' ILE . 49.3 mt-10 -81.51 94.39 6.86 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 9.4 t -80.67 116.53 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.925 -171.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.539 ' CD2' HG23 ' C' ' 30' ' ' THR . 0.8 OUTLIER -107.5 144.9 33.8 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 175.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' C' ' 28' ' ' THR . 3.5 m -137.02 147.64 26.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.566 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 37.0 mtpt -120.29 123.64 43.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 17.0 p -81.89 179.82 7.67 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.668 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 6.2 mp -67.06 -29.13 68.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.683 0.674 . . . . 0.0 110.134 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.47 -5.91 12.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.783 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 8.7 t 66.21 22.6 10.96 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.539 0.685 . . . . 0.0 110.611 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -47.23 -56.54 6.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.203 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 71.7 m 62.29 96.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.849 0.718 . . . . 0.0 110.615 -174.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -133.11 153.42 51.54 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.425 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.539 HG23 ' CD2' ' C' ' 20' ' ' LEU . 16.3 p -100.11 151.4 21.44 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -170.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.555 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 26.8 m-85 -141.43 55.56 1.52 Allowed 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.246 -175.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.516 ' CG1' ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -60.95 120.84 7.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 123.407 1.575 . . . . 0.0 113.801 -174.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.6 m -138.03 -168.76 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 110.729 -2.942 . . . . 0.0 111.446 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -76.94 -158.96 9.39 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.052 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . -110.13 23.64 14.06 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 120.9 0.381 . . . . 0.0 111.371 -177.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 7.5 tt0 166.19 -17.47 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.418 -163.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -41.25 -64.86 0.5 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.48 1.113 . . . . 0.0 112.262 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.472 ' O ' HG11 ' C' ' 39' ' ' VAL . 66.1 m-20 -131.0 -95.01 0.37 Allowed 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.632 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 86.0 -30.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 O-C-N 125.041 1.463 . . . . 0.0 110.819 -162.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.79 -70.28 0.55 Allowed 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.228 1.013 . . . . 0.0 109.095 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . 0.433 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 43.7 mt-10 -62.03 -26.66 68.37 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.393 173.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.72 ' O ' HG21 ' C' ' 46' ' ' ILE . 0.2 OUTLIER -56.82 -53.71 54.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.255 172.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.454 ' N ' ' HD1' ' C' ' 42' ' ' PHE . 18.8 mtpp -61.79 -41.89 98.32 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.521 0.677 . . . . 0.0 110.721 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -58.46 -40.28 82.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.662 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -69.92 -44.82 68.87 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.027 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.72 HG21 ' O ' ' C' ' 42' ' ' PHE . 4.3 pt -75.22 -13.23 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.792 -0.185 . . . . 0.0 111.225 -172.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -43.49 -45.64 6.52 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.33 -43.09 34.23 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.892 -0.505 . . . . 0.0 111.804 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -20.28 63.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.516 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.649 HG21 ' O ' ' C' ' 46' ' ' ILE . 31.5 m -112.07 -6.68 11.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t 68.85 19.72 8.23 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.724 0.773 . . . . 0.0 109.018 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 8.6 mm -125.71 112.42 25.06 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.385 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 4.7 Cg_exo -69.73 146.31 59.97 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.138 1.892 . . . . 0.0 111.494 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.3 p -53.0 -24.82 10.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.476 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.27 -32.37 55.56 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.36 0.412 . . . . 0.0 111.894 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' C' ' 86' ' ' GLU . 27.0 mtpp -97.92 -19.93 17.77 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 109.847 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' C' ' 53' ' ' PRO . 25.8 tt0 -66.52 123.26 19.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.92 -170.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . 0.528 ' HD2' ' HG2' ' C' ' 87' ' ' ARG . 43.5 mtp85 -124.93 115.4 20.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.204 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 51.6 mt -86.96 111.41 20.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.979 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 38' ' ' GLU . 5.6 mt -109.93 113.63 44.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 O-C-N 121.568 -0.707 . . . . 0.0 112.01 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' C' ' 66' ' ' LEU . 21.1 t80 -129.38 126.89 39.86 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 60.5 34.17 20.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.022 0.439 . . . . 0.0 110.379 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.99 5.44 40.09 Favored Glycine 0 N--CA 1.453 -0.211 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.899 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -87.43 133.4 33.74 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.97 87.6 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.261 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.597 ' HB3' ' CD2' ' C' ' 75' ' ' TYR . 0.8 OUTLIER -68.28 141.63 55.81 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -155.4 -168.97 3.0 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.684 -0.406 . . . . 0.0 109.955 -173.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.541 ' HA ' HG13 ' C' ' 39' ' ' VAL . 8.9 p-10 -67.43 0.24 3.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.608 0.763 . . . . 0.0 112.577 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.17 -4.02 3.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.521 0.729 . . . . 0.0 112.846 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.43 ' HA ' HG11 ' C' ' 39' ' ' VAL . 49.2 mttp 81.95 177.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.951 0.9 . . . . 0.0 111.865 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.407 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 65.5 mttm 74.66 75.12 0.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.145 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.01 -45.39 85.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.292 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -69.55 -25.84 64.2 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . 0.407 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 69.3 mm-40 -67.46 -24.71 65.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.575 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.597 ' CD2' ' HB3' ' C' ' 66' ' ' LEU . 6.9 m-30 -86.42 -10.21 54.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.447 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 1.3 m120 47.89 35.33 4.75 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.328 1.051 . . . . 0.0 113.471 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.449 HG21 HG23 ' C' ' 19' ' ' VAL . 16.5 m -90.55 16.19 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -175.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.539 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -73.18 102.78 1.29 Allowed Glycine 0 N--CA 1.431 -1.658 0 CA-C-O 122.792 1.218 . . . . 0.0 112.082 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.21 14.59 62.01 Favored Glycine 0 C--N 1.283 -2.401 0 CA-C-N 112.052 -2.074 . . . . 0.0 113.045 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -124.23 147.5 48.01 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.566 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 34.0 m -84.13 124.26 39.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 121.971 0.891 . . . . 0.0 112.313 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.449 HG22 ' N ' ' C' ' 83' ' ' HIS . 74.0 mt -77.77 171.6 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.433 173.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.449 ' N ' HG22 ' C' ' 82' ' ' ILE . 45.5 m80 -118.85 119.52 34.62 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.465 -0.772 . . . . 0.0 109.775 170.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.46 HD11 ' H ' ' C' ' 85' ' ' VAL . 25.9 tp -100.59 145.14 28.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -171.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.605 HG22 ' ND1' ' A' ' 14' ' ' HIS . 2.8 p -153.5 -174.33 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.481 0.658 . . . . 0.0 109.973 171.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' C' ' 56' ' ' LYS . 4.7 pt-20 -117.98 161.22 20.15 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.858 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . 0.528 ' HG2' ' HD2' ' C' ' 58' ' ' ARG . 29.1 mtm105 -82.38 159.98 22.9 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 171.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -68.74 139.2 90.99 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.601 -175.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . 0.541 ' HB2' ' OE1' ' C' ' 91' ' ' GLN . 38.1 Cg_exo -63.02 162.85 24.46 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 124.146 3.23 . . . . 0.0 112.683 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.95 56.59 2.48 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.335 2.69 . . . . 0.0 113.366 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . 0.541 ' OE1' ' HB2' ' C' ' 89' ' ' PRO . 7.8 pm0 179.18 -26.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.281 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' C' ' 93' ' ' HIS . 13.1 t 42.44 42.76 2.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.633 1.173 . . . . 0.0 113.231 169.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' C' ' 92' ' ' THR . 14.5 m-70 70.15 -63.12 0.41 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.357 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 pp -144.23 137.34 13.91 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.383 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.97 152.16 40.58 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.333 2.022 . . . . 0.0 111.526 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 8.5 t -164.07 149.26 10.49 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.0 -60.42 8.44 Favored Glycine 0 C--O 1.236 0.258 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.849 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 58.32 36.8 25.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.228 0.537 . . . . 0.0 110.962 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 17.2 t -95.27 77.33 3.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.997 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 13.9 m -84.44 53.05 2.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.659 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.315 -1.269 . . . . 0.0 111.17 -178.251 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.1 t -164.33 94.61 0.72 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.003 0.43 . . . . 0.0 110.025 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -77.27 -51.33 11.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.355 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.83 108.55 5.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.923 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -143.39 -63.97 0.39 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.752 -175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.551 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . 55.32 61.79 2.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.206 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -88.69 104.66 7.81 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.62 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 4' ' ' ALA . 97.7 Cg_endo -86.96 178.05 3.78 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.351 2.034 . . . . 0.0 111.52 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.594 ' CB ' ' HG2' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -140.71 93.4 8.55 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.192 173.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 7' ' ' HIS . 19.0 Cg_endo -53.26 -24.43 26.71 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 C-N-CA 123.664 2.91 . . . . 0.0 113.834 173.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.8 34.61 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.295 0 C-N-CA 119.304 -1.427 . . . . 0.0 114.478 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.594 ' HG2' ' CB ' ' A' ' 7' ' ' HIS . 16.7 ptp180 -71.73 97.13 1.71 Allowed 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.353 1.073 . . . . 0.0 109.48 174.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.682 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 8.4 m-85 -116.79 164.59 14.43 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.819 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.588 ' CB ' HD21 ' A' ' 40' ' ' LEU . 54.5 t80 -138.98 112.58 8.3 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.572 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -91.9 110.52 21.87 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.468 ' CG ' HG11 ' C' ' 85' ' ' VAL . 9.8 p80 -69.15 -17.98 63.89 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -169.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 13.5 p -73.33 -39.11 65.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.255 174.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.7 m -78.19 -29.68 48.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.321 0.581 . . . . 0.0 110.646 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER 58.58 28.8 17.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.694 -176.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.54 146.23 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.682 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.1 tt0 -70.06 144.53 52.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.231 0.538 . . . . 0.0 111.034 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.628 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.2 pt -132.08 167.91 25.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.77 -175.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 14.1 t -125.28 95.01 42.17 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 164.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.557 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 3.5 Cg_endo -54.28 175.85 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.842 1 C-N-CA 125.423 4.082 . . . . 0.0 116.973 -169.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.665 ' HB2' HG13 ' A' ' 28' ' ' ILE . 37.8 mtt180 -107.5 48.32 0.85 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 112.565 -2.107 . . . . 0.0 107.023 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 0.79 -61.71 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.116 0 CA-C-N 110.811 -2.904 . . . . 0.0 117.253 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -32.18 -36.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 123.553 2.835 . . . . 0.0 113.819 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.511 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -115.68 -22.62 9.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.181 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.561 ' C ' HD11 ' A' ' 37' ' ' ILE . 58.4 m-85 68.1 58.6 0.46 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.406 1.098 . . . . 0.0 110.32 -168.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.665 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -110.71 162.57 8.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.304 176.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.5 t -96.16 146.61 31.61 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.628 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 67.6 Cg_endo -81.6 -22.3 5.6 Favored 'Trans proline' 0 CA--C 1.5 -1.224 0 C-N-CA 122.606 2.204 . . . . 0.0 108.031 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.538 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 68.5 mtt-85 -81.7 -25.14 35.73 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 112.892 -1.958 . . . . 0.0 113.752 -177.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.6 p -146.23 -7.25 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.637 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 60.35 32.35 20.65 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.744 0.783 . . . . 0.0 111.033 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.1 m -113.19 146.39 39.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.744 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.57 37.64 2.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.14 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 87.8 m-85 -92.34 38.77 1.01 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.255 0.55 . . . . 0.0 110.041 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.59 HG22 ' CD1' ' A' ' 20' ' ' ILE . 7.1 pt -110.94 133.67 55.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.614 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.5 pt-20 -121.95 136.15 54.91 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 172.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.26 135.9 40.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.219 0.533 . . . . 0.0 109.692 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.588 HD21 ' CB ' ' A' ' 12' ' ' PHE . 8.7 mt . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.328 -171.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' MET . . . . . 0.442 ' SD ' ' HA ' ' C' ' 7' ' ' HIS . 52.1 mtt . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.511 0.196 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.49 -69.79 0.17 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.536 0.734 . . . . 0.0 112.151 177.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -151.27 120.35 6.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 59.89 -162.43 0.25 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -174.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 57.69 71.19 0.59 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.223 0.535 . . . . 0.0 111.789 171.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . 0.442 ' HA ' ' SD ' ' C' ' 2' ' ' MET . 44.1 m80 -79.27 162.91 25.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.761 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -92.36 18.01 9.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.337 0.589 . . . . 0.0 110.645 -173.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -101.94 11.22 38.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.528 0.68 . . . . 0.0 109.468 173.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.83 156.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.548 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -67.54 -60.39 2.6 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 18.7 t70 176.23 -50.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.09 95.99 2.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.172 164.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -78.64 -2.9 41.3 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.278 -175.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . 0.45 ' HD3' HG22 ' C' ' 32' ' ' ILE . 33.0 mttp 49.51 -165.47 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.067 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 49.9 ttm -170.56 -31.12 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.933 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.737 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -104.08 147.87 26.91 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.294 0.569 . . . . 0.0 109.524 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.452 ' HA ' ' CG1' ' C' ' 32' ' ' ILE . 4.5 mt-10 -106.86 83.55 1.86 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' C' ' 30' ' ' THR . 4.2 t -72.06 143.63 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.441 -166.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.755 ' HB3' ' CG1' ' C' ' 81' ' ' VAL . 7.9 mt -128.65 156.71 43.0 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.77 ' O ' ' HA ' ' C' ' 28' ' ' THR . 21.5 m -145.36 152.89 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.619 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 35.7 mtpt -138.24 110.44 7.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.952 0.501 . . . . 0.0 109.983 173.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.36 108.69 20.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.869 0.366 . . . . 0.0 111.072 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.423 ' C ' ' H ' ' C' ' 26' ' ' SER . 4.6 mm? 55.97 22.01 5.44 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.541 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . 0.441 ' HA ' ' HE2' ' C' ' 22' ' ' LYS . 34.8 t70 76.5 -22.98 0.25 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.524 173.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.423 ' H ' ' C ' ' C' ' 24' ' ' LEU . 15.1 m -58.63 -44.04 89.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.13 0.491 . . . . 0.0 110.14 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -106.95 171.55 7.3 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.04 0.924 . . . . 0.0 111.576 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 51.5 m -173.17 103.56 0.13 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 113.087 -1.869 . . . . 0.0 107.846 178.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' C' ' 20' ' ' LEU . 83.8 mtt180 -130.71 168.18 17.6 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.77 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 2.1 p -108.52 148.32 30.43 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.551 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 40.6 m-85 -139.73 65.07 1.44 Allowed 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.44 0.638 . . . . 0.0 110.365 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.452 ' CG1' ' HA ' ' C' ' 18' ' ' GLU . 2.5 mp -55.23 118.45 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 123.214 1.483 . . . . 0.0 113.776 -176.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.94 -171.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 111.347 -2.661 . . . . 0.0 111.209 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.08 157.18 20.07 Favored Glycine 0 C--N 1.307 -1.082 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.144 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.737 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -63.42 -18.78 64.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -172.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -147.74 22.47 1.13 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -75.53 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.224 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.612 ' O ' HG13 ' C' ' 39' ' ' VAL . 8.1 m120 -128.74 -91.94 0.47 Allowed 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.612 HG13 ' O ' ' C' ' 38' ' ' ASN . 0.3 OUTLIER 82.04 -28.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.035 1.459 . . . . 0.0 112.12 -166.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.632 ' O ' ' HG2' ' C' ' 43' ' ' LYS . 0.0 OUTLIER -80.77 -68.96 0.64 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.557 1.17 . . . . 0.0 108.78 174.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.53 -29.62 70.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.476 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.607 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -62.18 -53.21 58.57 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.184 175.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.636 ' HB2' ' OE1' ' C' ' 57' ' ' GLN . 3.3 ptmt -67.3 -34.1 76.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.192 0.52 . . . . 0.0 110.136 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.499 ' HA ' ' HB3' ' C' ' 54' ' ' SER . 16.7 tt0 -59.46 -37.01 77.07 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.657 175.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -69.98 -40.73 75.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.925 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.609 ' O ' HG22 ' C' ' 50' ' ' VAL . 18.4 pt -81.46 -7.64 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -174.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.24 -59.76 1.44 Allowed 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.24 -34.54 70.86 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.849 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -28.22 69.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.609 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.4 m -106.16 -2.75 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 29.0 m 69.53 19.61 7.42 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.536 0.684 . . . . 0.0 109.586 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.6 mm -127.65 117.12 21.08 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.165 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' C' ' 47' ' ' ALA . 5.0 Cg_exo -68.75 149.8 73.45 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.636 1.558 . . . . 0.0 111.751 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.499 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 29.6 p -53.88 -25.72 21.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.254 -176.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -79.68 -13.6 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -116.24 -33.04 5.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.636 ' OE1' ' HB2' ' C' ' 43' ' ' LYS . 8.7 pt20 -65.33 129.61 40.35 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.985 0.898 . . . . 0.0 111.997 -173.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' C' ' 84' ' ' LEU . 38.5 mmt180 -115.51 116.06 27.55 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.761 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.699 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 11.7 mt -84.23 106.01 15.52 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.346 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.521 HG21 ' O ' ' A' ' 37' ' ' ILE . 26.6 mt -99.1 118.53 45.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.534 -0.729 . . . . 0.0 111.69 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.452 ' OH ' ' HG2' ' C' ' 80' ' ' LYS . 64.5 t80 -135.19 130.2 34.95 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' C' ' 61' ' ' TYR . 48.1 mt-30 61.8 33.62 17.65 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.053 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 68.3 4.58 37.8 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.43 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -99.17 133.41 43.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.99 88.68 2.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.314 0.578 . . . . 0.0 110.013 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.1 OUTLIER -67.93 155.18 40.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.162 178.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . 0.44 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.5 pt20 -161.95 -167.19 1.6 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.686 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.579 ' HA ' HG12 ' C' ' 39' ' ' VAL . 1.5 p-10 -58.81 -2.48 0.23 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.041 0.936 . . . . 0.0 112.893 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' C' ' 67' ' ' GLN . 27.8 t70 -62.25 -9.12 6.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.574 0.75 . . . . 0.0 112.573 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' C' ' 69' ' ' ASP . 37.5 mtmm 78.81 174.9 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.758 0.823 . . . . 0.0 112.41 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.47 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 32.6 mtmm 78.6 71.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 124.209 0.943 . . . . 0.0 111.362 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 3.5 mm? -62.19 -44.14 97.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' C' ' 35' ' ' ALA . 2.3 pt20 -66.02 -19.47 65.87 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . 0.47 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 36.7 mm-40 -70.52 -28.39 64.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.563 ' CD1' HD23 ' C' ' 66' ' ' LEU . 18.9 m-85 -87.29 -23.51 24.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 60.59 43.66 12.48 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.905 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.406 HG23 HG21 ' C' ' 19' ' ' VAL . 19.6 m -91.3 -8.06 10.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.658 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -50.03 100.34 0.04 OUTLIER Glycine 0 CA--C 1.493 -1.305 0 CA-C-O 122.914 1.286 . . . . 0.0 113.944 168.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.93 10.38 49.54 Favored Glycine 0 C--N 1.29 -1.993 0 CA-C-N 111.629 -2.286 . . . . 0.0 114.725 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . 0.558 ' C ' ' HB2' ' C' ' 20' ' ' LEU . 0.0 OUTLIER -132.47 148.18 52.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.524 0.662 . . . . 0.0 111.118 -178.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.755 ' CG1' ' HB3' ' C' ' 20' ' ' LEU . 35.6 m -80.52 122.04 35.01 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-O 121.741 0.781 . . . . 0.0 111.934 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.463 HG23 ' HB3' ' C' ' 59' ' ' LEU . 77.6 mt -80.18 160.46 4.15 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.828 174.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.438 ' N ' HG22 ' C' ' 82' ' ' ILE . 54.8 m80 -117.71 114.73 23.77 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 121.657 -0.652 . . . . 0.0 109.989 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' C' ' 58' ' ' ARG . 8.0 mp -90.49 157.34 17.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.468 HG11 ' CG ' ' A' ' 14' ' ' HIS . 4.1 t -117.6 156.63 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.618 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' C' ' 86' ' ' GLU . 0.2 OUTLIER -113.58 122.85 48.46 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.461 179.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . 0.522 ' HE ' ' HA ' ' C' ' 87' ' ' ARG . 1.1 mmp_? -84.08 176.84 8.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 121.643 -0.66 . . . . 0.0 111.891 176.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.88 154.8 57.06 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.834 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.45 157.81 29.84 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.101 2.534 . . . . 0.0 111.917 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.15 55.32 3.45 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.921 2.414 . . . . 0.0 112.5 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' C' ' 95' ' ' PRO . 31.4 tt0 -93.16 -68.78 0.78 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.832 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t 46.88 -151.44 0.09 Allowed 'General case' 0 CA--C 1.539 0.542 0 O-C-N 124.28 0.987 . . . . 0.0 111.695 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -66.65 -54.12 26.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.653 0.263 . . . . 0.0 110.497 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.38 104.55 52.96 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.107 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' C' ' 91' ' ' GLN . 41.2 Cg_endo -67.75 130.29 21.65 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.815 2.343 . . . . 0.0 112.962 -174.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 45.7 t -65.16 -32.06 73.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.64 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.59 -63.01 0.32 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.002 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.34 129.52 50.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.832 0.349 . . . . 0.0 110.434 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 45.3 m -90.68 -54.53 3.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.373 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 44.6 m 51.91 63.41 2.25 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.529 0.518 . . . . 0.0 111.483 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.307 -1.274 . . . . 0.0 111.411 -179.697 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 16.8 m -77.47 130.37 36.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -149.84 160.91 43.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.964 0.411 . . . . 0.0 110.96 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.12 97.87 7.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.817 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.96 56.73 1.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.153 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.25 -5.86 45.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.048 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.0 t -124.35 79.21 60.79 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.908 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.16 -76.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.597 2.198 . . . . 0.0 112.086 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 68.43 130.23 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 O-C-N 123.734 0.646 . . . . 0.0 111.1 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.56 13.46 2.08 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 123.046 2.497 . . . . 0.0 112.37 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.22 7.2 64.11 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.349 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -70.29 95.98 1.07 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.338 0.59 . . . . 0.0 110.526 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.57 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 6.7 m-85 -116.3 166.41 12.08 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.982 171.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.538 ' CB ' HD11 ' A' ' 40' ' ' LEU . 60.6 t80 -139.48 123.74 18.01 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.446 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.55 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -98.02 101.05 12.43 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.589 ' HD2' ' OE1' ' A' ' 38' ' ' GLU . 11.9 p80 -52.91 -24.95 10.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.27 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -67.5 -46.76 71.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.769 0.319 . . . . 0.0 110.443 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.0 m -74.58 -28.24 60.83 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.497 0.665 . . . . 0.0 109.852 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.68 29.6 17.56 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.02 -170.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.03 144.39 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 37.5 tt0 -73.67 148.67 42.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.124 0.488 . . . . 0.0 110.844 -175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 37' ' ' ILE . 6.2 pt -139.01 168.38 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.265 -172.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 47.2 t -122.74 101.3 39.8 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 160.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.548 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 11.1 Cg_endo -54.36 175.32 0.14 Allowed 'Trans proline' 0 C--N 1.328 -0.502 1 C-N-CA 125.582 4.188 . . . . 0.0 116.215 -171.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.552 ' CB ' HD13 ' A' ' 28' ' ' ILE . 29.8 mtt180 -101.82 45.69 0.96 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 112.587 -2.097 . . . . 0.0 107.096 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -1.98 -59.03 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.861 0 CA-C-N 110.41 -3.086 . . . . 0.0 117.654 175.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.29 44.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.268 1.978 . . . . 0.0 112.857 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' HB3' HG12 ' A' ' 28' ' ' ILE . 4.8 t70 177.68 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.942 0.897 . . . . 0.0 109.653 -174.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 70.69 58.13 0.22 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.328 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.552 HD13 ' CB ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -114.76 163.52 11.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 113.307 -1.77 . . . . 0.0 108.833 175.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 2.1 t -95.88 144.42 27.79 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 79.6 Cg_endo -81.09 -22.89 5.69 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 C-N-CA 122.807 2.338 . . . . 0.0 108.182 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.501 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 50.2 mtt180 -89.09 -6.31 57.17 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.835 -1.984 . . . . 0.0 114.485 -176.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.7 p -156.06 -14.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 171.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 61.25 22.59 12.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.364 0.602 . . . . 0.0 111.709 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.9 m -96.13 141.55 29.37 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 166.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.56 51.82 4.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.007 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 39.8 m-85 -107.88 45.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.588 HG21 HD12 ' A' ' 20' ' ' ILE . 5.9 pt -113.66 143.87 22.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.922 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.589 ' OE1' ' HD2' ' A' ' 14' ' ' HIS . 1.4 pm0 -120.65 149.53 42.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 165.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -81.27 133.82 35.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.62 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.538 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.425 -0.797 . . . . 0.0 110.409 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.53 -58.59 0.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.441 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -77.65 126.39 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.252 0.549 . . . . 0.0 110.557 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' C' ' 6' ' ' HIS . 56.4 m80 -135.55 98.4 3.93 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' C' ' 5' ' ' HIS . 25.4 m-70 72.89 -54.41 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.144 0.903 . . . . 0.0 110.748 -173.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . 0.501 ' O ' ' HB2' ' C' ' 8' ' ' HIS . 5.7 t-160 -75.66 142.77 42.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 176.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' C' ' 7' ' ' HIS . 28.8 m80 73.41 75.28 0.13 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.689 0.618 . . . . 0.0 110.548 -173.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -77.82 63.72 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.49 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.416 HG22 ' N ' ' C' ' 11' ' ' ASP . 7.6 p -93.1 156.97 3.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.418 0.628 . . . . 0.0 110.863 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . 0.416 ' N ' HG22 ' C' ' 10' ' ' VAL . 24.5 t70 -132.03 66.15 1.56 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.412 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.22 65.2 5.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.064 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 60.7 41.7 14.69 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.507 -172.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -76.92 -56.53 4.51 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.469 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -76.11 -179.05 4.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.838 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.507 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 22.9 mmt 59.6 83.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.54 0.525 . . . . 0.0 110.724 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.554 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 0.4 OUTLIER -102.18 138.07 39.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.686 178.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.521 ' HG2' HG12 ' C' ' 32' ' ' ILE . 10.3 mt-10 -85.08 98.55 10.49 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.565 0.698 . . . . 0.0 109.287 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' C' ' 30' ' ' THR . 17.1 t -79.5 83.64 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 122.482 1.134 . . . . 0.0 110.904 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.569 ' HB3' ' CG1' ' C' ' 81' ' ' VAL . 12.3 mt -75.66 142.58 42.52 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.472 HG22 ' HB ' ' C' ' 82' ' ' ILE . 82.0 t -156.18 125.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 121.952 0.101 . . . . 0.0 110.889 -171.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.622 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 0.1 OUTLIER -111.97 162.82 14.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.152 0.501 . . . . 0.0 110.901 -178.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' THR . . . . . 0.529 HG23 ' O ' ' C' ' 84' ' ' LEU . 11.3 p -132.3 -174.22 3.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.836 176.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 3.4 mp -65.83 -29.77 70.29 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.142 0.496 . . . . 0.0 110.178 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.42 5.48 3.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.204 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 20.6 t 63.59 18.38 11.05 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.065 0.459 . . . . 0.0 111.484 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -49.95 -65.89 0.49 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.468 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 43.9 m 56.37 90.61 0.04 OUTLIER 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.909 0.862 . . . . 0.0 110.662 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -126.15 151.06 47.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.337 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -99.9 143.41 30.15 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.129 0.49 . . . . 0.0 111.301 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.498 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 29.2 m-85 -126.5 62.82 1.28 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 123.578 0.751 . . . . 0.0 109.766 -175.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.521 HG12 ' HG2' ' C' ' 18' ' ' GLU . 2.9 mp -57.02 121.98 5.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 123.114 1.435 . . . . 0.0 114.745 -172.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.453 ' CG2' ' HG ' ' C' ' 72' ' ' LEU . 16.7 m -141.81 167.01 16.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 111.267 -2.697 . . . . 0.0 112.523 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -96.57 52.16 1.53 Allowed Glycine 0 C--N 1.306 -1.089 0 CA-C-N 114.549 -1.205 . . . . 0.0 114.595 -168.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.536 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.61 -44.67 0.52 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 171.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -132.1 26.61 4.56 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -75.37 0.07 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.87 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -146.58 -79.3 0.16 Allowed 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.665 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 90.56 -29.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 125.375 1.672 . . . . 0.0 111.438 -167.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.468 ' HD2' ' HG2' ' C' ' 70' ' ' LYS . 0.1 OUTLIER -84.24 -70.35 0.58 Allowed 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 122.202 1.001 . . . . 0.0 109.14 177.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.04 -26.57 67.72 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.632 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.665 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -56.14 -50.14 71.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.162 171.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.619 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 43.6 mttp -64.59 -42.32 95.68 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.219 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -56.0 -36.73 68.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.572 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -70.11 -46.71 64.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.755 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.588 HG22 ' O ' ' C' ' 42' ' ' PHE . 8.5 pt -78.1 -13.79 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.792 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.98 -51.2 3.28 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.25 -45.47 69.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -28.07 64.83 Favored 'General case' 0 N--CA 1.424 -1.734 0 C-N-CA 122.868 0.467 . . . . 0.0 112.164 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' C' ' 84' ' ' LEU . 27.6 m -106.41 -3.81 9.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.18 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 82.6 p 63.35 23.7 13.87 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 122.054 0.93 . . . . 0.0 109.54 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.1 mm -131.63 120.44 17.71 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.244 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -67.73 152.8 77.29 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.034 1.823 . . . . 0.0 112.588 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 29.9 t -50.06 -40.89 46.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.358 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.495 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 15.7 pt-20 -67.12 -17.85 65.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.839 -177.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.495 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 67.7 mttm -121.09 -0.91 9.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -173.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.619 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 9.3 pt20 -96.07 142.26 28.49 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.626 -0.829 . . . . 0.0 112.863 -175.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . 0.473 ' HG3' ' HG2' ' C' ' 87' ' ' ARG . 98.0 mtt180 -114.94 121.85 44.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.266 173.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 9.0 mp -92.07 107.3 19.11 Favored 'General case' 0 C--O 1.207 -1.164 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 37' ' ' ILE . 2.8 mt -105.2 106.37 20.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 120.973 0.416 . . . . 0.0 111.114 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -117.62 114.63 23.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.75 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 56.99 41.14 28.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.033 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.7 -15.47 36.34 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.205 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 tpm_? -81.06 126.87 31.97 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.504 -0.409 . . . . 0.0 110.208 -176.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . 0.438 HG21 ' HB2' ' A' ' 38' ' ' GLU . 15.8 t -83.48 90.28 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.973 0.416 . . . . 0.0 109.943 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.6 OUTLIER -75.6 134.14 40.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . 0.5 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 6.9 pt20 -135.22 -168.57 2.21 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.161 -171.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.58 ' HA ' HG12 ' C' ' 39' ' ' VAL . 5.7 p-10 -71.13 2.37 4.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.529 0.732 . . . . 0.0 112.296 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . 0.5 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 19.4 t70 -61.11 1.52 0.17 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.455 1.102 . . . . 0.0 113.146 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.468 ' HG2' ' HD2' ' C' ' 40' ' ' LYS . 47.4 mtmt 83.44 158.44 0.12 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 168.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 72.2 95.18 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.749 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.453 ' HG ' ' CG2' ' C' ' 33' ' ' VAL . 3.6 mm? -62.58 -36.8 83.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.81 177.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.95 -19.16 64.16 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -175.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.48 -27.87 63.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.53 ' CD1' HD21 ' C' ' 66' ' ' LEU . 25.4 m-85 -87.78 -22.36 24.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.731 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.1 t30 61.18 40.63 14.49 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.781 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.407 HG23 HD13 ' C' ' 82' ' ' ILE . 26.4 m -92.43 27.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.743 -175.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.554 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.03 101.74 1.61 Allowed Glycine 0 N--CA 1.433 -1.558 0 CA-C-O 122.744 1.191 . . . . 0.0 112.733 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.28 13.7 50.99 Favored Glycine 0 C--N 1.283 -2.366 0 CA-C-N 112.21 -1.995 . . . . 0.0 114.108 172.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -127.01 147.61 50.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.622 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 3.0 m -79.03 127.44 39.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.605 0.717 . . . . 0.0 112.636 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.472 ' HB ' HG22 ' C' ' 21' ' ' VAL . 27.0 mt -88.71 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.301 171.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.445 ' N ' HG23 ' C' ' 82' ' ' ILE . 86.0 t60 -109.82 133.33 53.27 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 121.821 -0.55 . . . . 0.0 110.094 166.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.529 ' O ' HG23 ' C' ' 23' ' ' THR . 5.8 mt -108.8 138.34 45.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.805 0.812 . . . . 0.0 112.244 170.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.448 ' CG2' ' H ' ' C' ' 86' ' ' GLU . 2.6 p -156.41 -172.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.367 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' C' ' 56' ' ' LYS . 6.7 pt-20 -97.33 145.95 25.63 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.222 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . 0.473 ' HG2' ' HG3' ' C' ' 58' ' ' ARG . 90.0 mtt180 -73.3 177.28 5.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.603 176.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -66.28 147.56 98.85 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.497 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 88' ' ' ALA . 21.7 Cg_exo -67.48 145.09 69.68 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.248 2.632 . . . . 0.0 111.741 173.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.72 77.89 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.6 2.2 . . . . 0.0 111.603 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -71.48 -16.22 62.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.733 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -117.38 21.14 13.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.445 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 68.84 -56.92 0.52 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.659 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -106.02 97.97 17.21 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -60.4 -48.65 10.96 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.768 2.312 . . . . 0.0 112.069 -177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 13.5 t -178.69 -175.81 0.44 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.71 156.1 9.76 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.564 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -102.53 90.99 4.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.043 0.449 . . . . 0.0 109.856 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -77.1 68.63 3.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.35 0.595 . . . . 0.0 110.525 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 6.3 p -88.15 -175.93 5.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.717 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.258 -1.301 . . . . 0.0 111.255 177.749 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.5 m -79.13 -70.04 0.53 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.542 0.171 . . . . 0.0 110.62 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm 38.08 43.49 0.56 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.012 0.925 . . . . 0.0 112.804 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.63 -26.35 54.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.433 0.635 . . . . 0.0 109.671 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -126.78 82.38 2.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.622 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.52 -42.76 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.259 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 p -112.49 107.42 55.18 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.313 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -66.32 87.1 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.802 2.335 . . . . 0.0 112.055 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.419 ' C ' ' H ' ' A' ' 9' ' ' GLY . 34.9 m80 -143.42 146.65 36.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.232 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.28 32.86 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.108 2.539 . . . . 0.0 112.516 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.485 ' O ' HG23 ' A' ' 21' ' ' VAL . . . -108.63 1.09 32.29 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.377 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 3.0 mpt_? -90.91 84.47 5.79 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.353 -0.423 . . . . 0.0 110.382 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.622 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 12.3 m-85 -118.04 165.9 13.19 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.326 0.584 . . . . 0.0 109.521 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CB ' HD11 ' A' ' 40' ' ' LEU . 74.1 t80 -140.29 118.85 12.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.569 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -98.7 128.55 45.0 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -83.97 -21.32 31.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -167.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 32.0 p -72.36 -31.72 65.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 118.479 0.581 . . . . 0.0 110.016 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.404 ' C ' ' HG ' ' A' ' 17' ' ' SER . 94.5 m -85.64 -20.5 29.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.525 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.404 ' HG ' ' C ' ' A' ' 16' ' ' CYS . 24.8 p 51.22 32.23 7.84 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.116 0.966 . . . . 0.0 112.375 -175.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.426 HG23 HH11 ' A' ' 31' ' ' ARG . 2.8 m -141.42 157.2 21.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.494 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 32.8 tt0 -79.01 145.23 34.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.076 0.465 . . . . 0.0 111.196 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.642 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.3 pt -134.07 167.17 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.21 -173.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 45.3 t -122.76 94.34 47.58 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 163.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.622 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.65 175.35 0.29 Allowed 'Trans proline' 0 C--N 1.325 -0.709 1 C-N-CA 125.537 4.158 . . . . 0.0 116.522 -168.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.618 ' HB2' HG13 ' A' ' 28' ' ' ILE . 36.8 mtt180 -105.74 46.94 0.89 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.702 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -1.46 -60.92 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.932 0 CA-C-N 110.582 -3.008 . . . . 0.0 116.575 174.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 63.2 Cg_exo -33.58 -31.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.469 2.78 . . . . 0.0 114.55 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.537 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -122.13 -19.08 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.358 0.599 . . . . 0.0 111.745 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.472 ' C ' HD13 ' A' ' 37' ' ' ILE . 50.5 m-85 68.01 58.94 0.46 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.615 -171.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.618 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -111.81 161.38 10.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 113.328 -1.76 . . . . 0.0 108.966 178.299 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.486 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -95.92 146.38 31.22 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.642 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 83.9 Cg_endo -81.32 -21.03 6.71 Favored 'Trans proline' 0 CA--C 1.5 -1.188 0 C-N-CA 122.668 2.245 . . . . 0.0 108.238 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.478 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 84.5 mtt180 -86.79 -15.1 40.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.032 -1.894 . . . . 0.0 114.398 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 31.1 p -151.58 -10.69 0.21 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 175.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 60.42 33.6 20.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.559 0.695 . . . . 0.0 111.217 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 m -113.91 146.32 40.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.47 33.15 3.25 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.826 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 97.9 m-85 -87.88 43.45 1.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.2 0.524 . . . . 0.0 110.649 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.578 HG21 ' CD1' ' A' ' 20' ' ' ILE . 4.6 pt -111.24 135.37 50.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.8 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -117.03 145.01 43.96 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -77.12 135.87 38.59 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.465 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.787 -174.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.462 0.172 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.99 144.45 39.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.011 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 74.4 -32.87 0.24 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.19 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -76.1 71.26 2.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.347 0.594 . . . . 0.0 110.404 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -139.76 99.35 3.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.178 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -76.99 71.84 3.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.535 0.683 . . . . 0.0 110.778 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -152.03 128.46 10.65 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -68.45 104.13 1.83 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.086 0.469 . . . . 0.0 111.379 -174.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 m -88.77 142.93 12.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 171.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.67 -60.3 0.26 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.115 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.85 -18.64 36.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.464 0.65 . . . . 0.0 109.51 169.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -97.68 7.39 46.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.622 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.75 -9.14 58.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.159 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -49.93 145.65 5.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.664 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.565 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 45.7 ttm -148.79 118.25 6.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.024 0.44 . . . . 0.0 110.672 -176.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.565 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 1.2 mt -105.55 137.98 42.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.51 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.461 ' HA ' HG13 ' C' ' 32' ' ' ILE . 32.5 tt0 -84.36 96.75 9.15 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.2 t -78.62 104.62 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.189 -172.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.593 ' C ' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -93.41 145.11 24.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.486 HG23 ' HB ' ' C' ' 82' ' ' ILE . 68.6 t -151.9 121.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 117.921 0.328 . . . . 0.0 110.957 -171.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.563 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 36.8 mtpt -103.51 122.19 44.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' THR . . . . . 0.506 ' O ' HD23 ' C' ' 24' ' ' LEU . 4.5 m -70.01 -62.61 1.32 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.117 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.506 HD23 ' O ' ' C' ' 23' ' ' THR . 0.4 OUTLIER -145.07 27.34 1.29 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.709 0.766 . . . . 0.0 109.841 -178.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 30.0 t70 85.11 -28.06 0.09 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.225 173.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 44.6 t -62.11 -42.71 99.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -106.64 175.94 5.33 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.336 1.065 . . . . 0.0 112.238 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.524 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 18.4 m -170.79 103.07 0.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.951 -1.931 . . . . 0.0 106.413 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -122.49 153.44 39.17 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.65 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p -101.41 141.29 34.5 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-O 121.219 0.533 . . . . 0.0 112.251 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.494 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 29.4 m-85 -133.81 57.71 1.8 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.663 0.744 . . . . 0.0 109.758 -174.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.461 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.8 mp -57.24 119.19 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 123.362 1.553 . . . . 0.0 114.353 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 17.3 m -143.66 -168.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 110.915 -2.857 . . . . 0.0 111.627 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -96.4 159.11 21.76 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.054 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.534 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -59.65 -31.17 69.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.21 0.529 . . . . 0.0 112.187 -175.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.32 31.7 2.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.486 0.66 . . . . 0.0 109.258 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -74.33 0.14 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.026 -176.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.582 ' O ' HG13 ' C' ' 39' ' ' VAL . 8.5 m120 -128.82 -90.71 0.49 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.661 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 81.83 -30.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 124.794 1.309 . . . . 0.0 111.9 -165.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.491 ' HD2' ' HG2' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -80.23 -69.48 0.59 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 122.286 1.041 . . . . 0.0 108.516 176.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.17 -29.26 69.68 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 113.445 -1.707 . . . . 0.0 111.003 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.661 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.9 t80 -60.64 -53.49 56.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.523 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.648 ' HB2' ' OE1' ' C' ' 57' ' ' GLN . 0.0 OUTLIER -69.82 -33.64 72.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.99 0.424 . . . . 0.0 110.928 -179.444 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -38.64 87.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.718 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -69.65 -48.59 59.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.194 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.583 ' O ' HG22 ' C' ' 50' ' ' VAL . 17.3 pt -70.49 -12.12 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -173.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.29 -56.28 2.47 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.54 -44.3 87.28 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -25.27 65.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.338 0.59 . . . . 0.0 111.087 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.583 HG22 ' O ' ' C' ' 46' ' ' ILE . 30.9 m -110.48 -3.31 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.334 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 60.6 p 64.67 22.08 12.53 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.796 0.807 . . . . 0.0 109.49 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.7 mm -127.66 115.46 20.97 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.274 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 4.6 Cg_exo -73.97 147.02 38.13 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 121.936 1.758 . . . . 0.0 111.306 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -52.55 -24.85 8.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.765 0.826 . . . . 0.0 112.96 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 8.9 pt-20 -68.68 -41.74 78.81 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.677 0.275 . . . . 0.0 111.493 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.497 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 27.4 mtpp -96.2 -25.08 15.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.574 0.702 . . . . 0.0 109.686 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.648 ' OE1' ' HB2' ' C' ' 43' ' ' LYS . 17.8 tt0 -61.1 118.57 6.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.287 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -123.16 119.11 29.27 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.02 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 6.4 mt -84.79 116.29 23.19 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 37' ' ' ILE . 3.3 mt -114.89 122.04 68.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.831 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -136.32 132.72 36.04 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 57.46 35.39 25.83 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.104 0.478 . . . . 0.0 110.753 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.03 4.93 37.74 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.529 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -91.73 140.08 30.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.71 90.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.481 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -83.03 144.06 30.18 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.144 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -156.89 -167.4 2.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.522 -175.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.567 ' HA ' HG12 ' C' ' 39' ' ' VAL . 6.8 p-10 -60.78 0.22 0.23 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.969 1.308 . . . . 0.0 113.368 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 34.0 t70 -60.55 -10.69 5.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.506 0.722 . . . . 0.0 112.421 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.491 ' HG2' ' HD2' ' C' ' 40' ' ' LYS . 57.1 mtmt 88.33 -175.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.149 0.98 . . . . 0.0 112.615 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.422 ' HG2' ' C ' ' C' ' 70' ' ' LYS . 16.5 pttp 47.52 84.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.62 1.2 . . . . 0.0 113.06 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.46 HD22 HG22 ' C' ' 39' ' ' VAL . 35.2 mt -64.94 -32.22 73.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.608 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' C' ' 35' ' ' ALA . 10.3 pt20 -67.26 -18.4 65.2 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.01 -28.7 66.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.547 ' CD1' HD23 ' C' ' 66' ' ' LEU . 25.1 m-85 -86.96 -22.48 25.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.621 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.7 t30 62.09 37.11 14.88 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.001 174.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -88.92 18.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.053 0.454 . . . . 0.0 111.754 -174.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.565 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -73.95 102.81 1.37 Allowed Glycine 0 N--CA 1.427 -1.928 0 CA-C-O 122.779 1.211 . . . . 0.0 111.873 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.36 15.25 60.69 Favored Glycine 0 C--N 1.283 -2.364 0 CA-C-N 112.021 -2.09 . . . . 0.0 112.618 176.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -119.72 145.5 46.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.593 ' HA ' ' C ' ' C' ' 20' ' ' LEU . 34.3 m -83.07 123.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-O 122.111 0.957 . . . . 0.0 111.152 175.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.517 HG23 ' N ' ' C' ' 83' ' ' HIS . 57.6 mt -79.07 170.35 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.094 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.517 ' N ' HG23 ' C' ' 82' ' ' ILE . 44.6 m80 -118.26 116.89 27.69 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 mt -90.63 141.82 28.39 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.257 0.551 . . . . 0.0 111.521 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.431 ' CG2' HD12 ' C' ' 60' ' ' ILE . 31.9 m -142.5 164.48 17.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.677 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -110.93 123.78 50.83 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.302 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -93.62 175.8 6.6 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.637 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.61 162.84 24.14 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.292 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' C' ' 91' ' ' GLN . 45.2 Cg_exo -60.68 159.57 27.9 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.639 2.226 . . . . 0.0 111.522 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.68 41.22 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.074 2.516 . . . . 0.0 112.904 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' C' ' 89' ' ' PRO . 11.5 pt20 -96.75 -29.25 13.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.397 176.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -96.79 85.21 3.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.898 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -87.94 55.77 3.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.145 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mp -118.5 89.68 37.29 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.733 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.35 -36.17 1.02 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.354 2.036 . . . . 0.0 111.594 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 10.5 t 47.53 68.18 0.69 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.667 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.34 -84.59 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.66 72.36 9.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.127 0.489 . . . . 0.0 110.206 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 11.0 p -66.49 -39.57 88.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.742 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 36.7 t -143.52 71.85 1.34 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.239 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.6 -1.111 . . . . 0.0 111.538 179.651 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 30.2 t 69.73 -74.07 0.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.103 0.561 . . . . 0.0 111.213 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm -124.19 -47.72 1.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.712 0.292 . . . . 0.0 110.471 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.74 -77.21 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.226 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -124.59 -42.83 2.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.863 0.363 . . . . 0.0 110.594 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.13 153.77 7.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.007 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.9 m -116.47 94.97 44.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.605 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.62 88.55 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.825 2.35 . . . . 0.0 112.089 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.527 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 27.9 m170 -118.54 -61.27 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.281 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 7' ' ' HIS . 66.7 Cg_endo -82.02 136.49 9.22 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 121.877 1.718 . . . . 0.0 113.619 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.33 -2.62 38.3 Favored Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -102.51 92.02 4.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.648 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.6 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 17.9 m-85 -116.2 162.59 17.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 171.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CB ' HD13 ' A' ' 40' ' ' LEU . 55.3 t80 -141.01 116.63 10.24 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.394 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.511 ' HB2' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -93.83 114.55 26.81 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.565 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.422 ' CG ' HG12 ' C' ' 85' ' ' VAL . 19.0 p80 -69.23 -12.81 61.99 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.878 -176.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 38.9 m -71.57 -39.26 70.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 110.705 173.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.1 m -88.35 -27.58 21.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 110.813 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.53 28.48 17.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.696 -170.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.446 HG13 ' CZ ' ' A' ' 31' ' ' ARG . 97.5 t -131.34 144.53 37.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.445 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 25.8 tt0 -74.93 145.83 42.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 110.453 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.652 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.9 pt -135.7 167.84 24.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.343 -170.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.481 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 61.3 t -124.59 95.69 42.39 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 164.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.8 176.31 0.23 Allowed 'Trans proline' 0 C--N 1.325 -0.681 1 C-N-CA 125.386 4.057 . . . . 0.0 116.216 -173.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.56 ' HB2' HG13 ' A' ' 28' ' ' ILE . 7.8 mtt180 -112.43 52.19 0.78 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 112.711 -2.041 . . . . 0.0 107.155 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 4.04 -61.4 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.016 0 CA-C-N 111.06 -2.791 . . . . 0.0 117.221 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 13.1 Cg_exo -34.12 -37.42 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.899 2.399 . . . . 0.0 113.701 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.09 -23.75 9.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.848 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.566 ' C ' HD12 ' A' ' 37' ' ' ILE . 60.4 m-85 65.18 57.41 0.94 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.304 1.049 . . . . 0.0 109.303 -168.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.56 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.4 OUTLIER -105.7 162.61 4.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.521 176.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.5 t -94.62 145.01 28.87 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 70.3 Cg_endo -83.78 -20.33 4.61 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.938 2.425 . . . . 0.0 108.688 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.482 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 12.5 mtp180 -89.02 -7.91 55.03 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.016 -1.902 . . . . 0.0 114.014 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.4 p -162.66 -8.4 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 15.7 tt0 62.31 28.17 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.137 0.494 . . . . 0.0 112.213 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.1 p -99.58 150.86 21.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.8 25.77 7.2 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.711 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.461 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 75.7 m-85 -89.48 48.99 1.67 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.105 0.479 . . . . 0.0 110.551 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.587 HG23 ' CD1' ' A' ' 20' ' ' ILE . 3.5 pt -110.73 138.56 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.485 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.458 ' HB2' HG23 ' C' ' 65' ' ' VAL . 7.2 pt-20 -123.19 137.67 54.83 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -68.24 140.62 56.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.59 HD13 ' CB ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.499 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 91.3 mtp . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.762 0.315 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.77 128.88 38.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.354 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -134.96 -70.48 0.49 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.572 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -136.74 142.29 43.03 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 42.8 t60 62.27 73.81 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.455 0.645 . . . . 0.0 109.353 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -55.15 144.69 23.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.844 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -113.97 62.78 0.66 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.618 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -121.14 140.47 51.94 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 33.5 m -65.71 167.27 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 123.157 0.286 . . . . 0.0 110.671 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 65.96 71.43 0.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.729 0.776 . . . . 0.0 109.517 -174.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' C' ' 13' ' ' ASP . 21.7 m-20 -83.15 -155.4 0.16 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.707 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' C' ' 12' ' ' ASP . 2.0 m-20 80.49 129.9 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.785 0.834 . . . . 0.0 111.37 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -89.39 -37.07 15.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.377 -171.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -68.33 176.56 2.73 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.55 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 63.8 ttp 64.06 96.79 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.377 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.631 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 1.2 mt -106.25 131.39 53.54 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.066 173.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.514 ' HA ' HG13 ' C' ' 32' ' ' ILE . 33.9 tt0 -82.5 96.24 7.96 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.624 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 2.5 t -80.45 124.57 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -173.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.4 OUTLIER -110.45 145.62 37.33 Favored 'General case' 0 N--CA 1.417 -2.075 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 171.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.586 HG22 ' HB ' ' C' ' 82' ' ' ILE . 55.4 t -148.38 126.75 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 117.905 0.321 . . . . 0.0 110.404 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.529 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 42.4 mtmt -111.9 127.13 55.75 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.34 0.59 . . . . 0.0 110.029 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 37.3 p -84.1 -178.68 7.03 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.414 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -63.15 -28.81 70.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.238 0.472 . . . . 0.0 111.101 178.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.77 -3.77 30.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.79 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 68.2 m 63.9 17.63 10.67 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.302 0.641 . . . . 0.0 112.145 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' C' ' 28' ' ' THR . 59.7 mt-30 -46.14 -51.15 14.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.66 177.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' C' ' 27' ' ' GLN . 97.3 m 65.28 97.28 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.028 -176.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -122.56 151.81 41.02 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.951 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 3.5 p -99.14 140.2 33.67 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.624 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 24.9 m-85 -136.52 60.78 1.66 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.841 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.514 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.6 mp -57.71 128.88 18.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 122.898 1.332 . . . . 0.0 114.304 -172.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.614 HG11 ' CD2' ' C' ' 42' ' ' PHE . 15.3 m -122.78 -169.88 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 112.053 -2.34 . . . . 0.0 111.546 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -125.57 33.34 3.63 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.17 -175.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.661 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . 65.72 18.36 11.15 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 167.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.661 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 10.1 tt0 157.61 -11.85 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.82 0.819 . . . . 0.0 109.163 -166.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.8 tpt -45.4 -73.68 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.844 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.474 ' O ' HG12 ' C' ' 39' ' ' VAL . 77.9 m-20 -141.25 -88.57 0.16 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.554 ' HA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 92.84 -30.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 125.297 1.623 . . . . 0.0 111.274 -164.624 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -66.9 0.78 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 122.393 1.092 . . . . 0.0 108.873 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -61.76 -28.24 69.3 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 113.065 -1.88 . . . . 0.0 111.706 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.614 ' CD2' HG11 ' C' ' 33' ' ' VAL . 0.1 OUTLIER -57.27 -52.87 63.6 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 171.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.429 ' HA ' HG12 ' C' ' 46' ' ' ILE . 24.2 mtpp -67.01 -41.37 86.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.092 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -60.09 -34.71 73.83 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.044 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.6 -48.2 60.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.621 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.63 ' O ' HG21 ' C' ' 50' ' ' VAL . 20.6 pt -74.86 -10.42 13.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.307 -175.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -46.67 -40.64 13.52 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.04 -45.91 19.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -34.13 73.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.104 0.478 . . . . 0.0 110.765 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.63 HG21 ' O ' ' C' ' 46' ' ' ILE . 30.1 m -99.88 -8.12 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.158 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 31.5 m 68.8 20.14 8.15 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.837 0.827 . . . . 0.0 109.775 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.2 mm -123.29 110.98 30.41 Favored Pre-proline 0 N--CA 1.44 -0.935 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.72 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.39 143.11 68.61 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 122.622 2.214 . . . . 0.0 111.902 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' SER . . . . . 0.422 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 35.2 t -51.13 -28.31 10.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.843 -172.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.29 -30.96 60.54 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.877 0.37 . . . . 0.0 111.541 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -95.19 -28.83 14.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.827 0.823 . . . . 0.0 109.206 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.423 HE22 HG13 ' C' ' 46' ' ' ILE . 17.1 tt0 -63.67 122.64 16.85 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.124 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . 0.423 ' O ' HG22 ' C' ' 85' ' ' VAL . 72.6 mtp85 -120.97 123.76 43.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.756 -0.202 . . . . 0.0 110.462 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -90.95 124.06 34.92 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.503 HG21 ' O ' ' A' ' 37' ' ' ILE . 4.6 mt -118.29 125.75 74.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 O-C-N 121.622 -0.674 . . . . 0.0 111.595 172.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.456 ' CD2' HG12 ' C' ' 77' ' ' VAL . 55.1 t80 -138.64 131.87 30.05 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 46.23 40.39 7.43 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.104 0.478 . . . . 0.0 111.357 -170.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.91 5.73 58.39 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.923 -0.58 . . . . 0.0 113.617 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.582 ' HD3' ' N ' ' C' ' 65' ' ' VAL . 0.0 OUTLIER -99.22 131.26 45.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . 0.582 ' N ' ' HD3' ' C' ' 64' ' ' ARG . 2.0 t -82.41 90.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.113 0.482 . . . . 0.0 110.391 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.572 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.4 OUTLIER -71.78 148.1 46.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -158.31 -169.81 2.9 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.835 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.539 ' HA ' HG11 ' C' ' 39' ' ' VAL . 6.7 p-10 -67.04 -2.39 5.37 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.663 0.785 . . . . 0.0 112.233 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 20.9 t70 -68.73 -2.74 9.99 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.082 0.553 . . . . 0.0 111.802 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.454 ' HA ' ' CG1' ' C' ' 39' ' ' VAL . 53.5 mtmt 75.9 -162.47 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.685 178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' C' ' 70' ' ' LYS . 48.5 mttp 77.51 57.18 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.831 0.707 . . . . 0.0 109.659 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.557 HD11 ' H ' ' C' ' 36' ' ' GLN . 22.0 mt -61.72 -56.36 20.46 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.827 -174.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -72.64 -15.86 61.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.073 0.464 . . . . 0.0 111.461 -176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -73.14 -28.93 62.52 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.051 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.572 ' CD1' HD22 ' C' ' 66' ' ' LEU . 24.0 m-85 -75.31 -25.38 57.81 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 61.51 26.39 16.13 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.382 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' C' ' 61' ' ' TYR . 31.3 m -83.04 21.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.902 -175.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.631 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.54 98.97 1.43 Allowed Glycine 0 N--CA 1.431 -1.675 0 CA-C-O 122.418 1.01 . . . . 0.0 111.985 177.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.23 14.14 39.84 Favored Glycine 0 C--N 1.285 -2.262 0 CA-C-N 112.382 -1.909 . . . . 0.0 114.541 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -128.68 147.32 50.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 16.6 m -80.19 125.78 39.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-O 121.881 0.848 . . . . 0.0 111.637 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.586 ' HB ' HG22 ' C' ' 21' ' ' VAL . 57.5 mt -80.25 171.17 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.8 173.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.507 ' N ' HG23 ' C' ' 82' ' ' ILE . 37.6 m80 -118.22 122.01 41.91 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 122.012 -0.43 . . . . 0.0 109.924 174.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mt -85.75 156.86 20.44 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.43 HG13 ' N ' ' C' ' 86' ' ' GLU . 8.0 t -120.88 161.02 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.417 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . 0.43 ' N ' HG13 ' C' ' 85' ' ' VAL . 40.5 tt0 -136.06 127.06 27.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.964 172.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -85.09 162.93 19.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.296 0.569 . . . . 0.0 109.945 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.8 141.67 30.05 Favored Pre-proline 0 N--CA 1.438 -1.071 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.029 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . 0.511 ' HB2' ' HG2' ' C' ' 91' ' ' GLN . 23.3 Cg_exo -67.16 149.91 81.92 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.275 2.65 . . . . 0.0 112.119 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.43 -18.79 40.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.696 2.931 . . . . 0.0 114.029 -171.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . 0.511 ' HG2' ' HB2' ' C' ' 89' ' ' PRO . 8.5 pt20 -57.02 -35.79 69.68 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.303 176.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.7 t -108.97 136.05 49.14 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -155.77 76.19 0.93 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.952 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 49.6 tp 58.64 80.3 0.28 Allowed Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.321 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.22 -38.43 66.21 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.769 2.312 . . . . 0.0 111.731 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 34.1 t 57.79 51.65 8.98 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.237 0.541 . . . . 0.0 110.4 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -98.14 -68.84 0.94 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.212 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.6 81.48 1.47 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 38.9 m 71.28 -67.16 0.27 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.885 0.741 . . . . 0.0 111.221 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 21.6 m 59.52 44.23 15.04 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.311 0.576 . . . . 0.0 110.595 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.868 0 CA-C-O 118.635 -1.092 . . . . 0.0 111.895 -178.287 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 18.5 p -59.91 -58.69 7.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.567 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -136.68 124.93 23.15 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.16 138.73 3.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.33 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -89.9 148.17 23.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.849 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 60.46 75.94 0.39 Allowed 'General case' 0 C--O 1.233 0.195 0 O-C-N 123.81 0.694 . . . . 0.0 110.607 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 15.9 m -58.19 137.37 84.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.212 -177.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 9.6 Cg_exo -69.62 93.84 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.735 2.29 . . . . 0.0 112.256 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.443 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 17.9 m-70 -60.81 -55.54 43.75 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 7' ' ' HIS . 43.8 Cg_endo -83.48 22.33 0.94 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.29 1.993 . . . . 0.0 112.409 175.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.18 2.32 8.35 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.635 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -75.73 80.81 2.68 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 123.318 0.647 . . . . 0.0 110.587 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.634 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 17.0 m-85 -118.21 164.27 15.42 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.636 0.731 . . . . 0.0 110.752 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.645 ' CB ' HD13 ' A' ' 40' ' ' LEU . 54.9 t80 -140.92 120.28 13.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.877 178.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -98.57 121.37 40.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.222 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.627 ' CE1' ' HB ' ' C' ' 85' ' ' VAL . 8.9 p80 -76.69 -23.44 53.18 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 24.6 p -71.09 -38.15 72.41 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.272 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.6 m -74.85 -34.81 62.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.084 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.75 32.01 21.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.161 -172.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.5 t -131.65 144.12 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 38.7 tt0 -74.33 143.28 45.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.116 0.484 . . . . 0.0 110.885 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.656 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 4.0 pt -131.86 168.32 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.216 -169.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.423 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 57.7 t -123.53 98.29 40.95 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 162.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.579 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 6.8 Cg_endo -57.3 175.12 0.39 Allowed 'Trans proline' 0 C--N 1.326 -0.613 1 C-N-CA 125.302 4.001 . . . . 0.0 116.675 -169.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.653 ' HB2' HG13 ' A' ' 28' ' ' ILE . 26.0 mtt180 -107.68 47.38 0.89 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 112.629 -2.078 . . . . 0.0 107.183 176.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -0.07 -61.27 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 110.718 -2.947 . . . . 0.0 116.993 174.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.448 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 31.2 Cg_exo -30.96 -38.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 123.591 2.861 . . . . 0.0 114.176 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.515 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.48 -18.05 11.59 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.705 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.472 ' C ' HD11 ' A' ' 37' ' ' ILE . 62.8 m-85 67.11 45.93 1.62 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.04 -172.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.653 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -94.07 161.61 2.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.653 174.622 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.648 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -96.61 145.73 30.08 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.656 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 78.7 Cg_endo -80.46 -20.27 8.33 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 122.861 2.374 . . . . 0.0 108.089 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.648 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.1 mtt-85 -80.19 -34.77 37.19 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 112.658 -2.065 . . . . 0.0 113.712 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.8 p -137.59 -8.74 1.67 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 61.29 35.42 18.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.474 0.654 . . . . 0.0 111.061 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 m -113.09 146.36 39.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.545 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.55 45.86 3.57 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.741 -177.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 57.9 m-85 -102.4 44.38 1.02 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.961 0.41 . . . . 0.0 110.268 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.576 HG22 ' HB2' ' A' ' 13' ' ' CYS . 5.8 pt -115.27 139.21 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.191 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -123.86 145.67 48.93 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.34 131.36 39.13 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.645 HD13 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.857 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.982 0.42 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.0 107.19 3.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.066 0.46 . . . . 0.0 111.125 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -119.8 32.6 5.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.831 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -93.8 -79.66 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 76.2 m80 48.44 -110.13 0.35 Allowed 'General case' 0 C--O 1.233 0.2 0 O-C-N 123.561 0.538 . . . . 0.0 111.508 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 51.0 m80 50.64 53.07 13.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.255 0.55 . . . . 0.0 111.5 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -117.26 142.97 46.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.584 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . 0.428 ' O ' ' HE3' ' C' ' 16' ' ' MET . 41.3 p-80 -155.25 124.04 6.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.496 -178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.512 HG22 ' O ' ' C' ' 10' ' ' VAL . 9.5 m -122.12 128.57 75.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.324 0.583 . . . . 0.0 109.912 174.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' C' ' 10' ' ' VAL . 38.2 t70 160.95 57.02 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.541 -170.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 34.2 t70 59.12 80.35 0.19 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.419 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -129.7 124.67 34.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.38 -36.23 78.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.186 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . 0.539 ' HA ' ' HB3' ' C' ' 35' ' ' ALA . 96.3 mttt -70.14 -174.86 0.86 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.449 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 50.9 mtm 66.57 83.2 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.073 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.592 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 3.7 mt -98.58 132.71 43.77 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.509 ' HA ' HG13 ' C' ' 32' ' ' ILE . 25.6 tt0 -82.23 93.92 7.2 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.617 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 3.1 t -77.06 104.85 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.06 -172.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.614 ' CB ' HG12 ' C' ' 81' ' ' VAL . 1.1 mt -92.76 142.27 27.53 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.56 HG21 ' HB ' ' C' ' 82' ' ' ILE . 59.4 t -147.95 128.92 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -174.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.582 ' CD ' HG21 ' C' ' 81' ' ' VAL . 79.2 mttt -114.24 159.81 19.73 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.361 0.601 . . . . 0.0 109.804 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 27.8 p -107.42 -165.84 1.1 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.99 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.457 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 4.4 mm? -44.48 -37.42 3.46 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 15.4 t70 178.29 -31.38 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 29.5 m -42.82 -75.64 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.877 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -128.71 172.9 10.8 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.371 1.081 . . . . 0.0 113.911 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.452 ' OG1' ' HE2' ' C' ' 22' ' ' LYS . 53.7 m -141.84 103.22 4.3 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 112.76 -2.018 . . . . 0.0 107.543 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -123.33 161.93 23.71 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.795 -177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.5 p -103.69 143.44 32.78 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.468 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.617 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 27.6 m-85 -137.14 59.0 1.7 Allowed 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.271 -174.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -57.92 124.26 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 123.352 1.548 . . . . 0.0 113.872 -174.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' C' ' 16' ' ' MET . 17.2 m -135.27 -165.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 111.104 -2.771 . . . . 0.0 111.324 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.04 -161.76 37.32 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.741 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' C' ' 72' ' ' LEU . . . -100.91 -12.86 18.62 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.577 0.703 . . . . 0.0 111.296 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -166.95 26.57 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -172.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 18.3 ttt -71.95 -73.05 0.2 Allowed 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 111.816 -2.447 . . . . 0.0 110.941 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.618 ' O ' HG11 ' C' ' 39' ' ' VAL . 70.5 m-20 -131.11 -98.18 0.32 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 178.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.618 HG11 ' O ' ' C' ' 38' ' ' ASN . 0.3 OUTLIER 86.7 -16.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 125.341 1.651 . . . . 0.0 111.731 -167.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' C' ' 43' ' ' LYS . 0.1 OUTLIER -88.69 -70.79 0.63 Allowed 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.048 0.928 . . . . 0.0 108.965 171.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.12 -29.4 70.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.099 173.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.602 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -62.08 -54.43 41.41 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.438 175.314 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' C' ' 40' ' ' LYS . 20.0 ptmt -68.25 -33.66 74.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -42.66 82.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.103 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -68.71 -43.26 76.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.439 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.593 ' O ' HG21 ' C' ' 50' ' ' VAL . 16.1 pt -78.35 -10.75 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -172.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.2 -61.02 0.95 Allowed 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.75 86.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -32.82 71.15 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.055 0.455 . . . . 0.0 111.049 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.593 HG21 ' O ' ' C' ' 46' ' ' ILE . 24.3 m -103.63 -3.36 9.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.453 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 48.2 t 69.58 20.04 7.2 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.65 0.738 . . . . 0.0 109.318 178.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.2 mm -123.38 110.67 30.41 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.174 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 6.0 Cg_exo -72.8 146.03 41.95 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.371 2.047 . . . . 0.0 111.299 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -54.49 -24.62 21.27 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.608 0.763 . . . . 0.0 112.285 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -73.6 -26.3 60.74 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -107.66 -26.41 10.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 109.981 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.527 ' OE1' HD13 ' C' ' 46' ' ' ILE . 9.9 tt0 -57.96 118.3 5.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.9 -173.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -122.37 118.0 27.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.314 172.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 5.2 mp -84.7 117.87 24.06 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 37' ' ' ILE . 7.0 mt -115.12 118.12 57.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.169 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -132.39 128.15 36.97 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 58.68 38.83 24.95 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.508 0.505 . . . . 0.0 110.627 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.79 4.17 13.15 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.258 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -89.18 133.98 34.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.14 89.68 2.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.3 OUTLIER -75.04 130.57 39.54 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -143.11 -172.72 3.74 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.511 -170.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.537 ' HA ' HG13 ' C' ' 39' ' ' VAL . 4.4 p-10 -64.3 -3.06 2.52 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.44 0.696 . . . . 0.0 112.145 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 33.7 t70 -68.35 -4.94 16.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.072 0.549 . . . . 0.0 112.293 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' C' ' 69' ' ' ASP . 35.8 mtmm 74.44 -158.21 0.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.375 0.67 . . . . 0.0 110.939 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.527 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 54.3 mttp 71.91 54.08 0.19 Allowed 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.552 0.532 . . . . 0.0 110.692 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.565 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 60.1 mt -63.43 -44.28 95.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.181 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . 0.432 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 9.3 pt20 -70.08 -20.44 63.21 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.742 0.306 . . . . 0.0 111.466 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . 0.527 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 28.0 mm-40 -71.1 -28.01 64.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.555 ' CD1' HD21 ' C' ' 66' ' ' LEU . 19.3 m-85 -83.7 -24.72 31.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 57.66 37.85 27.48 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.807 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -87.31 20.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.539 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.592 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.69 99.93 1.53 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-O 122.767 1.204 . . . . 0.0 112.322 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.88 14.34 43.34 Favored Glycine 0 C--N 1.284 -2.307 0 CA-C-N 112.223 -1.989 . . . . 0.0 113.72 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -124.33 147.49 48.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.614 HG12 ' CB ' ' C' ' 20' ' ' LEU . 4.5 m -82.05 128.53 38.64 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-O 122.055 0.931 . . . . 0.0 111.43 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.56 ' HB ' HG21 ' C' ' 21' ' ' VAL . 54.3 mt -86.9 168.44 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.122 175.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.452 ' N ' HG23 ' C' ' 82' ' ' ILE . 40.7 m80 -117.42 115.03 24.4 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.889 -0.507 . . . . 0.0 110.162 175.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.411 HD12 HG22 ' C' ' 50' ' ' VAL . 13.4 mt -90.67 157.36 17.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.291 0.567 . . . . 0.0 112.379 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.627 ' HB ' ' CE1' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -154.81 154.23 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.917 -175.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . 0.522 ' HB2' ' CD1' ' C' ' 52' ' ' ILE . 44.5 tt0 -112.68 120.57 41.99 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.05 169.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -104.17 177.56 4.81 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.318 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.56 148.34 56.27 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.986 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.18 166.55 5.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.212 2.608 . . . . 0.0 112.385 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.68 63.15 4.73 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.894 2.396 . . . . 0.0 112.018 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -96.25 20.93 9.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.652 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.8 t -74.25 139.99 44.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.438 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -83.4 -22.76 32.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.682 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.21 115.23 27.46 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.846 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.09 158.02 31.94 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.658 2.239 . . . . 0.0 111.96 177.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 46.9 t 62.05 58.72 1.8 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.202 0.525 . . . . 0.0 109.874 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.19 64.51 3.44 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.006 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -160.64 179.24 8.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.739 0.304 . . . . 0.0 110.334 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 45.9 m -132.55 65.05 1.59 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.979 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 16.0 m -72.81 131.37 42.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.665 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 118.504 -1.164 . . . . 0.0 111.723 -179.497 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 112.193 -0.363 . . . . 0.0 112.193 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.6 p -72.61 -33.27 66.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.305 0.574 . . . . 0.0 110.091 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.1 mtp -110.96 75.17 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.135 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.21 81.83 8.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.268 0.556 . . . . 0.0 110.48 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -132.06 167.13 20.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.852 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.34 93.73 3.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.286 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 t -153.08 97.54 2.82 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.855 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.43 -18.19 12.47 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.753 2.302 . . . . 0.0 113.753 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -59.55 -47.15 98.4 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -175.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -85.65 20.45 1.23 Allowed 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 122.225 1.95 . . . . 0.0 112.037 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.63 109.04 1.42 Allowed Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.132 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -154.03 80.35 1.13 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.611 -0.794 . . . . 0.0 108.947 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 5.9 m-85 -116.74 167.53 11.01 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.041 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.544 ' CB ' HD11 ' A' ' 40' ' ' LEU . 48.8 t80 -140.87 114.39 8.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.28 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.593 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -93.49 118.02 30.81 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.51 177.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.429 ' HE2' ' CD1' ' C' ' 60' ' ' ILE . 1.1 p80 -76.68 -20.49 56.56 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.544 -171.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.593 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 16.1 p -72.91 -31.61 64.76 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.82 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.2 m -83.43 -30.61 27.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.189 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.02 28.29 16.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.409 -171.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.88 144.76 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 34.7 tt0 -71.23 146.66 48.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.512 -175.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.694 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 2.6 pt -138.62 166.61 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.847 -172.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.477 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 99.1 t -124.08 97.86 39.97 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 163.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.574 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 5.6 Cg_endo -57.24 173.76 0.59 Allowed 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 124.912 3.741 . . . . 0.0 116.571 -170.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HB2' HG13 ' A' ' 28' ' ' ILE . 15.2 mtt85 -107.35 47.33 0.89 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 112.489 -2.142 . . . . 0.0 107.59 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.506 HD23 ' CE1' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -6.28 -53.69 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 171.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -35.09 -36.16 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.561 2.174 . . . . 0.0 113.428 171.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.483 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.09 -17.56 10.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.352 177.398 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.506 ' CE1' HD23 ' A' ' 24' ' ' LEU . 74.7 m-85 69.68 50.99 0.47 Allowed 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.603 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.483 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -104.81 159.85 5.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.615 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.494 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 t -95.5 144.56 28.02 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.694 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 87.2 Cg_endo -81.24 -17.48 9.09 Favored 'Trans proline' 0 CA--C 1.5 -1.179 0 C-N-CA 122.761 2.308 . . . . 0.0 108.24 -173.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 60.5 mtt-85 -91.57 -13.81 31.37 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 112.937 -1.938 . . . . 0.0 114.617 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.0 p -153.16 -9.48 0.16 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 60.95 29.18 18.86 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.381 0.61 . . . . 0.0 110.91 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.2 m -109.24 146.97 33.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.487 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.21 28.95 4.46 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.772 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.413 ' HB3' ' CE1' ' A' ' 14' ' ' HIS . 63.0 m-85 -85.86 47.64 1.48 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.568 -0.372 . . . . 0.0 110.462 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 13' ' ' CYS . 5.7 pt -115.58 139.0 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.516 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -123.42 148.28 46.29 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -80.52 134.24 35.92 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.434 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.544 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.808 -174.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 60.3 ttp . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.77 -73.43 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.915 0.76 . . . . 0.0 111.397 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -167.33 -69.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 24.2 m80 65.77 141.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.808 0.692 . . . . 0.0 111.897 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -88.7 100.67 13.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.401 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -72.48 130.0 39.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.635 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -76.55 84.83 3.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.526 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -75.46 124.04 26.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.858 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 p -74.4 146.07 10.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.438 0.637 . . . . 0.0 110.765 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 30.1 t70 177.9 89.45 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.431 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 17.3 t70 69.55 103.6 0.06 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.19 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -95.08 78.53 3.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.24 0.543 . . . . 0.0 110.949 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.91 -24.79 64.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 171.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -57.38 157.63 6.4 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.51 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.565 ' H ' ' HA2' ' C' ' 34' ' ' GLY . 1.9 mpt? -112.24 -51.74 2.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.459 -174.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.586 HD12 ' HA ' ' C' ' 35' ' ' ALA . 0.7 OUTLIER -104.71 135.62 45.76 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.643 -171.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.485 ' HA ' HG13 ' C' ' 32' ' ' ILE . 36.4 tt0 -88.91 94.27 9.88 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.675 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.3 t -79.48 128.29 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -172.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.519 ' CB ' HG11 ' C' ' 81' ' ' VAL . 0.8 OUTLIER -114.21 150.14 34.74 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' C' ' 28' ' ' THR . 18.5 m -135.32 150.91 29.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.602 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 36.7 mtpt -125.72 96.38 4.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.712 0.291 . . . . 0.0 110.297 174.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' THR . . . . . 0.459 HG23 ' O ' ' C' ' 84' ' ' LEU . 0.2 OUTLIER -92.27 167.38 12.05 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 171.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -64.37 -48.97 73.46 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.883 0.373 . . . . 0.0 111.642 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.05 -12.36 38.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.336 0.588 . . . . 0.0 110.228 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -91.96 -23.6 19.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.294 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 67.59 -75.06 0.06 Allowed 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.464 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 78.7 m -157.56 118.18 3.5 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -136.24 154.56 50.88 Favored 'General case' 0 C--O 1.223 -0.333 0 O-C-N 122.288 -0.258 . . . . 0.0 110.31 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.518 HG22 ' CD2' ' C' ' 20' ' ' LEU . 4.1 p -108.79 147.34 32.19 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -171.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.675 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 31.0 m-85 -140.16 65.14 1.43 Allowed 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 123.292 0.637 . . . . 0.0 111.289 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.485 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.7 mp -59.56 122.17 9.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 123.073 1.415 . . . . 0.0 113.81 -175.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.532 HG12 ' CD2' ' C' ' 42' ' ' PHE . 15.8 m -130.74 -173.71 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 111.723 -2.49 . . . . 0.0 111.461 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.565 ' HA2' ' H ' ' C' ' 16' ' ' MET . . . -120.48 45.61 1.21 Allowed Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.146 -1.026 . . . . 0.0 114.464 -173.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.586 ' HA ' HD12 ' C' ' 17' ' ' LEU . . . 68.16 -36.24 0.3 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 169.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -144.8 20.71 1.64 Allowed 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -172.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 2.0 ttt -66.72 -69.38 0.31 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 112.196 -2.274 . . . . 0.0 110.332 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -142.42 -101.02 0.13 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.655 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.603 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 101.37 -27.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 125.516 1.76 . . . . 0.0 110.189 -165.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' C' ' 40' ' ' LYS . 0.0 OUTLIER -83.99 -71.14 0.52 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 122.127 0.965 . . . . 0.0 109.056 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.11 -27.22 69.24 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.721 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.71 ' O ' HG23 ' C' ' 46' ' ' ILE . 6.3 t80 -58.95 -52.44 65.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.566 173.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 51.3 mtpt -61.55 -42.75 99.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.028 0.442 . . . . 0.0 110.642 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -55.6 -40.92 72.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.361 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -68.98 -47.01 66.63 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.971 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.71 HG23 ' O ' ' C' ' 42' ' ' PHE . 4.1 pt -76.01 -13.06 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.415 -173.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.2 -60.6 1.2 Allowed 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.01 93.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.745 0.307 . . . . 0.0 111.699 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -17.69 64.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.475 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.544 HG21 ' O ' ' C' ' 46' ' ' ILE . 17.8 m -113.33 -6.63 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 33.6 t 69.55 22.18 6.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.648 0.737 . . . . 0.0 109.192 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.1 mm -130.06 117.04 17.99 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.635 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.461 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 5.5 Cg_exo -74.99 148.32 35.15 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.962 1.774 . . . . 0.0 111.12 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -55.12 -25.91 34.82 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.153 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.5 pt-20 -68.54 -24.65 64.66 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.653 0.263 . . . . 0.0 111.623 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.464 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 95.8 mttt -115.64 -17.76 11.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.446 0.641 . . . . 0.0 110.427 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.429 ' HA ' HG22 ' C' ' 52' ' ' ILE . 23.0 tt0 -66.28 119.35 11.39 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.596 -170.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -114.54 113.66 24.72 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.651 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.743 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 47.7 mt -82.62 105.27 13.53 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.512 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.1 mt -102.13 103.62 15.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.611 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -118.6 132.51 56.19 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.628 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 40.64 45.55 2.04 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.985 0.803 . . . . 0.0 111.705 -171.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.95 -6.28 20.83 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.654 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -87.03 129.71 34.78 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 t -87.38 89.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.081 0.467 . . . . 0.0 109.905 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.743 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.1 OUTLIER -76.96 155.84 32.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.103 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . 0.44 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.7 pt20 -160.16 -169.31 2.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.286 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.527 ' HA ' HG11 ' C' ' 39' ' ' VAL . 1.8 p-10 -61.6 1.34 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.251 1.42 . . . . 0.0 113.116 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' C' ' 67' ' ' GLN . 13.4 t70 -65.29 9.85 0.1 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.155 0.982 . . . . 0.0 113.103 -178.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' C' ' 68' ' ' ASP . 51.4 mttp 84.18 159.69 0.11 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.449 1.1 . . . . 0.0 113.648 170.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.4 ' HB3' ' HG2' ' C' ' 74' ' ' GLU . 95.3 mttt 67.89 89.56 0.1 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.123 -1.399 . . . . 0.0 113.005 173.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.433 HD13 ' CG2' ' C' ' 33' ' ' VAL . 11.3 mt -63.9 -36.1 82.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.559 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -66.89 -24.46 66.11 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . 0.4 ' HG2' ' HB3' ' C' ' 71' ' ' LYS . 26.1 mm-40 -62.19 -27.78 69.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.241 0.543 . . . . 0.0 109.623 176.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.534 ' CD1' HD21 ' C' ' 66' ' ' LEU . 17.8 m-85 -94.01 -12.24 29.07 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.781 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 3.8 m120 47.83 45.29 18.57 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.417 1.087 . . . . 0.0 113.366 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 29.5 m -86.68 19.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -74.35 102.41 1.37 Allowed Glycine 0 N--CA 1.429 -1.789 0 CA-C-O 122.989 1.327 . . . . 0.0 112.976 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.26 13.73 53.33 Favored Glycine 0 C--N 1.283 -2.394 0 CA-C-N 111.967 -2.116 . . . . 0.0 114.002 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -127.84 154.7 45.15 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.66 -0.318 . . . . 0.0 110.247 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.602 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 35.0 m -87.03 122.93 39.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.818 0.818 . . . . 0.0 112.157 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . . . . . . . . . 62.3 mt -86.7 135.26 25.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.512 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.404 ' O ' ' HB ' ' C' ' 60' ' ' ILE . 69.5 m80 -93.93 114.62 26.86 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.459 ' O ' HG23 ' C' ' 23' ' ' THR . 2.7 pp -127.37 157.13 40.78 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 118.786 -1.166 . . . . 0.0 113.517 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -159.56 -174.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.533 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.16 142.81 35.23 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.238 167.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -81.31 176.98 9.28 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 169.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.78 156.27 12.96 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.651 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.09 152.41 18.65 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.624 2.216 . . . . 0.0 112.111 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.23 58.07 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.368 2.712 . . . . 0.0 113.317 -173.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -146.53 20.89 1.34 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.676 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 3.6 t -118.22 111.28 18.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.944 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -160.81 102.31 1.31 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.37 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.43 98.39 43.48 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.257 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.36 143.73 83.65 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.588 2.192 . . . . 0.0 111.224 174.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 7.3 m -60.0 -27.52 66.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.043 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -111.74 34.22 5.36 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.248 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.19 -65.36 0.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.894 -0.18 . . . . 0.0 110.772 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 16.6 m 58.51 78.27 0.26 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.736 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 56.4 m 62.04 69.09 0.64 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.847 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.311 -1.272 . . . . 0.0 111.321 179.573 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 41.5 m -88.32 106.32 18.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.924 0.393 . . . . 0.0 110.298 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -65.38 -46.2 81.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 3' ' ' GLU . . . 60.6 89.59 0.07 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.935 0.772 . . . . 0.0 112.372 173.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 13.8 mm-40 72.65 105.17 0.07 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.869 177.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.37 108.85 3.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.146 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 t 61.95 75.07 0.45 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.918 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -85.0 52.33 3.37 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.045 2.497 . . . . 0.0 111.604 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -162.89 155.98 16.68 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.3 70.84 6.6 Favored 'Trans proline' 0 N--CA 1.431 -2.168 0 C-N-CA 122.765 2.31 . . . . 0.0 112.804 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.48 8.46 24.34 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.594 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -121.5 85.53 2.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.892 0.346 . . . . 0.0 110.835 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.476 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 8.2 m-85 -117.99 165.21 13.99 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.34 0.59 . . . . 0.0 109.809 171.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.457 ' CB ' HD11 ' A' ' 40' ' ' LEU . 50.1 t80 -140.26 115.15 9.62 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.491 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.571 ' HB2' HG22 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -93.88 108.1 19.92 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -64.88 -15.4 61.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.652 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.5 t -72.34 -36.8 68.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.887 0.375 . . . . 0.0 110.478 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.461 ' HB3' HG23 ' A' ' 18' ' ' VAL . 66.0 m -88.77 -23.89 22.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.423 0.63 . . . . 0.0 110.594 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.07 30.61 20.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.272 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.461 HG23 ' HB3' ' A' ' 16' ' ' CYS . 2.6 m -138.38 162.95 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.694 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -83.42 145.24 29.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.608 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 3.5 pt -137.21 168.42 21.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.094 -171.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 45.9 t -125.14 99.58 34.09 Favored Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 162.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 12.9 Cg_endo -55.37 175.24 0.19 Allowed 'Trans proline' 0 C--N 1.328 -0.538 1 C-N-CA 125.306 4.004 . . . . 0.0 116.257 -173.17 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HB2' HG13 ' A' ' 28' ' ' ILE . 26.0 mtt180 -109.15 48.99 0.84 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.86 -1.973 . . . . 0.0 106.888 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 27' ' ' TYR . 1.8 mm? 3.05 -61.47 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.362 0 CA-C-N 111.09 -2.777 . . . . 0.0 117.334 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -34.86 -34.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 123.103 2.535 . . . . 0.0 114.42 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.53 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.84 -21.83 9.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.937 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.507 ' C ' HD12 ' A' ' 37' ' ' ILE . 77.3 m-85 65.57 57.6 0.86 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.148 0.975 . . . . 0.0 109.795 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -109.19 163.01 6.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 113.492 -1.686 . . . . 0.0 109.542 176.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 1.4 t -95.92 146.15 30.81 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.608 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 86.8 Cg_endo -83.32 -20.29 5.02 Favored 'Trans proline' 0 CA--C 1.501 -1.15 0 C-N-CA 122.607 2.205 . . . . 0.0 108.85 -175.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.469 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 63.3 mtt180 -86.16 -14.07 45.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.259 -1.791 . . . . 0.0 114.104 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 p -152.36 -14.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 8.4 tt0 62.72 36.59 13.25 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.028 0.531 . . . . 0.0 112.161 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 98.2 p -108.44 154.18 22.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 166.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.46 33.91 3.79 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.801 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.26 47.79 1.21 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.369 . . . . 0.0 111.045 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.571 HG21 HD13 ' A' ' 20' ' ' ILE . 3.6 pt -114.03 139.55 39.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.779 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' HB3' ' CD1' ' C' ' 60' ' ' ILE . 13.1 pt-20 -117.83 143.41 46.31 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -79.13 139.17 38.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.07 0.462 . . . . 0.0 109.836 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.457 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.933 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.102 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' MET . . . . . 0.457 ' HA ' ' HE3' ' C' ' 2' ' ' MET . 5.7 tpt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 120.636 0.255 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.86 133.26 43.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.94 0.4 . . . . 0.0 111.452 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -137.55 38.23 2.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.948 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -85.77 71.46 10.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.229 0.538 . . . . 0.0 110.7 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -146.37 121.98 10.45 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -128.62 104.72 7.82 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.96 0.41 . . . . 0.0 110.896 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -123.01 34.65 5.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.321 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -75.98 83.83 2.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.925 0.393 . . . . 0.0 110.902 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -122.27 146.64 27.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.265 0.555 . . . . 0.0 110.209 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -120.17 -80.83 0.63 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.274 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -114.01 -34.56 5.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 168.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -78.24 74.79 4.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.714 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -70.52 -49.07 52.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.156 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.11 147.18 44.81 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.891 175.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.501 ' H ' ' HA2' ' C' ' 34' ' ' GLY . 94.1 mmm -112.76 -54.99 2.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.213 -167.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.589 HD13 ' HA ' ' C' ' 35' ' ' ALA . 0.6 OUTLIER -99.95 127.46 46.14 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.859 -171.029 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.522 ' HA ' HG13 ' C' ' 32' ' ' ILE . 40.5 tt0 -84.59 92.64 8.19 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.644 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.8 t -76.96 126.24 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.956 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -174.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.611 ' HB2' ' CG1' ' C' ' 81' ' ' VAL . 0.2 OUTLIER -114.21 155.02 26.87 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 170.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.898 ' O ' ' HA ' ' C' ' 28' ' ' THR . 15.7 m -140.82 155.35 22.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.542 ' HG3' ' CG2' ' C' ' 81' ' ' VAL . 45.0 mtmt -134.35 114.18 12.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 169.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' THR . . . . . 0.537 ' HB ' ' OE2' ' C' ' 86' ' ' GLU . 65.0 p -83.6 -178.95 7.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.637 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 mt -69.93 -24.6 63.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 110.172 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.13 4.38 17.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.131 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 7.1 t 64.96 22.67 12.49 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.163 0.506 . . . . 0.0 111.366 172.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -48.24 -58.12 4.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.292 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.898 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 95.0 m 56.02 96.12 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.516 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -133.93 170.44 15.62 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.205 -0.31 . . . . 0.0 110.674 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.53 HG23 ' CD2' ' C' ' 20' ' ' LEU . 2.6 p -112.09 145.21 40.15 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.644 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 29.5 m-85 -140.85 65.93 1.39 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.177 0.513 . . . . 0.0 110.895 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.522 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -60.32 121.7 8.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 123.384 1.564 . . . . 0.0 114.117 -174.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.549 HG13 ' CD2' ' C' ' 42' ' ' PHE . 10.9 m -125.08 -174.17 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 111.036 -2.802 . . . . 0.0 111.348 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.501 ' HA2' ' H ' ' C' ' 16' ' ' MET . . . -126.78 45.6 1.14 Allowed Glycine 0 C--N 1.317 -0.497 0 C-N-CA 119.78 -1.2 . . . . 0.0 114.119 -173.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.589 ' HA ' HD13 ' C' ' 17' ' ' LEU . . . 69.81 -26.29 0.15 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 169.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -163.33 25.51 0.09 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' MET . . . . . 0.521 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 31.7 tpp -77.14 -68.75 0.58 Allowed 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 112.15 -2.295 . . . . 0.0 109.659 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.574 ' O ' ' HB ' ' C' ' 39' ' ' VAL . 18.2 m120 -142.69 -157.1 0.74 Allowed 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.587 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 2.8 p 159.68 -16.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -70.48 0.6 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.248 -1.796 . . . . 0.0 108.24 169.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -62.68 -32.74 73.86 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.207 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.587 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -57.92 -51.69 68.57 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 173.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' C' ' 43' ' ' LYS . 31.3 mtpt -64.11 -39.3 93.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.99 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -56.6 -36.23 69.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.159 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -69.01 -39.79 79.08 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 122.911 0.484 . . . . 0.0 111.342 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.61 HD12 ' OE1' ' C' ' 57' ' ' GLN . 5.7 pt -84.55 -13.15 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.118 -175.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.32 -55.01 2.86 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.02 87.22 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -31.85 71.71 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.295 0.569 . . . . 0.0 110.868 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.541 HG22 ' O ' ' C' ' 46' ' ' ILE . 29.9 m -102.66 -2.06 9.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.033 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 84.3 p 63.12 23.55 13.99 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.812 0.815 . . . . 0.0 109.461 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.6 mm -130.45 115.29 17.2 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.781 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.48 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 4.5 Cg_exo -69.54 147.09 63.52 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.369 2.046 . . . . 0.0 111.061 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -51.37 -25.73 6.56 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.769 0.668 . . . . 0.0 112.059 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.48 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 10.2 pt-20 -70.75 -36.13 72.99 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.631 0.253 . . . . 0.0 111.568 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.43 -27.54 14.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.376 0.607 . . . . 0.0 110.363 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.61 ' OE1' HD12 ' C' ' 46' ' ' ILE . 6.0 tt0 -68.36 136.44 53.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.239 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . 0.428 ' HB2' ' CG2' ' C' ' 85' ' ' VAL . 47.2 mtm180 -137.48 137.37 38.62 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.33 172.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' C' ' 66' ' ' LEU . 38.6 mt -96.28 123.61 39.98 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.957 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 37' ' ' ILE . 9.9 mt -112.84 122.29 66.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 119.227 0.921 . . . . 0.0 111.374 169.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.647 ' CD2' HG11 ' C' ' 77' ' ' VAL . 36.3 t80 -128.36 119.12 24.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.615 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 58.36 37.4 25.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.117 0.484 . . . . 0.0 110.414 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.46 -4.95 65.78 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.747 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' C' ' 64' ' ' ARG . 2.5 tpm_? -92.43 126.0 37.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.35 90.74 3.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.371 0.605 . . . . 0.0 110.559 -174.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' C' ' 75' ' ' TYR . 0.1 OUTLIER -72.6 154.59 40.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.738 -178.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -152.44 -170.47 3.65 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.214 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.456 ' HA ' HG12 ' C' ' 39' ' ' VAL . 7.8 p-10 -69.64 -2.37 11.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.174 0.589 . . . . 0.0 112.125 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 18.4 t70 -62.91 -9.98 11.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.442 ' HA ' ' CG1' ' C' ' 39' ' ' VAL . 52.9 mtmt 77.53 -175.51 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.739 0.815 . . . . 0.0 111.888 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.446 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 35.5 mmtp 75.09 69.02 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.634 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 30.7 mt -66.89 -39.75 87.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.563 -176.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -67.81 -19.87 65.12 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 120.793 0.33 . . . . 0.0 111.521 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . 0.446 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 17.0 mm-40 -71.05 -27.08 63.39 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.449 ' CD1' HD21 ' C' ' 66' ' ' LEU . 25.2 m-85 -88.28 -25.11 22.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 61.7 t30 60.07 34.24 21.31 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.07 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.647 HG11 ' CD2' ' C' ' 61' ' ' TYR . 17.5 m -83.67 11.92 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -174.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.546 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -71.24 100.81 0.9 Allowed Glycine 0 N--CA 1.431 -1.661 0 CA-C-O 122.634 1.13 . . . . 0.0 113.298 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.5 13.41 28.28 Favored Glycine 0 C--N 1.285 -2.268 0 CA-C-N 112.123 -2.039 . . . . 0.0 115.804 170.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -136.04 148.56 48.41 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.68 0.74 . . . . 0.0 110.507 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.611 ' CG1' ' HB2' ' C' ' 20' ' ' LEU . 27.2 m -74.48 118.94 20.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 CA-C-O 121.97 0.89 . . . . 0.0 112.502 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.423 HG21 ' N ' ' C' ' 83' ' ' HIS . 84.8 mt -70.76 160.6 5.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.514 173.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.423 ' N ' HG21 ' C' ' 82' ' ' ILE . 66.0 m-70 -115.56 117.65 30.93 Favored 'General case' 0 C--N 1.319 -0.761 0 O-C-N 121.338 -0.851 . . . . 0.0 109.564 173.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.43 ' CD1' ' HB ' ' C' ' 21' ' ' VAL . 10.2 mp -85.29 160.94 19.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.238 0.542 . . . . 0.0 111.699 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.428 ' CG2' ' HB2' ' C' ' 58' ' ' ARG . 5.6 m -112.61 134.71 54.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . 0.537 ' OE2' ' HB ' ' C' ' 23' ' ' THR . 30.7 mt-10 -116.47 121.82 42.96 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.788 -177.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -83.41 176.58 8.98 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.32 146.87 88.32 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.96 157.85 36.73 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.073 2.515 . . . . 0.0 111.811 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -48.42 138.99 23.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.449 2.766 . . . . 0.0 112.296 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -77.58 -16.78 58.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.965 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -71.75 147.87 46.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.041 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -85.78 -7.81 58.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.321 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 8.9 tt -67.02 122.76 84.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.002 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.09 110.42 1.01 Allowed 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.717 2.278 . . . . 0.0 112.272 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -73.38 -169.5 0.67 Allowed 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.03 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.04 -111.54 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.734 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 54.5 39.47 31.11 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.545 0.688 . . . . 0.0 109.986 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 2.6 p -99.16 -173.23 2.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.358 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 13.1 t -72.18 -37.97 69.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.185 0.517 . . . . 0.0 109.644 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.9 -0.945 . . . . 0.0 111.782 179.084 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.4 t -77.37 129.2 35.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.008 0.432 . . . . 0.0 110.706 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt -93.29 -7.74 44.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.303 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.56 82.23 1.58 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.371 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.56 141.61 28.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.451 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.71 97.11 6.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.927 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.0 p -168.8 122.5 0.71 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.12 -36.42 97.93 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.566 2.178 . . . . 0.0 110.754 173.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -135.92 122.75 14.38 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 169.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.76 40.71 0.82 Allowed 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 123.259 2.639 . . . . 0.0 113.681 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.93 99.68 0.04 OUTLIER Glycine 0 CA--C 1.502 -0.724 0 CA-C-O 121.933 0.741 . . . . 0.0 111.83 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.423 ' HG2' HD13 ' A' ' 40' ' ' LEU . 43.4 ttm180 -161.45 82.04 0.61 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 113.96 -1.12 . . . . 0.0 110.94 -172.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.508 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 6.3 m-85 -116.62 148.69 40.72 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.875 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.484 ' CB ' HD21 ' A' ' 40' ' ' LEU . 37.9 t80 -118.17 116.12 26.18 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.455 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.566 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -92.53 131.73 37.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.509 ' CD2' HG23 ' C' ' 85' ' ' VAL . 72.6 m-70 -85.8 -27.33 25.23 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -169.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 30.7 p -71.36 -30.63 66.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.319 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.416 ' O ' HG22 ' A' ' 18' ' ' VAL . 84.9 m -83.42 -33.01 25.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.091 0.472 . . . . 0.0 110.211 172.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.0 34.28 24.09 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.114 -173.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 16' ' ' CYS . 18.9 t -138.89 145.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.26 146.36 45.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.18 0.514 . . . . 0.0 112.003 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.615 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 2.3 pt -136.14 167.42 24.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.624 -172.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.63 111.39 31.41 Favored Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 159.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.508 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 22.2 Cg_endo -69.04 175.84 6.99 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 124.372 3.381 . . . . 0.0 115.687 -167.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 13.8 mtt180 -108.77 48.86 0.84 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.859 -1.973 . . . . 0.0 106.798 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -1.05 -58.66 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.057 0 CA-C-N 110.964 -2.835 . . . . 0.0 117.056 171.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.434 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 20.0 Cg_exo -37.98 -33.98 0.29 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.706 2.271 . . . . 0.0 113.774 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.521 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.49 -21.0 10.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.777 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' C ' HD12 ' A' ' 37' ' ' ILE . 80.3 m-85 65.49 56.27 0.97 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.356 1.074 . . . . 0.0 109.878 -169.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -109.59 162.85 7.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.38 -1.737 . . . . 0.0 109.606 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.5 t -97.46 147.53 33.12 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.615 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 65.6 Cg_endo -82.56 -19.82 6.08 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.851 2.367 . . . . 0.0 108.046 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.628 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 94.9 mtt-85 -82.69 -24.55 33.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 113.007 -1.906 . . . . 0.0 114.114 -178.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.432 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 28.6 p -147.2 -12.21 0.42 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 8.1 tt0 62.27 29.2 17.33 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.329 0.585 . . . . 0.0 111.02 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 m -106.26 146.76 29.94 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 170.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.27 44.47 3.29 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.572 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 95.4 m-85 -103.95 45.03 0.98 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.52 0.676 . . . . 0.0 109.851 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.566 ' CG2' ' HB2' ' A' ' 13' ' ' CYS . 10.7 pt -113.41 138.76 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.943 -176.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.489 ' HB3' HD12 ' C' ' 60' ' ' ILE . 13.4 pt-20 -129.57 143.85 51.01 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -79.5 133.39 36.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.024 0.44 . . . . 0.0 110.314 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.484 HD21 ' CB ' ' A' ' 12' ' ' PHE . 8.2 mt . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.708 -170.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.7 -79.97 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.338 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -175.95 -43.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.634 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 32.7 m80 62.52 -166.87 0.21 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.62 0.575 . . . . 0.0 110.371 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 59.67 41.05 19.19 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -73.74 -79.67 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.014 -175.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' C' ' 9' ' ' HIS . 67.4 m-70 46.94 36.57 4.11 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.574 0.547 . . . . 0.0 112.453 173.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' C' ' 8' ' ' HIS . 64.1 m-70 68.42 -51.79 0.55 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.949 0.499 . . . . 0.0 110.757 -170.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.09 151.41 23.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.089 173.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' C' ' 12' ' ' ASP . 3.1 p-10 -57.02 -72.52 0.08 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.824 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . 0.446 ' H ' ' CG ' ' C' ' 11' ' ' ASP . 15.7 t70 176.03 -73.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -172.91 -158.54 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.51 -18.71 61.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 168.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -66.58 -178.58 0.72 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.137 170.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 92.3 mmm 57.31 80.67 0.16 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.175 0.512 . . . . 0.0 110.877 -177.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.557 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 5.2 mt -90.37 137.73 32.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.093 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.517 ' HA ' HG13 ' C' ' 32' ' ' ILE . 41.4 tt0 -88.79 89.56 8.04 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.61 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 7.9 t -74.79 97.29 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.978 -173.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.652 ' HB3' ' CG1' ' C' ' 81' ' ' VAL . 4.4 mt -88.89 153.14 21.28 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' C' ' 28' ' ' THR . 33.9 m -144.81 147.55 18.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.343 0.257 . . . . 0.0 110.402 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.617 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 79.8 mttt -131.17 120.41 23.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' THR . . . . . 0.405 HG22 ' O ' ' C' ' 84' ' ' LEU . 3.3 p -102.47 113.85 27.55 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.811 0.339 . . . . 0.0 111.09 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' C' ' 26' ' ' SER . 4.6 mm? 56.05 19.01 3.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.744 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 21.5 t70 71.94 -8.82 1.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.941 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.449 ' H ' ' C ' ' C' ' 24' ' ' LEU . 10.2 m -69.89 -39.19 76.39 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.553 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -110.5 174.06 6.04 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.844 0.83 . . . . 0.0 111.332 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.717 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 53.5 m -167.95 98.59 0.45 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.51 -1.677 . . . . 0.0 108.232 175.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -131.57 172.36 12.32 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.148 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.441 HG21 ' HG ' ' C' ' 20' ' ' LEU . 1.6 p -115.04 151.58 33.98 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.61 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 28.4 m-85 -137.46 58.64 1.7 Allowed 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 124.141 0.977 . . . . 0.0 109.812 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.517 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.4 mp -58.71 123.27 10.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 123.443 1.592 . . . . 0.0 114.38 -172.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' C' ' 16' ' ' MET . 10.7 m -124.66 -170.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 110.79 -2.913 . . . . 0.0 111.635 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.94 45.42 1.21 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.725 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.703 ' O ' ' HB3' ' C' ' 36' ' ' GLN . . . 68.06 17.12 9.51 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 165.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.703 ' HB3' ' O ' ' C' ' 35' ' ' ALA . 3.0 pt20 158.94 -9.08 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.292 0.568 . . . . 0.0 109.718 -162.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.2 tpt -39.83 -66.61 0.29 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.855 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.467 ' O ' HG13 ' C' ' 39' ' ' VAL . 26.2 m-80 -148.6 -88.52 0.08 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.684 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 89.29 -27.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 O-C-N 125.393 1.683 . . . . 0.0 111.559 -167.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -70.9 0.52 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.246 1.022 . . . . 0.0 108.873 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.46 -27.06 69.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.052 173.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.684 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.4 OUTLIER -56.74 -52.29 65.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.364 173.614 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 54.7 mtpt -61.02 -43.75 98.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.42 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -54.8 -39.19 68.2 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.306 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -70.23 -43.73 70.0 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.066 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.645 HG22 ' O ' ' C' ' 42' ' ' PHE . 3.9 pt -79.1 -11.66 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 120.458 0.17 . . . . 0.0 110.945 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.24 -55.48 3.29 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.793 0.683 . . . . 0.0 112.675 -177.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.31 -39.45 74.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -27.96 69.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.053 0.454 . . . . 0.0 111.0 -176.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.568 HG22 ' O ' ' C' ' 46' ' ' ILE . 28.9 m -108.27 -0.9 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.445 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 84.3 p 63.48 23.63 13.75 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.868 0.842 . . . . 0.0 109.464 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.0 mm -128.7 114.13 19.23 Favored Pre-proline 0 N--CA 1.439 -1.007 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.721 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.2 145.99 39.94 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.688 2.259 . . . . 0.0 111.929 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 41.1 t -53.08 -25.56 13.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.647 -174.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.496 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.6 pt-20 -70.76 -27.44 63.94 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.726 0.298 . . . . 0.0 111.474 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.496 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 92.8 mttt -109.0 -22.43 12.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.504 0.668 . . . . 0.0 109.936 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.408 ' HA ' ' CG2' ' C' ' 52' ' ' ILE . 23.6 tt0 -65.03 122.85 17.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.158 -169.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -127.41 115.55 19.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.982 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' C' ' 66' ' ' LEU . 5.3 mp -86.04 105.6 16.6 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.531 HG22 ' O ' ' A' ' 37' ' ' ILE . 13.4 mt -99.61 110.98 27.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 121.268 0.556 . . . . 0.0 111.811 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.484 ' CD2' HG12 ' C' ' 77' ' ' VAL . 50.0 t80 -122.12 121.02 35.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.261 173.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 60.31 39.32 19.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.983 0.421 . . . . 0.0 110.752 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.44 -1.45 27.73 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.679 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 6.2 mmp_? -88.73 140.46 29.42 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.44 87.87 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 0.0 110.611 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' C' ' 59' ' ' LEU . 6.1 mp -65.31 122.55 17.38 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.812 173.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . 0.401 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 19.1 pt20 -144.19 -170.21 3.3 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.23 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.532 ' HA ' HG12 ' C' ' 39' ' ' VAL . 2.2 p-10 -66.67 0.35 2.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.285 1.034 . . . . 0.0 112.599 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . 0.401 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 12.7 t70 -62.85 -2.68 1.25 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.516 0.726 . . . . 0.0 112.679 -177.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.419 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.1 mtmp? 81.71 172.06 0.12 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.12 0.968 . . . . 0.0 112.977 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.467 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 42.1 mtmt 71.0 86.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.937 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.491 ' HB2' ' N ' ' C' ' 36' ' ' GLN . 41.8 mt -71.68 -49.62 37.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.382 -176.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . 0.474 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 29.8 pt20 -67.91 -17.08 64.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . 0.467 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 7.0 mm-40 -63.67 -28.82 70.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.579 ' CD1' ' HG ' ' C' ' 66' ' ' LEU . 42.1 m-85 -85.11 -23.28 28.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.256 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.1 t30 59.72 30.04 19.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.377 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . 0.484 HG12 ' CD2' ' C' ' 61' ' ' TYR . 18.0 m -85.21 25.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -175.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.557 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -76.33 100.4 1.4 Allowed Glycine 0 N--CA 1.431 -1.65 0 CA-C-O 122.552 1.085 . . . . 0.0 111.929 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.95 13.23 34.63 Favored Glycine 0 C--N 1.284 -2.318 0 CA-C-N 112.364 -1.918 . . . . 0.0 114.278 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . 0.427 ' C ' ' HB2' ' C' ' 20' ' ' LEU . 8.2 mptt -126.19 144.19 50.86 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.142 0.471 . . . . 0.0 110.113 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.652 ' CG1' ' HB3' ' C' ' 20' ' ' LEU . 35.2 m -80.22 125.5 39.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.809 0.814 . . . . 0.0 111.524 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.517 HG21 ' HB3' ' C' ' 59' ' ' LEU . 42.6 mt -84.99 171.43 1.17 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.813 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -118.48 113.97 22.14 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 121.759 -0.588 . . . . 0.0 110.131 174.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.445 HD13 ' HB ' ' C' ' 21' ' ' VAL . 8.6 mp -103.32 139.41 38.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.058 0.456 . . . . 0.0 110.756 178.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.509 HG23 ' CD2' ' A' ' 14' ' ' HIS . 7.1 m -148.74 167.81 3.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.734 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . 0.417 ' OE1' ' HB3' ' C' ' 56' ' ' LYS . 0.1 OUTLIER -98.03 147.36 24.59 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.012 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -68.01 179.1 1.58 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.162 0.506 . . . . 0.0 111.429 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.78 155.85 3.75 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.198 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.68 137.48 66.85 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 122.266 1.977 . . . . 0.0 112.45 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.72 51.84 3.96 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 123.287 2.658 . . . . 0.0 113.019 -173.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -88.61 2.91 52.26 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.061 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 12.9 t -144.48 156.74 44.32 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.904 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -134.93 24.49 3.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.116 0.484 . . . . 0.0 110.163 176.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 57.3 mt -97.49 120.74 60.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.402 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.24 133.69 36.22 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.628 2.219 . . . . 0.0 111.715 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 8.9 t -76.11 57.81 1.15 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.072 0.463 . . . . 0.0 110.743 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.36 -103.48 1.51 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.066 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.66 108.45 20.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.646 0.26 . . . . 0.0 110.406 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 8.7 t -81.57 84.65 6.69 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 31.9 t 64.79 79.58 0.25 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.157 -1.357 . . . . 0.0 111.488 178.834 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.776 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.6 m -77.89 77.53 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.361 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptp -118.88 4.72 11.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.832 -174.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.68 53.75 2.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.21 0.529 . . . . 0.0 110.57 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -97.61 -17.7 19.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.986 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.8 119.92 21.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.011 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.5 m -153.69 95.82 2.83 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.431 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.31 65.01 7.98 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.023 2.482 . . . . 0.0 113.015 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -103.64 -46.91 0.16 Allowed Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.15 67.0 4.18 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 121.916 1.744 . . . . 0.0 113.36 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.94 -12.09 2.2 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.568 172.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -154.99 90.22 1.27 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.823 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.566 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.1 m-85 -117.92 145.39 44.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 169.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CB ' HD13 ' A' ' 40' ' ' LEU . 60.8 t80 -119.21 122.04 41.07 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.349 172.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.64 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -99.28 130.0 45.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.744 177.434 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -85.11 -26.57 26.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.446 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 26.4 p -70.33 -45.47 66.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.425 -174.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.464 ' C ' ' HG ' ' A' ' 17' ' ' SER . 18.6 p -95.05 -0.88 53.24 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.918 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.464 ' HG ' ' C ' ' A' ' 16' ' ' CYS . 35.9 p 50.5 43.18 27.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.586 1.155 . . . . 0.0 113.739 175.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 16' ' ' CYS . 32.1 t -133.3 144.69 35.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.8 148.27 40.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.58 ' CD1' HG21 ' A' ' 37' ' ' ILE . 4.1 pt -140.35 167.57 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.657 0.741 . . . . 0.0 112.93 -167.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.44 106.85 39.67 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 159.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.566 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 25.6 Cg_endo -68.74 175.64 6.97 Favored 'Trans proline' 0 C--N 1.32 -0.921 0 C-N-CA 124.688 3.592 . . . . 0.0 116.546 -166.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.489 ' CB ' HD12 ' A' ' 28' ' ' ILE . 83.7 mtt180 -108.87 48.48 0.86 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 112.65 -2.068 . . . . 0.0 107.434 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -3.28 -59.53 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.85 0 CA-C-N 110.854 -2.885 . . . . 0.0 117.479 173.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 26.8 Cg_exo -37.25 -37.01 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 122.59 2.194 . . . . 0.0 113.53 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.509 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -112.22 -21.49 11.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.704 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 42.2 m-85 68.99 57.41 0.39 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.259 1.028 . . . . 0.0 110.057 -170.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.509 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -111.49 163.79 8.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.159 176.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.452 ' SG ' HG23 ' A' ' 20' ' ' ILE . 1.5 t -95.72 142.4 24.53 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.545 ' HD3' HD11 ' A' ' 20' ' ' ILE . 91.9 Cg_endo -83.35 -18.82 5.75 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.074 1.85 . . . . 0.0 108.577 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.52 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 58.2 mtt180 -95.47 15.96 18.25 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.241 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 31' ' ' ARG . 14.3 p 175.64 -11.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.405 0.441 . . . . 0.0 111.901 172.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 10.4 tt0 63.95 29.71 14.35 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.197 0.522 . . . . 0.0 112.124 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -99.7 148.29 24.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.48 168.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.24 21.98 21.82 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.892 -175.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 74.9 m-85 -86.32 47.73 1.51 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.709 0.29 . . . . 0.0 110.985 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.64 ' CG2' ' HB2' ' A' ' 13' ' ' CYS . 6.6 pt -110.31 131.59 60.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.191 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -118.63 145.94 45.05 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -78.79 143.43 36.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.24 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.414 HD13 ' CB ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.148 -173.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.03 -61.46 0.45 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.643 0.777 . . . . 0.0 112.403 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -80.19 79.66 6.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 110.799 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -73.92 -47.31 38.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.032 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -169.77 -39.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.819 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -157.57 169.68 24.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -111.94 57.73 0.64 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.133 0.492 . . . . 0.0 111.958 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -99.07 70.02 1.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 165.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 27.2 m -82.46 143.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 122.099 0.952 . . . . 0.0 111.913 -170.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -117.03 7.92 13.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.431 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.46 85.64 5.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.032 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -124.39 -0.44 8.2 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.506 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.73 -36.71 85.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.388 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -51.26 140.78 16.15 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.299 0.571 . . . . 0.0 111.788 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.523 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 13.4 tmm? -171.82 122.67 0.51 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.931 -173.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.764 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -106.3 142.76 35.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 172.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.489 ' HA ' HG13 ' C' ' 32' ' ' ILE . 38.8 tt0 -92.78 91.45 7.48 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 173.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' C' ' 30' ' ' THR . 2.9 t -76.2 103.1 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.757 -169.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -92.31 133.96 35.36 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.329 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.485 HG21 ' HB ' ' C' ' 82' ' ' ILE . 52.1 t -142.38 121.13 8.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -175.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.524 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 41.9 mtpt -95.7 154.09 17.39 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 50.9 p -120.21 165.13 15.22 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.662 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.02 -10.09 46.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.137 0.494 . . . . 0.0 110.943 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -75.13 3.04 9.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.233 171.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 50.6 m 74.13 14.58 3.82 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.282 0.633 . . . . 0.0 111.863 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -94.61 -178.12 4.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.58 0.705 . . . . 0.0 111.313 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 53.1 m -144.31 117.41 8.91 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.35 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -129.22 151.45 49.88 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.629 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 4.2 p -104.87 144.12 32.21 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.537 ' HB2' HG11 ' C' ' 19' ' ' VAL . 35.8 m-85 -139.09 62.36 1.54 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.82 0.819 . . . . 0.0 110.147 -174.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.489 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.2 mp -60.25 122.75 11.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 123.221 1.486 . . . . 0.0 114.901 -173.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' C' ' 16' ' ' MET . 19.5 m -140.35 -166.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 111.116 -2.765 . . . . 0.0 112.377 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -80.33 177.84 54.16 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.79 174.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.764 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -79.8 -15.07 58.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.372 0.606 . . . . 0.0 111.476 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -161.93 27.75 0.12 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' MET . . . . . 0.442 ' HB2' ' HA3' ' C' ' 34' ' ' GLY . 4.5 ttp -57.69 -75.95 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.394 -174.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.453 ' O ' HG12 ' C' ' 39' ' ' VAL . 11.7 m120 -121.97 -82.33 0.65 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 120.903 0.383 . . . . 0.0 111.401 -177.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.666 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 78.31 -25.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 O-C-N 124.95 1.406 . . . . 0.0 113.068 -173.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.15 -68.87 0.71 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 122.35 1.071 . . . . 0.0 109.075 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -57.77 -32.67 67.72 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.028 -1.896 . . . . 0.0 110.221 171.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.666 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -63.33 -50.46 69.93 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.999 176.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . 0.686 ' HG3' ' OE1' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -59.11 -48.34 81.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.824 0.345 . . . . 0.0 110.278 176.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -57.31 -33.05 67.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.438 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -69.72 -51.12 37.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.284 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.693 HD13 ' OE1' ' C' ' 57' ' ' GLN . 17.7 pt -74.97 -14.31 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.525 -177.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.36 -57.09 2.27 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 124.165 0.916 . . . . 0.0 113.293 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.12 87.44 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -57.4 -43.73 83.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.484 0.659 . . . . 0.0 110.485 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.607 HG23 ' O ' ' C' ' 46' ' ' ILE . 27.1 m -88.16 -6.25 10.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.286 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m 67.87 21.1 9.14 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 121.62 0.724 . . . . 0.0 109.409 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.5 mm -129.67 111.81 17.6 Favored Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.325 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.449 ' HA ' ' HB2' ' C' ' 47' ' ' ALA . 5.0 Cg_exo -71.39 147.83 53.45 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.84 2.36 . . . . 0.0 111.554 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 37.9 t -51.15 -25.2 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.021 0.928 . . . . 0.0 112.81 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.458 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.5 pt-20 -78.14 -21.28 50.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 111.685 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.458 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 46.0 mtpt -112.9 -15.36 12.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.481 . . . . 0.0 110.195 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.693 ' OE1' HD13 ' C' ' 46' ' ' ILE . 9.6 tt0 -75.8 122.71 24.48 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.163 -174.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -121.73 124.2 43.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.743 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.519 HD11 ' HZ1' ' C' ' 43' ' ' LYS . 87.1 mt -88.29 118.23 27.75 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 37' ' ' ILE . 5.7 mt -114.27 113.12 42.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.047 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -126.15 121.73 33.66 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 59.95 38.39 20.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.792 -177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.03 -4.85 36.33 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.013 -0.54 . . . . 0.0 113.532 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -88.04 130.61 34.93 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.63 88.92 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.059 0.456 . . . . 0.0 109.848 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.522 HD23 ' CD1' ' C' ' 75' ' ' TYR . 0.3 OUTLIER -74.02 142.79 45.73 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -155.16 -168.65 2.93 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.042 -171.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.578 ' HA ' HG11 ' C' ' 39' ' ' VAL . 4.7 p-10 -60.78 -1.85 0.46 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.087 0.955 . . . . 0.0 113.421 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -68.53 -3.29 11.09 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.181 0.592 . . . . 0.0 112.165 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 57.6 mttp 76.63 -165.45 0.06 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.862 0.865 . . . . 0.0 110.623 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 mttt 68.69 55.85 0.46 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.463 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 31.1 mt -61.78 -33.04 73.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -71.72 -18.18 62.16 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 120.746 0.308 . . . . 0.0 111.575 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -76.44 -26.8 55.82 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.522 ' CD1' HD23 ' C' ' 66' ' ' LEU . 16.2 m-85 -82.63 -24.03 34.0 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 58.5 t30 62.88 41.52 8.6 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.596 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.26 -5.25 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-N 112.955 -1.929 . . . . 0.0 112.748 -158.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.639 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -52.58 104.92 0.2 Allowed Glycine 0 CA--C 1.487 -1.666 0 CA-C-O 123.329 1.516 . . . . 0.0 113.769 173.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.97 14.21 59.58 Favored Glycine 0 C--N 1.287 -2.194 0 CA-C-N 111.388 -2.406 . . . . 0.0 113.961 168.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -121.49 138.95 54.07 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 13.1 m -74.76 127.81 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 122.191 0.996 . . . . 0.0 111.46 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.485 ' HB ' HG21 ' C' ' 21' ' ' VAL . 12.6 mt -86.25 167.86 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.838 174.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.418 ' N ' HG21 ' C' ' 82' ' ' ILE . 65.2 m80 -118.92 115.3 24.08 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 19.5 tp -92.45 132.79 36.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.276 0.56 . . . . 0.0 111.914 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 m -133.91 170.0 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.342 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -122.89 122.55 38.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.915 0.388 . . . . 0.0 111.27 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -102.91 164.34 11.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.02 152.29 78.22 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.948 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -62.73 141.6 85.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.562 2.175 . . . . 0.0 112.16 175.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.45 65.07 8.05 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.804 2.336 . . . . 0.0 112.229 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -100.97 -20.03 15.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.921 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 14.8 t -152.4 151.36 30.72 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.847 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -87.46 78.91 8.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 tt 71.99 120.71 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.35 0 O-C-N 124.009 0.818 . . . . 0.0 110.162 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.52 103.52 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.624 2.216 . . . . 0.0 112.042 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 25.9 t -62.72 126.45 27.39 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.809 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.93 -134.17 10.36 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.062 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.9 83.02 4.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.997 0.427 . . . . 0.0 110.992 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -77.62 -17.57 57.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.297 0.57 . . . . 0.0 109.939 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 38.9 t -129.86 -53.99 1.14 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.304 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.569 -1.129 . . . . 0.0 111.46 -178.438 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 111.841 -0.503 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 2.9 p -67.82 108.79 3.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.051 0.453 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 mtm -82.15 -42.1 19.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.103 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 3' ' ' GLU . . . -84.24 79.92 9.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.565 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 2' ' ' ALA . 35.2 tt0 73.43 145.44 0.08 Allowed 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.938 0.774 . . . . 0.0 110.882 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.76 67.77 2.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.259 0.552 . . . . 0.0 110.519 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.6 p -79.98 145.71 61.95 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.253 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.19 139.08 88.67 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.259 1.973 . . . . 0.0 110.951 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -96.33 120.77 61.87 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 121.105 0.479 . . . . 0.0 111.164 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.572 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 70.9 Cg_endo -80.37 153.95 21.28 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.422 2.748 . . . . 0.0 113.827 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.23 -112.89 1.56 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.441 ' HB3' HD13 ' A' ' 40' ' ' LEU . 77.6 mtp180 -88.13 107.13 18.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.895 0.378 . . . . 0.0 110.587 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.8 m-85 -116.25 144.82 43.72 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.412 173.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.509 ' CB ' HD23 ' A' ' 40' ' ' LEU . 53.8 t80 -114.24 121.59 44.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.762 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -98.43 119.52 37.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 174.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -76.88 -13.33 60.0 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.468 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 36.3 t -70.89 -42.04 70.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.353 0.597 . . . . 0.0 110.581 175.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -85.21 -27.03 26.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.581 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 1.6 m 58.09 29.5 17.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.214 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.37 144.25 34.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -74.82 147.64 40.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.177 0.513 . . . . 0.0 111.267 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.605 ' HB ' ' CD ' ' A' ' 30' ' ' PRO . 4.6 pt -133.36 169.7 21.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.841 -169.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.37 108.64 35.61 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 158.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.685 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 15.0 Cg_endo -69.06 177.49 5.05 Favored 'Trans proline' 0 C--N 1.328 -0.53 0 C-N-CA 125.181 3.921 . . . . 0.0 115.315 -170.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.588 ' HB2' HG13 ' A' ' 28' ' ' ILE . 8.2 mtt180 -112.57 50.46 0.87 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.592 174.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.481 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -0.3 -60.23 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 CA-C-N 111.334 -2.667 . . . . 0.0 116.365 172.316 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 24' ' ' LEU . 27.7 Cg_exo -34.79 -36.4 0.12 Allowed 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 123.045 2.497 . . . . 0.0 114.386 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.513 ' CB ' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -110.35 -22.92 11.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.72 178.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.443 ' C ' HD13 ' A' ' 37' ' ' ILE . 64.9 m-85 66.24 49.26 1.51 Allowed 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.642 -168.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.588 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -98.17 162.18 2.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.07 174.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.542 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.8 t -97.63 147.1 32.53 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.605 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 66.6 Cg_endo -80.93 -22.84 5.9 Favored 'Trans proline' 0 CA--C 1.499 -1.261 0 C-N-CA 122.897 2.398 . . . . 0.0 108.21 -174.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.516 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 80.1 mtt-85 -81.66 -30.02 32.9 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 112.819 -1.991 . . . . 0.0 113.776 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.4 p -141.6 -7.02 0.99 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.429 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 17.6 tt0 59.47 27.37 16.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.552 0.691 . . . . 0.0 111.219 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -107.71 143.02 36.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.369 171.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.37 33.24 2.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.899 -0.667 . . . . 0.0 114.012 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 41.1 m-85 -89.54 45.08 1.25 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.101 0.477 . . . . 0.0 110.423 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.536 ' O ' ' HA2' ' C' ' 63' ' ' GLY . 10.4 pt -112.32 132.48 60.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.227 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB3' HD12 ' C' ' 60' ' ' ILE . 7.5 pt-20 -120.08 136.23 54.66 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.95 137.57 39.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.971 0.415 . . . . 0.0 110.094 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.509 HD23 ' CB ' ' A' ' 12' ' ' PHE . 10.4 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.363 -172.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.04 155.7 17.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.816 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -62.23 -51.52 67.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.213 0.53 . . . . 0.0 109.946 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -117.16 164.71 14.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.311 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -75.49 69.16 2.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.307 0.575 . . . . 0.0 110.463 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -145.13 103.38 3.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.572 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -81.31 -0.59 41.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.966 0.412 . . . . 0.0 111.135 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -138.0 128.79 26.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 170.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 33.5 m -138.98 150.39 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.033 0.444 . . . . 0.0 111.521 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -143.43 17.38 1.86 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.2 44.34 1.01 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.634 -170.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -119.59 69.58 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -88.63 -45.81 9.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.881 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -67.12 178.78 1.33 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.523 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 45.5 ttm 65.51 91.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.152 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' LEU . . . . . 0.632 ' HB3' ' HA2' ' C' ' 78' ' ' GLY . 0.0 OUTLIER -108.69 142.53 39.07 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.104 176.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.517 ' HA ' HG13 ' C' ' 32' ' ' ILE . 37.8 mt-10 -85.04 94.69 8.89 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.5 t -77.9 111.46 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.613 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.4 mt -100.02 146.97 26.12 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' C' ' 28' ' ' THR . 9.4 m -137.32 153.9 29.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' LYS . . . . . 0.522 ' HG3' ' CG2' ' C' ' 81' ' ' VAL . 41.0 mtmt -125.77 133.18 52.14 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 3.2 m -78.3 -45.63 22.23 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.121 -172.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.84 -43.17 0.12 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 27.2 t70 177.96 -43.26 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.312 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 24.6 t -66.1 -45.69 80.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.483 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -93.32 176.2 6.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 122.634 1.207 . . . . 0.0 113.036 -175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 25.5 m -176.1 104.81 0.07 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 112.068 -2.333 . . . . 0.0 106.817 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -131.21 157.55 42.91 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.442 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' THR . . . . . 0.535 HG22 ' CD2' ' C' ' 20' ' ' LEU . 16.8 p -103.76 149.11 25.32 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -172.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' PHE . . . . . 0.613 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 27.6 m-85 -140.36 63.11 1.48 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.376 -177.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . 0.517 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -59.17 122.69 9.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 122.973 1.368 . . . . 0.0 114.154 -174.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.647 HG12 ' CD1' ' C' ' 42' ' ' PHE . 13.9 m -135.74 -168.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 111.498 -2.592 . . . . 0.0 112.107 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.47 38.72 2.56 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.457 -0.878 . . . . 0.0 114.423 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . 71.09 16.99 6.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 163.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.71 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 9.7 tt0 153.43 -7.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.787 0.803 . . . . 0.0 108.933 -166.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' MET . . . . . 0.483 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 35.8 tpp -47.94 -66.52 0.39 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.296 173.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.483 ' OD1' ' HG3' ' C' ' 37' ' ' MET . 18.3 m120 -139.99 -162.68 1.38 Allowed 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 168.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.604 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 8.1 p 173.72 -19.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.485 ' HE2' ' HE2' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -83.05 -70.65 0.54 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.123 173.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -62.77 -32.45 73.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.531 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.647 ' CD1' HG12 ' C' ' 33' ' ' VAL . 5.9 t80 -59.05 -52.17 66.89 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.625 175.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -68.04 -35.67 78.64 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.638 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -56.39 -40.43 74.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.026 0.441 . . . . 0.0 111.133 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -69.56 -41.15 76.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.742 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.614 ' O ' HG21 ' C' ' 50' ' ' VAL . 6.2 pt -76.59 -16.62 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -176.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -39.17 -59.57 1.0 Allowed 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.81 95.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -23.57 67.32 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.177 0.513 . . . . 0.0 111.097 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . 0.62 HG22 ' OE1' ' C' ' 57' ' ' GLN . 26.7 m -108.91 -5.93 10.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.096 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t 69.17 19.63 7.86 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.558 0.694 . . . . 0.0 109.637 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 3.4 mm -129.26 118.4 19.22 Favored Pre-proline 0 N--CA 1.444 -0.761 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.726 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' PRO . . . . . 0.427 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 5.1 Cg_exo -70.1 146.67 58.75 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.121 1.88 . . . . 0.0 111.188 177.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 8.7 t -53.48 -26.18 19.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.009 -176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.7 pt-20 -71.63 -32.45 67.96 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.899 0.38 . . . . 0.0 110.998 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.448 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 57.4 mtpt -99.45 -24.42 14.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.36 0.6 . . . . 0.0 110.123 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.62 ' OE1' HG22 ' C' ' 50' ' ' VAL . 6.2 tt0 -69.2 122.64 19.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.728 -173.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -112.02 122.63 48.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.674 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.521 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 95.3 mt -88.46 110.75 21.1 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 38' ' ' GLU . 10.2 mt -108.64 113.88 45.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.95 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -133.54 132.54 41.05 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 59.11 34.21 23.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.401 -173.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 67.83 2.31 22.58 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.777 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -91.16 136.48 33.06 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -90.64 89.18 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.43 0.633 . . . . 0.0 109.563 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.547 HD21 ' CD1' ' C' ' 75' ' ' TYR . 0.3 OUTLIER -73.67 140.94 46.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.918 178.577 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -153.53 -169.31 3.26 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.561 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' ASP . . . . . 0.484 ' HA ' HG12 ' C' ' 39' ' ' VAL . 7.4 p-10 -65.56 -0.43 2.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.268 0.627 . . . . 0.0 112.161 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 38.4 t70 -58.32 -10.9 2.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.296 1.038 . . . . 0.0 113.367 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.485 ' HE2' ' HE2' ' C' ' 40' ' ' LYS . 89.5 mttt 85.6 175.16 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.285 1.034 . . . . 0.0 113.226 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 64.74 86.02 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.916 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.611 ' HB2' ' C ' ' C' ' 35' ' ' ALA . 57.9 mt -75.42 -34.15 60.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.41 -19.3 65.76 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 120.699 0.285 . . . . 0.0 111.636 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -68.8 -28.41 66.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' TYR . . . . . 0.547 ' CD1' HD21 ' C' ' 66' ' ' LEU . 20.9 m-85 -85.85 -23.26 27.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.1 t30 61.07 36.52 18.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.848 -1.524 . . . . 0.0 110.852 171.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.04 25.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.711 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -72.14 95.14 0.65 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-O 122.203 0.89 . . . . 0.0 113.074 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.64 14.77 45.73 Favored Glycine 0 C--N 1.305 -1.179 0 CA-C-N 113.341 -1.429 . . . . 0.0 113.508 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -119.01 149.82 40.99 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.052 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 10.5 m -82.68 124.07 39.04 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-O 122.299 1.047 . . . . 0.0 111.177 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' ILE . . . . . 0.497 HG21 ' N ' ' C' ' 83' ' ' HIS . 68.2 mt -81.95 167.3 2.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.925 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' HIS . . . . . 0.497 ' N ' HG21 ' C' ' 82' ' ' ILE . 54.8 m80 -118.71 115.11 23.82 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -113.94 151.47 32.24 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.051 -1.059 . . . . 0.0 112.562 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.94 -174.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 113.174 -1.83 . . . . 0.0 110.352 -176.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.88 170.91 9.5 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.239 168.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -77.5 176.91 8.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.078 0.466 . . . . 0.0 111.323 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.85 150.31 77.54 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.557 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.69 135.92 11.82 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.957 1.771 . . . . 0.0 112.365 -175.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -87.8 55.46 2.68 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.943 2.428 . . . . 0.0 111.843 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -67.75 -16.58 64.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.153 0.501 . . . . 0.0 110.814 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -142.74 35.83 1.43 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 172.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 45.2 m80 68.15 -78.88 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.572 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -121.41 107.48 36.77 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -64.66 104.23 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.452 2.101 . . . . 0.0 112.25 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 29.0 t -72.02 -33.72 68.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.115 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.4 84.79 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.429 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.18 71.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.935 0.398 . . . . 0.0 111.2 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 20.4 m -111.64 19.9 17.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.146 0.498 . . . . 0.0 110.805 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 18.8 m -98.26 101.16 12.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.983 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.936 0 CA-C-O 118.739 -1.034 . . . . 0.0 111.298 176.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 120.407 0.146 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 10.0 m-85 -120.67 165.29 15.27 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 167.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CB ' HD21 ' A' ' 40' ' ' LEU . 75.4 t80 -137.22 117.44 13.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.687 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -97.55 120.95 38.86 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -74.69 -15.64 60.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.748 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.6 m -70.78 -37.28 73.34 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.937 0.399 . . . . 0.0 111.147 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' HG23 ' A' ' 18' ' ' VAL . 90.5 m -89.48 -16.0 31.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.695 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 p 49.64 31.35 4.2 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.256 -171.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 16' ' ' CYS . 98.0 t -141.13 146.91 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.539 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 25.5 tt0 -70.39 149.0 47.75 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.343 0.402 . . . . 0.0 111.235 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.703 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.4 pt -138.12 167.01 22.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.477 -173.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.496 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 40.5 t -122.96 96.68 44.67 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 163.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.662 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.88 177.12 0.19 Allowed 'Trans proline' 0 C--N 1.325 -0.691 1 C-N-CA 125.455 4.103 . . . . 0.0 116.426 -170.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.544 ' HB2' HG13 ' A' ' 28' ' ' ILE . 36.7 mtt180 -112.97 51.01 0.85 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 112.818 -1.992 . . . . 0.0 107.565 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' A' ' 27' ' ' TYR . 3.1 mm? 3.0 -60.81 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.213 0 CA-C-N 111.507 -2.588 . . . . 0.0 117.555 171.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 32.6 Cg_exo -37.12 -32.84 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.613 2.209 . . . . 0.0 113.826 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.558 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -118.29 -20.39 8.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.558 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.41 ' C ' HD11 ' A' ' 37' ' ' ILE . 44.1 m-85 65.25 46.66 2.59 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.57 1.176 . . . . 0.0 109.767 -170.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -92.0 163.77 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 113.315 -1.766 . . . . 0.0 109.793 174.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -94.29 144.49 28.1 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.143 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.678 ' HD3' HD12 ' A' ' 20' ' ' ILE . 68.3 Cg_endo -80.72 -22.43 6.45 Favored 'Trans proline' 0 CA--C 1.5 -1.208 0 C-N-CA 122.711 2.274 . . . . 0.0 108.083 -171.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 51.6 mtt180 -81.24 -34.76 31.92 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.968 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.4 p -139.27 -8.42 1.31 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.333 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 60.11 25.98 15.32 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.0 m -98.5 133.69 42.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 166.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.03 30.76 2.62 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.007 -172.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 51.8 m-85 -86.58 47.99 1.56 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.498 0.666 . . . . 0.0 109.842 176.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.703 HG21 ' CD1' ' A' ' 20' ' ' ILE . 9.6 pt -111.33 133.45 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.382 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' HB3' HD13 ' C' ' 60' ' ' ILE . 11.5 pt-20 -117.2 141.48 48.23 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -79.29 131.99 36.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.206 0.527 . . . . 0.0 109.848 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.452 HD21 ' CB ' ' A' ' 12' ' ' PHE . 2.5 mt . . . . . 0 C--O 1.25 1.12 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.877 -173.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.505 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 12.2 tpt . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 120.823 0.344 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.735 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -99.19 148.29 24.25 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.543 ' HA ' HG13 ' C' ' 32' ' ' ILE . 30.2 tt0 -98.72 91.58 5.17 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.3 t -78.79 106.11 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.443 -168.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.614 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -94.64 140.93 29.21 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.66 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' C' ' 82' ' ' ILE . 70.7 t -151.68 120.44 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 37.7 mtpt -95.54 159.18 15.12 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 63.3 p . . . . . 0 C--N 1.314 -0.954 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.783 -171.927 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 22.8 m . . . . . 0 C--O 1.232 0.18 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -125.59 152.89 44.51 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.63 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p -99.1 145.42 27.16 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.162 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.478 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 29.0 m-85 -135.88 58.54 1.74 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.654 -175.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.543 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -57.35 122.29 6.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 123.381 1.563 . . . . 0.0 114.362 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -142.94 -165.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 110.677 -2.965 . . . . 0.0 111.39 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -81.57 -179.85 53.13 Favored Glycine 0 C--N 1.312 -0.769 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.123 174.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.735 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -78.78 -23.83 45.04 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-N 117.254 0.527 . . . . 0.0 110.132 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -151.75 23.08 0.69 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -162.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' MET . . . . . 0.49 ' HB2' ' HA3' ' C' ' 34' ' ' GLY . 25.5 ttt -73.6 -68.75 0.48 Allowed 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 111.409 -2.632 . . . . 0.0 110.805 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.454 ' OD1' ' HG2' ' C' ' 37' ' ' MET . 23.6 m120 -126.19 -94.52 0.46 Allowed 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.585 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 82.94 -38.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 O-C-N 124.305 1.003 . . . . 0.0 111.128 -162.366 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.528 ' HA ' ' CB ' ' C' ' 68' ' ' ASP . 0.0 OUTLIER -78.97 -69.46 0.57 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 122.512 1.148 . . . . 0.0 108.939 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 41' ' ' GLU . . . . . 0.413 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 20.7 mt-10 -63.08 -27.82 69.66 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.902 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.585 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 2.6 t80 -59.05 -50.34 74.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.328 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.485 ' HE3' ' OG ' ' C' ' 54' ' ' SER . 23.1 mtpp -60.61 -41.27 94.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.988 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -57.73 -38.39 75.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.175 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -70.43 -45.97 64.81 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.209 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.602 ' O ' HG22 ' C' ' 50' ' ' VAL . 17.0 pt -76.78 -10.63 13.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -174.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -43.92 -49.46 8.42 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.63 -38.28 48.28 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.707 -0.397 . . . . 0.0 112.065 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -28.21 69.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.987 0.422 . . . . 0.0 110.996 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.602 HG22 ' O ' ' C' ' 46' ' ' ILE . 34.8 m -109.11 -5.84 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.47 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 46.1 m 68.13 20.65 8.9 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 121.629 0.728 . . . . 0.0 109.768 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.6 mm -122.95 111.2 30.97 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.546 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 7.1 Cg_exo -70.49 141.6 42.65 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.61 2.207 . . . . 0.0 111.695 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.485 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 42.8 t -50.75 -26.19 5.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.73 -173.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.402 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 13.4 pt-20 -72.75 -36.31 67.69 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.402 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 89.0 mttt -94.85 -32.28 13.33 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.741 0.782 . . . . 0.0 109.468 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.465 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 20.8 tt0 -51.92 132.43 32.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.664 -1.607 . . . . 0.0 111.48 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -133.95 113.02 11.73 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.524 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 37.8 mt -84.89 118.38 24.48 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 38' ' ' GLU . 5.4 mt -117.25 121.17 67.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.664 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -137.85 132.82 33.12 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 59.15 32.87 22.45 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.534 0.521 . . . . 0.0 110.14 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 67.85 4.18 32.47 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.87 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -88.7 142.08 27.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -90.24 89.41 3.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.631 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -81.14 131.86 35.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 67' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' C' ' 69' ' ' ASP . 9.3 pt20 -144.67 -177.32 5.44 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.536 -176.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.547 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.7 p-10 -70.51 -3.22 16.87 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.751 0.821 . . . . 0.0 112.033 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 69' ' ' ASP . . . . . 0.426 ' H ' ' HG3' ' C' ' 67' ' ' GLN . 33.1 t70 -70.32 -21.63 62.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -174.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -131.85 -142.22 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.196 -0.315 . . . . 0.0 111.442 -169.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' C' ' 71' ' ' LYS . 9.9 mptt -126.64 167.17 16.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.623 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.487 HD23 HG23 ' C' ' 39' ' ' VAL . 7.3 mt -70.61 -37.31 73.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.022 0.439 . . . . 0.0 111.758 -175.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 73' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' C' ' 35' ' ' ALA . 23.1 tp60 -70.66 -18.65 62.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.521 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -61.61 -29.41 70.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.83 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.631 ' CD1' HD22 ' C' ' 66' ' ' LEU . 36.8 m-85 -103.66 -18.62 14.65 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.65 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.8 t30 59.22 52.6 5.96 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.904 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 35.1 m -95.23 14.98 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -171.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -57.56 99.27 0.1 OUTLIER Glycine 0 CA--C 1.492 -1.381 0 CA-C-O 122.915 1.286 . . . . 0.0 113.789 171.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.94 14.92 47.4 Favored Glycine 0 C--N 1.284 -2.328 0 CA-C-N 111.877 -2.162 . . . . 0.0 114.132 171.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.35 141.19 50.29 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 122.495 -0.414 . . . . 0.0 110.642 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.614 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 21.2 m -78.37 123.96 36.02 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-O 121.932 0.872 . . . . 0.0 111.104 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' C' ' 21' ' ' VAL . 66.3 mt -82.6 168.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.0 172.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.501 ' N ' HG22 ' C' ' 82' ' ' ILE . 62.5 m80 -118.27 115.5 24.86 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 15.0 mt -88.42 148.73 24.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.17 0.51 . . . . 0.0 111.452 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.133 -178.335 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 121.651 0.739 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.605 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 9.0 m-85 -115.88 169.6 9.11 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.513 -1.222 . . . . 0.0 108.39 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.642 ' HB2' HD21 ' A' ' 40' ' ' LEU . 38.4 t80 -142.0 113.62 7.83 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.917 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 31.6 p -83.09 87.67 6.9 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.813 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.535 ' CE1' HG13 ' C' ' 85' ' ' VAL . 30.3 p80 -66.17 -14.72 62.32 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.619 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.766 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 3.0 p -67.08 -49.08 66.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.044 0.449 . . . . 0.0 110.437 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.9 -5.61 28.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.626 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m 65.16 55.44 1.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.034 172.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.94 145.36 24.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.4 tt0 -86.25 138.92 31.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.132 0.492 . . . . 0.0 110.709 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.783 HD11 HG21 ' A' ' 37' ' ' ILE . 6.2 pt -143.49 166.87 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -164.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 46.5 t -120.07 94.81 48.89 Favored Pre-proline 0 N--CA 1.447 -0.578 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 160.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 9.8 Cg_endo -56.73 171.36 1.03 Allowed 'Trans proline' 0 C--N 1.32 -0.965 1 C-N-CA 125.479 4.119 . . . . 0.0 117.186 -167.23 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HB2' HG13 ' A' ' 28' ' ' ILE . 98.3 mtt180 -101.91 47.48 0.9 Allowed 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 112.4 -2.182 . . . . 0.0 107.205 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -8.53 -54.25 0.01 OUTLIER Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 110.467 -3.06 . . . . 0.0 115.606 172.491 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 19.2 Cg_exo -35.27 -33.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 123.216 2.611 . . . . 0.0 114.512 173.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.511 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -122.91 -19.01 6.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.121 0.486 . . . . 0.0 111.42 177.236 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.482 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 90.5 m-85 73.04 53.28 0.13 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.162 -174.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -108.78 164.16 5.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 113.628 -1.624 . . . . 0.0 108.086 177.21 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 27.1 p -94.49 139.12 22.24 Favored Pre-proline 0 N--CA 1.424 -1.733 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.638 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 85.4 Cg_endo -78.63 -25.31 6.67 Favored 'Trans proline' 0 CA--C 1.493 -1.545 0 C-N-CA 123.535 2.823 . . . . 0.0 108.822 -166.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 52.9 mtt180 -79.68 -28.86 40.67 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.381 -2.19 . . . . 0.0 113.162 -175.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -157.7 9.8 0.18 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.322 -170.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 49.48 64.24 1.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 167.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.554 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -133.3 147.88 51.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.169 169.266 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -88.46 6.85 83.13 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.49 -0.862 . . . . 0.0 114.089 -170.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.766 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 69.8 m-85 -83.4 59.46 5.07 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.505 -0.409 . . . . 0.0 111.485 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.783 HG21 HD11 ' A' ' 20' ' ' ILE . 3.5 pt -112.73 141.56 27.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.07 0.462 . . . . 0.0 111.769 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.539 ' HB3' HD13 ' C' ' 60' ' ' ILE . 9.9 pt-20 -129.23 153.71 47.51 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -84.78 143.4 29.14 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.642 HD21 ' HB2' ' A' ' 12' ' ' PHE . 7.9 mt . . . . . 0 C--N 1.311 -1.066 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.899 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.657 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 24.6 ptt? . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 121.086 0.47 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.882 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.4 OUTLIER -104.09 133.07 49.65 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 170.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.608 ' HA ' HG13 ' C' ' 32' ' ' ILE . 26.0 mt-10 -80.45 96.56 6.78 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.614 HG22 HG23 ' C' ' 77' ' ' VAL . 3.0 t -81.63 104.64 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.5 -172.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -93.31 141.78 28.05 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' C' ' 82' ' ' ILE . 69.5 t -147.84 118.09 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 118.219 0.463 . . . . 0.0 110.781 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.637 ' HG2' ' OG1' ' C' ' 28' ' ' THR . 73.5 mttt -100.09 115.05 28.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 23' ' ' THR . . . . . 0.417 HG21 HG12 ' C' ' 50' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.315 -0.934 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.637 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 22.0 m . . . . . 0 C--O 1.233 0.227 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -126.67 154.72 43.69 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.332 -1.304 . . . . 0.0 109.547 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 2.4 p -103.03 141.91 35.01 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.489 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 26.8 m-85 -138.08 59.54 1.65 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.247 0.546 . . . . 0.0 109.991 -173.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.608 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.2 mp -54.88 125.46 9.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 123.04 1.4 . . . . 0.0 114.501 -173.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.754 HG21 HD13 ' C' ' 72' ' ' LEU . 15.6 m -132.7 -169.23 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 111.892 -2.413 . . . . 0.0 111.429 -176.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.68 40.85 1.99 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.239 -0.982 . . . . 0.0 114.323 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.882 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 70.07 -28.67 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 168.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -154.48 24.7 0.46 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -76.2 -68.11 0.62 Allowed 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 112.51 -2.132 . . . . 0.0 111.046 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.441 ' O ' HG12 ' C' ' 39' ' ' VAL . 96.0 m-20 -132.29 -87.51 0.45 Allowed 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.655 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 82.41 -37.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 124.746 1.279 . . . . 0.0 111.372 -166.033 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.97 -68.17 0.66 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 122.591 1.186 . . . . 0.0 108.653 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.29 -28.0 69.42 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 112.616 -2.084 . . . . 0.0 110.819 173.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.655 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.2 t80 -58.32 -49.52 76.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.89 174.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.519 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 14.9 mtpp -62.97 -41.2 99.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.92 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -61.63 -37.29 83.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.035 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -70.35 -43.2 70.68 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.532 ' O ' HG22 ' C' ' 50' ' ' VAL . 18.2 pt -76.87 -12.13 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.281 -0.262 . . . . 0.0 110.948 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.94 -55.51 3.71 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 -42.82 91.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -21.64 65.64 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.241 0.543 . . . . 0.0 111.276 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.532 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.7 m -112.31 -3.69 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.44 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 32.9 t 65.8 22.42 11.47 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.843 0.83 . . . . 0.0 109.049 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 11.5 mm -131.35 111.76 15.36 Favored Pre-proline 0 N--CA 1.437 -1.095 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.799 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.507 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 7.2 Cg_exo -68.29 151.68 76.3 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.496 2.13 . . . . 0.0 111.445 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.501 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 32.0 t -51.99 -32.65 34.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.572 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.596 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 13.5 pt-20 -66.26 -33.06 74.9 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.815 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.596 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 90.6 mttt -106.56 -1.04 23.4 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.371 0.605 . . . . 0.0 110.518 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.519 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 24.0 tt0 -90.21 123.62 34.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.109 -168.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.476 ' O ' HG23 ' C' ' 85' ' ' VAL . 29.1 mtm105 -121.77 115.4 22.6 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.402 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 53.5 mt -87.94 122.68 31.84 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 122.452 0.301 . . . . 0.0 110.968 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.539 HD13 ' HB3' ' A' ' 38' ' ' GLU . 8.8 mt -114.63 112.07 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 121.494 -0.754 . . . . 0.0 111.39 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.5 ' CG ' HG12 ' C' ' 77' ' ' VAL . 41.0 t80 -116.62 133.12 56.39 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 62' ' ' GLN . . . . . 0.486 ' HG2' ' CD2' ' C' ' 61' ' ' TYR . 18.3 pt20 39.55 46.14 1.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.142 0.901 . . . . 0.0 112.153 -174.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.71 5.2 63.61 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.864 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -94.85 141.64 28.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.88 98.39 7.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.175 0.512 . . . . 0.0 109.951 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.54 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.0 OUTLIER -90.26 152.09 21.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.228 -176.083 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -158.14 -166.79 2.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.32 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.621 ' HA ' HG13 ' C' ' 39' ' ' VAL . 5.1 p-10 -62.49 0.54 0.46 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.052 0.941 . . . . 0.0 112.592 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.59 -11.65 0.96 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.376 1.071 . . . . 0.0 112.957 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.548 ' H ' HG11 ' C' ' 39' ' ' VAL . 7.8 mtmp? 84.55 167.43 0.09 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.481 1.112 . . . . 0.0 113.429 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 68.29 83.79 0.16 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.053 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.754 HD13 HG21 ' C' ' 33' ' ' VAL . 13.6 mt -64.47 -32.19 73.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.513 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 73' ' ' GLN . . . . . 0.428 ' H ' ' HG2' ' C' ' 73' ' ' GLN . 22.5 pt20 -68.83 -29.07 67.33 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.641 -176.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.49 -27.73 67.25 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.54 ' CD1' HD22 ' C' ' 66' ' ' LEU . 30.7 m-85 -82.96 -23.11 33.56 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.5 t30 63.44 36.67 11.2 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.707 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.614 HG23 HG22 ' C' ' 19' ' ' VAL . 20.0 m -85.25 26.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.646 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -86.09 102.36 2.68 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-O 122.926 1.292 . . . . 0.0 113.441 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.89 13.26 56.83 Favored Glycine 0 C--N 1.285 -2.29 0 CA-C-N 112.266 -1.967 . . . . 0.0 114.022 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -133.58 152.53 51.91 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 18.4 m -79.11 126.07 38.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.904 0.859 . . . . 0.0 112.62 -175.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.621 ' HB ' HG22 ' C' ' 21' ' ' VAL . 46.2 mt -71.21 161.68 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.339 168.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.432 ' N ' HG22 ' C' ' 82' ' ' ILE . 45.5 m80 -116.01 113.0 22.63 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 171.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.446 ' CD1' HG11 ' C' ' 50' ' ' VAL . 1.6 mt -85.84 157.86 20.11 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.504 -176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.535 HG13 ' CE1' ' A' ' 14' ' ' HIS . 2.7 t . . . . . 0 C--N 1.32 -0.717 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 10.9 ptt180 . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.852 0.834 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.544 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 8.6 m-85 -122.43 174.05 7.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.701 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CB ' HD11 ' A' ' 40' ' ' LEU . 79.1 t80 -142.05 121.27 13.04 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.119 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -100.98 120.29 39.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.812 176.472 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.521 ' CD2' HG21 ' C' ' 85' ' ' VAL . 62.6 m-70 -74.43 -16.24 60.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.565 -175.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.97 -35.8 72.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.42 ' O ' HG23 ' A' ' 18' ' ' VAL . 88.0 m -91.71 -23.84 19.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.313 0.578 . . . . 0.0 110.319 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.411 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER 56.23 31.42 18.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.421 -173.24 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 16' ' ' CYS . 39.7 t -136.82 148.31 26.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.763 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 32.3 tt0 -67.19 147.34 53.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.895 0.379 . . . . 0.0 111.326 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.773 ' CD1' HG21 ' A' ' 37' ' ' ILE . 4.2 pt -139.89 168.73 17.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.564 -175.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.471 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 94.0 t -126.4 101.29 28.04 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 162.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 6.0 Cg_endo -56.39 174.77 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 125.273 3.982 . . . . 0.0 116.736 -171.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.505 ' HB2' HG13 ' A' ' 28' ' ' ILE . 8.6 mtt180 -107.25 47.2 0.89 Allowed 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.875 175.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 1.6 -61.73 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.941 0 CA-C-N 110.783 -2.917 . . . . 0.0 116.912 175.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 39.2 Cg_exo -30.24 -34.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 124.017 3.145 . . . . 0.0 114.904 175.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.571 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.86 -19.65 9.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 54.7 m-85 68.79 47.62 0.81 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.41 -171.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -101.24 161.47 3.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.237 176.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.9 OUTLIER -97.35 145.54 29.83 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.423 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.759 ' HD3' HD12 ' A' ' 20' ' ' ILE . 83.2 Cg_endo -84.26 -15.61 6.44 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 C-N-CA 122.415 2.077 . . . . 0.0 108.864 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.542 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 60.1 mtt-85 -85.12 -21.37 29.3 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.354 -1.748 . . . . 0.0 114.074 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.2 p -149.03 -7.25 0.37 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 58.22 30.81 19.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.803 0.811 . . . . 0.0 111.207 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.7 m -112.47 139.22 48.23 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.583 172.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.38 53.72 4.69 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.419 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 84.5 m-85 -112.18 46.67 1.13 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.413 0.625 . . . . 0.0 110.011 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.773 HG21 ' CD1' ' A' ' 20' ' ' ILE . 3.4 pt -112.15 138.54 40.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.41 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HB2' HG22 ' C' ' 65' ' ' VAL . 11.2 pt-20 -117.18 141.92 47.68 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -73.6 142.74 46.55 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.161 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.948 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.8 OUTLIER -102.86 131.03 50.05 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 111.456 -172.579 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.593 ' HA ' HG13 ' C' ' 32' ' ' ILE . 41.9 tt0 -88.01 94.43 9.79 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 5.6 t -80.75 104.87 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.513 -173.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.728 ' HB3' HG12 ' C' ' 81' ' ' VAL . 1.0 OUTLIER -94.13 141.87 28.05 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 174.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' C' ' 82' ' ' ILE . 78.9 t -150.36 121.32 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.328 0.513 . . . . 0.0 110.585 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 26.2 mtpt -108.36 164.37 12.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.494 0.664 . . . . 0.0 110.669 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 48.7 p . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.663 167.631 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 61.2 m . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -118.95 159.69 23.36 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.869 -1.132 . . . . 0.0 112.215 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 1.4 p -100.66 139.65 36.04 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.947 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.625 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 23.3 m-85 -133.83 55.86 1.88 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.231 -171.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.593 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -54.55 123.11 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 123.38 1.562 . . . . 0.0 113.979 -174.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.453 HG21 HD22 ' C' ' 72' ' ' LEU . 11.2 m -126.87 -175.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 110.961 -2.836 . . . . 0.0 111.196 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.65 52.72 0.8 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.512 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.948 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 71.01 -29.29 0.19 Allowed 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 167.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -162.19 23.83 0.11 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -172.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' MET . . . . . 0.551 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 16.0 tpt -72.2 -69.24 0.41 Allowed 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 111.754 -2.476 . . . . 0.0 111.435 -171.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.551 ' OD1' ' HG3' ' C' ' 37' ' ' MET . 24.8 m120 -129.18 -82.86 0.57 Allowed 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.09 0.472 . . . . 0.0 111.229 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.709 ' O ' ' HD2' ' C' ' 43' ' ' LYS . 0.4 OUTLIER 74.36 -31.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.744 -165.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' C' ' 43' ' ' LYS . 0.1 OUTLIER -84.15 -67.94 0.75 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.489 1.138 . . . . 0.0 109.661 178.367 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.17 -25.7 61.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.235 170.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.672 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 1.2 t80 -60.74 -48.63 80.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.425 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.709 ' HD2' ' O ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -53.15 -48.92 67.55 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.862 0.839 . . . . 0.0 109.037 173.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -35.47 74.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.887 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -69.16 -50.95 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.098 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.609 ' O ' HG22 ' C' ' 50' ' ' VAL . 25.5 pt -78.88 -12.44 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.85 -59.3 1.46 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.14 75.34 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.269 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -34.51 72.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.887 0.375 . . . . 0.0 111.113 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.609 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.8 m -100.39 -3.01 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.228 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 26.4 t 69.16 19.75 7.83 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 121.752 0.787 . . . . 0.0 109.287 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.3 mm -128.36 117.67 20.17 Favored Pre-proline 0 N--CA 1.442 -0.836 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.627 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.538 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.0 Cg_exo -65.52 149.37 87.75 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.924 1.749 . . . . 0.0 113.149 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.465 ' CB ' ' HB3' ' C' ' 43' ' ' LYS . 2.2 p -53.37 -29.94 37.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.463 -1.698 . . . . 0.0 113.375 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.8 pt-20 -82.07 -7.47 59.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.65 -176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.57 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 96.0 mttt -125.13 -31.31 3.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.567 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.608 ' OE1' ' HG3' ' C' ' 43' ' ' LYS . 3.3 pt20 -62.6 136.92 58.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.304 0.573 . . . . 0.0 111.185 -174.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -121.49 129.93 53.24 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.798 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' C' ' 66' ' ' LEU . 4.2 mp -91.18 134.57 34.43 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.56 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.3 mt -126.76 115.06 40.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.334 0.588 . . . . 0.0 112.001 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -124.11 116.59 23.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.518 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 61.02 34.87 19.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.494 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.16 -7.39 60.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.483 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 10.1 mmm180 -85.39 127.62 34.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -86.11 91.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.084 0.469 . . . . 0.0 110.227 -176.093 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.691 HD22 ' CD1' ' C' ' 75' ' ' TYR . 1.6 mt -73.24 136.54 44.65 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 67' ' ' GLN . . . . . 0.493 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 8.5 pt20 -149.89 -168.31 3.07 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.275 -171.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.566 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.8 p-10 -66.42 -0.43 2.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.064 0.946 . . . . 0.0 112.629 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' ASP . . . . . 0.493 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 9.2 t70 -69.07 2.46 2.74 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.734 0.813 . . . . 0.0 112.62 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.52 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.8 mtpt 72.74 -177.37 0.19 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.155 175.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 70.58 66.84 0.19 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.979 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.533 ' HA ' ' CD2' ' C' ' 75' ' ' TYR . 6.6 mt -64.12 -41.84 97.08 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.549 -175.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 73' ' ' GLN . . . . . 0.461 ' H ' ' HG2' ' C' ' 73' ' ' GLN . 17.1 pt20 -71.13 -18.27 62.53 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -70.07 -27.69 64.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.691 ' CD1' HD22 ' C' ' 66' ' ' LEU . 22.5 m-85 -74.17 -24.22 59.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 t30 64.09 36.49 9.7 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 123.392 1.568 . . . . 0.0 107.403 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.466 ' CG1' HG22 ' C' ' 19' ' ' VAL . 0.5 OUTLIER -96.41 0.79 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.059 -161.782 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.578 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -70.41 102.27 1.0 Allowed Glycine 0 N--CA 1.432 -1.591 0 CA-C-O 122.723 1.18 . . . . 0.0 112.824 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.68 13.84 26.83 Favored Glycine 0 C--N 1.283 -2.413 0 CA-C-N 112.24 -1.98 . . . . 0.0 114.325 173.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -124.78 154.36 41.06 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.728 HG12 ' HB3' ' C' ' 20' ' ' LEU . 2.8 m -85.28 131.02 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.093 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.661 HD13 HD12 ' C' ' 66' ' ' LEU . 56.5 mt -83.96 160.56 3.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.246 172.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.446 ' N ' HG22 ' C' ' 82' ' ' ILE . 67.4 m170 -109.22 112.49 24.68 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 166.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.446 HD22 HG12 ' C' ' 21' ' ' VAL . 0.6 OUTLIER -101.15 153.66 19.4 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.426 -0.91 . . . . 0.0 108.618 172.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.521 HG21 ' CD2' ' A' ' 14' ' ' HIS . 17.3 m . . . . . 0 C--N 1.308 -1.221 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.208 -174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.474 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 94.5 mtt180 . . . . . 0 C--O 1.224 -0.264 0 CA-C-O 120.688 0.28 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.67 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 14.2 m-85 -115.15 149.45 37.61 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.952 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.544 ' CB ' HD21 ' A' ' 40' ' ' LEU . 71.7 t80 -124.73 120.01 30.57 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.72 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -96.22 121.09 37.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.321 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -73.22 -20.22 60.92 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.388 -173.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -71.15 -30.86 66.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.851 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' O ' HG23 ' A' ' 18' ' ' VAL . 53.4 m -90.94 -18.42 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.475 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.8 p 51.49 30.28 6.18 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.888 0.742 . . . . 0.0 110.843 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 16' ' ' CYS . 73.9 t -144.73 145.71 20.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 20' ' ' ILE . 26.3 tt0 -74.96 151.98 38.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.109 0.481 . . . . 0.0 111.779 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.754 HD12 ' HD3' ' A' ' 30' ' ' PRO . 3.7 pt -138.24 168.51 19.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.958 -171.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.46 109.98 36.12 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 159.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.67 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 18.1 Cg_endo -69.94 174.92 8.96 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 124.45 3.433 . . . . 0.0 115.736 -166.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.493 ' HB2' HG13 ' A' ' 28' ' ' ILE . 75.9 mtt180 -106.64 47.69 0.87 Allowed 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.856 -1.975 . . . . 0.0 106.768 174.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -8.34 -55.9 0.01 OUTLIER Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 110.673 -2.967 . . . . 0.0 116.517 174.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 45.8 Cg_exo -34.13 -35.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 123.255 2.637 . . . . 0.0 114.34 175.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.566 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.19 -19.34 10.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.319 0.58 . . . . 0.0 111.839 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 68.41 55.3 0.51 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.991 -169.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -109.63 163.1 6.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.561 175.323 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -95.19 146.32 31.12 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.754 ' HD3' HD12 ' A' ' 20' ' ' ILE . 52.8 Cg_endo -82.82 -21.88 4.65 Favored 'Trans proline' 0 CA--C 1.504 -0.993 0 C-N-CA 123.202 2.601 . . . . 0.0 108.47 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.4 mtt-85 -79.29 -29.06 42.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.835 -1.984 . . . . 0.0 113.377 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.0 p -147.9 -3.84 0.51 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.69 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 14.7 tt0 60.15 40.51 18.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.067 0.461 . . . . 0.0 111.832 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.4 p -112.59 155.82 23.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.87 44.13 2.09 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.798 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 86.6 m-85 -109.13 47.5 0.92 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.293 0.568 . . . . 0.0 110.158 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.624 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.7 pt -111.86 147.43 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.272 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.532 ' HB2' HG22 ' C' ' 65' ' ' VAL . 12.6 pt-20 -135.57 147.17 48.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.594 0.235 . . . . 0.0 110.804 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.26 144.81 55.72 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 ' CB ' ' A' ' 12' ' ' PHE . 13.5 mt . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.028 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.465 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 50.2 ttm . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.648 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 0.9 OUTLIER -101.45 132.12 47.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.038 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.584 ' HA ' HG13 ' C' ' 32' ' ' ILE . 30.6 mt-10 -83.87 94.72 8.28 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.554 HG11 ' CZ ' ' C' ' 42' ' ' PHE . 5.4 t -79.23 92.65 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.098 -172.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 1.5 mp -85.24 133.16 34.18 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' C' ' 82' ' ' ILE . 71.1 t -141.58 116.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 40.7 mtpt -88.29 153.58 21.09 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 C--N 1.309 -1.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.397 -178.292 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 39.1 m . . . . . 0 C--O 1.233 0.185 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -118.48 149.55 41.09 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.376 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -106.52 141.94 36.99 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.178 0.513 . . . . 0.0 111.777 -174.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.478 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 35.9 m-85 -130.9 60.18 1.66 Allowed 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.722 -174.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.584 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -56.58 121.32 4.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 123.338 1.542 . . . . 0.0 114.48 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.87 -166.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 111.038 -2.801 . . . . 0.0 111.57 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -95.62 -170.82 35.89 Favored Glycine 0 C--N 1.312 -0.758 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.396 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.809 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . -103.9 83.24 2.09 Favored 'General case' 0 CA--C 1.477 -1.855 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.809 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 84.4 mt-30 108.6 15.88 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 O-C-N 126.599 2.437 . . . . 0.0 107.795 170.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -76.79 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.063 -2.335 . . . . 0.0 111.528 171.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.486 ' CG ' ' HB2' ' C' ' 41' ' ' GLU . 90.5 m-20 -123.55 -98.5 0.43 Allowed 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.596 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 84.22 -35.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 123.931 0.892 . . . . 0.0 110.648 -162.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.535 ' HA ' ' CB ' ' C' ' 68' ' ' ASP . 0.0 OUTLIER -81.43 -69.53 0.6 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.3 1.048 . . . . 0.0 108.959 177.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 41' ' ' GLU . . . . . 0.486 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 43.3 mt-10 -61.12 -28.95 69.47 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.012 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.596 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.1 t80 -61.1 -51.61 68.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.406 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 52.3 mtpt -58.5 -45.53 88.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.445 0.641 . . . . 0.0 110.358 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -59.79 -34.83 73.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.207 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -70.12 -47.76 60.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.789 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.57 ' O ' HG22 ' C' ' 50' ' ' VAL . 24.2 pt -75.04 -16.96 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.971 -0.104 . . . . 0.0 111.133 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -39.92 -61.0 0.91 Allowed 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -176.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.4 77.48 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.371 -0.532 . . . . 0.0 112.376 -173.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -26.73 68.46 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.181 0.515 . . . . 0.0 110.832 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.57 HG22 ' O ' ' C' ' 46' ' ' ILE . 22.2 m -104.66 -0.77 10.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.849 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 55.1 p 66.16 20.27 11.14 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.766 0.826 . . . . 0.0 109.842 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.7 mm -128.82 112.59 18.88 Favored Pre-proline 0 N--CA 1.437 -1.123 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.073 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.586 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.9 Cg_exo -69.29 146.78 64.22 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.471 2.114 . . . . 0.0 111.284 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.452 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 44.2 t -51.95 -25.97 9.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.347 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.5 pt-20 -79.51 -24.52 42.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.706 0.288 . . . . 0.0 111.342 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.484 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 48.2 mtpt -106.79 -16.27 14.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.854 0.359 . . . . 0.0 110.363 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.534 ' OE1' HD11 ' C' ' 46' ' ' ILE . 0.0 OUTLIER -87.25 148.86 24.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.726 -174.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -139.03 132.25 29.84 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.587 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 52.7 mt -90.67 109.68 20.85 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.598 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.3 mt -106.39 113.73 43.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.263 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.582 ' OH ' ' HD3' ' C' ' 80' ' ' LYS . 50.3 t80 -118.03 127.82 54.17 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 62' ' ' GLN . . . . . 0.462 ' HG2' ' CD2' ' C' ' 61' ' ' TYR . 21.5 pt20 40.98 46.77 2.5 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.028 0.931 . . . . 0.0 112.244 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.28 5.87 78.26 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.686 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -99.4 134.88 41.62 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 38' ' ' GLU . 2.1 t -88.96 90.07 3.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.078 0.466 . . . . 0.0 109.746 -177.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.597 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -73.91 132.14 42.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.122 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -144.83 173.01 12.23 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.201 -171.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.535 ' CB ' ' HA ' ' C' ' 40' ' ' LYS . 5.9 p-10 -70.73 -2.86 16.01 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.896 0.879 . . . . 0.0 113.06 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.25 -15.63 49.53 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.179 -0.326 . . . . 0.0 111.609 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.498 ' HB3' ' OE1' ' C' ' 74' ' ' GLU . 4.0 mtpm? -122.44 -151.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.52 -169.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.504 ' HB2' ' HG3' ' C' ' 74' ' ' GLU . 97.7 mttt -125.25 151.14 46.33 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.838 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.493 HD23 HG23 ' C' ' 39' ' ' VAL . 35.5 mt -57.32 -53.11 61.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 73' ' ' GLN . . . . . 0.571 ' CB ' ' HG3' ' C' ' 36' ' ' GLN . 53.2 tt0 -71.54 -14.4 62.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.565 -170.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 74' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' C' ' 71' ' ' LYS . 46.2 mt-10 -63.09 -29.24 70.65 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.597 ' CD1' HD22 ' C' ' 66' ' ' LEU . 60.5 m-85 -93.91 -21.24 19.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.2 t30 52.87 52.16 14.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.588 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.441 HG21 HD11 ' C' ' 82' ' ' ILE . 29.9 m -93.27 19.85 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.307 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.648 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -75.18 102.39 1.45 Allowed Glycine 0 CA--C 1.482 -2.01 0 CA-C-O 122.483 1.046 . . . . 0.0 111.713 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.12 14.97 46.65 Favored Glycine 0 C--N 1.281 -2.481 0 CA-C-N 112.562 -1.819 . . . . 0.0 112.107 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 80' ' ' LYS . . . . . 0.582 ' HD3' ' OH ' ' C' ' 61' ' ' TYR . 81.2 mttt -123.46 142.33 51.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 16.3 m -82.35 133.91 28.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.907 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' C' ' 21' ' ' VAL . 29.1 mt -92.56 170.19 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.265 175.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.486 ' N ' HG22 ' C' ' 82' ' ' ILE . 70.5 m80 -118.56 114.49 22.88 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.531 HD11 HD12 ' C' ' 46' ' ' ILE . 0.9 OUTLIER -89.79 141.45 28.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.383 0.611 . . . . 0.0 111.743 178.654 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.671 -178.191 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 10' ' ' ARG . 10.6 ptt180 . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 121.471 0.653 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.686 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 14.3 m-85 -120.17 167.24 12.44 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.401 ' CB ' HD11 ' A' ' 40' ' ' LEU . 65.7 t80 -140.35 114.56 9.15 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.446 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -95.44 114.97 26.79 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.567 174.27 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -69.9 -18.09 63.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.118 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.545 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 43.9 t -68.66 -35.44 77.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.081 0.467 . . . . 0.0 110.708 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.443 ' O ' HG23 ' A' ' 18' ' ' VAL . 92.6 m -95.16 -15.26 23.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.817 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.5 p 51.57 29.87 5.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.237 1.015 . . . . 0.0 111.582 -173.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 16' ' ' CYS . 97.2 t -139.39 147.25 24.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.761 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.66 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 31.4 tt0 -67.48 149.15 50.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.17 0.509 . . . . 0.0 111.092 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.809 HD11 HG21 ' A' ' 37' ' ' ILE . 3.5 pt -138.68 167.36 21.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.856 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 19.4 t -122.64 96.23 45.79 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 164.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.686 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 9.5 Cg_endo -58.36 176.48 0.39 Allowed 'Trans proline' 0 C--N 1.325 -0.697 1 C-N-CA 125.349 4.033 . . . . 0.0 117.776 -167.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.525 ' C ' ' HD2' ' A' ' 25' ' ' PRO . 40.2 mtt180 -112.25 51.42 0.81 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.764 -2.471 . . . . 0.0 106.848 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -7.32 -53.73 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.911 0 CA-C-N 111.705 -2.498 . . . . 0.0 115.965 172.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.525 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 24.1 Cg_exo -31.17 -39.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.398 2.732 . . . . 0.0 114.204 174.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.56 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -120.03 -16.64 8.57 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.296 0.57 . . . . 0.0 111.342 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.473 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 66.3 m-85 70.87 52.26 0.29 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.018 -1.447 . . . . 0.0 109.728 -169.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.56 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -106.38 162.26 5.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.165 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -98.23 149.2 35.49 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.237 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 62.2 Cg_endo -83.88 -18.73 5.28 Favored 'Trans proline' 0 CA--C 1.501 -1.135 0 C-N-CA 123.117 2.545 . . . . 0.0 108.59 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.5 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 56.0 mtt180 -88.58 -11.89 44.25 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.07 -1.877 . . . . 0.0 114.192 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 p -156.77 -11.43 0.09 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 61.16 29.48 18.83 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.558 0.694 . . . . 0.0 111.171 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.5 m -107.18 142.94 36.1 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -79.55 38.07 2.08 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.507 -175.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 50.9 m-85 -93.49 39.93 1.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.744 0.307 . . . . 0.0 111.054 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.809 HG21 HD11 ' A' ' 20' ' ' ILE . 6.1 pt -109.87 141.51 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.505 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.2 pt-20 -117.37 144.16 45.23 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 169.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -79.72 129.5 34.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.401 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.909 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 47.0 tpp . . . . . 0 C--O 1.234 0.281 0 CA-C-O 120.975 0.417 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.757 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -91.69 146.55 23.68 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' C' ' 32' ' ' ILE . 15.1 mt-10 -95.04 91.48 6.37 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 169.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.6 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 4.9 t -78.38 105.21 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.2 -170.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.631 ' C ' ' HA ' ' C' ' 81' ' ' VAL . 0.5 OUTLIER -96.25 142.58 28.23 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 175.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' C' ' 82' ' ' ILE . 54.7 t -148.05 124.53 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.899 0.381 . . . . 0.0 110.628 -173.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.493 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 43.0 mtpt -105.06 141.3 36.87 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.547 176.34 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 51.0 m . . . . . 0 C--O 1.236 0.344 0 CA-C-O 120.601 0.239 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -127.36 155.83 42.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.814 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.571 HG22 ' CD2' ' C' ' 20' ' ' LEU . 11.8 p -95.49 142.01 28.35 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 121.382 0.611 . . . . 0.0 112.223 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.6 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 25.6 m-85 -132.72 56.17 1.86 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.224 -174.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.592 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -56.87 121.17 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 123.353 1.549 . . . . 0.0 114.412 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.7 m -140.43 -163.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 110.777 -2.919 . . . . 0.0 111.307 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.51 165.48 19.24 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.154 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.757 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -68.43 -16.2 63.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.637 0.732 . . . . 0.0 112.16 -175.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -158.8 25.33 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -167.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 51.0 ttm -79.47 -72.64 0.38 Allowed 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 111.699 -2.501 . . . . 0.0 110.928 -176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.528 ' O ' HG12 ' C' ' 39' ' ' VAL . 80.0 m-20 -125.51 -99.51 0.4 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.712 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 83.88 -29.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 C-N-CA 125.161 1.385 . . . . 0.0 111.502 -162.094 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.74 -68.13 0.74 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.346 1.07 . . . . 0.0 109.122 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.55 -30.34 69.71 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.949 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.658 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 7.0 t80 -58.34 -51.08 71.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.848 174.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.605 ' HB3' ' OE1' ' C' ' 57' ' ' GLN . 47.8 mtpt -61.24 -47.01 88.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.109 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -56.53 -36.8 69.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.892 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -70.6 -43.79 68.62 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.649 ' O ' HG22 ' C' ' 50' ' ' VAL . 22.1 pt -77.77 -8.51 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -175.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.03 -56.83 1.77 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.74 -36.79 50.37 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.272 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -33.06 71.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.018 0.437 . . . . 0.0 110.9 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.649 HG22 ' O ' ' C' ' 46' ' ' ILE . 34.5 m -105.38 -2.63 9.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.885 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 59.6 p 64.78 21.23 12.33 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 122.003 0.906 . . . . 0.0 109.298 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.2 mm -122.63 117.21 28.98 Favored Pre-proline 0 N--CA 1.439 -0.976 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.302 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.569 ' O ' ' HG3' ' C' ' 57' ' ' GLN . 4.6 Cg_exo -71.76 150.16 55.62 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.961 1.774 . . . . 0.0 112.226 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.632 ' HA ' ' OE1' ' C' ' 57' ' ' GLN . 0.9 OUTLIER -52.12 -25.17 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.096 -176.48 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.547 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.4 pt-20 -74.67 -26.91 60.17 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.207 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.547 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 47.9 mttm -105.66 -25.01 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.688 0.28 . . . . 0.0 111.526 -173.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.632 ' OE1' ' HA ' ' C' ' 54' ' ' SER . 88.9 mt-30 -56.55 126.17 25.39 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.895 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -122.95 110.14 15.01 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' C' ' 82' ' ' ILE . 1.1 mm? -87.11 112.48 21.96 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.512 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.7 mt -110.33 120.61 61.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 121.809 -0.557 . . . . 0.0 111.024 175.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -128.75 134.61 48.48 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 41.97 42.38 2.29 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.987 0.804 . . . . 0.0 111.732 -173.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.98 4.02 61.62 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.593 -0.731 . . . . 0.0 113.608 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -96.15 130.82 43.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.3 99.22 9.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.297 0.57 . . . . 0.0 110.451 -175.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.505 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -86.16 154.66 21.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.054 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -165.91 -169.77 1.59 Allowed 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.958 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.712 ' HA ' HG13 ' C' ' 39' ' ' VAL . 5.1 p-10 -64.94 -1.4 2.0 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.902 0.881 . . . . 0.0 113.123 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.97 -7.2 3.52 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.42 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.8 mttp 88.22 170.57 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.48 1.112 . . . . 0.0 111.827 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.543 ' HB3' ' HG2' ' C' ' 74' ' ' GLU . 13.5 mmmm 71.45 79.52 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.617 177.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.612 HD21 HG23 ' C' ' 39' ' ' VAL . 37.2 mt -68.82 -29.22 67.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.849 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 73' ' ' GLN . . . . . 0.436 ' HB2' ' HB1' ' C' ' 35' ' ' ALA . 46.8 tt0 -68.52 -27.17 65.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.401 . . . . 0.0 111.364 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' GLU . . . . . 0.543 ' HG2' ' HB3' ' C' ' 71' ' ' LYS . 58.8 mm-40 -63.48 -27.12 69.06 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.546 ' CD2' ' HA ' ' C' ' 72' ' ' LEU . 7.8 m-85 -90.17 -23.07 21.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 60.9 t30 55.31 46.79 22.82 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.198 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.444 HG23 HG22 ' C' ' 19' ' ' VAL . 33.1 m -93.66 4.36 7.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 119.957 -0.697 . . . . 0.0 112.862 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.669 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -56.22 100.37 0.1 Allowed Glycine 0 CA--C 1.491 -1.435 0 CA-C-O 122.918 1.288 . . . . 0.0 113.68 171.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.47 14.8 49.42 Favored Glycine 0 C--N 1.289 -2.076 0 CA-C-N 111.367 -2.417 . . . . 0.0 113.534 173.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -124.37 139.91 53.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.545 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.631 ' HA ' ' C ' ' C' ' 20' ' ' LEU . 22.2 m -80.08 126.48 39.39 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.748 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' C' ' 21' ' ' VAL . 60.9 mt -83.11 167.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.452 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.509 ' N ' HG22 ' C' ' 82' ' ' ILE . 42.9 m80 -114.42 114.63 26.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 171.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.436 HD12 ' N ' ' C' ' 85' ' ' VAL . 15.8 tp -97.23 133.01 42.43 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.203 0.525 . . . . 0.0 110.135 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.436 ' N ' HD12 ' C' ' 84' ' ' LEU . 25.2 m . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.367 -177.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 121.19 0.519 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.738 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.9 m-85 -124.93 151.96 44.73 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 172.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -124.04 118.29 26.64 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.262 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -96.37 117.67 31.32 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.048 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.737 ' CG ' HG13 ' C' ' 85' ' ' VAL . 12.6 p80 -75.07 -10.68 59.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.89 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 49.7 t -71.97 -37.52 69.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.159 0.505 . . . . 0.0 109.727 175.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.3 m -91.0 -27.94 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.182 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.86 32.05 21.39 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.267 -171.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.56 144.45 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -71.83 146.5 47.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.234 0.54 . . . . 0.0 111.093 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.795 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.5 pt -134.04 166.71 28.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.266 -171.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -118.44 110.22 39.4 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 158.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.738 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 12.1 Cg_endo -69.28 176.16 6.77 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.441 3.427 . . . . 0.0 114.777 -170.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.678 ' HB2' HG13 ' A' ' 28' ' ' ILE . 40.7 mtt180 -107.02 47.77 0.87 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 113.532 -1.667 . . . . 0.0 106.707 175.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.64 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 1.6 mm? 0.82 -62.62 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.147 0 CA-C-N 111.032 -2.804 . . . . 0.0 117.107 174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 22.1 Cg_exo -35.21 -35.04 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.949 2.433 . . . . 0.0 113.611 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.582 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -112.76 -22.84 10.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.631 -177.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 22.5 m-85 68.48 45.25 1.16 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.026 0.917 . . . . 0.0 110.528 -170.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.678 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -97.53 162.01 2.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.517 172.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.4 t -97.08 146.07 30.69 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.795 ' HD3' HD12 ' A' ' 20' ' ' ILE . 66.9 Cg_endo -79.84 -23.15 7.04 Favored 'Trans proline' 0 CA--C 1.498 -1.315 0 C-N-CA 122.582 2.188 . . . . 0.0 107.785 -174.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.594 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 91.2 mtt-85 -79.21 -35.34 41.84 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 112.683 -2.053 . . . . 0.0 113.556 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.2 p -135.76 -7.74 2.15 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.582 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 11.3 tt0 56.95 31.08 19.17 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.507 0.67 . . . . 0.0 111.511 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.3 m -110.72 145.97 37.11 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.321 170.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.6 52.99 4.81 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.372 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 72.2 m-85 -109.0 43.86 1.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.551 -0.382 . . . . 0.0 110.684 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.68 HG21 ' CD1' ' A' ' 20' ' ' ILE . 11.7 pt -114.31 139.96 37.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.255 -175.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.06 155.52 30.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.36 127.84 39.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.381 0.61 . . . . 0.0 110.747 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.007 -170.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 73.7 mtm . . . . . 0 N--CA 1.463 0.225 0 CA-C-O 121.15 0.5 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.856 HD22 ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -98.58 149.05 23.17 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 172.452 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' C' ' 32' ' ' ILE . 34.2 tt0 -102.17 87.92 3.19 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' C' ' 30' ' ' THR . 2.4 t -77.41 127.05 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.025 -167.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.703 ' HB3' HG12 ' C' ' 81' ' ' VAL . 1.0 OUTLIER -113.05 147.91 36.25 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 170.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' C' ' 82' ' ' ILE . 66.0 t -153.83 114.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -171.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 38.7 mtpt -99.96 172.1 7.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.371 0.605 . . . . 0.0 110.28 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' THR . . . . . 0.442 HG23 HD12 ' C' ' 84' ' ' LEU . 6.1 p . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.814 172.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 53.8 m . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -120.49 158.58 26.96 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.15 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 4.2 p -104.26 147.67 27.22 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.527 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 42.1 m-85 -140.96 63.82 1.44 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.487 0.66 . . . . 0.0 110.314 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.59 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.4 mp -54.88 125.4 9.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 123.215 1.483 . . . . 0.0 114.458 -174.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.562 HG21 HD13 ' C' ' 72' ' ' LEU . 15.4 m -131.81 -170.47 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 111.507 -2.588 . . . . 0.0 111.927 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -113.17 40.27 2.57 Favored Glycine 0 C--N 1.317 -0.498 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.706 -175.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.856 ' HA ' HD22 ' C' ' 17' ' ' LEU . . . 68.9 -50.43 0.59 Allowed 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 124.224 1.01 . . . . 0.0 113.529 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -130.72 23.44 5.03 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' MET . . . . . 0.412 ' HB2' ' H ' ' C' ' 34' ' ' GLY . 2.1 ttt -66.16 -72.27 0.17 Allowed 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.93 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.602 ' O ' ' HD2' ' C' ' 40' ' ' LYS . 37.2 m-80 -129.04 -91.1 0.48 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.613 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.5 OUTLIER 85.19 -40.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 O-C-N 124.5 1.125 . . . . 0.0 110.814 -164.133 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.602 ' HD2' ' O ' ' C' ' 38' ' ' ASN . 0.0 OUTLIER -74.14 -69.48 0.44 Allowed 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 122.449 1.118 . . . . 0.0 108.594 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.08 -26.52 68.59 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.186 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.613 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 5.8 t80 -59.2 -52.65 64.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.753 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.532 ' HD3' ' HB3' ' C' ' 68' ' ' ASP . 7.1 ptmm? -68.58 -38.73 80.94 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.355 0.598 . . . . 0.0 110.974 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' C' ' 54' ' ' SER . 1.3 tm-20 -54.56 -41.52 69.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.138 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -69.67 -51.57 33.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.539 ' O ' HG22 ' C' ' 50' ' ' VAL . 22.5 pt -70.69 -10.01 13.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.341 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.61 -36.63 0.61 Allowed 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.45 -50.57 11.43 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.944 -0.473 . . . . 0.0 111.938 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -28.41 69.47 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.23 0.538 . . . . 0.0 110.79 -176.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.539 HG22 ' O ' ' C' ' 46' ' ' ILE . 6.7 m -96.34 -11.46 8.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.542 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 18.6 m 68.36 19.79 8.82 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 121.55 0.69 . . . . 0.0 109.91 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 3.6 mm -129.35 118.21 19.07 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.856 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.467 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.9 Cg_exo -67.29 148.5 80.2 Favored 'Trans proline' 0 CA--C 1.514 -0.475 0 C-N-CA 122.27 1.98 . . . . 0.0 111.147 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.455 ' OG ' ' HG3' ' C' ' 43' ' ' LYS . 41.8 t -51.19 -33.26 26.66 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.155 0.285 . . . . 0.0 111.748 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.466 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 8.5 pt-20 -66.42 -30.19 70.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.782 0.325 . . . . 0.0 111.441 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.466 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 55.7 mtpt -101.11 -23.79 14.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.071 0.462 . . . . 0.0 110.281 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.44 ' HB2' HG22 ' C' ' 52' ' ' ILE . 7.1 tt0 -76.19 119.44 20.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.058 -172.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -113.91 123.08 48.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.277 170.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.667 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 19.4 mt -89.79 113.87 25.49 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 37' ' ' ILE . 9.2 mt -108.36 126.44 65.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 121.289 -0.882 . . . . 0.0 111.424 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.509 ' CZ ' ' HB3' ' C' ' 80' ' ' LYS . 31.0 t80 -139.12 127.26 22.52 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 169.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 60.67 35.84 19.7 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.547 0.529 . . . . 0.0 110.549 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 71.33 2.28 47.77 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.596 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -89.0 137.86 31.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.87 88.92 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -76.46 128.11 34.16 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -147.33 177.01 9.56 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.905 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.599 ' CB ' ' HA ' ' C' ' 40' ' ' LYS . 4.0 p-10 -65.69 -1.85 3.11 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.105 0.962 . . . . 0.0 113.469 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -81.48 -13.37 58.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -131.32 -154.44 0.63 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.912 -0.493 . . . . 0.0 112.053 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.403 ' HB2' ' HG2' ' C' ' 74' ' ' GLU . 0.3 OUTLIER -108.82 -179.67 3.93 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 175.633 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 2.9 mt -86.27 -34.09 20.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.025 0.44 . . . . 0.0 110.809 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -66.92 -23.72 66.01 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.403 0.681 . . . . 0.0 111.183 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' GLU . . . . . 0.403 ' HG2' ' HB2' ' C' ' 71' ' ' LYS . 20.0 mm-40 -59.39 -28.81 67.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.655 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.638 ' CD1' HD22 ' C' ' 66' ' ' LEU . 34.0 m-85 -105.16 -16.05 14.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.114 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 55.83 52.49 10.68 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.996 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.515 HG23 HG22 ' C' ' 19' ' ' VAL . 28.2 m -93.08 16.6 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.559 -174.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.654 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -64.41 101.47 0.51 Allowed Glycine 0 CA--C 1.481 -2.033 0 CA-C-O 122.774 1.208 . . . . 0.0 112.785 172.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.34 15.13 56.19 Favored Glycine 0 C--N 1.283 -2.378 0 CA-C-N 111.868 -2.166 . . . . 0.0 112.599 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 80' ' ' LYS . . . . . 0.509 ' HB3' ' CZ ' ' C' ' 61' ' ' TYR . 73.1 mmtt -116.37 145.32 43.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 118.85 -0.595 . . . . 0.0 109.638 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.703 HG12 ' HB3' ' C' ' 20' ' ' LEU . 3.1 m -86.7 130.17 37.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.379 173.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' C' ' 21' ' ' VAL . 56.3 mt -88.48 169.17 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.869 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.518 ' N ' HG22 ' C' ' 82' ' ' ILE . 58.4 m80 -112.45 121.94 46.27 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.442 HD12 HG23 ' C' ' 23' ' ' THR . 20.6 mt -78.32 152.71 32.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.971 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.737 HG13 ' CG ' ' A' ' 14' ' ' HIS . 5.7 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.773 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HG2' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.296 0 CA-C-O 121.897 0.856 . . . . 0.0 110.637 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.627 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 5.5 m-85 -118.45 169.8 9.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.264 175.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CB ' HD11 ' A' ' 40' ' ' LEU . 61.9 t80 -138.43 116.11 11.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.595 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -96.36 114.61 26.31 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.808 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.565 ' CD2' HG12 ' C' ' 85' ' ' VAL . 8.9 p80 -73.16 -8.69 56.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.702 0.286 . . . . 0.0 111.406 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 42.6 t -72.6 -32.7 66.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.359 0.6 . . . . 0.0 110.182 173.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.5 m -99.46 -25.9 14.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.391 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER 58.21 31.04 20.3 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.384 -171.236 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.65 144.75 34.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.5 tt0 -64.28 148.34 50.43 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.158 0.286 . . . . 0.0 110.745 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.711 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.2 pt -140.42 166.98 18.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.51 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 74.9 t -125.6 97.32 36.61 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 164.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.627 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 6.5 Cg_endo -55.94 174.91 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 125.06 3.84 . . . . 0.0 115.798 -171.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.495 ' HB2' HG13 ' A' ' 28' ' ' ILE . 5.3 mtt180 -108.62 49.85 0.8 Allowed 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.156 -1.838 . . . . 0.0 106.937 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.455 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.3 mm? 3.92 -61.98 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 110.952 -2.84 . . . . 0.0 117.049 171.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 15.8 Cg_exo -36.96 -33.44 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.69 2.26 . . . . 0.0 113.908 176.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.542 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.93 -22.38 9.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.326 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.461 ' C ' HD11 ' A' ' 37' ' ' ILE . 70.6 m-85 65.28 54.13 1.22 Allowed 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.171 0.986 . . . . 0.0 110.228 -169.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -104.93 161.13 4.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.985 176.131 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.7 t -96.28 145.84 30.26 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 81.7 Cg_endo -82.55 -20.52 5.69 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.702 2.268 . . . . 0.0 108.279 -174.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.416 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 18.2 mtt180 -89.37 -15.3 33.65 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 112.952 -1.931 . . . . 0.0 114.694 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.8 p -151.53 -8.09 0.23 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 10.1 tt0 60.79 25.2 15.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 111.586 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 m -103.36 141.89 35.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 169.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.59 30.87 2.49 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.268 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.528 ' HD2' ' NE2' ' A' ' 14' ' ' HIS . 35.8 m-85 -89.39 52.6 2.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.597 0.713 . . . . 0.0 110.146 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.711 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.6 pt -122.6 134.17 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.598 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HB3' HD13 ' C' ' 60' ' ' ILE . 11.4 pt-20 -119.75 144.03 47.48 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -75.81 138.49 41.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.531 ' HB2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.666 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.2 mt -109.12 134.76 51.28 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.427 0.632 . . . . 0.0 110.543 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.583 ' HA ' HG13 ' C' ' 32' ' ' ILE . 36.9 mt-10 -89.77 93.33 9.4 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.278 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 2.7 t -77.41 124.11 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -171.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.641 ' C ' ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -109.28 146.53 34.13 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 171.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.583 HG22 ' HB ' ' C' ' 82' ' ' ILE . 36.4 t -151.07 125.07 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -172.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.565 ' HE3' HG21 ' C' ' 81' ' ' VAL . 72.2 mttt -110.93 110.98 21.8 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.171 0.51 . . . . 0.0 110.789 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 23' ' ' THR . . . . . 0.484 HG23 ' HB2' ' C' ' 84' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.425 0 CA-C-O 121.614 0.721 . . . . 0.0 110.289 164.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.51 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 71.8 m . . . . . 0 C--O 1.235 0.299 0 CA-C-O 120.958 0.409 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -135.28 159.04 42.8 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.223 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.541 HG22 ' CD2' ' C' ' 20' ' ' LEU . 8.5 p -96.23 148.55 22.61 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.837 -174.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.591 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 34.3 m-85 -140.21 63.05 1.49 Allowed 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.135 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.583 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.7 mp -59.92 120.18 5.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 123.445 1.593 . . . . 0.0 113.838 -175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.465 ' CG2' HD13 ' C' ' 72' ' ' LEU . 15.5 m -138.12 -172.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 111.016 -2.811 . . . . 0.0 111.565 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.69 175.86 34.51 Favored Glycine 0 C--N 1.308 -0.973 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.954 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.752 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -90.55 50.17 1.79 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -169.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.661 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 3.3 mt-30 139.21 2.22 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 O-C-N 125.189 1.555 . . . . 0.0 109.42 -171.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 22.9 tpp -44.95 -70.49 0.1 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.769 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.432 ' CG ' ' HB2' ' C' ' 41' ' ' GLU . 26.9 m-80 -136.98 -99.09 0.2 Allowed 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 174.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.638 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 94.72 -29.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 125.151 1.532 . . . . 0.0 110.293 -162.182 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.612 ' HE2' ' O ' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -79.91 -71.11 0.47 Allowed 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.485 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 41' ' ' GLU . . . . . 0.432 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 40.4 mt-10 -63.01 -28.06 69.84 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.851 174.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.638 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 4.7 t80 -58.51 -54.36 47.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.739 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.54 ' HD3' ' HB3' ' C' ' 68' ' ' ASP . 8.9 ptmm? -69.6 -37.19 76.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.483 0.659 . . . . 0.0 111.209 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' C' ' 54' ' ' SER . 1.2 tm-20 -56.07 -44.18 78.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.225 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -69.77 -39.04 76.91 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.544 ' O ' HG22 ' C' ' 50' ' ' VAL . 20.0 pt -83.1 -6.61 10.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -173.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -38.1 -57.48 1.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.97 -36.05 69.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.073 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -20.51 66.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.861 0.362 . . . . 0.0 111.455 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.544 HG22 ' O ' ' C' ' 46' ' ' ILE . 14.6 m -111.76 -6.36 11.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.429 176.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 35.7 m 70.33 21.14 5.86 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.705 0.628 . . . . 0.0 109.475 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.3 mm -126.03 112.96 24.23 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.131 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.493 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.1 Cg_exo -70.94 145.52 50.56 Favored 'Trans proline' 0 CA--C 1.506 -0.876 0 C-N-CA 122.452 2.101 . . . . 0.0 110.784 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.549 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 1.9 p -54.79 -24.72 23.97 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 123.725 0.64 . . . . 0.0 112.647 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.9 pt-20 -75.12 -33.79 61.61 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.947 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.443 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 38.7 mtpt -98.02 -11.04 23.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.361 0.601 . . . . 0.0 109.503 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.549 ' HB3' ' HA ' ' C' ' 54' ' ' SER . 9.3 tt0 -82.99 119.59 24.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.105 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' C' ' 58' ' ' ARG . 22.2 mtm180 -127.66 126.92 42.85 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 171.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.718 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 22.8 mt -84.85 108.04 17.31 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.443 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.582 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.3 mt -99.95 118.35 46.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.39 173.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -132.37 125.99 32.17 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 171.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 58.37 36.37 25.44 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.209 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 76.63 0.9 69.43 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.489 175.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 16.9 mmm180 -98.13 141.49 30.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -92.72 95.15 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 120.937 0.399 . . . . 0.0 110.399 -176.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -82.96 138.91 33.62 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -147.37 -176.08 5.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.928 0.394 . . . . 0.0 111.446 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.54 ' HB3' ' HD3' ' C' ' 43' ' ' LYS . 2.8 p-10 -69.49 -3.58 15.22 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.593 1.157 . . . . 0.0 113.337 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -75.8 -19.83 58.67 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.612 ' O ' ' HE2' ' C' ' 40' ' ' LYS . 39.5 mtmt -130.56 -147.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -170.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.422 ' HB2' ' HG2' ' C' ' 74' ' ' GLU . 33.8 mmtp -120.35 153.18 36.83 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.795 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.465 HD13 ' CG2' ' C' ' 33' ' ' VAL . 45.4 mt -58.01 -50.73 72.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 73' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 7.3 tp60 -68.3 -22.42 64.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.909 0.385 . . . . 0.0 111.444 -174.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 74' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' C' ' 71' ' ' LYS . 31.1 mm-40 -60.72 -28.89 69.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.273 0.559 . . . . 0.0 109.947 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.506 ' CD1' HD22 ' C' ' 66' ' ' LEU . 39.5 m-85 -93.72 -19.81 20.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.398 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 t30 59.75 38.5 21.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.41 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.428 HG21 HD11 ' C' ' 82' ' ' ILE . 29.3 m -88.73 22.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -73.98 103.35 1.45 Allowed Glycine 0 N--CA 1.428 -1.876 0 CA-C-O 122.786 1.215 . . . . 0.0 112.787 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.51 12.98 46.14 Favored Glycine 0 C--N 1.284 -2.311 0 CA-C-N 112.185 -2.007 . . . . 0.0 115.157 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -128.37 148.27 50.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.273 0.536 . . . . 0.0 110.561 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.641 ' HA ' ' C ' ' C' ' 20' ' ' LEU . 18.4 m -78.54 120.91 30.43 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-O 122.007 0.908 . . . . 0.0 111.599 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.583 ' HB ' HG22 ' C' ' 21' ' ' VAL . 28.1 mt -76.7 166.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.003 173.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.493 ' N ' HG22 ' C' ' 82' ' ' ILE . 52.7 m170 -118.32 116.21 26.28 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.702 -0.624 . . . . 0.0 109.98 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.545 HD21 HD23 ' C' ' 59' ' ' LEU . 11.4 mt -90.81 157.82 17.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.565 HG12 ' CD2' ' A' ' 14' ' ' HIS . 2.4 m . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.987 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 19.5 mtm180 . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 121.402 0.62 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.599 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 14.7 m-85 -125.22 167.39 14.92 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -144.58 121.22 11.13 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.116 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.3 p -91.29 91.89 8.38 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.259 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -56.25 -41.77 76.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.367 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.2 t -55.3 -49.43 72.17 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.427 0.455 . . . . 0.0 112.196 -174.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.54 5.35 44.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.6 0.714 . . . . 0.0 111.559 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.4 p 53.32 58.31 5.36 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.058 1.343 . . . . 0.0 114.266 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -142.77 146.27 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 174.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 28.7 tt0 -89.18 139.42 30.5 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.537 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.972 HD11 HG21 ' A' ' 37' ' ' ILE . 7.0 pt -143.9 168.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -163.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.451 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 42.2 t -118.99 100.78 50.59 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 114.332 -1.304 . . . . 0.0 107.536 161.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.705 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . 1.2 Cg_endo -53.09 177.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.853 1 C-N-CA 126.078 4.519 . . . . 0.0 118.669 -168.466 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.522 ' HB2' HG13 ' A' ' 28' ' ' ILE . 62.9 mtt180 -117.94 50.81 1.11 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 111.34 -2.663 . . . . 0.0 107.388 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.433 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.6 mm? -8.71 -57.87 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 127.703 2.401 . . . . 0.0 117.325 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -32.98 -34.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 123.513 2.809 . . . . 0.0 114.378 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.584 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -124.42 -18.48 5.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.536 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.528 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 49.3 m-85 69.98 42.98 0.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.189 -171.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.584 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -91.33 165.19 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.119 174.133 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.471 ' CB ' HD13 ' A' ' 20' ' ' ILE . 25.2 p -95.49 144.06 27.18 Favored Pre-proline 0 N--CA 1.432 -1.338 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.636 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 44.1 Cg_endo -83.25 -22.55 3.96 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 123.278 2.652 . . . . 0.0 109.151 -168.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.528 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 60.0 mtt180 -81.96 -24.83 35.3 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 112.689 -2.051 . . . . 0.0 113.054 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.08 11.23 0.07 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 49.63 66.86 1.0 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.28 145.77 43.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.452 167.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -85.63 33.68 3.44 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.47 -174.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -108.95 52.03 0.72 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.133 0.492 . . . . 0.0 111.068 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.972 HG21 HD11 ' A' ' 20' ' ' ILE . 3.7 pt -111.58 138.86 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.77 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' HB2' HG22 ' C' ' 65' ' ' VAL . 2.9 pt-20 -116.39 147.71 41.37 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -80.25 122.46 26.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.852 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.599 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 41.6 tpp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.383 0.611 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.899 HD22 ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -102.09 145.97 28.58 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.524 ' HA ' HG13 ' C' ' 32' ' ' ILE . 43.2 tt0 -97.91 91.88 5.55 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 170.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' C' ' 30' ' ' THR . 4.5 t -76.82 98.68 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.099 -170.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.61 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.4 mt -87.28 132.97 33.75 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' C' ' 82' ' ' ILE . 88.0 t -145.05 120.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.158 0.504 . . . . 0.0 110.322 -173.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.734 ' HG2' ' OG1' ' C' ' 28' ' ' THR . 44.4 mtpt -92.1 144.27 25.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 23' ' ' THR . . . . . 0.537 HG22 ' HB2' ' C' ' 84' ' ' LEU . 18.6 p . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.734 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 19.9 m . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -121.07 150.14 41.65 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.94 0.4 . . . . 0.0 110.885 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.8 p -99.56 144.82 28.2 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.241 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.471 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 34.2 m-85 -132.58 60.18 1.7 Allowed 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.614 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.5 mp -57.96 118.85 2.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 123.06 1.41 . . . . 0.0 114.367 -173.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.474 HG11 ' HD2' ' C' ' 42' ' ' PHE . 16.6 m -138.36 170.51 16.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 111.625 -2.534 . . . . 0.0 112.593 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' C' ' 37' ' ' MET . . . -84.88 50.33 4.38 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.08 -1.418 . . . . 0.0 114.188 -168.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.899 ' HA ' HD22 ' C' ' 17' ' ' LEU . . . 65.39 -48.2 0.37 Allowed 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 124.255 1.022 . . . . 0.0 113.482 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.512 ' HA ' ' HB3' ' C' ' 71' ' ' LYS . 24.4 pt20 -139.82 26.04 2.31 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -164.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 37' ' ' MET . . . . . 0.419 ' HB2' ' H ' ' C' ' 34' ' ' GLY . 1.7 tmt? -59.64 -70.99 0.14 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 111.63 -2.532 . . . . 0.0 111.019 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.424 ' O ' ' HB ' ' C' ' 39' ' ' VAL . 13.5 m-80 -144.23 -92.02 0.11 Allowed 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.679 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 96.44 -29.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 O-C-N 125.702 1.876 . . . . 0.0 110.891 -166.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' C' ' 70' ' ' LYS . 0.9 OUTLIER -80.44 -71.39 0.46 Allowed 'General case' 0 N--CA 1.423 -1.813 0 CA-C-O 122.158 0.98 . . . . 0.0 108.859 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.89 -26.59 68.67 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 113.754 -1.567 . . . . 0.0 111.239 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.679 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.6 OUTLIER -59.37 -51.6 69.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.984 174.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.519 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 17.7 mtpp -63.51 -42.06 98.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.96 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -56.14 -37.0 68.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.282 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -69.76 -47.35 63.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.807 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.641 ' O ' HG22 ' C' ' 50' ' ' VAL . 7.4 pt -74.45 -11.46 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.994 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.5 -58.39 2.27 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.64 -37.53 67.96 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.845 -175.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -36.66 83.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.102 0.477 . . . . 0.0 110.648 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.641 HG22 ' O ' ' C' ' 46' ' ' ILE . 24.5 m -98.68 -1.71 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.946 177.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p 60.66 26.58 16.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.014 0.911 . . . . 0.0 109.533 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.3 mm -128.59 113.74 19.36 Favored Pre-proline 0 N--CA 1.434 -1.269 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.099 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 3.7 Cg_exo -69.98 143.65 50.43 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.131 1.888 . . . . 0.0 111.525 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.508 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 35.3 t -51.58 -24.72 5.71 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.331 1.02 . . . . 0.0 112.286 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.48 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.6 pt-20 -72.41 -43.71 63.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.604 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.48 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 96.6 mttt -88.2 -29.13 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.856 0.836 . . . . 0.0 109.382 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.519 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 19.3 tt0 -57.62 131.61 50.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.401 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -136.38 123.76 22.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.876 175.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.523 ' HB3' HG21 ' C' ' 82' ' ' ILE . 46.4 mt -86.73 104.36 16.05 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.098 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.565 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.0 mt -101.94 116.98 46.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.884 -0.51 . . . . 0.0 111.251 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -127.2 113.89 16.94 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 173.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 60.96 43.08 11.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.24 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 72.99 -4.58 22.81 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.142 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -88.32 125.39 34.66 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -87.92 88.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.283 0.564 . . . . 0.0 109.816 -176.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.663 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.5 OUTLIER -68.55 133.69 48.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.104 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -142.65 -176.92 5.06 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.641 -170.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.599 ' HA ' HG13 ' C' ' 39' ' ' VAL . 11.4 p-10 -71.88 -0.61 11.76 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.22 1.008 . . . . 0.0 112.627 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -79.89 -21.93 43.42 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.443 ' O ' ' HE3' ' C' ' 40' ' ' LYS . 68.7 mttt -123.93 -148.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -167.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' C' ' 36' ' ' GLN . 0.0 OUTLIER -127.17 163.58 23.54 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.083 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 2.9 mm? -66.25 -36.99 84.45 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 118.482 0.583 . . . . 0.0 111.167 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 73' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' C' ' 35' ' ' ALA . 35.0 tt0 -70.66 -18.15 62.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.858 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' GLU . . . . . 0.426 ' HG3' ' HB3' ' C' ' 70' ' ' LYS . 16.9 mm-40 -64.72 -28.84 69.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.464 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.663 ' CD1' HD22 ' C' ' 66' ' ' LEU . 17.8 m-85 -95.54 -22.52 17.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.867 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 t30 63.77 52.35 2.2 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 123.038 1.399 . . . . 0.0 107.76 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.69 -0.86 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 CA-C-N 112.78 -2.009 . . . . 0.0 112.705 -162.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.553 ' CA ' ' HG ' ' C' ' 17' ' ' LEU . . . -47.3 102.45 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.403 0 CA-C-O 122.904 1.28 . . . . 0.0 114.37 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.18 14.29 56.23 Favored Glycine 0 C--N 1.287 -2.188 0 CA-C-N 111.725 -2.237 . . . . 0.0 114.265 170.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -117.23 142.43 47.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.809 0.305 . . . . 0.0 110.25 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.642 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 15.6 m -79.34 124.13 37.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.676 0.751 . . . . 0.0 112.596 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.658 HD13 HD12 ' C' ' 66' ' ' LEU . 25.5 mt -86.87 168.71 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.487 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.501 ' N ' HG22 ' C' ' 82' ' ' ILE . 46.2 m-70 -119.3 115.65 24.6 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 121.965 -0.459 . . . . 0.0 110.168 174.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.537 ' HB2' HG22 ' C' ' 23' ' ' THR . 11.3 mt -91.52 144.64 25.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.103 0.478 . . . . 0.0 111.235 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.837 -176.815 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.667 ' HG2' HD12 ' A' ' 40' ' ' LEU . 38.5 ttt180 . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.929 0.395 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.532 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 8.6 m-85 -117.93 141.21 48.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.955 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.424 ' HB2' HD11 ' A' ' 40' ' ' LEU . 74.4 t80 -112.61 115.69 29.0 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.436 170.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.691 ' HB2' HG22 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -91.11 118.99 30.88 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.094 174.037 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -80.38 -7.89 59.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.263 -174.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 7.9 t -72.04 -51.52 21.32 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.911 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' HG23 ' A' ' 18' ' ' VAL . 26.9 p -100.94 2.97 41.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.312 0.577 . . . . 0.0 110.324 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p 54.4 45.43 27.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.812 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 16' ' ' CYS . 21.7 t -141.61 147.89 21.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.626 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.58 142.1 42.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.561 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.73 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.9 pt -133.17 167.05 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.703 0.763 . . . . 0.0 112.916 -170.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.9 t -117.79 108.31 42.99 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.303 160.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 19.1 Cg_endo -70.19 176.14 7.5 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 124.404 3.402 . . . . 0.0 116.552 -166.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HB2' HG13 ' A' ' 28' ' ' ILE . 62.6 mtt180 -114.05 49.17 1.02 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 112.924 -1.944 . . . . 0.0 107.802 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.428 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.6 mm? -0.44 -61.74 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.124 0 CA-C-N 111.308 -2.678 . . . . 0.0 117.763 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -32.38 -36.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.377 2.718 . . . . 0.0 114.397 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.553 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.98 -19.76 9.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.786 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.428 ' CE1' HD13 ' A' ' 24' ' ' LEU . 56.4 m-85 66.91 46.23 1.67 Allowed 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.227 -169.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.553 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -92.09 164.04 2.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 113.82 -1.537 . . . . 0.0 110.341 174.367 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.435 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -96.41 144.11 27.28 Favored Pre-proline 0 C--N 1.306 -1.303 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.015 177.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.73 ' HD3' HD12 ' A' ' 20' ' ' ILE . 47.5 Cg_endo -84.87 -15.91 5.57 Favored 'Trans proline' 0 CA--C 1.5 -1.212 0 C-N-CA 123.55 2.833 . . . . 0.0 108.627 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 85.7 mtt-85 -91.21 -14.18 31.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.177 -1.829 . . . . 0.0 114.0 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.4 p -163.33 3.77 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG2' HG21 ' A' ' 28' ' ' ILE . 17.7 tt0 55.41 36.91 28.09 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.542 0.687 . . . . 0.0 112.162 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.449 ' HB3' ' CD2' ' A' ' 36' ' ' PHE . 16.7 m -116.81 136.43 52.96 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.493 172.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.67 28.26 2.46 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.086 -0.578 . . . . 0.0 113.925 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 80.0 m-85 -86.57 44.24 1.14 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.087 0.47 . . . . 0.0 109.799 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.713 HG21 ' CD1' ' A' ' 20' ' ' ILE . 19.6 pt -110.86 132.79 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.104 -176.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.428 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.9 pt-20 -121.7 139.81 53.09 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -76.35 128.64 35.25 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.667 HD12 ' HG2' ' A' ' 10' ' ' ARG . 13.0 mt . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.319 -167.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' C' ' 35' ' ' ALA . 26.1 ttt . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.759 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -102.08 140.43 36.36 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.786 -179.061 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.588 ' HA ' HG13 ' C' ' 32' ' ' ILE . 4.6 mt-10 -97.21 90.75 5.23 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.966 174.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 24.4 t -78.61 76.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 123.31 1.529 . . . . 0.0 111.019 -169.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.902 ' HB3' HG12 ' C' ' 81' ' ' VAL . 4.3 mt -69.98 140.37 52.94 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.56 HG22 ' HB ' ' C' ' 82' ' ' ILE . 47.4 t -153.44 115.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.986 0.422 . . . . 0.0 110.131 -169.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 34.8 mtpt -98.9 125.44 44.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.317 -0.827 0 CA-C-O 121.031 0.443 . . . . 0.0 111.467 177.45 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 97.5 m . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 120.761 0.315 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' C' ' 29' ' ' ARG . 66.2 mtt180 -128.09 150.06 50.13 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.094 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.503 ' OG1' HD23 ' C' ' 20' ' ' LEU . 0.2 OUTLIER -97.09 139.94 32.34 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.626 -176.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.605 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 38.0 m-85 -127.0 67.67 1.27 Allowed 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.613 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.588 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -58.78 120.63 4.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 123.384 1.564 . . . . 0.0 114.189 -174.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' C' ' 42' ' ' PHE . 17.8 m -136.99 -170.3 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 110.94 -2.846 . . . . 0.0 110.812 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.447 ' O ' HD22 ' C' ' 17' ' ' LEU . . . -88.93 176.74 44.32 Favored Glycine 0 C--N 1.307 -1.06 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.773 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.759 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -68.73 -17.66 64.09 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 117.818 0.809 . . . . 0.0 112.286 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -163.73 27.07 0.08 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -55.58 -76.53 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 112.019 -2.355 . . . . 0.0 111.219 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.58 ' O ' HG12 ' C' ' 39' ' ' VAL . 83.8 m-20 -128.79 -84.9 0.57 Allowed 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.355 174.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.723 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 88.12 -28.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 125.594 1.809 . . . . 0.0 111.646 -167.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -72.6 0.5 Allowed 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.013 0.911 . . . . 0.0 109.402 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.2 -27.86 67.5 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.368 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.56 ' HZ ' HG11 ' C' ' 19' ' ' VAL . 0.6 OUTLIER -62.25 -50.32 72.21 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.35 174.53 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.671 ' HD2' ' O ' ' C' ' 39' ' ' VAL . 0.0 OUTLIER -58.37 -43.16 88.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.089 0.471 . . . . 0.0 110.756 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -57.03 -34.24 68.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.523 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -70.9 -44.51 66.09 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.691 ' O ' HG22 ' C' ' 50' ' ' VAL . 21.5 pt -77.98 -16.77 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.835 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.06 -49.61 2.56 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.06 -42.49 60.12 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.797 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -16.6 63.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.925 0.393 . . . . 0.0 110.976 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.691 HG22 ' O ' ' C' ' 46' ' ' ILE . 29.0 m -112.06 -9.1 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.891 176.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t 70.62 19.79 5.98 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.768 0.794 . . . . 0.0 109.283 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.7 mm -128.48 110.03 19.23 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.873 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.544 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 6.4 Cg_exo -68.37 146.82 70.09 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.173 1.915 . . . . 0.0 111.09 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -54.91 -25.7 30.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.898 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.483 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.7 pt-20 -75.31 -18.01 60.13 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 111.082 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.483 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 98.7 mttt -120.29 -0.95 10.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.401 . . . . 0.0 110.773 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.681 ' OE1' HD11 ' C' ' 46' ' ' ILE . 0.0 OUTLIER -93.1 126.18 38.07 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.335 -175.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.456 ' NH2' HG11 ' C' ' 65' ' ' VAL . 66.5 mtp85 -122.35 123.6 41.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.05 173.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.607 ' HB3' HG21 ' C' ' 82' ' ' ILE . 2.1 mm? -92.25 104.49 16.85 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.734 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.613 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.6 mt -101.64 122.93 54.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.893 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.457 ' OH ' ' HD3' ' C' ' 80' ' ' LYS . 29.5 t80 -135.24 131.94 37.24 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 171.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 48.44 38.78 11.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.033 -172.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.88 6.4 63.58 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.848 -0.615 . . . . 0.0 113.169 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' C' ' 64' ' ' ARG . 4.2 mmp_? -98.16 133.52 42.49 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.456 HG11 ' NH2' ' C' ' 58' ' ' ARG . 0.6 OUTLIER -88.17 94.45 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.265 0.555 . . . . 0.0 110.471 -176.002 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.3 OUTLIER -82.66 156.1 24.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 67' ' ' GLN . . . . . 0.482 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 16.4 pt20 -169.97 -169.12 0.83 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.601 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.723 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.3 p-10 -62.41 -0.02 0.52 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.771 0.828 . . . . 0.0 112.228 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' ASP . . . . . 0.482 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 28.9 t70 -63.38 -4.33 2.6 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.016 0.926 . . . . 0.0 112.782 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.476 ' HA ' HG11 ' C' ' 39' ' ' VAL . 51.5 mtmt 83.55 167.89 0.1 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 169.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.435 ' HB3' ' HG3' ' C' ' 74' ' ' GLU . 13.9 mptt 67.35 79.12 0.23 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.939 -178.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 20.8 mt -62.27 -33.23 74.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.648 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -69.36 -19.03 63.84 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 122.696 0.399 . . . . 0.0 112.005 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 74' ' ' GLU . . . . . 0.435 ' HG3' ' HB3' ' C' ' 71' ' ' LYS . 32.1 mt-10 -73.05 -27.85 61.98 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.535 ' CD1' HD22 ' C' ' 66' ' ' LEU . 15.7 m-85 -87.97 -21.99 24.54 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.4 t30 58.89 40.37 22.73 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.709 174.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.512 HG11 HD11 ' C' ' 82' ' ' ILE . 17.4 m -87.92 10.22 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.84 -171.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -60.91 99.48 0.2 Allowed Glycine 0 CA--C 1.488 -1.6 0 CA-C-O 122.785 1.214 . . . . 0.0 113.226 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 79' ' ' GLY . . . . . 0.41 ' C ' HD12 ' C' ' 20' ' ' LEU . . . 94.35 15.25 48.17 Favored Glycine 0 C--N 1.284 -2.357 0 CA-C-N 112.091 -2.055 . . . . 0.0 114.132 172.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' LYS . . . . . 0.457 ' HD3' ' OH ' ' C' ' 61' ' ' TYR . 55.2 mttm -126.75 140.47 52.36 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.902 HG12 ' HB3' ' C' ' 20' ' ' LEU . 33.9 m -75.83 134.02 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.854 0.835 . . . . 0.0 110.732 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.607 HG21 ' HB3' ' C' ' 59' ' ' LEU . 59.4 mt -89.78 169.8 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.969 172.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.524 ' N ' HG22 ' C' ' 82' ' ' ILE . 56.8 m80 -115.95 112.38 21.77 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.474 HD12 ' N ' ' C' ' 85' ' ' VAL . 13.7 tp -97.83 130.63 44.74 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 121.218 0.533 . . . . 0.0 110.296 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.474 ' N ' HD12 ' C' ' 84' ' ' LEU . 30.6 m . . . . . 0 C--N 1.311 -1.102 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.978 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 C--O 1.233 0.216 0 CA-C-O 121.483 0.659 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.691 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.6 m-85 -115.42 166.2 12.14 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.141 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.592 ' HB2' HD11 ' A' ' 40' ' ' LEU . 39.0 t80 -140.64 119.44 12.53 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.317 178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -95.9 107.12 19.35 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.782 177.037 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.42 ' CD2' HG21 ' C' ' 85' ' ' VAL . 20.2 p-80 -62.23 -15.73 48.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.808 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 7.0 t -71.71 -31.12 66.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.645 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.1 m -98.65 -26.14 14.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.156 0.503 . . . . 0.0 110.607 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.37 28.55 15.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.345 -171.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.68 143.53 40.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 36.9 tt0 -71.82 148.39 46.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.11 0.481 . . . . 0.0 110.831 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.727 HD11 HG21 ' A' ' 37' ' ' ILE . 3.6 pt -138.68 167.04 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.719 -170.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 20.9 t -123.36 96.85 43.46 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 163.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.691 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 9.2 Cg_endo -56.0 176.16 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.872 1 C-N-CA 125.328 4.018 . . . . 0.0 116.529 -170.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.74 ' HB2' HG13 ' A' ' 28' ' ' ILE . 24.5 mtt180 -110.25 49.82 0.83 Allowed 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 112.488 -2.142 . . . . 0.0 107.692 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -0.75 -58.25 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 CA-C-N 111.21 -2.723 . . . . 0.0 117.047 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 18.6 Cg_exo -37.15 -31.19 0.12 Allowed 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.88 2.387 . . . . 0.0 114.074 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.554 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -123.69 -19.88 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.357 0.599 . . . . 0.0 111.765 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.436 ' C ' HD11 ' A' ' 37' ' ' ILE . 47.0 m-85 67.34 45.49 1.61 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.28 -171.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.74 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.4 OUTLIER -92.43 160.45 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.723 173.489 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -96.0 144.64 28.18 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.662 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 96.8 Cg_endo -79.52 -21.55 8.66 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 122.672 2.248 . . . . 0.0 108.049 -172.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.1 mtt-85 -79.92 -37.79 33.87 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 112.561 -2.109 . . . . 0.0 113.567 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.0 p -133.75 -6.92 2.81 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.463 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 59.32 30.91 20.71 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.509 0.671 . . . . 0.0 111.661 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 m -111.48 144.24 41.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.467 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.23 41.06 2.6 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.109 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 60.5 m-85 -96.04 46.02 1.08 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.106 0.479 . . . . 0.0 109.934 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.727 HG21 HD11 ' A' ' 20' ' ' ILE . 3.5 pt -113.31 134.63 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.796 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB3' HD13 ' C' ' 60' ' ' ILE . 0.7 OUTLIER -119.14 141.69 48.6 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -79.9 137.27 36.86 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.455 -175.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.538 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 26.5 ptt? . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.187 0.518 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.9 mt -105.04 132.15 51.64 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.562 ' HA ' ' CG1' ' C' ' 32' ' ' ILE . 49.3 mt-10 -81.51 94.39 6.86 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.58 HG22 HG23 ' C' ' 77' ' ' VAL . 9.4 t -80.67 116.53 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.925 -171.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.573 ' CB ' HG12 ' C' ' 81' ' ' VAL . 0.8 OUTLIER -107.5 144.9 33.8 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 175.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' C' ' 28' ' ' THR . 3.5 m -137.02 147.64 26.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.567 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 37.0 mtpt -120.29 123.64 43.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--N 1.315 -0.93 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.789 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 71.7 m . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 121.017 0.437 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -133.11 153.42 51.54 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.425 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.568 HG22 ' CD2' ' C' ' 20' ' ' LEU . 16.3 p -100.11 151.4 21.44 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -170.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.634 ' HE2' HG21 ' C' ' 21' ' ' VAL . 26.8 m-85 -141.43 55.56 1.52 Allowed 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.246 -175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.562 ' CG1' ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -60.95 120.84 7.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 123.407 1.575 . . . . 0.0 113.801 -174.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.6 m -138.03 -168.76 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 110.729 -2.942 . . . . 0.0 111.446 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -76.94 -158.96 9.39 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.052 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.566 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -110.13 23.64 14.06 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 120.9 0.381 . . . . 0.0 111.371 -177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 39.6 tt0 166.19 -17.47 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.418 -163.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -41.25 -64.86 0.5 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.48 1.113 . . . . 0.0 112.262 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.465 ' O ' HG12 ' C' ' 39' ' ' VAL . 66.1 m-20 -131.0 -95.01 0.37 Allowed 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.677 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 86.0 -30.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 O-C-N 125.041 1.463 . . . . 0.0 110.819 -162.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.79 -70.28 0.55 Allowed 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.228 1.013 . . . . 0.0 109.095 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 41' ' ' GLU . . . . . 0.44 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 43.7 mt-10 -62.03 -26.66 68.37 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.393 173.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.755 ' O ' HG23 ' C' ' 46' ' ' ILE . 0.2 OUTLIER -56.82 -53.71 54.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.255 172.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.448 ' N ' ' HD1' ' C' ' 42' ' ' PHE . 18.8 mtpp -61.79 -41.89 98.32 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.521 0.677 . . . . 0.0 110.721 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -58.46 -40.28 82.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.662 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -69.92 -44.82 68.87 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.027 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.755 HG23 ' O ' ' C' ' 42' ' ' PHE . 4.3 pt -75.22 -13.23 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.792 -0.185 . . . . 0.0 111.225 -172.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -43.49 -45.64 6.52 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.33 -43.09 34.23 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.892 -0.505 . . . . 0.0 111.804 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -20.28 63.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.516 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.655 HG22 ' O ' ' C' ' 46' ' ' ILE . 31.5 m -112.07 -6.68 11.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t 68.85 19.72 8.23 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.724 0.773 . . . . 0.0 109.018 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.64 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 8.6 mm -125.71 112.42 25.06 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.385 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.602 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 4.7 Cg_exo -69.73 146.31 59.97 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.138 1.892 . . . . 0.0 111.494 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.3 p -53.0 -24.82 10.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.476 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 12.8 pt-20 -77.27 -32.37 55.56 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.36 0.412 . . . . 0.0 111.894 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -97.92 -19.93 17.77 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 109.847 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' C' ' 53' ' ' PRO . 25.8 tt0 -66.52 123.26 19.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.92 -170.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 43.5 mtp85 -124.93 115.4 20.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.204 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.593 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 51.6 mt -86.96 111.41 20.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.979 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 38' ' ' GLU . 5.6 mt -109.93 113.63 44.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 O-C-N 121.568 -0.707 . . . . 0.0 112.01 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' C' ' 66' ' ' LEU . 21.1 t80 -129.38 126.89 39.86 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 60.5 34.17 20.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.022 0.439 . . . . 0.0 110.379 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.99 5.44 40.09 Favored Glycine 0 N--CA 1.453 -0.211 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.899 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -87.43 133.4 33.74 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.97 87.6 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.261 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.602 ' HB3' ' CD2' ' C' ' 75' ' ' TYR . 0.8 OUTLIER -68.28 141.63 55.81 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.458 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 67' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' C' ' 69' ' ' ASP . 10.6 pt20 -155.4 -168.97 3.0 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.684 -0.406 . . . . 0.0 109.955 -173.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.677 ' HA ' HG13 ' C' ' 39' ' ' VAL . 8.9 p-10 -67.43 0.24 3.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.608 0.763 . . . . 0.0 112.577 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' ASP . . . . . 0.441 ' H ' ' HG3' ' C' ' 67' ' ' GLN . 29.1 t70 -64.17 -4.02 3.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.521 0.729 . . . . 0.0 112.846 -174.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.416 ' H ' HG11 ' C' ' 39' ' ' VAL . 49.2 mttp 81.95 177.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.951 0.9 . . . . 0.0 111.865 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.421 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 65.5 mttm 74.66 75.12 0.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.145 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.473 HD12 ' H ' ' C' ' 36' ' ' GLN . 56.6 mt -65.01 -45.39 85.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.292 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -69.55 -25.84 64.2 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 74' ' ' GLU . . . . . 0.421 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 69.3 mm-40 -67.46 -24.71 65.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.575 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.602 ' CD2' ' HB3' ' C' ' 66' ' ' LEU . 6.9 m-30 -86.42 -10.21 54.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.447 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 1.3 m120 47.89 35.33 4.75 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.328 1.051 . . . . 0.0 113.471 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.58 HG23 HG22 ' C' ' 19' ' ' VAL . 16.5 m -90.55 16.19 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -175.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.556 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -73.18 102.78 1.29 Allowed Glycine 0 N--CA 1.431 -1.658 0 CA-C-O 122.792 1.218 . . . . 0.0 112.082 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.21 14.59 62.01 Favored Glycine 0 C--N 1.283 -2.401 0 CA-C-N 112.052 -2.074 . . . . 0.0 113.045 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -124.23 147.5 48.01 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.573 HG12 ' CB ' ' C' ' 20' ' ' LEU . 34.0 m -84.13 124.26 39.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 121.971 0.891 . . . . 0.0 112.313 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.52 HG22 ' N ' ' C' ' 83' ' ' HIS . 74.0 mt -77.77 171.6 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.433 173.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.52 ' N ' HG22 ' C' ' 82' ' ' ILE . 45.5 m80 -118.85 119.52 34.62 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.465 -0.772 . . . . 0.0 109.775 170.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.468 HD12 ' H ' ' C' ' 85' ' ' VAL . 25.9 tp -100.59 145.14 28.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -171.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.468 ' H ' HD12 ' C' ' 84' ' ' LEU . 2.8 p . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.481 0.658 . . . . 0.0 109.973 171.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 16.7 ptp180 . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 122.353 1.073 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.69 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 8.4 m-85 -116.79 164.59 14.43 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.819 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.611 ' CB ' HD21 ' A' ' 40' ' ' LEU . 54.5 t80 -138.98 112.58 8.3 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.572 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.596 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -91.9 110.52 21.87 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.474 ' CG ' HG13 ' C' ' 85' ' ' VAL . 9.8 p80 -69.15 -17.98 63.89 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -169.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 13.5 p -73.33 -39.11 65.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.255 174.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.7 m -78.19 -29.68 48.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.321 0.581 . . . . 0.0 110.646 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER 58.58 28.8 17.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.694 -176.462 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.54 146.23 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.69 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.1 tt0 -70.06 144.53 52.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.231 0.538 . . . . 0.0 111.034 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.719 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.2 pt -132.08 167.91 25.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.77 -175.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 14.1 t -125.28 95.01 42.17 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 164.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 3.5 Cg_endo -54.28 175.85 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.842 1 C-N-CA 125.423 4.082 . . . . 0.0 116.973 -169.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.709 ' HB2' HG13 ' A' ' 28' ' ' ILE . 37.8 mtt180 -107.5 48.32 0.85 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 112.565 -2.107 . . . . 0.0 107.023 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 0.79 -61.71 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.116 0 CA-C-N 110.811 -2.904 . . . . 0.0 117.253 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -32.18 -36.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 123.553 2.835 . . . . 0.0 113.819 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.531 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -115.68 -22.62 9.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.181 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.513 ' C ' HD11 ' A' ' 37' ' ' ILE . 58.4 m-85 68.1 58.6 0.46 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.406 1.098 . . . . 0.0 110.32 -168.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.709 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -110.71 162.57 8.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.304 176.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.5 t -96.16 146.61 31.61 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.624 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 67.6 Cg_endo -81.6 -22.3 5.6 Favored 'Trans proline' 0 CA--C 1.5 -1.224 0 C-N-CA 122.606 2.204 . . . . 0.0 108.031 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.539 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 68.5 mtt-85 -81.7 -25.14 35.73 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 112.892 -1.958 . . . . 0.0 113.752 -177.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.6 p -146.23 -7.25 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.637 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 60.35 32.35 20.65 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.744 0.783 . . . . 0.0 111.033 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.1 m -113.19 146.39 39.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.744 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.57 37.64 2.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.14 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 87.8 m-85 -92.34 38.77 1.01 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.255 0.55 . . . . 0.0 110.041 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.719 HG21 ' CD1' ' A' ' 20' ' ' ILE . 7.1 pt -110.94 133.67 55.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.614 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HB2' HG22 ' C' ' 65' ' ' VAL . 10.5 pt-20 -121.95 136.15 54.91 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 172.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.26 135.9 40.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.219 0.533 . . . . 0.0 109.692 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.611 HD21 ' CB ' ' A' ' 12' ' ' PHE . 8.7 mt . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.328 -171.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -104.08 147.87 26.91 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.294 0.569 . . . . 0.0 109.524 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.499 ' HA ' HG13 ' C' ' 32' ' ' ILE . 4.5 mt-10 -106.86 83.55 1.86 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' C' ' 30' ' ' THR . 4.2 t -72.06 143.63 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.441 -166.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 1.018 ' HB3' HG12 ' C' ' 81' ' ' VAL . 7.9 mt -128.65 156.71 43.0 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' C' ' 28' ' ' THR . 21.5 m -145.36 152.89 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.601 ' HG3' ' CB ' ' C' ' 81' ' ' VAL . 35.7 mtpt -138.24 110.44 7.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.952 0.501 . . . . 0.0 109.983 173.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 120.869 0.366 . . . . 0.0 111.072 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.734 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 51.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' C' ' 20' ' ' LEU . 83.8 mtt180 -130.71 168.18 17.6 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.77 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 2.1 p -108.52 148.32 30.43 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.658 ' HE2' HG21 ' C' ' 21' ' ' VAL . 40.6 m-85 -139.73 65.07 1.44 Allowed 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.44 0.638 . . . . 0.0 110.365 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.574 HG23 ' O ' ' C' ' 17' ' ' LEU . 2.5 mp -55.23 118.45 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 123.214 1.483 . . . . 0.0 113.776 -176.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.41 HG13 ' O ' ' C' ' 31' ' ' PHE . 19.7 m -136.94 -171.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 111.347 -2.661 . . . . 0.0 111.209 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.08 157.18 20.07 Favored Glycine 0 C--N 1.307 -1.082 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.144 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.795 ' HA ' HD21 ' C' ' 17' ' ' LEU . . . -63.42 -18.78 64.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -172.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -147.74 22.47 1.13 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -75.53 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.224 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.609 ' O ' HG12 ' C' ' 39' ' ' VAL . 88.0 m-20 -128.74 -91.94 0.47 Allowed 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.664 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 82.04 -28.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.035 1.459 . . . . 0.0 112.12 -166.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' C' ' 43' ' ' LYS . 0.0 OUTLIER -80.77 -68.96 0.64 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.557 1.17 . . . . 0.0 108.78 174.349 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.53 -29.62 70.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.476 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.618 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -62.18 -53.21 58.57 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.184 175.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.651 ' HG2' ' O ' ' C' ' 40' ' ' LYS . 3.3 ptmt -67.3 -34.1 76.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.192 0.52 . . . . 0.0 110.136 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.512 ' HA ' ' HB3' ' C' ' 54' ' ' SER . 16.7 tt0 -59.46 -37.01 77.07 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.657 175.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -69.98 -40.73 75.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.925 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.617 ' O ' HG22 ' C' ' 50' ' ' VAL . 18.4 pt -81.46 -7.64 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -174.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.24 -59.76 1.44 Allowed 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.24 -34.54 70.86 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.849 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -28.22 69.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.617 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.4 m -106.16 -2.75 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 29.0 m 69.53 19.61 7.42 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.536 0.684 . . . . 0.0 109.586 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.6 mm -127.65 117.12 21.08 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.165 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.522 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.0 Cg_exo -68.75 149.8 73.45 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.636 1.558 . . . . 0.0 111.751 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.544 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 29.6 p -53.88 -25.72 21.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.254 -176.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -79.68 -13.6 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -116.24 -33.04 5.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.639 ' OE1' ' HB2' ' C' ' 43' ' ' LYS . 8.7 pt20 -65.33 129.61 40.35 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.985 0.898 . . . . 0.0 111.997 -173.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' C' ' 84' ' ' LEU . 38.5 mmt180 -115.51 116.06 27.55 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.761 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.709 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 11.7 mt -84.23 106.01 15.52 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.346 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.53 HG21 ' O ' ' A' ' 37' ' ' ILE . 26.6 mt -99.1 118.53 45.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.534 -0.729 . . . . 0.0 111.69 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.444 ' OH ' ' HG2' ' C' ' 80' ' ' LYS . 64.5 t80 -135.19 130.2 34.95 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 62' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' C' ' 61' ' ' TYR . 48.1 mt-30 61.8 33.62 17.65 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.053 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 63' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 68.3 4.58 37.8 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.43 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -99.17 133.41 43.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -89.99 88.68 2.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.314 0.578 . . . . 0.0 110.013 -175.716 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.709 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.1 OUTLIER -67.93 155.18 40.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.162 178.706 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 67' ' ' GLN . . . . . 0.415 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.5 pt20 -161.95 -167.19 1.6 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.686 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.664 ' HA ' HG13 ' C' ' 39' ' ' VAL . 1.5 p-10 -58.81 -2.48 0.23 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.041 0.936 . . . . 0.0 112.893 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 69' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 27.8 t70 -62.25 -9.12 6.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.574 0.75 . . . . 0.0 112.573 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.518 ' H ' HG11 ' C' ' 39' ' ' VAL . 37.5 mtmm 78.81 174.9 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.758 0.823 . . . . 0.0 112.41 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.491 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 32.6 mtmm 78.6 71.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 124.209 0.943 . . . . 0.0 111.362 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 3.5 mm? -62.19 -44.14 97.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 73' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' C' ' 35' ' ' ALA . 5.7 pt20 -66.02 -19.47 65.87 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 74' ' ' GLU . . . . . 0.491 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 36.7 mm-40 -70.52 -28.39 64.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.584 ' CD1' HD22 ' C' ' 66' ' ' LEU . 18.9 m-85 -87.29 -23.51 24.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 60.59 43.66 12.48 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.905 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.563 HG23 HG22 ' C' ' 19' ' ' VAL . 19.6 m -91.3 -8.06 10.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.714 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -50.03 100.34 0.04 OUTLIER Glycine 0 CA--C 1.493 -1.305 0 CA-C-O 122.914 1.286 . . . . 0.0 113.944 168.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.93 10.38 49.54 Favored Glycine 0 C--N 1.29 -1.993 0 CA-C-N 111.629 -2.286 . . . . 0.0 114.725 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 80' ' ' LYS . . . . . 0.574 ' C ' ' HB2' ' C' ' 20' ' ' LEU . 0.0 OUTLIER -132.47 148.18 52.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.524 0.662 . . . . 0.0 111.118 -178.551 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 1.018 HG12 ' HB3' ' C' ' 20' ' ' LEU . 35.6 m -80.52 122.04 35.01 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-O 121.741 0.781 . . . . 0.0 111.934 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.49 HG21 ' HB3' ' C' ' 59' ' ' LEU . 77.6 mt -80.18 160.46 4.15 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.828 174.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.438 ' N ' HG22 ' C' ' 82' ' ' ILE . 54.8 m80 -117.71 114.73 23.77 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 121.657 -0.652 . . . . 0.0 109.989 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' C' ' 58' ' ' ARG . 8.0 mp -90.49 157.34 17.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.474 HG13 ' CG ' ' A' ' 14' ' ' HIS . 4.1 t . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.618 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.338 0.59 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.603 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 6.7 m-85 -116.3 166.41 12.08 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.982 171.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 40' ' ' LEU . 60.6 t80 -139.48 123.74 18.01 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.446 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.571 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -98.02 101.05 12.43 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.41 ' CD2' HG21 ' C' ' 85' ' ' VAL . 7.8 p-80 -52.91 -24.95 10.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.27 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -67.5 -46.76 71.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.769 0.319 . . . . 0.0 110.443 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.0 m -74.58 -28.24 60.83 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.497 0.665 . . . . 0.0 109.852 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.68 29.6 17.56 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.02 -170.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.03 144.39 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 37.5 tt0 -73.67 148.67 42.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.124 0.488 . . . . 0.0 110.844 -175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.73 HD12 ' HD3' ' A' ' 30' ' ' PRO . 6.2 pt -139.01 168.38 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.265 -172.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.519 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 47.2 t -122.74 101.3 39.8 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 160.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 11.1 Cg_endo -54.36 175.32 0.14 Allowed 'Trans proline' 0 C--N 1.328 -0.502 1 C-N-CA 125.582 4.188 . . . . 0.0 116.215 -171.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.492 ' HD3' HD12 ' A' ' 28' ' ' ILE . 29.8 mtt180 -101.82 45.69 0.96 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 112.587 -2.097 . . . . 0.0 107.096 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.48 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -1.98 -59.03 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.861 0 CA-C-N 110.41 -3.086 . . . . 0.0 117.654 175.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.29 44.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.268 1.978 . . . . 0.0 112.857 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.575 ' HB3' HG12 ' A' ' 28' ' ' ILE . 4.8 t70 177.68 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.942 0.897 . . . . 0.0 109.653 -174.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.448 ' CE1' HD13 ' A' ' 24' ' ' LEU . 93.8 m-85 70.69 58.13 0.22 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.328 -173.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.575 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -114.76 163.52 11.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 113.307 -1.77 . . . . 0.0 108.833 175.306 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.458 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 2.1 t -95.88 144.42 27.79 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.73 ' HD3' HD12 ' A' ' 20' ' ' ILE . 79.6 Cg_endo -81.09 -22.89 5.69 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 C-N-CA 122.807 2.338 . . . . 0.0 108.182 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.517 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 50.2 mtt180 -89.09 -6.31 57.17 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.835 -1.984 . . . . 0.0 114.485 -176.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.7 p -156.06 -14.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 171.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 61.25 22.59 12.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.364 0.602 . . . . 0.0 111.709 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.9 m -96.13 141.55 29.37 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 166.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.56 51.82 4.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.007 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -107.88 45.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.722 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.9 pt -113.66 143.87 22.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.922 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.507 ' HB3' HD13 ' C' ' 60' ' ' ILE . 1.4 pm0 -120.65 149.53 42.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 165.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -81.27 133.82 35.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.62 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.425 -0.797 . . . . 0.0 110.409 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.525 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 22.9 mmt . . . . . 0 N--CA 1.465 0.325 0 CA-C-O 121.149 0.499 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.726 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.4 OUTLIER -102.18 138.07 39.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.686 178.725 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' C' ' 32' ' ' ILE . 10.3 mt-10 -85.08 98.55 10.49 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.565 0.698 . . . . 0.0 109.287 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' C' ' 30' ' ' THR . 17.1 t -79.5 83.64 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 122.482 1.134 . . . . 0.0 110.904 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.625 ' HB3' HG12 ' C' ' 81' ' ' VAL . 12.3 mt -75.66 142.58 42.52 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' C' ' 82' ' ' ILE . 82.0 t -156.18 125.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 121.952 0.101 . . . . 0.0 110.889 -171.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.649 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 0.1 OUTLIER -111.97 162.82 14.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.152 0.501 . . . . 0.0 110.901 -178.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 23' ' ' THR . . . . . 0.535 HG22 ' O ' ' C' ' 84' ' ' LEU . 11.3 p . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.836 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 43.9 m . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.909 0.862 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -126.15 151.06 47.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.337 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -99.9 143.41 30.15 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.129 0.49 . . . . 0.0 111.301 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.489 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 29.2 m-85 -126.5 62.82 1.28 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 123.578 0.751 . . . . 0.0 109.766 -175.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.59 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -57.02 121.98 5.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 123.114 1.435 . . . . 0.0 114.745 -172.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' HG ' ' C' ' 72' ' ' LEU . 16.7 m -141.81 167.01 16.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 111.267 -2.697 . . . . 0.0 112.523 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -96.57 52.16 1.53 Allowed Glycine 0 C--N 1.306 -1.089 0 CA-C-N 114.549 -1.205 . . . . 0.0 114.595 -168.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.726 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.61 -44.67 0.52 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 171.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -132.1 26.61 4.56 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -75.37 0.07 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.87 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -146.58 -79.3 0.16 Allowed 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.696 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.4 OUTLIER 90.56 -29.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 125.375 1.672 . . . . 0.0 111.438 -167.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.47 ' HD2' ' HG2' ' C' ' 70' ' ' LYS . 0.1 OUTLIER -84.24 -70.35 0.58 Allowed 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 122.202 1.001 . . . . 0.0 109.14 177.787 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.04 -26.57 67.72 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.632 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.674 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -56.14 -50.14 71.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.162 171.411 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.617 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 43.6 mttp -64.59 -42.32 95.68 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.219 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -56.0 -36.73 68.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.572 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -70.11 -46.71 64.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.755 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.591 HG23 ' O ' ' C' ' 42' ' ' PHE . 8.5 pt -78.1 -13.79 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.792 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.98 -51.2 3.28 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.25 -45.47 69.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -28.07 64.83 Favored 'General case' 0 N--CA 1.424 -1.734 0 C-N-CA 122.868 0.467 . . . . 0.0 112.164 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.528 HG11 ' CD1' ' C' ' 84' ' ' LEU . 27.6 m -106.41 -3.81 9.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.18 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 82.6 p 63.35 23.7 13.87 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 122.054 0.93 . . . . 0.0 109.54 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.1 mm -131.63 120.44 17.71 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.244 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -67.73 152.8 77.29 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.034 1.823 . . . . 0.0 112.588 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.501 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 29.9 t -50.06 -40.89 46.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.358 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.549 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 15.7 pt-20 -67.12 -17.85 65.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.839 -177.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.549 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 67.7 mttm -121.09 -0.91 9.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -173.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.617 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 9.3 pt20 -96.07 142.26 28.49 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.626 -0.829 . . . . 0.0 112.863 -175.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.486 ' O ' HD23 ' C' ' 84' ' ' LEU . 98.0 mtt180 -114.94 121.85 44.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.266 173.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 9.0 mp -92.07 107.3 19.11 Favored 'General case' 0 C--O 1.207 -1.164 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.551 HG21 ' O ' ' A' ' 37' ' ' ILE . 2.8 mt -105.2 106.37 20.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 120.973 0.416 . . . . 0.0 111.114 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.442 ' HB2' HG23 ' C' ' 82' ' ' ILE . 53.0 t80 -117.62 114.63 23.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.75 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 56.99 41.14 28.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.033 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.7 -15.47 36.34 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.205 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 tpm_? -81.06 126.87 31.97 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.504 -0.409 . . . . 0.0 110.208 -176.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 38' ' ' GLU . 15.8 t -83.48 90.28 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.973 0.416 . . . . 0.0 109.943 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.6 OUTLIER -75.6 134.14 40.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.342 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 67' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 6.9 pt20 -135.22 -168.57 2.21 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.161 -171.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.696 ' HA ' HG13 ' C' ' 39' ' ' VAL . 5.7 p-10 -71.13 2.37 4.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.529 0.732 . . . . 0.0 112.296 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 69' ' ' ASP . . . . . 0.54 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 19.4 t70 -61.11 1.52 0.17 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.455 1.102 . . . . 0.0 113.146 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.472 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.4 mtmt 83.44 158.44 0.12 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 168.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.4 ' HB3' ' HG3' ' C' ' 74' ' ' GLU . 34.6 mmtp 72.2 95.18 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.749 174.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.482 ' HG ' ' CG2' ' C' ' 33' ' ' VAL . 3.6 mm? -62.58 -36.8 83.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.81 177.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -68.95 -19.16 64.16 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -175.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 74' ' ' GLU . . . . . 0.4 ' HG3' ' HB3' ' C' ' 71' ' ' LYS . 26.8 mt-10 -71.48 -27.87 63.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 174.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.547 ' CD1' HD22 ' C' ' 66' ' ' LEU . 25.4 m-85 -87.78 -22.36 24.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.731 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.1 t30 61.18 40.63 14.49 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.781 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.406 HG23 HG22 ' C' ' 19' ' ' VAL . 26.4 m -92.43 27.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.743 -175.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.569 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.03 101.74 1.61 Allowed Glycine 0 N--CA 1.433 -1.558 0 CA-C-O 122.744 1.191 . . . . 0.0 112.733 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.28 13.7 50.99 Favored Glycine 0 C--N 1.283 -2.366 0 CA-C-N 112.21 -1.995 . . . . 0.0 114.108 172.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -127.01 147.61 50.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.649 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 3.0 m -79.03 127.44 39.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.605 0.717 . . . . 0.0 112.636 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.575 ' HB ' HG22 ' C' ' 21' ' ' VAL . 27.0 mt -88.71 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.301 171.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.537 ' N ' HG22 ' C' ' 82' ' ' ILE . 55.7 t-80 -109.82 133.33 53.27 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 121.821 -0.55 . . . . 0.0 110.094 166.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.535 ' O ' HG22 ' C' ' 23' ' ' THR . 5.8 mt -108.8 138.34 45.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.805 0.812 . . . . 0.0 112.244 170.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.502 ' HB ' ' CE1' ' C' ' 83' ' ' HIS . 2.6 p . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.367 177.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 3.0 mpt_? . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.93 0.395 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.631 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 12.3 m-85 -118.04 165.9 13.19 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.326 0.584 . . . . 0.0 109.521 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.419 ' CB ' HD11 ' A' ' 40' ' ' LEU . 74.1 t80 -140.29 118.85 12.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.569 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -98.7 128.55 45.0 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.508 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -83.97 -21.32 31.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -167.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 32.0 p -72.36 -31.72 65.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 118.479 0.581 . . . . 0.0 110.016 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.445 ' HB3' HG22 ' A' ' 18' ' ' VAL . 94.5 m -85.64 -20.5 29.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.525 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.8 p 51.22 32.23 7.84 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.116 0.966 . . . . 0.0 112.375 -175.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 16' ' ' CYS . 2.8 m -141.42 157.2 21.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.494 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.628 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 32.8 tt0 -79.01 145.23 34.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.076 0.465 . . . . 0.0 111.196 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.738 HD11 HG21 ' A' ' 37' ' ' ILE . 3.3 pt -134.07 167.17 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.21 -173.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 45.3 t -122.76 94.34 47.58 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 163.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.631 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.65 175.35 0.29 Allowed 'Trans proline' 0 C--N 1.325 -0.709 1 C-N-CA 125.537 4.158 . . . . 0.0 116.522 -168.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.663 ' HB2' HG13 ' A' ' 28' ' ' ILE . 36.8 mtt180 -105.74 46.94 0.89 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.702 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -1.46 -60.92 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.932 0 CA-C-N 110.582 -3.008 . . . . 0.0 116.575 174.36 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.445 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 63.2 Cg_exo -33.58 -31.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.469 2.78 . . . . 0.0 114.55 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.568 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -122.13 -19.08 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.358 0.599 . . . . 0.0 111.745 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.41 ' C ' HD11 ' A' ' 37' ' ' ILE . 50.5 m-85 68.01 58.94 0.46 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.615 -171.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.663 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -111.81 161.38 10.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 113.328 -1.76 . . . . 0.0 108.966 178.299 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.483 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -95.92 146.38 31.22 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.636 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 83.9 Cg_endo -81.32 -21.03 6.71 Favored 'Trans proline' 0 CA--C 1.5 -1.188 0 C-N-CA 122.668 2.245 . . . . 0.0 108.238 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.493 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 84.5 mtt180 -86.79 -15.1 40.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.032 -1.894 . . . . 0.0 114.398 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.1 p -151.58 -10.69 0.21 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 60.42 33.6 20.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.559 0.695 . . . . 0.0 111.217 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 m -113.91 146.32 40.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.47 33.15 3.25 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.826 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 97.9 m-85 -87.88 43.45 1.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.2 0.524 . . . . 0.0 110.649 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.738 HG21 HD11 ' A' ' 20' ' ' ILE . 4.6 pt -111.24 135.37 50.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.8 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -117.03 145.01 43.96 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -77.12 135.87 38.59 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.787 -174.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.58 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 45.7 ttm . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 121.024 0.44 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.771 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.2 mt -105.55 137.98 42.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.51 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.541 ' HA ' HG13 ' C' ' 32' ' ' ILE . 32.5 tt0 -84.36 96.75 9.15 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.2 t -78.62 104.62 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.189 -172.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.618 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -93.41 145.11 24.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.592 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' C' ' 82' ' ' ILE . 68.6 t -151.9 121.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 117.921 0.328 . . . . 0.0 110.957 -171.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.574 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 36.8 mtpt -103.51 122.19 44.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.117 -179.223 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.547 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 18.4 m . . . . . 0 C--O 1.232 0.18 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -122.49 153.44 39.17 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.65 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p -101.41 141.29 34.5 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-O 121.219 0.533 . . . . 0.0 112.251 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.509 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 29.4 m-85 -133.81 57.71 1.8 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.663 0.744 . . . . 0.0 109.758 -174.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.541 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.8 mp -57.24 119.19 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 123.362 1.553 . . . . 0.0 114.353 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 17.3 m -143.66 -168.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 110.915 -2.857 . . . . 0.0 111.627 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -96.4 159.11 21.76 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.054 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.771 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -59.65 -31.17 69.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.21 0.529 . . . . 0.0 112.187 -175.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -138.32 31.7 2.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.486 0.66 . . . . 0.0 109.258 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -74.33 0.14 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.026 -176.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.575 ' O ' HG12 ' C' ' 39' ' ' VAL . 92.9 m-20 -128.82 -90.71 0.49 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.711 HG23 HD21 ' C' ' 72' ' ' LEU . 0.3 OUTLIER 81.83 -30.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 124.794 1.309 . . . . 0.0 111.9 -165.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.51 ' HD2' ' HG2' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -80.23 -69.48 0.59 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 122.286 1.041 . . . . 0.0 108.516 176.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.17 -29.26 69.68 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 113.445 -1.707 . . . . 0.0 111.003 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.676 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.9 t80 -60.64 -53.49 56.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.523 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.66 ' HB2' ' OE1' ' C' ' 57' ' ' GLN . 0.0 OUTLIER -69.82 -33.64 72.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.99 0.424 . . . . 0.0 110.928 -179.444 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -38.64 87.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.718 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -69.65 -48.59 59.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.194 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.578 ' O ' HG22 ' C' ' 50' ' ' VAL . 17.3 pt -70.49 -12.12 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -173.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.29 -56.28 2.47 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.54 -44.3 87.28 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -25.27 65.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.338 0.59 . . . . 0.0 111.087 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.578 HG22 ' O ' ' C' ' 46' ' ' ILE . 30.9 m -110.48 -3.31 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.334 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 60.6 p 64.67 22.08 12.53 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.796 0.807 . . . . 0.0 109.49 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.7 mm -127.66 115.46 20.97 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.274 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 4.6 Cg_exo -73.97 147.02 38.13 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 121.936 1.758 . . . . 0.0 111.306 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.439 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 4.0 p -52.55 -24.85 8.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.765 0.826 . . . . 0.0 112.96 -175.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.56 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 8.9 pt-20 -68.68 -41.74 78.81 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.677 0.275 . . . . 0.0 111.493 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.56 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 27.4 mtpp -96.2 -25.08 15.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.574 0.702 . . . . 0.0 109.686 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.66 ' OE1' ' HB2' ' C' ' 43' ' ' LYS . 17.8 tt0 -61.1 118.57 6.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.287 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -123.16 119.11 29.27 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.02 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 6.4 mt -84.79 116.29 23.19 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.542 HG21 ' O ' ' A' ' 37' ' ' ILE . 3.3 mt -114.89 122.04 68.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.831 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -136.32 132.72 36.04 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 57.46 35.39 25.83 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.104 0.478 . . . . 0.0 110.753 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.03 4.93 37.74 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.529 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -91.73 140.08 30.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.71 90.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.481 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -83.03 144.06 30.18 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.144 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -156.89 -167.4 2.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.522 -175.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.658 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.8 p-10 -60.78 0.22 0.23 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.969 1.308 . . . . 0.0 113.368 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 69' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 34.0 t70 -60.55 -10.69 5.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.506 0.722 . . . . 0.0 112.421 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.522 ' H ' HG11 ' C' ' 39' ' ' VAL . 57.1 mtmt 88.33 -175.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.149 0.98 . . . . 0.0 112.615 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.433 ' HG2' ' C ' ' C' ' 70' ' ' LYS . 16.5 pttp 47.52 84.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.62 1.2 . . . . 0.0 113.06 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.711 HD21 HG23 ' C' ' 39' ' ' VAL . 35.2 mt -64.94 -32.22 73.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.608 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 73' ' ' GLN . . . . . 0.455 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 10.3 pt20 -67.26 -18.4 65.2 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.01 -28.7 66.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.553 ' CD1' HD22 ' C' ' 66' ' ' LEU . 25.1 m-85 -86.96 -22.48 25.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.621 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.7 t30 62.09 37.11 14.88 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.001 174.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -88.92 18.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.053 0.454 . . . . 0.0 111.754 -174.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -73.95 102.81 1.37 Allowed Glycine 0 N--CA 1.427 -1.928 0 CA-C-O 122.779 1.211 . . . . 0.0 111.873 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.36 15.25 60.69 Favored Glycine 0 C--N 1.283 -2.364 0 CA-C-N 112.021 -2.09 . . . . 0.0 112.618 176.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -119.72 145.5 46.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.618 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 34.3 m -83.07 123.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-O 122.111 0.957 . . . . 0.0 111.152 175.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' C' ' 21' ' ' VAL . 57.6 mt -79.07 170.35 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.094 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.531 ' N ' HG22 ' C' ' 82' ' ' ILE . 44.6 m80 -118.26 116.89 27.69 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.425 ' CD1' HG11 ' C' ' 50' ' ' VAL . 9.4 mt -90.63 141.82 28.39 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.257 0.551 . . . . 0.0 111.521 177.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.512 HG21 HD11 ' C' ' 60' ' ' ILE . 31.9 m . . . . . 0 C--N 1.314 -0.953 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.677 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 . . . . . 0 CA--C 1.511 -0.527 0 CA-C-O 121.47 0.652 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 17.9 m-85 -116.2 162.59 17.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 171.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.536 ' CB ' HD11 ' A' ' 40' ' ' LEU . 55.3 t80 -141.01 116.63 10.24 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.394 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -93.83 114.55 26.81 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.565 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.434 ' CG ' HG13 ' C' ' 85' ' ' VAL . 19.0 p80 -69.23 -12.81 61.99 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.878 -176.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 38.9 m -71.57 -39.26 70.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 110.705 173.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.1 m -88.35 -27.58 21.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 110.813 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.53 28.48 17.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.696 -170.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.457 HG11 ' CZ ' ' A' ' 31' ' ' ARG . 97.5 t -131.34 144.53 37.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.445 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 25.8 tt0 -74.93 145.83 42.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 110.453 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.9 pt -135.7 167.84 24.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.343 -170.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 61.3 t -124.59 95.69 42.39 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 164.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.8 176.31 0.23 Allowed 'Trans proline' 0 C--N 1.325 -0.681 1 C-N-CA 125.386 4.057 . . . . 0.0 116.216 -173.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.583 ' HB2' HG13 ' A' ' 28' ' ' ILE . 7.8 mtt180 -112.43 52.19 0.78 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 112.711 -2.041 . . . . 0.0 107.155 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 4.04 -61.4 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.016 0 CA-C-N 111.06 -2.791 . . . . 0.0 117.221 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 13.1 Cg_exo -34.12 -37.42 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.899 2.399 . . . . 0.0 113.701 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.497 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.09 -23.75 9.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.848 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.536 ' C ' HD11 ' A' ' 37' ' ' ILE . 60.4 m-85 65.18 57.41 0.94 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.304 1.049 . . . . 0.0 109.303 -168.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.583 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.4 OUTLIER -105.7 162.61 4.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.521 176.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.475 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.5 t -94.62 145.01 28.87 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.659 ' HD3' HD12 ' A' ' 20' ' ' ILE . 70.3 Cg_endo -83.78 -20.33 4.61 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.938 2.425 . . . . 0.0 108.688 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.487 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 12.5 mtp180 -89.02 -7.91 55.03 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.016 -1.902 . . . . 0.0 114.014 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.4 p -162.66 -8.4 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 15.7 tt0 62.31 28.17 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.137 0.494 . . . . 0.0 112.213 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.1 p -99.58 150.86 21.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.8 25.77 7.2 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.711 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.461 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 75.7 m-85 -89.48 48.99 1.67 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.105 0.479 . . . . 0.0 110.551 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.753 HG21 ' CD1' ' A' ' 20' ' ' ILE . 3.5 pt -110.73 138.56 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.485 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' C' ' 65' ' ' VAL . 7.2 pt-20 -123.19 137.67 54.83 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -68.24 140.62 56.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.499 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 63.8 ttp . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.696 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.2 mt -106.25 131.39 53.54 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.066 173.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.62 ' HA ' HG13 ' C' ' 32' ' ' ILE . 33.9 tt0 -82.5 96.24 7.96 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.636 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 2.5 t -80.45 124.57 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -173.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.666 ' CB ' HG12 ' C' ' 81' ' ' VAL . 0.4 OUTLIER -110.45 145.62 37.33 Favored 'General case' 0 N--CA 1.417 -2.075 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 171.1 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.705 HG22 ' HB ' ' C' ' 82' ' ' ILE . 55.4 t -148.38 126.75 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 117.905 0.321 . . . . 0.0 110.404 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.536 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 42.4 mtmt -111.9 127.13 55.75 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.34 0.59 . . . . 0.0 110.029 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 C--N 1.307 -1.282 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.414 172.37 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 97.3 m . . . . . 0 C--O 1.237 0.416 0 CA-C-O 120.781 0.324 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -122.56 151.81 41.02 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.951 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 3.5 p -99.14 140.2 33.67 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.636 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 24.9 m-85 -136.52 60.78 1.66 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.841 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.62 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.6 mp -57.71 128.88 18.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 122.898 1.332 . . . . 0.0 114.304 -172.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.62 HG11 ' CD2' ' C' ' 42' ' ' PHE . 15.3 m -122.78 -169.88 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 112.053 -2.34 . . . . 0.0 111.546 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -125.57 33.34 3.63 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.17 -175.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.696 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 65.72 18.36 11.15 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 167.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.862 ' H ' HD12 ' C' ' 72' ' ' LEU . 62.9 tt0 157.61 -11.85 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.82 0.819 . . . . 0.0 109.163 -166.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.8 tpt -45.4 -73.68 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.844 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.459 ' O ' HG12 ' C' ' 39' ' ' VAL . 77.9 m-20 -141.25 -88.57 0.16 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.694 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 92.84 -30.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 125.297 1.623 . . . . 0.0 111.274 -164.624 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -66.9 0.78 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 122.393 1.092 . . . . 0.0 108.873 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -61.76 -28.24 69.3 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 113.065 -1.88 . . . . 0.0 111.706 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.62 ' CD2' HG11 ' C' ' 33' ' ' VAL . 0.1 OUTLIER -57.27 -52.87 63.6 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 171.722 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.453 ' HA ' HG12 ' C' ' 46' ' ' ILE . 24.2 mtpp -67.01 -41.37 86.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.092 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -60.09 -34.71 73.83 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.044 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.6 -48.2 60.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.621 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.639 ' O ' HG22 ' C' ' 50' ' ' VAL . 20.6 pt -74.86 -10.42 13.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.307 -175.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -46.67 -40.64 13.52 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.04 -45.91 19.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -34.13 73.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.104 0.478 . . . . 0.0 110.765 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.639 HG22 ' O ' ' C' ' 46' ' ' ILE . 30.1 m -99.88 -8.12 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.158 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 31.5 m 68.8 20.14 8.15 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.837 0.827 . . . . 0.0 109.775 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.2 mm -123.29 110.98 30.41 Favored Pre-proline 0 N--CA 1.44 -0.935 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.72 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.417 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 14.1 Cg_exo -66.39 143.11 68.61 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 122.622 2.214 . . . . 0.0 111.902 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.433 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 35.2 t -51.13 -28.31 10.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.843 -172.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.45 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 10.8 pt-20 -75.29 -30.96 60.54 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.877 0.37 . . . . 0.0 111.541 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 55.1 mtpt -95.19 -28.83 14.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.827 0.823 . . . . 0.0 109.206 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.43 HE22 HG13 ' C' ' 46' ' ' ILE . 17.1 tt0 -63.67 122.64 16.85 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.124 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.431 ' O ' HG23 ' C' ' 85' ' ' VAL . 72.6 mtp85 -120.97 123.76 43.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.756 -0.202 . . . . 0.0 110.462 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 94.1 mt -90.95 124.06 34.92 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 177.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.556 HG21 ' O ' ' A' ' 37' ' ' ILE . 4.6 mt -118.29 125.75 74.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 O-C-N 121.622 -0.674 . . . . 0.0 111.595 172.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.46 ' CD2' HG12 ' C' ' 77' ' ' VAL . 55.1 t80 -138.64 131.87 30.05 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 46.23 40.39 7.43 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.104 0.478 . . . . 0.0 111.357 -170.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.91 5.73 58.39 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.923 -0.58 . . . . 0.0 113.617 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.586 ' HD3' ' N ' ' C' ' 65' ' ' VAL . 0.0 OUTLIER -99.22 131.26 45.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.305 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.586 ' N ' ' HD3' ' C' ' 64' ' ' ARG . 2.0 t -82.41 90.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.113 0.482 . . . . 0.0 110.391 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.594 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.4 OUTLIER -71.78 148.1 46.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.452 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -158.31 -169.81 2.9 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.835 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.694 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.7 p-10 -67.04 -2.39 5.37 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.663 0.785 . . . . 0.0 112.233 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 69' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 20.9 t70 -68.73 -2.74 9.99 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.082 0.553 . . . . 0.0 111.802 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.54 ' H ' HG11 ' C' ' 39' ' ' VAL . 53.5 mtmt 75.9 -162.47 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.685 178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' C' ' 70' ' ' LYS . 48.5 mttp 77.51 57.18 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.831 0.707 . . . . 0.0 109.659 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.862 HD12 ' H ' ' C' ' 36' ' ' GLN . 22.0 mt -61.72 -56.36 20.46 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.827 -174.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -72.64 -15.86 61.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.073 0.464 . . . . 0.0 111.461 -176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -73.14 -28.93 62.52 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.051 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.594 ' CD1' HD22 ' C' ' 66' ' ' LEU . 24.0 m-85 -75.31 -25.38 57.81 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 61.51 26.39 16.13 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.382 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.46 HG12 ' CD2' ' C' ' 61' ' ' TYR . 31.3 m -83.04 21.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.902 -175.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.647 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.54 98.97 1.43 Allowed Glycine 0 N--CA 1.431 -1.675 0 CA-C-O 122.418 1.01 . . . . 0.0 111.985 177.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.23 14.14 39.84 Favored Glycine 0 C--N 1.285 -2.262 0 CA-C-N 112.382 -1.909 . . . . 0.0 114.541 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -128.68 147.32 50.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.666 HG12 ' CB ' ' C' ' 20' ' ' LEU . 16.6 m -80.19 125.78 39.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-O 121.881 0.848 . . . . 0.0 111.637 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.705 ' HB ' HG22 ' C' ' 21' ' ' VAL . 57.5 mt -80.25 171.17 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.8 173.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.546 ' N ' HG22 ' C' ' 82' ' ' ILE . 37.6 m80 -118.22 122.01 41.91 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 122.012 -0.43 . . . . 0.0 109.924 174.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mt -85.75 156.86 20.44 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.434 HG13 ' CG ' ' A' ' 14' ' ' HIS . 8.0 t . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.417 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HG2' HD23 ' A' ' 40' ' ' LEU . 58.8 ttt180 . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 121.229 0.538 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.657 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 17.0 m-85 -118.21 164.27 15.42 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.636 0.731 . . . . 0.0 110.752 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.654 ' CB ' HD11 ' A' ' 40' ' ' LEU . 54.9 t80 -140.92 120.28 13.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.877 178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -98.57 121.37 40.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.222 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.644 ' CE1' ' HB ' ' C' ' 85' ' ' VAL . 8.9 p80 -76.69 -23.44 53.18 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 24.6 p -71.09 -38.15 72.41 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.272 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.6 m -74.85 -34.81 62.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.084 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.75 32.01 21.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.161 -172.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.5 t -131.65 144.12 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.657 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 38.7 tt0 -74.33 143.28 45.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.116 0.484 . . . . 0.0 110.885 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.74 HD11 HG21 ' A' ' 37' ' ' ILE . 4.0 pt -131.86 168.32 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.216 -169.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.424 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 57.7 t -123.53 98.29 40.95 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 162.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.592 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 6.8 Cg_endo -57.3 175.12 0.39 Allowed 'Trans proline' 0 C--N 1.326 -0.613 1 C-N-CA 125.302 4.001 . . . . 0.0 116.675 -169.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.696 ' HB2' HG13 ' A' ' 28' ' ' ILE . 26.0 mtt180 -107.68 47.38 0.89 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 112.629 -2.078 . . . . 0.0 107.183 176.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -0.07 -61.27 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 110.718 -2.947 . . . . 0.0 116.993 174.754 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 31.2 Cg_exo -30.96 -38.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 123.591 2.861 . . . . 0.0 114.176 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.545 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.48 -18.05 11.59 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.705 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.432 ' C ' HD11 ' A' ' 37' ' ' ILE . 62.8 m-85 67.11 45.93 1.62 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.04 -172.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.696 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -94.07 161.61 2.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.653 174.622 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -96.61 145.73 30.08 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.035 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.656 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 78.7 Cg_endo -80.46 -20.27 8.33 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 122.861 2.374 . . . . 0.0 108.089 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.655 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.1 mtt-85 -80.19 -34.77 37.19 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 112.658 -2.065 . . . . 0.0 113.712 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.8 p -137.59 -8.74 1.67 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 61.29 35.42 18.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.474 0.654 . . . . 0.0 111.061 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 m -113.09 146.36 39.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.545 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -84.55 45.86 3.57 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.741 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 57.9 m-85 -102.4 44.38 1.02 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.961 0.41 . . . . 0.0 110.268 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.74 HG21 HD11 ' A' ' 20' ' ' ILE . 5.8 pt -115.27 139.21 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.191 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB2' HG22 ' C' ' 65' ' ' VAL . 12.9 pt-20 -123.86 145.67 48.93 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.34 131.36 39.13 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.654 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.857 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.636 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 50.9 mtm . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 121.014 0.435 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.692 HD11 ' HA ' ' C' ' 35' ' ' ALA . 3.7 mt -98.58 132.71 43.77 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.575 ' HA ' HG13 ' C' ' 32' ' ' ILE . 25.6 tt0 -82.23 93.92 7.2 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.631 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 3.1 t -77.06 104.85 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.06 -172.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.651 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.1 mt -92.76 142.27 27.53 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.695 HG22 ' HB ' ' C' ' 82' ' ' ILE . 59.4 t -147.95 128.92 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -174.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.608 ' HE3' HG21 ' C' ' 81' ' ' VAL . 79.2 mttt -114.24 159.81 19.73 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.361 0.601 . . . . 0.0 109.804 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 C--N 1.308 -1.229 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.99 172.33 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.447 ' OG1' ' HE2' ' C' ' 22' ' ' LYS . 53.7 m . . . . . 0 C--O 1.231 0.123 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 29' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' C' ' 29' ' ' ARG . 73.1 mtt180 -123.33 161.93 23.71 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.795 -177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.5 p -103.69 143.44 32.78 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.468 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.631 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 27.6 m-85 -137.14 59.0 1.7 Allowed 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.271 -174.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -57.92 124.26 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 123.352 1.548 . . . . 0.0 113.872 -174.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' C' ' 16' ' ' MET . 17.2 m -135.27 -165.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 111.104 -2.771 . . . . 0.0 111.324 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.04 -161.76 37.32 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.741 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.692 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -100.91 -12.86 18.62 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.577 0.703 . . . . 0.0 111.296 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -166.95 26.57 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -172.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 18.3 ttt -71.95 -73.05 0.2 Allowed 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 111.816 -2.447 . . . . 0.0 110.941 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.605 ' O ' HG12 ' C' ' 39' ' ' VAL . 70.5 m-20 -131.11 -98.18 0.32 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 178.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 86.7 -16.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 125.341 1.651 . . . . 0.0 111.731 -167.157 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' C' ' 43' ' ' LYS . 0.1 OUTLIER -88.69 -70.79 0.63 Allowed 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.048 0.928 . . . . 0.0 108.965 171.255 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.12 -29.4 70.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.099 173.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.64 ' CD2' ' HA ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -62.08 -54.43 41.41 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.438 175.314 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' C' ' 40' ' ' LYS . 20.0 ptmt -68.25 -33.66 74.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -42.66 82.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.103 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -68.71 -43.26 76.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.439 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.603 ' O ' HG22 ' C' ' 50' ' ' VAL . 16.1 pt -78.35 -10.75 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -172.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.65 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.2 -61.02 0.95 Allowed 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.75 86.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -32.82 71.15 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.055 0.455 . . . . 0.0 111.049 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.603 HG22 ' O ' ' C' ' 46' ' ' ILE . 24.3 m -103.63 -3.36 9.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.453 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 48.2 t 69.58 20.04 7.2 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.65 0.738 . . . . 0.0 109.318 178.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.2 mm -123.38 110.67 30.41 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.174 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.499 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 6.0 Cg_exo -72.8 146.03 41.95 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.371 2.047 . . . . 0.0 111.299 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 8.0 p -54.49 -24.62 21.27 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.608 0.763 . . . . 0.0 112.285 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 15.1 pt-20 -73.6 -26.3 60.74 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -107.66 -26.41 10.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 109.981 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.535 ' OE1' HD11 ' C' ' 46' ' ' ILE . 9.9 tt0 -57.96 118.3 5.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.9 -173.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.413 HH11 HG11 ' C' ' 65' ' ' VAL . 26.1 mmt85 -122.37 118.0 27.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.314 172.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 5.2 mp -84.7 117.87 24.06 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.537 HG21 ' O ' ' A' ' 37' ' ' ILE . 7.0 mt -115.12 118.12 57.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.169 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -132.39 128.15 36.97 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 58.68 38.83 24.95 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.508 0.505 . . . . 0.0 110.627 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.79 4.17 13.15 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.258 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -89.18 133.98 34.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.437 HG22 ' HB2' ' A' ' 38' ' ' GLU . 2.1 t -85.14 89.68 2.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.3 OUTLIER -75.04 130.57 39.54 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -143.11 -172.72 3.74 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.511 -170.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.621 ' HA ' HG13 ' C' ' 39' ' ' VAL . 4.4 p-10 -64.3 -3.06 2.52 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.44 0.696 . . . . 0.0 112.145 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.35 -4.94 16.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.072 0.549 . . . . 0.0 112.293 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 74.44 -158.21 0.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.375 0.67 . . . . 0.0 110.939 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.537 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 54.3 mttp 71.91 54.08 0.19 Allowed 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.552 0.532 . . . . 0.0 110.692 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 60.1 mt -63.43 -44.28 95.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.181 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 73' ' ' GLN . . . . . 0.439 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 9.3 pt20 -70.08 -20.44 63.21 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.742 0.306 . . . . 0.0 111.466 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 74' ' ' GLU . . . . . 0.537 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 28.0 mm-40 -71.1 -28.01 64.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.555 ' CD1' HD22 ' C' ' 66' ' ' LEU . 19.3 m-85 -83.7 -24.72 31.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 57.66 37.85 27.48 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.807 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -87.31 20.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.539 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.608 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.69 99.93 1.53 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-O 122.767 1.204 . . . . 0.0 112.322 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.88 14.34 43.34 Favored Glycine 0 C--N 1.284 -2.307 0 CA-C-N 112.223 -1.989 . . . . 0.0 113.72 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -124.33 147.49 48.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.651 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 4.5 m -82.05 128.53 38.64 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-O 122.055 0.931 . . . . 0.0 111.43 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.695 ' HB ' HG22 ' C' ' 21' ' ' VAL . 54.3 mt -86.9 168.44 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.122 175.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.468 ' N ' HG22 ' C' ' 82' ' ' ILE . 40.7 m80 -117.42 115.03 24.4 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.889 -0.507 . . . . 0.0 110.162 175.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.452 HD13 HG21 ' C' ' 50' ' ' VAL . 13.4 mt -90.67 157.36 17.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.291 0.567 . . . . 0.0 112.379 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.644 ' HB ' ' CE1' ' A' ' 14' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.917 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 10' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.605 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 5.9 m-85 -116.74 167.53 11.01 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.041 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CB ' HD11 ' A' ' 40' ' ' LEU . 48.8 t80 -140.87 114.39 8.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.28 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.599 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -93.49 118.02 30.81 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.51 177.122 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' A' ' 36' ' ' PHE . 1.1 p80 -76.68 -20.49 56.56 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.544 -171.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 16.1 p -72.91 -31.61 64.76 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.82 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.2 m -83.43 -30.61 27.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.189 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.02 28.29 16.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.409 -171.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.88 144.76 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 34.7 tt0 -71.23 146.66 48.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.512 -175.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.7 ' CD1' HG21 ' A' ' 37' ' ' ILE . 2.6 pt -138.62 166.61 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.847 -172.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.482 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 99.1 t -124.08 97.86 39.97 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 163.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 5.6 Cg_endo -57.24 173.76 0.59 Allowed 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 124.912 3.741 . . . . 0.0 116.571 -170.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.501 ' HB2' HG13 ' A' ' 28' ' ' ILE . 15.2 mtt85 -107.35 47.33 0.89 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 112.489 -2.142 . . . . 0.0 107.59 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -6.28 -53.69 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 171.675 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -35.09 -36.16 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.561 2.174 . . . . 0.0 113.428 171.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.506 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.09 -17.56 10.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.352 177.398 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.423 ' CE1' HD23 ' A' ' 24' ' ' LEU . 74.7 m-85 69.68 50.99 0.47 Allowed 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.603 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.506 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -104.81 159.85 5.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.615 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.493 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 t -95.5 144.56 28.02 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.69 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 87.2 Cg_endo -81.24 -17.48 9.09 Favored 'Trans proline' 0 CA--C 1.5 -1.179 0 C-N-CA 122.761 2.308 . . . . 0.0 108.24 -173.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.429 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 60.5 mtt-85 -91.57 -13.81 31.37 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 112.937 -1.938 . . . . 0.0 114.617 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.0 p -153.16 -9.48 0.16 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 60.95 29.18 18.86 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.381 0.61 . . . . 0.0 110.91 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.2 m -109.24 146.97 33.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.487 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.21 28.95 4.46 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.772 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 63.0 m-85 -85.86 47.64 1.48 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.568 -0.372 . . . . 0.0 110.462 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.7 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.7 pt -115.58 139.0 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.516 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.493 ' HB3' HD13 ' C' ' 60' ' ' ILE . 6.5 pt-20 -123.42 148.28 46.29 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -80.52 134.24 35.92 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.434 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.547 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.808 -174.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.414 ' N ' ' HA2' ' C' ' 34' ' ' GLY . 1.9 mpt? . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.877 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.7 OUTLIER -104.71 135.62 45.76 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.643 -171.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.565 ' HA ' HG13 ' C' ' 32' ' ' ILE . 36.4 tt0 -88.91 94.27 9.88 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.3 t -79.48 128.29 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -172.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.595 ' CB ' HG12 ' C' ' 81' ' ' VAL . 0.8 OUTLIER -114.21 150.14 34.74 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.225 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.573 HG21 ' HE2' ' C' ' 31' ' ' PHE . 18.5 m -135.32 150.91 29.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.606 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 36.7 mtpt -125.72 96.38 4.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.712 0.291 . . . . 0.0 110.297 174.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 23' ' ' THR . . . . . 0.47 HG23 ' O ' ' C' ' 84' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.316 -0.891 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 171.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 78.7 m . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -136.24 154.56 50.88 Favored 'General case' 0 C--O 1.223 -0.333 0 O-C-N 122.288 -0.258 . . . . 0.0 110.31 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.538 HG22 ' CD2' ' C' ' 20' ' ' LEU . 4.1 p -108.79 147.34 32.19 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -171.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.67 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 31.0 m-85 -140.16 65.14 1.43 Allowed 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 123.292 0.637 . . . . 0.0 111.289 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.565 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.7 mp -59.56 122.17 9.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 123.073 1.415 . . . . 0.0 113.81 -175.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.662 HG21 HD13 ' C' ' 72' ' ' LEU . 15.8 m -130.74 -173.71 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 111.723 -2.49 . . . . 0.0 111.461 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.414 ' HA2' ' N ' ' C' ' 16' ' ' MET . . . -120.48 45.61 1.21 Allowed Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.146 -1.026 . . . . 0.0 114.464 -173.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.877 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.16 -36.24 0.3 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 169.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -144.8 20.71 1.64 Allowed 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -172.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 2.0 ttt -66.72 -69.38 0.31 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 112.196 -2.274 . . . . 0.0 110.332 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -142.42 -101.02 0.13 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.655 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.711 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.4 OUTLIER 101.37 -27.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 125.516 1.76 . . . . 0.0 110.189 -165.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' C' ' 40' ' ' LYS . 0.0 OUTLIER -83.99 -71.14 0.52 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 122.127 0.965 . . . . 0.0 109.056 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 41' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' C' ' 40' ' ' LYS . 43.6 mt-10 -63.11 -27.22 69.24 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.721 174.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.742 ' O ' HG23 ' C' ' 46' ' ' ILE . 6.3 t80 -58.95 -52.44 65.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.566 173.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' C' ' 57' ' ' GLN . 51.3 mtpt -61.55 -42.75 99.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.028 0.442 . . . . 0.0 110.642 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -55.6 -40.92 72.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.361 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -68.98 -47.01 66.63 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.971 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.742 HG23 ' O ' ' C' ' 42' ' ' PHE . 4.1 pt -76.01 -13.06 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.415 -173.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.2 -60.6 1.2 Allowed 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.01 93.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.745 0.307 . . . . 0.0 111.699 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -17.69 64.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.475 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.551 HG22 ' O ' ' C' ' 46' ' ' ILE . 17.8 m -113.33 -6.63 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 33.6 t 69.55 22.18 6.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.648 0.737 . . . . 0.0 109.192 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.1 mm -130.06 117.04 17.99 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.635 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.501 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 5.5 Cg_exo -74.99 148.32 35.15 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.962 1.774 . . . . 0.0 111.12 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -55.12 -25.91 34.82 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.153 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.5 pt-20 -68.54 -24.65 64.66 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.653 0.263 . . . . 0.0 111.623 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 95.8 mttt -115.64 -17.76 11.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.446 0.641 . . . . 0.0 110.427 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.453 ' HA ' HG21 ' C' ' 52' ' ' ILE . 23.0 tt0 -66.28 119.35 11.39 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.596 -170.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.404 ' HB3' ' CG1' ' C' ' 65' ' ' VAL . 28.0 mmt180 -114.54 113.66 24.72 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.651 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.756 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 47.7 mt -82.62 105.27 13.53 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.1 mt -102.13 103.62 15.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.611 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -118.6 132.51 56.19 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.628 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 40.64 45.55 2.04 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.985 0.803 . . . . 0.0 111.705 -171.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.95 -6.28 20.83 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.654 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -87.03 129.71 34.78 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 38' ' ' GLU . 1.6 t -87.38 89.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.081 0.467 . . . . 0.0 109.905 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.1 OUTLIER -76.96 155.84 32.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.103 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 67' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.7 pt20 -160.16 -169.31 2.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.286 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.711 ' HA ' HG13 ' C' ' 39' ' ' VAL . 1.8 p-10 -61.6 1.34 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.251 1.42 . . . . 0.0 113.116 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 69' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' C' ' 67' ' ' GLN . 13.4 t70 -65.29 9.85 0.1 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.155 0.982 . . . . 0.0 113.103 -178.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' C' ' 68' ' ' ASP . 51.4 mttp 84.18 159.69 0.11 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.449 1.1 . . . . 0.0 113.648 170.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.449 ' HB3' ' HG2' ' C' ' 74' ' ' GLU . 95.3 mttt 67.89 89.56 0.1 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.123 -1.399 . . . . 0.0 113.005 173.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.662 HD13 HG21 ' C' ' 33' ' ' VAL . 11.3 mt -63.9 -36.1 82.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.559 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 73' ' ' GLN . . . . . 0.41 ' HG2' ' H ' ' C' ' 73' ' ' GLN . 4.3 pt20 -66.89 -24.46 66.11 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 74' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' C' ' 71' ' ' LYS . 26.1 mm-40 -62.19 -27.78 69.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.241 0.543 . . . . 0.0 109.623 176.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.554 ' CD1' HD22 ' C' ' 66' ' ' LEU . 17.8 m-85 -94.01 -12.24 29.07 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.781 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 3.8 m120 47.83 45.29 18.57 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.417 1.087 . . . . 0.0 113.366 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.455 HG23 HG22 ' C' ' 19' ' ' VAL . 29.5 m -86.68 19.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -74.35 102.41 1.37 Allowed Glycine 0 N--CA 1.429 -1.789 0 CA-C-O 122.989 1.327 . . . . 0.0 112.976 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.26 13.73 53.33 Favored Glycine 0 C--N 1.283 -2.394 0 CA-C-N 111.967 -2.116 . . . . 0.0 114.002 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -127.84 154.7 45.15 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.66 -0.318 . . . . 0.0 110.247 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.606 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 35.0 m -87.03 122.93 39.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.818 0.818 . . . . 0.0 112.157 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 82' ' ' ILE . . . . . . . . . . . . . 62.3 mt -86.7 135.26 25.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.512 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.414 ' O ' ' HB ' ' C' ' 60' ' ' ILE . 69.5 m80 -93.93 114.62 26.86 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.47 ' O ' HG23 ' C' ' 23' ' ' THR . 2.7 pp -127.37 157.13 40.78 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 118.786 -1.166 . . . . 0.0 113.517 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.533 -178.416 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.602 0.239 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.478 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 8.2 m-85 -117.99 165.21 13.99 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.34 0.59 . . . . 0.0 109.809 171.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.554 ' HB2' HD11 ' A' ' 40' ' ' LEU . 50.1 t80 -140.26 115.15 9.62 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.491 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -93.88 108.1 19.92 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.584 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.409 ' CD2' HG12 ' C' ' 85' ' ' VAL . 12.6 p80 -64.88 -15.4 61.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.652 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.5 t -72.34 -36.8 68.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.887 0.375 . . . . 0.0 110.478 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.526 ' HB3' HG22 ' A' ' 18' ' ' VAL . 66.0 m -88.77 -23.89 22.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.423 0.63 . . . . 0.0 110.594 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.07 30.61 20.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.272 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 16' ' ' CYS . 2.6 m -138.38 162.95 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.694 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -83.42 145.24 29.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.849 HD12 ' HD3' ' A' ' 30' ' ' PRO . 3.5 pt -137.21 168.42 21.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.094 -171.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.476 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 45.9 t -125.14 99.58 34.09 Favored Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 162.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HD3' HG13 ' A' ' 20' ' ' ILE . 12.9 Cg_endo -55.37 175.24 0.19 Allowed 'Trans proline' 0 C--N 1.328 -0.538 1 C-N-CA 125.306 4.004 . . . . 0.0 116.257 -173.17 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.522 ' HB2' HG13 ' A' ' 28' ' ' ILE . 26.0 mtt180 -109.15 48.99 0.84 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.86 -1.973 . . . . 0.0 106.888 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.422 HD13 ' CE1' ' A' ' 27' ' ' TYR . 1.8 mm? 3.05 -61.47 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.362 0 CA-C-N 111.09 -2.777 . . . . 0.0 117.334 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -34.86 -34.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 123.103 2.535 . . . . 0.0 114.42 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.571 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.84 -21.83 9.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.937 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.456 ' C ' HD11 ' A' ' 37' ' ' ILE . 77.3 m-85 65.57 57.6 0.86 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.148 0.975 . . . . 0.0 109.795 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -109.19 163.01 6.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 113.492 -1.686 . . . . 0.0 109.542 176.362 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 1.4 t -95.92 146.15 30.81 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.849 ' HD3' HD12 ' A' ' 20' ' ' ILE . 86.8 Cg_endo -83.32 -20.29 5.02 Favored 'Trans proline' 0 CA--C 1.501 -1.15 0 C-N-CA 122.607 2.205 . . . . 0.0 108.85 -175.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.402 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 63.3 mtt180 -86.16 -14.07 45.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.259 -1.791 . . . . 0.0 114.104 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 p -152.36 -14.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 8.4 tt0 62.72 36.59 13.25 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.028 0.531 . . . . 0.0 112.161 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 98.2 p -108.44 154.18 22.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 166.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.46 33.91 3.79 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.801 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 60.8 m-85 -94.26 47.79 1.21 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.369 . . . . 0.0 111.045 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 20' ' ' ILE . 3.6 pt -114.03 139.55 39.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.779 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.542 ' HB3' HD13 ' C' ' 60' ' ' ILE . 13.1 pt-20 -117.83 143.41 46.31 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -79.13 139.17 38.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.07 0.462 . . . . 0.0 109.836 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.933 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.102 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.863 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.6 OUTLIER -99.95 127.46 46.14 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.859 -171.029 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.613 ' HA ' HG13 ' C' ' 32' ' ' ILE . 40.5 tt0 -84.59 92.64 8.19 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.8 t -76.96 126.24 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.956 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -174.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.622 ' HB2' ' CG1' ' C' ' 81' ' ' VAL . 0.2 OUTLIER -114.21 155.02 26.87 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 170.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.897 ' O ' ' HA ' ' C' ' 28' ' ' THR . 15.7 m -140.82 155.35 22.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.56 ' HG3' ' CG2' ' C' ' 81' ' ' VAL . 45.0 mtmt -134.35 114.18 12.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 169.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.637 176.349 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.897 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 95.0 m . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.516 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -133.93 170.44 15.62 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.205 -0.31 . . . . 0.0 110.674 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.546 HG22 ' CD2' ' C' ' 20' ' ' LEU . 2.6 p -112.09 145.21 40.15 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.639 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 29.5 m-85 -140.85 65.93 1.39 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.177 0.513 . . . . 0.0 110.895 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.613 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -60.32 121.7 8.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 123.384 1.564 . . . . 0.0 114.117 -174.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.556 HG11 ' CD2' ' C' ' 42' ' ' PHE . 10.9 m -125.08 -174.17 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 111.036 -2.802 . . . . 0.0 111.348 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.78 45.6 1.14 Allowed Glycine 0 C--N 1.317 -0.497 0 C-N-CA 119.78 -1.2 . . . . 0.0 114.119 -173.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.863 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 69.81 -26.29 0.15 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 169.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -163.33 25.51 0.09 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' MET . . . . . 0.55 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 31.7 tpp -77.14 -68.75 0.58 Allowed 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 112.15 -2.295 . . . . 0.0 109.659 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.557 ' O ' ' HB ' ' C' ' 39' ' ' VAL . 18.2 m120 -142.69 -157.1 0.74 Allowed 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.595 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 2.8 p 159.68 -16.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.41 ' HD3' ' H ' ' C' ' 40' ' ' LYS . 0.0 OUTLIER -86.05 -70.48 0.6 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.248 -1.796 . . . . 0.0 108.24 169.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -62.68 -32.74 73.86 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.207 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.595 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -57.92 -51.69 68.57 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 173.194 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' C' ' 43' ' ' LYS . 31.3 mtpt -64.11 -39.3 93.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.99 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -56.6 -36.23 69.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.159 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -69.01 -39.79 79.08 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 122.911 0.484 . . . . 0.0 111.342 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.619 HD11 ' OE1' ' C' ' 57' ' ' GLN . 5.7 pt -84.55 -13.15 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.118 -175.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.32 -55.01 2.86 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.02 87.22 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -31.85 71.71 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.295 0.569 . . . . 0.0 110.868 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.547 HG22 ' O ' ' C' ' 46' ' ' ILE . 29.9 m -102.66 -2.06 9.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.033 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 84.3 p 63.12 23.55 13.99 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.812 0.815 . . . . 0.0 109.461 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' C' ' 57' ' ' GLN . 5.6 mm -130.45 115.29 17.2 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.781 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.524 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 4.5 Cg_exo -69.54 147.09 63.52 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.369 2.046 . . . . 0.0 111.061 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -51.37 -25.73 6.56 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.769 0.668 . . . . 0.0 112.059 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 10.2 pt-20 -70.75 -36.13 72.99 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.631 0.253 . . . . 0.0 111.568 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.428 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 98.4 mttt -98.43 -27.54 14.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.376 0.607 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.619 ' OE1' HD11 ' C' ' 46' ' ' ILE . 6.0 tt0 -68.36 136.44 53.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.239 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 58' ' ' ARG . . . . . 0.477 ' HB2' HG22 ' C' ' 85' ' ' VAL . 47.2 mtm180 -137.48 137.37 38.62 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.33 172.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.434 ' HB3' HG21 ' C' ' 82' ' ' ILE . 38.6 mt -96.28 123.61 39.98 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.957 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.562 HG21 ' O ' ' A' ' 37' ' ' ILE . 9.9 mt -112.84 122.29 66.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 119.227 0.921 . . . . 0.0 111.374 169.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.662 ' CD2' HG12 ' C' ' 77' ' ' VAL . 36.3 t80 -128.36 119.12 24.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.615 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 58.36 37.4 25.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.117 0.484 . . . . 0.0 110.414 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.46 -4.95 65.78 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.747 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.469 ' HA ' ' NE ' ' C' ' 64' ' ' ARG . 2.5 tpm_? -92.43 126.0 37.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -92.35 90.74 3.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.371 0.605 . . . . 0.0 110.559 -174.847 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.45 ' CD1' HG11 ' C' ' 77' ' ' VAL . 0.1 OUTLIER -72.6 154.59 40.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.738 -178.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -152.44 -170.47 3.65 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.214 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.568 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.8 p-10 -69.64 -2.37 11.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.174 0.589 . . . . 0.0 112.125 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.91 -9.98 11.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.545 ' HA ' HG11 ' C' ' 39' ' ' VAL . 52.9 mtmt 77.53 -175.51 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.739 0.815 . . . . 0.0 111.888 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.466 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 35.5 mmtp 75.09 69.02 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.634 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 30.7 mt -66.89 -39.75 87.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.563 -176.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -67.81 -19.87 65.12 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 120.793 0.33 . . . . 0.0 111.521 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 74' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 17.0 mm-40 -71.05 -27.08 63.39 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.447 ' CD1' HD22 ' C' ' 66' ' ' LEU . 25.2 m-85 -88.28 -25.11 22.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 61.7 t30 60.07 34.24 21.31 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.07 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.662 HG12 ' CD2' ' C' ' 61' ' ' TYR . 17.5 m -83.67 11.92 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -174.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.561 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -71.24 100.81 0.9 Allowed Glycine 0 N--CA 1.431 -1.661 0 CA-C-O 122.634 1.13 . . . . 0.0 113.298 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.5 13.41 28.28 Favored Glycine 0 C--N 1.285 -2.268 0 CA-C-N 112.123 -2.039 . . . . 0.0 115.804 170.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -136.04 148.56 48.41 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.68 0.74 . . . . 0.0 110.507 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.622 ' CG1' ' HB2' ' C' ' 20' ' ' LEU . 27.2 m -74.48 118.94 20.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 CA-C-O 121.97 0.89 . . . . 0.0 112.502 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' C' ' 59' ' ' LEU . 84.8 mt -70.76 160.6 5.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.514 173.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.412 ' N ' HG22 ' C' ' 82' ' ' ILE . 66.0 m-70 -115.56 117.65 30.93 Favored 'General case' 0 C--N 1.319 -0.761 0 O-C-N 121.338 -0.851 . . . . 0.0 109.564 173.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.45 ' CD1' ' HB ' ' C' ' 21' ' ' VAL . 10.2 mp -85.29 160.94 19.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.238 0.542 . . . . 0.0 111.699 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' C' ' 58' ' ' ARG . 5.6 m . . . . . 0 C--N 1.324 -0.522 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG2' HD12 ' A' ' 40' ' ' LEU . 43.4 ttm180 . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.283 0.563 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.509 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 6.3 m-85 -116.62 148.69 40.72 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.875 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.507 ' CB ' HD21 ' A' ' 40' ' ' LEU . 37.9 t80 -118.17 116.12 26.18 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.455 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.59 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -92.53 131.73 37.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.416 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.53 ' CD2' HG21 ' C' ' 85' ' ' VAL . 72.6 m-70 -85.8 -27.33 25.23 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -169.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.7 p -71.36 -30.63 66.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.319 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.425 ' O ' HG23 ' A' ' 18' ' ' VAL . 84.9 m -83.42 -33.01 25.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.091 0.472 . . . . 0.0 110.211 172.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.0 34.28 24.09 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.114 -173.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 16' ' ' CYS . 18.9 t -138.89 145.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.26 146.36 45.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.18 0.514 . . . . 0.0 112.003 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.804 HD12 ' HD3' ' A' ' 30' ' ' PRO . 2.3 pt -136.14 167.42 24.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.624 -172.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.63 111.39 31.41 Favored Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 159.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.509 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 22.2 Cg_endo -69.04 175.84 6.99 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 124.372 3.381 . . . . 0.0 115.687 -167.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.576 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 13.8 mtt180 -108.77 48.86 0.84 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.859 -1.973 . . . . 0.0 106.798 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.412 HD23 ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -1.05 -58.66 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.057 0 CA-C-N 110.964 -2.835 . . . . 0.0 117.056 171.213 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.435 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 20.0 Cg_exo -37.98 -33.98 0.29 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.706 2.271 . . . . 0.0 113.774 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.557 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.49 -21.0 10.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.777 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 65.49 56.27 0.97 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.356 1.074 . . . . 0.0 109.878 -169.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -109.59 162.85 7.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.38 -1.737 . . . . 0.0 109.606 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.5 t -97.46 147.53 33.12 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.804 ' HD3' HD12 ' A' ' 20' ' ' ILE . 65.6 Cg_endo -82.56 -19.82 6.08 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.851 2.367 . . . . 0.0 108.046 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.62 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 94.9 mtt-85 -82.69 -24.55 33.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 113.007 -1.906 . . . . 0.0 114.114 -178.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.6 p -147.2 -12.21 0.42 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 8.1 tt0 62.27 29.2 17.33 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.329 0.585 . . . . 0.0 111.02 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 m -106.26 146.76 29.94 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 170.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.27 44.47 3.29 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.572 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 95.4 m-85 -103.95 45.03 0.98 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.52 0.676 . . . . 0.0 109.851 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.671 HG21 ' CD1' ' A' ' 20' ' ' ILE . 10.7 pt -113.41 138.76 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.943 -176.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.499 ' HB3' HD13 ' C' ' 60' ' ' ILE . 13.4 pt-20 -129.57 143.85 51.01 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -79.5 133.39 36.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.024 0.44 . . . . 0.0 110.314 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.507 HD21 ' CB ' ' A' ' 12' ' ' PHE . 8.2 mt . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.708 -170.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 92.3 mmm . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 121.175 0.512 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.777 HD11 ' HA ' ' C' ' 35' ' ' ALA . 5.2 mt -90.37 137.73 32.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.093 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.62 ' HA ' HG13 ' C' ' 32' ' ' ILE . 41.4 tt0 -88.79 89.56 8.04 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.623 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 7.9 t -74.79 97.29 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.978 -173.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.899 ' HB3' HG12 ' C' ' 81' ' ' VAL . 4.4 mt -88.89 153.14 21.28 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' C' ' 28' ' ' THR . 33.9 m -144.81 147.55 18.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.343 0.257 . . . . 0.0 110.402 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.645 ' HE3' HG21 ' C' ' 81' ' ' VAL . 79.8 mttt -131.17 120.41 23.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 23' ' ' THR . . . . . 0.413 HG22 ' O ' ' C' ' 84' ' ' LEU . 3.3 p . . . . . 0 C--N 1.315 -0.898 0 CA-C-O 120.811 0.339 . . . . 0.0 111.09 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.683 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 53.5 m . . . . . 0 C--O 1.235 0.315 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 29' ' ' ARG . . . . . 0.412 ' O ' HG22 ' C' ' 21' ' ' VAL . 78.4 mtt180 -131.57 172.36 12.32 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.148 -176.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 1.6 p -115.04 151.58 33.98 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.623 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 28.4 m-85 -137.46 58.64 1.7 Allowed 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 124.141 0.977 . . . . 0.0 109.812 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.62 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.4 mp -58.71 123.27 10.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 123.443 1.592 . . . . 0.0 114.38 -172.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.64 HG21 HD13 ' C' ' 72' ' ' LEU . 10.7 m -124.66 -170.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 110.79 -2.913 . . . . 0.0 111.635 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.94 45.42 1.21 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.725 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.777 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.06 17.12 9.51 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 165.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.652 ' HB3' ' O ' ' C' ' 35' ' ' ALA . 9.0 pt20 158.94 -9.08 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.292 0.568 . . . . 0.0 109.718 -162.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.2 tpt -39.83 -66.61 0.29 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.855 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.441 ' O ' HG12 ' C' ' 39' ' ' VAL . 26.2 m-80 -148.6 -88.52 0.08 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.692 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 89.29 -27.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 O-C-N 125.393 1.683 . . . . 0.0 111.559 -167.561 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -70.9 0.52 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.246 1.022 . . . . 0.0 108.873 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.46 -27.06 69.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.052 173.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.692 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.4 OUTLIER -56.74 -52.29 65.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.364 173.614 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 54.7 mtpt -61.02 -43.75 98.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.42 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -54.8 -39.19 68.2 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.306 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -70.23 -43.73 70.0 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.066 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.675 HG23 ' O ' ' C' ' 42' ' ' PHE . 3.9 pt -79.1 -11.66 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 120.458 0.17 . . . . 0.0 110.945 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.24 -55.48 3.29 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.793 0.683 . . . . 0.0 112.675 -177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.31 -39.45 74.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -27.96 69.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.053 0.454 . . . . 0.0 111.0 -176.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.592 HG22 ' O ' ' C' ' 46' ' ' ILE . 28.9 m -108.27 -0.9 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.445 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 84.3 p 63.48 23.63 13.75 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.868 0.842 . . . . 0.0 109.464 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.0 mm -128.7 114.13 19.23 Favored Pre-proline 0 N--CA 1.439 -1.007 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.721 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.2 145.99 39.94 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.688 2.259 . . . . 0.0 111.929 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 41.1 t -53.08 -25.56 13.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.647 -174.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.54 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.6 pt-20 -70.76 -27.44 63.94 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.726 0.298 . . . . 0.0 111.474 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.54 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 92.8 mttt -109.0 -22.43 12.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.504 0.668 . . . . 0.0 109.936 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.421 ' HA ' HG21 ' C' ' 52' ' ' ILE . 23.6 tt0 -65.03 122.85 17.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.158 -169.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -127.41 115.55 19.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.982 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.658 ' HB3' HG21 ' C' ' 82' ' ' ILE . 5.3 mp -86.04 105.6 16.6 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.556 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.4 mt -99.61 110.98 27.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 121.268 0.556 . . . . 0.0 111.811 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.487 ' CD2' HG12 ' C' ' 77' ' ' VAL . 50.0 t80 -122.12 121.02 35.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.261 173.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 60.31 39.32 19.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.983 0.421 . . . . 0.0 110.752 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.44 -1.45 27.73 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.679 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 6.2 mmp_? -88.73 140.46 29.42 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.44 87.87 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 0.0 110.611 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.603 ' HG ' ' CD1' ' C' ' 75' ' ' TYR . 6.1 mp -65.31 122.55 17.38 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.812 173.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 67' ' ' GLN . . . . . 0.428 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 19.1 pt20 -144.19 -170.21 3.3 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.23 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.613 ' HA ' HG13 ' C' ' 39' ' ' VAL . 2.2 p-10 -66.67 0.35 2.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.285 1.034 . . . . 0.0 112.599 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 69' ' ' ASP . . . . . 0.428 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 12.7 t70 -62.85 -2.68 1.25 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.516 0.726 . . . . 0.0 112.679 -177.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? 81.71 172.06 0.12 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.12 0.968 . . . . 0.0 112.977 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.488 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 42.1 mtmt 71.0 86.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.937 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.64 HD13 HG21 ' C' ' 33' ' ' VAL . 41.8 mt -71.68 -49.62 37.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.382 -176.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 73' ' ' GLN . . . . . 0.513 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 29.8 pt20 -67.91 -17.08 64.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 74' ' ' GLU . . . . . 0.488 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 7.0 mm-40 -63.67 -28.82 70.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.603 ' CD1' ' HG ' ' C' ' 66' ' ' LEU . 42.1 m-85 -85.11 -23.28 28.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.256 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.1 t30 59.72 30.04 19.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.377 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 77' ' ' VAL . . . . . 0.557 HG11 HD21 ' C' ' 66' ' ' LEU . 18.0 m -85.21 25.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -175.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.567 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -76.33 100.4 1.4 Allowed Glycine 0 N--CA 1.431 -1.65 0 CA-C-O 122.552 1.085 . . . . 0.0 111.929 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.95 13.23 34.63 Favored Glycine 0 C--N 1.284 -2.318 0 CA-C-N 112.364 -1.918 . . . . 0.0 114.278 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 80' ' ' LYS . . . . . 0.441 ' C ' ' HB2' ' C' ' 20' ' ' LEU . 8.2 mptt -126.19 144.19 50.86 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.142 0.471 . . . . 0.0 110.113 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.899 HG12 ' HB3' ' C' ' 20' ' ' LEU . 35.2 m -80.22 125.5 39.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.809 0.814 . . . . 0.0 111.524 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.658 HG21 ' HB3' ' C' ' 59' ' ' LEU . 42.6 mt -84.99 171.43 1.17 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.813 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.55 ' N ' HG22 ' C' ' 82' ' ' ILE . 49.2 m80 -118.48 113.97 22.14 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 121.759 -0.588 . . . . 0.0 110.131 174.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.475 HD13 ' HB ' ' C' ' 21' ' ' VAL . 8.6 mp -103.32 139.41 38.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.058 0.456 . . . . 0.0 110.756 178.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.53 HG21 ' CD2' ' A' ' 14' ' ' HIS . 7.1 m . . . . . 0 C--N 1.322 -0.625 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.734 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.591 0.234 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.567 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.1 m-85 -117.92 145.39 44.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 169.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -119.21 122.04 41.07 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.349 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.671 ' HB2' HG22 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -99.28 130.0 45.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.744 177.434 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -85.11 -26.57 26.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.43 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.4 p -70.33 -45.47 66.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.425 -174.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.461 ' O ' HG23 ' A' ' 18' ' ' VAL . 18.6 p -95.05 -0.88 53.24 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.918 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.9 p 50.5 43.18 27.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.586 1.155 . . . . 0.0 113.739 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 16' ' ' CYS . 32.1 t -133.3 144.69 35.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.8 148.27 40.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.739 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.1 pt -140.35 167.57 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.657 0.741 . . . . 0.0 112.93 -167.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.44 106.85 39.67 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 159.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.567 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 25.6 Cg_endo -68.74 175.64 6.97 Favored 'Trans proline' 0 C--N 1.32 -0.921 0 C-N-CA 124.688 3.592 . . . . 0.0 116.546 -166.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HB2' HG13 ' A' ' 28' ' ' ILE . 83.7 mtt180 -108.87 48.48 0.86 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 112.65 -2.068 . . . . 0.0 107.434 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.408 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -3.28 -59.53 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.85 0 CA-C-N 110.854 -2.885 . . . . 0.0 117.479 173.434 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 26.8 Cg_exo -37.25 -37.01 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 122.59 2.194 . . . . 0.0 113.53 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.556 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -112.22 -21.49 11.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.704 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 42.2 m-85 68.99 57.41 0.39 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.259 1.028 . . . . 0.0 110.057 -170.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.556 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -111.49 163.79 8.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.159 176.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 20' ' ' ILE . 1.5 t -95.72 142.4 24.53 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.739 ' HD3' HD12 ' A' ' 20' ' ' ILE . 91.9 Cg_endo -83.35 -18.82 5.75 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.074 1.85 . . . . 0.0 108.577 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.527 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 58.2 mtt180 -95.47 15.96 18.25 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.241 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 31' ' ' ARG . 14.3 p 175.64 -11.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.405 0.441 . . . . 0.0 111.901 172.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 10.4 tt0 63.95 29.71 14.35 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.197 0.522 . . . . 0.0 112.124 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -99.7 148.29 24.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.48 168.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.24 21.98 21.82 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.892 -175.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 74.9 m-85 -86.32 47.73 1.51 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.709 0.29 . . . . 0.0 110.985 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.705 HG21 ' CD1' ' A' ' 20' ' ' ILE . 6.6 pt -110.31 131.59 60.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.191 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HB3' HD13 ' C' ' 60' ' ' ILE . 9.3 pt-20 -118.63 145.94 45.05 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -78.79 143.43 36.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.24 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.148 -173.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.528 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 13.4 tmm? . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.773 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -106.3 142.76 35.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 172.639 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.581 ' HA ' HG13 ' C' ' 32' ' ' ILE . 38.8 tt0 -92.78 91.45 7.48 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 173.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' C' ' 30' ' ' THR . 2.9 t -76.2 103.1 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.757 -169.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.668 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -92.31 133.96 35.36 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.329 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.497 HG22 ' HB ' ' C' ' 82' ' ' ILE . 52.1 t -142.38 121.13 8.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -175.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.538 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 41.9 mtpt -95.7 154.09 17.39 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 23' ' ' THR . . . . . 0.41 HG22 HD23 ' C' ' 84' ' ' LEU . 50.9 p . . . . . 0 C--N 1.306 -1.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.662 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 53.1 m . . . . . 0 C--O 1.233 0.211 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -129.22 151.45 49.88 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.629 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 4.2 p -104.87 144.12 32.21 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.522 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 35.8 m-85 -139.09 62.36 1.54 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.82 0.819 . . . . 0.0 110.147 -174.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.581 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.2 mp -60.25 122.75 11.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 123.221 1.486 . . . . 0.0 114.901 -173.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' C' ' 16' ' ' MET . 19.5 m -140.35 -166.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 111.116 -2.765 . . . . 0.0 112.377 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -80.33 177.84 54.16 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.79 174.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.773 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -79.8 -15.07 58.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.372 0.606 . . . . 0.0 111.476 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -161.93 27.75 0.12 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 37' ' ' MET . . . . . 0.434 ' HB2' ' HA3' ' C' ' 34' ' ' GLY . 4.5 ttp -57.69 -75.95 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.394 -174.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.462 ' O ' HG12 ' C' ' 39' ' ' VAL . 94.7 m-20 -121.97 -82.33 0.65 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 120.903 0.383 . . . . 0.0 111.401 -177.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.677 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 78.31 -25.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 O-C-N 124.95 1.406 . . . . 0.0 113.068 -173.387 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.15 -68.87 0.71 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 122.35 1.071 . . . . 0.0 109.075 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -57.77 -32.67 67.72 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.028 -1.896 . . . . 0.0 110.221 171.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.677 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -63.33 -50.46 69.93 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.999 176.501 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 43' ' ' LYS . . . . . 0.692 ' HG3' ' OE1' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -59.11 -48.34 81.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.824 0.345 . . . . 0.0 110.278 176.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -57.31 -33.05 67.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.438 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -69.72 -51.12 37.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.284 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.701 HD11 ' OE1' ' C' ' 57' ' ' GLN . 17.7 pt -74.97 -14.31 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.525 -177.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.36 -57.09 2.27 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 124.165 0.916 . . . . 0.0 113.293 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.12 87.44 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -57.4 -43.73 83.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.484 0.659 . . . . 0.0 110.485 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.612 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.1 m -88.16 -6.25 10.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.286 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m 67.87 21.1 9.14 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 121.62 0.724 . . . . 0.0 109.409 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.5 mm -129.67 111.81 17.6 Favored Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.325 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.55 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.0 Cg_exo -71.39 147.83 53.45 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.84 2.36 . . . . 0.0 111.554 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 37.9 t -51.15 -25.2 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.021 0.928 . . . . 0.0 112.81 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.487 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.5 pt-20 -78.14 -21.28 50.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 111.685 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.487 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 46.0 mtpt -112.9 -15.36 12.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.481 . . . . 0.0 110.195 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.701 ' OE1' HD11 ' C' ' 46' ' ' ILE . 9.6 tt0 -75.8 122.71 24.48 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.163 -174.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -121.73 124.2 43.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.743 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.51 HD11 ' HZ1' ' C' ' 43' ' ' LYS . 87.1 mt -88.29 118.23 27.75 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.436 HD13 ' HB3' ' A' ' 38' ' ' GLU . 5.7 mt -114.27 113.12 42.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.047 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -126.15 121.73 33.66 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 59.95 38.39 20.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.792 -177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.03 -4.85 36.33 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.013 -0.54 . . . . 0.0 113.532 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -88.04 130.61 34.93 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.63 88.92 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.059 0.456 . . . . 0.0 109.848 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.536 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.3 OUTLIER -74.02 142.79 45.73 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -155.16 -168.65 2.93 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.042 -171.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.675 ' HA ' HG13 ' C' ' 39' ' ' VAL . 4.7 p-10 -60.78 -1.85 0.46 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.087 0.955 . . . . 0.0 113.421 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -68.53 -3.29 11.09 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.181 0.592 . . . . 0.0 112.165 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.506 ' H ' HG11 ' C' ' 39' ' ' VAL . 57.6 mttp 76.63 -165.45 0.06 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.862 0.865 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 mttt 68.69 55.85 0.46 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.463 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.614 HD21 HG23 ' C' ' 39' ' ' VAL . 31.1 mt -61.78 -33.04 73.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -71.72 -18.18 62.16 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 120.746 0.308 . . . . 0.0 111.575 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -76.44 -26.8 55.82 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.555 ' HD2' HD23 ' C' ' 72' ' ' LEU . 16.2 m-85 -82.63 -24.03 34.0 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 58.5 t30 62.88 41.52 8.6 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.596 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.26 -5.25 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-N 112.955 -1.929 . . . . 0.0 112.748 -158.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.692 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -52.58 104.92 0.2 Allowed Glycine 0 CA--C 1.487 -1.666 0 CA-C-O 123.329 1.516 . . . . 0.0 113.769 173.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.97 14.21 59.58 Favored Glycine 0 C--N 1.287 -2.194 0 CA-C-N 111.388 -2.406 . . . . 0.0 113.961 168.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -121.49 138.95 54.07 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.668 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 13.1 m -74.76 127.81 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 122.191 0.996 . . . . 0.0 111.46 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.5 HD13 HD12 ' C' ' 66' ' ' LEU . 12.6 mt -86.25 167.86 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.838 174.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.453 ' N ' HG22 ' C' ' 82' ' ' ILE . 65.2 m80 -118.92 115.3 24.08 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.41 HD23 HG22 ' C' ' 23' ' ' THR . 19.5 tp -92.45 132.79 36.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.276 0.56 . . . . 0.0 111.914 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 m . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.342 177.635 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HB3' HD12 ' A' ' 40' ' ' LEU . 77.6 mtp180 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 120.895 0.378 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.691 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.8 m-85 -116.25 144.82 43.72 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.412 173.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.53 ' CB ' HD21 ' A' ' 40' ' ' LEU . 53.8 t80 -114.24 121.59 44.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.762 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -98.43 119.52 37.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 174.698 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -76.88 -13.33 60.0 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.468 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 36.3 t -70.89 -42.04 70.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.353 0.597 . . . . 0.0 110.581 175.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -85.21 -27.03 26.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.581 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 1.6 m 58.09 29.5 17.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.214 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.37 144.25 34.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -74.82 147.64 40.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.177 0.513 . . . . 0.0 111.267 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.794 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.6 pt -133.36 169.7 21.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.841 -169.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.37 108.64 35.61 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 158.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.691 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 15.0 Cg_endo -69.06 177.49 5.05 Favored 'Trans proline' 0 C--N 1.328 -0.53 0 C-N-CA 125.181 3.921 . . . . 0.0 115.315 -170.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.6 ' HB2' HG13 ' A' ' 28' ' ' ILE . 8.2 mtt180 -112.57 50.46 0.87 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.592 174.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.509 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -0.3 -60.23 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 CA-C-N 111.334 -2.667 . . . . 0.0 116.365 172.316 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 24' ' ' LEU . 27.7 Cg_exo -34.79 -36.4 0.12 Allowed 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 123.045 2.497 . . . . 0.0 114.386 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.533 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -110.35 -22.92 11.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.72 178.462 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 66.24 49.26 1.51 Allowed 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.642 -168.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.6 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -98.17 162.18 2.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.07 174.511 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.542 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.8 t -97.63 147.1 32.53 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.794 ' HD3' HD12 ' A' ' 20' ' ' ILE . 66.6 Cg_endo -80.93 -22.84 5.9 Favored 'Trans proline' 0 CA--C 1.499 -1.261 0 C-N-CA 122.897 2.398 . . . . 0.0 108.21 -174.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.516 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 80.1 mtt-85 -81.66 -30.02 32.9 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 112.819 -1.991 . . . . 0.0 113.776 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.4 p -141.6 -7.02 0.99 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.429 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 17.6 tt0 59.47 27.37 16.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.552 0.691 . . . . 0.0 111.219 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -107.71 143.02 36.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.369 171.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.37 33.24 2.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.899 -0.667 . . . . 0.0 114.012 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 41.1 m-85 -89.54 45.08 1.25 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.101 0.477 . . . . 0.0 110.423 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.688 HG21 ' CD1' ' A' ' 20' ' ' ILE . 10.4 pt -112.32 132.48 60.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.227 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' C' ' 65' ' ' VAL . 7.5 pt-20 -120.08 136.23 54.66 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.95 137.57 39.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.971 0.415 . . . . 0.0 110.094 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.53 HD21 ' CB ' ' A' ' 12' ' ' PHE . 10.4 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.363 -172.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 16' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 45.5 ttm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.266 0.555 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 17' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -108.69 142.53 39.07 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.104 176.932 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.628 ' HA ' HG13 ' C' ' 32' ' ' ILE . 37.8 mt-10 -85.04 94.69 8.89 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.5 t -77.9 111.46 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.613 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.665 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.4 mt -100.02 146.97 26.12 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.67 HG21 ' HE2' ' C' ' 31' ' ' PHE . 9.4 m -137.32 153.9 29.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 22' ' ' LYS . . . . . 0.543 ' HG3' ' CG2' ' C' ' 81' ' ' VAL . 41.0 mtmt -125.77 133.18 52.14 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.314 -0.944 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.121 -172.418 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 25.5 m . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -131.21 157.55 42.91 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.442 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 30' ' ' THR . . . . . 0.562 HG22 ' CD2' ' C' ' 20' ' ' LEU . 16.8 p -103.76 149.11 25.32 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -172.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 31' ' ' PHE . . . . . 0.67 ' HE2' HG21 ' C' ' 21' ' ' VAL . 27.6 m-85 -140.36 63.11 1.48 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.376 -177.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.628 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -59.17 122.69 9.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 122.973 1.368 . . . . 0.0 114.154 -174.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.639 HG11 ' CD1' ' C' ' 42' ' ' PHE . 13.9 m -135.74 -168.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 111.498 -2.592 . . . . 0.0 112.107 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.47 38.72 2.56 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.457 -0.878 . . . . 0.0 114.423 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 35' ' ' ALA . . . . . 0.734 ' HB2' HD21 ' C' ' 17' ' ' LEU . . . 71.09 16.99 6.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 163.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.733 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 56.3 tt0 153.43 -7.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.787 0.803 . . . . 0.0 108.933 -166.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 37' ' ' MET . . . . . 0.493 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 35.8 tpp -47.94 -66.52 0.39 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.296 173.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.493 ' OD1' ' HG3' ' C' ' 37' ' ' MET . 18.3 m120 -139.99 -162.68 1.38 Allowed 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 168.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.643 HG13 ' HA ' ' C' ' 68' ' ' ASP . 8.1 p 173.72 -19.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.538 ' HE2' ' HE2' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -83.05 -70.65 0.54 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.123 173.369 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -62.77 -32.45 73.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.531 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.639 ' CD1' HG11 ' C' ' 33' ' ' VAL . 5.9 t80 -59.05 -52.17 66.89 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.625 175.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 43' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -68.04 -35.67 78.64 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.638 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -56.39 -40.43 74.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.026 0.441 . . . . 0.0 111.133 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -69.56 -41.15 76.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.742 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 46' ' ' ILE . . . . . 0.625 ' O ' HG22 ' C' ' 50' ' ' VAL . 6.2 pt -76.59 -16.62 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -176.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -39.17 -59.57 1.0 Allowed 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.81 95.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -23.57 67.32 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.177 0.513 . . . . 0.0 111.097 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.628 HG21 ' OE1' ' C' ' 57' ' ' GLN . 26.7 m -108.91 -5.93 10.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.096 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t 69.17 19.63 7.86 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.558 0.694 . . . . 0.0 109.637 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 52' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 3.4 mm -129.26 118.4 19.22 Favored Pre-proline 0 N--CA 1.444 -0.761 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.726 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 53' ' ' PRO . . . . . 0.481 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 5.1 Cg_exo -70.1 146.67 58.75 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.121 1.88 . . . . 0.0 111.188 177.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 54' ' ' SER . . . . . 0.427 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 8.7 t -53.48 -26.18 19.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.009 -176.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.526 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.7 pt-20 -71.63 -32.45 67.96 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.899 0.38 . . . . 0.0 110.998 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 57.4 mtpt -99.45 -24.42 14.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.36 0.6 . . . . 0.0 110.123 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.628 ' OE1' HG21 ' C' ' 50' ' ' VAL . 6.2 tt0 -69.2 122.64 19.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.728 -173.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -112.02 122.63 48.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.674 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 95.3 mt -88.46 110.75 21.1 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.463 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.2 mt -108.64 113.88 45.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.95 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -133.54 132.54 41.05 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 59.11 34.21 23.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.401 -173.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 63' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 67.83 2.31 22.58 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.777 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -91.16 136.48 33.06 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -90.64 89.18 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.43 0.633 . . . . 0.0 109.563 -176.332 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.562 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.3 OUTLIER -73.67 140.94 46.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.918 178.577 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -153.53 -169.31 3.26 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.561 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 68' ' ' ASP . . . . . 0.643 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.4 p-10 -65.56 -0.43 2.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.268 0.627 . . . . 0.0 112.161 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 69' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 38.4 t70 -58.32 -10.9 2.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.296 1.038 . . . . 0.0 113.367 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.538 ' HE2' ' HE2' ' C' ' 40' ' ' LYS . 89.5 mttt 85.6 175.16 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.285 1.034 . . . . 0.0 113.226 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 64.74 86.02 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.916 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.621 ' HB2' ' C ' ' C' ' 35' ' ' ALA . 57.9 mt -75.42 -34.15 60.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -66.41 -19.3 65.76 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 120.699 0.285 . . . . 0.0 111.636 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -68.8 -28.41 66.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 75' ' ' TYR . . . . . 0.562 ' CD1' HD22 ' C' ' 66' ' ' LEU . 20.9 m-85 -85.85 -23.26 27.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.1 t30 61.07 36.52 18.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.848 -1.524 . . . . 0.0 110.852 171.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.04 25.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.711 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.723 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -72.14 95.14 0.65 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-O 122.203 0.89 . . . . 0.0 113.074 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.64 14.77 45.73 Favored Glycine 0 C--N 1.305 -1.179 0 CA-C-N 113.341 -1.429 . . . . 0.0 113.508 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -119.01 149.82 40.99 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.052 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.665 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 10.5 m -82.68 124.07 39.04 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-O 122.299 1.047 . . . . 0.0 111.177 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 82' ' ' ILE . . . . . 0.481 HG22 ' N ' ' C' ' 83' ' ' HIS . 68.2 mt -81.95 167.3 2.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.925 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 83' ' ' HIS . . . . . 0.481 ' N ' HG22 ' C' ' 82' ' ' ILE . 88.8 m-70 -118.71 115.11 23.82 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.446 HD21 HG11 ' C' ' 50' ' ' VAL . 4.3 pp -113.94 151.47 32.24 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.051 -1.059 . . . . 0.0 112.562 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.415 0 CA-C-N 113.174 -1.83 . . . . 0.0 110.352 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 18.4 m -54.91 -41.49 71.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.324 0.583 . . . . 0.0 109.72 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 ttm -95.89 123.89 39.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.064 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' A' ' 5' ' ' SER . . . 66.48 90.38 0.09 Allowed 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.869 0.731 . . . . 0.0 111.013 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.2 pm0 -66.24 114.23 5.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.225 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.61 22.61 9.99 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.008 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.591 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 23.2 t -118.72 113.46 36.25 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.44 96.46 1.04 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.726 2.284 . . . . 0.0 111.966 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -88.21 131.47 42.49 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.561 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -87.6 22.7 0.87 Allowed 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 123.242 2.628 . . . . 0.0 114.019 -168.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.75 -4.96 86.98 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -121.12 92.2 3.7 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.861 -0.2 . . . . 0.0 110.707 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 10.0 m-85 -120.67 165.29 15.27 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 167.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CB ' HD21 ' A' ' 40' ' ' LEU . 75.4 t80 -137.22 117.44 13.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.687 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -97.55 120.95 38.86 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -74.69 -15.64 60.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.748 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.6 m -70.78 -37.28 73.34 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.937 0.399 . . . . 0.0 111.147 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' HG23 ' A' ' 18' ' ' VAL . 90.5 m -89.48 -16.0 31.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.695 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 p 49.64 31.35 4.2 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.256 -171.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 16' ' ' CYS . 98.0 t -141.13 146.91 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.539 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 25.5 tt0 -70.39 149.0 47.75 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.343 0.402 . . . . 0.0 111.235 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.703 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.4 pt -138.12 167.01 22.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.477 -173.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.496 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 40.5 t -122.96 96.68 44.67 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 163.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.662 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.88 177.12 0.19 Allowed 'Trans proline' 0 C--N 1.325 -0.691 1 C-N-CA 125.455 4.103 . . . . 0.0 116.426 -170.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.544 ' HB2' HG13 ' A' ' 28' ' ' ILE . 36.7 mtt180 -112.97 51.01 0.85 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 112.818 -1.992 . . . . 0.0 107.565 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' A' ' 27' ' ' TYR . 3.1 mm? 3.0 -60.81 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.213 0 CA-C-N 111.507 -2.588 . . . . 0.0 117.555 171.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 32.6 Cg_exo -37.12 -32.84 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.613 2.209 . . . . 0.0 113.826 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.558 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -118.29 -20.39 8.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.558 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.41 ' C ' HD11 ' A' ' 37' ' ' ILE . 44.1 m-85 65.25 46.66 2.59 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.57 1.176 . . . . 0.0 109.767 -170.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -92.0 163.77 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 113.315 -1.766 . . . . 0.0 109.793 174.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -94.29 144.49 28.1 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.678 ' HD3' HD12 ' A' ' 20' ' ' ILE . 68.3 Cg_endo -80.72 -22.43 6.45 Favored 'Trans proline' 0 CA--C 1.5 -1.208 0 C-N-CA 122.711 2.274 . . . . 0.0 108.083 -171.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 51.6 mtt180 -81.24 -34.76 31.92 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.968 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.4 p -139.27 -8.42 1.31 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.333 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 60.11 25.98 15.32 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.0 m -98.5 133.69 42.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 166.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.03 30.76 2.62 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.007 -172.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 51.8 m-85 -86.58 47.99 1.56 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.498 0.666 . . . . 0.0 109.842 176.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.703 HG21 ' CD1' ' A' ' 20' ' ' ILE . 9.6 pt -111.33 133.45 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.382 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' HB3' HD13 ' C' ' 60' ' ' ILE . 11.5 pt-20 -117.2 141.48 48.23 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -79.29 131.99 36.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.206 0.527 . . . . 0.0 109.848 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.452 HD21 ' CB ' ' A' ' 12' ' ' PHE . 2.5 mt . . . . . 0 C--O 1.25 1.12 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.877 -173.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.16 107.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.743 0.652 . . . . 0.0 111.762 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 38.7 m80 65.14 46.26 2.78 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.823 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -83.88 -59.04 2.54 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 38.7 t60 51.13 54.09 11.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.512 0.672 . . . . 0.0 111.53 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -145.91 76.73 1.47 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 52.9 m80 67.5 87.94 0.12 Allowed 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 124.064 0.853 . . . . 0.0 108.915 -171.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -56.63 -29.35 62.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.563 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.7 148.85 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.886 0.85 . . . . 0.0 110.353 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -158.15 -40.47 0.06 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.088 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -69.76 -68.43 0.41 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.321 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.98 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.75 0.656 . . . . 0.0 111.559 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.21 -29.07 54.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.294 0.568 . . . . 0.0 109.986 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' LYS . . . . . 0.514 ' HA ' ' HB2' ' C' ' 35' ' ' ALA . 51.4 mtpt -72.69 -174.99 1.55 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.703 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.505 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 12.2 tpt 69.12 96.86 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.463 0.477 . . . . 0.0 110.335 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.735 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -99.19 148.29 24.25 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.543 ' HA ' HG13 ' C' ' 32' ' ' ILE . 30.2 tt0 -98.72 91.58 5.17 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.3 t -78.79 106.11 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.443 -168.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.614 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -94.64 140.93 29.21 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' C' ' 82' ' ' ILE . 70.7 t -151.68 120.44 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 37.7 mtpt -95.54 159.18 15.12 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 63.3 p -106.89 -42.23 4.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.783 -171.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.78 -46.57 0.06 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.731 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -178.07 -48.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.154 0.502 . . . . 0.0 110.158 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -62.53 -40.4 96.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.85 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -108.12 176.07 5.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.521 1.153 . . . . 0.0 113.637 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 22.8 m -176.68 102.88 0.06 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.146 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -125.59 152.89 44.51 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.63 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p -99.1 145.42 27.16 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.162 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.478 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 29.0 m-85 -135.88 58.54 1.74 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.654 -175.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.543 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -57.35 122.29 6.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 123.381 1.563 . . . . 0.0 114.362 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -142.94 -165.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 110.677 -2.965 . . . . 0.0 111.39 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -81.57 -179.85 53.13 Favored Glycine 0 C--N 1.312 -0.769 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.123 174.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.735 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -78.78 -23.83 45.04 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-N 117.254 0.527 . . . . 0.0 110.132 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -151.75 23.08 0.69 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -162.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' MET . . . . . 0.49 ' HB2' ' HA3' ' C' ' 34' ' ' GLY . 25.5 ttt -73.6 -68.75 0.48 Allowed 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 111.409 -2.632 . . . . 0.0 110.805 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.454 ' OD1' ' HG2' ' C' ' 37' ' ' MET . 23.6 m120 -126.19 -94.52 0.46 Allowed 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.585 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 82.94 -38.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 O-C-N 124.305 1.003 . . . . 0.0 111.128 -162.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.528 ' HA ' ' CB ' ' C' ' 68' ' ' ASP . 0.0 OUTLIER -78.97 -69.46 0.57 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 122.512 1.148 . . . . 0.0 108.939 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 41' ' ' GLU . . . . . 0.413 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 20.7 mt-10 -63.08 -27.82 69.66 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.902 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.585 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 2.6 t80 -59.05 -50.34 74.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.328 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.485 ' HE3' ' OG ' ' C' ' 54' ' ' SER . 23.1 mtpp -60.61 -41.27 94.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.988 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -57.73 -38.39 75.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.175 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -70.43 -45.97 64.81 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.209 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.602 ' O ' HG22 ' C' ' 50' ' ' VAL . 17.0 pt -76.78 -10.63 13.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -174.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -43.92 -49.46 8.42 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.63 -38.28 48.28 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.707 -0.397 . . . . 0.0 112.065 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -28.21 69.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.987 0.422 . . . . 0.0 110.996 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.602 HG22 ' O ' ' C' ' 46' ' ' ILE . 34.8 m -109.11 -5.84 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.47 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 46.1 m 68.13 20.65 8.9 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 121.629 0.728 . . . . 0.0 109.768 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.6 mm -122.95 111.2 30.97 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.546 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 7.1 Cg_exo -70.49 141.6 42.65 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.61 2.207 . . . . 0.0 111.695 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.485 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 42.8 t -50.75 -26.19 5.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.73 -173.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.402 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 13.4 pt-20 -72.75 -36.31 67.69 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.402 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 89.0 mttt -94.85 -32.28 13.33 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.741 0.782 . . . . 0.0 109.468 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.465 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 20.8 tt0 -51.92 132.43 32.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.664 -1.607 . . . . 0.0 111.48 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -133.95 113.02 11.73 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.524 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 37.8 mt -84.89 118.38 24.48 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 38' ' ' GLU . 5.4 mt -117.25 121.17 67.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.664 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -137.85 132.82 33.12 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 59.15 32.87 22.45 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.534 0.521 . . . . 0.0 110.14 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 67.85 4.18 32.47 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.87 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -88.7 142.08 27.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -90.24 89.41 3.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.631 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -81.14 131.86 35.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 67' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' C' ' 69' ' ' ASP . 9.3 pt20 -144.67 -177.32 5.44 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.536 -176.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.547 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.7 p-10 -70.51 -3.22 16.87 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.751 0.821 . . . . 0.0 112.033 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' ASP . . . . . 0.426 ' H ' ' HG3' ' C' ' 67' ' ' GLN . 33.1 t70 -70.32 -21.63 62.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -174.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -131.85 -142.22 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.196 -0.315 . . . . 0.0 111.442 -169.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' C' ' 71' ' ' LYS . 9.9 mptt -126.64 167.17 16.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.623 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.487 HD23 HG23 ' C' ' 39' ' ' VAL . 7.3 mt -70.61 -37.31 73.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.022 0.439 . . . . 0.0 111.758 -175.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 73' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' C' ' 35' ' ' ALA . 23.1 tp60 -70.66 -18.65 62.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.521 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -61.61 -29.41 70.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.83 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.631 ' CD1' HD22 ' C' ' 66' ' ' LEU . 36.8 m-85 -103.66 -18.62 14.65 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.65 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.8 t30 59.22 52.6 5.96 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.904 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 35.1 m -95.23 14.98 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -171.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -57.56 99.27 0.1 OUTLIER Glycine 0 CA--C 1.492 -1.381 0 CA-C-O 122.915 1.286 . . . . 0.0 113.789 171.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.94 14.92 47.4 Favored Glycine 0 C--N 1.284 -2.328 0 CA-C-N 111.877 -2.162 . . . . 0.0 114.132 171.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.35 141.19 50.29 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 122.495 -0.414 . . . . 0.0 110.642 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.614 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 21.2 m -78.37 123.96 36.02 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-O 121.932 0.872 . . . . 0.0 111.104 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' C' ' 21' ' ' VAL . 66.3 mt -82.6 168.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.0 172.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.501 ' N ' HG22 ' C' ' 82' ' ' ILE . 62.5 m80 -118.27 115.5 24.86 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 15.0 mt -88.42 148.73 24.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.17 0.51 . . . . 0.0 111.452 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.6 164.56 15.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.133 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.12 124.48 45.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.398 177.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -98.81 175.35 5.99 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.185 0.517 . . . . 0.0 111.251 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.77 148.97 95.12 Favored Pre-proline 0 N--CA 1.443 -0.793 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' C' ' 90' ' ' PRO . 41.4 Cg_exo -55.74 135.46 69.62 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.939 1.759 . . . . 0.0 111.639 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 90' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' C' ' 89' ' ' PRO . 68.8 Cg_endo -94.13 49.25 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.134 2.556 . . . . 0.0 112.227 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -74.41 -27.49 60.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.387 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 11.6 t -80.16 -20.16 45.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.381 0.61 . . . . 0.0 109.822 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -87.91 -30.6 19.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.044 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 48.8 tp -119.4 90.0 41.52 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.642 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.71 153.05 64.8 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.591 2.194 . . . . 0.0 111.294 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 46.3 t 65.63 88.35 0.11 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.341 0.591 . . . . 0.0 110.516 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.33 46.4 2.82 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.527 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.51 -59.38 1.95 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.759 0.314 . . . . 0.0 110.246 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 69.8 m -69.53 107.69 3.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.738 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 33.0 m 59.15 42.78 18.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.831 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.93 0 CA-C-O 119.195 -0.781 . . . . 0.0 111.471 -179.457 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.0 t -163.3 141.72 8.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.912 0.387 . . . . 0.0 110.798 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt -144.2 108.2 4.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.924 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.82 56.9 1.79 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.266 0.555 . . . . 0.0 110.714 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -83.7 61.61 6.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.742 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.79 87.56 5.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.34 -175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 t 66.32 96.22 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.845 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.72 83.8 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 123.031 2.487 . . . . 0.0 112.308 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -80.02 -45.08 1.48 Allowed Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -87.33 52.81 2.49 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 122.021 1.814 . . . . 0.0 111.593 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.45 ' O ' HG22 ' A' ' 21' ' ' VAL . . . 159.5 110.29 0.27 Allowed Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.742 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -139.4 86.03 2.09 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.443 -0.878 . . . . 0.0 109.547 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.605 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 9.0 m-85 -115.88 169.6 9.11 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.513 -1.222 . . . . 0.0 108.39 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.642 ' HB2' HD21 ' A' ' 40' ' ' LEU . 38.4 t80 -142.0 113.62 7.83 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.917 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 31.6 p -83.09 87.67 6.9 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.813 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.535 ' CE1' HG13 ' C' ' 85' ' ' VAL . 30.3 p80 -66.17 -14.72 62.32 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.619 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.766 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 3.0 p -67.08 -49.08 66.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.044 0.449 . . . . 0.0 110.437 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.9 -5.61 28.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.626 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m 65.16 55.44 1.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.034 172.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.94 145.36 24.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.4 tt0 -86.25 138.92 31.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.132 0.492 . . . . 0.0 110.709 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.783 HD11 HG21 ' A' ' 37' ' ' ILE . 6.2 pt -143.49 166.87 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -164.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 9' ' ' GLY . 46.5 t -120.07 94.81 48.89 Favored Pre-proline 0 N--CA 1.447 -0.578 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 160.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 9.8 Cg_endo -56.73 171.36 1.03 Allowed 'Trans proline' 0 C--N 1.32 -0.965 1 C-N-CA 125.479 4.119 . . . . 0.0 117.186 -167.23 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HB2' HG13 ' A' ' 28' ' ' ILE . 98.3 mtt180 -101.91 47.48 0.9 Allowed 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 112.4 -2.182 . . . . 0.0 107.205 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -8.53 -54.25 0.01 OUTLIER Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 110.467 -3.06 . . . . 0.0 115.606 172.491 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 19.2 Cg_exo -35.27 -33.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 123.216 2.611 . . . . 0.0 114.512 173.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.511 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -122.91 -19.01 6.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.121 0.486 . . . . 0.0 111.42 177.236 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.482 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 90.5 m-85 73.04 53.28 0.13 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.162 -174.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -108.78 164.16 5.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 113.628 -1.624 . . . . 0.0 108.086 177.21 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 27.1 p -94.49 139.12 22.24 Favored Pre-proline 0 N--CA 1.424 -1.733 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.638 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 85.4 Cg_endo -78.63 -25.31 6.67 Favored 'Trans proline' 0 CA--C 1.493 -1.545 0 C-N-CA 123.535 2.823 . . . . 0.0 108.822 -166.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 52.9 mtt180 -79.68 -28.86 40.67 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.381 -2.19 . . . . 0.0 113.162 -175.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -157.7 9.8 0.18 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.322 -170.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 49.48 64.24 1.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 167.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.554 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -133.3 147.88 51.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.169 169.266 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -88.46 6.85 83.13 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.49 -0.862 . . . . 0.0 114.089 -170.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.766 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 69.8 m-85 -83.4 59.46 5.07 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.505 -0.409 . . . . 0.0 111.485 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.783 HG21 HD11 ' A' ' 20' ' ' ILE . 3.5 pt -112.73 141.56 27.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.07 0.462 . . . . 0.0 111.769 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.539 ' HB3' HD13 ' C' ' 60' ' ' ILE . 9.9 pt-20 -129.23 153.71 47.51 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -84.78 143.4 29.14 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.642 HD21 ' HB2' ' A' ' 12' ' ' PHE . 7.9 mt . . . . . 0 C--N 1.311 -1.066 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.899 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.495 0.188 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.34 41.19 31.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.554 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -99.17 21.02 12.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.468 0.651 . . . . 0.0 110.144 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' C' ' 6' ' ' HIS . 15.4 p80 -93.05 60.9 3.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.074 171.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 6' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' C' ' 5' ' ' HIS . 44.9 m80 67.72 95.33 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.191 -167.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -77.32 66.09 3.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.769 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -83.93 141.32 31.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.42 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 61.56 83.89 0.14 Allowed 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.503 0.502 . . . . 0.0 110.615 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.99 147.55 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.362 0.601 . . . . 0.0 110.551 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -145.51 45.47 1.3 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.239 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -98.3 20.5 12.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.292 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.06 146.17 53.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.261 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.44 -10.63 59.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.501 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 48.6 mttm 46.64 -170.62 0.01 OUTLIER 'General case' 0 C--N 1.339 0.117 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.657 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 24.6 ptt? -171.79 111.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.193 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.882 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.4 OUTLIER -104.09 133.07 49.65 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 170.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.608 ' HA ' HG13 ' C' ' 32' ' ' ILE . 26.0 mt-10 -80.45 96.56 6.78 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.614 HG22 HG23 ' C' ' 77' ' ' VAL . 3.0 t -81.63 104.64 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.5 -172.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -93.31 141.78 28.05 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' C' ' 82' ' ' ILE . 69.5 t -147.84 118.09 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 118.219 0.463 . . . . 0.0 110.781 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.637 ' HG2' ' OG1' ' C' ' 28' ' ' THR . 73.5 mttt -100.09 115.05 28.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.417 HG21 HG12 ' C' ' 50' ' ' VAL . 0.1 OUTLIER -98.55 -173.24 2.5 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.467 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 32.3 mt -82.11 -60.3 2.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.433 0.635 . . . . 0.0 111.021 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -91.01 -18.53 24.46 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.883 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -103.33 -40.33 6.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.798 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 67.25 -177.36 0.2 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.74 0.816 . . . . 0.0 112.564 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.637 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 22.0 m -38.69 101.34 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.591 -175.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -126.67 154.72 43.69 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.332 -1.304 . . . . 0.0 109.547 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 2.4 p -103.03 141.91 35.01 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.489 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 26.8 m-85 -138.08 59.54 1.65 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.247 0.546 . . . . 0.0 109.991 -173.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.608 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.2 mp -54.88 125.46 9.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 123.04 1.4 . . . . 0.0 114.501 -173.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.754 HG21 HD13 ' C' ' 72' ' ' LEU . 15.6 m -132.7 -169.23 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 111.892 -2.413 . . . . 0.0 111.429 -176.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.68 40.85 1.99 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.239 -0.982 . . . . 0.0 114.323 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.882 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 70.07 -28.67 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 168.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -154.48 24.7 0.46 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -76.2 -68.11 0.62 Allowed 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 112.51 -2.132 . . . . 0.0 111.046 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.441 ' O ' HG12 ' C' ' 39' ' ' VAL . 96.0 m-20 -132.29 -87.51 0.45 Allowed 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.655 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 82.41 -37.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 124.746 1.279 . . . . 0.0 111.372 -166.033 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.97 -68.17 0.66 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 122.591 1.186 . . . . 0.0 108.653 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.29 -28.0 69.42 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 112.616 -2.084 . . . . 0.0 110.819 173.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.655 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.2 t80 -58.32 -49.52 76.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.89 174.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.519 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 14.9 mtpp -62.97 -41.2 99.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.92 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -61.63 -37.29 83.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.035 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -70.35 -43.2 70.68 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.532 ' O ' HG22 ' C' ' 50' ' ' VAL . 18.2 pt -76.87 -12.13 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.281 -0.262 . . . . 0.0 110.948 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.94 -55.51 3.71 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 -42.82 91.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -21.64 65.64 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.241 0.543 . . . . 0.0 111.276 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.532 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.7 m -112.31 -3.69 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.44 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 32.9 t 65.8 22.42 11.47 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.843 0.83 . . . . 0.0 109.049 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 11.5 mm -131.35 111.76 15.36 Favored Pre-proline 0 N--CA 1.437 -1.095 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.799 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.507 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 7.2 Cg_exo -68.29 151.68 76.3 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.496 2.13 . . . . 0.0 111.445 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.501 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 32.0 t -51.99 -32.65 34.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.572 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.596 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 13.5 pt-20 -66.26 -33.06 74.9 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.815 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.596 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 90.6 mttt -106.56 -1.04 23.4 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.371 0.605 . . . . 0.0 110.518 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.519 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 24.0 tt0 -90.21 123.62 34.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.109 -168.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.476 ' O ' HG23 ' C' ' 85' ' ' VAL . 29.1 mtm105 -121.77 115.4 22.6 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.402 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 53.5 mt -87.94 122.68 31.84 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 122.452 0.301 . . . . 0.0 110.968 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.539 HD13 ' HB3' ' A' ' 38' ' ' GLU . 8.8 mt -114.63 112.07 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 121.494 -0.754 . . . . 0.0 111.39 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.5 ' CG ' HG12 ' C' ' 77' ' ' VAL . 41.0 t80 -116.62 133.12 56.39 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 62' ' ' GLN . . . . . 0.486 ' HG2' ' CD2' ' C' ' 61' ' ' TYR . 18.3 pt20 39.55 46.14 1.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.142 0.901 . . . . 0.0 112.153 -174.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.71 5.2 63.61 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.864 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -94.85 141.64 28.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.88 98.39 7.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.175 0.512 . . . . 0.0 109.951 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.54 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.0 OUTLIER -90.26 152.09 21.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.228 -176.083 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -158.14 -166.79 2.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.32 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.621 ' HA ' HG13 ' C' ' 39' ' ' VAL . 5.1 p-10 -62.49 0.54 0.46 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.052 0.941 . . . . 0.0 112.592 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.59 -11.65 0.96 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.376 1.071 . . . . 0.0 112.957 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.548 ' H ' HG11 ' C' ' 39' ' ' VAL . 7.8 mtmp? 84.55 167.43 0.09 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.481 1.112 . . . . 0.0 113.429 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 68.29 83.79 0.16 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.053 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.754 HD13 HG21 ' C' ' 33' ' ' VAL . 13.6 mt -64.47 -32.19 73.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.513 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 73' ' ' GLN . . . . . 0.428 ' H ' ' HG2' ' C' ' 73' ' ' GLN . 22.5 pt20 -68.83 -29.07 67.33 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.641 -176.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.49 -27.73 67.25 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.54 ' CD1' HD22 ' C' ' 66' ' ' LEU . 30.7 m-85 -82.96 -23.11 33.56 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.5 t30 63.44 36.67 11.2 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.707 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.614 HG23 HG22 ' C' ' 19' ' ' VAL . 20.0 m -85.25 26.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.646 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -86.09 102.36 2.68 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-O 122.926 1.292 . . . . 0.0 113.441 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.89 13.26 56.83 Favored Glycine 0 C--N 1.285 -2.29 0 CA-C-N 112.266 -1.967 . . . . 0.0 114.022 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -133.58 152.53 51.91 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 18.4 m -79.11 126.07 38.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.904 0.859 . . . . 0.0 112.62 -175.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.621 ' HB ' HG22 ' C' ' 21' ' ' VAL . 46.2 mt -71.21 161.68 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.339 168.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.432 ' N ' HG22 ' C' ' 82' ' ' ILE . 45.5 m80 -116.01 113.0 22.63 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 171.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.446 ' CD1' HG11 ' C' ' 50' ' ' VAL . 1.6 mt -85.84 157.86 20.11 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.504 -176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.535 HG13 ' CE1' ' A' ' 14' ' ' HIS . 2.7 t -114.65 147.83 17.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 174.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -126.41 122.43 35.28 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.501 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -93.01 176.73 6.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.828 0.347 . . . . 0.0 111.69 -171.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.37 154.59 42.01 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.89 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.8 149.59 40.59 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.605 2.203 . . . . 0.0 111.381 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.61 135.61 39.53 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.625 2.217 . . . . 0.0 112.325 -173.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -68.35 -25.5 65.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.395 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 6.4 t 35.97 65.32 0.44 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 124.577 1.173 . . . . 0.0 113.303 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -66.32 -46.94 75.15 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.21 113.79 60.98 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.537 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.49 140.4 93.11 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.678 2.252 . . . . 0.0 112.407 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 32.5 t -58.79 125.78 24.91 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.366 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.08 -23.89 2.41 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.67 40.55 2.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.126 0.489 . . . . 0.0 110.916 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 15.9 t -78.49 -20.26 51.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.486 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 68.8 p -74.64 110.24 8.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.539 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.348 -1.251 . . . . 0.0 111.704 178.535 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.8 t -74.43 118.92 17.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.859 0.361 . . . . 0.0 110.202 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.51 89.98 1.89 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.44 18.79 7.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.214 0.53 . . . . 0.0 110.276 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -96.75 141.85 29.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.002 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.84 -24.91 40.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.083 0.468 . . . . 0.0 110.073 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -152.41 74.5 7.35 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.124 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.64 -43.6 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.141 1.894 . . . . 0.0 111.834 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 6.4 p-80 -169.08 136.53 1.55 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.707 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 77.8 Cg_endo -95.54 57.24 0.19 Allowed 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 123.763 2.975 . . . . 0.0 111.799 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.23 16.27 0.29 Allowed Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.76 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 10.9 ptt180 -71.37 106.21 3.81 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.852 0.834 . . . . 0.0 110.907 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.544 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 8.6 m-85 -122.43 174.05 7.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.701 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CB ' HD11 ' A' ' 40' ' ' LEU . 79.1 t80 -142.05 121.27 13.04 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.119 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -100.98 120.29 39.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.812 176.472 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.521 ' CD2' HG21 ' C' ' 85' ' ' VAL . 62.6 m-70 -74.43 -16.24 60.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.565 -175.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.97 -35.8 72.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.42 ' O ' HG23 ' A' ' 18' ' ' VAL . 88.0 m -91.71 -23.84 19.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.313 0.578 . . . . 0.0 110.319 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.411 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER 56.23 31.42 18.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.421 -173.24 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 16' ' ' CYS . 39.7 t -136.82 148.31 26.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.763 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 32.3 tt0 -67.19 147.34 53.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.895 0.379 . . . . 0.0 111.326 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.773 ' CD1' HG21 ' A' ' 37' ' ' ILE . 4.2 pt -139.89 168.73 17.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.564 -175.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 94.0 t -126.4 101.29 28.04 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 162.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 6.0 Cg_endo -56.39 174.77 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 125.273 3.982 . . . . 0.0 116.736 -171.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.505 ' HB2' HG13 ' A' ' 28' ' ' ILE . 8.6 mtt180 -107.25 47.2 0.89 Allowed 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.875 175.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 1.6 -61.73 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.941 0 CA-C-N 110.783 -2.917 . . . . 0.0 116.912 175.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 39.2 Cg_exo -30.24 -34.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 124.017 3.145 . . . . 0.0 114.904 175.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.571 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.86 -19.65 9.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 54.7 m-85 68.79 47.62 0.81 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.41 -171.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -101.24 161.47 3.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.237 176.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.9 OUTLIER -97.35 145.54 29.83 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.423 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.759 ' HD3' HD12 ' A' ' 20' ' ' ILE . 83.2 Cg_endo -84.26 -15.61 6.44 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 C-N-CA 122.415 2.077 . . . . 0.0 108.864 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.542 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 60.1 mtt-85 -85.12 -21.37 29.3 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.354 -1.748 . . . . 0.0 114.074 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.2 p -149.03 -7.25 0.37 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 58.22 30.81 19.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.803 0.811 . . . . 0.0 111.207 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.7 m -112.47 139.22 48.23 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.583 172.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.38 53.72 4.69 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.419 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.711 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 84.5 m-85 -112.18 46.67 1.13 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.413 0.625 . . . . 0.0 110.011 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.773 HG21 ' CD1' ' A' ' 20' ' ' ILE . 3.4 pt -112.15 138.54 40.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.41 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HB2' HG22 ' C' ' 65' ' ' VAL . 11.2 pt-20 -117.18 141.92 47.68 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -73.6 142.74 46.55 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.161 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 111.547 0.202 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.53 7.91 2.16 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.738 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -154.78 37.39 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.359 0.6 . . . . 0.0 110.8 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -111.88 -61.8 1.66 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -78.97 93.13 5.03 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -76.18 101.84 5.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.452 0.644 . . . . 0.0 111.704 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -80.16 56.42 2.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -148.98 88.34 1.59 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.93 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.87 150.9 3.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.945 0.403 . . . . 0.0 110.659 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -117.15 41.39 2.78 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 122.192 0.996 . . . . 0.0 108.662 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.27 166.46 13.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.388 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 16.8 t70 81.96 -16.4 0.62 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.645 0.778 . . . . 0.0 111.464 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.22 -55.23 11.2 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 71.1 mttt 46.22 -175.27 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.97 -52.02 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.18 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.948 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.8 OUTLIER -102.86 131.03 50.05 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 111.456 -172.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.593 ' HA ' HG13 ' C' ' 32' ' ' ILE . 41.9 tt0 -88.01 94.43 9.79 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 5.6 t -80.75 104.87 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.513 -173.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.728 ' HB3' HG12 ' C' ' 81' ' ' VAL . 1.0 OUTLIER -94.13 141.87 28.05 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 174.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' C' ' 82' ' ' ILE . 78.9 t -150.36 121.32 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.328 0.513 . . . . 0.0 110.585 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 26.2 mtpt -108.36 164.37 12.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.494 0.664 . . . . 0.0 110.669 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 48.7 p -103.95 -162.73 0.92 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.663 167.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.711 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 4.0 mm? -43.53 -42.51 5.01 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 22.6 t70 177.88 -28.57 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.731 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 12.9 p -54.26 -35.08 62.14 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.724 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -138.67 173.82 11.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.628 1.204 . . . . 0.0 113.325 -172.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 61.2 m -172.82 94.89 0.12 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.322 -2.217 . . . . 0.0 106.589 176.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -118.95 159.69 23.36 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.869 -1.132 . . . . 0.0 112.215 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 1.4 p -100.66 139.65 36.04 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.947 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.625 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 23.3 m-85 -133.83 55.86 1.88 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.231 -171.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.593 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -54.55 123.11 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 123.38 1.562 . . . . 0.0 113.979 -174.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.453 HG21 HD22 ' C' ' 72' ' ' LEU . 11.2 m -126.87 -175.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 110.961 -2.836 . . . . 0.0 111.196 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.65 52.72 0.8 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.512 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.948 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 71.01 -29.29 0.19 Allowed 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 167.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -162.19 23.83 0.11 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -172.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' MET . . . . . 0.551 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 16.0 tpt -72.2 -69.24 0.41 Allowed 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 111.754 -2.476 . . . . 0.0 111.435 -171.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.551 ' OD1' ' HG3' ' C' ' 37' ' ' MET . 24.8 m120 -129.18 -82.86 0.57 Allowed 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.09 0.472 . . . . 0.0 111.229 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.709 ' O ' ' HD2' ' C' ' 43' ' ' LYS . 0.4 OUTLIER 74.36 -31.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.744 -165.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' C' ' 43' ' ' LYS . 0.1 OUTLIER -84.15 -67.94 0.75 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.489 1.138 . . . . 0.0 109.661 178.367 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.17 -25.7 61.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.235 170.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.672 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 1.2 t80 -60.74 -48.63 80.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.425 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.709 ' HD2' ' O ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -53.15 -48.92 67.55 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.862 0.839 . . . . 0.0 109.037 173.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -35.47 74.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.887 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -69.16 -50.95 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.098 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.609 ' O ' HG22 ' C' ' 50' ' ' VAL . 25.5 pt -78.88 -12.44 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.85 -59.3 1.46 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.14 75.34 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.269 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -34.51 72.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.887 0.375 . . . . 0.0 111.113 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.609 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.8 m -100.39 -3.01 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.228 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 26.4 t 69.16 19.75 7.83 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 121.752 0.787 . . . . 0.0 109.287 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.3 mm -128.36 117.67 20.17 Favored Pre-proline 0 N--CA 1.442 -0.836 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.627 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.538 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.0 Cg_exo -65.52 149.37 87.75 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.924 1.749 . . . . 0.0 113.149 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.465 ' CB ' ' HB3' ' C' ' 43' ' ' LYS . 2.2 p -53.37 -29.94 37.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.463 -1.698 . . . . 0.0 113.375 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.8 pt-20 -82.07 -7.47 59.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.65 -176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.57 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 96.0 mttt -125.13 -31.31 3.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.567 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.608 ' OE1' ' HG3' ' C' ' 43' ' ' LYS . 3.3 pt20 -62.6 136.92 58.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.304 0.573 . . . . 0.0 111.185 -174.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -121.49 129.93 53.24 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.798 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' C' ' 66' ' ' LEU . 4.2 mp -91.18 134.57 34.43 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.56 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.3 mt -126.76 115.06 40.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.334 0.588 . . . . 0.0 112.001 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -124.11 116.59 23.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.518 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 61.02 34.87 19.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.494 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.16 -7.39 60.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.483 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 10.1 mmm180 -85.39 127.62 34.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -86.11 91.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.084 0.469 . . . . 0.0 110.227 -176.093 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.691 HD22 ' CD1' ' C' ' 75' ' ' TYR . 1.6 mt -73.24 136.54 44.65 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 67' ' ' GLN . . . . . 0.493 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 8.5 pt20 -149.89 -168.31 3.07 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.275 -171.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.566 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.8 p-10 -66.42 -0.43 2.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.064 0.946 . . . . 0.0 112.629 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' ASP . . . . . 0.493 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 9.2 t70 -69.07 2.46 2.74 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.734 0.813 . . . . 0.0 112.62 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.52 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.8 mtpt 72.74 -177.37 0.19 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.155 175.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 70.58 66.84 0.19 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.979 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.533 ' HA ' ' CD2' ' C' ' 75' ' ' TYR . 6.6 mt -64.12 -41.84 97.08 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.549 -175.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 73' ' ' GLN . . . . . 0.461 ' H ' ' HG2' ' C' ' 73' ' ' GLN . 17.1 pt20 -71.13 -18.27 62.53 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -70.07 -27.69 64.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.691 ' CD1' HD22 ' C' ' 66' ' ' LEU . 22.5 m-85 -74.17 -24.22 59.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 t30 64.09 36.49 9.7 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 123.392 1.568 . . . . 0.0 107.403 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.466 ' CG1' HG22 ' C' ' 19' ' ' VAL . 0.5 OUTLIER -96.41 0.79 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.059 -161.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.578 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -70.41 102.27 1.0 Allowed Glycine 0 N--CA 1.432 -1.591 0 CA-C-O 122.723 1.18 . . . . 0.0 112.824 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.68 13.84 26.83 Favored Glycine 0 C--N 1.283 -2.413 0 CA-C-N 112.24 -1.98 . . . . 0.0 114.325 173.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -124.78 154.36 41.06 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.728 HG12 ' HB3' ' C' ' 20' ' ' LEU . 2.8 m -85.28 131.02 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.093 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.661 HD13 HD12 ' C' ' 66' ' ' LEU . 56.5 mt -83.96 160.56 3.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.246 172.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.446 ' N ' HG22 ' C' ' 82' ' ' ILE . 67.4 m170 -109.22 112.49 24.68 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 166.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.446 HD22 HG12 ' C' ' 21' ' ' VAL . 0.6 OUTLIER -101.15 153.66 19.4 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.426 -0.91 . . . . 0.0 108.618 172.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.521 HG21 ' CD2' ' A' ' 14' ' ' HIS . 17.3 m -127.52 -178.65 2.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.208 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 86' ' ' GLU . . . . . 0.538 ' HG2' ' H ' ' C' ' 87' ' ' ARG . 25.9 tt0 -77.17 175.71 9.41 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.283 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ARG . . . . . 0.538 ' H ' ' HG2' ' C' ' 86' ' ' GLU . 5.0 mtm180 -63.6 166.3 7.03 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.549 0.69 . . . . 0.0 111.058 -175.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' C' ' 89' ' ' PRO . . . -68.47 171.45 5.97 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.051 176.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' C' ' 88' ' ' ALA . 75.6 Cg_exo -53.31 150.63 25.31 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.068 1.845 . . . . 0.0 112.212 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.42 59.14 4.66 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.125 2.55 . . . . 0.0 112.825 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 91' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' C' ' 89' ' ' PRO . 2.4 pt20 -76.83 -16.55 59.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.782 177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t 38.04 52.66 1.57 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.095 0.958 . . . . 0.0 112.661 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -70.36 -53.93 14.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.019 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 95.5 mt -134.59 93.5 18.37 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.97 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.65 -23.8 48.77 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.422 2.081 . . . . 0.0 112.181 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 20.3 t -164.33 148.06 9.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.32 35.12 1.85 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.058 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.59 80.87 1.84 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.19 0.519 . . . . 0.0 110.32 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 11.4 t -107.63 -146.37 0.4 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.635 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 24.9 m 65.79 87.13 0.12 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.488 0.661 . . . . 0.0 110.942 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 179.355 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 2.7 p -98.13 -14.06 20.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 110.581 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm -86.27 71.66 10.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.8 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.12 125.63 32.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.8 150.52 20.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.023 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.46 66.77 9.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.04 0.448 . . . . 0.0 110.335 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -101.35 114.05 65.76 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.928 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.66 143.74 69.33 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.353 2.036 . . . . 0.0 111.936 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.406 ' O ' ' HE1' ' A' ' 11' ' ' TYR . 24.5 m-70 -72.49 -43.96 9.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.54 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.73 101.85 0.81 Allowed 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 122.071 1.847 . . . . 0.0 112.543 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.03 -112.69 0.97 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.012 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 94.5 mtt180 -79.28 87.81 4.96 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.938 -0.631 . . . . 0.0 110.779 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.67 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 14.2 m-85 -115.15 149.45 37.61 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.952 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.544 ' CB ' HD21 ' A' ' 40' ' ' LEU . 71.7 t80 -124.73 120.01 30.57 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.72 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -96.22 121.09 37.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.321 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -73.22 -20.22 60.92 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.388 -173.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -71.15 -30.86 66.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.851 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' O ' HG23 ' A' ' 18' ' ' VAL . 53.4 m -90.94 -18.42 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.475 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.8 p 51.49 30.28 6.18 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.888 0.742 . . . . 0.0 110.843 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 16' ' ' CYS . 73.9 t -144.73 145.71 20.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 20' ' ' ILE . 26.3 tt0 -74.96 151.98 38.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.109 0.481 . . . . 0.0 111.779 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.754 HD12 ' HD3' ' A' ' 30' ' ' PRO . 3.7 pt -138.24 168.51 19.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.958 -171.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.46 109.98 36.12 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 159.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.67 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 18.1 Cg_endo -69.94 174.92 8.96 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 124.45 3.433 . . . . 0.0 115.736 -166.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.493 ' HB2' HG13 ' A' ' 28' ' ' ILE . 75.9 mtt180 -106.64 47.69 0.87 Allowed 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.856 -1.975 . . . . 0.0 106.768 174.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -8.34 -55.9 0.01 OUTLIER Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 110.673 -2.967 . . . . 0.0 116.517 174.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 45.8 Cg_exo -34.13 -35.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 123.255 2.637 . . . . 0.0 114.34 175.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.566 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.19 -19.34 10.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.319 0.58 . . . . 0.0 111.839 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 68.41 55.3 0.51 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.991 -169.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -109.63 163.1 6.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.561 175.323 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -95.19 146.32 31.12 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.754 ' HD3' HD12 ' A' ' 20' ' ' ILE . 52.8 Cg_endo -82.82 -21.88 4.65 Favored 'Trans proline' 0 CA--C 1.504 -0.993 0 C-N-CA 123.202 2.601 . . . . 0.0 108.47 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.4 mtt-85 -79.29 -29.06 42.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.835 -1.984 . . . . 0.0 113.377 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.0 p -147.9 -3.84 0.51 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.69 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 14.7 tt0 60.15 40.51 18.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.067 0.461 . . . . 0.0 111.832 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.4 p -112.59 155.82 23.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.87 44.13 2.09 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.798 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 86.6 m-85 -109.13 47.5 0.92 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.293 0.568 . . . . 0.0 110.158 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.624 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.7 pt -111.86 147.43 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.272 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.532 ' HB2' HG22 ' C' ' 65' ' ' VAL . 12.6 pt-20 -135.57 147.17 48.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.594 0.235 . . . . 0.0 110.804 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.26 144.81 55.72 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 ' CB ' ' A' ' 12' ' ' PHE . 13.5 mt . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.028 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.863 0.363 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.28 7.97 38.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.702 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -97.07 -13.6 22.11 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.121 -0.231 . . . . 0.0 110.994 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -76.73 69.39 3.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.859 0.361 . . . . 0.0 111.827 -176.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -148.11 138.41 22.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.39 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 5.9 t60 53.5 62.6 2.56 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.652 0.595 . . . . 0.0 111.631 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -118.75 -51.18 2.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 62.4 t60 56.22 78.0 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.805 0.691 . . . . 0.0 110.527 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.406 ' C ' ' H ' ' C' ' 12' ' ' ASP . 31.0 m -94.77 169.93 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.955 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 19.4 t70 76.92 -39.51 0.34 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.055 0.942 . . . . 0.0 110.694 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' C' ' 10' ' ' VAL . 22.2 t70 -122.86 112.85 18.36 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.219 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 36.2 t70 58.14 58.98 3.26 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.891 0.853 . . . . 0.0 110.01 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -70.46 -28.6 65.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.39 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -56.31 143.11 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.465 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 50.2 ttm -166.66 112.1 0.79 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.312 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.648 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 0.9 OUTLIER -101.45 132.12 47.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.038 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.584 ' HA ' HG13 ' C' ' 32' ' ' ILE . 30.6 mt-10 -83.87 94.72 8.28 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.554 HG11 ' CZ ' ' C' ' 42' ' ' PHE . 5.4 t -79.23 92.65 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.098 -172.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 1.5 mp -85.24 133.16 34.18 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' C' ' 82' ' ' ILE . 71.1 t -141.58 116.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 40.7 mtpt -88.29 153.58 21.09 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p -118.86 171.59 8.12 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.397 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 8.5 mt -68.08 -7.34 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.788 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -85.16 8.87 16.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.71 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 16.9 m 71.86 13.27 6.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.641 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.52 -177.73 4.5 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.409 0.623 . . . . 0.0 110.756 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 39.1 m -141.27 113.44 7.98 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.519 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -118.48 149.55 41.09 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.376 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -106.52 141.94 36.99 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.178 0.513 . . . . 0.0 111.777 -174.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.478 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 35.9 m-85 -130.9 60.18 1.66 Allowed 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.722 -174.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.584 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -56.58 121.32 4.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 123.338 1.542 . . . . 0.0 114.48 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.87 -166.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 111.038 -2.801 . . . . 0.0 111.57 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -95.62 -170.82 35.89 Favored Glycine 0 C--N 1.312 -0.758 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.396 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.809 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . -103.9 83.24 2.09 Favored 'General case' 0 CA--C 1.477 -1.855 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.809 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 84.4 mt-30 108.6 15.88 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 O-C-N 126.599 2.437 . . . . 0.0 107.795 170.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -76.79 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.063 -2.335 . . . . 0.0 111.528 171.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.486 ' CG ' ' HB2' ' C' ' 41' ' ' GLU . 90.5 m-20 -123.55 -98.5 0.43 Allowed 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.596 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 84.22 -35.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 123.931 0.892 . . . . 0.0 110.648 -162.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.535 ' HA ' ' CB ' ' C' ' 68' ' ' ASP . 0.0 OUTLIER -81.43 -69.53 0.6 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.3 1.048 . . . . 0.0 108.959 177.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 41' ' ' GLU . . . . . 0.486 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 43.3 mt-10 -61.12 -28.95 69.47 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.012 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.596 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.1 t80 -61.1 -51.61 68.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.406 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 52.3 mtpt -58.5 -45.53 88.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.445 0.641 . . . . 0.0 110.358 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -59.79 -34.83 73.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.207 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -70.12 -47.76 60.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.789 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.57 ' O ' HG22 ' C' ' 50' ' ' VAL . 24.2 pt -75.04 -16.96 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.971 -0.104 . . . . 0.0 111.133 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -39.92 -61.0 0.91 Allowed 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -176.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.4 77.48 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.371 -0.532 . . . . 0.0 112.376 -173.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -26.73 68.46 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.181 0.515 . . . . 0.0 110.832 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.57 HG22 ' O ' ' C' ' 46' ' ' ILE . 22.2 m -104.66 -0.77 10.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.849 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 55.1 p 66.16 20.27 11.14 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.766 0.826 . . . . 0.0 109.842 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.7 mm -128.82 112.59 18.88 Favored Pre-proline 0 N--CA 1.437 -1.123 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.073 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.586 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.9 Cg_exo -69.29 146.78 64.22 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.471 2.114 . . . . 0.0 111.284 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.452 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 44.2 t -51.95 -25.97 9.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.347 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.5 pt-20 -79.51 -24.52 42.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.706 0.288 . . . . 0.0 111.342 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' C' ' 87' ' ' ARG . 48.2 mtpt -106.79 -16.27 14.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.854 0.359 . . . . 0.0 110.363 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.534 ' OE1' HD11 ' C' ' 46' ' ' ILE . 0.0 OUTLIER -87.25 148.86 24.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.726 -174.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -139.03 132.25 29.84 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.587 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 52.7 mt -90.67 109.68 20.85 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.598 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.3 mt -106.39 113.73 43.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.263 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.582 ' OH ' ' HD3' ' C' ' 80' ' ' LYS . 50.3 t80 -118.03 127.82 54.17 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 62' ' ' GLN . . . . . 0.462 ' HG2' ' CD2' ' C' ' 61' ' ' TYR . 21.5 pt20 40.98 46.77 2.5 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.028 0.931 . . . . 0.0 112.244 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.28 5.87 78.26 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.686 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -99.4 134.88 41.62 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 38' ' ' GLU . 2.1 t -88.96 90.07 3.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.078 0.466 . . . . 0.0 109.746 -177.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.597 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -73.91 132.14 42.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.122 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -144.83 173.01 12.23 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.201 -171.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.535 ' CB ' ' HA ' ' C' ' 40' ' ' LYS . 5.9 p-10 -70.73 -2.86 16.01 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.896 0.879 . . . . 0.0 113.06 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.25 -15.63 49.53 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.179 -0.326 . . . . 0.0 111.609 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.498 ' HB3' ' OE1' ' C' ' 74' ' ' GLU . 4.0 mtpm? -122.44 -151.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.52 -169.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.504 ' HB2' ' HG3' ' C' ' 74' ' ' GLU . 97.7 mttt -125.25 151.14 46.33 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.838 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.493 HD23 HG23 ' C' ' 39' ' ' VAL . 35.5 mt -57.32 -53.11 61.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 73' ' ' GLN . . . . . 0.571 ' CB ' ' HG3' ' C' ' 36' ' ' GLN . 53.2 tt0 -71.54 -14.4 62.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.565 -170.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 74' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' C' ' 71' ' ' LYS . 46.2 mt-10 -63.09 -29.24 70.65 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.597 ' CD1' HD22 ' C' ' 66' ' ' LEU . 60.5 m-85 -93.91 -21.24 19.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.2 t30 52.87 52.16 14.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.588 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.441 HG21 HD11 ' C' ' 82' ' ' ILE . 29.9 m -93.27 19.85 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.307 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.648 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -75.18 102.39 1.45 Allowed Glycine 0 CA--C 1.482 -2.01 0 CA-C-O 122.483 1.046 . . . . 0.0 111.713 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.12 14.97 46.65 Favored Glycine 0 C--N 1.281 -2.481 0 CA-C-N 112.562 -1.819 . . . . 0.0 112.107 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 80' ' ' LYS . . . . . 0.582 ' HD3' ' OH ' ' C' ' 61' ' ' TYR . 81.2 mttt -123.46 142.33 51.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 16.3 m -82.35 133.91 28.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.907 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' C' ' 21' ' ' VAL . 29.1 mt -92.56 170.19 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.265 175.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.486 ' N ' HG22 ' C' ' 82' ' ' ILE . 70.5 m80 -118.56 114.49 22.88 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.531 HD11 HD12 ' C' ' 46' ' ' ILE . 0.9 OUTLIER -89.79 141.45 28.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.383 0.611 . . . . 0.0 111.743 178.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m -151.83 170.78 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.671 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' GLU . . . . . 0.507 ' HB2' HD12 ' C' ' 52' ' ' ILE . 32.4 tt0 -110.8 148.37 32.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.374 175.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' C' ' 56' ' ' LYS . 63.8 mtm180 -63.76 166.55 6.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.905 0.859 . . . . 0.0 110.983 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.45 ' HB1' ' HD2' ' C' ' 89' ' ' PRO . . . -73.26 172.5 7.94 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.568 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.45 ' HD2' ' HB1' ' C' ' 88' ' ' ALA . 75.2 Cg_exo -54.39 150.79 32.38 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.767 1.644 . . . . 0.0 111.386 174.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 90' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' C' ' 89' ' ' PRO . 3.2 Cg_exo -73.35 30.36 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.956 2.438 . . . . 0.0 113.289 -174.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 91' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' C' ' 89' ' ' PRO . 7.2 pt20 -80.61 -26.35 37.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.189 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -82.58 83.52 7.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.943 0.877 . . . . 0.0 110.726 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -146.09 87.05 1.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.071 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' C' ' 94' ' ' LEU . 1.5 pt? -124.95 110.88 27.24 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.125 0.488 . . . . 0.0 111.033 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.06 -25.92 82.09 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 123.046 2.497 . . . . 0.0 112.283 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 7.9 p -86.88 28.2 0.92 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.81 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.92 -52.91 6.06 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.844 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 51.96 72.5 0.38 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.9 0.48 . . . . 0.0 111.732 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 39.6 t -75.54 93.1 2.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.093 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 9.3 t 60.64 71.39 0.57 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.655 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.671 -1.072 . . . . 0.0 111.59 178.733 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 111.709 -0.557 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 4.8 p -133.24 153.06 51.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.544 0.211 . . . . 0.0 110.725 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tmm? 71.11 87.78 0.11 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.56 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.47 -37.6 10.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.204 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -87.9 151.32 22.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.015 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.72 11.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 t 56.44 78.86 0.36 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.21 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -71.31 79.37 1.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.78 2.32 . . . . 0.0 111.962 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.468 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 42.3 m-70 64.91 88.71 0.11 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.233 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 7' ' ' HIS . 18.6 Cg_endo -51.25 112.89 0.9 Allowed 'Trans proline' 0 N--CA 1.444 -1.408 0 C-N-CA 124.442 3.428 . . . . 0.0 114.482 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.64 -117.86 1.79 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 172.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 10' ' ' ARG . 10.6 ptt180 -167.79 101.1 0.47 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.471 0.653 . . . . 0.0 111.082 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.686 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 14.3 m-85 -120.17 167.24 12.44 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.401 ' CB ' HD11 ' A' ' 40' ' ' LEU . 65.7 t80 -140.35 114.56 9.15 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.446 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -95.44 114.97 26.79 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.567 174.27 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -69.9 -18.09 63.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.118 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.545 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 43.9 t -68.66 -35.44 77.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.081 0.467 . . . . 0.0 110.708 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.443 ' O ' HG23 ' A' ' 18' ' ' VAL . 92.6 m -95.16 -15.26 23.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.817 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.5 p 51.57 29.87 5.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.237 1.015 . . . . 0.0 111.582 -173.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 16' ' ' CYS . 97.2 t -139.39 147.25 24.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.761 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.66 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 31.4 tt0 -67.48 149.15 50.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.17 0.509 . . . . 0.0 111.092 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.809 HD11 HG21 ' A' ' 37' ' ' ILE . 3.5 pt -138.68 167.36 21.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.856 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 19.4 t -122.64 96.23 45.79 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 164.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.686 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 9.5 Cg_endo -58.36 176.48 0.39 Allowed 'Trans proline' 0 C--N 1.325 -0.697 1 C-N-CA 125.349 4.033 . . . . 0.0 117.776 -167.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.525 ' C ' ' HD2' ' A' ' 25' ' ' PRO . 40.2 mtt180 -112.25 51.42 0.81 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.764 -2.471 . . . . 0.0 106.848 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -7.32 -53.73 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.911 0 CA-C-N 111.705 -2.498 . . . . 0.0 115.965 172.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.525 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 24.1 Cg_exo -31.17 -39.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.398 2.732 . . . . 0.0 114.204 174.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.56 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -120.03 -16.64 8.57 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.296 0.57 . . . . 0.0 111.342 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.473 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 66.3 m-85 70.87 52.26 0.29 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.018 -1.447 . . . . 0.0 109.728 -169.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.56 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -106.38 162.26 5.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.165 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -98.23 149.2 35.49 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.237 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 62.2 Cg_endo -83.88 -18.73 5.28 Favored 'Trans proline' 0 CA--C 1.501 -1.135 0 C-N-CA 123.117 2.545 . . . . 0.0 108.59 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.5 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 56.0 mtt180 -88.58 -11.89 44.25 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.07 -1.877 . . . . 0.0 114.192 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 p -156.77 -11.43 0.09 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 61.16 29.48 18.83 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.558 0.694 . . . . 0.0 111.171 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.5 m -107.18 142.94 36.1 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -79.55 38.07 2.08 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.507 -175.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 50.9 m-85 -93.49 39.93 1.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.744 0.307 . . . . 0.0 111.054 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.809 HG21 HD11 ' A' ' 20' ' ' ILE . 6.1 pt -109.87 141.51 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.505 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.2 pt-20 -117.37 144.16 45.23 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 169.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -79.72 129.5 34.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.507 ' HG ' ' OE1' ' C' ' 91' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.909 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.811 0.338 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.08 136.26 33.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.628 0.252 . . . . 0.0 110.713 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -119.48 123.25 43.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.483 . . . . 0.0 110.121 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -65.33 -36.6 84.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.586 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -151.59 -69.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.599 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -133.49 50.7 2.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.957 0.408 . . . . 0.0 110.965 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 83.3 t60 48.85 58.54 5.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.682 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -126.32 90.46 3.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.267 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.33 146.89 11.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.12 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -100.74 -29.3 12.35 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.471 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -104.67 -93.55 0.35 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.398 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 t70 56.0 -154.04 0.33 Allowed 'General case' 0 C--O 1.235 0.316 0 O-C-N 123.604 0.565 . . . . 0.0 110.059 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -86.71 -3.14 59.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.045 0.45 . . . . 0.0 110.463 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -56.8 166.95 0.85 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.925 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 47.0 tpp 61.24 89.53 0.08 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.906 -177.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.757 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -91.69 146.55 23.68 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' C' ' 32' ' ' ILE . 15.1 mt-10 -95.04 91.48 6.37 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 169.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.6 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 4.9 t -78.38 105.21 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.2 -170.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.631 ' C ' ' HA ' ' C' ' 81' ' ' VAL . 0.5 OUTLIER -96.25 142.58 28.23 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 175.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' C' ' 82' ' ' ILE . 54.7 t -148.05 124.53 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.899 0.381 . . . . 0.0 110.628 -173.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.493 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 43.0 mtpt -105.06 141.3 36.87 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 36.3 p -112.02 -179.88 3.81 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.547 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.41 -15.45 62.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.195 0.522 . . . . 0.0 110.854 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -81.48 0.08 39.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.828 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 69.6 m 61.52 22.62 13.04 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.691 0.758 . . . . 0.0 111.573 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -55.67 -56.68 17.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.779 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 51.0 m 54.37 94.33 0.02 OUTLIER 'General case' 0 C--O 1.236 0.344 0 O-C-N 124.284 0.99 . . . . 0.0 110.765 -173.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -127.36 155.83 42.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.814 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.571 HG22 ' CD2' ' C' ' 20' ' ' LEU . 11.8 p -95.49 142.01 28.35 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 121.382 0.611 . . . . 0.0 112.223 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.6 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 25.6 m-85 -132.72 56.17 1.86 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.224 -174.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.592 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -56.87 121.17 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 123.353 1.549 . . . . 0.0 114.412 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.7 m -140.43 -163.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 110.777 -2.919 . . . . 0.0 111.307 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.51 165.48 19.24 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.154 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.757 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -68.43 -16.2 63.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.637 0.732 . . . . 0.0 112.16 -175.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -158.8 25.33 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -167.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 51.0 ttm -79.47 -72.64 0.38 Allowed 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 111.699 -2.501 . . . . 0.0 110.928 -176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.528 ' O ' HG12 ' C' ' 39' ' ' VAL . 80.0 m-20 -125.51 -99.51 0.4 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.712 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 83.88 -29.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 C-N-CA 125.161 1.385 . . . . 0.0 111.502 -162.094 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.74 -68.13 0.74 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.346 1.07 . . . . 0.0 109.122 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.55 -30.34 69.71 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.949 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.658 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 7.0 t80 -58.34 -51.08 71.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.848 174.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.605 ' HB3' ' OE1' ' C' ' 57' ' ' GLN . 47.8 mtpt -61.24 -47.01 88.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.109 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -56.53 -36.8 69.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.892 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -70.6 -43.79 68.62 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.649 ' O ' HG22 ' C' ' 50' ' ' VAL . 22.1 pt -77.77 -8.51 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -175.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.03 -56.83 1.77 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.74 -36.79 50.37 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.272 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -33.06 71.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.018 0.437 . . . . 0.0 110.9 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.649 HG22 ' O ' ' C' ' 46' ' ' ILE . 34.5 m -105.38 -2.63 9.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.885 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 59.6 p 64.78 21.23 12.33 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 122.003 0.906 . . . . 0.0 109.298 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.2 mm -122.63 117.21 28.98 Favored Pre-proline 0 N--CA 1.439 -0.976 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.302 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.569 ' O ' ' HG3' ' C' ' 57' ' ' GLN . 4.6 Cg_exo -71.76 150.16 55.62 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.961 1.774 . . . . 0.0 112.226 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.632 ' HA ' ' OE1' ' C' ' 57' ' ' GLN . 0.9 OUTLIER -52.12 -25.17 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.096 -176.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.547 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.4 pt-20 -74.67 -26.91 60.17 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.207 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.547 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 47.9 mttm -105.66 -25.01 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.688 0.28 . . . . 0.0 111.526 -173.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.632 ' OE1' ' HA ' ' C' ' 54' ' ' SER . 88.9 mt-30 -56.55 126.17 25.39 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.895 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -122.95 110.14 15.01 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' C' ' 82' ' ' ILE . 1.1 mm? -87.11 112.48 21.96 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.512 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.7 mt -110.33 120.61 61.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 121.809 -0.557 . . . . 0.0 111.024 175.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -128.75 134.61 48.48 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 41.97 42.38 2.29 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.987 0.804 . . . . 0.0 111.732 -173.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.98 4.02 61.62 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.593 -0.731 . . . . 0.0 113.608 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -96.15 130.82 43.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.3 99.22 9.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.297 0.57 . . . . 0.0 110.451 -175.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.505 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -86.16 154.66 21.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.054 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -165.91 -169.77 1.59 Allowed 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.958 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.712 ' HA ' HG13 ' C' ' 39' ' ' VAL . 5.1 p-10 -64.94 -1.4 2.0 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.902 0.881 . . . . 0.0 113.123 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.97 -7.2 3.52 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.42 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.8 mttp 88.22 170.57 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.48 1.112 . . . . 0.0 111.827 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.543 ' HB3' ' HG2' ' C' ' 74' ' ' GLU . 13.5 mmmm 71.45 79.52 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.617 177.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.612 HD21 HG23 ' C' ' 39' ' ' VAL . 37.2 mt -68.82 -29.22 67.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.849 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 73' ' ' GLN . . . . . 0.436 ' HB2' ' HB1' ' C' ' 35' ' ' ALA . 46.8 tt0 -68.52 -27.17 65.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.401 . . . . 0.0 111.364 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' GLU . . . . . 0.543 ' HG2' ' HB3' ' C' ' 71' ' ' LYS . 58.8 mm-40 -63.48 -27.12 69.06 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.546 ' CD2' ' HA ' ' C' ' 72' ' ' LEU . 7.8 m-85 -90.17 -23.07 21.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 60.9 t30 55.31 46.79 22.82 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.198 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.444 HG23 HG22 ' C' ' 19' ' ' VAL . 33.1 m -93.66 4.36 7.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 119.957 -0.697 . . . . 0.0 112.862 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.669 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -56.22 100.37 0.1 Allowed Glycine 0 CA--C 1.491 -1.435 0 CA-C-O 122.918 1.288 . . . . 0.0 113.68 171.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.47 14.8 49.42 Favored Glycine 0 C--N 1.289 -2.076 0 CA-C-N 111.367 -2.417 . . . . 0.0 113.534 173.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -124.37 139.91 53.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.545 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.631 ' HA ' ' C ' ' C' ' 20' ' ' LEU . 22.2 m -80.08 126.48 39.39 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.748 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' C' ' 21' ' ' VAL . 60.9 mt -83.11 167.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.452 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.509 ' N ' HG22 ' C' ' 82' ' ' ILE . 42.9 m80 -114.42 114.63 26.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 171.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.436 HD12 ' N ' ' C' ' 85' ' ' VAL . 15.8 tp -97.23 133.01 42.43 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.203 0.525 . . . . 0.0 110.135 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.436 ' N ' HD12 ' C' ' 84' ' ' LEU . 25.2 m -129.14 172.38 15.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.367 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -70.95 179.94 2.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.879 173.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' C' ' 87' ' ' ARG . 43.0 mtm180 -60.47 165.23 3.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.991 0.901 . . . . 0.0 110.781 -175.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.26 146.22 32.31 Favored Pre-proline 0 N--CA 1.425 -1.684 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.56 -175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.55 160.14 37.38 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.242 2.628 . . . . 0.0 111.058 174.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.12 87.36 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.654 2.236 . . . . 0.0 111.746 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 91' ' ' GLN . . . . . 0.507 ' OE1' ' HG ' ' A' ' 40' ' ' LEU . 16.9 pt20 -124.39 7.71 8.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.752 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 6.0 t -64.29 102.35 0.51 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.04 0.924 . . . . 0.0 110.823 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -109.66 10.43 24.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.898 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.479 HD21 ' O ' ' C' ' 98' ' ' ALA . 42.2 tp -127.66 76.11 77.31 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.787 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -88.28 161.12 6.95 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.602 2.201 . . . . 0.0 113.093 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t 60.61 68.56 0.75 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.355 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.05 -141.09 39.0 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.232 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' ALA . . . . . 0.479 ' O ' HD21 ' C' ' 94' ' ' LEU . . . 64.13 13.99 8.24 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.028 0.531 . . . . 0.0 111.969 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -85.52 67.17 10.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.499 0.666 . . . . 0.0 109.411 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 16.2 m -136.85 171.26 14.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.349 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.923 -0.932 . . . . 0.0 111.57 177.732 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.966 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 18.0 m -76.63 147.04 37.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 62.26 84.73 0.13 Allowed 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.547 0.529 . . . . 0.0 110.524 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.28 129.8 36.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.964 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -90.08 69.28 7.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.407 0.622 . . . . 0.0 109.628 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.37 -29.29 37.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.462 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.8 t -83.25 142.22 43.64 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.634 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.07 63.94 2.58 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.9 2.4 . . . . 0.0 112.678 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.9 m80 71.5 135.59 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 123.427 0.691 . . . . 0.0 111.188 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HA ' HG11 ' A' ' 21' ' ' VAL . 84.7 Cg_endo -74.32 116.16 4.54 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.058 2.506 . . . . 0.0 113.568 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.88 -116.17 4.15 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -167.48 98.43 0.49 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.19 0.519 . . . . 0.0 111.735 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.738 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.9 m-85 -124.93 151.96 44.73 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 172.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -124.04 118.29 26.64 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.262 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -96.37 117.67 31.32 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.048 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.737 ' CG ' HG13 ' C' ' 85' ' ' VAL . 12.6 p80 -75.07 -10.68 59.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.89 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 49.7 t -71.97 -37.52 69.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.159 0.505 . . . . 0.0 109.727 175.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.3 m -91.0 -27.94 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.182 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.86 32.05 21.39 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.267 -171.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.56 144.45 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -71.83 146.5 47.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.234 0.54 . . . . 0.0 111.093 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.795 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.5 pt -134.04 166.71 28.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.266 -171.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 8' ' ' PRO . 48.3 t -118.44 110.22 39.4 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 158.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.738 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 12.1 Cg_endo -69.28 176.16 6.77 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.441 3.427 . . . . 0.0 114.777 -170.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.678 ' HB2' HG13 ' A' ' 28' ' ' ILE . 40.7 mtt180 -107.02 47.77 0.87 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 113.532 -1.667 . . . . 0.0 106.707 175.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.64 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 1.6 mm? 0.82 -62.62 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.147 0 CA-C-N 111.032 -2.804 . . . . 0.0 117.107 174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 22.1 Cg_exo -35.21 -35.04 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.949 2.433 . . . . 0.0 113.611 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.582 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -112.76 -22.84 10.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.631 -177.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 22.5 m-85 68.48 45.25 1.16 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.026 0.917 . . . . 0.0 110.528 -170.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.678 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -97.53 162.01 2.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.517 172.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.4 t -97.08 146.07 30.69 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.795 ' HD3' HD12 ' A' ' 20' ' ' ILE . 66.9 Cg_endo -79.84 -23.15 7.04 Favored 'Trans proline' 0 CA--C 1.498 -1.315 0 C-N-CA 122.582 2.188 . . . . 0.0 107.785 -174.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.594 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 91.2 mtt-85 -79.21 -35.34 41.84 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 112.683 -2.053 . . . . 0.0 113.556 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.2 p -135.76 -7.74 2.15 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.582 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 11.3 tt0 56.95 31.08 19.17 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.507 0.67 . . . . 0.0 111.511 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.3 m -110.72 145.97 37.11 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.321 170.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.6 52.99 4.81 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.372 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.491 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 72.2 m-85 -109.0 43.86 1.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.551 -0.382 . . . . 0.0 110.684 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.68 HG21 ' CD1' ' A' ' 20' ' ' ILE . 11.7 pt -114.31 139.96 37.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.255 -175.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.06 155.52 30.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.36 127.84 39.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.381 0.61 . . . . 0.0 110.747 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.007 -170.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.2 54.66 0.83 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.876 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 64.41 -91.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 174.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -93.3 82.66 4.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.168 0.508 . . . . 0.0 109.971 -177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -85.89 -4.38 59.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.67 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -79.75 59.26 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.786 0.803 . . . . 0.0 110.257 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -128.88 43.17 3.19 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.623 -1.172 . . . . 0.0 107.942 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -75.92 76.7 2.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.634 -174.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.577 HG22 ' H ' ' C' ' 12' ' ' ASP . 5.0 p -87.86 154.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.7 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 11' ' ' ASP . . . . . 0.485 ' OD2' ' HE2' ' C' ' 15' ' ' LYS . 5.0 m-20 -120.43 36.57 4.52 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.713 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' ASP . . . . . 0.577 ' H ' HG22 ' C' ' 10' ' ' VAL . 13.8 m-20 45.3 -102.68 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.016 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -130.72 16.34 5.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.03 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.95 -45.48 81.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.428 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' LYS . . . . . 0.485 ' HE2' ' OD2' ' C' ' 11' ' ' ASP . 67.3 mttm -59.87 161.47 6.45 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.962 175.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 73.7 mtm 66.32 96.73 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.198 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.856 HD22 ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -98.58 149.05 23.17 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 172.452 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' C' ' 32' ' ' ILE . 34.2 tt0 -102.17 87.92 3.19 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' C' ' 30' ' ' THR . 2.4 t -77.41 127.05 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.025 -167.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.703 ' HB3' HG12 ' C' ' 81' ' ' VAL . 1.0 OUTLIER -113.05 147.91 36.25 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 170.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' C' ' 82' ' ' ILE . 66.0 t -153.83 114.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -171.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 38.7 mtpt -99.96 172.1 7.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.371 0.605 . . . . 0.0 110.28 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.442 HG23 HD12 ' C' ' 84' ' ' LEU . 6.1 p -116.35 -171.53 2.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.814 172.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 4.3 mm? -42.06 -41.25 2.52 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -177.0 -29.83 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.061 -168.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 17.4 m -47.8 -82.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.827 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -128.13 177.54 6.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -171.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 53.8 m -135.02 111.87 10.13 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.0 -1.909 . . . . 0.0 107.253 170.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -120.49 158.58 26.96 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.15 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 4.2 p -104.26 147.67 27.22 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.527 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 42.1 m-85 -140.96 63.82 1.44 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.487 0.66 . . . . 0.0 110.314 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.59 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.4 mp -54.88 125.4 9.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 123.215 1.483 . . . . 0.0 114.458 -174.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.562 HG21 HD13 ' C' ' 72' ' ' LEU . 15.4 m -131.81 -170.47 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 111.507 -2.588 . . . . 0.0 111.927 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -113.17 40.27 2.57 Favored Glycine 0 C--N 1.317 -0.498 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.706 -175.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.856 ' HA ' HD22 ' C' ' 17' ' ' LEU . . . 68.9 -50.43 0.59 Allowed 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 124.224 1.01 . . . . 0.0 113.529 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -130.72 23.44 5.03 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' MET . . . . . 0.412 ' HB2' ' H ' ' C' ' 34' ' ' GLY . 2.1 ttt -66.16 -72.27 0.17 Allowed 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.93 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.602 ' O ' ' HD2' ' C' ' 40' ' ' LYS . 37.2 m-80 -129.04 -91.1 0.48 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.613 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.5 OUTLIER 85.19 -40.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 O-C-N 124.5 1.125 . . . . 0.0 110.814 -164.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.602 ' HD2' ' O ' ' C' ' 38' ' ' ASN . 0.0 OUTLIER -74.14 -69.48 0.44 Allowed 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 122.449 1.118 . . . . 0.0 108.594 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.08 -26.52 68.59 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.186 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.613 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 5.8 t80 -59.2 -52.65 64.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.753 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.532 ' HD3' ' HB3' ' C' ' 68' ' ' ASP . 7.1 ptmm? -68.58 -38.73 80.94 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.355 0.598 . . . . 0.0 110.974 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' C' ' 54' ' ' SER . 1.3 tm-20 -54.56 -41.52 69.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.138 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -69.67 -51.57 33.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.539 ' O ' HG22 ' C' ' 50' ' ' VAL . 22.5 pt -70.69 -10.01 13.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.341 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.61 -36.63 0.61 Allowed 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.45 -50.57 11.43 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.944 -0.473 . . . . 0.0 111.938 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -28.41 69.47 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.23 0.538 . . . . 0.0 110.79 -176.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.539 HG22 ' O ' ' C' ' 46' ' ' ILE . 6.7 m -96.34 -11.46 8.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.542 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 18.6 m 68.36 19.79 8.82 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 121.55 0.69 . . . . 0.0 109.91 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 3.6 mm -129.35 118.21 19.07 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.856 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.467 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.9 Cg_exo -67.29 148.5 80.2 Favored 'Trans proline' 0 CA--C 1.514 -0.475 0 C-N-CA 122.27 1.98 . . . . 0.0 111.147 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.455 ' OG ' ' HG3' ' C' ' 43' ' ' LYS . 41.8 t -51.19 -33.26 26.66 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.155 0.285 . . . . 0.0 111.748 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.466 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 8.5 pt-20 -66.42 -30.19 70.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.782 0.325 . . . . 0.0 111.441 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.466 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 55.7 mtpt -101.11 -23.79 14.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.071 0.462 . . . . 0.0 110.281 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.44 ' HB2' HG22 ' C' ' 52' ' ' ILE . 7.1 tt0 -76.19 119.44 20.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.058 -172.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -113.91 123.08 48.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.277 170.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.667 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 19.4 mt -89.79 113.87 25.49 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 37' ' ' ILE . 9.2 mt -108.36 126.44 65.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 121.289 -0.882 . . . . 0.0 111.424 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.509 ' CZ ' ' HB3' ' C' ' 80' ' ' LYS . 31.0 t80 -139.12 127.26 22.52 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 169.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 60.67 35.84 19.7 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.547 0.529 . . . . 0.0 110.549 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 71.33 2.28 47.77 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.596 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -89.0 137.86 31.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.87 88.92 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -76.46 128.11 34.16 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -147.33 177.01 9.56 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.905 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.599 ' CB ' ' HA ' ' C' ' 40' ' ' LYS . 4.0 p-10 -65.69 -1.85 3.11 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.105 0.962 . . . . 0.0 113.469 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -81.48 -13.37 58.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -131.32 -154.44 0.63 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.912 -0.493 . . . . 0.0 112.053 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.403 ' HB2' ' HG2' ' C' ' 74' ' ' GLU . 0.3 OUTLIER -108.82 -179.67 3.93 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 175.633 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 2.9 mt -86.27 -34.09 20.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.025 0.44 . . . . 0.0 110.809 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.92 -23.72 66.01 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.403 0.681 . . . . 0.0 111.183 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' GLU . . . . . 0.403 ' HG2' ' HB2' ' C' ' 71' ' ' LYS . 20.0 mm-40 -59.39 -28.81 67.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.655 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.638 ' CD1' HD22 ' C' ' 66' ' ' LEU . 34.0 m-85 -105.16 -16.05 14.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.114 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 55.83 52.49 10.68 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.996 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.515 HG23 HG22 ' C' ' 19' ' ' VAL . 28.2 m -93.08 16.6 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.559 -174.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.654 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -64.41 101.47 0.51 Allowed Glycine 0 CA--C 1.481 -2.033 0 CA-C-O 122.774 1.208 . . . . 0.0 112.785 172.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.34 15.13 56.19 Favored Glycine 0 C--N 1.283 -2.378 0 CA-C-N 111.868 -2.166 . . . . 0.0 112.599 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 80' ' ' LYS . . . . . 0.509 ' HB3' ' CZ ' ' C' ' 61' ' ' TYR . 73.1 mmtt -116.37 145.32 43.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 118.85 -0.595 . . . . 0.0 109.638 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.703 HG12 ' HB3' ' C' ' 20' ' ' LEU . 3.1 m -86.7 130.17 37.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.379 173.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' C' ' 21' ' ' VAL . 56.3 mt -88.48 169.17 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.869 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.518 ' N ' HG22 ' C' ' 82' ' ' ILE . 58.4 m80 -112.45 121.94 46.27 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.442 HD12 HG23 ' C' ' 23' ' ' THR . 20.6 mt -78.32 152.71 32.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.971 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.737 HG13 ' CG ' ' A' ' 14' ' ' HIS . 5.7 t -143.45 159.51 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.773 -172.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 86' ' ' GLU . . . . . 0.517 ' O ' HG12 ' C' ' 85' ' ' VAL . 1.5 pm0 -93.17 175.02 6.93 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.403 170.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.34 150.89 45.3 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.219 1.009 . . . . 0.0 111.604 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.72 156.03 55.89 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 113.373 -1.74 . . . . 0.0 111.489 -173.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.4 155.06 32.1 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.741 2.294 . . . . 0.0 111.114 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.9 37.47 0.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.685 2.257 . . . . 0.0 113.668 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -6.88 47.48 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.094 -0.378 . . . . 0.0 110.285 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.0 t -66.38 -4.2 7.6 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.964 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -65.48 -18.51 65.37 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 121.301 0.572 . . . . 0.0 110.087 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 tp -126.12 130.81 23.87 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.162 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.75 103.34 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.316 2.011 . . . . 0.0 111.73 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 30.5 t -68.72 99.37 1.01 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.683 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.32 -118.12 9.04 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.523 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.01 15.68 14.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.548 0.213 . . . . 0.0 111.554 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -66.61 97.64 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.747 0.308 . . . . 0.0 110.455 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 13.3 t 62.38 34.79 15.38 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.103 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.274 -1.292 . . . . 0.0 111.544 179.809 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 42.0 m -86.29 123.56 31.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.792 0.33 . . . . 0.0 110.61 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 tpp -159.31 -59.73 0.07 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.874 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.98 114.12 11.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.562 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 61.95 25.15 15.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.887 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.37 77.62 0.93 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.298 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 m -66.68 116.4 34.33 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.796 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -64.31 -28.12 63.55 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.708 2.272 . . . . 0.0 112.83 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -134.95 127.23 18.17 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.661 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -81.51 37.54 0.69 Allowed 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.409 2.74 . . . . 0.0 112.597 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.52 72.17 0.37 Allowed Glycine 0 CA--C 1.487 -1.689 0 CA-C-O 122.54 1.078 . . . . 0.0 111.518 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.637 ' HD3' ' H ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -72.03 109.27 5.73 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 112.222 -1.989 . . . . 0.0 110.637 -178.328 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.627 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 5.5 m-85 -118.45 169.8 9.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.264 175.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CB ' HD11 ' A' ' 40' ' ' LEU . 61.9 t80 -138.43 116.11 11.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.595 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -96.36 114.61 26.31 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.808 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.565 ' CD2' HG12 ' C' ' 85' ' ' VAL . 8.9 p80 -73.16 -8.69 56.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.702 0.286 . . . . 0.0 111.406 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 42.6 t -72.6 -32.7 66.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.359 0.6 . . . . 0.0 110.182 173.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.5 m -99.46 -25.9 14.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.391 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER 58.21 31.04 20.3 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.384 -171.236 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.65 144.75 34.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.5 tt0 -64.28 148.34 50.43 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.158 0.286 . . . . 0.0 110.745 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.711 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.2 pt -140.42 166.98 18.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.51 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 74.9 t -125.6 97.32 36.61 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 164.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.627 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 6.5 Cg_endo -55.94 174.91 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 125.06 3.84 . . . . 0.0 115.798 -171.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' HB2' HG13 ' A' ' 28' ' ' ILE . 5.3 mtt180 -108.62 49.85 0.8 Allowed 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.156 -1.838 . . . . 0.0 106.937 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.455 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.3 mm? 3.92 -61.98 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 110.952 -2.84 . . . . 0.0 117.049 171.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 15.8 Cg_exo -36.96 -33.44 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.69 2.26 . . . . 0.0 113.908 176.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.542 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.93 -22.38 9.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.326 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.461 ' C ' HD11 ' A' ' 37' ' ' ILE . 70.6 m-85 65.28 54.13 1.22 Allowed 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.171 0.986 . . . . 0.0 110.228 -169.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -104.93 161.13 4.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.985 176.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.7 t -96.28 145.84 30.26 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 81.7 Cg_endo -82.55 -20.52 5.69 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.702 2.268 . . . . 0.0 108.279 -174.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.416 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 18.2 mtt180 -89.37 -15.3 33.65 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 112.952 -1.931 . . . . 0.0 114.694 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.8 p -151.53 -8.09 0.23 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 10.1 tt0 60.79 25.2 15.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 111.586 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 m -103.36 141.89 35.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 169.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.59 30.87 2.49 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.268 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 35.8 m-85 -89.39 52.6 2.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.597 0.713 . . . . 0.0 110.146 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.711 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.6 pt -122.6 134.17 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.598 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HB3' HD13 ' C' ' 60' ' ' ILE . 11.4 pt-20 -119.75 144.03 47.48 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -75.81 138.49 41.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.531 ' HB2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.666 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 48.3 ttp . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.609 0.242 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 3' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' C' ' 4' ' ' HIS . . . -101.39 -34.19 9.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' C' ' 3' ' ' ALA . 14.5 m80 70.81 -67.84 0.23 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.439 0.696 . . . . 0.0 111.765 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -115.35 176.16 5.19 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -63.87 -37.58 87.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 19.52 -85.98 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 O-C-N 125.578 1.798 . . . . 0.0 113.9 172.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -144.97 96.19 2.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.422 . . . . 0.0 110.516 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -75.6 94.46 3.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.72 149.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 122.228 1.014 . . . . 0.0 113.223 -169.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -136.65 -63.74 0.61 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.545 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' ASP . . . . . 0.435 ' OD2' ' HB2' ' C' ' 14' ' ' ASP . 38.4 t70 70.76 127.02 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 124.093 0.871 . . . . 0.0 112.43 169.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.29 59.8 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.578 0.704 . . . . 0.0 110.241 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' ASP . . . . . 0.435 ' HB2' ' OD2' ' C' ' 12' ' ' ASP . 30.2 t70 -85.38 -16.58 39.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.975 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 15' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' C' ' 32' ' ' ILE . 37.3 mttm -71.36 172.39 9.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.169 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ttt -140.89 -36.44 0.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.2 mt -109.12 134.76 51.28 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.427 0.632 . . . . 0.0 110.543 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.583 ' HA ' HG13 ' C' ' 32' ' ' ILE . 36.9 mt-10 -89.77 93.33 9.4 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.278 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 2.7 t -77.41 124.11 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -171.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.641 ' C ' ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -109.28 146.53 34.13 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 171.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.583 HG22 ' HB ' ' C' ' 82' ' ' ILE . 36.4 t -151.07 125.07 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -172.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.565 ' HE3' HG21 ' C' ' 81' ' ' VAL . 72.2 mttt -110.93 110.98 21.8 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.171 0.51 . . . . 0.0 110.789 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.484 HG23 ' HB2' ' C' ' 84' ' ' LEU . 0.0 OUTLIER -81.8 87.93 6.33 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.614 0.721 . . . . 0.0 110.289 164.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER 62.61 18.81 10.84 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.679 176.476 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 37.0 t70 76.87 -16.49 0.63 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.363 -1.744 . . . . 0.0 111.2 170.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 37.6 m -62.91 -30.39 71.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.03 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' GLN . . . . . 0.432 ' OE1' ' HA ' ' C' ' 50' ' ' VAL . 73.8 mt-30 -102.13 -72.0 0.7 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.51 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 71.8 m 53.63 95.2 0.02 OUTLIER 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.15 0.58 . . . . 0.0 111.412 -171.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -135.28 159.04 42.8 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.223 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.541 HG22 ' CD2' ' C' ' 20' ' ' LEU . 8.5 p -96.23 148.55 22.61 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.837 -174.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.591 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 34.3 m-85 -140.21 63.05 1.49 Allowed 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.135 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.583 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.7 mp -59.92 120.18 5.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 123.445 1.593 . . . . 0.0 113.838 -175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.465 ' CG2' HD13 ' C' ' 72' ' ' LEU . 15.5 m -138.12 -172.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 111.016 -2.811 . . . . 0.0 111.565 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.69 175.86 34.51 Favored Glycine 0 C--N 1.308 -0.973 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.954 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.752 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -90.55 50.17 1.79 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -169.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.661 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 3.3 mt-30 139.21 2.22 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 O-C-N 125.189 1.555 . . . . 0.0 109.42 -171.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 22.9 tpp -44.95 -70.49 0.1 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.769 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.432 ' CG ' ' HB2' ' C' ' 41' ' ' GLU . 26.9 m-80 -136.98 -99.09 0.2 Allowed 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 174.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.638 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 94.72 -29.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 125.151 1.532 . . . . 0.0 110.293 -162.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.612 ' HE2' ' O ' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -79.91 -71.11 0.47 Allowed 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.485 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 41' ' ' GLU . . . . . 0.432 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 40.4 mt-10 -63.01 -28.06 69.84 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.851 174.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.638 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 4.7 t80 -58.51 -54.36 47.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.739 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.54 ' HD3' ' HB3' ' C' ' 68' ' ' ASP . 8.9 ptmm? -69.6 -37.19 76.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.483 0.659 . . . . 0.0 111.209 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' C' ' 54' ' ' SER . 1.2 tm-20 -56.07 -44.18 78.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.225 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -69.77 -39.04 76.91 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.544 ' O ' HG22 ' C' ' 50' ' ' VAL . 20.0 pt -83.1 -6.61 10.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -173.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -38.1 -57.48 1.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.97 -36.05 69.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.073 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -20.51 66.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.861 0.362 . . . . 0.0 111.455 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.544 HG22 ' O ' ' C' ' 46' ' ' ILE . 14.6 m -111.76 -6.36 11.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.429 176.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 35.7 m 70.33 21.14 5.86 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.705 0.628 . . . . 0.0 109.475 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.3 mm -126.03 112.96 24.23 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.131 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.493 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.1 Cg_exo -70.94 145.52 50.56 Favored 'Trans proline' 0 CA--C 1.506 -0.876 0 C-N-CA 122.452 2.101 . . . . 0.0 110.784 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.549 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 1.9 p -54.79 -24.72 23.97 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 123.725 0.64 . . . . 0.0 112.647 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.9 pt-20 -75.12 -33.79 61.61 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.947 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.443 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 38.7 mtpt -98.02 -11.04 23.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.361 0.601 . . . . 0.0 109.503 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.549 ' HB3' ' HA ' ' C' ' 54' ' ' SER . 9.3 tt0 -82.99 119.59 24.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.105 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' C' ' 58' ' ' ARG . 22.2 mtm180 -127.66 126.92 42.85 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 171.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.718 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 22.8 mt -84.85 108.04 17.31 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.443 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.582 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.3 mt -99.95 118.35 46.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.39 173.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -132.37 125.99 32.17 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 171.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 58.37 36.37 25.44 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.209 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 76.63 0.9 69.43 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.489 175.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 16.9 mmm180 -98.13 141.49 30.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -92.72 95.15 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 120.937 0.399 . . . . 0.0 110.399 -176.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -82.96 138.91 33.62 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -147.37 -176.08 5.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.928 0.394 . . . . 0.0 111.446 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.54 ' HB3' ' HD3' ' C' ' 43' ' ' LYS . 2.8 p-10 -69.49 -3.58 15.22 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.593 1.157 . . . . 0.0 113.337 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -75.8 -19.83 58.67 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.612 ' O ' ' HE2' ' C' ' 40' ' ' LYS . 39.5 mtmt -130.56 -147.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -170.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.422 ' HB2' ' HG2' ' C' ' 74' ' ' GLU . 33.8 mmtp -120.35 153.18 36.83 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.795 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.465 HD13 ' CG2' ' C' ' 33' ' ' VAL . 45.4 mt -58.01 -50.73 72.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 73' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 7.3 tp60 -68.3 -22.42 64.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.909 0.385 . . . . 0.0 111.444 -174.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 74' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' C' ' 71' ' ' LYS . 31.1 mm-40 -60.72 -28.89 69.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.273 0.559 . . . . 0.0 109.947 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.506 ' CD1' HD22 ' C' ' 66' ' ' LEU . 39.5 m-85 -93.72 -19.81 20.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.398 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 t30 59.75 38.5 21.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.41 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.428 HG21 HD11 ' C' ' 82' ' ' ILE . 29.3 m -88.73 22.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -73.98 103.35 1.45 Allowed Glycine 0 N--CA 1.428 -1.876 0 CA-C-O 122.786 1.215 . . . . 0.0 112.787 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.51 12.98 46.14 Favored Glycine 0 C--N 1.284 -2.311 0 CA-C-N 112.185 -2.007 . . . . 0.0 115.157 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -128.37 148.27 50.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.273 0.536 . . . . 0.0 110.561 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.641 ' HA ' ' C ' ' C' ' 20' ' ' LEU . 18.4 m -78.54 120.91 30.43 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-O 122.007 0.908 . . . . 0.0 111.599 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.583 ' HB ' HG22 ' C' ' 21' ' ' VAL . 28.1 mt -76.7 166.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.003 173.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.493 ' N ' HG22 ' C' ' 82' ' ' ILE . 52.7 m170 -118.32 116.21 26.28 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.702 -0.624 . . . . 0.0 109.98 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.545 HD21 HD23 ' C' ' 59' ' ' LEU . 11.4 mt -90.81 157.82 17.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.565 HG12 ' CD2' ' A' ' 14' ' ' HIS . 2.4 m -131.49 161.38 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.987 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -128.07 122.68 32.72 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 167.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -74.53 171.79 13.16 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.136 0.493 . . . . 0.0 110.059 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -126.24 136.89 29.2 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.42 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.483 ' HA ' ' HD3' ' C' ' 90' ' ' PRO . 39.3 Cg_exo -63.11 137.42 61.58 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 123.286 2.657 . . . . 0.0 112.328 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 90' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' C' ' 89' ' ' PRO . 5.2 Cg_exo -77.82 19.52 0.77 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.961 2.441 . . . . 0.0 112.718 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -96.87 -18.95 19.2 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.168 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.413 HG23 ' O ' ' C' ' 92' ' ' THR . 10.2 t -141.43 108.19 5.38 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.611 0.72 . . . . 0.0 110.319 171.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -88.31 -23.15 23.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.763 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' C' ' 95' ' ' PRO . 93.0 mt -77.4 136.33 64.67 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.428 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 22.7 Cg_exo -62.25 118.64 5.54 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.747 2.298 . . . . 0.0 111.773 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 22.9 t -153.87 99.21 2.26 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.977 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.88 8.68 66.93 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.845 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.9 77.2 1.7 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.031 0.443 . . . . 0.0 110.824 -177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 45.8 m -121.46 2.73 10.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 57.2 m -94.41 37.41 1.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 110.627 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.42 -1.211 . . . . 0.0 111.184 178.702 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 4.2 p -76.8 115.73 16.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.757 0.313 . . . . 0.0 110.79 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -156.29 -36.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.716 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.07 106.28 8.27 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.04 -39.42 4.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.658 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.41 -37.89 88.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.264 0.554 . . . . 0.0 110.498 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.455 ' HB2' ' HA3' ' A' ' 9' ' ' GLY . 49.2 m -145.2 80.47 11.05 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.592 174.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.62 -47.43 16.33 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.23 2.62 . . . . 0.0 114.562 -174.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.627 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 38.3 m80 -86.19 -66.41 0.19 Allowed Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -173.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' A' ' 7' ' ' HIS . 22.3 Cg_endo -84.16 0.66 9.13 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.44 2.093 . . . . 0.0 112.724 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 5' ' ' SER . . . -96.68 1.99 62.05 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.75 -174.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 19.5 mtm180 -97.89 86.68 3.81 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.402 0.62 . . . . 0.0 110.941 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.599 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 14.7 m-85 -125.22 167.39 14.92 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -144.58 121.22 11.13 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.116 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.3 p -91.29 91.89 8.38 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.259 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -56.25 -41.77 76.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.367 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.2 t -55.3 -49.43 72.17 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.427 0.455 . . . . 0.0 112.196 -174.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.54 5.35 44.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.6 0.714 . . . . 0.0 111.559 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.4 p 53.32 58.31 5.36 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.058 1.343 . . . . 0.0 114.266 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -142.77 146.27 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 174.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 28.7 tt0 -89.18 139.42 30.5 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.537 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.972 HD11 HG21 ' A' ' 37' ' ' ILE . 7.0 pt -143.9 168.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -163.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.451 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 42.2 t -118.99 100.78 50.59 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 114.332 -1.304 . . . . 0.0 107.536 161.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.705 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . 1.2 Cg_endo -53.09 177.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.853 1 C-N-CA 126.078 4.519 . . . . 0.0 118.669 -168.466 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.522 ' HB2' HG13 ' A' ' 28' ' ' ILE . 62.9 mtt180 -117.94 50.81 1.11 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 111.34 -2.663 . . . . 0.0 107.388 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.433 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.6 mm? -8.71 -57.87 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 127.703 2.401 . . . . 0.0 117.325 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -32.98 -34.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 123.513 2.809 . . . . 0.0 114.378 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.584 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -124.42 -18.48 5.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.536 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.528 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 49.3 m-85 69.98 42.98 0.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.189 -171.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.584 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -91.33 165.19 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.119 174.133 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.471 ' CB ' HD13 ' A' ' 20' ' ' ILE . 25.2 p -95.49 144.06 27.18 Favored Pre-proline 0 N--CA 1.432 -1.338 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.636 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 44.1 Cg_endo -83.25 -22.55 3.96 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 123.278 2.652 . . . . 0.0 109.151 -168.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.528 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 60.0 mtt180 -81.96 -24.83 35.3 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 112.689 -2.051 . . . . 0.0 113.054 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.08 11.23 0.07 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 49.63 66.86 1.0 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.28 145.77 43.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.452 167.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -85.63 33.68 3.44 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.47 -174.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -108.95 52.03 0.72 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.133 0.492 . . . . 0.0 111.068 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.972 HG21 HD11 ' A' ' 20' ' ' ILE . 3.7 pt -111.58 138.86 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.77 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' HB2' HG22 ' C' ' 65' ' ' VAL . 2.9 pt-20 -116.39 147.71 41.37 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -80.25 122.46 26.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.852 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.599 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.35 -82.29 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 O-C-N 124.03 0.831 . . . . 0.0 111.395 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 56.04 78.66 0.19 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.363 0.601 . . . . 0.0 110.509 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -82.46 136.81 34.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.435 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -91.92 27.19 2.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.527 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -143.46 114.56 7.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.159 0.504 . . . . 0.0 109.816 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -122.75 -174.88 3.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.76 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -73.64 93.31 2.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.87 166.59 4.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.753 -174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -146.75 71.52 1.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.707 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' ASP . . . . . 0.418 ' HA ' ' HB2' ' C' ' 15' ' ' LYS . 41.8 m-20 -79.8 62.65 4.11 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.677 -175.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -99.75 -52.29 3.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.041 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.07 -33.77 13.25 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.429 0.633 . . . . 0.0 109.322 171.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' C' ' 35' ' ' ALA . 61.9 mttm -70.34 176.82 3.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.261 176.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 41.6 tpp 62.75 95.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.687 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.899 HD22 ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -102.09 145.97 28.58 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.524 ' HA ' HG13 ' C' ' 32' ' ' ILE . 43.2 tt0 -97.91 91.88 5.55 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 170.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' C' ' 30' ' ' THR . 4.5 t -76.82 98.68 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.099 -170.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.61 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.4 mt -87.28 132.97 33.75 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' C' ' 82' ' ' ILE . 88.0 t -145.05 120.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.158 0.504 . . . . 0.0 110.322 -173.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.734 ' HG2' ' OG1' ' C' ' 28' ' ' THR . 44.4 mtpt -92.1 144.27 25.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.537 HG22 ' HB2' ' C' ' 84' ' ' LEU . 18.6 p -120.06 114.32 21.82 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' C' ' 25' ' ' ASP . 0.4 OUTLIER 62.7 -47.89 0.19 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 177.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' C' ' 24' ' ' LEU . 31.1 t70 167.38 -27.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.428 0.691 . . . . 0.0 109.511 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -58.3 -72.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.216 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -131.77 -177.65 4.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.768 0.794 . . . . 0.0 112.171 -169.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.734 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 19.9 m -133.59 117.21 16.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.742 -1.572 . . . . 0.0 108.803 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -121.07 150.14 41.65 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.94 0.4 . . . . 0.0 110.885 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.8 p -99.56 144.82 28.2 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.241 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.471 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 34.2 m-85 -132.58 60.18 1.7 Allowed 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.614 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.5 mp -57.96 118.85 2.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 123.06 1.41 . . . . 0.0 114.367 -173.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.474 HG11 ' HD2' ' C' ' 42' ' ' PHE . 16.6 m -138.36 170.51 16.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 111.625 -2.534 . . . . 0.0 112.593 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' C' ' 37' ' ' MET . . . -84.88 50.33 4.38 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.08 -1.418 . . . . 0.0 114.188 -168.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.899 ' HA ' HD22 ' C' ' 17' ' ' LEU . . . 65.39 -48.2 0.37 Allowed 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 124.255 1.022 . . . . 0.0 113.482 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.512 ' HA ' ' HB3' ' C' ' 71' ' ' LYS . 3.9 pt20 -139.82 26.04 2.31 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -164.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 37' ' ' MET . . . . . 0.419 ' HB2' ' H ' ' C' ' 34' ' ' GLY . 1.7 tmt? -59.64 -70.99 0.14 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 111.63 -2.532 . . . . 0.0 111.019 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.424 ' O ' ' HB ' ' C' ' 39' ' ' VAL . 13.5 m-80 -144.23 -92.02 0.11 Allowed 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.679 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 96.44 -29.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 O-C-N 125.702 1.876 . . . . 0.0 110.891 -166.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' C' ' 70' ' ' LYS . 0.9 OUTLIER -80.44 -71.39 0.46 Allowed 'General case' 0 N--CA 1.423 -1.813 0 CA-C-O 122.158 0.98 . . . . 0.0 108.859 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.89 -26.59 68.67 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 113.754 -1.567 . . . . 0.0 111.239 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.679 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.6 OUTLIER -59.37 -51.6 69.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.984 174.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.519 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 17.7 mtpp -63.51 -42.06 98.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.96 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -56.14 -37.0 68.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.282 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -69.76 -47.35 63.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.807 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.641 ' O ' HG22 ' C' ' 50' ' ' VAL . 7.4 pt -74.45 -11.46 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.994 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.5 -58.39 2.27 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.64 -37.53 67.96 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.845 -175.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -36.66 83.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.102 0.477 . . . . 0.0 110.648 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.641 HG22 ' O ' ' C' ' 46' ' ' ILE . 24.5 m -98.68 -1.71 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.946 177.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p 60.66 26.58 16.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.014 0.911 . . . . 0.0 109.533 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.3 mm -128.59 113.74 19.36 Favored Pre-proline 0 N--CA 1.434 -1.269 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.099 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 3.7 Cg_exo -69.98 143.65 50.43 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.131 1.888 . . . . 0.0 111.525 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.508 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 35.3 t -51.58 -24.72 5.71 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.331 1.02 . . . . 0.0 112.286 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.48 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.6 pt-20 -72.41 -43.71 63.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.604 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.48 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 96.6 mttt -88.2 -29.13 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.856 0.836 . . . . 0.0 109.382 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.519 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 19.3 tt0 -57.62 131.61 50.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.401 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -136.38 123.76 22.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.876 175.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.523 ' HB3' HG21 ' C' ' 82' ' ' ILE . 46.4 mt -86.73 104.36 16.05 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.098 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.565 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.0 mt -101.94 116.98 46.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.884 -0.51 . . . . 0.0 111.251 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -127.2 113.89 16.94 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 173.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 60.96 43.08 11.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.24 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 72.99 -4.58 22.81 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.142 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -88.32 125.39 34.66 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -87.92 88.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.283 0.564 . . . . 0.0 109.816 -176.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.663 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.5 OUTLIER -68.55 133.69 48.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.104 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -142.65 -176.92 5.06 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.641 -170.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.599 ' HA ' HG13 ' C' ' 39' ' ' VAL . 11.4 p-10 -71.88 -0.61 11.76 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.22 1.008 . . . . 0.0 112.627 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -79.89 -21.93 43.42 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.443 ' O ' ' HE3' ' C' ' 40' ' ' LYS . 68.7 mttt -123.93 -148.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -167.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' C' ' 36' ' ' GLN . 0.0 OUTLIER -127.17 163.58 23.54 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.083 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 2.9 mm? -66.25 -36.99 84.45 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 118.482 0.583 . . . . 0.0 111.167 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 73' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' C' ' 35' ' ' ALA . 35.0 tt0 -70.66 -18.15 62.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.858 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' GLU . . . . . 0.426 ' HG3' ' HB3' ' C' ' 70' ' ' LYS . 16.9 mm-40 -64.72 -28.84 69.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.464 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.663 ' CD1' HD22 ' C' ' 66' ' ' LEU . 17.8 m-85 -95.54 -22.52 17.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.867 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 t30 63.77 52.35 2.2 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 123.038 1.399 . . . . 0.0 107.76 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.69 -0.86 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 CA-C-N 112.78 -2.009 . . . . 0.0 112.705 -162.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.553 ' CA ' ' HG ' ' C' ' 17' ' ' LEU . . . -47.3 102.45 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.403 0 CA-C-O 122.904 1.28 . . . . 0.0 114.37 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.18 14.29 56.23 Favored Glycine 0 C--N 1.287 -2.188 0 CA-C-N 111.725 -2.237 . . . . 0.0 114.265 170.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -117.23 142.43 47.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.809 0.305 . . . . 0.0 110.25 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.642 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 15.6 m -79.34 124.13 37.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.676 0.751 . . . . 0.0 112.596 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.658 HD13 HD12 ' C' ' 66' ' ' LEU . 25.5 mt -86.87 168.71 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.487 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.501 ' N ' HG22 ' C' ' 82' ' ' ILE . 46.2 m-70 -119.3 115.65 24.6 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 121.965 -0.459 . . . . 0.0 110.168 174.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.537 ' HB2' HG22 ' C' ' 23' ' ' THR . 11.3 mt -91.52 144.64 25.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.103 0.478 . . . . 0.0 111.235 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 31.0 m -142.05 169.39 13.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.837 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.76 150.03 32.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.137 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -71.35 177.2 4.05 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.291 0.567 . . . . 0.0 111.633 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.416 ' HB1' ' HD2' ' C' ' 89' ' ' PRO . . . -60.27 168.7 2.09 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.375 174.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.416 ' HD2' ' HB1' ' C' ' 88' ' ' ALA . 77.2 Cg_exo -53.55 158.39 8.0 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.198 1.932 . . . . 0.0 112.062 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.45 60.49 3.37 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.212 2.608 . . . . 0.0 113.393 -172.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -89.89 -3.34 58.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.811 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -84.82 131.17 34.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.86 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 71.23 -42.8 0.54 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.827 0.851 . . . . 0.0 111.528 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -90.01 116.66 66.9 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.78 110.4 1.45 Allowed 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.404 2.07 . . . . 0.0 112.754 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 23.2 t -76.91 145.81 38.0 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.46 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.64 81.97 1.44 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.272 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 58.6 47.47 13.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.884 0.373 . . . . 0.0 110.576 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 77.9 p 50.65 29.66 4.32 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.918 0.887 . . . . 0.0 112.053 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 15.9 m 60.2 29.03 18.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.995 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.905 -0.942 . . . . 0.0 112.386 177.545 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.7 t -132.31 85.65 2.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.05 0.452 . . . . 0.0 109.872 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -81.48 107.75 14.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.614 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.87 -16.64 37.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.581 0.705 . . . . 0.0 109.639 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.97 -172.07 3.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.148 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.34 58.61 5.06 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 123.604 0.565 . . . . 0.0 110.521 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m 65.72 75.44 0.34 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.126 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.81 -0.92 10.29 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.764 2.31 . . . . 0.0 112.76 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -122.45 128.87 25.29 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.728 0.299 . . . . 0.0 111.066 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.06 50.49 3.13 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.347 2.698 . . . . 0.0 112.553 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.95 3.1 25.72 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.669 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.667 ' HG2' HD12 ' A' ' 40' ' ' LEU . 38.5 ttt180 -114.74 83.4 1.89 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.071 -0.564 . . . . 0.0 110.809 -177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.532 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 8.6 m-85 -117.93 141.21 48.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.955 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.424 ' HB2' HD11 ' A' ' 40' ' ' LEU . 74.4 t80 -112.61 115.69 29.0 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.436 170.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.691 ' HB2' HG22 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -91.11 118.99 30.88 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.094 174.037 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -80.38 -7.89 59.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.263 -174.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 7.9 t -72.04 -51.52 21.32 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.911 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' HG23 ' A' ' 18' ' ' VAL . 26.9 p -100.94 2.97 41.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.312 0.577 . . . . 0.0 110.324 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p 54.4 45.43 27.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.812 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 16' ' ' CYS . 21.7 t -141.61 147.89 21.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.626 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.58 142.1 42.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.561 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.73 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.9 pt -133.17 167.05 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.703 0.763 . . . . 0.0 112.916 -170.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.9 t -117.79 108.31 42.99 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.303 160.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 19.1 Cg_endo -70.19 176.14 7.5 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 124.404 3.402 . . . . 0.0 116.552 -166.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HB2' HG13 ' A' ' 28' ' ' ILE . 62.6 mtt180 -114.05 49.17 1.02 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 112.924 -1.944 . . . . 0.0 107.802 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.428 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.6 mm? -0.44 -61.74 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.124 0 CA-C-N 111.308 -2.678 . . . . 0.0 117.763 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -32.38 -36.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.377 2.718 . . . . 0.0 114.397 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.553 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.98 -19.76 9.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.786 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.428 ' CE1' HD13 ' A' ' 24' ' ' LEU . 56.4 m-85 66.91 46.23 1.67 Allowed 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.227 -169.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.553 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -92.09 164.04 2.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 113.82 -1.537 . . . . 0.0 110.341 174.367 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.435 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -96.41 144.11 27.28 Favored Pre-proline 0 C--N 1.306 -1.303 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.015 177.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.73 ' HD3' HD12 ' A' ' 20' ' ' ILE . 47.5 Cg_endo -84.87 -15.91 5.57 Favored 'Trans proline' 0 CA--C 1.5 -1.212 0 C-N-CA 123.55 2.833 . . . . 0.0 108.627 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 85.7 mtt-85 -91.21 -14.18 31.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.177 -1.829 . . . . 0.0 114.0 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.4 p -163.33 3.77 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG2' HG21 ' A' ' 28' ' ' ILE . 17.7 tt0 55.41 36.91 28.09 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.542 0.687 . . . . 0.0 112.162 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.449 ' HB3' ' CD2' ' A' ' 36' ' ' PHE . 16.7 m -116.81 136.43 52.96 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.493 172.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.67 28.26 2.46 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.086 -0.578 . . . . 0.0 113.925 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 80.0 m-85 -86.57 44.24 1.14 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.087 0.47 . . . . 0.0 109.799 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.713 HG21 ' CD1' ' A' ' 20' ' ' ILE . 19.6 pt -110.86 132.79 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.104 -176.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.9 pt-20 -121.7 139.81 53.09 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -76.35 128.64 35.25 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.667 HD12 ' HG2' ' A' ' 10' ' ' ARG . 13.0 mt . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.319 -167.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.43 91.62 4.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.724 0.297 . . . . 0.0 110.682 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 60.34 -161.81 0.27 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.741 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 60.11 46.42 10.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.413 0.625 . . . . 0.0 109.338 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -86.44 14.93 5.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.935 -169.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -56.5 -44.15 80.4 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -120.51 115.82 24.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.042 172.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -86.36 164.41 17.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.15 140.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.149 0.5 . . . . 0.0 110.737 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -124.24 -19.14 5.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.499 0.666 . . . . 0.0 109.419 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -87.07 51.1 2.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.429 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -142.28 155.43 45.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.083 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.43 -26.19 60.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.434 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' C' ' 33' ' ' VAL . 40.9 mttm -82.33 178.16 8.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.739 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' C' ' 35' ' ' ALA . 26.1 ttt -149.1 -36.57 0.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -175.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.759 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -102.08 140.43 36.36 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.786 -179.061 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.588 ' HA ' HG13 ' C' ' 32' ' ' ILE . 4.6 mt-10 -97.21 90.75 5.23 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.966 174.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 24.4 t -78.61 76.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 123.31 1.529 . . . . 0.0 111.019 -169.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.902 ' HB3' HG12 ' C' ' 81' ' ' VAL . 4.3 mt -69.98 140.37 52.94 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.56 HG22 ' HB ' ' C' ' 82' ' ' ILE . 47.4 t -153.44 115.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.986 0.422 . . . . 0.0 110.131 -169.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 34.8 mtpt -98.9 125.44 44.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.628 ' O ' HD22 ' C' ' 24' ' ' LEU . 5.7 p -81.97 -60.66 2.15 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.031 0.443 . . . . 0.0 111.467 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.628 HD22 ' O ' ' C' ' 23' ' ' THR . 1.7 mm? -140.17 26.42 2.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.02 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 11.5 t70 84.23 -35.22 0.06 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.082 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 6.1 m -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.758 0.314 . . . . 0.0 111.19 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -92.09 -76.85 0.45 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 97.5 m 56.67 93.39 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.761 0.315 . . . . 0.0 110.638 -170.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' C' ' 29' ' ' ARG . 66.2 mtt180 -128.09 150.06 50.13 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.094 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.503 ' OG1' HD23 ' C' ' 20' ' ' LEU . 0.2 OUTLIER -97.09 139.94 32.34 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.626 -176.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.605 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 38.0 m-85 -127.0 67.67 1.27 Allowed 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.613 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.588 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -58.78 120.63 4.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 123.384 1.564 . . . . 0.0 114.189 -174.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' C' ' 15' ' ' LYS . 17.8 m -136.99 -170.3 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 110.94 -2.846 . . . . 0.0 110.812 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.447 ' O ' HD22 ' C' ' 17' ' ' LEU . . . -88.93 176.74 44.32 Favored Glycine 0 C--N 1.307 -1.06 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.773 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.759 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -68.73 -17.66 64.09 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 117.818 0.809 . . . . 0.0 112.286 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -163.73 27.07 0.08 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -55.58 -76.53 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 112.019 -2.355 . . . . 0.0 111.219 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.58 ' O ' HG12 ' C' ' 39' ' ' VAL . 83.8 m-20 -128.79 -84.9 0.57 Allowed 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.355 174.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.723 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 88.12 -28.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 125.594 1.809 . . . . 0.0 111.646 -167.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -72.6 0.5 Allowed 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.013 0.911 . . . . 0.0 109.402 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.2 -27.86 67.5 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.368 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.56 ' HZ ' HG11 ' C' ' 19' ' ' VAL . 0.6 OUTLIER -62.25 -50.32 72.21 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.35 174.53 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.671 ' HD2' ' O ' ' C' ' 39' ' ' VAL . 0.0 OUTLIER -58.37 -43.16 88.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.089 0.471 . . . . 0.0 110.756 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -57.03 -34.24 68.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.523 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -70.9 -44.51 66.09 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.691 ' O ' HG22 ' C' ' 50' ' ' VAL . 21.5 pt -77.98 -16.77 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.835 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.06 -49.61 2.56 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.06 -42.49 60.12 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.797 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -16.6 63.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.925 0.393 . . . . 0.0 110.976 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.691 HG22 ' O ' ' C' ' 46' ' ' ILE . 29.0 m -112.06 -9.1 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.891 176.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t 70.62 19.79 5.98 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.768 0.794 . . . . 0.0 109.283 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.7 mm -128.48 110.03 19.23 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.873 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.544 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 6.4 Cg_exo -68.37 146.82 70.09 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.173 1.915 . . . . 0.0 111.09 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -54.91 -25.7 30.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.898 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.483 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.7 pt-20 -75.31 -18.01 60.13 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 111.082 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.628 ' O ' ' HG3' ' C' ' 87' ' ' ARG . 98.7 mttt -120.29 -0.95 10.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.401 . . . . 0.0 110.773 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.681 ' OE1' HD11 ' C' ' 46' ' ' ILE . 0.0 OUTLIER -93.1 126.18 38.07 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.335 -175.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.47 ' CD ' ' HG2' ' C' ' 87' ' ' ARG . 66.5 mtp85 -122.35 123.6 41.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.05 173.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.607 ' HB3' HG21 ' C' ' 82' ' ' ILE . 2.1 mm? -92.25 104.49 16.85 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.734 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.613 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.6 mt -101.64 122.93 54.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.893 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.457 ' OH ' ' HD3' ' C' ' 80' ' ' LYS . 29.5 t80 -135.24 131.94 37.24 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 171.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 48.44 38.78 11.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.033 -172.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.88 6.4 63.58 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.848 -0.615 . . . . 0.0 113.169 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' C' ' 64' ' ' ARG . 4.2 mmp_? -98.16 133.52 42.49 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.456 HG11 ' NH2' ' C' ' 58' ' ' ARG . 0.6 OUTLIER -88.17 94.45 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.265 0.555 . . . . 0.0 110.471 -176.002 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.3 OUTLIER -82.66 156.1 24.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 67' ' ' GLN . . . . . 0.482 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 16.4 pt20 -169.97 -169.12 0.83 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.601 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.723 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.3 p-10 -62.41 -0.02 0.52 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.771 0.828 . . . . 0.0 112.228 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' ASP . . . . . 0.482 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 28.9 t70 -63.38 -4.33 2.6 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.016 0.926 . . . . 0.0 112.782 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.476 ' HA ' HG11 ' C' ' 39' ' ' VAL . 51.5 mtmt 83.55 167.89 0.1 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 169.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.435 ' HB3' ' HG3' ' C' ' 74' ' ' GLU . 13.9 mptt 67.35 79.12 0.23 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.939 -178.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 20.8 mt -62.27 -33.23 74.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.648 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -69.36 -19.03 63.84 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 122.696 0.399 . . . . 0.0 112.005 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' GLU . . . . . 0.435 ' HG3' ' HB3' ' C' ' 71' ' ' LYS . 32.1 mt-10 -73.05 -27.85 61.98 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.535 ' CD1' HD22 ' C' ' 66' ' ' LEU . 15.7 m-85 -87.97 -21.99 24.54 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.4 t30 58.89 40.37 22.73 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.709 174.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.512 HG11 HD11 ' C' ' 82' ' ' ILE . 17.4 m -87.92 10.22 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.84 -171.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -60.91 99.48 0.2 Allowed Glycine 0 CA--C 1.488 -1.6 0 CA-C-O 122.785 1.214 . . . . 0.0 113.226 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 79' ' ' GLY . . . . . 0.41 ' C ' HD12 ' C' ' 20' ' ' LEU . . . 94.35 15.25 48.17 Favored Glycine 0 C--N 1.284 -2.357 0 CA-C-N 112.091 -2.055 . . . . 0.0 114.132 172.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' LYS . . . . . 0.457 ' HD3' ' OH ' ' C' ' 61' ' ' TYR . 55.2 mttm -126.75 140.47 52.36 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.902 HG12 ' HB3' ' C' ' 20' ' ' LEU . 33.9 m -75.83 134.02 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.854 0.835 . . . . 0.0 110.732 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.607 HG21 ' HB3' ' C' ' 59' ' ' LEU . 59.4 mt -89.78 169.8 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.969 172.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.524 ' N ' HG22 ' C' ' 82' ' ' ILE . 56.8 m80 -115.95 112.38 21.77 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.474 HD12 ' N ' ' C' ' 85' ' ' VAL . 13.7 tp -97.83 130.63 44.74 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 121.218 0.533 . . . . 0.0 110.296 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.474 ' N ' HD12 ' C' ' 84' ' ' LEU . 30.6 m -131.38 151.81 36.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.978 -176.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 86' ' ' GLU . . . . . 0.464 ' HB3' HD12 ' C' ' 52' ' ' ILE . 3.2 pt-20 -87.96 143.81 26.89 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.324 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ARG . . . . . 0.628 ' HG3' ' O ' ' C' ' 56' ' ' LYS . 54.2 mtt180 -80.76 166.12 21.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.641 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.7 144.44 97.87 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.895 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.9 155.7 62.56 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.101 2.534 . . . . 0.0 112.346 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.08 50.08 2.11 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.906 2.404 . . . . 0.0 113.15 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -100.59 -49.56 4.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.2 t -129.45 150.21 50.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.945 170.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 54.7 t60 60.32 54.85 3.77 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.643 0.735 . . . . 0.0 109.467 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.555 HD23 ' H ' ' C' ' 94' ' ' LEU . 1.3 pt? -109.38 115.58 56.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.231 -175.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.96 -29.55 11.93 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.475 2.117 . . . . 0.0 111.659 176.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 22.6 t -67.44 117.41 9.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.842 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.55 -78.58 1.85 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.517 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 64.29 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.442 0.697 . . . . 0.0 112.174 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 9.7 t 63.48 91.42 0.07 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.392 0.615 . . . . 0.0 110.323 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 8.4 m -87.67 62.2 6.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.136 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.72 -1.044 . . . . 0.0 112.094 177.663 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 112.131 -0.388 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 12.9 p -77.44 95.92 4.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.046 0.45 . . . . 0.0 110.721 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm -160.17 -54.5 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.821 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.12 115.13 4.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.17 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.36 77.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.483 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 66.72 -73.33 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.93 0.769 . . . . 0.0 111.034 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.418 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 58.1 m -151.32 82.04 5.9 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.61 57.59 6.44 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.949 2.433 . . . . 0.0 113.172 -175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.441 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 27.5 t-80 -166.49 -51.57 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.603 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 7' ' ' HIS . 97.1 Cg_endo -95.69 125.12 0.33 Allowed 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 122.497 2.132 . . . . 0.0 111.923 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.629 ' HA3' HG13 ' A' ' 21' ' ' VAL . . . 114.28 5.37 21.37 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 119.506 -1.33 . . . . 0.0 112.289 -176.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -70.96 81.68 0.66 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.483 0.659 . . . . 0.0 110.237 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.691 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.6 m-85 -115.42 166.2 12.14 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.141 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.592 ' HB2' HD11 ' A' ' 40' ' ' LEU . 39.0 t80 -140.64 119.44 12.53 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.317 178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -95.9 107.12 19.35 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.782 177.037 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.42 ' CD2' HG21 ' C' ' 85' ' ' VAL . 20.2 p-80 -62.23 -15.73 48.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.808 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 7.0 t -71.71 -31.12 66.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.645 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.1 m -98.65 -26.14 14.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.156 0.503 . . . . 0.0 110.607 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.37 28.55 15.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.345 -171.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.68 143.53 40.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 36.9 tt0 -71.82 148.39 46.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.11 0.481 . . . . 0.0 110.831 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.727 HD11 HG21 ' A' ' 37' ' ' ILE . 3.6 pt -138.68 167.04 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.719 -170.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.629 HG13 ' HA3' ' A' ' 9' ' ' GLY . 20.9 t -123.36 96.85 43.46 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 163.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.691 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 9.2 Cg_endo -56.0 176.16 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.872 1 C-N-CA 125.328 4.018 . . . . 0.0 116.529 -170.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.74 ' HB2' HG13 ' A' ' 28' ' ' ILE . 24.5 mtt180 -110.25 49.82 0.83 Allowed 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 112.488 -2.142 . . . . 0.0 107.692 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -0.75 -58.25 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 CA-C-N 111.21 -2.723 . . . . 0.0 117.047 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 18.6 Cg_exo -37.15 -31.19 0.12 Allowed 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.88 2.387 . . . . 0.0 114.074 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.554 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -123.69 -19.88 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.357 0.599 . . . . 0.0 111.765 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.436 ' C ' HD11 ' A' ' 37' ' ' ILE . 47.0 m-85 67.34 45.49 1.61 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.28 -171.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.74 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.4 OUTLIER -92.43 160.45 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.723 173.489 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -96.0 144.64 28.18 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.662 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 96.8 Cg_endo -79.52 -21.55 8.66 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 122.672 2.248 . . . . 0.0 108.049 -172.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.1 mtt-85 -79.92 -37.79 33.87 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 112.561 -2.109 . . . . 0.0 113.567 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.0 p -133.75 -6.92 2.81 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.463 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 59.32 30.91 20.71 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.509 0.671 . . . . 0.0 111.661 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 m -111.48 144.24 41.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.467 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.23 41.06 2.6 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.109 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.682 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 60.5 m-85 -96.04 46.02 1.08 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.106 0.479 . . . . 0.0 109.934 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.727 HG21 HD11 ' A' ' 20' ' ' ILE . 3.5 pt -113.31 134.63 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.796 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB3' HD13 ' C' ' 60' ' ' ILE . 0.7 OUTLIER -119.14 141.69 48.6 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -79.9 137.27 36.86 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.455 -175.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.931 0.396 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.79 121.84 3.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.69 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -80.01 75.09 6.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.354 0.597 . . . . 0.0 110.531 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 t60 54.77 49.07 18.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.257 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -109.39 15.33 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.424 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 19.3 m80 -96.63 110.97 23.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.043 0.449 . . . . 0.0 110.641 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -145.5 -172.96 3.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -83.11 -47.66 11.4 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.24 142.41 42.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.442 171.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -104.95 -22.85 13.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.04 0.448 . . . . 0.0 110.028 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -83.47 78.17 9.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.655 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -81.51 74.42 8.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.68 0.753 . . . . 0.0 110.613 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.2 -2.7 49.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.764 174.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -68.03 150.79 48.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.173 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.538 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 26.5 ptt? -163.35 122.47 2.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.187 0.518 . . . . 0.0 111.401 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.9 mt -105.04 132.15 51.64 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.562 ' HA ' ' CG1' ' C' ' 32' ' ' ILE . 49.3 mt-10 -81.51 94.39 6.86 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.58 HG22 HG23 ' C' ' 77' ' ' VAL . 9.4 t -80.67 116.53 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.925 -171.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.573 ' CB ' HG12 ' C' ' 81' ' ' VAL . 0.8 OUTLIER -107.5 144.9 33.8 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 175.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' C' ' 28' ' ' THR . 3.5 m -137.02 147.64 26.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.567 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 37.0 mtpt -120.29 123.64 43.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 17.0 p -81.89 179.82 7.67 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.682 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 6.2 mp -67.06 -29.13 68.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.683 0.674 . . . . 0.0 110.134 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.47 -5.91 12.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.783 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 8.7 t 66.21 22.6 10.96 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.539 0.685 . . . . 0.0 110.611 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -47.23 -56.54 6.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.203 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 71.7 m 62.29 96.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.849 0.718 . . . . 0.0 110.615 -174.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -133.11 153.42 51.54 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.425 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.568 HG22 ' CD2' ' C' ' 20' ' ' LEU . 16.3 p -100.11 151.4 21.44 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -170.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.634 ' HE2' HG21 ' C' ' 21' ' ' VAL . 26.8 m-85 -141.43 55.56 1.52 Allowed 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.246 -175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.562 ' CG1' ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -60.95 120.84 7.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 123.407 1.575 . . . . 0.0 113.801 -174.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.6 m -138.03 -168.76 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 110.729 -2.942 . . . . 0.0 111.446 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -76.94 -158.96 9.39 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.052 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.566 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -110.13 23.64 14.06 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 120.9 0.381 . . . . 0.0 111.371 -177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 39.6 tt0 166.19 -17.47 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.418 -163.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -41.25 -64.86 0.5 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.48 1.113 . . . . 0.0 112.262 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.465 ' O ' HG12 ' C' ' 39' ' ' VAL . 66.1 m-20 -131.0 -95.01 0.37 Allowed 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.677 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 86.0 -30.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 O-C-N 125.041 1.463 . . . . 0.0 110.819 -162.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.79 -70.28 0.55 Allowed 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.228 1.013 . . . . 0.0 109.095 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' GLU . . . . . 0.44 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 43.7 mt-10 -62.03 -26.66 68.37 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.393 173.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.755 ' O ' HG23 ' C' ' 46' ' ' ILE . 0.2 OUTLIER -56.82 -53.71 54.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.255 172.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.448 ' N ' ' HD1' ' C' ' 42' ' ' PHE . 18.8 mtpp -61.79 -41.89 98.32 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.521 0.677 . . . . 0.0 110.721 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -58.46 -40.28 82.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.662 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -69.92 -44.82 68.87 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.027 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.755 HG23 ' O ' ' C' ' 42' ' ' PHE . 4.3 pt -75.22 -13.23 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.792 -0.185 . . . . 0.0 111.225 -172.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -43.49 -45.64 6.52 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.33 -43.09 34.23 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.892 -0.505 . . . . 0.0 111.804 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -20.28 63.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.516 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.655 HG22 ' O ' ' C' ' 46' ' ' ILE . 31.5 m -112.07 -6.68 11.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t 68.85 19.72 8.23 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.724 0.773 . . . . 0.0 109.018 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.64 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 8.6 mm -125.71 112.42 25.06 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.385 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.602 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 4.7 Cg_exo -69.73 146.31 59.97 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.138 1.892 . . . . 0.0 111.494 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.3 p -53.0 -24.82 10.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.476 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 12.8 pt-20 -77.27 -32.37 55.56 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.36 0.412 . . . . 0.0 111.894 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' C' ' 86' ' ' GLU . 27.0 mtpp -97.92 -19.93 17.77 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 109.847 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' C' ' 53' ' ' PRO . 25.8 tt0 -66.52 123.26 19.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.92 -170.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.568 ' HD2' ' HG2' ' C' ' 87' ' ' ARG . 43.5 mtp85 -124.93 115.4 20.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.204 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.593 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 51.6 mt -86.96 111.41 20.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.979 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 38' ' ' GLU . 5.6 mt -109.93 113.63 44.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 O-C-N 121.568 -0.707 . . . . 0.0 112.01 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' C' ' 66' ' ' LEU . 21.1 t80 -129.38 126.89 39.86 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 60.5 34.17 20.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.022 0.439 . . . . 0.0 110.379 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.99 5.44 40.09 Favored Glycine 0 N--CA 1.453 -0.211 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.899 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -87.43 133.4 33.74 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.97 87.6 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.261 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.602 ' HB3' ' CD2' ' C' ' 75' ' ' TYR . 0.8 OUTLIER -68.28 141.63 55.81 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.458 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 67' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' C' ' 69' ' ' ASP . 10.6 pt20 -155.4 -168.97 3.0 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.684 -0.406 . . . . 0.0 109.955 -173.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.677 ' HA ' HG13 ' C' ' 39' ' ' VAL . 8.9 p-10 -67.43 0.24 3.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.608 0.763 . . . . 0.0 112.577 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' ASP . . . . . 0.441 ' H ' ' HG3' ' C' ' 67' ' ' GLN . 29.1 t70 -64.17 -4.02 3.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.521 0.729 . . . . 0.0 112.846 -174.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.416 ' H ' HG11 ' C' ' 39' ' ' VAL . 49.2 mttp 81.95 177.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.951 0.9 . . . . 0.0 111.865 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.421 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 65.5 mttm 74.66 75.12 0.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.145 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.473 HD12 ' H ' ' C' ' 36' ' ' GLN . 56.6 mt -65.01 -45.39 85.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.292 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -69.55 -25.84 64.2 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' GLU . . . . . 0.421 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 69.3 mm-40 -67.46 -24.71 65.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.575 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.602 ' CD2' ' HB3' ' C' ' 66' ' ' LEU . 6.9 m-30 -86.42 -10.21 54.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.447 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 1.3 m120 47.89 35.33 4.75 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.328 1.051 . . . . 0.0 113.471 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.58 HG23 HG22 ' C' ' 19' ' ' VAL . 16.5 m -90.55 16.19 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -175.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.556 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -73.18 102.78 1.29 Allowed Glycine 0 N--CA 1.431 -1.658 0 CA-C-O 122.792 1.218 . . . . 0.0 112.082 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.21 14.59 62.01 Favored Glycine 0 C--N 1.283 -2.401 0 CA-C-N 112.052 -2.074 . . . . 0.0 113.045 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -124.23 147.5 48.01 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.573 HG12 ' CB ' ' C' ' 20' ' ' LEU . 34.0 m -84.13 124.26 39.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 121.971 0.891 . . . . 0.0 112.313 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.52 HG22 ' N ' ' C' ' 83' ' ' HIS . 74.0 mt -77.77 171.6 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.433 173.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.52 ' N ' HG22 ' C' ' 82' ' ' ILE . 45.5 m80 -118.85 119.52 34.62 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.465 -0.772 . . . . 0.0 109.775 170.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.468 HD12 ' H ' ' C' ' 85' ' ' VAL . 25.9 tp -100.59 145.14 28.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -171.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.77 HG22 ' H ' ' C' ' 86' ' ' GLU . 2.8 p -153.5 -174.33 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.481 0.658 . . . . 0.0 109.973 171.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 86' ' ' GLU . . . . . 0.77 ' H ' HG22 ' C' ' 85' ' ' VAL . 4.7 pt-20 -117.98 161.22 20.15 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.858 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ARG . . . . . 0.568 ' HG2' ' HD2' ' C' ' 58' ' ' ARG . 29.1 mtm105 -82.38 159.98 22.9 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 171.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -68.74 139.2 90.99 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.601 -175.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.56 ' HB2' ' OE1' ' C' ' 91' ' ' GLN . 38.1 Cg_exo -63.02 162.85 24.46 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 124.146 3.23 . . . . 0.0 112.683 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.95 56.59 2.48 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.335 2.69 . . . . 0.0 113.366 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' GLN . . . . . 0.56 ' OE1' ' HB2' ' C' ' 89' ' ' PRO . 7.8 pm0 179.18 -26.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.281 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 13.1 t 42.44 42.76 2.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.633 1.173 . . . . 0.0 113.231 169.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 70.15 -63.12 0.41 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.357 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 pp -144.23 137.34 13.91 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.383 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.97 152.16 40.58 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.333 2.022 . . . . 0.0 111.526 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 8.5 t -164.07 149.26 10.49 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.0 -60.42 8.44 Favored Glycine 0 C--O 1.236 0.258 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.849 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 58.32 36.8 25.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.228 0.537 . . . . 0.0 110.962 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 17.2 t -95.27 77.33 3.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.997 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 13.9 m -84.44 53.05 2.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.659 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.315 -1.269 . . . . 0.0 111.17 -178.251 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.1 t -164.33 94.61 0.72 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.003 0.43 . . . . 0.0 110.025 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -77.27 -51.33 11.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.355 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.83 108.55 5.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.923 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -143.39 -63.97 0.39 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.752 -175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.559 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . 55.32 61.79 2.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.206 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -88.69 104.66 7.81 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.62 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 4' ' ' ALA . 97.7 Cg_endo -86.96 178.05 3.78 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.351 2.034 . . . . 0.0 111.52 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.607 ' CB ' ' HG2' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -140.71 93.4 8.55 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.192 173.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 7' ' ' HIS . 19.0 Cg_endo -53.26 -24.43 26.71 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 C-N-CA 123.664 2.91 . . . . 0.0 113.834 173.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.8 34.61 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.295 0 C-N-CA 119.304 -1.427 . . . . 0.0 114.478 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.607 ' HG2' ' CB ' ' A' ' 7' ' ' HIS . 16.7 ptp180 -71.73 97.13 1.71 Allowed 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.353 1.073 . . . . 0.0 109.48 174.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.69 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 8.4 m-85 -116.79 164.59 14.43 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.819 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.611 ' CB ' HD21 ' A' ' 40' ' ' LEU . 54.5 t80 -138.98 112.58 8.3 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.572 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.596 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -91.9 110.52 21.87 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.474 ' CG ' HG13 ' C' ' 85' ' ' VAL . 9.8 p80 -69.15 -17.98 63.89 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -169.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 13.5 p -73.33 -39.11 65.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.255 174.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.7 m -78.19 -29.68 48.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.321 0.581 . . . . 0.0 110.646 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER 58.58 28.8 17.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.694 -176.462 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.54 146.23 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.69 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.1 tt0 -70.06 144.53 52.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.231 0.538 . . . . 0.0 111.034 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.719 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.2 pt -132.08 167.91 25.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.77 -175.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 14.1 t -125.28 95.01 42.17 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 164.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 3.5 Cg_endo -54.28 175.85 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.842 1 C-N-CA 125.423 4.082 . . . . 0.0 116.973 -169.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.709 ' HB2' HG13 ' A' ' 28' ' ' ILE . 37.8 mtt180 -107.5 48.32 0.85 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 112.565 -2.107 . . . . 0.0 107.023 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 0.79 -61.71 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.116 0 CA-C-N 110.811 -2.904 . . . . 0.0 117.253 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -32.18 -36.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 123.553 2.835 . . . . 0.0 113.819 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.531 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -115.68 -22.62 9.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.181 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.513 ' C ' HD11 ' A' ' 37' ' ' ILE . 58.4 m-85 68.1 58.6 0.46 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.406 1.098 . . . . 0.0 110.32 -168.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.709 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -110.71 162.57 8.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.304 176.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.5 t -96.16 146.61 31.61 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.624 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 67.6 Cg_endo -81.6 -22.3 5.6 Favored 'Trans proline' 0 CA--C 1.5 -1.224 0 C-N-CA 122.606 2.204 . . . . 0.0 108.031 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.539 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 68.5 mtt-85 -81.7 -25.14 35.73 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 112.892 -1.958 . . . . 0.0 113.752 -177.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.6 p -146.23 -7.25 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.637 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 60.35 32.35 20.65 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.744 0.783 . . . . 0.0 111.033 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.1 m -113.19 146.39 39.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.744 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.57 37.64 2.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.14 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 87.8 m-85 -92.34 38.77 1.01 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.255 0.55 . . . . 0.0 110.041 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.719 HG21 ' CD1' ' A' ' 20' ' ' ILE . 7.1 pt -110.94 133.67 55.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.614 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HB2' HG22 ' C' ' 65' ' ' VAL . 10.5 pt-20 -121.95 136.15 54.91 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 172.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.26 135.9 40.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.219 0.533 . . . . 0.0 109.692 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.611 HD21 ' CB ' ' A' ' 12' ' ' PHE . 8.7 mt . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.328 -171.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 2' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' C' ' 7' ' ' HIS . 52.1 mtt . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.511 0.196 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.49 -69.79 0.17 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.536 0.734 . . . . 0.0 112.151 177.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -151.27 120.35 6.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 59.89 -162.43 0.25 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -174.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 57.69 71.19 0.59 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.223 0.535 . . . . 0.0 111.789 171.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' HIS . . . . . 0.453 ' HA ' ' SD ' ' C' ' 2' ' ' MET . 44.1 m80 -79.27 162.91 25.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.761 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -92.36 18.01 9.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.337 0.589 . . . . 0.0 110.645 -173.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -101.94 11.22 38.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.528 0.68 . . . . 0.0 109.468 173.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.83 156.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.548 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -67.54 -60.39 2.6 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 18.7 t70 176.23 -50.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.09 95.99 2.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.172 164.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -78.64 -2.9 41.3 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.278 -175.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 15' ' ' LYS . . . . . 0.797 ' HD3' HG22 ' C' ' 32' ' ' ILE . 33.0 mttp 49.51 -165.47 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.067 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 49.9 ttm -170.56 -31.12 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.933 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -104.08 147.87 26.91 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.294 0.569 . . . . 0.0 109.524 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.499 ' HA ' HG13 ' C' ' 32' ' ' ILE . 4.5 mt-10 -106.86 83.55 1.86 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' C' ' 30' ' ' THR . 4.2 t -72.06 143.63 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.441 -166.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 1.018 ' HB3' HG12 ' C' ' 81' ' ' VAL . 7.9 mt -128.65 156.71 43.0 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' C' ' 28' ' ' THR . 21.5 m -145.36 152.89 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.601 ' HG3' ' CB ' ' C' ' 81' ' ' VAL . 35.7 mtpt -138.24 110.44 7.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.952 0.501 . . . . 0.0 109.983 173.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.36 108.69 20.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.869 0.366 . . . . 0.0 111.072 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 mm? 55.97 22.01 5.44 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.541 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' ASP . . . . . 0.481 ' HA ' ' HE2' ' C' ' 22' ' ' LYS . 34.8 t70 76.5 -22.98 0.25 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.524 173.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 15.1 m -58.63 -44.04 89.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.13 0.491 . . . . 0.0 110.14 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -106.95 171.55 7.3 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.04 0.924 . . . . 0.0 111.576 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.734 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 51.5 m -173.17 103.56 0.13 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 113.087 -1.869 . . . . 0.0 107.846 178.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 29' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' C' ' 20' ' ' LEU . 83.8 mtt180 -130.71 168.18 17.6 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.77 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 2.1 p -108.52 148.32 30.43 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.658 ' HE2' HG21 ' C' ' 21' ' ' VAL . 40.6 m-85 -139.73 65.07 1.44 Allowed 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.44 0.638 . . . . 0.0 110.365 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.797 HG22 ' HD3' ' C' ' 15' ' ' LYS . 2.5 mp -55.23 118.45 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 123.214 1.483 . . . . 0.0 113.776 -176.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.41 HG13 ' O ' ' C' ' 31' ' ' PHE . 19.7 m -136.94 -171.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 111.347 -2.661 . . . . 0.0 111.209 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.08 157.18 20.07 Favored Glycine 0 C--N 1.307 -1.082 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.144 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.795 ' HA ' HD21 ' C' ' 17' ' ' LEU . . . -63.42 -18.78 64.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -172.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -147.74 22.47 1.13 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -75.53 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.224 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.609 ' O ' HG12 ' C' ' 39' ' ' VAL . 88.0 m-20 -128.74 -91.94 0.47 Allowed 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.664 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 82.04 -28.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.035 1.459 . . . . 0.0 112.12 -166.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' C' ' 43' ' ' LYS . 0.0 OUTLIER -80.77 -68.96 0.64 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.557 1.17 . . . . 0.0 108.78 174.349 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.53 -29.62 70.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.476 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.618 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -62.18 -53.21 58.57 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.184 175.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.651 ' HG2' ' O ' ' C' ' 40' ' ' LYS . 3.3 ptmt -67.3 -34.1 76.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.192 0.52 . . . . 0.0 110.136 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.512 ' HA ' ' HB3' ' C' ' 54' ' ' SER . 16.7 tt0 -59.46 -37.01 77.07 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.657 175.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -69.98 -40.73 75.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.925 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.617 ' O ' HG22 ' C' ' 50' ' ' VAL . 18.4 pt -81.46 -7.64 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -174.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.24 -59.76 1.44 Allowed 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.24 -34.54 70.86 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.849 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -28.22 69.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.617 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.4 m -106.16 -2.75 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 29.0 m 69.53 19.61 7.42 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.536 0.684 . . . . 0.0 109.586 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.6 mm -127.65 117.12 21.08 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.165 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.522 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.0 Cg_exo -68.75 149.8 73.45 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.636 1.558 . . . . 0.0 111.751 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.544 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 29.6 p -53.88 -25.72 21.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.254 -176.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -79.68 -13.6 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -116.24 -33.04 5.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.639 ' OE1' ' HB2' ' C' ' 43' ' ' LYS . 8.7 pt20 -65.33 129.61 40.35 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.985 0.898 . . . . 0.0 111.997 -173.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' C' ' 84' ' ' LEU . 38.5 mmt180 -115.51 116.06 27.55 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.761 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.709 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 11.7 mt -84.23 106.01 15.52 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.346 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.53 HG21 ' O ' ' A' ' 37' ' ' ILE . 26.6 mt -99.1 118.53 45.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.534 -0.729 . . . . 0.0 111.69 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.444 ' OH ' ' HG2' ' C' ' 80' ' ' LYS . 64.5 t80 -135.19 130.2 34.95 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 62' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' C' ' 61' ' ' TYR . 48.1 mt-30 61.8 33.62 17.65 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.053 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 63' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 68.3 4.58 37.8 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.43 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -99.17 133.41 43.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -89.99 88.68 2.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.314 0.578 . . . . 0.0 110.013 -175.716 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.709 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.1 OUTLIER -67.93 155.18 40.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.162 178.706 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 67' ' ' GLN . . . . . 0.415 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.5 pt20 -161.95 -167.19 1.6 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.686 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.664 ' HA ' HG13 ' C' ' 39' ' ' VAL . 1.5 p-10 -58.81 -2.48 0.23 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.041 0.936 . . . . 0.0 112.893 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 69' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 27.8 t70 -62.25 -9.12 6.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.574 0.75 . . . . 0.0 112.573 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.518 ' H ' HG11 ' C' ' 39' ' ' VAL . 37.5 mtmm 78.81 174.9 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.758 0.823 . . . . 0.0 112.41 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.491 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 32.6 mtmm 78.6 71.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 124.209 0.943 . . . . 0.0 111.362 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 3.5 mm? -62.19 -44.14 97.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 73' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' C' ' 35' ' ' ALA . 5.7 pt20 -66.02 -19.47 65.87 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 74' ' ' GLU . . . . . 0.491 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 36.7 mm-40 -70.52 -28.39 64.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.584 ' CD1' HD22 ' C' ' 66' ' ' LEU . 18.9 m-85 -87.29 -23.51 24.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 60.59 43.66 12.48 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.905 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.563 HG23 HG22 ' C' ' 19' ' ' VAL . 19.6 m -91.3 -8.06 10.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.714 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -50.03 100.34 0.04 OUTLIER Glycine 0 CA--C 1.493 -1.305 0 CA-C-O 122.914 1.286 . . . . 0.0 113.944 168.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.93 10.38 49.54 Favored Glycine 0 C--N 1.29 -1.993 0 CA-C-N 111.629 -2.286 . . . . 0.0 114.725 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 80' ' ' LYS . . . . . 0.574 ' C ' ' HB2' ' C' ' 20' ' ' LEU . 0.0 OUTLIER -132.47 148.18 52.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.524 0.662 . . . . 0.0 111.118 -178.551 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 1.018 HG12 ' HB3' ' C' ' 20' ' ' LEU . 35.6 m -80.52 122.04 35.01 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-O 121.741 0.781 . . . . 0.0 111.934 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.49 HG21 ' HB3' ' C' ' 59' ' ' LEU . 77.6 mt -80.18 160.46 4.15 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.828 174.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.438 ' N ' HG22 ' C' ' 82' ' ' ILE . 54.8 m80 -117.71 114.73 23.77 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 121.657 -0.652 . . . . 0.0 109.989 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' C' ' 58' ' ' ARG . 8.0 mp -90.49 157.34 17.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.474 HG13 ' CG ' ' A' ' 14' ' ' HIS . 4.1 t -117.6 156.63 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.618 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 86' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' C' ' 86' ' ' GLU . 0.2 OUTLIER -113.58 122.85 48.46 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.461 179.117 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 87' ' ' ARG . . . . . 0.516 ' HA ' ' HE ' ' C' ' 87' ' ' ARG . 1.1 mmp_? -84.08 176.84 8.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 121.643 -0.66 . . . . 0.0 111.891 176.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.88 154.8 57.06 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.834 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.45 157.81 29.84 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.101 2.534 . . . . 0.0 111.917 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.15 55.32 3.45 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.921 2.414 . . . . 0.0 112.5 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -93.16 -68.78 0.78 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.832 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t 46.88 -151.44 0.09 Allowed 'General case' 0 CA--C 1.539 0.542 0 O-C-N 124.28 0.987 . . . . 0.0 111.695 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -66.65 -54.12 26.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.653 0.263 . . . . 0.0 110.497 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.38 104.55 52.96 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.107 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.75 130.29 21.65 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.815 2.343 . . . . 0.0 112.962 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 45.7 t -65.16 -32.06 73.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.64 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.59 -63.01 0.32 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.002 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.34 129.52 50.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.832 0.349 . . . . 0.0 110.434 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 45.3 m -90.68 -54.53 3.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.373 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 44.6 m 51.91 63.41 2.25 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.529 0.518 . . . . 0.0 111.483 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.307 -1.274 . . . . 0.0 111.411 -179.697 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 16.8 m -77.47 130.37 36.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -149.84 160.91 43.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.964 0.411 . . . . 0.0 110.96 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.12 97.87 7.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.817 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.96 56.73 1.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.153 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.25 -5.86 45.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.048 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.0 t -124.35 79.21 60.79 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.908 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.16 -76.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.597 2.198 . . . . 0.0 112.086 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 68.43 130.23 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 O-C-N 123.734 0.646 . . . . 0.0 111.1 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.56 13.46 2.08 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 123.046 2.497 . . . . 0.0 112.37 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.22 7.2 64.11 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.349 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -70.29 95.98 1.07 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.338 0.59 . . . . 0.0 110.526 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.603 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 6.7 m-85 -116.3 166.41 12.08 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.982 171.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 40' ' ' LEU . 60.6 t80 -139.48 123.74 18.01 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.446 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.571 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -98.02 101.05 12.43 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.41 ' CD2' HG21 ' C' ' 85' ' ' VAL . 7.8 p-80 -52.91 -24.95 10.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.27 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -67.5 -46.76 71.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.769 0.319 . . . . 0.0 110.443 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.0 m -74.58 -28.24 60.83 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.497 0.665 . . . . 0.0 109.852 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.68 29.6 17.56 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.02 -170.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.03 144.39 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 37.5 tt0 -73.67 148.67 42.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.124 0.488 . . . . 0.0 110.844 -175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.73 HD12 ' HD3' ' A' ' 30' ' ' PRO . 6.2 pt -139.01 168.38 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.265 -172.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.519 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 47.2 t -122.74 101.3 39.8 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 160.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 11.1 Cg_endo -54.36 175.32 0.14 Allowed 'Trans proline' 0 C--N 1.328 -0.502 1 C-N-CA 125.582 4.188 . . . . 0.0 116.215 -171.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.492 ' HD3' HD12 ' A' ' 28' ' ' ILE . 29.8 mtt180 -101.82 45.69 0.96 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 112.587 -2.097 . . . . 0.0 107.096 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.48 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -1.98 -59.03 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.861 0 CA-C-N 110.41 -3.086 . . . . 0.0 117.654 175.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.29 44.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.268 1.978 . . . . 0.0 112.857 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.575 ' HB3' HG12 ' A' ' 28' ' ' ILE . 4.8 t70 177.68 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.942 0.897 . . . . 0.0 109.653 -174.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.448 ' CE1' HD13 ' A' ' 24' ' ' LEU . 93.8 m-85 70.69 58.13 0.22 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.328 -173.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.575 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -114.76 163.52 11.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 113.307 -1.77 . . . . 0.0 108.833 175.306 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.458 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 2.1 t -95.88 144.42 27.79 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.73 ' HD3' HD12 ' A' ' 20' ' ' ILE . 79.6 Cg_endo -81.09 -22.89 5.69 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 C-N-CA 122.807 2.338 . . . . 0.0 108.182 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.517 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 50.2 mtt180 -89.09 -6.31 57.17 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.835 -1.984 . . . . 0.0 114.485 -176.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.7 p -156.06 -14.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 171.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 61.25 22.59 12.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.364 0.602 . . . . 0.0 111.709 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.9 m -96.13 141.55 29.37 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 166.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.56 51.82 4.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.007 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.54 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 39.8 m-85 -107.88 45.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.722 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.9 pt -113.66 143.87 22.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.922 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.507 ' HB3' HD13 ' C' ' 60' ' ' ILE . 1.4 pm0 -120.65 149.53 42.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 165.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -81.27 133.82 35.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.62 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.425 -0.797 . . . . 0.0 110.409 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.53 -58.59 0.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.441 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -77.65 126.39 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.252 0.549 . . . . 0.0 110.557 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' C' ' 6' ' ' HIS . 56.4 m80 -135.55 98.4 3.93 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 6' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' C' ' 5' ' ' HIS . 25.4 m-70 72.89 -54.41 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.144 0.903 . . . . 0.0 110.748 -173.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 7' ' ' HIS . . . . . 0.506 ' O ' ' HB2' ' C' ' 8' ' ' HIS . 5.7 t-160 -75.66 142.77 42.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 176.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' C' ' 7' ' ' HIS . 28.8 m80 73.41 75.28 0.13 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.689 0.618 . . . . 0.0 110.548 -173.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -77.82 63.72 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.49 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.414 HG22 ' N ' ' C' ' 11' ' ' ASP . 7.6 p -93.1 156.97 3.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.418 0.628 . . . . 0.0 110.863 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 11' ' ' ASP . . . . . 0.414 ' N ' HG22 ' C' ' 10' ' ' VAL . 24.5 t70 -132.03 66.15 1.56 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.412 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.22 65.2 5.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.064 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 60.7 41.7 14.69 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.507 -172.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -76.92 -56.53 4.51 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.469 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -76.11 -179.05 4.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.838 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.525 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 22.9 mmt 59.6 83.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.54 0.525 . . . . 0.0 110.724 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.726 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.4 OUTLIER -102.18 138.07 39.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.686 178.725 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' C' ' 32' ' ' ILE . 10.3 mt-10 -85.08 98.55 10.49 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.565 0.698 . . . . 0.0 109.287 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' C' ' 30' ' ' THR . 17.1 t -79.5 83.64 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 122.482 1.134 . . . . 0.0 110.904 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.625 ' HB3' HG12 ' C' ' 81' ' ' VAL . 12.3 mt -75.66 142.58 42.52 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' C' ' 82' ' ' ILE . 82.0 t -156.18 125.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 121.952 0.101 . . . . 0.0 110.889 -171.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.649 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 0.1 OUTLIER -111.97 162.82 14.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.152 0.501 . . . . 0.0 110.901 -178.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.535 HG22 ' O ' ' C' ' 84' ' ' LEU . 11.3 p -132.3 -174.22 3.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.836 176.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.54 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 3.4 mp -65.83 -29.77 70.29 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.142 0.496 . . . . 0.0 110.178 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.42 5.48 3.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.204 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 20.6 t 63.59 18.38 11.05 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.065 0.459 . . . . 0.0 111.484 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -49.95 -65.89 0.49 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.468 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 43.9 m 56.37 90.61 0.04 OUTLIER 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.909 0.862 . . . . 0.0 110.662 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -126.15 151.06 47.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.337 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -99.9 143.41 30.15 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.129 0.49 . . . . 0.0 111.301 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.489 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 29.2 m-85 -126.5 62.82 1.28 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 123.578 0.751 . . . . 0.0 109.766 -175.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.59 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -57.02 121.98 5.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 123.114 1.435 . . . . 0.0 114.745 -172.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' HG ' ' C' ' 72' ' ' LEU . 16.7 m -141.81 167.01 16.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 111.267 -2.697 . . . . 0.0 112.523 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -96.57 52.16 1.53 Allowed Glycine 0 C--N 1.306 -1.089 0 CA-C-N 114.549 -1.205 . . . . 0.0 114.595 -168.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.726 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.61 -44.67 0.52 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 171.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -132.1 26.61 4.56 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -75.37 0.07 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.87 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -146.58 -79.3 0.16 Allowed 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.696 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.4 OUTLIER 90.56 -29.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 125.375 1.672 . . . . 0.0 111.438 -167.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.47 ' HD2' ' HG2' ' C' ' 70' ' ' LYS . 0.1 OUTLIER -84.24 -70.35 0.58 Allowed 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 122.202 1.001 . . . . 0.0 109.14 177.787 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.04 -26.57 67.72 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.632 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.674 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -56.14 -50.14 71.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.162 171.411 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.617 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 43.6 mttp -64.59 -42.32 95.68 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.219 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -56.0 -36.73 68.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.572 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -70.11 -46.71 64.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.755 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.591 HG23 ' O ' ' C' ' 42' ' ' PHE . 8.5 pt -78.1 -13.79 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.792 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.98 -51.2 3.28 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.25 -45.47 69.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -28.07 64.83 Favored 'General case' 0 N--CA 1.424 -1.734 0 C-N-CA 122.868 0.467 . . . . 0.0 112.164 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.528 HG11 ' CD1' ' C' ' 84' ' ' LEU . 27.6 m -106.41 -3.81 9.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.18 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 82.6 p 63.35 23.7 13.87 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 122.054 0.93 . . . . 0.0 109.54 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.1 mm -131.63 120.44 17.71 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.244 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -67.73 152.8 77.29 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.034 1.823 . . . . 0.0 112.588 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.501 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 29.9 t -50.06 -40.89 46.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.358 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.549 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 15.7 pt-20 -67.12 -17.85 65.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.839 -177.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.549 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 67.7 mttm -121.09 -0.91 9.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -173.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.617 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 9.3 pt20 -96.07 142.26 28.49 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.626 -0.829 . . . . 0.0 112.863 -175.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.53 ' HG3' ' HG2' ' C' ' 87' ' ' ARG . 98.0 mtt180 -114.94 121.85 44.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.266 173.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 9.0 mp -92.07 107.3 19.11 Favored 'General case' 0 C--O 1.207 -1.164 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.551 HG21 ' O ' ' A' ' 37' ' ' ILE . 2.8 mt -105.2 106.37 20.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 120.973 0.416 . . . . 0.0 111.114 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.442 ' HB2' HG23 ' C' ' 82' ' ' ILE . 53.0 t80 -117.62 114.63 23.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.75 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 56.99 41.14 28.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.033 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.7 -15.47 36.34 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.205 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 tpm_? -81.06 126.87 31.97 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.504 -0.409 . . . . 0.0 110.208 -176.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 38' ' ' GLU . 15.8 t -83.48 90.28 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.973 0.416 . . . . 0.0 109.943 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.6 OUTLIER -75.6 134.14 40.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.342 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 67' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 6.9 pt20 -135.22 -168.57 2.21 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.161 -171.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.696 ' HA ' HG13 ' C' ' 39' ' ' VAL . 5.7 p-10 -71.13 2.37 4.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.529 0.732 . . . . 0.0 112.296 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 69' ' ' ASP . . . . . 0.54 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 19.4 t70 -61.11 1.52 0.17 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.455 1.102 . . . . 0.0 113.146 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.472 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.4 mtmt 83.44 158.44 0.12 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 168.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.4 ' HB3' ' HG3' ' C' ' 74' ' ' GLU . 34.6 mmtp 72.2 95.18 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.749 174.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.482 ' HG ' ' CG2' ' C' ' 33' ' ' VAL . 3.6 mm? -62.58 -36.8 83.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.81 177.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -68.95 -19.16 64.16 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -175.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 74' ' ' GLU . . . . . 0.4 ' HG3' ' HB3' ' C' ' 71' ' ' LYS . 26.8 mt-10 -71.48 -27.87 63.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 174.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.547 ' CD1' HD22 ' C' ' 66' ' ' LEU . 25.4 m-85 -87.78 -22.36 24.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.731 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.1 t30 61.18 40.63 14.49 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.781 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.406 HG23 HG22 ' C' ' 19' ' ' VAL . 26.4 m -92.43 27.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.743 -175.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.569 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.03 101.74 1.61 Allowed Glycine 0 N--CA 1.433 -1.558 0 CA-C-O 122.744 1.191 . . . . 0.0 112.733 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.28 13.7 50.99 Favored Glycine 0 C--N 1.283 -2.366 0 CA-C-N 112.21 -1.995 . . . . 0.0 114.108 172.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -127.01 147.61 50.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.649 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 3.0 m -79.03 127.44 39.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.605 0.717 . . . . 0.0 112.636 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.575 ' HB ' HG22 ' C' ' 21' ' ' VAL . 27.0 mt -88.71 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.301 171.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.537 ' N ' HG22 ' C' ' 82' ' ' ILE . 55.7 t-80 -109.82 133.33 53.27 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 121.821 -0.55 . . . . 0.0 110.094 166.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.535 ' O ' HG22 ' C' ' 23' ' ' THR . 5.8 mt -108.8 138.34 45.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.805 0.812 . . . . 0.0 112.244 170.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.741 HG22 ' H ' ' C' ' 86' ' ' GLU . 2.6 p -156.41 -172.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.367 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 86' ' ' GLU . . . . . 0.741 ' H ' HG22 ' C' ' 85' ' ' VAL . 6.7 pt-20 -97.33 145.95 25.63 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.222 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 87' ' ' ARG . . . . . 0.53 ' HG2' ' HG3' ' C' ' 58' ' ' ARG . 90.0 mtt180 -73.3 177.28 5.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.603 176.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -66.28 147.56 98.85 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.497 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' C' ' 88' ' ' ALA . 21.7 Cg_exo -67.48 145.09 69.68 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.248 2.632 . . . . 0.0 111.741 173.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.72 77.89 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.6 2.2 . . . . 0.0 111.603 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -71.48 -16.22 62.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.733 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -117.38 21.14 13.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.445 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 93' ' ' HIS . . . . . 0.404 ' O ' ' HD3' ' C' ' 95' ' ' PRO . 12.7 t-160 68.84 -56.92 0.52 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.659 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -106.02 97.97 17.21 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' C' ' 93' ' ' HIS . 25.3 Cg_exo -60.4 -48.65 10.96 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.768 2.312 . . . . 0.0 112.069 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 13.5 t -178.69 -175.81 0.44 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.71 156.1 9.76 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.564 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -102.53 90.99 4.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.043 0.449 . . . . 0.0 109.856 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -77.1 68.63 3.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.35 0.595 . . . . 0.0 110.525 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 6.3 p -88.15 -175.93 5.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.717 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.258 -1.301 . . . . 0.0 111.255 177.749 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.5 m -79.13 -70.04 0.53 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.542 0.171 . . . . 0.0 110.62 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm 38.08 43.49 0.56 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.012 0.925 . . . . 0.0 112.804 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.63 -26.35 54.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.433 0.635 . . . . 0.0 109.671 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -126.78 82.38 2.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.622 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.52 -42.76 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.259 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 p -112.49 107.42 55.18 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.313 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -66.32 87.1 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.802 2.335 . . . . 0.0 112.055 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -143.42 146.65 36.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.232 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.28 32.86 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.108 2.539 . . . . 0.0 112.516 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.514 ' O ' HG22 ' A' ' 21' ' ' VAL . . . -108.63 1.09 32.29 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.377 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 3.0 mpt_? -90.91 84.47 5.79 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.353 -0.423 . . . . 0.0 110.382 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.631 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 12.3 m-85 -118.04 165.9 13.19 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.326 0.584 . . . . 0.0 109.521 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.419 ' CB ' HD11 ' A' ' 40' ' ' LEU . 74.1 t80 -140.29 118.85 12.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.569 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -98.7 128.55 45.0 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.508 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -83.97 -21.32 31.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -167.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 32.0 p -72.36 -31.72 65.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 118.479 0.581 . . . . 0.0 110.016 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.445 ' HB3' HG22 ' A' ' 18' ' ' VAL . 94.5 m -85.64 -20.5 29.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.525 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.8 p 51.22 32.23 7.84 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.116 0.966 . . . . 0.0 112.375 -175.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 16' ' ' CYS . 2.8 m -141.42 157.2 21.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.494 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.628 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 32.8 tt0 -79.01 145.23 34.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.076 0.465 . . . . 0.0 111.196 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.738 HD11 HG21 ' A' ' 37' ' ' ILE . 3.3 pt -134.07 167.17 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.21 -173.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 9' ' ' GLY . 45.3 t -122.76 94.34 47.58 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 163.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.631 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.65 175.35 0.29 Allowed 'Trans proline' 0 C--N 1.325 -0.709 1 C-N-CA 125.537 4.158 . . . . 0.0 116.522 -168.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.663 ' HB2' HG13 ' A' ' 28' ' ' ILE . 36.8 mtt180 -105.74 46.94 0.89 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.702 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -1.46 -60.92 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.932 0 CA-C-N 110.582 -3.008 . . . . 0.0 116.575 174.36 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.445 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 63.2 Cg_exo -33.58 -31.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.469 2.78 . . . . 0.0 114.55 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.568 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -122.13 -19.08 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.358 0.599 . . . . 0.0 111.745 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.41 ' C ' HD11 ' A' ' 37' ' ' ILE . 50.5 m-85 68.01 58.94 0.46 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.615 -171.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.663 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -111.81 161.38 10.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 113.328 -1.76 . . . . 0.0 108.966 178.299 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.483 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -95.92 146.38 31.22 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.636 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 83.9 Cg_endo -81.32 -21.03 6.71 Favored 'Trans proline' 0 CA--C 1.5 -1.188 0 C-N-CA 122.668 2.245 . . . . 0.0 108.238 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.493 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 84.5 mtt180 -86.79 -15.1 40.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.032 -1.894 . . . . 0.0 114.398 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 31.1 p -151.58 -10.69 0.21 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 175.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 60.42 33.6 20.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.559 0.695 . . . . 0.0 111.217 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 m -113.91 146.32 40.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.47 33.15 3.25 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.826 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 97.9 m-85 -87.88 43.45 1.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.2 0.524 . . . . 0.0 110.649 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.738 HG21 HD11 ' A' ' 20' ' ' ILE . 4.6 pt -111.24 135.37 50.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.8 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -117.03 145.01 43.96 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -77.12 135.87 38.59 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.787 -174.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.462 0.172 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.99 144.45 39.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.011 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 74.4 -32.87 0.24 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.19 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -76.1 71.26 2.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.347 0.594 . . . . 0.0 110.404 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -139.76 99.35 3.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.178 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -76.99 71.84 3.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.535 0.683 . . . . 0.0 110.778 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -152.03 128.46 10.65 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -68.45 104.13 1.83 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.086 0.469 . . . . 0.0 111.379 -174.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 m -88.77 142.93 12.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 171.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.67 -60.3 0.26 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.115 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.85 -18.64 36.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.464 0.65 . . . . 0.0 109.51 169.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -97.68 7.39 46.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.622 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.75 -9.14 58.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.159 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 15' ' ' LYS . . . . . 0.404 ' O ' ' HA2' ' C' ' 34' ' ' GLY . 65.6 mttm -49.93 145.65 5.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.664 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.58 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 45.7 ttm -148.79 118.25 6.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.024 0.44 . . . . 0.0 110.672 -176.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.771 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.2 mt -105.55 137.98 42.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.51 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.541 ' HA ' HG13 ' C' ' 32' ' ' ILE . 32.5 tt0 -84.36 96.75 9.15 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.2 t -78.62 104.62 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.189 -172.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.618 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -93.41 145.11 24.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.592 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' C' ' 82' ' ' ILE . 68.6 t -151.9 121.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 117.921 0.328 . . . . 0.0 110.957 -171.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.574 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 36.8 mtpt -103.51 122.19 44.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.503 ' O ' HD22 ' C' ' 24' ' ' LEU . 4.5 m -70.01 -62.61 1.32 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.117 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.503 HD22 ' O ' ' C' ' 23' ' ' THR . 0.4 OUTLIER -145.07 27.34 1.29 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.709 0.766 . . . . 0.0 109.841 -178.594 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 25' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 30.0 t70 85.11 -28.06 0.09 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.225 173.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 44.6 t -62.11 -42.71 99.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -106.64 175.94 5.33 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.336 1.065 . . . . 0.0 112.238 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.547 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 18.4 m -170.79 103.07 0.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.951 -1.931 . . . . 0.0 106.413 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -122.49 153.44 39.17 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.65 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p -101.41 141.29 34.5 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-O 121.219 0.533 . . . . 0.0 112.251 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.509 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 29.4 m-85 -133.81 57.71 1.8 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.663 0.744 . . . . 0.0 109.758 -174.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.541 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.8 mp -57.24 119.19 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 123.362 1.553 . . . . 0.0 114.353 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 17.3 m -143.66 -168.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 110.915 -2.857 . . . . 0.0 111.627 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -96.4 159.11 21.76 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.054 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.771 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -59.65 -31.17 69.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.21 0.529 . . . . 0.0 112.187 -175.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.32 31.7 2.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.486 0.66 . . . . 0.0 109.258 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -74.33 0.14 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.026 -176.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.575 ' O ' HG12 ' C' ' 39' ' ' VAL . 92.9 m-20 -128.82 -90.71 0.49 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.711 HG23 HD21 ' C' ' 72' ' ' LEU . 0.3 OUTLIER 81.83 -30.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 124.794 1.309 . . . . 0.0 111.9 -165.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.51 ' HD2' ' HG2' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -80.23 -69.48 0.59 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 122.286 1.041 . . . . 0.0 108.516 176.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.17 -29.26 69.68 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 113.445 -1.707 . . . . 0.0 111.003 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.676 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.9 t80 -60.64 -53.49 56.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.523 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.66 ' HB2' ' OE1' ' C' ' 57' ' ' GLN . 0.0 OUTLIER -69.82 -33.64 72.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.99 0.424 . . . . 0.0 110.928 -179.444 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -38.64 87.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.718 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -69.65 -48.59 59.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.194 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.578 ' O ' HG22 ' C' ' 50' ' ' VAL . 17.3 pt -70.49 -12.12 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -173.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.29 -56.28 2.47 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.54 -44.3 87.28 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -25.27 65.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.338 0.59 . . . . 0.0 111.087 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.578 HG22 ' O ' ' C' ' 46' ' ' ILE . 30.9 m -110.48 -3.31 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.334 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 60.6 p 64.67 22.08 12.53 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.796 0.807 . . . . 0.0 109.49 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.7 mm -127.66 115.46 20.97 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.274 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 4.6 Cg_exo -73.97 147.02 38.13 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 121.936 1.758 . . . . 0.0 111.306 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.439 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 4.0 p -52.55 -24.85 8.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.765 0.826 . . . . 0.0 112.96 -175.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.56 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 8.9 pt-20 -68.68 -41.74 78.81 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.677 0.275 . . . . 0.0 111.493 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.56 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 27.4 mtpp -96.2 -25.08 15.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.574 0.702 . . . . 0.0 109.686 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.66 ' OE1' ' HB2' ' C' ' 43' ' ' LYS . 17.8 tt0 -61.1 118.57 6.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.287 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -123.16 119.11 29.27 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.02 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 6.4 mt -84.79 116.29 23.19 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.542 HG21 ' O ' ' A' ' 37' ' ' ILE . 3.3 mt -114.89 122.04 68.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.831 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -136.32 132.72 36.04 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 57.46 35.39 25.83 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.104 0.478 . . . . 0.0 110.753 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.03 4.93 37.74 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.529 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -91.73 140.08 30.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.71 90.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.481 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -83.03 144.06 30.18 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.144 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -156.89 -167.4 2.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.522 -175.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.658 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.8 p-10 -60.78 0.22 0.23 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.969 1.308 . . . . 0.0 113.368 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 69' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 34.0 t70 -60.55 -10.69 5.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.506 0.722 . . . . 0.0 112.421 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.522 ' H ' HG11 ' C' ' 39' ' ' VAL . 57.1 mtmt 88.33 -175.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.149 0.98 . . . . 0.0 112.615 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.433 ' HG2' ' C ' ' C' ' 70' ' ' LYS . 16.5 pttp 47.52 84.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.62 1.2 . . . . 0.0 113.06 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.711 HD21 HG23 ' C' ' 39' ' ' VAL . 35.2 mt -64.94 -32.22 73.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.608 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 73' ' ' GLN . . . . . 0.455 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 10.3 pt20 -67.26 -18.4 65.2 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.01 -28.7 66.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.553 ' CD1' HD22 ' C' ' 66' ' ' LEU . 25.1 m-85 -86.96 -22.48 25.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.621 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.7 t30 62.09 37.11 14.88 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.001 174.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -88.92 18.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.053 0.454 . . . . 0.0 111.754 -174.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -73.95 102.81 1.37 Allowed Glycine 0 N--CA 1.427 -1.928 0 CA-C-O 122.779 1.211 . . . . 0.0 111.873 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.36 15.25 60.69 Favored Glycine 0 C--N 1.283 -2.364 0 CA-C-N 112.021 -2.09 . . . . 0.0 112.618 176.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -119.72 145.5 46.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.618 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 34.3 m -83.07 123.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-O 122.111 0.957 . . . . 0.0 111.152 175.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' C' ' 21' ' ' VAL . 57.6 mt -79.07 170.35 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.094 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.531 ' N ' HG22 ' C' ' 82' ' ' ILE . 44.6 m80 -118.26 116.89 27.69 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.425 ' CD1' HG11 ' C' ' 50' ' ' VAL . 9.4 mt -90.63 141.82 28.39 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.257 0.551 . . . . 0.0 111.521 177.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.512 HG21 HD11 ' C' ' 60' ' ' ILE . 31.9 m -142.5 164.48 17.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.677 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -110.93 123.78 50.83 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.302 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -93.62 175.8 6.6 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.637 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.61 162.84 24.14 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.292 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' C' ' 91' ' ' GLN . 45.2 Cg_exo -60.68 159.57 27.9 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.639 2.226 . . . . 0.0 111.522 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.68 41.22 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.074 2.516 . . . . 0.0 112.904 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 91' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' C' ' 89' ' ' PRO . 11.5 pt20 -96.75 -29.25 13.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.397 176.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -96.79 85.21 3.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.898 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -87.94 55.77 3.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.145 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mp -118.5 89.68 37.29 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.733 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.35 -36.17 1.02 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.354 2.036 . . . . 0.0 111.594 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 10.5 t 47.53 68.18 0.69 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.667 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.34 -84.59 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.66 72.36 9.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.127 0.489 . . . . 0.0 110.206 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 11.0 p -66.49 -39.57 88.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.742 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 36.7 t -143.52 71.85 1.34 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.239 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.6 -1.111 . . . . 0.0 111.538 179.651 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 30.2 t 69.73 -74.07 0.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.103 0.561 . . . . 0.0 111.213 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm -124.19 -47.72 1.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.712 0.292 . . . . 0.0 110.471 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.74 -77.21 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.226 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -124.59 -42.83 2.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.863 0.363 . . . . 0.0 110.594 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.13 153.77 7.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.007 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.9 m -116.47 94.97 44.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.605 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.62 88.55 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.825 2.35 . . . . 0.0 112.089 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.594 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 27.9 m170 -118.54 -61.27 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.281 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 7' ' ' HIS . 66.7 Cg_endo -82.02 136.49 9.22 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 121.877 1.718 . . . . 0.0 113.619 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.33 -2.62 38.3 Favored Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -102.51 92.02 4.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.648 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 17.9 m-85 -116.2 162.59 17.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 171.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.536 ' CB ' HD11 ' A' ' 40' ' ' LEU . 55.3 t80 -141.01 116.63 10.24 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.394 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -93.83 114.55 26.81 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.565 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.434 ' CG ' HG13 ' C' ' 85' ' ' VAL . 19.0 p80 -69.23 -12.81 61.99 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.878 -176.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 38.9 m -71.57 -39.26 70.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 110.705 173.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.1 m -88.35 -27.58 21.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 110.813 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.53 28.48 17.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.696 -170.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.457 HG11 ' CZ ' ' A' ' 31' ' ' ARG . 97.5 t -131.34 144.53 37.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.445 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 25.8 tt0 -74.93 145.83 42.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 110.453 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.9 pt -135.7 167.84 24.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.343 -170.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 61.3 t -124.59 95.69 42.39 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 164.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.8 176.31 0.23 Allowed 'Trans proline' 0 C--N 1.325 -0.681 1 C-N-CA 125.386 4.057 . . . . 0.0 116.216 -173.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.583 ' HB2' HG13 ' A' ' 28' ' ' ILE . 7.8 mtt180 -112.43 52.19 0.78 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 112.711 -2.041 . . . . 0.0 107.155 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 4.04 -61.4 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.016 0 CA-C-N 111.06 -2.791 . . . . 0.0 117.221 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 13.1 Cg_exo -34.12 -37.42 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.899 2.399 . . . . 0.0 113.701 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.497 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.09 -23.75 9.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.848 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.536 ' C ' HD11 ' A' ' 37' ' ' ILE . 60.4 m-85 65.18 57.41 0.94 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.304 1.049 . . . . 0.0 109.303 -168.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.583 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.4 OUTLIER -105.7 162.61 4.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.521 176.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.475 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.5 t -94.62 145.01 28.87 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.659 ' HD3' HD12 ' A' ' 20' ' ' ILE . 70.3 Cg_endo -83.78 -20.33 4.61 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.938 2.425 . . . . 0.0 108.688 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.487 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 12.5 mtp180 -89.02 -7.91 55.03 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.016 -1.902 . . . . 0.0 114.014 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.4 p -162.66 -8.4 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 15.7 tt0 62.31 28.17 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.137 0.494 . . . . 0.0 112.213 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.1 p -99.58 150.86 21.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.8 25.77 7.2 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.711 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 75.7 m-85 -89.48 48.99 1.67 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.105 0.479 . . . . 0.0 110.551 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.753 HG21 ' CD1' ' A' ' 20' ' ' ILE . 3.5 pt -110.73 138.56 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.485 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' C' ' 65' ' ' VAL . 7.2 pt-20 -123.19 137.67 54.83 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -68.24 140.62 56.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.499 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 91.3 mtp . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.762 0.315 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.77 128.88 38.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.354 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -134.96 -70.48 0.49 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.572 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -136.74 142.29 43.03 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 42.8 t60 62.27 73.81 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.455 0.645 . . . . 0.0 109.353 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -55.15 144.69 23.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.844 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -113.97 62.78 0.66 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.618 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -121.14 140.47 51.94 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 33.5 m -65.71 167.27 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 123.157 0.286 . . . . 0.0 110.671 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 65.96 71.43 0.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.729 0.776 . . . . 0.0 109.517 -174.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' C' ' 13' ' ' ASP . 21.7 m-20 -83.15 -155.4 0.16 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.707 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' C' ' 12' ' ' ASP . 2.0 m-20 80.49 129.9 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.785 0.834 . . . . 0.0 111.37 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -89.39 -37.07 15.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.377 -171.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -68.33 176.56 2.73 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 63.8 ttp 64.06 96.79 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.377 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.696 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.2 mt -106.25 131.39 53.54 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.066 173.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.62 ' HA ' HG13 ' C' ' 32' ' ' ILE . 33.9 tt0 -82.5 96.24 7.96 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.636 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 2.5 t -80.45 124.57 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -173.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.666 ' CB ' HG12 ' C' ' 81' ' ' VAL . 0.4 OUTLIER -110.45 145.62 37.33 Favored 'General case' 0 N--CA 1.417 -2.075 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 171.1 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.705 HG22 ' HB ' ' C' ' 82' ' ' ILE . 55.4 t -148.38 126.75 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 117.905 0.321 . . . . 0.0 110.404 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.536 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 42.4 mtmt -111.9 127.13 55.75 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.34 0.59 . . . . 0.0 110.029 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 37.3 p -84.1 -178.68 7.03 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.414 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -63.15 -28.81 70.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.238 0.472 . . . . 0.0 111.101 178.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.77 -3.77 30.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.79 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 68.2 m 63.9 17.63 10.67 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.302 0.641 . . . . 0.0 112.145 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' GLN . . . . . 0.408 ' O ' ' HB ' ' C' ' 28' ' ' THR . 59.7 mt-30 -46.14 -51.15 14.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.66 177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' C' ' 27' ' ' GLN . 97.3 m 65.28 97.28 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.028 -176.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -122.56 151.81 41.02 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.951 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 3.5 p -99.14 140.2 33.67 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.636 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 24.9 m-85 -136.52 60.78 1.66 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.841 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.62 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.6 mp -57.71 128.88 18.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 122.898 1.332 . . . . 0.0 114.304 -172.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.62 HG11 ' CD2' ' C' ' 42' ' ' PHE . 15.3 m -122.78 -169.88 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 112.053 -2.34 . . . . 0.0 111.546 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -125.57 33.34 3.63 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.17 -175.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.696 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 65.72 18.36 11.15 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 167.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.862 ' H ' HD12 ' C' ' 72' ' ' LEU . 62.9 tt0 157.61 -11.85 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.82 0.819 . . . . 0.0 109.163 -166.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.8 tpt -45.4 -73.68 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.844 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.459 ' O ' HG12 ' C' ' 39' ' ' VAL . 77.9 m-20 -141.25 -88.57 0.16 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.694 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 92.84 -30.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 125.297 1.623 . . . . 0.0 111.274 -164.624 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -66.9 0.78 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 122.393 1.092 . . . . 0.0 108.873 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -61.76 -28.24 69.3 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 113.065 -1.88 . . . . 0.0 111.706 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.62 ' CD2' HG11 ' C' ' 33' ' ' VAL . 0.1 OUTLIER -57.27 -52.87 63.6 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 171.722 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.453 ' HA ' HG12 ' C' ' 46' ' ' ILE . 24.2 mtpp -67.01 -41.37 86.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.092 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -60.09 -34.71 73.83 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.044 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.6 -48.2 60.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.621 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.639 ' O ' HG22 ' C' ' 50' ' ' VAL . 20.6 pt -74.86 -10.42 13.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.307 -175.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -46.67 -40.64 13.52 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.04 -45.91 19.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -34.13 73.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.104 0.478 . . . . 0.0 110.765 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.639 HG22 ' O ' ' C' ' 46' ' ' ILE . 30.1 m -99.88 -8.12 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.158 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 31.5 m 68.8 20.14 8.15 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.837 0.827 . . . . 0.0 109.775 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.2 mm -123.29 110.98 30.41 Favored Pre-proline 0 N--CA 1.44 -0.935 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.72 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.417 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 14.1 Cg_exo -66.39 143.11 68.61 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 122.622 2.214 . . . . 0.0 111.902 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.433 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 35.2 t -51.13 -28.31 10.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.843 -172.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.45 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 10.8 pt-20 -75.29 -30.96 60.54 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.877 0.37 . . . . 0.0 111.541 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 55.1 mtpt -95.19 -28.83 14.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.827 0.823 . . . . 0.0 109.206 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.43 HE22 HG13 ' C' ' 46' ' ' ILE . 17.1 tt0 -63.67 122.64 16.85 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.124 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.431 ' O ' HG23 ' C' ' 85' ' ' VAL . 72.6 mtp85 -120.97 123.76 43.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.756 -0.202 . . . . 0.0 110.462 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 94.1 mt -90.95 124.06 34.92 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 177.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.556 HG21 ' O ' ' A' ' 37' ' ' ILE . 4.6 mt -118.29 125.75 74.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 O-C-N 121.622 -0.674 . . . . 0.0 111.595 172.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.46 ' CD2' HG12 ' C' ' 77' ' ' VAL . 55.1 t80 -138.64 131.87 30.05 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 46.23 40.39 7.43 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.104 0.478 . . . . 0.0 111.357 -170.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.91 5.73 58.39 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.923 -0.58 . . . . 0.0 113.617 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.586 ' HD3' ' N ' ' C' ' 65' ' ' VAL . 0.0 OUTLIER -99.22 131.26 45.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.586 ' N ' ' HD3' ' C' ' 64' ' ' ARG . 2.0 t -82.41 90.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.113 0.482 . . . . 0.0 110.391 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.594 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.4 OUTLIER -71.78 148.1 46.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.452 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -158.31 -169.81 2.9 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.835 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.694 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.7 p-10 -67.04 -2.39 5.37 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.663 0.785 . . . . 0.0 112.233 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 69' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 20.9 t70 -68.73 -2.74 9.99 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.082 0.553 . . . . 0.0 111.802 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.54 ' H ' HG11 ' C' ' 39' ' ' VAL . 53.5 mtmt 75.9 -162.47 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.685 178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' C' ' 70' ' ' LYS . 48.5 mttp 77.51 57.18 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.831 0.707 . . . . 0.0 109.659 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.862 HD12 ' H ' ' C' ' 36' ' ' GLN . 22.0 mt -61.72 -56.36 20.46 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.827 -174.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -72.64 -15.86 61.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.073 0.464 . . . . 0.0 111.461 -176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -73.14 -28.93 62.52 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.051 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.594 ' CD1' HD22 ' C' ' 66' ' ' LEU . 24.0 m-85 -75.31 -25.38 57.81 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 61.51 26.39 16.13 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.382 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.46 HG12 ' CD2' ' C' ' 61' ' ' TYR . 31.3 m -83.04 21.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.902 -175.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.647 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.54 98.97 1.43 Allowed Glycine 0 N--CA 1.431 -1.675 0 CA-C-O 122.418 1.01 . . . . 0.0 111.985 177.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.23 14.14 39.84 Favored Glycine 0 C--N 1.285 -2.262 0 CA-C-N 112.382 -1.909 . . . . 0.0 114.541 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -128.68 147.32 50.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.666 HG12 ' CB ' ' C' ' 20' ' ' LEU . 16.6 m -80.19 125.78 39.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-O 121.881 0.848 . . . . 0.0 111.637 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.705 ' HB ' HG22 ' C' ' 21' ' ' VAL . 57.5 mt -80.25 171.17 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.8 173.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.546 ' N ' HG22 ' C' ' 82' ' ' ILE . 37.6 m80 -118.22 122.01 41.91 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 122.012 -0.43 . . . . 0.0 109.924 174.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mt -85.75 156.86 20.44 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.439 HG12 ' N ' ' C' ' 86' ' ' GLU . 8.0 t -120.88 161.02 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.417 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 86' ' ' GLU . . . . . 0.439 ' N ' HG12 ' C' ' 85' ' ' VAL . 40.5 tt0 -136.06 127.06 27.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.964 172.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -85.09 162.93 19.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.296 0.569 . . . . 0.0 109.945 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -88.8 141.67 30.05 Favored Pre-proline 0 N--CA 1.438 -1.071 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.029 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.536 ' HB2' ' HG2' ' C' ' 91' ' ' GLN . 23.3 Cg_exo -67.16 149.91 81.92 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.275 2.65 . . . . 0.0 112.119 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.43 -18.79 40.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.696 2.931 . . . . 0.0 114.029 -171.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 91' ' ' GLN . . . . . 0.536 ' HG2' ' HB2' ' C' ' 89' ' ' PRO . 8.5 pt20 -57.02 -35.79 69.68 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.303 176.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.7 t -108.97 136.05 49.14 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -155.77 76.19 0.93 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.952 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 49.6 tp 58.64 80.3 0.28 Allowed Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.321 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.22 -38.43 66.21 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.769 2.312 . . . . 0.0 111.731 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 34.1 t 57.79 51.65 8.98 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.237 0.541 . . . . 0.0 110.4 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -98.14 -68.84 0.94 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.212 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.6 81.48 1.47 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 38.9 m 71.28 -67.16 0.27 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.885 0.741 . . . . 0.0 111.221 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 21.6 m 59.52 44.23 15.04 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.311 0.576 . . . . 0.0 110.595 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.868 0 CA-C-O 118.635 -1.092 . . . . 0.0 111.895 -178.287 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 18.5 p -59.91 -58.69 7.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.567 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -136.68 124.93 23.15 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.16 138.73 3.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.33 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -89.9 148.17 23.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.849 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 60.46 75.94 0.39 Allowed 'General case' 0 C--O 1.233 0.195 0 O-C-N 123.81 0.694 . . . . 0.0 110.607 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 15.9 m -58.19 137.37 84.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.212 -177.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 9.6 Cg_exo -69.62 93.84 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.735 2.29 . . . . 0.0 112.256 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.496 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 22.5 m80 -60.81 -55.54 43.75 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 7' ' ' HIS . 43.8 Cg_endo -83.48 22.33 0.94 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.29 1.993 . . . . 0.0 112.409 175.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.18 2.32 8.35 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.635 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HG2' HD23 ' A' ' 40' ' ' LEU . 58.8 ttt180 -75.73 80.81 2.68 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 123.318 0.647 . . . . 0.0 110.587 -178.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.657 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 17.0 m-85 -118.21 164.27 15.42 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.636 0.731 . . . . 0.0 110.752 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.654 ' CB ' HD11 ' A' ' 40' ' ' LEU . 54.9 t80 -140.92 120.28 13.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.877 178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -98.57 121.37 40.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.222 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.644 ' CE1' ' HB ' ' C' ' 85' ' ' VAL . 8.9 p80 -76.69 -23.44 53.18 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 24.6 p -71.09 -38.15 72.41 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.272 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.6 m -74.85 -34.81 62.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.084 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.75 32.01 21.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.161 -172.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.5 t -131.65 144.12 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.657 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 38.7 tt0 -74.33 143.28 45.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.116 0.484 . . . . 0.0 110.885 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.74 HD11 HG21 ' A' ' 37' ' ' ILE . 4.0 pt -131.86 168.32 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.216 -169.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.424 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 57.7 t -123.53 98.29 40.95 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 162.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.592 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 6.8 Cg_endo -57.3 175.12 0.39 Allowed 'Trans proline' 0 C--N 1.326 -0.613 1 C-N-CA 125.302 4.001 . . . . 0.0 116.675 -169.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.696 ' HB2' HG13 ' A' ' 28' ' ' ILE . 26.0 mtt180 -107.68 47.38 0.89 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 112.629 -2.078 . . . . 0.0 107.183 176.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -0.07 -61.27 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 110.718 -2.947 . . . . 0.0 116.993 174.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 31.2 Cg_exo -30.96 -38.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 123.591 2.861 . . . . 0.0 114.176 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.545 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.48 -18.05 11.59 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.705 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.432 ' C ' HD11 ' A' ' 37' ' ' ILE . 62.8 m-85 67.11 45.93 1.62 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.04 -172.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.696 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -94.07 161.61 2.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.653 174.622 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -96.61 145.73 30.08 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.035 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.656 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 78.7 Cg_endo -80.46 -20.27 8.33 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 122.861 2.374 . . . . 0.0 108.089 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.655 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.1 mtt-85 -80.19 -34.77 37.19 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 112.658 -2.065 . . . . 0.0 113.712 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.8 p -137.59 -8.74 1.67 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 61.29 35.42 18.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.474 0.654 . . . . 0.0 111.061 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 m -113.09 146.36 39.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.545 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -84.55 45.86 3.57 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.741 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 57.9 m-85 -102.4 44.38 1.02 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.961 0.41 . . . . 0.0 110.268 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.74 HG21 HD11 ' A' ' 20' ' ' ILE . 5.8 pt -115.27 139.21 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.191 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB2' HG22 ' C' ' 65' ' ' VAL . 12.9 pt-20 -123.86 145.67 48.93 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.34 131.36 39.13 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.654 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.857 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.982 0.42 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.0 107.19 3.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.066 0.46 . . . . 0.0 111.125 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -119.8 32.6 5.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.831 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -93.8 -79.66 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 76.2 m80 48.44 -110.13 0.35 Allowed 'General case' 0 C--O 1.233 0.2 0 O-C-N 123.561 0.538 . . . . 0.0 111.508 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 51.0 m80 50.64 53.07 13.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.255 0.55 . . . . 0.0 111.5 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -117.26 142.97 46.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.584 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -155.25 124.04 6.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.496 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' C' ' 11' ' ' ASP . 9.5 m -122.12 128.57 75.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.324 0.583 . . . . 0.0 109.912 174.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 11' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' C' ' 10' ' ' VAL . 38.2 t70 160.95 57.02 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.541 -170.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 34.2 t70 59.12 80.35 0.19 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.419 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -129.7 124.67 34.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.38 -36.23 78.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.186 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 15' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' C' ' 35' ' ' ALA . 96.3 mttt -70.14 -174.86 0.86 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.449 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.636 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 50.9 mtm 66.57 83.2 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.073 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.692 HD11 ' HA ' ' C' ' 35' ' ' ALA . 3.7 mt -98.58 132.71 43.77 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.575 ' HA ' HG13 ' C' ' 32' ' ' ILE . 25.6 tt0 -82.23 93.92 7.2 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.631 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 3.1 t -77.06 104.85 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.06 -172.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.651 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.1 mt -92.76 142.27 27.53 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.695 HG22 ' HB ' ' C' ' 82' ' ' ILE . 59.4 t -147.95 128.92 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -174.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.608 ' HE3' HG21 ' C' ' 81' ' ' VAL . 79.2 mttt -114.24 159.81 19.73 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.361 0.601 . . . . 0.0 109.804 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 27.8 p -107.42 -165.84 1.1 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.99 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 4.4 mm? -44.48 -37.42 3.46 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 15.4 t70 178.29 -31.38 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 29.5 m -42.82 -75.64 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.877 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -128.71 172.9 10.8 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.371 1.081 . . . . 0.0 113.911 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.447 ' OG1' ' HE2' ' C' ' 22' ' ' LYS . 53.7 m -141.84 103.22 4.3 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 112.76 -2.018 . . . . 0.0 107.543 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 29' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' C' ' 29' ' ' ARG . 73.1 mtt180 -123.33 161.93 23.71 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.795 -177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.5 p -103.69 143.44 32.78 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.468 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.631 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 27.6 m-85 -137.14 59.0 1.7 Allowed 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.271 -174.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -57.92 124.26 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 123.352 1.548 . . . . 0.0 113.872 -174.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' C' ' 16' ' ' MET . 17.2 m -135.27 -165.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 111.104 -2.771 . . . . 0.0 111.324 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.04 -161.76 37.32 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.741 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.692 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -100.91 -12.86 18.62 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.577 0.703 . . . . 0.0 111.296 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -166.95 26.57 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -172.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 18.3 ttt -71.95 -73.05 0.2 Allowed 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 111.816 -2.447 . . . . 0.0 110.941 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.605 ' O ' HG12 ' C' ' 39' ' ' VAL . 70.5 m-20 -131.11 -98.18 0.32 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 178.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 86.7 -16.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 125.341 1.651 . . . . 0.0 111.731 -167.157 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' C' ' 43' ' ' LYS . 0.1 OUTLIER -88.69 -70.79 0.63 Allowed 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.048 0.928 . . . . 0.0 108.965 171.255 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.12 -29.4 70.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.099 173.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.64 ' CD2' ' HA ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -62.08 -54.43 41.41 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.438 175.314 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' C' ' 40' ' ' LYS . 20.0 ptmt -68.25 -33.66 74.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -42.66 82.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.103 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -68.71 -43.26 76.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.439 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.603 ' O ' HG22 ' C' ' 50' ' ' VAL . 16.1 pt -78.35 -10.75 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -172.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.65 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.2 -61.02 0.95 Allowed 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.75 86.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -32.82 71.15 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.055 0.455 . . . . 0.0 111.049 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.603 HG22 ' O ' ' C' ' 46' ' ' ILE . 24.3 m -103.63 -3.36 9.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.453 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 48.2 t 69.58 20.04 7.2 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.65 0.738 . . . . 0.0 109.318 178.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.2 mm -123.38 110.67 30.41 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.174 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.499 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 6.0 Cg_exo -72.8 146.03 41.95 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.371 2.047 . . . . 0.0 111.299 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 8.0 p -54.49 -24.62 21.27 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.608 0.763 . . . . 0.0 112.285 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 15.1 pt-20 -73.6 -26.3 60.74 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -107.66 -26.41 10.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 109.981 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.535 ' OE1' HD11 ' C' ' 46' ' ' ILE . 9.9 tt0 -57.96 118.3 5.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.9 -173.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.413 HH11 HG11 ' C' ' 65' ' ' VAL . 26.1 mmt85 -122.37 118.0 27.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.314 172.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 5.2 mp -84.7 117.87 24.06 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.537 HG21 ' O ' ' A' ' 37' ' ' ILE . 7.0 mt -115.12 118.12 57.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.169 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -132.39 128.15 36.97 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 58.68 38.83 24.95 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.508 0.505 . . . . 0.0 110.627 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.79 4.17 13.15 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.258 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -89.18 133.98 34.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.437 HG22 ' HB2' ' A' ' 38' ' ' GLU . 2.1 t -85.14 89.68 2.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.3 OUTLIER -75.04 130.57 39.54 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -143.11 -172.72 3.74 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.511 -170.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.621 ' HA ' HG13 ' C' ' 39' ' ' VAL . 4.4 p-10 -64.3 -3.06 2.52 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.44 0.696 . . . . 0.0 112.145 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.35 -4.94 16.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.072 0.549 . . . . 0.0 112.293 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 74.44 -158.21 0.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.375 0.67 . . . . 0.0 110.939 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.537 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 54.3 mttp 71.91 54.08 0.19 Allowed 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.552 0.532 . . . . 0.0 110.692 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 60.1 mt -63.43 -44.28 95.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.181 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 73' ' ' GLN . . . . . 0.439 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 9.3 pt20 -70.08 -20.44 63.21 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.742 0.306 . . . . 0.0 111.466 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 74' ' ' GLU . . . . . 0.537 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 28.0 mm-40 -71.1 -28.01 64.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.555 ' CD1' HD22 ' C' ' 66' ' ' LEU . 19.3 m-85 -83.7 -24.72 31.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 57.66 37.85 27.48 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.807 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -87.31 20.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.539 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.608 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.69 99.93 1.53 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-O 122.767 1.204 . . . . 0.0 112.322 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.88 14.34 43.34 Favored Glycine 0 C--N 1.284 -2.307 0 CA-C-N 112.223 -1.989 . . . . 0.0 113.72 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -124.33 147.49 48.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.651 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 4.5 m -82.05 128.53 38.64 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-O 122.055 0.931 . . . . 0.0 111.43 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.695 ' HB ' HG22 ' C' ' 21' ' ' VAL . 54.3 mt -86.9 168.44 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.122 175.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.468 ' N ' HG22 ' C' ' 82' ' ' ILE . 40.7 m80 -117.42 115.03 24.4 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.889 -0.507 . . . . 0.0 110.162 175.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.452 HD13 HG21 ' C' ' 50' ' ' VAL . 13.4 mt -90.67 157.36 17.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.291 0.567 . . . . 0.0 112.379 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.644 ' HB ' ' CE1' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -154.81 154.23 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.917 -175.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 86' ' ' GLU . . . . . 0.534 ' HB2' ' CD1' ' C' ' 52' ' ' ILE . 44.5 tt0 -112.68 120.57 41.99 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.05 169.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -104.17 177.56 4.81 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.318 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -57.56 148.34 56.27 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.986 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 88' ' ' ALA . 51.3 Cg_exo -58.18 166.55 5.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.212 2.608 . . . . 0.0 112.385 177.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.68 63.15 4.73 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.894 2.396 . . . . 0.0 112.018 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 91' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' C' ' 89' ' ' PRO . 7.1 pt20 -96.25 20.93 9.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.652 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.8 t -74.25 139.99 44.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.438 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -83.4 -22.76 32.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.682 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.21 115.23 27.46 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.846 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.09 158.02 31.94 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.658 2.239 . . . . 0.0 111.96 177.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 46.9 t 62.05 58.72 1.8 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.202 0.525 . . . . 0.0 109.874 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.19 64.51 3.44 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.006 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -160.64 179.24 8.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.739 0.304 . . . . 0.0 110.334 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 45.9 m -132.55 65.05 1.59 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.979 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 16.0 m -72.81 131.37 42.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.665 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 118.504 -1.164 . . . . 0.0 111.723 -179.497 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 112.193 -0.363 . . . . 0.0 112.193 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.6 p -72.61 -33.27 66.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.305 0.574 . . . . 0.0 110.091 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.1 mtp -110.96 75.17 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.135 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.21 81.83 8.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.268 0.556 . . . . 0.0 110.48 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -132.06 167.13 20.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.852 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.34 93.73 3.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.286 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 22.9 t -153.08 97.54 2.82 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.855 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.43 -18.19 12.47 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.753 2.302 . . . . 0.0 113.753 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -59.55 -47.15 98.4 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -175.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 5' ' ' SER . 76.2 Cg_endo -85.65 20.45 1.23 Allowed 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 122.225 1.95 . . . . 0.0 112.037 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.48 ' HA3' HG13 ' A' ' 21' ' ' VAL . . . 90.63 109.04 1.42 Allowed Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.132 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 10' ' ' ARG . 1.0 OUTLIER -154.03 80.35 1.13 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.611 -0.794 . . . . 0.0 108.947 178.122 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.605 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 5.9 m-85 -116.74 167.53 11.01 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.041 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CB ' HD11 ' A' ' 40' ' ' LEU . 48.8 t80 -140.87 114.39 8.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.28 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.599 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -93.49 118.02 30.81 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.51 177.122 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' A' ' 36' ' ' PHE . 1.1 p80 -76.68 -20.49 56.56 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.544 -171.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 16.1 p -72.91 -31.61 64.76 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.82 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.2 m -83.43 -30.61 27.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.189 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.02 28.29 16.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.409 -171.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.88 144.76 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 34.7 tt0 -71.23 146.66 48.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.512 -175.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.7 ' CD1' HG21 ' A' ' 37' ' ' ILE . 2.6 pt -138.62 166.61 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.847 -172.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.482 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 99.1 t -124.08 97.86 39.97 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 163.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 5.6 Cg_endo -57.24 173.76 0.59 Allowed 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 124.912 3.741 . . . . 0.0 116.571 -170.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.501 ' HB2' HG13 ' A' ' 28' ' ' ILE . 15.2 mtt85 -107.35 47.33 0.89 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 112.489 -2.142 . . . . 0.0 107.59 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -6.28 -53.69 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 171.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -35.09 -36.16 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.561 2.174 . . . . 0.0 113.428 171.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.506 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.09 -17.56 10.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.352 177.398 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.423 ' CE1' HD23 ' A' ' 24' ' ' LEU . 74.7 m-85 69.68 50.99 0.47 Allowed 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.603 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.506 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -104.81 159.85 5.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.615 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.493 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 t -95.5 144.56 28.02 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.69 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 87.2 Cg_endo -81.24 -17.48 9.09 Favored 'Trans proline' 0 CA--C 1.5 -1.179 0 C-N-CA 122.761 2.308 . . . . 0.0 108.24 -173.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.429 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 60.5 mtt-85 -91.57 -13.81 31.37 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 112.937 -1.938 . . . . 0.0 114.617 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.0 p -153.16 -9.48 0.16 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 60.95 29.18 18.86 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.381 0.61 . . . . 0.0 110.91 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.2 m -109.24 146.97 33.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.487 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.21 28.95 4.46 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.772 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 63.0 m-85 -85.86 47.64 1.48 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.568 -0.372 . . . . 0.0 110.462 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.7 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.7 pt -115.58 139.0 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.516 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.493 ' HB3' HD13 ' C' ' 60' ' ' ILE . 6.5 pt-20 -123.42 148.28 46.29 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -80.52 134.24 35.92 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.434 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.547 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.808 -174.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 60.3 ttp . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.77 -73.43 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.915 0.76 . . . . 0.0 111.397 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -167.33 -69.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 24.2 m80 65.77 141.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.808 0.692 . . . . 0.0 111.897 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -88.7 100.67 13.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.401 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -72.48 130.0 39.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.635 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -76.55 84.83 3.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.526 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -75.46 124.04 26.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.858 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 p -74.4 146.07 10.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.438 0.637 . . . . 0.0 110.765 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 30.1 t70 177.9 89.45 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.431 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 17.3 t70 69.55 103.6 0.06 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.19 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -95.08 78.53 3.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.24 0.543 . . . . 0.0 110.949 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.91 -24.79 64.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 171.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 15' ' ' LYS . . . . . 0.465 ' HD3' HG22 ' C' ' 32' ' ' ILE . 53.2 mttp -57.38 157.63 6.4 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.51 175.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.658 ' H ' ' HA2' ' C' ' 34' ' ' GLY . 1.9 mpt? -112.24 -51.74 2.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.459 -174.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.877 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.7 OUTLIER -104.71 135.62 45.76 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.643 -171.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.565 ' HA ' HG13 ' C' ' 32' ' ' ILE . 36.4 tt0 -88.91 94.27 9.88 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.3 t -79.48 128.29 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -172.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.595 ' CB ' HG12 ' C' ' 81' ' ' VAL . 0.8 OUTLIER -114.21 150.14 34.74 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.225 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.573 HG21 ' HE2' ' C' ' 31' ' ' PHE . 18.5 m -135.32 150.91 29.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.606 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 36.7 mtpt -125.72 96.38 4.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.712 0.291 . . . . 0.0 110.297 174.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.47 HG23 ' O ' ' C' ' 84' ' ' LEU . 0.2 OUTLIER -92.27 167.38 12.05 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 171.22 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -64.37 -48.97 73.46 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.883 0.373 . . . . 0.0 111.642 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.05 -12.36 38.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.336 0.588 . . . . 0.0 110.228 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -91.96 -23.6 19.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.294 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 67.59 -75.06 0.06 Allowed 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.464 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 78.7 m -157.56 118.18 3.5 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -136.24 154.56 50.88 Favored 'General case' 0 C--O 1.223 -0.333 0 O-C-N 122.288 -0.258 . . . . 0.0 110.31 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.538 HG22 ' CD2' ' C' ' 20' ' ' LEU . 4.1 p -108.79 147.34 32.19 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -171.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.67 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 31.0 m-85 -140.16 65.14 1.43 Allowed 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 123.292 0.637 . . . . 0.0 111.289 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.565 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.7 mp -59.56 122.17 9.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 123.073 1.415 . . . . 0.0 113.81 -175.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.662 HG21 HD13 ' C' ' 72' ' ' LEU . 15.8 m -130.74 -173.71 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 111.723 -2.49 . . . . 0.0 111.461 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.658 ' HA2' ' H ' ' C' ' 16' ' ' MET . . . -120.48 45.61 1.21 Allowed Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.146 -1.026 . . . . 0.0 114.464 -173.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.877 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.16 -36.24 0.3 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 169.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -144.8 20.71 1.64 Allowed 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -172.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 2.0 ttt -66.72 -69.38 0.31 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 112.196 -2.274 . . . . 0.0 110.332 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -142.42 -101.02 0.13 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.655 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.711 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.4 OUTLIER 101.37 -27.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 125.516 1.76 . . . . 0.0 110.189 -165.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' C' ' 40' ' ' LYS . 0.0 OUTLIER -83.99 -71.14 0.52 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 122.127 0.965 . . . . 0.0 109.056 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 41' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' C' ' 40' ' ' LYS . 43.6 mt-10 -63.11 -27.22 69.24 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.721 174.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.742 ' O ' HG23 ' C' ' 46' ' ' ILE . 6.3 t80 -58.95 -52.44 65.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.566 173.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' C' ' 57' ' ' GLN . 51.3 mtpt -61.55 -42.75 99.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.028 0.442 . . . . 0.0 110.642 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -55.6 -40.92 72.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.361 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -68.98 -47.01 66.63 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.971 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.742 HG23 ' O ' ' C' ' 42' ' ' PHE . 4.1 pt -76.01 -13.06 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.415 -173.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.2 -60.6 1.2 Allowed 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.01 93.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.745 0.307 . . . . 0.0 111.699 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -17.69 64.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.475 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.551 HG22 ' O ' ' C' ' 46' ' ' ILE . 17.8 m -113.33 -6.63 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 33.6 t 69.55 22.18 6.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.648 0.737 . . . . 0.0 109.192 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.1 mm -130.06 117.04 17.99 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.635 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.501 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 5.5 Cg_exo -74.99 148.32 35.15 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.962 1.774 . . . . 0.0 111.12 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -55.12 -25.91 34.82 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.153 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.5 pt-20 -68.54 -24.65 64.66 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.653 0.263 . . . . 0.0 111.623 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 95.8 mttt -115.64 -17.76 11.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.446 0.641 . . . . 0.0 110.427 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.453 ' HA ' HG21 ' C' ' 52' ' ' ILE . 23.0 tt0 -66.28 119.35 11.39 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.596 -170.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.42 ' HG3' ' HG3' ' C' ' 87' ' ' ARG . 28.0 mmt180 -114.54 113.66 24.72 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.651 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.756 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 47.7 mt -82.62 105.27 13.53 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.1 mt -102.13 103.62 15.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.611 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -118.6 132.51 56.19 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.628 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 40.64 45.55 2.04 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.985 0.803 . . . . 0.0 111.705 -171.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.95 -6.28 20.83 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.654 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -87.03 129.71 34.78 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 38' ' ' GLU . 1.6 t -87.38 89.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.081 0.467 . . . . 0.0 109.905 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.1 OUTLIER -76.96 155.84 32.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.103 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 67' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.7 pt20 -160.16 -169.31 2.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.286 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.711 ' HA ' HG13 ' C' ' 39' ' ' VAL . 1.8 p-10 -61.6 1.34 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.251 1.42 . . . . 0.0 113.116 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 69' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' C' ' 67' ' ' GLN . 13.4 t70 -65.29 9.85 0.1 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.155 0.982 . . . . 0.0 113.103 -178.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' C' ' 68' ' ' ASP . 51.4 mttp 84.18 159.69 0.11 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.449 1.1 . . . . 0.0 113.648 170.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.449 ' HB3' ' HG2' ' C' ' 74' ' ' GLU . 95.3 mttt 67.89 89.56 0.1 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.123 -1.399 . . . . 0.0 113.005 173.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.662 HD13 HG21 ' C' ' 33' ' ' VAL . 11.3 mt -63.9 -36.1 82.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.559 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 73' ' ' GLN . . . . . 0.41 ' HG2' ' H ' ' C' ' 73' ' ' GLN . 4.3 pt20 -66.89 -24.46 66.11 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 74' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' C' ' 71' ' ' LYS . 26.1 mm-40 -62.19 -27.78 69.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.241 0.543 . . . . 0.0 109.623 176.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.554 ' CD1' HD22 ' C' ' 66' ' ' LEU . 17.8 m-85 -94.01 -12.24 29.07 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.781 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 3.8 m120 47.83 45.29 18.57 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.417 1.087 . . . . 0.0 113.366 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.455 HG23 HG22 ' C' ' 19' ' ' VAL . 29.5 m -86.68 19.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -74.35 102.41 1.37 Allowed Glycine 0 N--CA 1.429 -1.789 0 CA-C-O 122.989 1.327 . . . . 0.0 112.976 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.26 13.73 53.33 Favored Glycine 0 C--N 1.283 -2.394 0 CA-C-N 111.967 -2.116 . . . . 0.0 114.002 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -127.84 154.7 45.15 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.66 -0.318 . . . . 0.0 110.247 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.606 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 35.0 m -87.03 122.93 39.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.818 0.818 . . . . 0.0 112.157 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 82' ' ' ILE . . . . . . . . . . . . . 62.3 mt -86.7 135.26 25.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.512 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.414 ' O ' ' HB ' ' C' ' 60' ' ' ILE . 69.5 m80 -93.93 114.62 26.86 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.47 ' O ' HG23 ' C' ' 23' ' ' THR . 2.7 pp -127.37 157.13 40.78 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 118.786 -1.166 . . . . 0.0 113.517 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -159.56 -174.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.533 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 86' ' ' GLU . . . . . 0.413 ' N ' HD12 ' C' ' 52' ' ' ILE . 10.7 pt-20 -106.16 142.81 35.23 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.238 167.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 87' ' ' ARG . . . . . 0.42 ' HG3' ' HG3' ' C' ' 58' ' ' ARG . 39.3 mtt180 -81.31 176.98 9.28 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 169.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.401 ' HB3' HG21 ' C' ' 92' ' ' THR . . . -56.78 156.27 12.96 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.651 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.09 152.41 18.65 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.624 2.216 . . . . 0.0 112.111 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.23 58.07 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.368 2.712 . . . . 0.0 113.317 -173.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -146.53 20.89 1.34 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.676 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.401 HG21 ' HB3' ' C' ' 88' ' ' ALA . 3.6 t -118.22 111.28 18.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.944 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 93' ' ' HIS . . . . . 0.4 ' O ' ' HD3' ' C' ' 95' ' ' PRO . 9.7 p-80 -160.81 102.31 1.31 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.37 175.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.43 98.39 43.48 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.257 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' C' ' 93' ' ' HIS . 22.5 Cg_exo -64.36 143.73 83.65 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.588 2.192 . . . . 0.0 111.224 174.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 7.3 m -60.0 -27.52 66.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.043 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -111.74 34.22 5.36 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.248 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.19 -65.36 0.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.894 -0.18 . . . . 0.0 110.772 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 16.6 m 58.51 78.27 0.26 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.736 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 56.4 m 62.04 69.09 0.64 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.847 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.311 -1.272 . . . . 0.0 111.321 179.573 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 41.5 m -88.32 106.32 18.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.924 0.393 . . . . 0.0 110.298 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -65.38 -46.2 81.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 3' ' ' GLU . . . 60.6 89.59 0.07 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.935 0.772 . . . . 0.0 112.372 173.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 13.8 mm-40 72.65 105.17 0.07 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.869 177.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.37 108.85 3.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.146 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 t 61.95 75.07 0.45 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.918 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -85.0 52.33 3.37 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.045 2.497 . . . . 0.0 111.604 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -162.89 155.98 16.68 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.3 70.84 6.6 Favored 'Trans proline' 0 N--CA 1.431 -2.168 0 C-N-CA 122.765 2.31 . . . . 0.0 112.804 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.48 8.46 24.34 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.594 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -121.5 85.53 2.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.892 0.346 . . . . 0.0 110.835 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.478 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 8.2 m-85 -117.99 165.21 13.99 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.34 0.59 . . . . 0.0 109.809 171.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.554 ' HB2' HD11 ' A' ' 40' ' ' LEU . 50.1 t80 -140.26 115.15 9.62 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.491 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.526 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -93.88 108.1 19.92 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.409 ' CD2' HG12 ' C' ' 85' ' ' VAL . 12.6 p80 -64.88 -15.4 61.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.652 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.5 t -72.34 -36.8 68.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.887 0.375 . . . . 0.0 110.478 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.526 ' HB3' HG22 ' A' ' 18' ' ' VAL . 66.0 m -88.77 -23.89 22.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.423 0.63 . . . . 0.0 110.594 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.07 30.61 20.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.272 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 16' ' ' CYS . 2.6 m -138.38 162.95 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.694 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -83.42 145.24 29.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.849 HD12 ' HD3' ' A' ' 30' ' ' PRO . 3.5 pt -137.21 168.42 21.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.094 -171.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.476 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 45.9 t -125.14 99.58 34.09 Favored Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 162.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HD3' HG13 ' A' ' 20' ' ' ILE . 12.9 Cg_endo -55.37 175.24 0.19 Allowed 'Trans proline' 0 C--N 1.328 -0.538 1 C-N-CA 125.306 4.004 . . . . 0.0 116.257 -173.17 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.522 ' HB2' HG13 ' A' ' 28' ' ' ILE . 26.0 mtt180 -109.15 48.99 0.84 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.86 -1.973 . . . . 0.0 106.888 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.422 HD13 ' CE1' ' A' ' 27' ' ' TYR . 1.8 mm? 3.05 -61.47 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.362 0 CA-C-N 111.09 -2.777 . . . . 0.0 117.334 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -34.86 -34.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 123.103 2.535 . . . . 0.0 114.42 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.571 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.84 -21.83 9.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.937 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.456 ' C ' HD11 ' A' ' 37' ' ' ILE . 77.3 m-85 65.57 57.6 0.86 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.148 0.975 . . . . 0.0 109.795 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -109.19 163.01 6.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 113.492 -1.686 . . . . 0.0 109.542 176.362 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 1.4 t -95.92 146.15 30.81 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.849 ' HD3' HD12 ' A' ' 20' ' ' ILE . 86.8 Cg_endo -83.32 -20.29 5.02 Favored 'Trans proline' 0 CA--C 1.501 -1.15 0 C-N-CA 122.607 2.205 . . . . 0.0 108.85 -175.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.402 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 63.3 mtt180 -86.16 -14.07 45.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.259 -1.791 . . . . 0.0 114.104 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 p -152.36 -14.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 8.4 tt0 62.72 36.59 13.25 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.028 0.531 . . . . 0.0 112.161 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 98.2 p -108.44 154.18 22.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 166.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.46 33.91 3.79 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.801 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 60.8 m-85 -94.26 47.79 1.21 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.369 . . . . 0.0 111.045 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 20' ' ' ILE . 3.6 pt -114.03 139.55 39.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.779 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.542 ' HB3' HD13 ' C' ' 60' ' ' ILE . 13.1 pt-20 -117.83 143.41 46.31 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -79.13 139.17 38.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.07 0.462 . . . . 0.0 109.836 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.933 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.102 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 5.7 tpt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 120.636 0.255 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.86 133.26 43.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.94 0.4 . . . . 0.0 111.452 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -137.55 38.23 2.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.948 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -85.77 71.46 10.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.229 0.538 . . . . 0.0 110.7 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -146.37 121.98 10.45 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -128.62 104.72 7.82 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.96 0.41 . . . . 0.0 110.896 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -123.01 34.65 5.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.321 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -75.98 83.83 2.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.925 0.393 . . . . 0.0 110.902 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -122.27 146.64 27.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.265 0.555 . . . . 0.0 110.209 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -120.17 -80.83 0.63 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.274 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -114.01 -34.56 5.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 168.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -78.24 74.79 4.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.714 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -70.52 -49.07 52.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.156 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 15' ' ' LYS . . . . . 0.447 ' HB3' HG22 ' C' ' 32' ' ' ILE . 97.3 mttt -61.11 147.18 44.81 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.891 175.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.579 ' H ' ' HA2' ' C' ' 34' ' ' GLY . 94.1 mmm -112.76 -54.99 2.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.213 -167.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.863 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.6 OUTLIER -99.95 127.46 46.14 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.859 -171.029 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.613 ' HA ' HG13 ' C' ' 32' ' ' ILE . 40.5 tt0 -84.59 92.64 8.19 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.8 t -76.96 126.24 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.956 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -174.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.622 ' HB2' ' CG1' ' C' ' 81' ' ' VAL . 0.2 OUTLIER -114.21 155.02 26.87 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 170.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.897 ' O ' ' HA ' ' C' ' 28' ' ' THR . 15.7 m -140.82 155.35 22.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.56 ' HG3' ' CG2' ' C' ' 81' ' ' VAL . 45.0 mtmt -134.35 114.18 12.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 169.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.547 ' HB ' ' OE2' ' C' ' 86' ' ' GLU . 65.0 p -83.6 -178.95 7.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.637 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' C' ' 86' ' ' GLU . 12.3 mt -69.93 -24.6 63.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 110.172 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.13 4.38 17.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.131 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 7.1 t 64.96 22.67 12.49 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.163 0.506 . . . . 0.0 111.366 172.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -48.24 -58.12 4.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.292 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.897 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 95.0 m 56.02 96.12 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.516 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -133.93 170.44 15.62 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.205 -0.31 . . . . 0.0 110.674 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.546 HG22 ' CD2' ' C' ' 20' ' ' LEU . 2.6 p -112.09 145.21 40.15 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.639 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 29.5 m-85 -140.85 65.93 1.39 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.177 0.513 . . . . 0.0 110.895 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.613 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -60.32 121.7 8.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 123.384 1.564 . . . . 0.0 114.117 -174.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.556 HG11 ' CD2' ' C' ' 42' ' ' PHE . 10.9 m -125.08 -174.17 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 111.036 -2.802 . . . . 0.0 111.348 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.579 ' HA2' ' H ' ' C' ' 16' ' ' MET . . . -126.78 45.6 1.14 Allowed Glycine 0 C--N 1.317 -0.497 0 C-N-CA 119.78 -1.2 . . . . 0.0 114.119 -173.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.863 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 69.81 -26.29 0.15 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 169.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -163.33 25.51 0.09 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 37' ' ' MET . . . . . 0.55 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 31.7 tpp -77.14 -68.75 0.58 Allowed 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 112.15 -2.295 . . . . 0.0 109.659 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.557 ' O ' ' HB ' ' C' ' 39' ' ' VAL . 18.2 m120 -142.69 -157.1 0.74 Allowed 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.595 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 2.8 p 159.68 -16.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.41 ' HD3' ' H ' ' C' ' 40' ' ' LYS . 0.0 OUTLIER -86.05 -70.48 0.6 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.248 -1.796 . . . . 0.0 108.24 169.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -62.68 -32.74 73.86 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.207 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.595 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -57.92 -51.69 68.57 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 173.194 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' C' ' 43' ' ' LYS . 31.3 mtpt -64.11 -39.3 93.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.99 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -56.6 -36.23 69.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.159 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -69.01 -39.79 79.08 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 122.911 0.484 . . . . 0.0 111.342 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.619 HD11 ' OE1' ' C' ' 57' ' ' GLN . 5.7 pt -84.55 -13.15 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.118 -175.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.32 -55.01 2.86 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.02 87.22 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -31.85 71.71 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.295 0.569 . . . . 0.0 110.868 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.547 HG22 ' O ' ' C' ' 46' ' ' ILE . 29.9 m -102.66 -2.06 9.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.033 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 84.3 p 63.12 23.55 13.99 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.812 0.815 . . . . 0.0 109.461 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' C' ' 57' ' ' GLN . 5.6 mm -130.45 115.29 17.2 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.781 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.524 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 4.5 Cg_exo -69.54 147.09 63.52 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.369 2.046 . . . . 0.0 111.061 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -51.37 -25.73 6.56 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.769 0.668 . . . . 0.0 112.059 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 10.2 pt-20 -70.75 -36.13 72.99 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.631 0.253 . . . . 0.0 111.568 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.428 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 98.4 mttt -98.43 -27.54 14.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.376 0.607 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.619 ' OE1' HD11 ' C' ' 46' ' ' ILE . 6.0 tt0 -68.36 136.44 53.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.239 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 58' ' ' ARG . . . . . 0.477 ' HB2' HG22 ' C' ' 85' ' ' VAL . 47.2 mtm180 -137.48 137.37 38.62 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.33 172.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.434 ' HB3' HG21 ' C' ' 82' ' ' ILE . 38.6 mt -96.28 123.61 39.98 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.957 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.562 HG21 ' O ' ' A' ' 37' ' ' ILE . 9.9 mt -112.84 122.29 66.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 119.227 0.921 . . . . 0.0 111.374 169.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.662 ' CD2' HG12 ' C' ' 77' ' ' VAL . 36.3 t80 -128.36 119.12 24.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.615 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 58.36 37.4 25.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.117 0.484 . . . . 0.0 110.414 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.46 -4.95 65.78 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.747 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.469 ' HA ' ' NE ' ' C' ' 64' ' ' ARG . 2.5 tpm_? -92.43 126.0 37.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -92.35 90.74 3.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.371 0.605 . . . . 0.0 110.559 -174.847 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.45 ' CD1' HG11 ' C' ' 77' ' ' VAL . 0.1 OUTLIER -72.6 154.59 40.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.738 -178.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -152.44 -170.47 3.65 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.214 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.568 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.8 p-10 -69.64 -2.37 11.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.174 0.589 . . . . 0.0 112.125 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.91 -9.98 11.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.545 ' HA ' HG11 ' C' ' 39' ' ' VAL . 52.9 mtmt 77.53 -175.51 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.739 0.815 . . . . 0.0 111.888 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.466 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 35.5 mmtp 75.09 69.02 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.634 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 30.7 mt -66.89 -39.75 87.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.563 -176.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -67.81 -19.87 65.12 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 120.793 0.33 . . . . 0.0 111.521 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 74' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 17.0 mm-40 -71.05 -27.08 63.39 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.447 ' CD1' HD22 ' C' ' 66' ' ' LEU . 25.2 m-85 -88.28 -25.11 22.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 61.7 t30 60.07 34.24 21.31 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.07 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.662 HG12 ' CD2' ' C' ' 61' ' ' TYR . 17.5 m -83.67 11.92 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -174.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.561 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -71.24 100.81 0.9 Allowed Glycine 0 N--CA 1.431 -1.661 0 CA-C-O 122.634 1.13 . . . . 0.0 113.298 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.5 13.41 28.28 Favored Glycine 0 C--N 1.285 -2.268 0 CA-C-N 112.123 -2.039 . . . . 0.0 115.804 170.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -136.04 148.56 48.41 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.68 0.74 . . . . 0.0 110.507 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.622 ' CG1' ' HB2' ' C' ' 20' ' ' LEU . 27.2 m -74.48 118.94 20.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 CA-C-O 121.97 0.89 . . . . 0.0 112.502 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' C' ' 59' ' ' LEU . 84.8 mt -70.76 160.6 5.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.514 173.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.412 ' N ' HG22 ' C' ' 82' ' ' ILE . 66.0 m-70 -115.56 117.65 30.93 Favored 'General case' 0 C--N 1.319 -0.761 0 O-C-N 121.338 -0.851 . . . . 0.0 109.564 173.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.45 ' CD1' ' HB ' ' C' ' 21' ' ' VAL . 10.2 mp -85.29 160.94 19.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.238 0.542 . . . . 0.0 111.699 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' C' ' 58' ' ' ARG . 5.6 m -112.61 134.71 54.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 86' ' ' GLU . . . . . 0.547 ' OE2' ' HB ' ' C' ' 23' ' ' THR . 30.7 mt-10 -116.47 121.82 42.96 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.788 -177.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -83.41 176.58 8.98 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.32 146.87 88.32 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.96 157.85 36.73 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.073 2.515 . . . . 0.0 111.811 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -48.42 138.99 23.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.449 2.766 . . . . 0.0 112.296 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -77.58 -16.78 58.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.965 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -71.75 147.87 46.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.041 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -85.78 -7.81 58.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.321 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 8.9 tt -67.02 122.76 84.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.002 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.09 110.42 1.01 Allowed 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.717 2.278 . . . . 0.0 112.272 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -73.38 -169.5 0.67 Allowed 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.03 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.04 -111.54 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.734 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 54.5 39.47 31.11 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.545 0.688 . . . . 0.0 109.986 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 2.6 p -99.16 -173.23 2.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.358 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 13.1 t -72.18 -37.97 69.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.185 0.517 . . . . 0.0 109.644 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.9 -0.945 . . . . 0.0 111.782 179.084 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.4 t -77.37 129.2 35.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.008 0.432 . . . . 0.0 110.706 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt -93.29 -7.74 44.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.303 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.56 82.23 1.58 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.371 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.4 OUTLIER -92.56 141.61 28.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.451 -179.167 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.71 97.11 6.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.927 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.0 p -168.8 122.5 0.71 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.12 -36.42 97.93 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.566 2.178 . . . . 0.0 110.754 173.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -135.92 122.75 14.38 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 169.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.76 40.71 0.82 Allowed 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 123.259 2.639 . . . . 0.0 113.681 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.93 99.68 0.04 OUTLIER Glycine 0 CA--C 1.502 -0.724 0 CA-C-O 121.933 0.741 . . . . 0.0 111.83 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG2' HD12 ' A' ' 40' ' ' LEU . 43.4 ttm180 -161.45 82.04 0.61 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 113.96 -1.12 . . . . 0.0 110.94 -172.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.509 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 6.3 m-85 -116.62 148.69 40.72 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.875 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.507 ' CB ' HD21 ' A' ' 40' ' ' LEU . 37.9 t80 -118.17 116.12 26.18 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.455 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.59 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -92.53 131.73 37.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.416 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.53 ' CD2' HG21 ' C' ' 85' ' ' VAL . 72.6 m-70 -85.8 -27.33 25.23 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -169.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.432 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 30.7 p -71.36 -30.63 66.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.319 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.425 ' O ' HG23 ' A' ' 18' ' ' VAL . 84.9 m -83.42 -33.01 25.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.091 0.472 . . . . 0.0 110.211 172.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.0 34.28 24.09 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.114 -173.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 16' ' ' CYS . 18.9 t -138.89 145.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.26 146.36 45.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.18 0.514 . . . . 0.0 112.003 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.804 HD12 ' HD3' ' A' ' 30' ' ' PRO . 2.3 pt -136.14 167.42 24.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.624 -172.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.63 111.39 31.41 Favored Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 159.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.509 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 22.2 Cg_endo -69.04 175.84 6.99 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 124.372 3.381 . . . . 0.0 115.687 -167.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.576 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 13.8 mtt180 -108.77 48.86 0.84 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.859 -1.973 . . . . 0.0 106.798 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.412 HD23 ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -1.05 -58.66 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.057 0 CA-C-N 110.964 -2.835 . . . . 0.0 117.056 171.213 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.435 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 20.0 Cg_exo -37.98 -33.98 0.29 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.706 2.271 . . . . 0.0 113.774 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.557 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.49 -21.0 10.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.777 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 65.49 56.27 0.97 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.356 1.074 . . . . 0.0 109.878 -169.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -109.59 162.85 7.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.38 -1.737 . . . . 0.0 109.606 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.5 t -97.46 147.53 33.12 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.804 ' HD3' HD12 ' A' ' 20' ' ' ILE . 65.6 Cg_endo -82.56 -19.82 6.08 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.851 2.367 . . . . 0.0 108.046 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.62 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 94.9 mtt-85 -82.69 -24.55 33.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 113.007 -1.906 . . . . 0.0 114.114 -178.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.432 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 28.6 p -147.2 -12.21 0.42 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 8.1 tt0 62.27 29.2 17.33 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.329 0.585 . . . . 0.0 111.02 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 m -106.26 146.76 29.94 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 170.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.27 44.47 3.29 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.572 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 95.4 m-85 -103.95 45.03 0.98 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.52 0.676 . . . . 0.0 109.851 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.671 HG21 ' CD1' ' A' ' 20' ' ' ILE . 10.7 pt -113.41 138.76 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.943 -176.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.499 ' HB3' HD13 ' C' ' 60' ' ' ILE . 13.4 pt-20 -129.57 143.85 51.01 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -79.5 133.39 36.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.024 0.44 . . . . 0.0 110.314 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.507 HD21 ' CB ' ' A' ' 12' ' ' PHE . 8.2 mt . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.708 -170.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.7 -79.97 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.338 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -175.95 -43.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.634 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 32.7 m80 62.52 -166.87 0.21 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.62 0.575 . . . . 0.0 110.371 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 59.67 41.05 19.19 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -73.74 -79.67 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.014 -175.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.434 ' O ' ' HB2' ' C' ' 9' ' ' HIS . 67.4 m-70 46.94 36.57 4.11 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.574 0.547 . . . . 0.0 112.453 173.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 9' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' C' ' 8' ' ' HIS . 64.1 m-70 68.42 -51.79 0.55 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.949 0.499 . . . . 0.0 110.757 -170.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.09 151.41 23.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.089 173.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' C' ' 12' ' ' ASP . 3.1 p-10 -57.02 -72.52 0.08 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.824 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 12' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' C' ' 11' ' ' ASP . 15.7 t70 176.03 -73.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -172.91 -158.54 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.51 -18.71 61.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 168.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -66.58 -178.58 0.72 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.137 170.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 92.3 mmm 57.31 80.67 0.16 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.175 0.512 . . . . 0.0 110.877 -177.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.777 HD11 ' HA ' ' C' ' 35' ' ' ALA . 5.2 mt -90.37 137.73 32.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.093 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.62 ' HA ' HG13 ' C' ' 32' ' ' ILE . 41.4 tt0 -88.79 89.56 8.04 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.623 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 7.9 t -74.79 97.29 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.978 -173.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.899 ' HB3' HG12 ' C' ' 81' ' ' VAL . 4.4 mt -88.89 153.14 21.28 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' C' ' 28' ' ' THR . 33.9 m -144.81 147.55 18.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.343 0.257 . . . . 0.0 110.402 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.645 ' HE3' HG21 ' C' ' 81' ' ' VAL . 79.8 mttt -131.17 120.41 23.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.413 HG22 ' O ' ' C' ' 84' ' ' LEU . 3.3 p -102.47 113.85 27.55 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.811 0.339 . . . . 0.0 111.09 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' C' ' 26' ' ' SER . 4.6 mm? 56.05 19.01 3.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.744 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 21.5 t70 71.94 -8.82 1.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.941 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' SER . . . . . 0.419 ' H ' ' C ' ' C' ' 24' ' ' LEU . 10.2 m -69.89 -39.19 76.39 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.553 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -110.5 174.06 6.04 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.844 0.83 . . . . 0.0 111.332 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.683 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 53.5 m -167.95 98.59 0.45 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.51 -1.677 . . . . 0.0 108.232 175.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 29' ' ' ARG . . . . . 0.412 ' O ' HG22 ' C' ' 21' ' ' VAL . 78.4 mtt180 -131.57 172.36 12.32 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.148 -176.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 1.6 p -115.04 151.58 33.98 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.623 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 28.4 m-85 -137.46 58.64 1.7 Allowed 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 124.141 0.977 . . . . 0.0 109.812 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.62 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.4 mp -58.71 123.27 10.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 123.443 1.592 . . . . 0.0 114.38 -172.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.64 HG21 HD13 ' C' ' 72' ' ' LEU . 10.7 m -124.66 -170.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 110.79 -2.913 . . . . 0.0 111.635 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.94 45.42 1.21 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.725 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.777 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.06 17.12 9.51 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 165.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.652 ' HB3' ' O ' ' C' ' 35' ' ' ALA . 9.0 pt20 158.94 -9.08 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.292 0.568 . . . . 0.0 109.718 -162.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.2 tpt -39.83 -66.61 0.29 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.855 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.441 ' O ' HG12 ' C' ' 39' ' ' VAL . 26.2 m-80 -148.6 -88.52 0.08 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.692 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 89.29 -27.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 O-C-N 125.393 1.683 . . . . 0.0 111.559 -167.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -70.9 0.52 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.246 1.022 . . . . 0.0 108.873 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.46 -27.06 69.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.052 173.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.692 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.4 OUTLIER -56.74 -52.29 65.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.364 173.614 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 54.7 mtpt -61.02 -43.75 98.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.42 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -54.8 -39.19 68.2 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.306 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -70.23 -43.73 70.0 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.066 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.675 HG23 ' O ' ' C' ' 42' ' ' PHE . 3.9 pt -79.1 -11.66 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 120.458 0.17 . . . . 0.0 110.945 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.24 -55.48 3.29 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.793 0.683 . . . . 0.0 112.675 -177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.31 -39.45 74.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -27.96 69.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.053 0.454 . . . . 0.0 111.0 -176.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.592 HG22 ' O ' ' C' ' 46' ' ' ILE . 28.9 m -108.27 -0.9 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.445 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 84.3 p 63.48 23.63 13.75 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.868 0.842 . . . . 0.0 109.464 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.0 mm -128.7 114.13 19.23 Favored Pre-proline 0 N--CA 1.439 -1.007 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.721 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.2 145.99 39.94 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.688 2.259 . . . . 0.0 111.929 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 41.1 t -53.08 -25.56 13.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.647 -174.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.54 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.6 pt-20 -70.76 -27.44 63.94 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.726 0.298 . . . . 0.0 111.474 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.54 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 92.8 mttt -109.0 -22.43 12.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.504 0.668 . . . . 0.0 109.936 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.421 ' HA ' HG21 ' C' ' 52' ' ' ILE . 23.6 tt0 -65.03 122.85 17.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.158 -169.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -127.41 115.55 19.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.982 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.658 ' HB3' HG21 ' C' ' 82' ' ' ILE . 5.3 mp -86.04 105.6 16.6 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.556 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.4 mt -99.61 110.98 27.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 121.268 0.556 . . . . 0.0 111.811 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.487 ' CD2' HG12 ' C' ' 77' ' ' VAL . 50.0 t80 -122.12 121.02 35.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.261 173.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 60.31 39.32 19.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.983 0.421 . . . . 0.0 110.752 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.44 -1.45 27.73 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.679 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 6.2 mmp_? -88.73 140.46 29.42 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.44 87.87 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 0.0 110.611 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.603 ' HG ' ' CD1' ' C' ' 75' ' ' TYR . 6.1 mp -65.31 122.55 17.38 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.812 173.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 67' ' ' GLN . . . . . 0.428 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 19.1 pt20 -144.19 -170.21 3.3 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.23 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.613 ' HA ' HG13 ' C' ' 39' ' ' VAL . 2.2 p-10 -66.67 0.35 2.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.285 1.034 . . . . 0.0 112.599 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 69' ' ' ASP . . . . . 0.428 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 12.7 t70 -62.85 -2.68 1.25 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.516 0.726 . . . . 0.0 112.679 -177.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? 81.71 172.06 0.12 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.12 0.968 . . . . 0.0 112.977 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.488 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 42.1 mtmt 71.0 86.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.937 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.64 HD13 HG21 ' C' ' 33' ' ' VAL . 41.8 mt -71.68 -49.62 37.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.382 -176.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 73' ' ' GLN . . . . . 0.513 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 29.8 pt20 -67.91 -17.08 64.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 74' ' ' GLU . . . . . 0.488 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 7.0 mm-40 -63.67 -28.82 70.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.603 ' CD1' ' HG ' ' C' ' 66' ' ' LEU . 42.1 m-85 -85.11 -23.28 28.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.256 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.1 t30 59.72 30.04 19.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.377 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 77' ' ' VAL . . . . . 0.557 HG11 HD21 ' C' ' 66' ' ' LEU . 18.0 m -85.21 25.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -175.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.567 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -76.33 100.4 1.4 Allowed Glycine 0 N--CA 1.431 -1.65 0 CA-C-O 122.552 1.085 . . . . 0.0 111.929 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.95 13.23 34.63 Favored Glycine 0 C--N 1.284 -2.318 0 CA-C-N 112.364 -1.918 . . . . 0.0 114.278 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 80' ' ' LYS . . . . . 0.441 ' C ' ' HB2' ' C' ' 20' ' ' LEU . 8.2 mptt -126.19 144.19 50.86 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.142 0.471 . . . . 0.0 110.113 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.899 HG12 ' HB3' ' C' ' 20' ' ' LEU . 35.2 m -80.22 125.5 39.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.809 0.814 . . . . 0.0 111.524 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.658 HG21 ' HB3' ' C' ' 59' ' ' LEU . 42.6 mt -84.99 171.43 1.17 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.813 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.55 ' N ' HG22 ' C' ' 82' ' ' ILE . 49.2 m80 -118.48 113.97 22.14 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 121.759 -0.588 . . . . 0.0 110.131 174.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.475 HD13 ' HB ' ' C' ' 21' ' ' VAL . 8.6 mp -103.32 139.41 38.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.058 0.456 . . . . 0.0 110.756 178.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.53 HG21 ' CD2' ' A' ' 14' ' ' HIS . 7.1 m -148.74 167.81 3.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.734 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 86' ' ' GLU . . . . . 0.425 ' OE1' ' HB3' ' C' ' 56' ' ' LYS . 0.1 OUTLIER -98.03 147.36 24.59 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.012 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -68.01 179.1 1.58 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.162 0.506 . . . . 0.0 111.429 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.78 155.85 3.75 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.198 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.68 137.48 66.85 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 122.266 1.977 . . . . 0.0 112.45 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.72 51.84 3.96 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 123.287 2.658 . . . . 0.0 113.019 -173.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -88.61 2.91 52.26 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.061 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 12.9 t -144.48 156.74 44.32 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.904 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -134.93 24.49 3.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.116 0.484 . . . . 0.0 110.163 176.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 57.3 mt -97.49 120.74 60.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.402 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.24 133.69 36.22 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.628 2.219 . . . . 0.0 111.715 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 8.9 t -76.11 57.81 1.15 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.072 0.463 . . . . 0.0 110.743 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.36 -103.48 1.51 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.066 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.66 108.45 20.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.646 0.26 . . . . 0.0 110.406 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 8.7 t -81.57 84.65 6.69 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 31.9 t 64.79 79.58 0.25 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.157 -1.357 . . . . 0.0 111.488 178.834 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.776 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.6 m -77.89 77.53 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.361 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptp -118.88 4.72 11.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.832 -174.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.68 53.75 2.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.21 0.529 . . . . 0.0 110.57 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -97.61 -17.7 19.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.986 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.8 119.92 21.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.011 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.5 m -153.69 95.82 2.83 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.431 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.31 65.01 7.98 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.023 2.482 . . . . 0.0 113.015 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -103.64 -46.91 0.16 Allowed Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.15 67.0 4.18 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 121.916 1.744 . . . . 0.0 113.36 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.94 -12.09 2.2 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.568 172.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -154.99 90.22 1.27 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.823 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.567 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.1 m-85 -117.92 145.39 44.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 169.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -119.21 122.04 41.07 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.349 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.671 ' HB2' HG22 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -99.28 130.0 45.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.744 177.434 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -85.11 -26.57 26.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.43 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.4 p -70.33 -45.47 66.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.425 -174.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.461 ' O ' HG23 ' A' ' 18' ' ' VAL . 18.6 p -95.05 -0.88 53.24 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.918 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.9 p 50.5 43.18 27.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.586 1.155 . . . . 0.0 113.739 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 16' ' ' CYS . 32.1 t -133.3 144.69 35.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.8 148.27 40.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.739 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.1 pt -140.35 167.57 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.657 0.741 . . . . 0.0 112.93 -167.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.44 106.85 39.67 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 159.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.567 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 25.6 Cg_endo -68.74 175.64 6.97 Favored 'Trans proline' 0 C--N 1.32 -0.921 0 C-N-CA 124.688 3.592 . . . . 0.0 116.546 -166.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HB2' HG13 ' A' ' 28' ' ' ILE . 83.7 mtt180 -108.87 48.48 0.86 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 112.65 -2.068 . . . . 0.0 107.434 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.408 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -3.28 -59.53 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.85 0 CA-C-N 110.854 -2.885 . . . . 0.0 117.479 173.434 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 26.8 Cg_exo -37.25 -37.01 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 122.59 2.194 . . . . 0.0 113.53 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.556 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -112.22 -21.49 11.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.704 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 42.2 m-85 68.99 57.41 0.39 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.259 1.028 . . . . 0.0 110.057 -170.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.556 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -111.49 163.79 8.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.159 176.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 20' ' ' ILE . 1.5 t -95.72 142.4 24.53 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.739 ' HD3' HD12 ' A' ' 20' ' ' ILE . 91.9 Cg_endo -83.35 -18.82 5.75 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.074 1.85 . . . . 0.0 108.577 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 58.2 mtt180 -95.47 15.96 18.25 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.241 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 31' ' ' ARG . 14.3 p 175.64 -11.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.405 0.441 . . . . 0.0 111.901 172.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 10.4 tt0 63.95 29.71 14.35 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.197 0.522 . . . . 0.0 112.124 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -99.7 148.29 24.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.48 168.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.24 21.98 21.82 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.892 -175.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 74.9 m-85 -86.32 47.73 1.51 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.709 0.29 . . . . 0.0 110.985 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.705 HG21 ' CD1' ' A' ' 20' ' ' ILE . 6.6 pt -110.31 131.59 60.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.191 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HB3' HD13 ' C' ' 60' ' ' ILE . 9.3 pt-20 -118.63 145.94 45.05 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -78.79 143.43 36.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.24 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.148 -173.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.03 -61.46 0.45 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.643 0.777 . . . . 0.0 112.403 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -80.19 79.66 6.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 110.799 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -73.92 -47.31 38.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.032 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -169.77 -39.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.819 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -157.57 169.68 24.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -111.94 57.73 0.64 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.133 0.492 . . . . 0.0 111.958 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -99.07 70.02 1.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 165.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 27.2 m -82.46 143.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 122.099 0.952 . . . . 0.0 111.913 -170.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -117.03 7.92 13.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.431 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.46 85.64 5.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.032 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -124.39 -0.44 8.2 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.506 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.73 -36.71 85.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.388 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -51.26 140.78 16.15 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.299 0.571 . . . . 0.0 111.788 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.528 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 13.4 tmm? -171.82 122.67 0.51 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.931 -173.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.773 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -106.3 142.76 35.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 172.639 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.581 ' HA ' HG13 ' C' ' 32' ' ' ILE . 38.8 tt0 -92.78 91.45 7.48 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 173.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' C' ' 30' ' ' THR . 2.9 t -76.2 103.1 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.757 -169.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.668 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -92.31 133.96 35.36 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.329 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.497 HG22 ' HB ' ' C' ' 82' ' ' ILE . 52.1 t -142.38 121.13 8.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -175.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.538 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 41.9 mtpt -95.7 154.09 17.39 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 23' ' ' THR . . . . . 0.41 HG22 HD23 ' C' ' 84' ' ' LEU . 50.9 p -120.21 165.13 15.22 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.662 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.02 -10.09 46.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.137 0.494 . . . . 0.0 110.943 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -75.13 3.04 9.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.233 171.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 50.6 m 74.13 14.58 3.82 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.282 0.633 . . . . 0.0 111.863 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -94.61 -178.12 4.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.58 0.705 . . . . 0.0 111.313 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 53.1 m -144.31 117.41 8.91 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.35 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -129.22 151.45 49.88 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.629 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 4.2 p -104.87 144.12 32.21 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.522 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 35.8 m-85 -139.09 62.36 1.54 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.82 0.819 . . . . 0.0 110.147 -174.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.581 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.2 mp -60.25 122.75 11.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 123.221 1.486 . . . . 0.0 114.901 -173.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' C' ' 16' ' ' MET . 19.5 m -140.35 -166.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 111.116 -2.765 . . . . 0.0 112.377 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -80.33 177.84 54.16 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.79 174.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.773 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -79.8 -15.07 58.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.372 0.606 . . . . 0.0 111.476 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -161.93 27.75 0.12 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 37' ' ' MET . . . . . 0.434 ' HB2' ' HA3' ' C' ' 34' ' ' GLY . 4.5 ttp -57.69 -75.95 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.394 -174.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.462 ' O ' HG12 ' C' ' 39' ' ' VAL . 94.7 m-20 -121.97 -82.33 0.65 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 120.903 0.383 . . . . 0.0 111.401 -177.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.677 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 78.31 -25.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 O-C-N 124.95 1.406 . . . . 0.0 113.068 -173.387 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.15 -68.87 0.71 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 122.35 1.071 . . . . 0.0 109.075 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -57.77 -32.67 67.72 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.028 -1.896 . . . . 0.0 110.221 171.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.677 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -63.33 -50.46 69.93 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.999 176.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 43' ' ' LYS . . . . . 0.692 ' HG3' ' OE1' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -59.11 -48.34 81.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.824 0.345 . . . . 0.0 110.278 176.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -57.31 -33.05 67.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.438 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -69.72 -51.12 37.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.284 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.701 HD11 ' OE1' ' C' ' 57' ' ' GLN . 17.7 pt -74.97 -14.31 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.525 -177.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.36 -57.09 2.27 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 124.165 0.916 . . . . 0.0 113.293 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.12 87.44 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -57.4 -43.73 83.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.484 0.659 . . . . 0.0 110.485 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.612 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.1 m -88.16 -6.25 10.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.286 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m 67.87 21.1 9.14 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 121.62 0.724 . . . . 0.0 109.409 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.5 mm -129.67 111.81 17.6 Favored Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.325 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.55 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.0 Cg_exo -71.39 147.83 53.45 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.84 2.36 . . . . 0.0 111.554 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 37.9 t -51.15 -25.2 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.021 0.928 . . . . 0.0 112.81 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.487 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.5 pt-20 -78.14 -21.28 50.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 111.685 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.487 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 46.0 mtpt -112.9 -15.36 12.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.481 . . . . 0.0 110.195 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.701 ' OE1' HD11 ' C' ' 46' ' ' ILE . 9.6 tt0 -75.8 122.71 24.48 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.163 -174.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -121.73 124.2 43.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.743 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.51 HD11 ' HZ1' ' C' ' 43' ' ' LYS . 87.1 mt -88.29 118.23 27.75 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.436 HD13 ' HB3' ' A' ' 38' ' ' GLU . 5.7 mt -114.27 113.12 42.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.047 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -126.15 121.73 33.66 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 59.95 38.39 20.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.792 -177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.03 -4.85 36.33 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.013 -0.54 . . . . 0.0 113.532 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -88.04 130.61 34.93 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.63 88.92 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.059 0.456 . . . . 0.0 109.848 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.536 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.3 OUTLIER -74.02 142.79 45.73 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -155.16 -168.65 2.93 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.042 -171.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.675 ' HA ' HG13 ' C' ' 39' ' ' VAL . 4.7 p-10 -60.78 -1.85 0.46 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.087 0.955 . . . . 0.0 113.421 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -68.53 -3.29 11.09 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.181 0.592 . . . . 0.0 112.165 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.506 ' H ' HG11 ' C' ' 39' ' ' VAL . 57.6 mttp 76.63 -165.45 0.06 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.862 0.865 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 mttt 68.69 55.85 0.46 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.463 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.614 HD21 HG23 ' C' ' 39' ' ' VAL . 31.1 mt -61.78 -33.04 73.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -71.72 -18.18 62.16 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 120.746 0.308 . . . . 0.0 111.575 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -76.44 -26.8 55.82 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.555 ' HD2' HD23 ' C' ' 72' ' ' LEU . 16.2 m-85 -82.63 -24.03 34.0 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 58.5 t30 62.88 41.52 8.6 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.596 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.26 -5.25 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-N 112.955 -1.929 . . . . 0.0 112.748 -158.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.692 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -52.58 104.92 0.2 Allowed Glycine 0 CA--C 1.487 -1.666 0 CA-C-O 123.329 1.516 . . . . 0.0 113.769 173.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.97 14.21 59.58 Favored Glycine 0 C--N 1.287 -2.194 0 CA-C-N 111.388 -2.406 . . . . 0.0 113.961 168.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -121.49 138.95 54.07 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.668 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 13.1 m -74.76 127.81 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 122.191 0.996 . . . . 0.0 111.46 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.5 HD13 HD12 ' C' ' 66' ' ' LEU . 12.6 mt -86.25 167.86 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.838 174.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.453 ' N ' HG22 ' C' ' 82' ' ' ILE . 65.2 m80 -118.92 115.3 24.08 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.41 HD23 HG22 ' C' ' 23' ' ' THR . 19.5 tp -92.45 132.79 36.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.276 0.56 . . . . 0.0 111.914 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 m -133.91 170.0 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.342 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 86' ' ' GLU . . . . . 0.436 ' HB2' HD12 ' C' ' 52' ' ' ILE . 42.7 tt0 -122.89 122.55 38.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.915 0.388 . . . . 0.0 111.27 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -102.91 164.34 11.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -134.02 152.29 78.22 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.948 -173.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 89' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 88' ' ' ALA . 36.8 Cg_exo -62.73 141.6 85.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.562 2.175 . . . . 0.0 112.16 175.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.45 65.07 8.05 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.804 2.336 . . . . 0.0 112.229 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -100.97 -20.03 15.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.921 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 14.8 t -152.4 151.36 30.72 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.847 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -87.46 78.91 8.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' C' ' 95' ' ' PRO . 6.1 tt 71.99 120.71 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.35 0 O-C-N 124.009 0.818 . . . . 0.0 110.162 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 34.6 Cg_exo -59.52 103.52 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.624 2.216 . . . . 0.0 112.042 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 25.9 t -62.72 126.45 27.39 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.809 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.93 -134.17 10.36 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.062 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.9 83.02 4.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.997 0.427 . . . . 0.0 110.992 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -77.62 -17.57 57.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.297 0.57 . . . . 0.0 109.939 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 38.9 t -129.86 -53.99 1.14 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.304 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.569 -1.129 . . . . 0.0 111.46 -178.438 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 111.841 -0.503 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 2.9 p -67.82 108.79 3.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.051 0.453 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 mtm -82.15 -42.1 19.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.103 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 3' ' ' GLU . . . -84.24 79.92 9.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.565 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 2' ' ' ALA . 35.2 tt0 73.43 145.44 0.08 Allowed 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.938 0.774 . . . . 0.0 110.882 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.76 67.77 2.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.259 0.552 . . . . 0.0 110.519 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 23.6 p -79.98 145.71 61.95 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.253 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 31.1 Cg_exo -59.19 139.08 88.67 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.259 1.973 . . . . 0.0 110.951 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -96.33 120.77 61.87 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 121.105 0.479 . . . . 0.0 111.164 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.627 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 70.9 Cg_endo -80.37 153.95 21.28 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.422 2.748 . . . . 0.0 113.827 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.23 -112.89 1.56 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HB3' HD12 ' A' ' 40' ' ' LEU . 77.6 mtp180 -88.13 107.13 18.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.895 0.378 . . . . 0.0 110.587 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.691 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.8 m-85 -116.25 144.82 43.72 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.412 173.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.53 ' CB ' HD21 ' A' ' 40' ' ' LEU . 53.8 t80 -114.24 121.59 44.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.762 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -98.43 119.52 37.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 174.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -76.88 -13.33 60.0 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.468 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 36.3 t -70.89 -42.04 70.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.353 0.597 . . . . 0.0 110.581 175.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -85.21 -27.03 26.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.581 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 1.6 m 58.09 29.5 17.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.214 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.37 144.25 34.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -74.82 147.64 40.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.177 0.513 . . . . 0.0 111.267 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.794 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.6 pt -133.36 169.7 21.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.841 -169.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.37 108.64 35.61 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 158.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.691 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 15.0 Cg_endo -69.06 177.49 5.05 Favored 'Trans proline' 0 C--N 1.328 -0.53 0 C-N-CA 125.181 3.921 . . . . 0.0 115.315 -170.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.6 ' HB2' HG13 ' A' ' 28' ' ' ILE . 8.2 mtt180 -112.57 50.46 0.87 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.592 174.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.509 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -0.3 -60.23 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 CA-C-N 111.334 -2.667 . . . . 0.0 116.365 172.316 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 24' ' ' LEU . 27.7 Cg_exo -34.79 -36.4 0.12 Allowed 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 123.045 2.497 . . . . 0.0 114.386 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.533 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -110.35 -22.92 11.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.72 178.462 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 66.24 49.26 1.51 Allowed 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.642 -168.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.6 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -98.17 162.18 2.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.07 174.511 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.542 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.8 t -97.63 147.1 32.53 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.794 ' HD3' HD12 ' A' ' 20' ' ' ILE . 66.6 Cg_endo -80.93 -22.84 5.9 Favored 'Trans proline' 0 CA--C 1.499 -1.261 0 C-N-CA 122.897 2.398 . . . . 0.0 108.21 -174.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.516 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 80.1 mtt-85 -81.66 -30.02 32.9 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 112.819 -1.991 . . . . 0.0 113.776 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.4 p -141.6 -7.02 0.99 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.429 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 17.6 tt0 59.47 27.37 16.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.552 0.691 . . . . 0.0 111.219 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -107.71 143.02 36.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.369 171.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.37 33.24 2.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.899 -0.667 . . . . 0.0 114.012 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 41.1 m-85 -89.54 45.08 1.25 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.101 0.477 . . . . 0.0 110.423 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.688 HG21 ' CD1' ' A' ' 20' ' ' ILE . 10.4 pt -112.32 132.48 60.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.227 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' C' ' 65' ' ' VAL . 7.5 pt-20 -120.08 136.23 54.66 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.95 137.57 39.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.971 0.415 . . . . 0.0 110.094 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.53 HD21 ' CB ' ' A' ' 12' ' ' PHE . 10.4 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.363 -172.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.04 155.7 17.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.816 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -62.23 -51.52 67.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.213 0.53 . . . . 0.0 109.946 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -117.16 164.71 14.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.311 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -75.49 69.16 2.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.307 0.575 . . . . 0.0 110.463 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -145.13 103.38 3.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.572 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -81.31 -0.59 41.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.966 0.412 . . . . 0.0 111.135 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -138.0 128.79 26.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 170.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 33.5 m -138.98 150.39 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.033 0.444 . . . . 0.0 111.521 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -143.43 17.38 1.86 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.2 44.34 1.01 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.634 -170.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -119.59 69.58 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -88.63 -45.81 9.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.881 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -67.12 178.78 1.33 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.523 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 45.5 ttm 65.51 91.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.152 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 17' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -108.69 142.53 39.07 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.104 176.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.628 ' HA ' HG13 ' C' ' 32' ' ' ILE . 37.8 mt-10 -85.04 94.69 8.89 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.5 t -77.9 111.46 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.613 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.665 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.4 mt -100.02 146.97 26.12 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.67 HG21 ' HE2' ' C' ' 31' ' ' PHE . 9.4 m -137.32 153.9 29.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 22' ' ' LYS . . . . . 0.543 ' HG3' ' CG2' ' C' ' 81' ' ' VAL . 41.0 mtmt -125.77 133.18 52.14 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 3.2 m -78.3 -45.63 22.23 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.121 -172.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.84 -43.17 0.12 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 27.2 t70 177.96 -43.26 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.312 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 24.6 t -66.1 -45.69 80.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.483 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -93.32 176.2 6.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 122.634 1.207 . . . . 0.0 113.036 -175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 25.5 m -176.1 104.81 0.07 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 112.068 -2.333 . . . . 0.0 106.817 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -131.21 157.55 42.91 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.442 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 30' ' ' THR . . . . . 0.562 HG22 ' CD2' ' C' ' 20' ' ' LEU . 16.8 p -103.76 149.11 25.32 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -172.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 31' ' ' PHE . . . . . 0.67 ' HE2' HG21 ' C' ' 21' ' ' VAL . 27.6 m-85 -140.36 63.11 1.48 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.376 -177.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.628 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -59.17 122.69 9.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 122.973 1.368 . . . . 0.0 114.154 -174.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.639 HG11 ' CD1' ' C' ' 42' ' ' PHE . 13.9 m -135.74 -168.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 111.498 -2.592 . . . . 0.0 112.107 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.47 38.72 2.56 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.457 -0.878 . . . . 0.0 114.423 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 35' ' ' ALA . . . . . 0.734 ' HB2' HD21 ' C' ' 17' ' ' LEU . . . 71.09 16.99 6.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 163.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.733 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 56.3 tt0 153.43 -7.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.787 0.803 . . . . 0.0 108.933 -166.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 37' ' ' MET . . . . . 0.493 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 35.8 tpp -47.94 -66.52 0.39 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.296 173.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.493 ' OD1' ' HG3' ' C' ' 37' ' ' MET . 18.3 m120 -139.99 -162.68 1.38 Allowed 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 168.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.643 HG13 ' HA ' ' C' ' 68' ' ' ASP . 8.1 p 173.72 -19.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.538 ' HE2' ' HE2' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -83.05 -70.65 0.54 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.123 173.369 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -62.77 -32.45 73.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.531 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.639 ' CD1' HG11 ' C' ' 33' ' ' VAL . 5.9 t80 -59.05 -52.17 66.89 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.625 175.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 43' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -68.04 -35.67 78.64 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.638 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -56.39 -40.43 74.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.026 0.441 . . . . 0.0 111.133 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -69.56 -41.15 76.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.742 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.625 ' O ' HG22 ' C' ' 50' ' ' VAL . 6.2 pt -76.59 -16.62 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -176.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -39.17 -59.57 1.0 Allowed 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.81 95.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -23.57 67.32 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.177 0.513 . . . . 0.0 111.097 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.628 HG21 ' OE1' ' C' ' 57' ' ' GLN . 26.7 m -108.91 -5.93 10.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.096 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t 69.17 19.63 7.86 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.558 0.694 . . . . 0.0 109.637 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 52' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 3.4 mm -129.26 118.4 19.22 Favored Pre-proline 0 N--CA 1.444 -0.761 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.726 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 53' ' ' PRO . . . . . 0.481 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 5.1 Cg_exo -70.1 146.67 58.75 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.121 1.88 . . . . 0.0 111.188 177.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 54' ' ' SER . . . . . 0.427 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 8.7 t -53.48 -26.18 19.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.009 -176.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.526 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.7 pt-20 -71.63 -32.45 67.96 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.899 0.38 . . . . 0.0 110.998 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 57.4 mtpt -99.45 -24.42 14.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.36 0.6 . . . . 0.0 110.123 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.628 ' OE1' HG21 ' C' ' 50' ' ' VAL . 6.2 tt0 -69.2 122.64 19.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.728 -173.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -112.02 122.63 48.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.674 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 95.3 mt -88.46 110.75 21.1 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.463 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.2 mt -108.64 113.88 45.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.95 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -133.54 132.54 41.05 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 59.11 34.21 23.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.401 -173.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 63' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 67.83 2.31 22.58 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.777 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -91.16 136.48 33.06 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -90.64 89.18 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.43 0.633 . . . . 0.0 109.563 -176.332 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.562 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.3 OUTLIER -73.67 140.94 46.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.918 178.577 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -153.53 -169.31 3.26 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.561 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 68' ' ' ASP . . . . . 0.643 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.4 p-10 -65.56 -0.43 2.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.268 0.627 . . . . 0.0 112.161 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 69' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 38.4 t70 -58.32 -10.9 2.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.296 1.038 . . . . 0.0 113.367 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.538 ' HE2' ' HE2' ' C' ' 40' ' ' LYS . 89.5 mttt 85.6 175.16 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.285 1.034 . . . . 0.0 113.226 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 64.74 86.02 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.916 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.621 ' HB2' ' C ' ' C' ' 35' ' ' ALA . 57.9 mt -75.42 -34.15 60.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -66.41 -19.3 65.76 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 120.699 0.285 . . . . 0.0 111.636 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -68.8 -28.41 66.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 75' ' ' TYR . . . . . 0.562 ' CD1' HD22 ' C' ' 66' ' ' LEU . 20.9 m-85 -85.85 -23.26 27.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.1 t30 61.07 36.52 18.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.848 -1.524 . . . . 0.0 110.852 171.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.04 25.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.711 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.723 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -72.14 95.14 0.65 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-O 122.203 0.89 . . . . 0.0 113.074 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.64 14.77 45.73 Favored Glycine 0 C--N 1.305 -1.179 0 CA-C-N 113.341 -1.429 . . . . 0.0 113.508 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -119.01 149.82 40.99 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.052 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.665 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 10.5 m -82.68 124.07 39.04 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-O 122.299 1.047 . . . . 0.0 111.177 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 82' ' ' ILE . . . . . 0.481 HG22 ' N ' ' C' ' 83' ' ' HIS . 68.2 mt -81.95 167.3 2.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.925 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 83' ' ' HIS . . . . . 0.481 ' N ' HG22 ' C' ' 82' ' ' ILE . 88.8 m-70 -118.71 115.11 23.82 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.446 HD21 HG11 ' C' ' 50' ' ' VAL . 4.3 pp -113.94 151.47 32.24 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.051 -1.059 . . . . 0.0 112.562 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.94 -174.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 113.174 -1.83 . . . . 0.0 110.352 -176.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.88 170.91 9.5 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.239 168.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -77.5 176.91 8.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.078 0.466 . . . . 0.0 111.323 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.85 150.31 77.54 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.557 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.69 135.92 11.82 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.957 1.771 . . . . 0.0 112.365 -175.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -87.8 55.46 2.68 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.943 2.428 . . . . 0.0 111.843 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -67.75 -16.58 64.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.153 0.501 . . . . 0.0 110.814 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -142.74 35.83 1.43 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 172.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 45.2 m80 68.15 -78.88 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.572 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -121.41 107.48 36.77 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -64.66 104.23 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.452 2.101 . . . . 0.0 112.25 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 29.0 t -72.02 -33.72 68.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.115 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.4 84.79 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.429 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.18 71.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.935 0.398 . . . . 0.0 111.2 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 20.4 m -111.64 19.9 17.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.146 0.498 . . . . 0.0 110.805 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 18.8 m -98.26 101.16 12.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.983 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.936 0 CA-C-O 118.739 -1.034 . . . . 0.0 111.298 176.968 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 120.407 0.146 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 10.0 m-85 -120.67 165.29 15.27 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 167.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CB ' HD21 ' A' ' 40' ' ' LEU . 75.4 t80 -137.22 117.44 13.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.687 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -97.55 120.95 38.86 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -74.69 -15.64 60.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.748 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.6 m -70.78 -37.28 73.34 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.937 0.399 . . . . 0.0 111.147 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' HG23 ' A' ' 18' ' ' VAL . 90.5 m -89.48 -16.0 31.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.695 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 p 49.64 31.35 4.2 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.256 -171.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 16' ' ' CYS . 98.0 t -141.13 146.91 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.539 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 25.5 tt0 -70.39 149.0 47.75 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.343 0.402 . . . . 0.0 111.235 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.703 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.4 pt -138.12 167.01 22.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.477 -173.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.496 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 40.5 t -122.96 96.68 44.67 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 163.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.662 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.88 177.12 0.19 Allowed 'Trans proline' 0 C--N 1.325 -0.691 1 C-N-CA 125.455 4.103 . . . . 0.0 116.426 -170.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.544 ' HB2' HG13 ' A' ' 28' ' ' ILE . 36.7 mtt180 -112.97 51.01 0.85 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 112.818 -1.992 . . . . 0.0 107.565 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' A' ' 27' ' ' TYR . 3.1 mm? 3.0 -60.81 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.213 0 CA-C-N 111.507 -2.588 . . . . 0.0 117.555 171.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 32.6 Cg_exo -37.12 -32.84 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.613 2.209 . . . . 0.0 113.826 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.558 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -118.29 -20.39 8.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.558 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.41 ' C ' HD11 ' A' ' 37' ' ' ILE . 44.1 m-85 65.25 46.66 2.59 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.57 1.176 . . . . 0.0 109.767 -170.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -92.0 163.77 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 113.315 -1.766 . . . . 0.0 109.793 174.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -94.29 144.49 28.1 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.678 ' HD3' HD12 ' A' ' 20' ' ' ILE . 68.3 Cg_endo -80.72 -22.43 6.45 Favored 'Trans proline' 0 CA--C 1.5 -1.208 0 C-N-CA 122.711 2.274 . . . . 0.0 108.083 -171.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 51.6 mtt180 -81.24 -34.76 31.92 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.968 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.4 p -139.27 -8.42 1.31 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.333 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 60.11 25.98 15.32 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.0 m -98.5 133.69 42.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 166.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.03 30.76 2.62 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.007 -172.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 51.8 m-85 -86.58 47.99 1.56 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.498 0.666 . . . . 0.0 109.842 176.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.703 HG21 ' CD1' ' A' ' 20' ' ' ILE . 9.6 pt -111.33 133.45 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.382 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' HB3' HD13 ' C' ' 60' ' ' ILE . 11.5 pt-20 -117.2 141.48 48.23 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -79.29 131.99 36.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.206 0.527 . . . . 0.0 109.848 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.452 HD21 ' CB ' ' A' ' 12' ' ' PHE . 2.5 mt . . . . . 0 C--O 1.25 1.12 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.877 -173.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.505 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 12.2 tpt . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 120.823 0.344 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.735 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -99.19 148.29 24.25 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.543 ' HA ' HG13 ' C' ' 32' ' ' ILE . 30.2 tt0 -98.72 91.58 5.17 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.3 t -78.79 106.11 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.443 -168.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.614 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -94.64 140.93 29.21 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' C' ' 82' ' ' ILE . 70.7 t -151.68 120.44 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 37.7 mtpt -95.54 159.18 15.12 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 63.3 p . . . . . 0 C--N 1.314 -0.954 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.783 -171.927 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 22.8 m . . . . . 0 C--O 1.232 0.18 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -125.59 152.89 44.51 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.63 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p -99.1 145.42 27.16 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.162 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.478 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 29.0 m-85 -135.88 58.54 1.74 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.654 -175.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.543 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -57.35 122.29 6.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 123.381 1.563 . . . . 0.0 114.362 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -142.94 -165.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 110.677 -2.965 . . . . 0.0 111.39 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -81.57 -179.85 53.13 Favored Glycine 0 C--N 1.312 -0.769 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.123 174.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.735 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -78.78 -23.83 45.04 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-N 117.254 0.527 . . . . 0.0 110.132 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -151.75 23.08 0.69 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -162.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . 0.49 ' HB2' ' HA3' ' C' ' 34' ' ' GLY . 25.5 ttt -73.6 -68.75 0.48 Allowed 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 111.409 -2.632 . . . . 0.0 110.805 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.454 ' OD1' ' HG2' ' C' ' 37' ' ' MET . 23.6 m120 -126.19 -94.52 0.46 Allowed 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.585 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 82.94 -38.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 O-C-N 124.305 1.003 . . . . 0.0 111.128 -162.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.528 ' HA ' ' CB ' ' C' ' 68' ' ' ASP . 0.0 OUTLIER -78.97 -69.46 0.57 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 122.512 1.148 . . . . 0.0 108.939 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . 0.413 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 20.7 mt-10 -63.08 -27.82 69.66 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.902 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.585 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 2.6 t80 -59.05 -50.34 74.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.328 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.485 ' HE3' ' OG ' ' C' ' 54' ' ' SER . 23.1 mtpp -60.61 -41.27 94.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.988 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -57.73 -38.39 75.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.175 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -70.43 -45.97 64.81 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.209 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.602 ' O ' HG22 ' C' ' 50' ' ' VAL . 17.0 pt -76.78 -10.63 13.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -174.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -43.92 -49.46 8.42 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.63 -38.28 48.28 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.707 -0.397 . . . . 0.0 112.065 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -28.21 69.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.987 0.422 . . . . 0.0 110.996 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.602 HG22 ' O ' ' C' ' 46' ' ' ILE . 34.8 m -109.11 -5.84 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.47 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 46.1 m 68.13 20.65 8.9 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 121.629 0.728 . . . . 0.0 109.768 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.6 mm -122.95 111.2 30.97 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.546 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 7.1 Cg_exo -70.49 141.6 42.65 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.61 2.207 . . . . 0.0 111.695 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.485 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 42.8 t -50.75 -26.19 5.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.73 -173.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.402 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 13.4 pt-20 -72.75 -36.31 67.69 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.402 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 89.0 mttt -94.85 -32.28 13.33 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.741 0.782 . . . . 0.0 109.468 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.465 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 20.8 tt0 -51.92 132.43 32.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.664 -1.607 . . . . 0.0 111.48 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -133.95 113.02 11.73 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.524 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 37.8 mt -84.89 118.38 24.48 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 38' ' ' GLU . 5.4 mt -117.25 121.17 67.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.664 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -137.85 132.82 33.12 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 59.15 32.87 22.45 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.534 0.521 . . . . 0.0 110.14 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 67.85 4.18 32.47 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.87 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -88.7 142.08 27.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -90.24 89.41 3.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.631 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -81.14 131.86 35.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' C' ' 69' ' ' ASP . 9.3 pt20 -144.67 -177.32 5.44 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.536 -176.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.547 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.7 p-10 -70.51 -3.22 16.87 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.751 0.821 . . . . 0.0 112.033 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . 0.426 ' H ' ' HG3' ' C' ' 67' ' ' GLN . 33.1 t70 -70.32 -21.63 62.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -174.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -131.85 -142.22 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.196 -0.315 . . . . 0.0 111.442 -169.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' C' ' 71' ' ' LYS . 9.9 mptt -126.64 167.17 16.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.623 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.487 HD23 HG23 ' C' ' 39' ' ' VAL . 7.3 mt -70.61 -37.31 73.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.022 0.439 . . . . 0.0 111.758 -175.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' C' ' 35' ' ' ALA . 23.1 tp60 -70.66 -18.65 62.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.521 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -61.61 -29.41 70.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.83 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.631 ' CD1' HD22 ' C' ' 66' ' ' LEU . 36.8 m-85 -103.66 -18.62 14.65 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.65 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.8 t30 59.22 52.6 5.96 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.904 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 35.1 m -95.23 14.98 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -171.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -57.56 99.27 0.1 OUTLIER Glycine 0 CA--C 1.492 -1.381 0 CA-C-O 122.915 1.286 . . . . 0.0 113.789 171.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.94 14.92 47.4 Favored Glycine 0 C--N 1.284 -2.328 0 CA-C-N 111.877 -2.162 . . . . 0.0 114.132 171.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.35 141.19 50.29 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 122.495 -0.414 . . . . 0.0 110.642 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.614 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 21.2 m -78.37 123.96 36.02 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-O 121.932 0.872 . . . . 0.0 111.104 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' C' ' 21' ' ' VAL . 66.3 mt -82.6 168.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.0 172.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.501 ' N ' HG22 ' C' ' 82' ' ' ILE . 62.5 m80 -118.27 115.5 24.86 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 15.0 mt -88.42 148.73 24.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.17 0.51 . . . . 0.0 111.452 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.133 -178.335 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 121.651 0.739 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.605 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 9.0 m-85 -115.88 169.6 9.11 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.513 -1.222 . . . . 0.0 108.39 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.642 ' HB2' HD21 ' A' ' 40' ' ' LEU . 38.4 t80 -142.0 113.62 7.83 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.917 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 31.6 p -83.09 87.67 6.9 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.813 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.535 ' CE1' HG13 ' C' ' 85' ' ' VAL . 30.3 p80 -66.17 -14.72 62.32 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.619 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.766 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 3.0 p -67.08 -49.08 66.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.044 0.449 . . . . 0.0 110.437 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.9 -5.61 28.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.626 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m 65.16 55.44 1.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.034 172.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.94 145.36 24.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.4 tt0 -86.25 138.92 31.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.132 0.492 . . . . 0.0 110.709 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.783 HD11 HG21 ' A' ' 37' ' ' ILE . 6.2 pt -143.49 166.87 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -164.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 46.5 t -120.07 94.81 48.89 Favored Pre-proline 0 N--CA 1.447 -0.578 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 160.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 9.8 Cg_endo -56.73 171.36 1.03 Allowed 'Trans proline' 0 C--N 1.32 -0.965 1 C-N-CA 125.479 4.119 . . . . 0.0 117.186 -167.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HB2' HG13 ' A' ' 28' ' ' ILE . 98.3 mtt180 -101.91 47.48 0.9 Allowed 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 112.4 -2.182 . . . . 0.0 107.205 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -8.53 -54.25 0.01 OUTLIER Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 110.467 -3.06 . . . . 0.0 115.606 172.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 19.2 Cg_exo -35.27 -33.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 123.216 2.611 . . . . 0.0 114.512 173.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.511 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -122.91 -19.01 6.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.121 0.486 . . . . 0.0 111.42 177.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.482 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 90.5 m-85 73.04 53.28 0.13 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.162 -174.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -108.78 164.16 5.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 113.628 -1.624 . . . . 0.0 108.086 177.21 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 27.1 p -94.49 139.12 22.24 Favored Pre-proline 0 N--CA 1.424 -1.733 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.638 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 85.4 Cg_endo -78.63 -25.31 6.67 Favored 'Trans proline' 0 CA--C 1.493 -1.545 0 C-N-CA 123.535 2.823 . . . . 0.0 108.822 -166.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 52.9 mtt180 -79.68 -28.86 40.67 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.381 -2.19 . . . . 0.0 113.162 -175.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -157.7 9.8 0.18 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.322 -170.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 49.48 64.24 1.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 167.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.554 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -133.3 147.88 51.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.169 169.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -88.46 6.85 83.13 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.49 -0.862 . . . . 0.0 114.089 -170.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.766 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 69.8 m-85 -83.4 59.46 5.07 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.505 -0.409 . . . . 0.0 111.485 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.783 HG21 HD11 ' A' ' 20' ' ' ILE . 3.5 pt -112.73 141.56 27.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.07 0.462 . . . . 0.0 111.769 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.539 ' HB3' HD13 ' C' ' 60' ' ' ILE . 9.9 pt-20 -129.23 153.71 47.51 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -84.78 143.4 29.14 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.642 HD21 ' HB2' ' A' ' 12' ' ' PHE . 7.9 mt . . . . . 0 C--N 1.311 -1.066 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.899 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.657 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 24.6 ptt? . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 121.086 0.47 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.882 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.4 OUTLIER -104.09 133.07 49.65 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 170.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.608 ' HA ' HG13 ' C' ' 32' ' ' ILE . 26.0 mt-10 -80.45 96.56 6.78 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.614 HG22 HG23 ' C' ' 77' ' ' VAL . 3.0 t -81.63 104.64 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.5 -172.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -93.31 141.78 28.05 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' C' ' 82' ' ' ILE . 69.5 t -147.84 118.09 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 118.219 0.463 . . . . 0.0 110.781 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.637 ' HG2' ' OG1' ' C' ' 28' ' ' THR . 73.5 mttt -100.09 115.05 28.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . 0.417 HG21 HG12 ' C' ' 50' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.315 -0.934 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.637 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 22.0 m . . . . . 0 C--O 1.233 0.227 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -126.67 154.72 43.69 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.332 -1.304 . . . . 0.0 109.547 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 2.4 p -103.03 141.91 35.01 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.489 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 26.8 m-85 -138.08 59.54 1.65 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.247 0.546 . . . . 0.0 109.991 -173.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.608 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.2 mp -54.88 125.46 9.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 123.04 1.4 . . . . 0.0 114.501 -173.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.754 HG21 HD13 ' C' ' 72' ' ' LEU . 15.6 m -132.7 -169.23 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 111.892 -2.413 . . . . 0.0 111.429 -176.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.68 40.85 1.99 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.239 -0.982 . . . . 0.0 114.323 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.882 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 70.07 -28.67 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 168.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -154.48 24.7 0.46 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -76.2 -68.11 0.62 Allowed 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 112.51 -2.132 . . . . 0.0 111.046 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.441 ' O ' HG12 ' C' ' 39' ' ' VAL . 10.9 m120 -132.29 -87.51 0.45 Allowed 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.655 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 82.41 -37.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 124.746 1.279 . . . . 0.0 111.372 -166.033 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.97 -68.17 0.66 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 122.591 1.186 . . . . 0.0 108.653 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.29 -28.0 69.42 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 112.616 -2.084 . . . . 0.0 110.819 173.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.655 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.2 t80 -58.32 -49.52 76.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.89 174.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.519 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 14.9 mtpp -62.97 -41.2 99.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.92 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -61.63 -37.29 83.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.035 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -70.35 -43.2 70.68 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.532 ' O ' HG22 ' C' ' 50' ' ' VAL . 18.2 pt -76.87 -12.13 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.281 -0.262 . . . . 0.0 110.948 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.94 -55.51 3.71 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 -42.82 91.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -21.64 65.64 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.241 0.543 . . . . 0.0 111.276 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.532 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.7 m -112.31 -3.69 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.44 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 32.9 t 65.8 22.42 11.47 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.843 0.83 . . . . 0.0 109.049 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 11.5 mm -131.35 111.76 15.36 Favored Pre-proline 0 N--CA 1.437 -1.095 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.799 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.507 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 7.2 Cg_exo -68.29 151.68 76.3 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.496 2.13 . . . . 0.0 111.445 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.501 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 32.0 t -51.99 -32.65 34.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.572 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.596 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 13.5 pt-20 -66.26 -33.06 74.9 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.815 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.596 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 90.6 mttt -106.56 -1.04 23.4 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.371 0.605 . . . . 0.0 110.518 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.519 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 24.0 tt0 -90.21 123.62 34.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.109 -168.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.476 ' O ' HG23 ' C' ' 85' ' ' VAL . 29.1 mtm105 -121.77 115.4 22.6 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.402 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 53.5 mt -87.94 122.68 31.84 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 122.452 0.301 . . . . 0.0 110.968 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.539 HD13 ' HB3' ' A' ' 38' ' ' GLU . 8.8 mt -114.63 112.07 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 121.494 -0.754 . . . . 0.0 111.39 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.5 ' CG ' HG12 ' C' ' 77' ' ' VAL . 41.0 t80 -116.62 133.12 56.39 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . 0.486 ' HG2' ' CD2' ' C' ' 61' ' ' TYR . 2.3 pt20 39.55 46.14 1.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.142 0.901 . . . . 0.0 112.153 -174.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.71 5.2 63.61 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.864 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -94.85 141.64 28.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.88 98.39 7.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.175 0.512 . . . . 0.0 109.951 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.54 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.0 OUTLIER -90.26 152.09 21.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.228 -176.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -158.14 -166.79 2.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.32 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.621 ' HA ' HG13 ' C' ' 39' ' ' VAL . 5.1 p-10 -62.49 0.54 0.46 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.052 0.941 . . . . 0.0 112.592 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.59 -11.65 0.96 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.376 1.071 . . . . 0.0 112.957 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.548 ' H ' HG11 ' C' ' 39' ' ' VAL . 7.8 mtmp? 84.55 167.43 0.09 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.481 1.112 . . . . 0.0 113.429 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 68.29 83.79 0.16 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.053 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.754 HD13 HG21 ' C' ' 33' ' ' VAL . 13.6 mt -64.47 -32.19 73.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.513 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . 0.428 ' H ' ' HG2' ' C' ' 73' ' ' GLN . 4.6 pt20 -68.83 -29.07 67.33 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.641 -176.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.49 -27.73 67.25 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.54 ' CD1' HD22 ' C' ' 66' ' ' LEU . 30.7 m-85 -82.96 -23.11 33.56 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.5 t30 63.44 36.67 11.2 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.707 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.614 HG23 HG22 ' C' ' 19' ' ' VAL . 20.0 m -85.25 26.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.646 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -86.09 102.36 2.68 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-O 122.926 1.292 . . . . 0.0 113.441 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.89 13.26 56.83 Favored Glycine 0 C--N 1.285 -2.29 0 CA-C-N 112.266 -1.967 . . . . 0.0 114.022 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -133.58 152.53 51.91 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 18.4 m -79.11 126.07 38.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.904 0.859 . . . . 0.0 112.62 -175.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.621 ' HB ' HG22 ' C' ' 21' ' ' VAL . 46.2 mt -71.21 161.68 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.339 168.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.432 ' N ' HG22 ' C' ' 82' ' ' ILE . 45.5 m80 -116.01 113.0 22.63 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 171.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.446 ' CD1' HG11 ' C' ' 50' ' ' VAL . 1.6 mt -85.84 157.86 20.11 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.504 -176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.535 HG13 ' CE1' ' A' ' 14' ' ' HIS . 2.7 t . . . . . 0 C--N 1.32 -0.717 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 10.9 ptt180 . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.852 0.834 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.544 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 8.6 m-85 -122.43 174.05 7.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.701 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CB ' HD11 ' A' ' 40' ' ' LEU . 79.1 t80 -142.05 121.27 13.04 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.119 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -100.98 120.29 39.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.812 176.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.521 ' CD2' HG21 ' C' ' 85' ' ' VAL . 62.6 m-70 -74.43 -16.24 60.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.565 -175.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.97 -35.8 72.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.42 ' O ' HG23 ' A' ' 18' ' ' VAL . 88.0 m -91.71 -23.84 19.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.313 0.578 . . . . 0.0 110.319 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.411 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER 56.23 31.42 18.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.421 -173.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 16' ' ' CYS . 39.7 t -136.82 148.31 26.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.763 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 32.3 tt0 -67.19 147.34 53.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.895 0.379 . . . . 0.0 111.326 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.773 ' CD1' HG21 ' A' ' 37' ' ' ILE . 4.2 pt -139.89 168.73 17.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.564 -175.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.471 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 94.0 t -126.4 101.29 28.04 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 162.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 6.0 Cg_endo -56.39 174.77 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 125.273 3.982 . . . . 0.0 116.736 -171.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.505 ' HB2' HG13 ' A' ' 28' ' ' ILE . 8.6 mtt180 -107.25 47.2 0.89 Allowed 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.875 175.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 1.6 -61.73 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.941 0 CA-C-N 110.783 -2.917 . . . . 0.0 116.912 175.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 39.2 Cg_exo -30.24 -34.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 124.017 3.145 . . . . 0.0 114.904 175.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.571 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.86 -19.65 9.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 54.7 m-85 68.79 47.62 0.81 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.41 -171.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -101.24 161.47 3.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.237 176.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.9 OUTLIER -97.35 145.54 29.83 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.759 ' HD3' HD12 ' A' ' 20' ' ' ILE . 83.2 Cg_endo -84.26 -15.61 6.44 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 C-N-CA 122.415 2.077 . . . . 0.0 108.864 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.542 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 60.1 mtt-85 -85.12 -21.37 29.3 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.354 -1.748 . . . . 0.0 114.074 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.2 p -149.03 -7.25 0.37 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 58.22 30.81 19.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.803 0.811 . . . . 0.0 111.207 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.7 m -112.47 139.22 48.23 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.583 172.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.38 53.72 4.69 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.419 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 84.5 m-85 -112.18 46.67 1.13 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.413 0.625 . . . . 0.0 110.011 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.773 HG21 ' CD1' ' A' ' 20' ' ' ILE . 3.4 pt -112.15 138.54 40.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.41 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HB2' HG22 ' C' ' 65' ' ' VAL . 11.2 pt-20 -117.18 141.92 47.68 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -73.6 142.74 46.55 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.161 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.948 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.8 OUTLIER -102.86 131.03 50.05 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 111.456 -172.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.593 ' HA ' HG13 ' C' ' 32' ' ' ILE . 41.9 tt0 -88.01 94.43 9.79 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 5.6 t -80.75 104.87 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.513 -173.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.728 ' HB3' HG12 ' C' ' 81' ' ' VAL . 1.0 OUTLIER -94.13 141.87 28.05 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 174.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' C' ' 82' ' ' ILE . 78.9 t -150.36 121.32 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.328 0.513 . . . . 0.0 110.585 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 26.2 mtpt -108.36 164.37 12.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.494 0.664 . . . . 0.0 110.669 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 48.7 p . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.663 167.631 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 61.2 m . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -118.95 159.69 23.36 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.869 -1.132 . . . . 0.0 112.215 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 1.4 p -100.66 139.65 36.04 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.947 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.625 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 23.3 m-85 -133.83 55.86 1.88 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.231 -171.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.593 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -54.55 123.11 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 123.38 1.562 . . . . 0.0 113.979 -174.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.453 HG21 HD22 ' C' ' 72' ' ' LEU . 11.2 m -126.87 -175.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 110.961 -2.836 . . . . 0.0 111.196 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.65 52.72 0.8 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.512 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.948 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 71.01 -29.29 0.19 Allowed 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 167.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -162.19 23.83 0.11 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -172.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . 0.551 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 16.0 tpt -72.2 -69.24 0.41 Allowed 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 111.754 -2.476 . . . . 0.0 111.435 -171.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.551 ' OD1' ' HG3' ' C' ' 37' ' ' MET . 24.8 m120 -129.18 -82.86 0.57 Allowed 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.09 0.472 . . . . 0.0 111.229 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.709 ' O ' ' HD2' ' C' ' 43' ' ' LYS . 0.4 OUTLIER 74.36 -31.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.744 -165.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' C' ' 43' ' ' LYS . 0.1 OUTLIER -84.15 -67.94 0.75 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.489 1.138 . . . . 0.0 109.661 178.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.17 -25.7 61.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.235 170.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.672 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 1.2 t80 -60.74 -48.63 80.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.425 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.709 ' HD2' ' O ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -53.15 -48.92 67.55 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.862 0.839 . . . . 0.0 109.037 173.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -35.47 74.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.887 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -69.16 -50.95 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.098 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.609 ' O ' HG22 ' C' ' 50' ' ' VAL . 25.5 pt -78.88 -12.44 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.85 -59.3 1.46 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.14 75.34 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.269 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -34.51 72.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.887 0.375 . . . . 0.0 111.113 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.609 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.8 m -100.39 -3.01 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.228 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 26.4 t 69.16 19.75 7.83 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 121.752 0.787 . . . . 0.0 109.287 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.3 mm -128.36 117.67 20.17 Favored Pre-proline 0 N--CA 1.442 -0.836 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.627 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.538 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.0 Cg_exo -65.52 149.37 87.75 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.924 1.749 . . . . 0.0 113.149 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.465 ' CB ' ' HB3' ' C' ' 43' ' ' LYS . 2.2 p -53.37 -29.94 37.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.463 -1.698 . . . . 0.0 113.375 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.8 pt-20 -82.07 -7.47 59.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.65 -176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.57 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 96.0 mttt -125.13 -31.31 3.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.567 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.608 ' OE1' ' HG3' ' C' ' 43' ' ' LYS . 3.3 pt20 -62.6 136.92 58.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.304 0.573 . . . . 0.0 111.185 -174.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -121.49 129.93 53.24 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.798 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' C' ' 66' ' ' LEU . 4.2 mp -91.18 134.57 34.43 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.56 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.3 mt -126.76 115.06 40.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.334 0.588 . . . . 0.0 112.001 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -124.11 116.59 23.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.518 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 61.02 34.87 19.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.494 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.16 -7.39 60.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.483 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 10.1 mmm180 -85.39 127.62 34.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -86.11 91.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.084 0.469 . . . . 0.0 110.227 -176.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.691 HD22 ' CD1' ' C' ' 75' ' ' TYR . 1.6 mt -73.24 136.54 44.65 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . 0.493 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 8.5 pt20 -149.89 -168.31 3.07 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.275 -171.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.566 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.8 p-10 -66.42 -0.43 2.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.064 0.946 . . . . 0.0 112.629 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . 0.493 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 9.2 t70 -69.07 2.46 2.74 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.734 0.813 . . . . 0.0 112.62 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.52 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.8 mtpt 72.74 -177.37 0.19 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.155 175.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 70.58 66.84 0.19 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.979 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.533 ' HA ' ' CD2' ' C' ' 75' ' ' TYR . 6.6 mt -64.12 -41.84 97.08 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.549 -175.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . 0.461 ' H ' ' HG2' ' C' ' 73' ' ' GLN . 3.7 pt20 -71.13 -18.27 62.53 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -70.07 -27.69 64.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.691 ' CD1' HD22 ' C' ' 66' ' ' LEU . 22.5 m-85 -74.17 -24.22 59.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 t30 64.09 36.49 9.7 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 123.392 1.568 . . . . 0.0 107.403 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.466 ' CG1' HG22 ' C' ' 19' ' ' VAL . 0.5 OUTLIER -96.41 0.79 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.059 -161.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.578 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -70.41 102.27 1.0 Allowed Glycine 0 N--CA 1.432 -1.591 0 CA-C-O 122.723 1.18 . . . . 0.0 112.824 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.68 13.84 26.83 Favored Glycine 0 C--N 1.283 -2.413 0 CA-C-N 112.24 -1.98 . . . . 0.0 114.325 173.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -124.78 154.36 41.06 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.728 HG12 ' HB3' ' C' ' 20' ' ' LEU . 2.8 m -85.28 131.02 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.093 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.661 HD13 HD12 ' C' ' 66' ' ' LEU . 56.5 mt -83.96 160.56 3.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.246 172.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.446 ' N ' HG22 ' C' ' 82' ' ' ILE . 67.4 m170 -109.22 112.49 24.68 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 166.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.446 HD22 HG12 ' C' ' 21' ' ' VAL . 0.6 OUTLIER -101.15 153.66 19.4 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.426 -0.91 . . . . 0.0 108.618 172.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.521 HG21 ' CD2' ' A' ' 14' ' ' HIS . 17.3 m . . . . . 0 C--N 1.308 -1.221 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.208 -174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.474 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 94.5 mtt180 . . . . . 0 C--O 1.224 -0.264 0 CA-C-O 120.688 0.28 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.67 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 14.2 m-85 -115.15 149.45 37.61 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.952 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.544 ' CB ' HD21 ' A' ' 40' ' ' LEU . 71.7 t80 -124.73 120.01 30.57 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.72 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -96.22 121.09 37.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -73.22 -20.22 60.92 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.388 -173.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -71.15 -30.86 66.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.851 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' O ' HG23 ' A' ' 18' ' ' VAL . 53.4 m -90.94 -18.42 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.475 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.8 p 51.49 30.28 6.18 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.888 0.742 . . . . 0.0 110.843 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 16' ' ' CYS . 73.9 t -144.73 145.71 20.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 20' ' ' ILE . 26.3 tt0 -74.96 151.98 38.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.109 0.481 . . . . 0.0 111.779 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.754 HD12 ' HD3' ' A' ' 30' ' ' PRO . 3.7 pt -138.24 168.51 19.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.958 -171.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.46 109.98 36.12 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 159.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.67 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 18.1 Cg_endo -69.94 174.92 8.96 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 124.45 3.433 . . . . 0.0 115.736 -166.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.493 ' HB2' HG13 ' A' ' 28' ' ' ILE . 75.9 mtt180 -106.64 47.69 0.87 Allowed 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.856 -1.975 . . . . 0.0 106.768 174.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -8.34 -55.9 0.01 OUTLIER Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 110.673 -2.967 . . . . 0.0 116.517 174.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 45.8 Cg_exo -34.13 -35.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 123.255 2.637 . . . . 0.0 114.34 175.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.566 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.19 -19.34 10.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.319 0.58 . . . . 0.0 111.839 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 68.41 55.3 0.51 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.991 -169.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -109.63 163.1 6.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.561 175.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -95.19 146.32 31.12 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.754 ' HD3' HD12 ' A' ' 20' ' ' ILE . 52.8 Cg_endo -82.82 -21.88 4.65 Favored 'Trans proline' 0 CA--C 1.504 -0.993 0 C-N-CA 123.202 2.601 . . . . 0.0 108.47 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.4 mtt-85 -79.29 -29.06 42.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.835 -1.984 . . . . 0.0 113.377 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.0 p -147.9 -3.84 0.51 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.69 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 14.7 tt0 60.15 40.51 18.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.067 0.461 . . . . 0.0 111.832 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.4 p -112.59 155.82 23.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.87 44.13 2.09 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.798 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 86.6 m-85 -109.13 47.5 0.92 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.293 0.568 . . . . 0.0 110.158 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.624 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.7 pt -111.86 147.43 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.272 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.532 ' HB2' HG22 ' C' ' 65' ' ' VAL . 12.6 pt-20 -135.57 147.17 48.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.594 0.235 . . . . 0.0 110.804 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.26 144.81 55.72 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 ' CB ' ' A' ' 12' ' ' PHE . 13.5 mt . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.028 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.465 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 50.2 ttm . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.648 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 0.9 OUTLIER -101.45 132.12 47.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.584 ' HA ' HG13 ' C' ' 32' ' ' ILE . 30.6 mt-10 -83.87 94.72 8.28 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.554 HG11 ' CZ ' ' C' ' 42' ' ' PHE . 5.4 t -79.23 92.65 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.098 -172.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 1.5 mp -85.24 133.16 34.18 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' C' ' 82' ' ' ILE . 71.1 t -141.58 116.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 40.7 mtpt -88.29 153.58 21.09 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 C--N 1.309 -1.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.397 -178.292 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 39.1 m . . . . . 0 C--O 1.233 0.185 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -118.48 149.55 41.09 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.376 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -106.52 141.94 36.99 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.178 0.513 . . . . 0.0 111.777 -174.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.478 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 35.9 m-85 -130.9 60.18 1.66 Allowed 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.722 -174.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.584 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -56.58 121.32 4.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 123.338 1.542 . . . . 0.0 114.48 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.87 -166.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 111.038 -2.801 . . . . 0.0 111.57 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -95.62 -170.82 35.89 Favored Glycine 0 C--N 1.312 -0.758 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.396 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.809 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . -103.9 83.24 2.09 Favored 'General case' 0 CA--C 1.477 -1.855 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.809 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 23.7 mt-30 108.6 15.88 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 O-C-N 126.599 2.437 . . . . 0.0 107.795 170.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -76.79 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.063 -2.335 . . . . 0.0 111.528 171.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.486 ' CG ' ' HB2' ' C' ' 41' ' ' GLU . 13.0 m120 -123.55 -98.5 0.43 Allowed 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.596 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 84.22 -35.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 123.931 0.892 . . . . 0.0 110.648 -162.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.535 ' HA ' ' CB ' ' C' ' 68' ' ' ASP . 0.0 OUTLIER -81.43 -69.53 0.6 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.3 1.048 . . . . 0.0 108.959 177.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . 0.486 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 43.3 mt-10 -61.12 -28.95 69.47 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.012 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.596 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.1 t80 -61.1 -51.61 68.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.406 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 52.3 mtpt -58.5 -45.53 88.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.445 0.641 . . . . 0.0 110.358 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -59.79 -34.83 73.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.207 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -70.12 -47.76 60.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.789 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.57 ' O ' HG22 ' C' ' 50' ' ' VAL . 24.2 pt -75.04 -16.96 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.971 -0.104 . . . . 0.0 111.133 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -39.92 -61.0 0.91 Allowed 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -176.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.4 77.48 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.371 -0.532 . . . . 0.0 112.376 -173.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -26.73 68.46 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.181 0.515 . . . . 0.0 110.832 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.57 HG22 ' O ' ' C' ' 46' ' ' ILE . 22.2 m -104.66 -0.77 10.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.849 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 55.1 p 66.16 20.27 11.14 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.766 0.826 . . . . 0.0 109.842 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.7 mm -128.82 112.59 18.88 Favored Pre-proline 0 N--CA 1.437 -1.123 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.073 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.586 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.9 Cg_exo -69.29 146.78 64.22 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.471 2.114 . . . . 0.0 111.284 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.452 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 44.2 t -51.95 -25.97 9.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.347 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.5 pt-20 -79.51 -24.52 42.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.706 0.288 . . . . 0.0 111.342 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.484 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 48.2 mtpt -106.79 -16.27 14.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.854 0.359 . . . . 0.0 110.363 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.534 ' OE1' HD11 ' C' ' 46' ' ' ILE . 0.0 OUTLIER -87.25 148.86 24.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.726 -174.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -139.03 132.25 29.84 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.587 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 52.7 mt -90.67 109.68 20.85 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.598 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.3 mt -106.39 113.73 43.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.263 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.582 ' OH ' ' HD3' ' C' ' 80' ' ' LYS . 50.3 t80 -118.03 127.82 54.17 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . 0.462 ' HG2' ' CD2' ' C' ' 61' ' ' TYR . 3.5 pt20 40.98 46.77 2.5 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.028 0.931 . . . . 0.0 112.244 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.28 5.87 78.26 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.686 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -99.4 134.88 41.62 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 38' ' ' GLU . 2.1 t -88.96 90.07 3.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.078 0.466 . . . . 0.0 109.746 -177.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.597 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -73.91 132.14 42.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -144.83 173.01 12.23 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.201 -171.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.535 ' CB ' ' HA ' ' C' ' 40' ' ' LYS . 5.9 p-10 -70.73 -2.86 16.01 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.896 0.879 . . . . 0.0 113.06 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.25 -15.63 49.53 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.179 -0.326 . . . . 0.0 111.609 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.498 ' HB3' ' OE1' ' C' ' 74' ' ' GLU . 4.0 mtpm? -122.44 -151.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.52 -169.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.504 ' HB2' ' HG3' ' C' ' 74' ' ' GLU . 97.7 mttt -125.25 151.14 46.33 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.838 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.493 HD23 HG23 ' C' ' 39' ' ' VAL . 35.5 mt -57.32 -53.11 61.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . 0.571 ' CB ' ' HG3' ' C' ' 36' ' ' GLN . 53.2 tt0 -71.54 -14.4 62.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.565 -170.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' C' ' 71' ' ' LYS . 46.2 mt-10 -63.09 -29.24 70.65 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.597 ' CD1' HD22 ' C' ' 66' ' ' LEU . 60.5 m-85 -93.91 -21.24 19.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.2 t30 52.87 52.16 14.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.588 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.441 HG21 HD11 ' C' ' 82' ' ' ILE . 29.9 m -93.27 19.85 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.307 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.648 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -75.18 102.39 1.45 Allowed Glycine 0 CA--C 1.482 -2.01 0 CA-C-O 122.483 1.046 . . . . 0.0 111.713 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.12 14.97 46.65 Favored Glycine 0 C--N 1.281 -2.481 0 CA-C-N 112.562 -1.819 . . . . 0.0 112.107 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . 0.582 ' HD3' ' OH ' ' C' ' 61' ' ' TYR . 81.2 mttt -123.46 142.33 51.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 16.3 m -82.35 133.91 28.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.907 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' C' ' 21' ' ' VAL . 29.1 mt -92.56 170.19 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.265 175.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.486 ' N ' HG22 ' C' ' 82' ' ' ILE . 70.5 m80 -118.56 114.49 22.88 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.531 HD11 HD12 ' C' ' 46' ' ' ILE . 0.9 OUTLIER -89.79 141.45 28.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.383 0.611 . . . . 0.0 111.743 178.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.671 -178.191 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 10' ' ' ARG . 10.6 ptt180 . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 121.471 0.653 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.686 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 14.3 m-85 -120.17 167.24 12.44 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.401 ' CB ' HD11 ' A' ' 40' ' ' LEU . 65.7 t80 -140.35 114.56 9.15 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.446 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -95.44 114.97 26.79 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.567 174.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -69.9 -18.09 63.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.118 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.545 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 43.9 t -68.66 -35.44 77.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.081 0.467 . . . . 0.0 110.708 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.443 ' O ' HG23 ' A' ' 18' ' ' VAL . 92.6 m -95.16 -15.26 23.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.817 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.5 p 51.57 29.87 5.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.237 1.015 . . . . 0.0 111.582 -173.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 16' ' ' CYS . 97.2 t -139.39 147.25 24.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.761 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.66 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 31.4 tt0 -67.48 149.15 50.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.17 0.509 . . . . 0.0 111.092 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.809 HD11 HG21 ' A' ' 37' ' ' ILE . 3.5 pt -138.68 167.36 21.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.856 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 19.4 t -122.64 96.23 45.79 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 164.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.686 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 9.5 Cg_endo -58.36 176.48 0.39 Allowed 'Trans proline' 0 C--N 1.325 -0.697 1 C-N-CA 125.349 4.033 . . . . 0.0 117.776 -167.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.525 ' C ' ' HD2' ' A' ' 25' ' ' PRO . 40.2 mtt180 -112.25 51.42 0.81 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.764 -2.471 . . . . 0.0 106.848 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -7.32 -53.73 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.911 0 CA-C-N 111.705 -2.498 . . . . 0.0 115.965 172.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.525 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 24.1 Cg_exo -31.17 -39.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.398 2.732 . . . . 0.0 114.204 174.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.56 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -120.03 -16.64 8.57 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.296 0.57 . . . . 0.0 111.342 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.473 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 66.3 m-85 70.87 52.26 0.29 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.018 -1.447 . . . . 0.0 109.728 -169.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.56 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -106.38 162.26 5.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.165 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -98.23 149.2 35.49 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 62.2 Cg_endo -83.88 -18.73 5.28 Favored 'Trans proline' 0 CA--C 1.501 -1.135 0 C-N-CA 123.117 2.545 . . . . 0.0 108.59 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.5 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 56.0 mtt180 -88.58 -11.89 44.25 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.07 -1.877 . . . . 0.0 114.192 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 p -156.77 -11.43 0.09 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 61.16 29.48 18.83 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.558 0.694 . . . . 0.0 111.171 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.5 m -107.18 142.94 36.1 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -79.55 38.07 2.08 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.507 -175.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 50.9 m-85 -93.49 39.93 1.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.744 0.307 . . . . 0.0 111.054 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.809 HG21 HD11 ' A' ' 20' ' ' ILE . 6.1 pt -109.87 141.51 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.505 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.2 pt-20 -117.37 144.16 45.23 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 169.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -79.72 129.5 34.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.401 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.909 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 47.0 tpp . . . . . 0 C--O 1.234 0.281 0 CA-C-O 120.975 0.417 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.757 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -91.69 146.55 23.68 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' C' ' 32' ' ' ILE . 15.1 mt-10 -95.04 91.48 6.37 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 169.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.6 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 4.9 t -78.38 105.21 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.2 -170.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.631 ' C ' ' HA ' ' C' ' 81' ' ' VAL . 0.5 OUTLIER -96.25 142.58 28.23 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 175.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' C' ' 82' ' ' ILE . 54.7 t -148.05 124.53 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.899 0.381 . . . . 0.0 110.628 -173.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.493 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 43.0 mtpt -105.06 141.3 36.87 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.547 176.34 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 51.0 m . . . . . 0 C--O 1.236 0.344 0 CA-C-O 120.601 0.239 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -127.36 155.83 42.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.814 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.571 HG22 ' CD2' ' C' ' 20' ' ' LEU . 11.8 p -95.49 142.01 28.35 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 121.382 0.611 . . . . 0.0 112.223 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.6 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 25.6 m-85 -132.72 56.17 1.86 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.224 -174.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.592 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -56.87 121.17 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 123.353 1.549 . . . . 0.0 114.412 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.7 m -140.43 -163.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 110.777 -2.919 . . . . 0.0 111.307 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.51 165.48 19.24 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.154 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.757 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -68.43 -16.2 63.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.637 0.732 . . . . 0.0 112.16 -175.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -158.8 25.33 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -167.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 51.0 ttm -79.47 -72.64 0.38 Allowed 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 111.699 -2.501 . . . . 0.0 110.928 -176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.528 ' O ' HG12 ' C' ' 39' ' ' VAL . 12.3 m120 -125.51 -99.51 0.4 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.712 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 83.88 -29.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 C-N-CA 125.161 1.385 . . . . 0.0 111.502 -162.094 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.74 -68.13 0.74 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.346 1.07 . . . . 0.0 109.122 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.55 -30.34 69.71 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.949 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.658 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 7.0 t80 -58.34 -51.08 71.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.848 174.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.605 ' HB3' ' OE1' ' C' ' 57' ' ' GLN . 47.8 mtpt -61.24 -47.01 88.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.109 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -56.53 -36.8 69.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.892 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -70.6 -43.79 68.62 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.649 ' O ' HG22 ' C' ' 50' ' ' VAL . 22.1 pt -77.77 -8.51 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -175.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.03 -56.83 1.77 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.74 -36.79 50.37 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.272 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -33.06 71.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.018 0.437 . . . . 0.0 110.9 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.649 HG22 ' O ' ' C' ' 46' ' ' ILE . 34.5 m -105.38 -2.63 9.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.885 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 59.6 p 64.78 21.23 12.33 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 122.003 0.906 . . . . 0.0 109.298 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.2 mm -122.63 117.21 28.98 Favored Pre-proline 0 N--CA 1.439 -0.976 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.302 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.569 ' O ' ' HG3' ' C' ' 57' ' ' GLN . 4.6 Cg_exo -71.76 150.16 55.62 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.961 1.774 . . . . 0.0 112.226 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.632 ' HA ' ' OE1' ' C' ' 57' ' ' GLN . 0.9 OUTLIER -52.12 -25.17 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.096 -176.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.547 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.4 pt-20 -74.67 -26.91 60.17 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.207 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.547 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 47.9 mttm -105.66 -25.01 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.688 0.28 . . . . 0.0 111.526 -173.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.632 ' OE1' ' HA ' ' C' ' 54' ' ' SER . 88.9 mt-30 -56.55 126.17 25.39 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.895 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -122.95 110.14 15.01 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' C' ' 82' ' ' ILE . 1.1 mm? -87.11 112.48 21.96 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.512 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.7 mt -110.33 120.61 61.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 121.809 -0.557 . . . . 0.0 111.024 175.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -128.75 134.61 48.48 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . 0.402 HE21 ' HB2' ' C' ' 62' ' ' GLN . 2.3 pt20 41.97 42.38 2.29 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.987 0.804 . . . . 0.0 111.732 -173.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.98 4.02 61.62 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.593 -0.731 . . . . 0.0 113.608 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -96.15 130.82 43.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.3 99.22 9.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.297 0.57 . . . . 0.0 110.451 -175.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.505 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -86.16 154.66 21.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.054 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -165.91 -169.77 1.59 Allowed 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.958 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.712 ' HA ' HG13 ' C' ' 39' ' ' VAL . 5.1 p-10 -64.94 -1.4 2.0 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.902 0.881 . . . . 0.0 113.123 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.97 -7.2 3.52 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.42 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.8 mttp 88.22 170.57 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.48 1.112 . . . . 0.0 111.827 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.543 ' HB3' ' HG2' ' C' ' 74' ' ' GLU . 13.5 mmmm 71.45 79.52 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.617 177.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.612 HD21 HG23 ' C' ' 39' ' ' VAL . 37.2 mt -68.82 -29.22 67.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.849 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . 0.436 ' HB2' ' HB1' ' C' ' 35' ' ' ALA . 46.8 tt0 -68.52 -27.17 65.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.401 . . . . 0.0 111.364 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . 0.543 ' HG2' ' HB3' ' C' ' 71' ' ' LYS . 58.8 mm-40 -63.48 -27.12 69.06 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.546 ' CD2' ' HA ' ' C' ' 72' ' ' LEU . 7.8 m-85 -90.17 -23.07 21.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 55.31 46.79 22.82 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.198 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.444 HG23 HG22 ' C' ' 19' ' ' VAL . 33.1 m -93.66 4.36 7.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 119.957 -0.697 . . . . 0.0 112.862 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.669 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -56.22 100.37 0.1 Allowed Glycine 0 CA--C 1.491 -1.435 0 CA-C-O 122.918 1.288 . . . . 0.0 113.68 171.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.47 14.8 49.42 Favored Glycine 0 C--N 1.289 -2.076 0 CA-C-N 111.367 -2.417 . . . . 0.0 113.534 173.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -124.37 139.91 53.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.545 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.631 ' HA ' ' C ' ' C' ' 20' ' ' LEU . 22.2 m -80.08 126.48 39.39 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.748 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' C' ' 21' ' ' VAL . 60.9 mt -83.11 167.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.452 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.509 ' N ' HG22 ' C' ' 82' ' ' ILE . 42.9 m80 -114.42 114.63 26.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 171.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.436 HD12 ' N ' ' C' ' 85' ' ' VAL . 15.8 tp -97.23 133.01 42.43 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.203 0.525 . . . . 0.0 110.135 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.436 ' N ' HD12 ' C' ' 84' ' ' LEU . 25.2 m . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.367 -177.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 121.19 0.519 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.738 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.9 m-85 -124.93 151.96 44.73 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 172.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -124.04 118.29 26.64 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.262 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -96.37 117.67 31.32 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.048 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.737 ' CG ' HG13 ' C' ' 85' ' ' VAL . 12.6 p80 -75.07 -10.68 59.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.89 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 49.7 t -71.97 -37.52 69.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.159 0.505 . . . . 0.0 109.727 175.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.3 m -91.0 -27.94 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.182 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.86 32.05 21.39 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.267 -171.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.56 144.45 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -71.83 146.5 47.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.234 0.54 . . . . 0.0 111.093 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.795 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.5 pt -134.04 166.71 28.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.266 -171.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -118.44 110.22 39.4 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 158.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.738 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 12.1 Cg_endo -69.28 176.16 6.77 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.441 3.427 . . . . 0.0 114.777 -170.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.678 ' HB2' HG13 ' A' ' 28' ' ' ILE . 40.7 mtt180 -107.02 47.77 0.87 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 113.532 -1.667 . . . . 0.0 106.707 175.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.64 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 1.6 mm? 0.82 -62.62 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.147 0 CA-C-N 111.032 -2.804 . . . . 0.0 117.107 174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 22.1 Cg_exo -35.21 -35.04 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.949 2.433 . . . . 0.0 113.611 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.582 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -112.76 -22.84 10.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.631 -177.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 22.5 m-85 68.48 45.25 1.16 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.026 0.917 . . . . 0.0 110.528 -170.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.678 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -97.53 162.01 2.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.517 172.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.4 t -97.08 146.07 30.69 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.795 ' HD3' HD12 ' A' ' 20' ' ' ILE . 66.9 Cg_endo -79.84 -23.15 7.04 Favored 'Trans proline' 0 CA--C 1.498 -1.315 0 C-N-CA 122.582 2.188 . . . . 0.0 107.785 -174.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.594 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 91.2 mtt-85 -79.21 -35.34 41.84 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 112.683 -2.053 . . . . 0.0 113.556 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.2 p -135.76 -7.74 2.15 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.582 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 11.3 tt0 56.95 31.08 19.17 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.507 0.67 . . . . 0.0 111.511 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.3 m -110.72 145.97 37.11 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.321 170.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.6 52.99 4.81 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.372 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 72.2 m-85 -109.0 43.86 1.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.551 -0.382 . . . . 0.0 110.684 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.68 HG21 ' CD1' ' A' ' 20' ' ' ILE . 11.7 pt -114.31 139.96 37.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.255 -175.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.06 155.52 30.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.36 127.84 39.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.381 0.61 . . . . 0.0 110.747 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.007 -170.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 73.7 mtm . . . . . 0 N--CA 1.463 0.225 0 CA-C-O 121.15 0.5 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.856 HD22 ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -98.58 149.05 23.17 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 172.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' C' ' 32' ' ' ILE . 34.2 tt0 -102.17 87.92 3.19 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' C' ' 30' ' ' THR . 2.4 t -77.41 127.05 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.025 -167.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.703 ' HB3' HG12 ' C' ' 81' ' ' VAL . 1.0 OUTLIER -113.05 147.91 36.25 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 170.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' C' ' 82' ' ' ILE . 66.0 t -153.83 114.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -171.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 38.7 mtpt -99.96 172.1 7.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.371 0.605 . . . . 0.0 110.28 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . 0.442 HG23 HD12 ' C' ' 84' ' ' LEU . 6.1 p . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.814 172.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 53.8 m . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -120.49 158.58 26.96 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.15 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 4.2 p -104.26 147.67 27.22 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.527 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 42.1 m-85 -140.96 63.82 1.44 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.487 0.66 . . . . 0.0 110.314 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.59 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.4 mp -54.88 125.4 9.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 123.215 1.483 . . . . 0.0 114.458 -174.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.562 HG21 HD13 ' C' ' 72' ' ' LEU . 15.4 m -131.81 -170.47 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 111.507 -2.588 . . . . 0.0 111.927 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -113.17 40.27 2.57 Favored Glycine 0 C--N 1.317 -0.498 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.706 -175.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.856 ' HA ' HD22 ' C' ' 17' ' ' LEU . . . 68.9 -50.43 0.59 Allowed 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 124.224 1.01 . . . . 0.0 113.529 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -130.72 23.44 5.03 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . 0.412 ' HB2' ' H ' ' C' ' 34' ' ' GLY . 2.1 ttt -66.16 -72.27 0.17 Allowed 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.93 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.602 ' O ' ' HD2' ' C' ' 40' ' ' LYS . 17.9 m120 -129.04 -91.1 0.48 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.613 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.5 OUTLIER 85.19 -40.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 O-C-N 124.5 1.125 . . . . 0.0 110.814 -164.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.602 ' HD2' ' O ' ' C' ' 38' ' ' ASN . 0.0 OUTLIER -74.14 -69.48 0.44 Allowed 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 122.449 1.118 . . . . 0.0 108.594 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.08 -26.52 68.59 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.186 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.613 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 5.8 t80 -59.2 -52.65 64.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.753 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.532 ' HD3' ' HB3' ' C' ' 68' ' ' ASP . 7.1 ptmm? -68.58 -38.73 80.94 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.355 0.598 . . . . 0.0 110.974 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' C' ' 54' ' ' SER . 1.3 tm-20 -54.56 -41.52 69.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.138 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -69.67 -51.57 33.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.539 ' O ' HG22 ' C' ' 50' ' ' VAL . 22.5 pt -70.69 -10.01 13.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.341 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.61 -36.63 0.61 Allowed 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.45 -50.57 11.43 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.944 -0.473 . . . . 0.0 111.938 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -28.41 69.47 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.23 0.538 . . . . 0.0 110.79 -176.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.539 HG22 ' O ' ' C' ' 46' ' ' ILE . 6.7 m -96.34 -11.46 8.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.542 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 18.6 m 68.36 19.79 8.82 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 121.55 0.69 . . . . 0.0 109.91 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 3.6 mm -129.35 118.21 19.07 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.856 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.467 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.9 Cg_exo -67.29 148.5 80.2 Favored 'Trans proline' 0 CA--C 1.514 -0.475 0 C-N-CA 122.27 1.98 . . . . 0.0 111.147 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.455 ' OG ' ' HG3' ' C' ' 43' ' ' LYS . 41.8 t -51.19 -33.26 26.66 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.155 0.285 . . . . 0.0 111.748 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.466 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 8.5 pt-20 -66.42 -30.19 70.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.782 0.325 . . . . 0.0 111.441 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.466 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 55.7 mtpt -101.11 -23.79 14.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.071 0.462 . . . . 0.0 110.281 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.44 ' HB2' HG22 ' C' ' 52' ' ' ILE . 7.1 tt0 -76.19 119.44 20.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.058 -172.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -113.91 123.08 48.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.277 170.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.667 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 19.4 mt -89.79 113.87 25.49 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 37' ' ' ILE . 9.2 mt -108.36 126.44 65.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 121.289 -0.882 . . . . 0.0 111.424 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.509 ' CZ ' ' HB3' ' C' ' 80' ' ' LYS . 31.0 t80 -139.12 127.26 22.52 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 169.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 60.67 35.84 19.7 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.547 0.529 . . . . 0.0 110.549 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 71.33 2.28 47.77 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.596 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -89.0 137.86 31.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.87 88.92 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -76.46 128.11 34.16 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -147.33 177.01 9.56 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.905 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.599 ' CB ' ' HA ' ' C' ' 40' ' ' LYS . 4.0 p-10 -65.69 -1.85 3.11 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.105 0.962 . . . . 0.0 113.469 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -81.48 -13.37 58.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -131.32 -154.44 0.63 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.912 -0.493 . . . . 0.0 112.053 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.403 ' HB2' ' HG2' ' C' ' 74' ' ' GLU . 0.3 OUTLIER -108.82 -179.67 3.93 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 175.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 2.9 mt -86.27 -34.09 20.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.025 0.44 . . . . 0.0 110.809 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.92 -23.72 66.01 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.403 0.681 . . . . 0.0 111.183 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . 0.403 ' HG2' ' HB2' ' C' ' 71' ' ' LYS . 20.0 mm-40 -59.39 -28.81 67.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.655 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.638 ' CD1' HD22 ' C' ' 66' ' ' LEU . 34.0 m-85 -105.16 -16.05 14.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.114 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 55.83 52.49 10.68 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.996 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.515 HG23 HG22 ' C' ' 19' ' ' VAL . 28.2 m -93.08 16.6 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.559 -174.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.654 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -64.41 101.47 0.51 Allowed Glycine 0 CA--C 1.481 -2.033 0 CA-C-O 122.774 1.208 . . . . 0.0 112.785 172.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.34 15.13 56.19 Favored Glycine 0 C--N 1.283 -2.378 0 CA-C-N 111.868 -2.166 . . . . 0.0 112.599 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . 0.509 ' HB3' ' CZ ' ' C' ' 61' ' ' TYR . 73.1 mmtt -116.37 145.32 43.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 118.85 -0.595 . . . . 0.0 109.638 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.703 HG12 ' HB3' ' C' ' 20' ' ' LEU . 3.1 m -86.7 130.17 37.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.379 173.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' C' ' 21' ' ' VAL . 56.3 mt -88.48 169.17 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.869 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.518 ' N ' HG22 ' C' ' 82' ' ' ILE . 58.4 m80 -112.45 121.94 46.27 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.442 HD12 HG23 ' C' ' 23' ' ' THR . 20.6 mt -78.32 152.71 32.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.971 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.737 HG13 ' CG ' ' A' ' 14' ' ' HIS . 5.7 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.773 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HG2' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.296 0 CA-C-O 121.897 0.856 . . . . 0.0 110.637 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.627 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 5.5 m-85 -118.45 169.8 9.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.264 175.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CB ' HD11 ' A' ' 40' ' ' LEU . 61.9 t80 -138.43 116.11 11.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.595 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -96.36 114.61 26.31 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.808 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.565 ' CD2' HG12 ' C' ' 85' ' ' VAL . 8.9 p80 -73.16 -8.69 56.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.702 0.286 . . . . 0.0 111.406 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 42.6 t -72.6 -32.7 66.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.359 0.6 . . . . 0.0 110.182 173.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.5 m -99.46 -25.9 14.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.391 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER 58.21 31.04 20.3 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.384 -171.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.65 144.75 34.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.5 tt0 -64.28 148.34 50.43 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.158 0.286 . . . . 0.0 110.745 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.711 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.2 pt -140.42 166.98 18.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.51 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 74.9 t -125.6 97.32 36.61 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 164.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.627 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 6.5 Cg_endo -55.94 174.91 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 125.06 3.84 . . . . 0.0 115.798 -171.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.495 ' HB2' HG13 ' A' ' 28' ' ' ILE . 5.3 mtt180 -108.62 49.85 0.8 Allowed 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.156 -1.838 . . . . 0.0 106.937 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.455 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.3 mm? 3.92 -61.98 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 110.952 -2.84 . . . . 0.0 117.049 171.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 15.8 Cg_exo -36.96 -33.44 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.69 2.26 . . . . 0.0 113.908 176.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.542 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.93 -22.38 9.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.326 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.461 ' C ' HD11 ' A' ' 37' ' ' ILE . 70.6 m-85 65.28 54.13 1.22 Allowed 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.171 0.986 . . . . 0.0 110.228 -169.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -104.93 161.13 4.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.985 176.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.7 t -96.28 145.84 30.26 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 81.7 Cg_endo -82.55 -20.52 5.69 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.702 2.268 . . . . 0.0 108.279 -174.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.416 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 18.2 mtt180 -89.37 -15.3 33.65 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 112.952 -1.931 . . . . 0.0 114.694 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.8 p -151.53 -8.09 0.23 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 10.1 tt0 60.79 25.2 15.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 111.586 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 m -103.36 141.89 35.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 169.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.59 30.87 2.49 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.268 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.528 ' HD2' ' NE2' ' A' ' 14' ' ' HIS . 35.8 m-85 -89.39 52.6 2.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.597 0.713 . . . . 0.0 110.146 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.711 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.6 pt -122.6 134.17 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.598 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HB3' HD13 ' C' ' 60' ' ' ILE . 11.4 pt-20 -119.75 144.03 47.48 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -75.81 138.49 41.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.531 ' HB2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.666 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.2 mt -109.12 134.76 51.28 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.427 0.632 . . . . 0.0 110.543 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.583 ' HA ' HG13 ' C' ' 32' ' ' ILE . 36.9 mt-10 -89.77 93.33 9.4 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.278 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 2.7 t -77.41 124.11 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -171.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.641 ' C ' ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -109.28 146.53 34.13 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 171.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.583 HG22 ' HB ' ' C' ' 82' ' ' ILE . 36.4 t -151.07 125.07 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -172.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.565 ' HE3' HG21 ' C' ' 81' ' ' VAL . 72.2 mttt -110.93 110.98 21.8 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.171 0.51 . . . . 0.0 110.789 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . 0.484 HG23 ' HB2' ' C' ' 84' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.425 0 CA-C-O 121.614 0.721 . . . . 0.0 110.289 164.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.51 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 71.8 m . . . . . 0 C--O 1.235 0.299 0 CA-C-O 120.958 0.409 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -135.28 159.04 42.8 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.223 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.541 HG22 ' CD2' ' C' ' 20' ' ' LEU . 8.5 p -96.23 148.55 22.61 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.837 -174.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.591 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 34.3 m-85 -140.21 63.05 1.49 Allowed 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.135 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.583 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.7 mp -59.92 120.18 5.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 123.445 1.593 . . . . 0.0 113.838 -175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.465 ' CG2' HD13 ' C' ' 72' ' ' LEU . 15.5 m -138.12 -172.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 111.016 -2.811 . . . . 0.0 111.565 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.69 175.86 34.51 Favored Glycine 0 C--N 1.308 -0.973 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.954 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.752 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -90.55 50.17 1.79 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -169.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.661 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 1.5 mt-30 139.21 2.22 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 O-C-N 125.189 1.555 . . . . 0.0 109.42 -171.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 22.9 tpp -44.95 -70.49 0.1 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.769 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.432 ' CG ' ' HB2' ' C' ' 41' ' ' GLU . 26.9 m-80 -136.98 -99.09 0.2 Allowed 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 174.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.638 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 94.72 -29.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 125.151 1.532 . . . . 0.0 110.293 -162.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.612 ' HE2' ' O ' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -79.91 -71.11 0.47 Allowed 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . 0.432 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 40.4 mt-10 -63.01 -28.06 69.84 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.851 174.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.638 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 4.7 t80 -58.51 -54.36 47.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.739 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.54 ' HD3' ' HB3' ' C' ' 68' ' ' ASP . 8.9 ptmm? -69.6 -37.19 76.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.483 0.659 . . . . 0.0 111.209 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' C' ' 54' ' ' SER . 1.2 tm-20 -56.07 -44.18 78.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.225 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -69.77 -39.04 76.91 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.544 ' O ' HG22 ' C' ' 50' ' ' VAL . 20.0 pt -83.1 -6.61 10.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -173.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -38.1 -57.48 1.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.97 -36.05 69.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.073 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -20.51 66.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.861 0.362 . . . . 0.0 111.455 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.544 HG22 ' O ' ' C' ' 46' ' ' ILE . 14.6 m -111.76 -6.36 11.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.429 176.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 35.7 m 70.33 21.14 5.86 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.705 0.628 . . . . 0.0 109.475 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.3 mm -126.03 112.96 24.23 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.131 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.493 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.1 Cg_exo -70.94 145.52 50.56 Favored 'Trans proline' 0 CA--C 1.506 -0.876 0 C-N-CA 122.452 2.101 . . . . 0.0 110.784 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.549 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 1.9 p -54.79 -24.72 23.97 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 123.725 0.64 . . . . 0.0 112.647 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.9 pt-20 -75.12 -33.79 61.61 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.947 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.443 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 38.7 mtpt -98.02 -11.04 23.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.361 0.601 . . . . 0.0 109.503 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.549 ' HB3' ' HA ' ' C' ' 54' ' ' SER . 9.3 tt0 -82.99 119.59 24.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.105 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' C' ' 58' ' ' ARG . 22.2 mtm180 -127.66 126.92 42.85 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 171.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.718 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 22.8 mt -84.85 108.04 17.31 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.443 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.582 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.3 mt -99.95 118.35 46.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.39 173.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -132.37 125.99 32.17 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 171.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 58.37 36.37 25.44 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.209 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 76.63 0.9 69.43 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.489 175.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 16.9 mmm180 -98.13 141.49 30.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -92.72 95.15 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 120.937 0.399 . . . . 0.0 110.399 -176.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -82.96 138.91 33.62 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -147.37 -176.08 5.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.928 0.394 . . . . 0.0 111.446 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.54 ' HB3' ' HD3' ' C' ' 43' ' ' LYS . 2.8 p-10 -69.49 -3.58 15.22 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.593 1.157 . . . . 0.0 113.337 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -75.8 -19.83 58.67 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.612 ' O ' ' HE2' ' C' ' 40' ' ' LYS . 39.5 mtmt -130.56 -147.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -170.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.422 ' HB2' ' HG2' ' C' ' 74' ' ' GLU . 33.8 mmtp -120.35 153.18 36.83 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.795 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.465 HD13 ' CG2' ' C' ' 33' ' ' VAL . 45.4 mt -58.01 -50.73 72.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 7.3 tp60 -68.3 -22.42 64.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.909 0.385 . . . . 0.0 111.444 -174.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' C' ' 71' ' ' LYS . 31.1 mm-40 -60.72 -28.89 69.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.273 0.559 . . . . 0.0 109.947 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.506 ' CD1' HD22 ' C' ' 66' ' ' LEU . 39.5 m-85 -93.72 -19.81 20.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.398 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 t30 59.75 38.5 21.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.41 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.428 HG21 HD11 ' C' ' 82' ' ' ILE . 29.3 m -88.73 22.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -73.98 103.35 1.45 Allowed Glycine 0 N--CA 1.428 -1.876 0 CA-C-O 122.786 1.215 . . . . 0.0 112.787 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.51 12.98 46.14 Favored Glycine 0 C--N 1.284 -2.311 0 CA-C-N 112.185 -2.007 . . . . 0.0 115.157 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -128.37 148.27 50.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.273 0.536 . . . . 0.0 110.561 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.641 ' HA ' ' C ' ' C' ' 20' ' ' LEU . 18.4 m -78.54 120.91 30.43 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-O 122.007 0.908 . . . . 0.0 111.599 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.583 ' HB ' HG22 ' C' ' 21' ' ' VAL . 28.1 mt -76.7 166.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.003 173.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.493 ' N ' HG22 ' C' ' 82' ' ' ILE . 52.7 m170 -118.32 116.21 26.28 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.702 -0.624 . . . . 0.0 109.98 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.545 HD21 HD23 ' C' ' 59' ' ' LEU . 11.4 mt -90.81 157.82 17.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.565 HG12 ' CD2' ' A' ' 14' ' ' HIS . 2.4 m . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.987 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 19.5 mtm180 . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 121.402 0.62 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.599 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 14.7 m-85 -125.22 167.39 14.92 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -144.58 121.22 11.13 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.116 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.3 p -91.29 91.89 8.38 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.259 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -56.25 -41.77 76.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.367 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.2 t -55.3 -49.43 72.17 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.427 0.455 . . . . 0.0 112.196 -174.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.54 5.35 44.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.6 0.714 . . . . 0.0 111.559 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.4 p 53.32 58.31 5.36 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.058 1.343 . . . . 0.0 114.266 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -142.77 146.27 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 174.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 28.7 tt0 -89.18 139.42 30.5 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.537 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.972 HD11 HG21 ' A' ' 37' ' ' ILE . 7.0 pt -143.9 168.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -163.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.451 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 42.2 t -118.99 100.78 50.59 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 114.332 -1.304 . . . . 0.0 107.536 161.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.705 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . 1.2 Cg_endo -53.09 177.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.853 1 C-N-CA 126.078 4.519 . . . . 0.0 118.669 -168.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.522 ' HB2' HG13 ' A' ' 28' ' ' ILE . 62.9 mtt180 -117.94 50.81 1.11 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 111.34 -2.663 . . . . 0.0 107.388 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.433 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.6 mm? -8.71 -57.87 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 127.703 2.401 . . . . 0.0 117.325 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -32.98 -34.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 123.513 2.809 . . . . 0.0 114.378 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.584 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -124.42 -18.48 5.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.536 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.528 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 49.3 m-85 69.98 42.98 0.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.189 -171.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.584 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -91.33 165.19 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.119 174.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.471 ' CB ' HD13 ' A' ' 20' ' ' ILE . 25.2 p -95.49 144.06 27.18 Favored Pre-proline 0 N--CA 1.432 -1.338 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.636 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 44.1 Cg_endo -83.25 -22.55 3.96 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 123.278 2.652 . . . . 0.0 109.151 -168.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.528 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 60.0 mtt180 -81.96 -24.83 35.3 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 112.689 -2.051 . . . . 0.0 113.054 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.08 11.23 0.07 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 49.63 66.86 1.0 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.28 145.77 43.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.452 167.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -85.63 33.68 3.44 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.47 -174.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -108.95 52.03 0.72 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.133 0.492 . . . . 0.0 111.068 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.972 HG21 HD11 ' A' ' 20' ' ' ILE . 3.7 pt -111.58 138.86 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.77 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' HB2' HG22 ' C' ' 65' ' ' VAL . 2.9 pt-20 -116.39 147.71 41.37 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -80.25 122.46 26.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.852 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.599 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 41.6 tpp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.383 0.611 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.899 HD22 ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -102.09 145.97 28.58 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.524 ' HA ' HG13 ' C' ' 32' ' ' ILE . 43.2 tt0 -97.91 91.88 5.55 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 170.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' C' ' 30' ' ' THR . 4.5 t -76.82 98.68 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.099 -170.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.61 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.4 mt -87.28 132.97 33.75 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' C' ' 82' ' ' ILE . 88.0 t -145.05 120.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.158 0.504 . . . . 0.0 110.322 -173.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.734 ' HG2' ' OG1' ' C' ' 28' ' ' THR . 44.4 mtpt -92.1 144.27 25.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . 0.537 HG22 ' HB2' ' C' ' 84' ' ' LEU . 18.6 p . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.734 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 19.9 m . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -121.07 150.14 41.65 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.94 0.4 . . . . 0.0 110.885 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.8 p -99.56 144.82 28.2 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.241 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.471 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 34.2 m-85 -132.58 60.18 1.7 Allowed 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.614 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.5 mp -57.96 118.85 2.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 123.06 1.41 . . . . 0.0 114.367 -173.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.474 HG11 ' HD2' ' C' ' 42' ' ' PHE . 16.6 m -138.36 170.51 16.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 111.625 -2.534 . . . . 0.0 112.593 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' C' ' 37' ' ' MET . . . -84.88 50.33 4.38 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.08 -1.418 . . . . 0.0 114.188 -168.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.899 ' HA ' HD22 ' C' ' 17' ' ' LEU . . . 65.39 -48.2 0.37 Allowed 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 124.255 1.022 . . . . 0.0 113.482 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.512 ' HA ' ' HB3' ' C' ' 71' ' ' LYS . 3.9 pt20 -139.82 26.04 2.31 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -164.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . 0.419 ' HB2' ' H ' ' C' ' 34' ' ' GLY . 1.7 tmt? -59.64 -70.99 0.14 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 111.63 -2.532 . . . . 0.0 111.019 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.424 ' O ' ' HB ' ' C' ' 39' ' ' VAL . 13.5 m-80 -144.23 -92.02 0.11 Allowed 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.679 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 96.44 -29.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 O-C-N 125.702 1.876 . . . . 0.0 110.891 -166.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' C' ' 70' ' ' LYS . 0.9 OUTLIER -80.44 -71.39 0.46 Allowed 'General case' 0 N--CA 1.423 -1.813 0 CA-C-O 122.158 0.98 . . . . 0.0 108.859 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.89 -26.59 68.67 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 113.754 -1.567 . . . . 0.0 111.239 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.679 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.6 OUTLIER -59.37 -51.6 69.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.984 174.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.519 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 17.7 mtpp -63.51 -42.06 98.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.96 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -56.14 -37.0 68.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.282 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -69.76 -47.35 63.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.807 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.641 ' O ' HG22 ' C' ' 50' ' ' VAL . 7.4 pt -74.45 -11.46 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.994 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.5 -58.39 2.27 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.64 -37.53 67.96 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.845 -175.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -36.66 83.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.102 0.477 . . . . 0.0 110.648 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.641 HG22 ' O ' ' C' ' 46' ' ' ILE . 24.5 m -98.68 -1.71 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.946 177.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p 60.66 26.58 16.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.014 0.911 . . . . 0.0 109.533 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.3 mm -128.59 113.74 19.36 Favored Pre-proline 0 N--CA 1.434 -1.269 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.099 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 3.7 Cg_exo -69.98 143.65 50.43 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.131 1.888 . . . . 0.0 111.525 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.508 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 35.3 t -51.58 -24.72 5.71 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.331 1.02 . . . . 0.0 112.286 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.48 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.6 pt-20 -72.41 -43.71 63.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.604 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.48 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 96.6 mttt -88.2 -29.13 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.856 0.836 . . . . 0.0 109.382 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.519 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 19.3 tt0 -57.62 131.61 50.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.401 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -136.38 123.76 22.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.876 175.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.523 ' HB3' HG21 ' C' ' 82' ' ' ILE . 46.4 mt -86.73 104.36 16.05 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.098 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.565 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.0 mt -101.94 116.98 46.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.884 -0.51 . . . . 0.0 111.251 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -127.2 113.89 16.94 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 173.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 60.96 43.08 11.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.24 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 72.99 -4.58 22.81 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.142 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -88.32 125.39 34.66 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -87.92 88.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.283 0.564 . . . . 0.0 109.816 -176.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.663 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.5 OUTLIER -68.55 133.69 48.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -142.65 -176.92 5.06 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.641 -170.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.599 ' HA ' HG13 ' C' ' 39' ' ' VAL . 11.4 p-10 -71.88 -0.61 11.76 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.22 1.008 . . . . 0.0 112.627 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -79.89 -21.93 43.42 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.443 ' O ' ' HE3' ' C' ' 40' ' ' LYS . 68.7 mttt -123.93 -148.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -167.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' C' ' 36' ' ' GLN . 0.0 OUTLIER -127.17 163.58 23.54 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 2.9 mm? -66.25 -36.99 84.45 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 118.482 0.583 . . . . 0.0 111.167 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' C' ' 35' ' ' ALA . 35.0 tt0 -70.66 -18.15 62.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.858 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . 0.426 ' HG3' ' HB3' ' C' ' 70' ' ' LYS . 16.9 mm-40 -64.72 -28.84 69.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.464 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.663 ' CD1' HD22 ' C' ' 66' ' ' LEU . 17.8 m-85 -95.54 -22.52 17.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.867 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 t30 63.77 52.35 2.2 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 123.038 1.399 . . . . 0.0 107.76 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.69 -0.86 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 CA-C-N 112.78 -2.009 . . . . 0.0 112.705 -162.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.553 ' CA ' ' HG ' ' C' ' 17' ' ' LEU . . . -47.3 102.45 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.403 0 CA-C-O 122.904 1.28 . . . . 0.0 114.37 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.18 14.29 56.23 Favored Glycine 0 C--N 1.287 -2.188 0 CA-C-N 111.725 -2.237 . . . . 0.0 114.265 170.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -117.23 142.43 47.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.809 0.305 . . . . 0.0 110.25 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.642 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 15.6 m -79.34 124.13 37.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.676 0.751 . . . . 0.0 112.596 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.658 HD13 HD12 ' C' ' 66' ' ' LEU . 25.5 mt -86.87 168.71 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.487 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.501 ' N ' HG22 ' C' ' 82' ' ' ILE . 46.2 m-70 -119.3 115.65 24.6 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 121.965 -0.459 . . . . 0.0 110.168 174.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.537 ' HB2' HG22 ' C' ' 23' ' ' THR . 11.3 mt -91.52 144.64 25.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.103 0.478 . . . . 0.0 111.235 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.837 -176.815 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.667 ' HG2' HD12 ' A' ' 40' ' ' LEU . 38.5 ttt180 . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.929 0.395 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.532 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 8.6 m-85 -117.93 141.21 48.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.955 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.424 ' HB2' HD11 ' A' ' 40' ' ' LEU . 74.4 t80 -112.61 115.69 29.0 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.436 170.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.691 ' HB2' HG22 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -91.11 118.99 30.88 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.094 174.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -80.38 -7.89 59.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.263 -174.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 7.9 t -72.04 -51.52 21.32 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.911 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' HG23 ' A' ' 18' ' ' VAL . 26.9 p -100.94 2.97 41.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.312 0.577 . . . . 0.0 110.324 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p 54.4 45.43 27.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.812 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 16' ' ' CYS . 21.7 t -141.61 147.89 21.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.626 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.58 142.1 42.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.561 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.73 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.9 pt -133.17 167.05 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.703 0.763 . . . . 0.0 112.916 -170.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.9 t -117.79 108.31 42.99 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.303 160.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 19.1 Cg_endo -70.19 176.14 7.5 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 124.404 3.402 . . . . 0.0 116.552 -166.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HB2' HG13 ' A' ' 28' ' ' ILE . 62.6 mtt180 -114.05 49.17 1.02 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 112.924 -1.944 . . . . 0.0 107.802 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.428 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.6 mm? -0.44 -61.74 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.124 0 CA-C-N 111.308 -2.678 . . . . 0.0 117.763 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -32.38 -36.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.377 2.718 . . . . 0.0 114.397 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.553 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.98 -19.76 9.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.786 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.428 ' CE1' HD13 ' A' ' 24' ' ' LEU . 56.4 m-85 66.91 46.23 1.67 Allowed 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.227 -169.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.553 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -92.09 164.04 2.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 113.82 -1.537 . . . . 0.0 110.341 174.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.435 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -96.41 144.11 27.28 Favored Pre-proline 0 C--N 1.306 -1.303 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.015 177.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.73 ' HD3' HD12 ' A' ' 20' ' ' ILE . 47.5 Cg_endo -84.87 -15.91 5.57 Favored 'Trans proline' 0 CA--C 1.5 -1.212 0 C-N-CA 123.55 2.833 . . . . 0.0 108.627 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 85.7 mtt-85 -91.21 -14.18 31.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.177 -1.829 . . . . 0.0 114.0 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.4 p -163.33 3.77 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG2' HG21 ' A' ' 28' ' ' ILE . 17.7 tt0 55.41 36.91 28.09 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.542 0.687 . . . . 0.0 112.162 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.449 ' HB3' ' CD2' ' A' ' 36' ' ' PHE . 16.7 m -116.81 136.43 52.96 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.493 172.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.67 28.26 2.46 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.086 -0.578 . . . . 0.0 113.925 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 80.0 m-85 -86.57 44.24 1.14 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.087 0.47 . . . . 0.0 109.799 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.713 HG21 ' CD1' ' A' ' 20' ' ' ILE . 19.6 pt -110.86 132.79 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.104 -176.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.428 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.9 pt-20 -121.7 139.81 53.09 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -76.35 128.64 35.25 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.667 HD12 ' HG2' ' A' ' 10' ' ' ARG . 13.0 mt . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.319 -167.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' C' ' 35' ' ' ALA . 26.1 ttt . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.759 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -102.08 140.43 36.36 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.786 -179.061 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.588 ' HA ' HG13 ' C' ' 32' ' ' ILE . 4.6 mt-10 -97.21 90.75 5.23 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.966 174.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 24.4 t -78.61 76.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 123.31 1.529 . . . . 0.0 111.019 -169.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.902 ' HB3' HG12 ' C' ' 81' ' ' VAL . 4.3 mt -69.98 140.37 52.94 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.56 HG22 ' HB ' ' C' ' 82' ' ' ILE . 47.4 t -153.44 115.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.986 0.422 . . . . 0.0 110.131 -169.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 34.8 mtpt -98.9 125.44 44.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.317 -0.827 0 CA-C-O 121.031 0.443 . . . . 0.0 111.467 177.45 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 97.5 m . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 120.761 0.315 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' C' ' 29' ' ' ARG . 66.2 mtt180 -128.09 150.06 50.13 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.094 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.503 ' OG1' HD23 ' C' ' 20' ' ' LEU . 0.2 OUTLIER -97.09 139.94 32.34 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.626 -176.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.605 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 38.0 m-85 -127.0 67.67 1.27 Allowed 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.613 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.588 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -58.78 120.63 4.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 123.384 1.564 . . . . 0.0 114.189 -174.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' C' ' 42' ' ' PHE . 17.8 m -136.99 -170.3 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 110.94 -2.846 . . . . 0.0 110.812 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.447 ' O ' HD22 ' C' ' 17' ' ' LEU . . . -88.93 176.74 44.32 Favored Glycine 0 C--N 1.307 -1.06 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.773 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.759 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -68.73 -17.66 64.09 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 117.818 0.809 . . . . 0.0 112.286 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -163.73 27.07 0.08 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -55.58 -76.53 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 112.019 -2.355 . . . . 0.0 111.219 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.58 ' O ' HG12 ' C' ' 39' ' ' VAL . 83.8 m-20 -128.79 -84.9 0.57 Allowed 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.355 174.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.723 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 88.12 -28.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 125.594 1.809 . . . . 0.0 111.646 -167.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -72.6 0.5 Allowed 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.013 0.911 . . . . 0.0 109.402 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.2 -27.86 67.5 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.368 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.56 ' HZ ' HG11 ' C' ' 19' ' ' VAL . 0.6 OUTLIER -62.25 -50.32 72.21 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.35 174.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.671 ' HD2' ' O ' ' C' ' 39' ' ' VAL . 0.0 OUTLIER -58.37 -43.16 88.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.089 0.471 . . . . 0.0 110.756 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -57.03 -34.24 68.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.523 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -70.9 -44.51 66.09 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.691 ' O ' HG22 ' C' ' 50' ' ' VAL . 21.5 pt -77.98 -16.77 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.835 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.06 -49.61 2.56 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.06 -42.49 60.12 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.797 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -16.6 63.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.925 0.393 . . . . 0.0 110.976 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.691 HG22 ' O ' ' C' ' 46' ' ' ILE . 29.0 m -112.06 -9.1 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.891 176.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t 70.62 19.79 5.98 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.768 0.794 . . . . 0.0 109.283 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.7 mm -128.48 110.03 19.23 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.873 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.544 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 6.4 Cg_exo -68.37 146.82 70.09 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.173 1.915 . . . . 0.0 111.09 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -54.91 -25.7 30.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.898 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.483 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.7 pt-20 -75.31 -18.01 60.13 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 111.082 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.483 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 98.7 mttt -120.29 -0.95 10.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.401 . . . . 0.0 110.773 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.681 ' OE1' HD11 ' C' ' 46' ' ' ILE . 0.0 OUTLIER -93.1 126.18 38.07 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.335 -175.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.456 ' NH2' HG11 ' C' ' 65' ' ' VAL . 66.5 mtp85 -122.35 123.6 41.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.05 173.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.607 ' HB3' HG21 ' C' ' 82' ' ' ILE . 2.1 mm? -92.25 104.49 16.85 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.734 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.613 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.6 mt -101.64 122.93 54.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.893 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.457 ' OH ' ' HD3' ' C' ' 80' ' ' LYS . 29.5 t80 -135.24 131.94 37.24 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 171.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 48.44 38.78 11.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.033 -172.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.88 6.4 63.58 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.848 -0.615 . . . . 0.0 113.169 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' C' ' 64' ' ' ARG . 4.2 mmp_? -98.16 133.52 42.49 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.456 HG11 ' NH2' ' C' ' 58' ' ' ARG . 0.6 OUTLIER -88.17 94.45 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.265 0.555 . . . . 0.0 110.471 -176.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.3 OUTLIER -82.66 156.1 24.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . 0.482 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 16.4 pt20 -169.97 -169.12 0.83 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.601 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.723 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.3 p-10 -62.41 -0.02 0.52 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.771 0.828 . . . . 0.0 112.228 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . 0.482 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 28.9 t70 -63.38 -4.33 2.6 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.016 0.926 . . . . 0.0 112.782 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.476 ' HA ' HG11 ' C' ' 39' ' ' VAL . 51.5 mtmt 83.55 167.89 0.1 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 169.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.435 ' HB3' ' HG3' ' C' ' 74' ' ' GLU . 13.9 mptt 67.35 79.12 0.23 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.939 -178.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 20.8 mt -62.27 -33.23 74.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.648 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -69.36 -19.03 63.84 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 122.696 0.399 . . . . 0.0 112.005 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . 0.435 ' HG3' ' HB3' ' C' ' 71' ' ' LYS . 32.1 mt-10 -73.05 -27.85 61.98 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.535 ' CD1' HD22 ' C' ' 66' ' ' LEU . 15.7 m-85 -87.97 -21.99 24.54 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.4 t30 58.89 40.37 22.73 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.709 174.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.512 HG11 HD11 ' C' ' 82' ' ' ILE . 17.4 m -87.92 10.22 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.84 -171.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -60.91 99.48 0.2 Allowed Glycine 0 CA--C 1.488 -1.6 0 CA-C-O 122.785 1.214 . . . . 0.0 113.226 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . 0.41 ' C ' HD12 ' C' ' 20' ' ' LEU . . . 94.35 15.25 48.17 Favored Glycine 0 C--N 1.284 -2.357 0 CA-C-N 112.091 -2.055 . . . . 0.0 114.132 172.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . 0.457 ' HD3' ' OH ' ' C' ' 61' ' ' TYR . 55.2 mttm -126.75 140.47 52.36 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.902 HG12 ' HB3' ' C' ' 20' ' ' LEU . 33.9 m -75.83 134.02 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.854 0.835 . . . . 0.0 110.732 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.607 HG21 ' HB3' ' C' ' 59' ' ' LEU . 59.4 mt -89.78 169.8 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.969 172.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.524 ' N ' HG22 ' C' ' 82' ' ' ILE . 56.8 m80 -115.95 112.38 21.77 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.474 HD12 ' N ' ' C' ' 85' ' ' VAL . 13.7 tp -97.83 130.63 44.74 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 121.218 0.533 . . . . 0.0 110.296 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.474 ' N ' HD12 ' C' ' 84' ' ' LEU . 30.6 m . . . . . 0 C--N 1.311 -1.102 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.978 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 C--O 1.233 0.216 0 CA-C-O 121.483 0.659 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.691 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.6 m-85 -115.42 166.2 12.14 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.141 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.592 ' HB2' HD11 ' A' ' 40' ' ' LEU . 39.0 t80 -140.64 119.44 12.53 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.317 178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -95.9 107.12 19.35 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.782 177.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -62.23 -15.73 48.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.808 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 7.0 t -71.71 -31.12 66.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.645 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.1 m -98.65 -26.14 14.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.156 0.503 . . . . 0.0 110.607 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.37 28.55 15.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.345 -171.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.68 143.53 40.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 36.9 tt0 -71.82 148.39 46.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.11 0.481 . . . . 0.0 110.831 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.727 HD11 HG21 ' A' ' 37' ' ' ILE . 3.6 pt -138.68 167.04 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.719 -170.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 20.9 t -123.36 96.85 43.46 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 163.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.691 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 9.2 Cg_endo -56.0 176.16 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.872 1 C-N-CA 125.328 4.018 . . . . 0.0 116.529 -170.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.74 ' HB2' HG13 ' A' ' 28' ' ' ILE . 24.5 mtt180 -110.25 49.82 0.83 Allowed 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 112.488 -2.142 . . . . 0.0 107.692 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -0.75 -58.25 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 CA-C-N 111.21 -2.723 . . . . 0.0 117.047 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 18.6 Cg_exo -37.15 -31.19 0.12 Allowed 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.88 2.387 . . . . 0.0 114.074 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.554 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -123.69 -19.88 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.357 0.599 . . . . 0.0 111.765 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.436 ' C ' HD11 ' A' ' 37' ' ' ILE . 47.0 m-85 67.34 45.49 1.61 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.28 -171.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.74 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.4 OUTLIER -92.43 160.45 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.723 173.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -96.0 144.64 28.18 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.662 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 96.8 Cg_endo -79.52 -21.55 8.66 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 122.672 2.248 . . . . 0.0 108.049 -172.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.1 mtt-85 -79.92 -37.79 33.87 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 112.561 -2.109 . . . . 0.0 113.567 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.0 p -133.75 -6.92 2.81 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.463 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 59.32 30.91 20.71 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.509 0.671 . . . . 0.0 111.661 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 m -111.48 144.24 41.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.467 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.23 41.06 2.6 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.109 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 60.5 m-85 -96.04 46.02 1.08 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.106 0.479 . . . . 0.0 109.934 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.727 HG21 HD11 ' A' ' 20' ' ' ILE . 3.5 pt -113.31 134.63 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.796 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB3' HD13 ' C' ' 60' ' ' ILE . 0.7 OUTLIER -119.14 141.69 48.6 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -79.9 137.27 36.86 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.455 -175.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.538 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 26.5 ptt? . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.187 0.518 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.9 mt -105.04 132.15 51.64 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.562 ' HA ' ' CG1' ' C' ' 32' ' ' ILE . 49.3 mt-10 -81.51 94.39 6.86 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.58 HG22 HG23 ' C' ' 77' ' ' VAL . 9.4 t -80.67 116.53 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.925 -171.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.573 ' CB ' HG12 ' C' ' 81' ' ' VAL . 0.8 OUTLIER -107.5 144.9 33.8 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 175.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' C' ' 28' ' ' THR . 3.5 m -137.02 147.64 26.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.567 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 37.0 mtpt -120.29 123.64 43.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--N 1.315 -0.93 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.789 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 71.7 m . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 121.017 0.437 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -133.11 153.42 51.54 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.425 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.568 HG22 ' CD2' ' C' ' 20' ' ' LEU . 16.3 p -100.11 151.4 21.44 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -170.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.634 ' HE2' HG21 ' C' ' 21' ' ' VAL . 26.8 m-85 -141.43 55.56 1.52 Allowed 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.246 -175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.562 ' CG1' ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -60.95 120.84 7.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 123.407 1.575 . . . . 0.0 113.801 -174.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.6 m -138.03 -168.76 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 110.729 -2.942 . . . . 0.0 111.446 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -76.94 -158.96 9.39 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.052 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.566 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -110.13 23.64 14.06 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 120.9 0.381 . . . . 0.0 111.371 -177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 7.5 tt0 166.19 -17.47 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.418 -163.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -41.25 -64.86 0.5 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.48 1.113 . . . . 0.0 112.262 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.465 ' O ' HG12 ' C' ' 39' ' ' VAL . 66.1 m-20 -131.0 -95.01 0.37 Allowed 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.677 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 86.0 -30.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 O-C-N 125.041 1.463 . . . . 0.0 110.819 -162.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.79 -70.28 0.55 Allowed 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.228 1.013 . . . . 0.0 109.095 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . 0.44 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 43.7 mt-10 -62.03 -26.66 68.37 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.393 173.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.755 ' O ' HG23 ' C' ' 46' ' ' ILE . 0.2 OUTLIER -56.82 -53.71 54.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.255 172.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.448 ' N ' ' HD1' ' C' ' 42' ' ' PHE . 18.8 mtpp -61.79 -41.89 98.32 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.521 0.677 . . . . 0.0 110.721 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -58.46 -40.28 82.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.662 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -69.92 -44.82 68.87 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.027 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.755 HG23 ' O ' ' C' ' 42' ' ' PHE . 4.3 pt -75.22 -13.23 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.792 -0.185 . . . . 0.0 111.225 -172.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -43.49 -45.64 6.52 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.33 -43.09 34.23 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.892 -0.505 . . . . 0.0 111.804 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -20.28 63.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.516 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.655 HG22 ' O ' ' C' ' 46' ' ' ILE . 31.5 m -112.07 -6.68 11.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t 68.85 19.72 8.23 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.724 0.773 . . . . 0.0 109.018 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.64 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 8.6 mm -125.71 112.42 25.06 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.385 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.602 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 4.7 Cg_exo -69.73 146.31 59.97 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.138 1.892 . . . . 0.0 111.494 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.3 p -53.0 -24.82 10.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.476 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 12.8 pt-20 -77.27 -32.37 55.56 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.36 0.412 . . . . 0.0 111.894 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -97.92 -19.93 17.77 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 109.847 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' C' ' 53' ' ' PRO . 25.8 tt0 -66.52 123.26 19.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.92 -170.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 43.5 mtp85 -124.93 115.4 20.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.204 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.593 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 51.6 mt -86.96 111.41 20.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.979 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 38' ' ' GLU . 5.6 mt -109.93 113.63 44.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 O-C-N 121.568 -0.707 . . . . 0.0 112.01 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' C' ' 66' ' ' LEU . 21.1 t80 -129.38 126.89 39.86 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 60.5 34.17 20.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.022 0.439 . . . . 0.0 110.379 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.99 5.44 40.09 Favored Glycine 0 N--CA 1.453 -0.211 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.899 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -87.43 133.4 33.74 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.97 87.6 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.261 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.602 ' HB3' ' CD2' ' C' ' 75' ' ' TYR . 0.8 OUTLIER -68.28 141.63 55.81 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' C' ' 69' ' ' ASP . 10.6 pt20 -155.4 -168.97 3.0 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.684 -0.406 . . . . 0.0 109.955 -173.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.677 ' HA ' HG13 ' C' ' 39' ' ' VAL . 8.9 p-10 -67.43 0.24 3.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.608 0.763 . . . . 0.0 112.577 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . 0.441 ' H ' ' HG3' ' C' ' 67' ' ' GLN . 29.1 t70 -64.17 -4.02 3.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.521 0.729 . . . . 0.0 112.846 -174.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.416 ' H ' HG11 ' C' ' 39' ' ' VAL . 49.2 mttp 81.95 177.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.951 0.9 . . . . 0.0 111.865 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.421 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 65.5 mttm 74.66 75.12 0.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.145 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.473 HD12 ' H ' ' C' ' 36' ' ' GLN . 56.6 mt -65.01 -45.39 85.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.292 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -69.55 -25.84 64.2 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . 0.421 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 69.3 mm-40 -67.46 -24.71 65.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.575 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.602 ' CD2' ' HB3' ' C' ' 66' ' ' LEU . 6.9 m-30 -86.42 -10.21 54.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.447 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 1.3 m120 47.89 35.33 4.75 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.328 1.051 . . . . 0.0 113.471 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.58 HG23 HG22 ' C' ' 19' ' ' VAL . 16.5 m -90.55 16.19 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -175.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.556 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -73.18 102.78 1.29 Allowed Glycine 0 N--CA 1.431 -1.658 0 CA-C-O 122.792 1.218 . . . . 0.0 112.082 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.21 14.59 62.01 Favored Glycine 0 C--N 1.283 -2.401 0 CA-C-N 112.052 -2.074 . . . . 0.0 113.045 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -124.23 147.5 48.01 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.573 HG12 ' CB ' ' C' ' 20' ' ' LEU . 34.0 m -84.13 124.26 39.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 121.971 0.891 . . . . 0.0 112.313 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.52 HG22 ' N ' ' C' ' 83' ' ' HIS . 74.0 mt -77.77 171.6 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.433 173.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.52 ' N ' HG22 ' C' ' 82' ' ' ILE . 45.5 m80 -118.85 119.52 34.62 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.465 -0.772 . . . . 0.0 109.775 170.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.468 HD12 ' H ' ' C' ' 85' ' ' VAL . 25.9 tp -100.59 145.14 28.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -171.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.468 ' H ' HD12 ' C' ' 84' ' ' LEU . 2.8 p . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.481 0.658 . . . . 0.0 109.973 171.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.591 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 16.7 ptp180 . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 122.353 1.073 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.69 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 8.4 m-85 -116.79 164.59 14.43 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.819 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.611 ' CB ' HD21 ' A' ' 40' ' ' LEU . 54.5 t80 -138.98 112.58 8.3 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.572 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.596 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -91.9 110.52 21.87 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.474 ' CG ' HG13 ' C' ' 85' ' ' VAL . 9.8 p80 -69.15 -17.98 63.89 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -169.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 13.5 p -73.33 -39.11 65.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.255 174.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.7 m -78.19 -29.68 48.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.321 0.581 . . . . 0.0 110.646 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER 58.58 28.8 17.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.694 -176.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.54 146.23 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.69 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.1 tt0 -70.06 144.53 52.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.231 0.538 . . . . 0.0 111.034 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.719 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.2 pt -132.08 167.91 25.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.77 -175.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 14.1 t -125.28 95.01 42.17 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 164.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 3.5 Cg_endo -54.28 175.85 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.842 1 C-N-CA 125.423 4.082 . . . . 0.0 116.973 -169.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.709 ' HB2' HG13 ' A' ' 28' ' ' ILE . 37.8 mtt180 -107.5 48.32 0.85 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 112.565 -2.107 . . . . 0.0 107.023 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 0.79 -61.71 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.116 0 CA-C-N 110.811 -2.904 . . . . 0.0 117.253 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -32.18 -36.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 123.553 2.835 . . . . 0.0 113.819 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.531 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -115.68 -22.62 9.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.181 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.513 ' C ' HD11 ' A' ' 37' ' ' ILE . 58.4 m-85 68.1 58.6 0.46 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.406 1.098 . . . . 0.0 110.32 -168.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.709 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -110.71 162.57 8.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.304 176.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.5 t -96.16 146.61 31.61 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.624 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 67.6 Cg_endo -81.6 -22.3 5.6 Favored 'Trans proline' 0 CA--C 1.5 -1.224 0 C-N-CA 122.606 2.204 . . . . 0.0 108.031 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.539 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 68.5 mtt-85 -81.7 -25.14 35.73 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 112.892 -1.958 . . . . 0.0 113.752 -177.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.6 p -146.23 -7.25 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.637 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 60.35 32.35 20.65 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.744 0.783 . . . . 0.0 111.033 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.1 m -113.19 146.39 39.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.744 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.57 37.64 2.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.14 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 87.8 m-85 -92.34 38.77 1.01 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.255 0.55 . . . . 0.0 110.041 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.719 HG21 ' CD1' ' A' ' 20' ' ' ILE . 7.1 pt -110.94 133.67 55.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.614 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HB2' HG22 ' C' ' 65' ' ' VAL . 10.5 pt-20 -121.95 136.15 54.91 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 172.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.26 135.9 40.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.219 0.533 . . . . 0.0 109.692 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.611 HD21 ' CB ' ' A' ' 12' ' ' PHE . 8.7 mt . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.328 -171.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -104.08 147.87 26.91 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.294 0.569 . . . . 0.0 109.524 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.499 ' HA ' HG13 ' C' ' 32' ' ' ILE . 4.5 mt-10 -106.86 83.55 1.86 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' C' ' 30' ' ' THR . 4.2 t -72.06 143.63 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.441 -166.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 1.018 ' HB3' HG12 ' C' ' 81' ' ' VAL . 7.9 mt -128.65 156.71 43.0 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' C' ' 28' ' ' THR . 21.5 m -145.36 152.89 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.601 ' HG3' ' CB ' ' C' ' 81' ' ' VAL . 35.7 mtpt -138.24 110.44 7.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.952 0.501 . . . . 0.0 109.983 173.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 120.869 0.366 . . . . 0.0 111.072 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.734 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 51.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' C' ' 20' ' ' LEU . 83.8 mtt180 -130.71 168.18 17.6 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.77 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 2.1 p -108.52 148.32 30.43 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.658 ' HE2' HG21 ' C' ' 21' ' ' VAL . 40.6 m-85 -139.73 65.07 1.44 Allowed 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.44 0.638 . . . . 0.0 110.365 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.574 HG23 ' O ' ' C' ' 17' ' ' LEU . 2.5 mp -55.23 118.45 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 123.214 1.483 . . . . 0.0 113.776 -176.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.41 HG13 ' O ' ' C' ' 31' ' ' PHE . 19.7 m -136.94 -171.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 111.347 -2.661 . . . . 0.0 111.209 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.08 157.18 20.07 Favored Glycine 0 C--N 1.307 -1.082 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.144 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.795 ' HA ' HD21 ' C' ' 17' ' ' LEU . . . -63.42 -18.78 64.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -172.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -147.74 22.47 1.13 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -75.53 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.224 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.609 ' O ' HG12 ' C' ' 39' ' ' VAL . 8.1 m120 -128.74 -91.94 0.47 Allowed 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.664 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 82.04 -28.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.035 1.459 . . . . 0.0 112.12 -166.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' C' ' 43' ' ' LYS . 0.0 OUTLIER -80.77 -68.96 0.64 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.557 1.17 . . . . 0.0 108.78 174.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.53 -29.62 70.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.476 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.618 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -62.18 -53.21 58.57 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.184 175.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.651 ' HG2' ' O ' ' C' ' 40' ' ' LYS . 3.3 ptmt -67.3 -34.1 76.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.192 0.52 . . . . 0.0 110.136 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.512 ' HA ' ' HB3' ' C' ' 54' ' ' SER . 16.7 tt0 -59.46 -37.01 77.07 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.657 175.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -69.98 -40.73 75.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.925 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.617 ' O ' HG22 ' C' ' 50' ' ' VAL . 18.4 pt -81.46 -7.64 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -174.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.24 -59.76 1.44 Allowed 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.24 -34.54 70.86 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.849 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -28.22 69.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.617 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.4 m -106.16 -2.75 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 29.0 m 69.53 19.61 7.42 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.536 0.684 . . . . 0.0 109.586 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.6 mm -127.65 117.12 21.08 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.165 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.522 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.0 Cg_exo -68.75 149.8 73.45 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.636 1.558 . . . . 0.0 111.751 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.544 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 29.6 p -53.88 -25.72 21.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.254 -176.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -79.68 -13.6 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -116.24 -33.04 5.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.639 ' OE1' ' HB2' ' C' ' 43' ' ' LYS . 8.7 pt20 -65.33 129.61 40.35 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.985 0.898 . . . . 0.0 111.997 -173.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' C' ' 84' ' ' LEU . 38.5 mmt180 -115.51 116.06 27.55 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.761 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.709 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 11.7 mt -84.23 106.01 15.52 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.346 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.53 HG21 ' O ' ' A' ' 37' ' ' ILE . 26.6 mt -99.1 118.53 45.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.534 -0.729 . . . . 0.0 111.69 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.444 ' OH ' ' HG2' ' C' ' 80' ' ' LYS . 64.5 t80 -135.19 130.2 34.95 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' C' ' 61' ' ' TYR . 48.1 mt-30 61.8 33.62 17.65 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.053 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 68.3 4.58 37.8 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.43 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -99.17 133.41 43.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -89.99 88.68 2.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.314 0.578 . . . . 0.0 110.013 -175.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.709 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.1 OUTLIER -67.93 155.18 40.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.162 178.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . 0.415 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.5 pt20 -161.95 -167.19 1.6 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.686 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.664 ' HA ' HG13 ' C' ' 39' ' ' VAL . 1.5 p-10 -58.81 -2.48 0.23 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.041 0.936 . . . . 0.0 112.893 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 27.8 t70 -62.25 -9.12 6.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.574 0.75 . . . . 0.0 112.573 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.518 ' H ' HG11 ' C' ' 39' ' ' VAL . 37.5 mtmm 78.81 174.9 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.758 0.823 . . . . 0.0 112.41 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.491 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 32.6 mtmm 78.6 71.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 124.209 0.943 . . . . 0.0 111.362 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 3.5 mm? -62.19 -44.14 97.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' C' ' 35' ' ' ALA . 2.3 pt20 -66.02 -19.47 65.87 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . 0.491 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 36.7 mm-40 -70.52 -28.39 64.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.584 ' CD1' HD22 ' C' ' 66' ' ' LEU . 18.9 m-85 -87.29 -23.51 24.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 60.59 43.66 12.48 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.905 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.563 HG23 HG22 ' C' ' 19' ' ' VAL . 19.6 m -91.3 -8.06 10.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.714 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -50.03 100.34 0.04 OUTLIER Glycine 0 CA--C 1.493 -1.305 0 CA-C-O 122.914 1.286 . . . . 0.0 113.944 168.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.93 10.38 49.54 Favored Glycine 0 C--N 1.29 -1.993 0 CA-C-N 111.629 -2.286 . . . . 0.0 114.725 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . 0.574 ' C ' ' HB2' ' C' ' 20' ' ' LEU . 0.0 OUTLIER -132.47 148.18 52.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.524 0.662 . . . . 0.0 111.118 -178.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 1.018 HG12 ' HB3' ' C' ' 20' ' ' LEU . 35.6 m -80.52 122.04 35.01 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-O 121.741 0.781 . . . . 0.0 111.934 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.49 HG21 ' HB3' ' C' ' 59' ' ' LEU . 77.6 mt -80.18 160.46 4.15 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.828 174.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.438 ' N ' HG22 ' C' ' 82' ' ' ILE . 54.8 m80 -117.71 114.73 23.77 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 121.657 -0.652 . . . . 0.0 109.989 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' C' ' 58' ' ' ARG . 8.0 mp -90.49 157.34 17.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.474 HG13 ' CG ' ' A' ' 14' ' ' HIS . 4.1 t . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.618 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.338 0.59 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.603 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 6.7 m-85 -116.3 166.41 12.08 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.982 171.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 40' ' ' LEU . 60.6 t80 -139.48 123.74 18.01 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.446 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.571 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -98.02 101.05 12.43 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.587 ' HD2' ' OE1' ' A' ' 38' ' ' GLU . 11.9 p80 -52.91 -24.95 10.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.27 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -67.5 -46.76 71.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.769 0.319 . . . . 0.0 110.443 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.0 m -74.58 -28.24 60.83 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.497 0.665 . . . . 0.0 109.852 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.68 29.6 17.56 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.02 -170.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.03 144.39 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 37.5 tt0 -73.67 148.67 42.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.124 0.488 . . . . 0.0 110.844 -175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.73 HD12 ' HD3' ' A' ' 30' ' ' PRO . 6.2 pt -139.01 168.38 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.265 -172.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.519 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 47.2 t -122.74 101.3 39.8 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 160.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 11.1 Cg_endo -54.36 175.32 0.14 Allowed 'Trans proline' 0 C--N 1.328 -0.502 1 C-N-CA 125.582 4.188 . . . . 0.0 116.215 -171.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.492 ' HD3' HD12 ' A' ' 28' ' ' ILE . 29.8 mtt180 -101.82 45.69 0.96 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 112.587 -2.097 . . . . 0.0 107.096 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.48 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -1.98 -59.03 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.861 0 CA-C-N 110.41 -3.086 . . . . 0.0 117.654 175.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.29 44.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.268 1.978 . . . . 0.0 112.857 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.575 ' HB3' HG12 ' A' ' 28' ' ' ILE . 4.8 t70 177.68 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.942 0.897 . . . . 0.0 109.653 -174.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.448 ' CE1' HD13 ' A' ' 24' ' ' LEU . 93.8 m-85 70.69 58.13 0.22 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.328 -173.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.575 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -114.76 163.52 11.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 113.307 -1.77 . . . . 0.0 108.833 175.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.458 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 2.1 t -95.88 144.42 27.79 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.73 ' HD3' HD12 ' A' ' 20' ' ' ILE . 79.6 Cg_endo -81.09 -22.89 5.69 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 C-N-CA 122.807 2.338 . . . . 0.0 108.182 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.517 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 50.2 mtt180 -89.09 -6.31 57.17 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.835 -1.984 . . . . 0.0 114.485 -176.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.7 p -156.06 -14.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 171.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 61.25 22.59 12.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.364 0.602 . . . . 0.0 111.709 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.9 m -96.13 141.55 29.37 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 166.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.56 51.82 4.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.007 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.499 ' HB3' ' CE1' ' A' ' 14' ' ' HIS . 39.8 m-85 -107.88 45.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.722 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.9 pt -113.66 143.87 22.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.922 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.587 ' OE1' ' HD2' ' A' ' 14' ' ' HIS . 1.4 pm0 -120.65 149.53 42.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 165.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -81.27 133.82 35.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.62 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.425 -0.797 . . . . 0.0 110.409 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.525 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 22.9 mmt . . . . . 0 N--CA 1.465 0.325 0 CA-C-O 121.149 0.499 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.726 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.4 OUTLIER -102.18 138.07 39.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.686 178.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' C' ' 32' ' ' ILE . 10.3 mt-10 -85.08 98.55 10.49 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.565 0.698 . . . . 0.0 109.287 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' C' ' 30' ' ' THR . 17.1 t -79.5 83.64 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 122.482 1.134 . . . . 0.0 110.904 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.625 ' HB3' HG12 ' C' ' 81' ' ' VAL . 12.3 mt -75.66 142.58 42.52 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' C' ' 82' ' ' ILE . 82.0 t -156.18 125.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 121.952 0.101 . . . . 0.0 110.889 -171.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.649 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 0.1 OUTLIER -111.97 162.82 14.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.152 0.501 . . . . 0.0 110.901 -178.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . 0.535 HG22 ' O ' ' C' ' 84' ' ' LEU . 11.3 p . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.836 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 43.9 m . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.909 0.862 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -126.15 151.06 47.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.337 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -99.9 143.41 30.15 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.129 0.49 . . . . 0.0 111.301 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.489 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 29.2 m-85 -126.5 62.82 1.28 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 123.578 0.751 . . . . 0.0 109.766 -175.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.59 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -57.02 121.98 5.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 123.114 1.435 . . . . 0.0 114.745 -172.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' HG ' ' C' ' 72' ' ' LEU . 16.7 m -141.81 167.01 16.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 111.267 -2.697 . . . . 0.0 112.523 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -96.57 52.16 1.53 Allowed Glycine 0 C--N 1.306 -1.089 0 CA-C-N 114.549 -1.205 . . . . 0.0 114.595 -168.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.726 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.61 -44.67 0.52 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 171.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -132.1 26.61 4.56 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -75.37 0.07 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.87 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -146.58 -79.3 0.16 Allowed 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.696 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.4 OUTLIER 90.56 -29.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 125.375 1.672 . . . . 0.0 111.438 -167.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.47 ' HD2' ' HG2' ' C' ' 70' ' ' LYS . 0.1 OUTLIER -84.24 -70.35 0.58 Allowed 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 122.202 1.001 . . . . 0.0 109.14 177.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.04 -26.57 67.72 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.632 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.674 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -56.14 -50.14 71.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.162 171.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.617 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 43.6 mttp -64.59 -42.32 95.68 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.219 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -56.0 -36.73 68.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.572 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -70.11 -46.71 64.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.755 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.591 HG23 ' O ' ' C' ' 42' ' ' PHE . 8.5 pt -78.1 -13.79 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.792 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.98 -51.2 3.28 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.25 -45.47 69.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -28.07 64.83 Favored 'General case' 0 N--CA 1.424 -1.734 0 C-N-CA 122.868 0.467 . . . . 0.0 112.164 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.528 HG11 ' CD1' ' C' ' 84' ' ' LEU . 27.6 m -106.41 -3.81 9.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.18 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 82.6 p 63.35 23.7 13.87 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 122.054 0.93 . . . . 0.0 109.54 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.1 mm -131.63 120.44 17.71 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.244 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -67.73 152.8 77.29 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.034 1.823 . . . . 0.0 112.588 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.501 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 29.9 t -50.06 -40.89 46.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.358 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.549 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 15.7 pt-20 -67.12 -17.85 65.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.839 -177.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.549 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 67.7 mttm -121.09 -0.91 9.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -173.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.617 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 9.3 pt20 -96.07 142.26 28.49 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.626 -0.829 . . . . 0.0 112.863 -175.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.486 ' O ' HD23 ' C' ' 84' ' ' LEU . 98.0 mtt180 -114.94 121.85 44.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.266 173.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 9.0 mp -92.07 107.3 19.11 Favored 'General case' 0 C--O 1.207 -1.164 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.551 HG21 ' O ' ' A' ' 37' ' ' ILE . 2.8 mt -105.2 106.37 20.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 120.973 0.416 . . . . 0.0 111.114 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.442 ' HB2' HG23 ' C' ' 82' ' ' ILE . 53.0 t80 -117.62 114.63 23.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.75 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 56.99 41.14 28.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.033 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.7 -15.47 36.34 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.205 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 tpm_? -81.06 126.87 31.97 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.504 -0.409 . . . . 0.0 110.208 -176.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 38' ' ' GLU . 15.8 t -83.48 90.28 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.973 0.416 . . . . 0.0 109.943 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.6 OUTLIER -75.6 134.14 40.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 6.9 pt20 -135.22 -168.57 2.21 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.161 -171.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.696 ' HA ' HG13 ' C' ' 39' ' ' VAL . 5.7 p-10 -71.13 2.37 4.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.529 0.732 . . . . 0.0 112.296 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . 0.54 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 19.4 t70 -61.11 1.52 0.17 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.455 1.102 . . . . 0.0 113.146 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.472 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.4 mtmt 83.44 158.44 0.12 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 168.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.4 ' HB3' ' HG3' ' C' ' 74' ' ' GLU . 34.6 mmtp 72.2 95.18 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.749 174.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.482 ' HG ' ' CG2' ' C' ' 33' ' ' VAL . 3.6 mm? -62.58 -36.8 83.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.81 177.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.95 -19.16 64.16 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -175.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . 0.4 ' HG3' ' HB3' ' C' ' 71' ' ' LYS . 26.8 mt-10 -71.48 -27.87 63.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 174.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.547 ' CD1' HD22 ' C' ' 66' ' ' LEU . 25.4 m-85 -87.78 -22.36 24.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.731 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.1 t30 61.18 40.63 14.49 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.781 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.406 HG23 HG22 ' C' ' 19' ' ' VAL . 26.4 m -92.43 27.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.743 -175.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.569 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.03 101.74 1.61 Allowed Glycine 0 N--CA 1.433 -1.558 0 CA-C-O 122.744 1.191 . . . . 0.0 112.733 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.28 13.7 50.99 Favored Glycine 0 C--N 1.283 -2.366 0 CA-C-N 112.21 -1.995 . . . . 0.0 114.108 172.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -127.01 147.61 50.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.649 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 3.0 m -79.03 127.44 39.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.605 0.717 . . . . 0.0 112.636 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.575 ' HB ' HG22 ' C' ' 21' ' ' VAL . 27.0 mt -88.71 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.301 171.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.537 ' N ' HG22 ' C' ' 82' ' ' ILE . 86.0 t60 -109.82 133.33 53.27 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 121.821 -0.55 . . . . 0.0 110.094 166.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.535 ' O ' HG22 ' C' ' 23' ' ' THR . 5.8 mt -108.8 138.34 45.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.805 0.812 . . . . 0.0 112.244 170.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.367 177.695 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 3.0 mpt_? . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.93 0.395 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.631 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 12.3 m-85 -118.04 165.9 13.19 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.326 0.584 . . . . 0.0 109.521 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.419 ' CB ' HD11 ' A' ' 40' ' ' LEU . 74.1 t80 -140.29 118.85 12.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.569 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -98.7 128.55 45.0 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -83.97 -21.32 31.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -167.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 32.0 p -72.36 -31.72 65.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 118.479 0.581 . . . . 0.0 110.016 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.445 ' HB3' HG22 ' A' ' 18' ' ' VAL . 94.5 m -85.64 -20.5 29.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.525 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.8 p 51.22 32.23 7.84 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.116 0.966 . . . . 0.0 112.375 -175.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 16' ' ' CYS . 2.8 m -141.42 157.2 21.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.494 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.628 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 32.8 tt0 -79.01 145.23 34.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.076 0.465 . . . . 0.0 111.196 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.738 HD11 HG21 ' A' ' 37' ' ' ILE . 3.3 pt -134.07 167.17 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.21 -173.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 45.3 t -122.76 94.34 47.58 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 163.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.631 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.65 175.35 0.29 Allowed 'Trans proline' 0 C--N 1.325 -0.709 1 C-N-CA 125.537 4.158 . . . . 0.0 116.522 -168.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.663 ' HB2' HG13 ' A' ' 28' ' ' ILE . 36.8 mtt180 -105.74 46.94 0.89 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.702 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -1.46 -60.92 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.932 0 CA-C-N 110.582 -3.008 . . . . 0.0 116.575 174.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.445 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 63.2 Cg_exo -33.58 -31.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.469 2.78 . . . . 0.0 114.55 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.568 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -122.13 -19.08 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.358 0.599 . . . . 0.0 111.745 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.41 ' C ' HD11 ' A' ' 37' ' ' ILE . 50.5 m-85 68.01 58.94 0.46 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.615 -171.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.663 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -111.81 161.38 10.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 113.328 -1.76 . . . . 0.0 108.966 178.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.483 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -95.92 146.38 31.22 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.636 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 83.9 Cg_endo -81.32 -21.03 6.71 Favored 'Trans proline' 0 CA--C 1.5 -1.188 0 C-N-CA 122.668 2.245 . . . . 0.0 108.238 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.493 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 84.5 mtt180 -86.79 -15.1 40.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.032 -1.894 . . . . 0.0 114.398 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.1 p -151.58 -10.69 0.21 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 60.42 33.6 20.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.559 0.695 . . . . 0.0 111.217 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 m -113.91 146.32 40.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.47 33.15 3.25 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.826 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 97.9 m-85 -87.88 43.45 1.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.2 0.524 . . . . 0.0 110.649 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.738 HG21 HD11 ' A' ' 20' ' ' ILE . 4.6 pt -111.24 135.37 50.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.8 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -117.03 145.01 43.96 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -77.12 135.87 38.59 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.787 -174.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.58 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 45.7 ttm . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 121.024 0.44 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.771 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.2 mt -105.55 137.98 42.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.51 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.541 ' HA ' HG13 ' C' ' 32' ' ' ILE . 32.5 tt0 -84.36 96.75 9.15 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.2 t -78.62 104.62 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.189 -172.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.618 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -93.41 145.11 24.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' C' ' 82' ' ' ILE . 68.6 t -151.9 121.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 117.921 0.328 . . . . 0.0 110.957 -171.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.574 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 36.8 mtpt -103.51 122.19 44.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.117 -179.223 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.547 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 18.4 m . . . . . 0 C--O 1.232 0.18 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -122.49 153.44 39.17 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.65 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p -101.41 141.29 34.5 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-O 121.219 0.533 . . . . 0.0 112.251 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.509 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 29.4 m-85 -133.81 57.71 1.8 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.663 0.744 . . . . 0.0 109.758 -174.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.541 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.8 mp -57.24 119.19 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 123.362 1.553 . . . . 0.0 114.353 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 17.3 m -143.66 -168.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 110.915 -2.857 . . . . 0.0 111.627 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -96.4 159.11 21.76 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.054 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.771 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -59.65 -31.17 69.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.21 0.529 . . . . 0.0 112.187 -175.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.32 31.7 2.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.486 0.66 . . . . 0.0 109.258 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -74.33 0.14 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.026 -176.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.575 ' O ' HG12 ' C' ' 39' ' ' VAL . 8.5 m120 -128.82 -90.71 0.49 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.711 HG23 HD21 ' C' ' 72' ' ' LEU . 0.3 OUTLIER 81.83 -30.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 124.794 1.309 . . . . 0.0 111.9 -165.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.51 ' HD2' ' HG2' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -80.23 -69.48 0.59 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 122.286 1.041 . . . . 0.0 108.516 176.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.17 -29.26 69.68 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 113.445 -1.707 . . . . 0.0 111.003 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.676 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.9 t80 -60.64 -53.49 56.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.523 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.66 ' HB2' ' OE1' ' C' ' 57' ' ' GLN . 0.0 OUTLIER -69.82 -33.64 72.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.99 0.424 . . . . 0.0 110.928 -179.444 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -38.64 87.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.718 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -69.65 -48.59 59.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.194 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.578 ' O ' HG22 ' C' ' 50' ' ' VAL . 17.3 pt -70.49 -12.12 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -173.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.29 -56.28 2.47 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.54 -44.3 87.28 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -25.27 65.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.338 0.59 . . . . 0.0 111.087 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.578 HG22 ' O ' ' C' ' 46' ' ' ILE . 30.9 m -110.48 -3.31 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.334 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 60.6 p 64.67 22.08 12.53 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.796 0.807 . . . . 0.0 109.49 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.7 mm -127.66 115.46 20.97 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.274 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 4.6 Cg_exo -73.97 147.02 38.13 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 121.936 1.758 . . . . 0.0 111.306 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.439 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 4.0 p -52.55 -24.85 8.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.765 0.826 . . . . 0.0 112.96 -175.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.56 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 8.9 pt-20 -68.68 -41.74 78.81 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.677 0.275 . . . . 0.0 111.493 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.56 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 27.4 mtpp -96.2 -25.08 15.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.574 0.702 . . . . 0.0 109.686 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.66 ' OE1' ' HB2' ' C' ' 43' ' ' LYS . 17.8 tt0 -61.1 118.57 6.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.287 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -123.16 119.11 29.27 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.02 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 6.4 mt -84.79 116.29 23.19 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.542 HG21 ' O ' ' A' ' 37' ' ' ILE . 3.3 mt -114.89 122.04 68.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.831 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -136.32 132.72 36.04 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 57.46 35.39 25.83 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.104 0.478 . . . . 0.0 110.753 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.03 4.93 37.74 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.529 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -91.73 140.08 30.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.71 90.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.481 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -83.03 144.06 30.18 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.144 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -156.89 -167.4 2.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.522 -175.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.658 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.8 p-10 -60.78 0.22 0.23 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.969 1.308 . . . . 0.0 113.368 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 34.0 t70 -60.55 -10.69 5.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.506 0.722 . . . . 0.0 112.421 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.522 ' H ' HG11 ' C' ' 39' ' ' VAL . 57.1 mtmt 88.33 -175.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.149 0.98 . . . . 0.0 112.615 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.433 ' HG2' ' C ' ' C' ' 70' ' ' LYS . 16.5 pttp 47.52 84.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.62 1.2 . . . . 0.0 113.06 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.711 HD21 HG23 ' C' ' 39' ' ' VAL . 35.2 mt -64.94 -32.22 73.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.608 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . 0.455 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 10.3 pt20 -67.26 -18.4 65.2 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.01 -28.7 66.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.553 ' CD1' HD22 ' C' ' 66' ' ' LEU . 25.1 m-85 -86.96 -22.48 25.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.621 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.7 t30 62.09 37.11 14.88 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.001 174.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -88.92 18.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.053 0.454 . . . . 0.0 111.754 -174.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -73.95 102.81 1.37 Allowed Glycine 0 N--CA 1.427 -1.928 0 CA-C-O 122.779 1.211 . . . . 0.0 111.873 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.36 15.25 60.69 Favored Glycine 0 C--N 1.283 -2.364 0 CA-C-N 112.021 -2.09 . . . . 0.0 112.618 176.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -119.72 145.5 46.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.618 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 34.3 m -83.07 123.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-O 122.111 0.957 . . . . 0.0 111.152 175.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' C' ' 21' ' ' VAL . 57.6 mt -79.07 170.35 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.094 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.531 ' N ' HG22 ' C' ' 82' ' ' ILE . 44.6 m80 -118.26 116.89 27.69 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.425 ' CD1' HG11 ' C' ' 50' ' ' VAL . 9.4 mt -90.63 141.82 28.39 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.257 0.551 . . . . 0.0 111.521 177.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.512 HG21 HD11 ' C' ' 60' ' ' ILE . 31.9 m . . . . . 0 C--N 1.314 -0.953 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.677 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 . . . . . 0 CA--C 1.511 -0.527 0 CA-C-O 121.47 0.652 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 17.9 m-85 -116.2 162.59 17.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 171.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.536 ' CB ' HD11 ' A' ' 40' ' ' LEU . 55.3 t80 -141.01 116.63 10.24 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.394 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -93.83 114.55 26.81 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.434 ' CG ' HG13 ' C' ' 85' ' ' VAL . 19.0 p80 -69.23 -12.81 61.99 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.878 -176.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 38.9 m -71.57 -39.26 70.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 110.705 173.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.1 m -88.35 -27.58 21.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 110.813 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.53 28.48 17.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.696 -170.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.457 HG11 ' CZ ' ' A' ' 31' ' ' ARG . 97.5 t -131.34 144.53 37.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.445 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 25.8 tt0 -74.93 145.83 42.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 110.453 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.9 pt -135.7 167.84 24.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.343 -170.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 61.3 t -124.59 95.69 42.39 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 164.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.8 176.31 0.23 Allowed 'Trans proline' 0 C--N 1.325 -0.681 1 C-N-CA 125.386 4.057 . . . . 0.0 116.216 -173.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.583 ' HB2' HG13 ' A' ' 28' ' ' ILE . 7.8 mtt180 -112.43 52.19 0.78 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 112.711 -2.041 . . . . 0.0 107.155 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 4.04 -61.4 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.016 0 CA-C-N 111.06 -2.791 . . . . 0.0 117.221 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 13.1 Cg_exo -34.12 -37.42 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.899 2.399 . . . . 0.0 113.701 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.497 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.09 -23.75 9.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.848 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.536 ' C ' HD11 ' A' ' 37' ' ' ILE . 60.4 m-85 65.18 57.41 0.94 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.304 1.049 . . . . 0.0 109.303 -168.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.583 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.4 OUTLIER -105.7 162.61 4.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.521 176.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.475 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.5 t -94.62 145.01 28.87 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.659 ' HD3' HD12 ' A' ' 20' ' ' ILE . 70.3 Cg_endo -83.78 -20.33 4.61 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.938 2.425 . . . . 0.0 108.688 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.487 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 12.5 mtp180 -89.02 -7.91 55.03 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.016 -1.902 . . . . 0.0 114.014 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.4 p -162.66 -8.4 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 15.7 tt0 62.31 28.17 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.137 0.494 . . . . 0.0 112.213 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.1 p -99.58 150.86 21.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.8 25.77 7.2 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.711 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.461 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 75.7 m-85 -89.48 48.99 1.67 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.105 0.479 . . . . 0.0 110.551 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.753 HG21 ' CD1' ' A' ' 20' ' ' ILE . 3.5 pt -110.73 138.56 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.485 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' C' ' 65' ' ' VAL . 7.2 pt-20 -123.19 137.67 54.83 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -68.24 140.62 56.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.499 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 63.8 ttp . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.696 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.2 mt -106.25 131.39 53.54 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.066 173.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.62 ' HA ' HG13 ' C' ' 32' ' ' ILE . 33.9 tt0 -82.5 96.24 7.96 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.636 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 2.5 t -80.45 124.57 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -173.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.666 ' CB ' HG12 ' C' ' 81' ' ' VAL . 0.4 OUTLIER -110.45 145.62 37.33 Favored 'General case' 0 N--CA 1.417 -2.075 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 171.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.705 HG22 ' HB ' ' C' ' 82' ' ' ILE . 55.4 t -148.38 126.75 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 117.905 0.321 . . . . 0.0 110.404 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.536 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 42.4 mtmt -111.9 127.13 55.75 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.34 0.59 . . . . 0.0 110.029 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 C--N 1.307 -1.282 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.414 172.37 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 97.3 m . . . . . 0 C--O 1.237 0.416 0 CA-C-O 120.781 0.324 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -122.56 151.81 41.02 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.951 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 3.5 p -99.14 140.2 33.67 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.636 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 24.9 m-85 -136.52 60.78 1.66 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.841 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.62 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.6 mp -57.71 128.88 18.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 122.898 1.332 . . . . 0.0 114.304 -172.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.62 HG11 ' CD2' ' C' ' 42' ' ' PHE . 15.3 m -122.78 -169.88 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 112.053 -2.34 . . . . 0.0 111.546 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -125.57 33.34 3.63 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.17 -175.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.696 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 65.72 18.36 11.15 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 167.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.862 ' H ' HD12 ' C' ' 72' ' ' LEU . 10.1 tt0 157.61 -11.85 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.82 0.819 . . . . 0.0 109.163 -166.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.8 tpt -45.4 -73.68 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.844 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.459 ' O ' HG12 ' C' ' 39' ' ' VAL . 77.9 m-20 -141.25 -88.57 0.16 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.694 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 92.84 -30.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 125.297 1.623 . . . . 0.0 111.274 -164.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -66.9 0.78 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 122.393 1.092 . . . . 0.0 108.873 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -61.76 -28.24 69.3 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 113.065 -1.88 . . . . 0.0 111.706 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.62 ' CD2' HG11 ' C' ' 33' ' ' VAL . 0.1 OUTLIER -57.27 -52.87 63.6 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 171.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.453 ' HA ' HG12 ' C' ' 46' ' ' ILE . 24.2 mtpp -67.01 -41.37 86.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.092 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -60.09 -34.71 73.83 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.044 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.6 -48.2 60.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.621 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.639 ' O ' HG22 ' C' ' 50' ' ' VAL . 20.6 pt -74.86 -10.42 13.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.307 -175.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -46.67 -40.64 13.52 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.04 -45.91 19.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -34.13 73.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.104 0.478 . . . . 0.0 110.765 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.639 HG22 ' O ' ' C' ' 46' ' ' ILE . 30.1 m -99.88 -8.12 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.158 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 31.5 m 68.8 20.14 8.15 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.837 0.827 . . . . 0.0 109.775 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.2 mm -123.29 110.98 30.41 Favored Pre-proline 0 N--CA 1.44 -0.935 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.72 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.417 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 14.1 Cg_exo -66.39 143.11 68.61 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 122.622 2.214 . . . . 0.0 111.902 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.433 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 35.2 t -51.13 -28.31 10.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.843 -172.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.45 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 10.8 pt-20 -75.29 -30.96 60.54 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.877 0.37 . . . . 0.0 111.541 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 55.1 mtpt -95.19 -28.83 14.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.827 0.823 . . . . 0.0 109.206 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.43 HE22 HG13 ' C' ' 46' ' ' ILE . 17.1 tt0 -63.67 122.64 16.85 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.124 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.431 ' O ' HG23 ' C' ' 85' ' ' VAL . 72.6 mtp85 -120.97 123.76 43.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.756 -0.202 . . . . 0.0 110.462 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 94.1 mt -90.95 124.06 34.92 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 177.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.556 HG21 ' O ' ' A' ' 37' ' ' ILE . 4.6 mt -118.29 125.75 74.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 O-C-N 121.622 -0.674 . . . . 0.0 111.595 172.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.46 ' CD2' HG12 ' C' ' 77' ' ' VAL . 55.1 t80 -138.64 131.87 30.05 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 46.23 40.39 7.43 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.104 0.478 . . . . 0.0 111.357 -170.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.91 5.73 58.39 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.923 -0.58 . . . . 0.0 113.617 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.586 ' HD3' ' N ' ' C' ' 65' ' ' VAL . 0.0 OUTLIER -99.22 131.26 45.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.586 ' N ' ' HD3' ' C' ' 64' ' ' ARG . 2.0 t -82.41 90.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.113 0.482 . . . . 0.0 110.391 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.594 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.4 OUTLIER -71.78 148.1 46.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -158.31 -169.81 2.9 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.835 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.694 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.7 p-10 -67.04 -2.39 5.37 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.663 0.785 . . . . 0.0 112.233 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 20.9 t70 -68.73 -2.74 9.99 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.082 0.553 . . . . 0.0 111.802 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.54 ' H ' HG11 ' C' ' 39' ' ' VAL . 53.5 mtmt 75.9 -162.47 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.685 178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' C' ' 70' ' ' LYS . 48.5 mttp 77.51 57.18 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.831 0.707 . . . . 0.0 109.659 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.862 HD12 ' H ' ' C' ' 36' ' ' GLN . 22.0 mt -61.72 -56.36 20.46 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.827 -174.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -72.64 -15.86 61.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.073 0.464 . . . . 0.0 111.461 -176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -73.14 -28.93 62.52 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.051 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.594 ' CD1' HD22 ' C' ' 66' ' ' LEU . 24.0 m-85 -75.31 -25.38 57.81 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 61.51 26.39 16.13 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.382 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.46 HG12 ' CD2' ' C' ' 61' ' ' TYR . 31.3 m -83.04 21.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.902 -175.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.647 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.54 98.97 1.43 Allowed Glycine 0 N--CA 1.431 -1.675 0 CA-C-O 122.418 1.01 . . . . 0.0 111.985 177.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.23 14.14 39.84 Favored Glycine 0 C--N 1.285 -2.262 0 CA-C-N 112.382 -1.909 . . . . 0.0 114.541 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -128.68 147.32 50.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.666 HG12 ' CB ' ' C' ' 20' ' ' LEU . 16.6 m -80.19 125.78 39.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-O 121.881 0.848 . . . . 0.0 111.637 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.705 ' HB ' HG22 ' C' ' 21' ' ' VAL . 57.5 mt -80.25 171.17 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.8 173.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.546 ' N ' HG22 ' C' ' 82' ' ' ILE . 37.6 m80 -118.22 122.01 41.91 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 122.012 -0.43 . . . . 0.0 109.924 174.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mt -85.75 156.86 20.44 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.434 HG13 ' CG ' ' A' ' 14' ' ' HIS . 8.0 t . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.417 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HG2' HD23 ' A' ' 40' ' ' LEU . 58.8 ttt180 . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 121.229 0.538 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.657 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 17.0 m-85 -118.21 164.27 15.42 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.636 0.731 . . . . 0.0 110.752 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.654 ' CB ' HD11 ' A' ' 40' ' ' LEU . 54.9 t80 -140.92 120.28 13.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.877 178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -98.57 121.37 40.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.222 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.644 ' CE1' ' HB ' ' C' ' 85' ' ' VAL . 8.9 p80 -76.69 -23.44 53.18 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 24.6 p -71.09 -38.15 72.41 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.272 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.6 m -74.85 -34.81 62.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.084 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.75 32.01 21.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.161 -172.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.5 t -131.65 144.12 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.657 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 38.7 tt0 -74.33 143.28 45.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.116 0.484 . . . . 0.0 110.885 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.74 HD11 HG21 ' A' ' 37' ' ' ILE . 4.0 pt -131.86 168.32 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.216 -169.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.424 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 57.7 t -123.53 98.29 40.95 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 162.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.592 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 6.8 Cg_endo -57.3 175.12 0.39 Allowed 'Trans proline' 0 C--N 1.326 -0.613 1 C-N-CA 125.302 4.001 . . . . 0.0 116.675 -169.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.696 ' HB2' HG13 ' A' ' 28' ' ' ILE . 26.0 mtt180 -107.68 47.38 0.89 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 112.629 -2.078 . . . . 0.0 107.183 176.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -0.07 -61.27 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 110.718 -2.947 . . . . 0.0 116.993 174.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 31.2 Cg_exo -30.96 -38.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 123.591 2.861 . . . . 0.0 114.176 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.545 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.48 -18.05 11.59 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.705 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.432 ' C ' HD11 ' A' ' 37' ' ' ILE . 62.8 m-85 67.11 45.93 1.62 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.04 -172.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.696 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -94.07 161.61 2.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.653 174.622 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -96.61 145.73 30.08 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.035 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.656 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 78.7 Cg_endo -80.46 -20.27 8.33 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 122.861 2.374 . . . . 0.0 108.089 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.655 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.1 mtt-85 -80.19 -34.77 37.19 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 112.658 -2.065 . . . . 0.0 113.712 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.8 p -137.59 -8.74 1.67 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 61.29 35.42 18.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.474 0.654 . . . . 0.0 111.061 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 m -113.09 146.36 39.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.545 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -84.55 45.86 3.57 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.741 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 57.9 m-85 -102.4 44.38 1.02 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.961 0.41 . . . . 0.0 110.268 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.74 HG21 HD11 ' A' ' 20' ' ' ILE . 5.8 pt -115.27 139.21 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.191 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB2' HG22 ' C' ' 65' ' ' VAL . 12.9 pt-20 -123.86 145.67 48.93 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.34 131.36 39.13 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.654 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.857 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.636 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 50.9 mtm . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 121.014 0.435 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.692 HD11 ' HA ' ' C' ' 35' ' ' ALA . 3.7 mt -98.58 132.71 43.77 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.575 ' HA ' HG13 ' C' ' 32' ' ' ILE . 25.6 tt0 -82.23 93.92 7.2 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.631 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 3.1 t -77.06 104.85 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.06 -172.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.651 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.1 mt -92.76 142.27 27.53 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.695 HG22 ' HB ' ' C' ' 82' ' ' ILE . 59.4 t -147.95 128.92 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -174.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.608 ' HE3' HG21 ' C' ' 81' ' ' VAL . 79.2 mttt -114.24 159.81 19.73 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.361 0.601 . . . . 0.0 109.804 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 C--N 1.308 -1.229 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.99 172.33 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.447 ' OG1' ' HE2' ' C' ' 22' ' ' LYS . 53.7 m . . . . . 0 C--O 1.231 0.123 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' C' ' 29' ' ' ARG . 73.1 mtt180 -123.33 161.93 23.71 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.795 -177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.5 p -103.69 143.44 32.78 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.468 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.631 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 27.6 m-85 -137.14 59.0 1.7 Allowed 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.271 -174.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -57.92 124.26 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 123.352 1.548 . . . . 0.0 113.872 -174.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' C' ' 16' ' ' MET . 17.2 m -135.27 -165.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 111.104 -2.771 . . . . 0.0 111.324 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.04 -161.76 37.32 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.741 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.692 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -100.91 -12.86 18.62 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.577 0.703 . . . . 0.0 111.296 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -166.95 26.57 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -172.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 18.3 ttt -71.95 -73.05 0.2 Allowed 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 111.816 -2.447 . . . . 0.0 110.941 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.605 ' O ' HG12 ' C' ' 39' ' ' VAL . 70.5 m-20 -131.11 -98.18 0.32 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 178.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 86.7 -16.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 125.341 1.651 . . . . 0.0 111.731 -167.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' C' ' 43' ' ' LYS . 0.1 OUTLIER -88.69 -70.79 0.63 Allowed 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.048 0.928 . . . . 0.0 108.965 171.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.12 -29.4 70.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.099 173.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.64 ' CD2' ' HA ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -62.08 -54.43 41.41 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.438 175.314 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' C' ' 40' ' ' LYS . 20.0 ptmt -68.25 -33.66 74.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -42.66 82.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.103 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -68.71 -43.26 76.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.439 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.603 ' O ' HG22 ' C' ' 50' ' ' VAL . 16.1 pt -78.35 -10.75 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -172.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.65 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.2 -61.02 0.95 Allowed 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.75 86.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -32.82 71.15 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.055 0.455 . . . . 0.0 111.049 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.603 HG22 ' O ' ' C' ' 46' ' ' ILE . 24.3 m -103.63 -3.36 9.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.453 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 48.2 t 69.58 20.04 7.2 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.65 0.738 . . . . 0.0 109.318 178.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.2 mm -123.38 110.67 30.41 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.174 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.499 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 6.0 Cg_exo -72.8 146.03 41.95 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.371 2.047 . . . . 0.0 111.299 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 8.0 p -54.49 -24.62 21.27 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.608 0.763 . . . . 0.0 112.285 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 15.1 pt-20 -73.6 -26.3 60.74 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -107.66 -26.41 10.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 109.981 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.535 ' OE1' HD11 ' C' ' 46' ' ' ILE . 9.9 tt0 -57.96 118.3 5.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.9 -173.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.413 HH11 HG11 ' C' ' 65' ' ' VAL . 26.1 mmt85 -122.37 118.0 27.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.314 172.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 5.2 mp -84.7 117.87 24.06 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.537 HG21 ' O ' ' A' ' 37' ' ' ILE . 7.0 mt -115.12 118.12 57.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.169 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -132.39 128.15 36.97 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 58.68 38.83 24.95 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.508 0.505 . . . . 0.0 110.627 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.79 4.17 13.15 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.258 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -89.18 133.98 34.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.437 HG22 ' HB2' ' A' ' 38' ' ' GLU . 2.1 t -85.14 89.68 2.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.3 OUTLIER -75.04 130.57 39.54 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -143.11 -172.72 3.74 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.511 -170.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.621 ' HA ' HG13 ' C' ' 39' ' ' VAL . 4.4 p-10 -64.3 -3.06 2.52 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.44 0.696 . . . . 0.0 112.145 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.35 -4.94 16.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.072 0.549 . . . . 0.0 112.293 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 74.44 -158.21 0.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.375 0.67 . . . . 0.0 110.939 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.537 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 54.3 mttp 71.91 54.08 0.19 Allowed 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.552 0.532 . . . . 0.0 110.692 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 60.1 mt -63.43 -44.28 95.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.181 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . 0.439 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 9.3 pt20 -70.08 -20.44 63.21 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.742 0.306 . . . . 0.0 111.466 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . 0.537 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 28.0 mm-40 -71.1 -28.01 64.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.555 ' CD1' HD22 ' C' ' 66' ' ' LEU . 19.3 m-85 -83.7 -24.72 31.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 57.66 37.85 27.48 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.807 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -87.31 20.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.539 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.608 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.69 99.93 1.53 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-O 122.767 1.204 . . . . 0.0 112.322 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.88 14.34 43.34 Favored Glycine 0 C--N 1.284 -2.307 0 CA-C-N 112.223 -1.989 . . . . 0.0 113.72 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -124.33 147.49 48.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.651 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 4.5 m -82.05 128.53 38.64 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-O 122.055 0.931 . . . . 0.0 111.43 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.695 ' HB ' HG22 ' C' ' 21' ' ' VAL . 54.3 mt -86.9 168.44 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.122 175.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.468 ' N ' HG22 ' C' ' 82' ' ' ILE . 40.7 m80 -117.42 115.03 24.4 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.889 -0.507 . . . . 0.0 110.162 175.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.452 HD13 HG21 ' C' ' 50' ' ' VAL . 13.4 mt -90.67 157.36 17.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.291 0.567 . . . . 0.0 112.379 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.644 ' HB ' ' CE1' ' A' ' 14' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.917 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 10' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.605 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 5.9 m-85 -116.74 167.53 11.01 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.041 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CB ' HD11 ' A' ' 40' ' ' LEU . 48.8 t80 -140.87 114.39 8.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.28 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.599 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -93.49 118.02 30.81 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.51 177.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' A' ' 36' ' ' PHE . 1.1 p80 -76.68 -20.49 56.56 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.544 -171.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 16.1 p -72.91 -31.61 64.76 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.82 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.2 m -83.43 -30.61 27.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.189 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.02 28.29 16.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.409 -171.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.88 144.76 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 34.7 tt0 -71.23 146.66 48.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.512 -175.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.7 ' CD1' HG21 ' A' ' 37' ' ' ILE . 2.6 pt -138.62 166.61 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.847 -172.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.482 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 99.1 t -124.08 97.86 39.97 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 163.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 5.6 Cg_endo -57.24 173.76 0.59 Allowed 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 124.912 3.741 . . . . 0.0 116.571 -170.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.501 ' HB2' HG13 ' A' ' 28' ' ' ILE . 15.2 mtt85 -107.35 47.33 0.89 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 112.489 -2.142 . . . . 0.0 107.59 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -6.28 -53.69 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 171.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -35.09 -36.16 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.561 2.174 . . . . 0.0 113.428 171.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.506 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.09 -17.56 10.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.352 177.398 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.423 ' CE1' HD23 ' A' ' 24' ' ' LEU . 74.7 m-85 69.68 50.99 0.47 Allowed 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.603 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.506 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -104.81 159.85 5.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.615 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.493 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 t -95.5 144.56 28.02 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.69 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 87.2 Cg_endo -81.24 -17.48 9.09 Favored 'Trans proline' 0 CA--C 1.5 -1.179 0 C-N-CA 122.761 2.308 . . . . 0.0 108.24 -173.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.429 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 60.5 mtt-85 -91.57 -13.81 31.37 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 112.937 -1.938 . . . . 0.0 114.617 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.0 p -153.16 -9.48 0.16 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 60.95 29.18 18.86 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.381 0.61 . . . . 0.0 110.91 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.2 m -109.24 146.97 33.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.487 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.21 28.95 4.46 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.772 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 63.0 m-85 -85.86 47.64 1.48 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.568 -0.372 . . . . 0.0 110.462 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.7 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.7 pt -115.58 139.0 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.516 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.493 ' HB3' HD13 ' C' ' 60' ' ' ILE . 6.5 pt-20 -123.42 148.28 46.29 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -80.52 134.24 35.92 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.434 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.547 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.808 -174.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.414 ' N ' ' HA2' ' C' ' 34' ' ' GLY . 1.9 mpt? . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.877 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.7 OUTLIER -104.71 135.62 45.76 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.643 -171.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.565 ' HA ' HG13 ' C' ' 32' ' ' ILE . 36.4 tt0 -88.91 94.27 9.88 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.3 t -79.48 128.29 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -172.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.595 ' CB ' HG12 ' C' ' 81' ' ' VAL . 0.8 OUTLIER -114.21 150.14 34.74 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.573 HG21 ' HE2' ' C' ' 31' ' ' PHE . 18.5 m -135.32 150.91 29.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.606 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 36.7 mtpt -125.72 96.38 4.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.712 0.291 . . . . 0.0 110.297 174.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . 0.47 HG23 ' O ' ' C' ' 84' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.316 -0.891 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 171.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 78.7 m . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -136.24 154.56 50.88 Favored 'General case' 0 C--O 1.223 -0.333 0 O-C-N 122.288 -0.258 . . . . 0.0 110.31 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.538 HG22 ' CD2' ' C' ' 20' ' ' LEU . 4.1 p -108.79 147.34 32.19 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -171.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.67 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 31.0 m-85 -140.16 65.14 1.43 Allowed 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 123.292 0.637 . . . . 0.0 111.289 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.565 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.7 mp -59.56 122.17 9.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 123.073 1.415 . . . . 0.0 113.81 -175.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.662 HG21 HD13 ' C' ' 72' ' ' LEU . 15.8 m -130.74 -173.71 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 111.723 -2.49 . . . . 0.0 111.461 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.414 ' HA2' ' N ' ' C' ' 16' ' ' MET . . . -120.48 45.61 1.21 Allowed Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.146 -1.026 . . . . 0.0 114.464 -173.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.877 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.16 -36.24 0.3 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 169.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -144.8 20.71 1.64 Allowed 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -172.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 2.0 ttt -66.72 -69.38 0.31 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 112.196 -2.274 . . . . 0.0 110.332 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -142.42 -101.02 0.13 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.655 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.711 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.4 OUTLIER 101.37 -27.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 125.516 1.76 . . . . 0.0 110.189 -165.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' C' ' 40' ' ' LYS . 0.0 OUTLIER -83.99 -71.14 0.52 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 122.127 0.965 . . . . 0.0 109.056 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' C' ' 40' ' ' LYS . 43.6 mt-10 -63.11 -27.22 69.24 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.721 174.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.742 ' O ' HG23 ' C' ' 46' ' ' ILE . 6.3 t80 -58.95 -52.44 65.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.566 173.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' C' ' 57' ' ' GLN . 51.3 mtpt -61.55 -42.75 99.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.028 0.442 . . . . 0.0 110.642 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -55.6 -40.92 72.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.361 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -68.98 -47.01 66.63 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.971 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.742 HG23 ' O ' ' C' ' 42' ' ' PHE . 4.1 pt -76.01 -13.06 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.415 -173.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.2 -60.6 1.2 Allowed 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.01 93.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.745 0.307 . . . . 0.0 111.699 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -17.69 64.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.475 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.551 HG22 ' O ' ' C' ' 46' ' ' ILE . 17.8 m -113.33 -6.63 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 33.6 t 69.55 22.18 6.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.648 0.737 . . . . 0.0 109.192 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.1 mm -130.06 117.04 17.99 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.635 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.501 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 5.5 Cg_exo -74.99 148.32 35.15 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.962 1.774 . . . . 0.0 111.12 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -55.12 -25.91 34.82 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.153 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.5 pt-20 -68.54 -24.65 64.66 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.653 0.263 . . . . 0.0 111.623 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 95.8 mttt -115.64 -17.76 11.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.446 0.641 . . . . 0.0 110.427 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.453 ' HA ' HG21 ' C' ' 52' ' ' ILE . 23.0 tt0 -66.28 119.35 11.39 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.596 -170.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.404 ' HB3' ' CG1' ' C' ' 65' ' ' VAL . 28.0 mmt180 -114.54 113.66 24.72 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.651 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.756 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 47.7 mt -82.62 105.27 13.53 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.1 mt -102.13 103.62 15.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.611 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -118.6 132.51 56.19 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.628 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 40.64 45.55 2.04 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.985 0.803 . . . . 0.0 111.705 -171.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.95 -6.28 20.83 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.654 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -87.03 129.71 34.78 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 38' ' ' GLU . 1.6 t -87.38 89.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.081 0.467 . . . . 0.0 109.905 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.1 OUTLIER -76.96 155.84 32.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.103 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.7 pt20 -160.16 -169.31 2.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.286 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.711 ' HA ' HG13 ' C' ' 39' ' ' VAL . 1.8 p-10 -61.6 1.34 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.251 1.42 . . . . 0.0 113.116 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' C' ' 67' ' ' GLN . 13.4 t70 -65.29 9.85 0.1 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.155 0.982 . . . . 0.0 113.103 -178.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' C' ' 68' ' ' ASP . 51.4 mttp 84.18 159.69 0.11 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.449 1.1 . . . . 0.0 113.648 170.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.449 ' HB3' ' HG2' ' C' ' 74' ' ' GLU . 95.3 mttt 67.89 89.56 0.1 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.123 -1.399 . . . . 0.0 113.005 173.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.662 HD13 HG21 ' C' ' 33' ' ' VAL . 11.3 mt -63.9 -36.1 82.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.559 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . 0.41 ' HG2' ' H ' ' C' ' 73' ' ' GLN . 4.3 pt20 -66.89 -24.46 66.11 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' C' ' 71' ' ' LYS . 26.1 mm-40 -62.19 -27.78 69.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.241 0.543 . . . . 0.0 109.623 176.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.554 ' CD1' HD22 ' C' ' 66' ' ' LEU . 17.8 m-85 -94.01 -12.24 29.07 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.781 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 3.8 m120 47.83 45.29 18.57 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.417 1.087 . . . . 0.0 113.366 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.455 HG23 HG22 ' C' ' 19' ' ' VAL . 29.5 m -86.68 19.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -74.35 102.41 1.37 Allowed Glycine 0 N--CA 1.429 -1.789 0 CA-C-O 122.989 1.327 . . . . 0.0 112.976 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.26 13.73 53.33 Favored Glycine 0 C--N 1.283 -2.394 0 CA-C-N 111.967 -2.116 . . . . 0.0 114.002 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -127.84 154.7 45.15 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.66 -0.318 . . . . 0.0 110.247 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.606 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 35.0 m -87.03 122.93 39.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.818 0.818 . . . . 0.0 112.157 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . . . . . . . . . 62.3 mt -86.7 135.26 25.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.512 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.414 ' O ' ' HB ' ' C' ' 60' ' ' ILE . 69.5 m80 -93.93 114.62 26.86 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.47 ' O ' HG23 ' C' ' 23' ' ' THR . 2.7 pp -127.37 157.13 40.78 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 118.786 -1.166 . . . . 0.0 113.517 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.533 -178.416 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.602 0.239 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.478 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 8.2 m-85 -117.99 165.21 13.99 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.34 0.59 . . . . 0.0 109.809 171.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.554 ' HB2' HD11 ' A' ' 40' ' ' LEU . 50.1 t80 -140.26 115.15 9.62 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.491 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -93.88 108.1 19.92 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.409 ' CD2' HG12 ' C' ' 85' ' ' VAL . 12.6 p80 -64.88 -15.4 61.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.652 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.5 t -72.34 -36.8 68.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.887 0.375 . . . . 0.0 110.478 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.526 ' HB3' HG22 ' A' ' 18' ' ' VAL . 66.0 m -88.77 -23.89 22.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.423 0.63 . . . . 0.0 110.594 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.07 30.61 20.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.272 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 16' ' ' CYS . 2.6 m -138.38 162.95 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.694 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -83.42 145.24 29.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.849 HD12 ' HD3' ' A' ' 30' ' ' PRO . 3.5 pt -137.21 168.42 21.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.094 -171.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.476 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 45.9 t -125.14 99.58 34.09 Favored Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 162.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HD3' HG13 ' A' ' 20' ' ' ILE . 12.9 Cg_endo -55.37 175.24 0.19 Allowed 'Trans proline' 0 C--N 1.328 -0.538 1 C-N-CA 125.306 4.004 . . . . 0.0 116.257 -173.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.522 ' HB2' HG13 ' A' ' 28' ' ' ILE . 26.0 mtt180 -109.15 48.99 0.84 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.86 -1.973 . . . . 0.0 106.888 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.422 HD13 ' CE1' ' A' ' 27' ' ' TYR . 1.8 mm? 3.05 -61.47 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.362 0 CA-C-N 111.09 -2.777 . . . . 0.0 117.334 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -34.86 -34.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 123.103 2.535 . . . . 0.0 114.42 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.571 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.84 -21.83 9.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.937 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.456 ' C ' HD11 ' A' ' 37' ' ' ILE . 77.3 m-85 65.57 57.6 0.86 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.148 0.975 . . . . 0.0 109.795 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -109.19 163.01 6.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 113.492 -1.686 . . . . 0.0 109.542 176.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 1.4 t -95.92 146.15 30.81 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.849 ' HD3' HD12 ' A' ' 20' ' ' ILE . 86.8 Cg_endo -83.32 -20.29 5.02 Favored 'Trans proline' 0 CA--C 1.501 -1.15 0 C-N-CA 122.607 2.205 . . . . 0.0 108.85 -175.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.402 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 63.3 mtt180 -86.16 -14.07 45.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.259 -1.791 . . . . 0.0 114.104 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 p -152.36 -14.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 8.4 tt0 62.72 36.59 13.25 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.028 0.531 . . . . 0.0 112.161 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 98.2 p -108.44 154.18 22.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 166.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.46 33.91 3.79 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.801 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 60.8 m-85 -94.26 47.79 1.21 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.369 . . . . 0.0 111.045 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 20' ' ' ILE . 3.6 pt -114.03 139.55 39.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.779 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.542 ' HB3' HD13 ' C' ' 60' ' ' ILE . 13.1 pt-20 -117.83 143.41 46.31 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -79.13 139.17 38.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.07 0.462 . . . . 0.0 109.836 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.933 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.102 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.863 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.6 OUTLIER -99.95 127.46 46.14 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.859 -171.029 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.613 ' HA ' HG13 ' C' ' 32' ' ' ILE . 40.5 tt0 -84.59 92.64 8.19 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.8 t -76.96 126.24 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.956 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -174.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.622 ' HB2' ' CG1' ' C' ' 81' ' ' VAL . 0.2 OUTLIER -114.21 155.02 26.87 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 170.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.897 ' O ' ' HA ' ' C' ' 28' ' ' THR . 15.7 m -140.82 155.35 22.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.56 ' HG3' ' CG2' ' C' ' 81' ' ' VAL . 45.0 mtmt -134.35 114.18 12.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 169.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.637 176.349 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.897 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 95.0 m . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.516 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -133.93 170.44 15.62 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.205 -0.31 . . . . 0.0 110.674 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.546 HG22 ' CD2' ' C' ' 20' ' ' LEU . 2.6 p -112.09 145.21 40.15 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.639 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 29.5 m-85 -140.85 65.93 1.39 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.177 0.513 . . . . 0.0 110.895 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.613 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -60.32 121.7 8.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 123.384 1.564 . . . . 0.0 114.117 -174.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.556 HG11 ' CD2' ' C' ' 42' ' ' PHE . 10.9 m -125.08 -174.17 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 111.036 -2.802 . . . . 0.0 111.348 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.78 45.6 1.14 Allowed Glycine 0 C--N 1.317 -0.497 0 C-N-CA 119.78 -1.2 . . . . 0.0 114.119 -173.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.863 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 69.81 -26.29 0.15 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 169.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -163.33 25.51 0.09 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . 0.55 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 31.7 tpp -77.14 -68.75 0.58 Allowed 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 112.15 -2.295 . . . . 0.0 109.659 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.557 ' O ' ' HB ' ' C' ' 39' ' ' VAL . 18.2 m120 -142.69 -157.1 0.74 Allowed 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.595 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 2.8 p 159.68 -16.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.41 ' HD3' ' H ' ' C' ' 40' ' ' LYS . 0.0 OUTLIER -86.05 -70.48 0.6 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.248 -1.796 . . . . 0.0 108.24 169.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -62.68 -32.74 73.86 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.207 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.595 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -57.92 -51.69 68.57 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 173.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' C' ' 43' ' ' LYS . 31.3 mtpt -64.11 -39.3 93.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.99 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -56.6 -36.23 69.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.159 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -69.01 -39.79 79.08 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 122.911 0.484 . . . . 0.0 111.342 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.619 HD11 ' OE1' ' C' ' 57' ' ' GLN . 5.7 pt -84.55 -13.15 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.118 -175.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.32 -55.01 2.86 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.02 87.22 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -31.85 71.71 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.295 0.569 . . . . 0.0 110.868 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.547 HG22 ' O ' ' C' ' 46' ' ' ILE . 29.9 m -102.66 -2.06 9.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.033 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 84.3 p 63.12 23.55 13.99 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.812 0.815 . . . . 0.0 109.461 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' C' ' 57' ' ' GLN . 5.6 mm -130.45 115.29 17.2 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.781 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.524 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 4.5 Cg_exo -69.54 147.09 63.52 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.369 2.046 . . . . 0.0 111.061 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -51.37 -25.73 6.56 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.769 0.668 . . . . 0.0 112.059 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 10.2 pt-20 -70.75 -36.13 72.99 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.631 0.253 . . . . 0.0 111.568 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.428 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 98.4 mttt -98.43 -27.54 14.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.376 0.607 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.619 ' OE1' HD11 ' C' ' 46' ' ' ILE . 6.0 tt0 -68.36 136.44 53.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.239 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . 0.477 ' HB2' HG22 ' C' ' 85' ' ' VAL . 47.2 mtm180 -137.48 137.37 38.62 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.33 172.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.434 ' HB3' HG21 ' C' ' 82' ' ' ILE . 38.6 mt -96.28 123.61 39.98 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.957 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.562 HG21 ' O ' ' A' ' 37' ' ' ILE . 9.9 mt -112.84 122.29 66.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 119.227 0.921 . . . . 0.0 111.374 169.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.662 ' CD2' HG12 ' C' ' 77' ' ' VAL . 36.3 t80 -128.36 119.12 24.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.615 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 58.36 37.4 25.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.117 0.484 . . . . 0.0 110.414 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.46 -4.95 65.78 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.747 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.469 ' HA ' ' NE ' ' C' ' 64' ' ' ARG . 2.5 tpm_? -92.43 126.0 37.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -92.35 90.74 3.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.371 0.605 . . . . 0.0 110.559 -174.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.45 ' CD1' HG11 ' C' ' 77' ' ' VAL . 0.1 OUTLIER -72.6 154.59 40.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.738 -178.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -152.44 -170.47 3.65 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.214 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.568 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.8 p-10 -69.64 -2.37 11.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.174 0.589 . . . . 0.0 112.125 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.91 -9.98 11.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.545 ' HA ' HG11 ' C' ' 39' ' ' VAL . 52.9 mtmt 77.53 -175.51 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.739 0.815 . . . . 0.0 111.888 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.466 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 35.5 mmtp 75.09 69.02 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.634 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 30.7 mt -66.89 -39.75 87.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.563 -176.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -67.81 -19.87 65.12 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 120.793 0.33 . . . . 0.0 111.521 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 17.0 mm-40 -71.05 -27.08 63.39 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.447 ' CD1' HD22 ' C' ' 66' ' ' LEU . 25.2 m-85 -88.28 -25.11 22.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 61.7 t30 60.07 34.24 21.31 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.07 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.662 HG12 ' CD2' ' C' ' 61' ' ' TYR . 17.5 m -83.67 11.92 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -174.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.561 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -71.24 100.81 0.9 Allowed Glycine 0 N--CA 1.431 -1.661 0 CA-C-O 122.634 1.13 . . . . 0.0 113.298 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.5 13.41 28.28 Favored Glycine 0 C--N 1.285 -2.268 0 CA-C-N 112.123 -2.039 . . . . 0.0 115.804 170.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -136.04 148.56 48.41 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.68 0.74 . . . . 0.0 110.507 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.622 ' CG1' ' HB2' ' C' ' 20' ' ' LEU . 27.2 m -74.48 118.94 20.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 CA-C-O 121.97 0.89 . . . . 0.0 112.502 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' C' ' 59' ' ' LEU . 84.8 mt -70.76 160.6 5.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.514 173.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.412 ' N ' HG22 ' C' ' 82' ' ' ILE . 66.0 m-70 -115.56 117.65 30.93 Favored 'General case' 0 C--N 1.319 -0.761 0 O-C-N 121.338 -0.851 . . . . 0.0 109.564 173.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.45 ' CD1' ' HB ' ' C' ' 21' ' ' VAL . 10.2 mp -85.29 160.94 19.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.238 0.542 . . . . 0.0 111.699 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' C' ' 58' ' ' ARG . 5.6 m . . . . . 0 C--N 1.324 -0.522 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG2' HD12 ' A' ' 40' ' ' LEU . 43.4 ttm180 . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.283 0.563 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.509 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 6.3 m-85 -116.62 148.69 40.72 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.875 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.507 ' CB ' HD21 ' A' ' 40' ' ' LEU . 37.9 t80 -118.17 116.12 26.18 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.455 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.59 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -92.53 131.73 37.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.53 ' CD2' HG21 ' C' ' 85' ' ' VAL . 72.6 m-70 -85.8 -27.33 25.23 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -169.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.7 p -71.36 -30.63 66.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.319 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.425 ' O ' HG23 ' A' ' 18' ' ' VAL . 84.9 m -83.42 -33.01 25.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.091 0.472 . . . . 0.0 110.211 172.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.0 34.28 24.09 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.114 -173.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 16' ' ' CYS . 18.9 t -138.89 145.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.26 146.36 45.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.18 0.514 . . . . 0.0 112.003 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.804 HD12 ' HD3' ' A' ' 30' ' ' PRO . 2.3 pt -136.14 167.42 24.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.624 -172.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.63 111.39 31.41 Favored Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 159.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.509 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 22.2 Cg_endo -69.04 175.84 6.99 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 124.372 3.381 . . . . 0.0 115.687 -167.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.576 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 13.8 mtt180 -108.77 48.86 0.84 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.859 -1.973 . . . . 0.0 106.798 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.412 HD23 ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -1.05 -58.66 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.057 0 CA-C-N 110.964 -2.835 . . . . 0.0 117.056 171.213 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.435 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 20.0 Cg_exo -37.98 -33.98 0.29 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.706 2.271 . . . . 0.0 113.774 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.557 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.49 -21.0 10.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.777 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 65.49 56.27 0.97 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.356 1.074 . . . . 0.0 109.878 -169.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -109.59 162.85 7.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.38 -1.737 . . . . 0.0 109.606 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.5 t -97.46 147.53 33.12 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.804 ' HD3' HD12 ' A' ' 20' ' ' ILE . 65.6 Cg_endo -82.56 -19.82 6.08 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.851 2.367 . . . . 0.0 108.046 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.62 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 94.9 mtt-85 -82.69 -24.55 33.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 113.007 -1.906 . . . . 0.0 114.114 -178.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.6 p -147.2 -12.21 0.42 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 8.1 tt0 62.27 29.2 17.33 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.329 0.585 . . . . 0.0 111.02 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 m -106.26 146.76 29.94 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 170.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.27 44.47 3.29 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.572 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 95.4 m-85 -103.95 45.03 0.98 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.52 0.676 . . . . 0.0 109.851 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.671 HG21 ' CD1' ' A' ' 20' ' ' ILE . 10.7 pt -113.41 138.76 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.943 -176.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.499 ' HB3' HD13 ' C' ' 60' ' ' ILE . 13.4 pt-20 -129.57 143.85 51.01 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -79.5 133.39 36.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.024 0.44 . . . . 0.0 110.314 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.507 HD21 ' CB ' ' A' ' 12' ' ' PHE . 8.2 mt . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.708 -170.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 92.3 mmm . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 121.175 0.512 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.777 HD11 ' HA ' ' C' ' 35' ' ' ALA . 5.2 mt -90.37 137.73 32.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.093 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.62 ' HA ' HG13 ' C' ' 32' ' ' ILE . 41.4 tt0 -88.79 89.56 8.04 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.623 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 7.9 t -74.79 97.29 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.978 -173.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.899 ' HB3' HG12 ' C' ' 81' ' ' VAL . 4.4 mt -88.89 153.14 21.28 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' C' ' 28' ' ' THR . 33.9 m -144.81 147.55 18.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.343 0.257 . . . . 0.0 110.402 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.645 ' HE3' HG21 ' C' ' 81' ' ' VAL . 79.8 mttt -131.17 120.41 23.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . 0.413 HG22 ' O ' ' C' ' 84' ' ' LEU . 3.3 p . . . . . 0 C--N 1.315 -0.898 0 CA-C-O 120.811 0.339 . . . . 0.0 111.09 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.683 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 53.5 m . . . . . 0 C--O 1.235 0.315 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . 0.412 ' O ' HG22 ' C' ' 21' ' ' VAL . 78.4 mtt180 -131.57 172.36 12.32 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.148 -176.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 1.6 p -115.04 151.58 33.98 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.623 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 28.4 m-85 -137.46 58.64 1.7 Allowed 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 124.141 0.977 . . . . 0.0 109.812 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.62 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.4 mp -58.71 123.27 10.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 123.443 1.592 . . . . 0.0 114.38 -172.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.64 HG21 HD13 ' C' ' 72' ' ' LEU . 10.7 m -124.66 -170.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 110.79 -2.913 . . . . 0.0 111.635 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.94 45.42 1.21 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.725 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.777 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.06 17.12 9.51 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 165.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.652 ' HB3' ' O ' ' C' ' 35' ' ' ALA . 3.0 pt20 158.94 -9.08 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.292 0.568 . . . . 0.0 109.718 -162.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.2 tpt -39.83 -66.61 0.29 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.855 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.441 ' O ' HG12 ' C' ' 39' ' ' VAL . 26.2 m-80 -148.6 -88.52 0.08 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.692 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 89.29 -27.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 O-C-N 125.393 1.683 . . . . 0.0 111.559 -167.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -70.9 0.52 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.246 1.022 . . . . 0.0 108.873 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.46 -27.06 69.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.052 173.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.692 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.4 OUTLIER -56.74 -52.29 65.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.364 173.614 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 54.7 mtpt -61.02 -43.75 98.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.42 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -54.8 -39.19 68.2 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.306 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -70.23 -43.73 70.0 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.066 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.675 HG23 ' O ' ' C' ' 42' ' ' PHE . 3.9 pt -79.1 -11.66 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 120.458 0.17 . . . . 0.0 110.945 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.24 -55.48 3.29 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.793 0.683 . . . . 0.0 112.675 -177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.31 -39.45 74.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -27.96 69.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.053 0.454 . . . . 0.0 111.0 -176.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.592 HG22 ' O ' ' C' ' 46' ' ' ILE . 28.9 m -108.27 -0.9 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.445 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 84.3 p 63.48 23.63 13.75 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.868 0.842 . . . . 0.0 109.464 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.0 mm -128.7 114.13 19.23 Favored Pre-proline 0 N--CA 1.439 -1.007 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.721 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.2 145.99 39.94 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.688 2.259 . . . . 0.0 111.929 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 41.1 t -53.08 -25.56 13.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.647 -174.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.54 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.6 pt-20 -70.76 -27.44 63.94 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.726 0.298 . . . . 0.0 111.474 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.54 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 92.8 mttt -109.0 -22.43 12.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.504 0.668 . . . . 0.0 109.936 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.421 ' HA ' HG21 ' C' ' 52' ' ' ILE . 23.6 tt0 -65.03 122.85 17.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.158 -169.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -127.41 115.55 19.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.982 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.658 ' HB3' HG21 ' C' ' 82' ' ' ILE . 5.3 mp -86.04 105.6 16.6 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.556 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.4 mt -99.61 110.98 27.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 121.268 0.556 . . . . 0.0 111.811 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.487 ' CD2' HG12 ' C' ' 77' ' ' VAL . 50.0 t80 -122.12 121.02 35.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.261 173.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 60.31 39.32 19.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.983 0.421 . . . . 0.0 110.752 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.44 -1.45 27.73 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.679 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 6.2 mmp_? -88.73 140.46 29.42 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.44 87.87 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 0.0 110.611 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.603 ' HG ' ' CD1' ' C' ' 75' ' ' TYR . 6.1 mp -65.31 122.55 17.38 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.812 173.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . 0.428 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 19.1 pt20 -144.19 -170.21 3.3 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.23 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.613 ' HA ' HG13 ' C' ' 39' ' ' VAL . 2.2 p-10 -66.67 0.35 2.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.285 1.034 . . . . 0.0 112.599 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . 0.428 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 12.7 t70 -62.85 -2.68 1.25 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.516 0.726 . . . . 0.0 112.679 -177.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? 81.71 172.06 0.12 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.12 0.968 . . . . 0.0 112.977 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.488 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 42.1 mtmt 71.0 86.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.937 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.64 HD13 HG21 ' C' ' 33' ' ' VAL . 41.8 mt -71.68 -49.62 37.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.382 -176.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . 0.513 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 29.8 pt20 -67.91 -17.08 64.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . 0.488 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 7.0 mm-40 -63.67 -28.82 70.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.603 ' CD1' ' HG ' ' C' ' 66' ' ' LEU . 42.1 m-85 -85.11 -23.28 28.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.256 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.1 t30 59.72 30.04 19.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.377 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . 0.557 HG11 HD21 ' C' ' 66' ' ' LEU . 18.0 m -85.21 25.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -175.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.567 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -76.33 100.4 1.4 Allowed Glycine 0 N--CA 1.431 -1.65 0 CA-C-O 122.552 1.085 . . . . 0.0 111.929 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.95 13.23 34.63 Favored Glycine 0 C--N 1.284 -2.318 0 CA-C-N 112.364 -1.918 . . . . 0.0 114.278 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . 0.441 ' C ' ' HB2' ' C' ' 20' ' ' LEU . 8.2 mptt -126.19 144.19 50.86 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.142 0.471 . . . . 0.0 110.113 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.899 HG12 ' HB3' ' C' ' 20' ' ' LEU . 35.2 m -80.22 125.5 39.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.809 0.814 . . . . 0.0 111.524 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.658 HG21 ' HB3' ' C' ' 59' ' ' LEU . 42.6 mt -84.99 171.43 1.17 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.813 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.55 ' N ' HG22 ' C' ' 82' ' ' ILE . 49.2 m80 -118.48 113.97 22.14 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 121.759 -0.588 . . . . 0.0 110.131 174.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.475 HD13 ' HB ' ' C' ' 21' ' ' VAL . 8.6 mp -103.32 139.41 38.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.058 0.456 . . . . 0.0 110.756 178.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.53 HG21 ' CD2' ' A' ' 14' ' ' HIS . 7.1 m . . . . . 0 C--N 1.322 -0.625 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.734 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.591 0.234 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.567 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.1 m-85 -117.92 145.39 44.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 169.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -119.21 122.04 41.07 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.349 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.671 ' HB2' HG22 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -99.28 130.0 45.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.744 177.434 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -85.11 -26.57 26.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.43 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.4 p -70.33 -45.47 66.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.425 -174.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.461 ' O ' HG23 ' A' ' 18' ' ' VAL . 18.6 p -95.05 -0.88 53.24 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.918 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.9 p 50.5 43.18 27.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.586 1.155 . . . . 0.0 113.739 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 16' ' ' CYS . 32.1 t -133.3 144.69 35.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.8 148.27 40.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.739 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.1 pt -140.35 167.57 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.657 0.741 . . . . 0.0 112.93 -167.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.44 106.85 39.67 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 159.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.567 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 25.6 Cg_endo -68.74 175.64 6.97 Favored 'Trans proline' 0 C--N 1.32 -0.921 0 C-N-CA 124.688 3.592 . . . . 0.0 116.546 -166.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HB2' HG13 ' A' ' 28' ' ' ILE . 83.7 mtt180 -108.87 48.48 0.86 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 112.65 -2.068 . . . . 0.0 107.434 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.408 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -3.28 -59.53 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.85 0 CA-C-N 110.854 -2.885 . . . . 0.0 117.479 173.434 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 26.8 Cg_exo -37.25 -37.01 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 122.59 2.194 . . . . 0.0 113.53 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.556 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -112.22 -21.49 11.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.704 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 42.2 m-85 68.99 57.41 0.39 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.259 1.028 . . . . 0.0 110.057 -170.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.556 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -111.49 163.79 8.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.159 176.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 20' ' ' ILE . 1.5 t -95.72 142.4 24.53 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.739 ' HD3' HD12 ' A' ' 20' ' ' ILE . 91.9 Cg_endo -83.35 -18.82 5.75 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.074 1.85 . . . . 0.0 108.577 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.527 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 58.2 mtt180 -95.47 15.96 18.25 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.241 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 31' ' ' ARG . 14.3 p 175.64 -11.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.405 0.441 . . . . 0.0 111.901 172.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 10.4 tt0 63.95 29.71 14.35 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.197 0.522 . . . . 0.0 112.124 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -99.7 148.29 24.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.48 168.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.24 21.98 21.82 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.892 -175.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 74.9 m-85 -86.32 47.73 1.51 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.709 0.29 . . . . 0.0 110.985 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.705 HG21 ' CD1' ' A' ' 20' ' ' ILE . 6.6 pt -110.31 131.59 60.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.191 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HB3' HD13 ' C' ' 60' ' ' ILE . 9.3 pt-20 -118.63 145.94 45.05 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -78.79 143.43 36.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.24 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.148 -173.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.528 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 13.4 tmm? . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.773 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -106.3 142.76 35.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 172.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.581 ' HA ' HG13 ' C' ' 32' ' ' ILE . 38.8 tt0 -92.78 91.45 7.48 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 173.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' C' ' 30' ' ' THR . 2.9 t -76.2 103.1 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.757 -169.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.668 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -92.31 133.96 35.36 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.329 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.497 HG22 ' HB ' ' C' ' 82' ' ' ILE . 52.1 t -142.38 121.13 8.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -175.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.538 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 41.9 mtpt -95.7 154.09 17.39 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . 0.41 HG22 HD23 ' C' ' 84' ' ' LEU . 50.9 p . . . . . 0 C--N 1.306 -1.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.662 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 53.1 m . . . . . 0 C--O 1.233 0.211 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -129.22 151.45 49.88 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.629 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 4.2 p -104.87 144.12 32.21 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.522 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 35.8 m-85 -139.09 62.36 1.54 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.82 0.819 . . . . 0.0 110.147 -174.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.581 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.2 mp -60.25 122.75 11.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 123.221 1.486 . . . . 0.0 114.901 -173.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' C' ' 16' ' ' MET . 19.5 m -140.35 -166.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 111.116 -2.765 . . . . 0.0 112.377 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -80.33 177.84 54.16 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.79 174.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.773 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -79.8 -15.07 58.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.372 0.606 . . . . 0.0 111.476 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -161.93 27.75 0.12 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . 0.434 ' HB2' ' HA3' ' C' ' 34' ' ' GLY . 4.5 ttp -57.69 -75.95 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.394 -174.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.462 ' O ' HG12 ' C' ' 39' ' ' VAL . 11.7 m120 -121.97 -82.33 0.65 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 120.903 0.383 . . . . 0.0 111.401 -177.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.677 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 78.31 -25.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 O-C-N 124.95 1.406 . . . . 0.0 113.068 -173.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.15 -68.87 0.71 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 122.35 1.071 . . . . 0.0 109.075 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -57.77 -32.67 67.72 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.028 -1.896 . . . . 0.0 110.221 171.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.677 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -63.33 -50.46 69.93 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.999 176.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . 0.692 ' HG3' ' OE1' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -59.11 -48.34 81.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.824 0.345 . . . . 0.0 110.278 176.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -57.31 -33.05 67.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.438 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -69.72 -51.12 37.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.284 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.701 HD11 ' OE1' ' C' ' 57' ' ' GLN . 17.7 pt -74.97 -14.31 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.525 -177.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.36 -57.09 2.27 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 124.165 0.916 . . . . 0.0 113.293 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.12 87.44 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -57.4 -43.73 83.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.484 0.659 . . . . 0.0 110.485 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.612 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.1 m -88.16 -6.25 10.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.286 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m 67.87 21.1 9.14 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 121.62 0.724 . . . . 0.0 109.409 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.5 mm -129.67 111.81 17.6 Favored Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.325 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.55 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.0 Cg_exo -71.39 147.83 53.45 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.84 2.36 . . . . 0.0 111.554 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 37.9 t -51.15 -25.2 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.021 0.928 . . . . 0.0 112.81 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.487 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.5 pt-20 -78.14 -21.28 50.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 111.685 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.487 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 46.0 mtpt -112.9 -15.36 12.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.481 . . . . 0.0 110.195 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.701 ' OE1' HD11 ' C' ' 46' ' ' ILE . 9.6 tt0 -75.8 122.71 24.48 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.163 -174.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -121.73 124.2 43.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.743 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.51 HD11 ' HZ1' ' C' ' 43' ' ' LYS . 87.1 mt -88.29 118.23 27.75 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.436 HD13 ' HB3' ' A' ' 38' ' ' GLU . 5.7 mt -114.27 113.12 42.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.047 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -126.15 121.73 33.66 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' C' ' 62' ' ' GLN . 15.1 mt-30 59.95 38.39 20.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.792 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.03 -4.85 36.33 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.013 -0.54 . . . . 0.0 113.532 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -88.04 130.61 34.93 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.63 88.92 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.059 0.456 . . . . 0.0 109.848 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.536 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.3 OUTLIER -74.02 142.79 45.73 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -155.16 -168.65 2.93 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.042 -171.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.675 ' HA ' HG13 ' C' ' 39' ' ' VAL . 4.7 p-10 -60.78 -1.85 0.46 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.087 0.955 . . . . 0.0 113.421 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -68.53 -3.29 11.09 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.181 0.592 . . . . 0.0 112.165 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.506 ' H ' HG11 ' C' ' 39' ' ' VAL . 57.6 mttp 76.63 -165.45 0.06 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.862 0.865 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 mttt 68.69 55.85 0.46 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.463 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.614 HD21 HG23 ' C' ' 39' ' ' VAL . 31.1 mt -61.78 -33.04 73.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -71.72 -18.18 62.16 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 120.746 0.308 . . . . 0.0 111.575 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -76.44 -26.8 55.82 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.555 ' HD2' HD23 ' C' ' 72' ' ' LEU . 16.2 m-85 -82.63 -24.03 34.0 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 58.5 t30 62.88 41.52 8.6 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.596 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.26 -5.25 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-N 112.955 -1.929 . . . . 0.0 112.748 -158.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.692 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -52.58 104.92 0.2 Allowed Glycine 0 CA--C 1.487 -1.666 0 CA-C-O 123.329 1.516 . . . . 0.0 113.769 173.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.97 14.21 59.58 Favored Glycine 0 C--N 1.287 -2.194 0 CA-C-N 111.388 -2.406 . . . . 0.0 113.961 168.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -121.49 138.95 54.07 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.668 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 13.1 m -74.76 127.81 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 122.191 0.996 . . . . 0.0 111.46 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.5 HD13 HD12 ' C' ' 66' ' ' LEU . 12.6 mt -86.25 167.86 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.838 174.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.453 ' N ' HG22 ' C' ' 82' ' ' ILE . 65.2 m80 -118.92 115.3 24.08 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.41 HD23 HG22 ' C' ' 23' ' ' THR . 19.5 tp -92.45 132.79 36.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.276 0.56 . . . . 0.0 111.914 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 m . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.342 177.635 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HB3' HD12 ' A' ' 40' ' ' LEU . 77.6 mtp180 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 120.895 0.378 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.691 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.8 m-85 -116.25 144.82 43.72 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.412 173.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.53 ' CB ' HD21 ' A' ' 40' ' ' LEU . 53.8 t80 -114.24 121.59 44.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.762 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -98.43 119.52 37.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 174.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -76.88 -13.33 60.0 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.468 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 36.3 t -70.89 -42.04 70.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.353 0.597 . . . . 0.0 110.581 175.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -85.21 -27.03 26.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.581 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 1.6 m 58.09 29.5 17.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.214 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.37 144.25 34.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -74.82 147.64 40.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.177 0.513 . . . . 0.0 111.267 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.794 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.6 pt -133.36 169.7 21.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.841 -169.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.37 108.64 35.61 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 158.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.691 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 15.0 Cg_endo -69.06 177.49 5.05 Favored 'Trans proline' 0 C--N 1.328 -0.53 0 C-N-CA 125.181 3.921 . . . . 0.0 115.315 -170.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.6 ' HB2' HG13 ' A' ' 28' ' ' ILE . 8.2 mtt180 -112.57 50.46 0.87 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.592 174.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.509 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -0.3 -60.23 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 CA-C-N 111.334 -2.667 . . . . 0.0 116.365 172.316 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 24' ' ' LEU . 27.7 Cg_exo -34.79 -36.4 0.12 Allowed 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 123.045 2.497 . . . . 0.0 114.386 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.533 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -110.35 -22.92 11.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.72 178.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 66.24 49.26 1.51 Allowed 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.642 -168.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.6 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -98.17 162.18 2.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.07 174.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.542 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.8 t -97.63 147.1 32.53 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.794 ' HD3' HD12 ' A' ' 20' ' ' ILE . 66.6 Cg_endo -80.93 -22.84 5.9 Favored 'Trans proline' 0 CA--C 1.499 -1.261 0 C-N-CA 122.897 2.398 . . . . 0.0 108.21 -174.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.516 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 80.1 mtt-85 -81.66 -30.02 32.9 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 112.819 -1.991 . . . . 0.0 113.776 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.4 p -141.6 -7.02 0.99 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.429 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 17.6 tt0 59.47 27.37 16.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.552 0.691 . . . . 0.0 111.219 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -107.71 143.02 36.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.369 171.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.37 33.24 2.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.899 -0.667 . . . . 0.0 114.012 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 41.1 m-85 -89.54 45.08 1.25 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.101 0.477 . . . . 0.0 110.423 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.688 HG21 ' CD1' ' A' ' 20' ' ' ILE . 10.4 pt -112.32 132.48 60.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.227 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' C' ' 65' ' ' VAL . 7.5 pt-20 -120.08 136.23 54.66 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.95 137.57 39.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.971 0.415 . . . . 0.0 110.094 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.53 HD21 ' CB ' ' A' ' 12' ' ' PHE . 10.4 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.363 -172.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 45.5 ttm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.266 0.555 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -108.69 142.53 39.07 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.104 176.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.628 ' HA ' HG13 ' C' ' 32' ' ' ILE . 37.8 mt-10 -85.04 94.69 8.89 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.5 t -77.9 111.46 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.613 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.665 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.4 mt -100.02 146.97 26.12 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.67 HG21 ' HE2' ' C' ' 31' ' ' PHE . 9.4 m -137.32 153.9 29.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' LYS . . . . . 0.543 ' HG3' ' CG2' ' C' ' 81' ' ' VAL . 41.0 mtmt -125.77 133.18 52.14 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.314 -0.944 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.121 -172.418 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 25.5 m . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -131.21 157.55 42.91 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.442 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . 0.562 HG22 ' CD2' ' C' ' 20' ' ' LEU . 16.8 p -103.76 149.11 25.32 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -172.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' PHE . . . . . 0.67 ' HE2' HG21 ' C' ' 21' ' ' VAL . 27.6 m-85 -140.36 63.11 1.48 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.376 -177.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.628 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -59.17 122.69 9.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 122.973 1.368 . . . . 0.0 114.154 -174.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.639 HG11 ' CD1' ' C' ' 42' ' ' PHE . 13.9 m -135.74 -168.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 111.498 -2.592 . . . . 0.0 112.107 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.47 38.72 2.56 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.457 -0.878 . . . . 0.0 114.423 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' ALA . . . . . 0.734 ' HB2' HD21 ' C' ' 17' ' ' LEU . . . 71.09 16.99 6.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 163.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.733 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 9.7 tt0 153.43 -7.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.787 0.803 . . . . 0.0 108.933 -166.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' MET . . . . . 0.493 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 35.8 tpp -47.94 -66.52 0.39 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.296 173.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.493 ' OD1' ' HG3' ' C' ' 37' ' ' MET . 18.3 m120 -139.99 -162.68 1.38 Allowed 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 168.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.643 HG13 ' HA ' ' C' ' 68' ' ' ASP . 8.1 p 173.72 -19.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.538 ' HE2' ' HE2' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -83.05 -70.65 0.54 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.123 173.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -62.77 -32.45 73.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.531 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.639 ' CD1' HG11 ' C' ' 33' ' ' VAL . 5.9 t80 -59.05 -52.17 66.89 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.625 175.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -68.04 -35.67 78.64 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.638 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -56.39 -40.43 74.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.026 0.441 . . . . 0.0 111.133 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -69.56 -41.15 76.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.742 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' ILE . . . . . 0.625 ' O ' HG22 ' C' ' 50' ' ' VAL . 6.2 pt -76.59 -16.62 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -176.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -39.17 -59.57 1.0 Allowed 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.81 95.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -23.57 67.32 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.177 0.513 . . . . 0.0 111.097 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.628 HG21 ' OE1' ' C' ' 57' ' ' GLN . 26.7 m -108.91 -5.93 10.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.096 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t 69.17 19.63 7.86 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.558 0.694 . . . . 0.0 109.637 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 3.4 mm -129.26 118.4 19.22 Favored Pre-proline 0 N--CA 1.444 -0.761 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.726 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' PRO . . . . . 0.481 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 5.1 Cg_exo -70.1 146.67 58.75 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.121 1.88 . . . . 0.0 111.188 177.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' SER . . . . . 0.427 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 8.7 t -53.48 -26.18 19.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.009 -176.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.526 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.7 pt-20 -71.63 -32.45 67.96 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.899 0.38 . . . . 0.0 110.998 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 57.4 mtpt -99.45 -24.42 14.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.36 0.6 . . . . 0.0 110.123 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.628 ' OE1' HG21 ' C' ' 50' ' ' VAL . 6.2 tt0 -69.2 122.64 19.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.728 -173.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -112.02 122.63 48.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.674 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 95.3 mt -88.46 110.75 21.1 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.463 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.2 mt -108.64 113.88 45.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.95 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -133.54 132.54 41.05 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 59.11 34.21 23.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.401 -173.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 67.83 2.31 22.58 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.777 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -91.16 136.48 33.06 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -90.64 89.18 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.43 0.633 . . . . 0.0 109.563 -176.332 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.562 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.3 OUTLIER -73.67 140.94 46.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.918 178.577 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -153.53 -169.31 3.26 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.561 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' ASP . . . . . 0.643 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.4 p-10 -65.56 -0.43 2.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.268 0.627 . . . . 0.0 112.161 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 38.4 t70 -58.32 -10.9 2.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.296 1.038 . . . . 0.0 113.367 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.538 ' HE2' ' HE2' ' C' ' 40' ' ' LYS . 89.5 mttt 85.6 175.16 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.285 1.034 . . . . 0.0 113.226 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 64.74 86.02 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.916 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.621 ' HB2' ' C ' ' C' ' 35' ' ' ALA . 57.9 mt -75.42 -34.15 60.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.41 -19.3 65.76 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 120.699 0.285 . . . . 0.0 111.636 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -68.8 -28.41 66.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' TYR . . . . . 0.562 ' CD1' HD22 ' C' ' 66' ' ' LEU . 20.9 m-85 -85.85 -23.26 27.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.1 t30 61.07 36.52 18.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.848 -1.524 . . . . 0.0 110.852 171.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.04 25.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.711 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.723 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -72.14 95.14 0.65 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-O 122.203 0.89 . . . . 0.0 113.074 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.64 14.77 45.73 Favored Glycine 0 C--N 1.305 -1.179 0 CA-C-N 113.341 -1.429 . . . . 0.0 113.508 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -119.01 149.82 40.99 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.052 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.665 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 10.5 m -82.68 124.07 39.04 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-O 122.299 1.047 . . . . 0.0 111.177 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' ILE . . . . . 0.481 HG22 ' N ' ' C' ' 83' ' ' HIS . 68.2 mt -81.95 167.3 2.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.925 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' HIS . . . . . 0.481 ' N ' HG22 ' C' ' 82' ' ' ILE . 54.8 m80 -118.71 115.11 23.82 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.446 HD21 HG11 ' C' ' 50' ' ' VAL . 4.3 pp -113.94 151.47 32.24 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.051 -1.059 . . . . 0.0 112.562 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.415 0 CA-C-N 113.174 -1.83 . . . . 0.0 110.352 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 18.4 m -54.91 -41.49 71.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.324 0.583 . . . . 0.0 109.72 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 ttm -95.89 123.89 39.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.064 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' A' ' 5' ' ' SER . . . 66.48 90.38 0.09 Allowed 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.869 0.731 . . . . 0.0 111.013 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.2 pm0 -66.24 114.23 5.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.225 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.61 22.61 9.99 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.008 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.591 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 23.2 t -118.72 113.46 36.25 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.44 96.46 1.04 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.726 2.284 . . . . 0.0 111.966 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -88.21 131.47 42.49 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.561 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -87.6 22.7 0.87 Allowed 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 123.242 2.628 . . . . 0.0 114.019 -168.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.75 -4.96 86.98 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -121.12 92.2 3.7 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.861 -0.2 . . . . 0.0 110.707 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 10.0 m-85 -120.67 165.29 15.27 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 167.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CB ' HD21 ' A' ' 40' ' ' LEU . 75.4 t80 -137.22 117.44 13.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.687 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -97.55 120.95 38.86 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -74.69 -15.64 60.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.748 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.6 m -70.78 -37.28 73.34 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.937 0.399 . . . . 0.0 111.147 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' HG23 ' A' ' 18' ' ' VAL . 90.5 m -89.48 -16.0 31.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.695 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 p 49.64 31.35 4.2 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.256 -171.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 16' ' ' CYS . 98.0 t -141.13 146.91 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.539 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 25.5 tt0 -70.39 149.0 47.75 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.343 0.402 . . . . 0.0 111.235 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.703 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.4 pt -138.12 167.01 22.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.477 -173.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.496 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 40.5 t -122.96 96.68 44.67 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 163.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.662 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.88 177.12 0.19 Allowed 'Trans proline' 0 C--N 1.325 -0.691 1 C-N-CA 125.455 4.103 . . . . 0.0 116.426 -170.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.544 ' HB2' HG13 ' A' ' 28' ' ' ILE . 36.7 mtt180 -112.97 51.01 0.85 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 112.818 -1.992 . . . . 0.0 107.565 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' A' ' 27' ' ' TYR . 3.1 mm? 3.0 -60.81 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.213 0 CA-C-N 111.507 -2.588 . . . . 0.0 117.555 171.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 32.6 Cg_exo -37.12 -32.84 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.613 2.209 . . . . 0.0 113.826 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.558 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -118.29 -20.39 8.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.558 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.41 ' C ' HD11 ' A' ' 37' ' ' ILE . 44.1 m-85 65.25 46.66 2.59 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.57 1.176 . . . . 0.0 109.767 -170.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -92.0 163.77 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 113.315 -1.766 . . . . 0.0 109.793 174.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -94.29 144.49 28.1 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.678 ' HD3' HD12 ' A' ' 20' ' ' ILE . 68.3 Cg_endo -80.72 -22.43 6.45 Favored 'Trans proline' 0 CA--C 1.5 -1.208 0 C-N-CA 122.711 2.274 . . . . 0.0 108.083 -171.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 51.6 mtt180 -81.24 -34.76 31.92 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.968 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.4 p -139.27 -8.42 1.31 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.333 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 60.11 25.98 15.32 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.0 m -98.5 133.69 42.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 166.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.03 30.76 2.62 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.007 -172.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 51.8 m-85 -86.58 47.99 1.56 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.498 0.666 . . . . 0.0 109.842 176.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.703 HG21 ' CD1' ' A' ' 20' ' ' ILE . 9.6 pt -111.33 133.45 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.382 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' HB3' HD13 ' C' ' 60' ' ' ILE . 11.5 pt-20 -117.2 141.48 48.23 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -79.29 131.99 36.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.206 0.527 . . . . 0.0 109.848 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.452 HD21 ' CB ' ' A' ' 12' ' ' PHE . 2.5 mt . . . . . 0 C--O 1.25 1.12 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.877 -173.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.16 107.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.743 0.652 . . . . 0.0 111.762 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 38.7 m80 65.14 46.26 2.78 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.823 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -83.88 -59.04 2.54 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 38.7 t60 51.13 54.09 11.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.512 0.672 . . . . 0.0 111.53 174.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -145.91 76.73 1.47 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 52.9 m80 67.5 87.94 0.12 Allowed 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 124.064 0.853 . . . . 0.0 108.915 -171.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -56.63 -29.35 62.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.563 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.7 148.85 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.886 0.85 . . . . 0.0 110.353 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -158.15 -40.47 0.06 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.088 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -69.76 -68.43 0.41 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.321 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.98 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.75 0.656 . . . . 0.0 111.559 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.21 -29.07 54.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.294 0.568 . . . . 0.0 109.986 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . 0.514 ' HA ' ' HB2' ' C' ' 35' ' ' ALA . 51.4 mtpt -72.69 -174.99 1.55 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.703 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.505 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 12.2 tpt 69.12 96.86 0.06 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.463 0.477 . . . . 0.0 110.335 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.735 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -99.19 148.29 24.25 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.543 ' HA ' HG13 ' C' ' 32' ' ' ILE . 30.2 tt0 -98.72 91.58 5.17 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.3 t -78.79 106.11 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.443 -168.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.614 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -94.64 140.93 29.21 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' C' ' 82' ' ' ILE . 70.7 t -151.68 120.44 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 37.7 mtpt -95.54 159.18 15.12 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 63.3 p -106.89 -42.23 4.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.783 -171.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.78 -46.57 0.06 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.731 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -178.07 -48.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.154 0.502 . . . . 0.0 110.158 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 10.9 t -62.53 -40.4 96.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.85 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -108.12 176.07 5.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.521 1.153 . . . . 0.0 113.637 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 22.8 m -176.68 102.88 0.06 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.146 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -125.59 152.89 44.51 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.63 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p -99.1 145.42 27.16 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.162 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.478 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 29.0 m-85 -135.88 58.54 1.74 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.654 -175.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.543 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -57.35 122.29 6.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 123.381 1.563 . . . . 0.0 114.362 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -142.94 -165.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 110.677 -2.965 . . . . 0.0 111.39 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -81.57 -179.85 53.13 Favored Glycine 0 C--N 1.312 -0.769 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.123 174.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.735 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -78.78 -23.83 45.04 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-N 117.254 0.527 . . . . 0.0 110.132 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -151.75 23.08 0.69 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -162.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . 0.49 ' HB2' ' HA3' ' C' ' 34' ' ' GLY . 25.5 ttt -73.6 -68.75 0.48 Allowed 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 111.409 -2.632 . . . . 0.0 110.805 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.454 ' OD1' ' HG2' ' C' ' 37' ' ' MET . 23.6 m120 -126.19 -94.52 0.46 Allowed 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.585 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 82.94 -38.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 O-C-N 124.305 1.003 . . . . 0.0 111.128 -162.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.528 ' HA ' ' CB ' ' C' ' 68' ' ' ASP . 0.0 OUTLIER -78.97 -69.46 0.57 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 122.512 1.148 . . . . 0.0 108.939 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . 0.413 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 20.7 mt-10 -63.08 -27.82 69.66 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.902 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.585 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 2.6 t80 -59.05 -50.34 74.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.328 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.485 ' HE3' ' OG ' ' C' ' 54' ' ' SER . 23.1 mtpp -60.61 -41.27 94.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.988 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -57.73 -38.39 75.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.175 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -70.43 -45.97 64.81 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.209 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.602 ' O ' HG22 ' C' ' 50' ' ' VAL . 17.0 pt -76.78 -10.63 13.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -174.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -43.92 -49.46 8.42 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.63 -38.28 48.28 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.707 -0.397 . . . . 0.0 112.065 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -28.21 69.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.987 0.422 . . . . 0.0 110.996 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.602 HG22 ' O ' ' C' ' 46' ' ' ILE . 34.8 m -109.11 -5.84 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.47 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 46.1 m 68.13 20.65 8.9 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 121.629 0.728 . . . . 0.0 109.768 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.6 mm -122.95 111.2 30.97 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.546 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 7.1 Cg_exo -70.49 141.6 42.65 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.61 2.207 . . . . 0.0 111.695 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.485 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 42.8 t -50.75 -26.19 5.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.73 -173.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.402 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 13.4 pt-20 -72.75 -36.31 67.69 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.402 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 89.0 mttt -94.85 -32.28 13.33 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.741 0.782 . . . . 0.0 109.468 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.465 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 20.8 tt0 -51.92 132.43 32.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.664 -1.607 . . . . 0.0 111.48 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -133.95 113.02 11.73 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.524 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 37.8 mt -84.89 118.38 24.48 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 38' ' ' GLU . 5.4 mt -117.25 121.17 67.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.664 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -137.85 132.82 33.12 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 59.15 32.87 22.45 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.534 0.521 . . . . 0.0 110.14 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 67.85 4.18 32.47 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.87 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -88.7 142.08 27.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -90.24 89.41 3.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.631 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -81.14 131.86 35.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' C' ' 69' ' ' ASP . 9.3 pt20 -144.67 -177.32 5.44 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.536 -176.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.547 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.7 p-10 -70.51 -3.22 16.87 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.751 0.821 . . . . 0.0 112.033 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . 0.426 ' H ' ' HG3' ' C' ' 67' ' ' GLN . 33.1 t70 -70.32 -21.63 62.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -174.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -131.85 -142.22 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.196 -0.315 . . . . 0.0 111.442 -169.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' C' ' 71' ' ' LYS . 9.9 mptt -126.64 167.17 16.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.623 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.487 HD23 HG23 ' C' ' 39' ' ' VAL . 7.3 mt -70.61 -37.31 73.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.022 0.439 . . . . 0.0 111.758 -175.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' C' ' 35' ' ' ALA . 23.1 tp60 -70.66 -18.65 62.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.521 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -61.61 -29.41 70.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.83 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.631 ' CD1' HD22 ' C' ' 66' ' ' LEU . 36.8 m-85 -103.66 -18.62 14.65 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.65 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.8 t30 59.22 52.6 5.96 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.904 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 35.1 m -95.23 14.98 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -171.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -57.56 99.27 0.1 OUTLIER Glycine 0 CA--C 1.492 -1.381 0 CA-C-O 122.915 1.286 . . . . 0.0 113.789 171.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.94 14.92 47.4 Favored Glycine 0 C--N 1.284 -2.328 0 CA-C-N 111.877 -2.162 . . . . 0.0 114.132 171.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.35 141.19 50.29 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 122.495 -0.414 . . . . 0.0 110.642 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.614 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 21.2 m -78.37 123.96 36.02 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-O 121.932 0.872 . . . . 0.0 111.104 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' C' ' 21' ' ' VAL . 66.3 mt -82.6 168.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.0 172.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.501 ' N ' HG22 ' C' ' 82' ' ' ILE . 62.5 m80 -118.27 115.5 24.86 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 15.0 mt -88.42 148.73 24.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.17 0.51 . . . . 0.0 111.452 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.6 164.56 15.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.133 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.12 124.48 45.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.398 177.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -98.81 175.35 5.99 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.185 0.517 . . . . 0.0 111.251 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.77 148.97 95.12 Favored Pre-proline 0 N--CA 1.443 -0.793 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' C' ' 90' ' ' PRO . 41.4 Cg_exo -55.74 135.46 69.62 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.939 1.759 . . . . 0.0 111.639 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' C' ' 89' ' ' PRO . 68.8 Cg_endo -94.13 49.25 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.134 2.556 . . . . 0.0 112.227 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -74.41 -27.49 60.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.387 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 11.6 t -80.16 -20.16 45.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.381 0.61 . . . . 0.0 109.822 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -87.91 -30.6 19.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.044 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 48.8 tp -119.4 90.0 41.52 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.642 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.71 153.05 64.8 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.591 2.194 . . . . 0.0 111.294 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 46.3 t 65.63 88.35 0.11 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.341 0.591 . . . . 0.0 110.516 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.33 46.4 2.82 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.527 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.51 -59.38 1.95 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.759 0.314 . . . . 0.0 110.246 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 69.8 m -69.53 107.69 3.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.738 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 33.0 m 59.15 42.78 18.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.831 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.93 0 CA-C-O 119.195 -0.781 . . . . 0.0 111.471 -179.457 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.0 t -163.3 141.72 8.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.912 0.387 . . . . 0.0 110.798 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt -144.2 108.2 4.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.924 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.82 56.9 1.79 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.266 0.555 . . . . 0.0 110.714 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -83.7 61.61 6.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.742 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.79 87.56 5.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.34 -175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 t 66.32 96.22 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.845 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.72 83.8 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 123.031 2.487 . . . . 0.0 112.308 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -80.02 -45.08 1.48 Allowed Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -87.33 52.81 2.49 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 122.021 1.814 . . . . 0.0 111.593 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.45 ' O ' HG22 ' A' ' 21' ' ' VAL . . . 159.5 110.29 0.27 Allowed Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.742 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -139.4 86.03 2.09 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.443 -0.878 . . . . 0.0 109.547 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.605 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 9.0 m-85 -115.88 169.6 9.11 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.513 -1.222 . . . . 0.0 108.39 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.642 ' HB2' HD21 ' A' ' 40' ' ' LEU . 38.4 t80 -142.0 113.62 7.83 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.917 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 31.6 p -83.09 87.67 6.9 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.813 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.535 ' CE1' HG13 ' C' ' 85' ' ' VAL . 30.3 p80 -66.17 -14.72 62.32 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.619 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.766 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 3.0 p -67.08 -49.08 66.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.044 0.449 . . . . 0.0 110.437 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.9 -5.61 28.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.626 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.2 m 65.16 55.44 1.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.034 172.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.94 145.36 24.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.4 tt0 -86.25 138.92 31.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.132 0.492 . . . . 0.0 110.709 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.783 HD11 HG21 ' A' ' 37' ' ' ILE . 6.2 pt -143.49 166.87 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -164.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 9' ' ' GLY . 46.5 t -120.07 94.81 48.89 Favored Pre-proline 0 N--CA 1.447 -0.578 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 160.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 9.8 Cg_endo -56.73 171.36 1.03 Allowed 'Trans proline' 0 C--N 1.32 -0.965 1 C-N-CA 125.479 4.119 . . . . 0.0 117.186 -167.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HB2' HG13 ' A' ' 28' ' ' ILE . 98.3 mtt180 -101.91 47.48 0.9 Allowed 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 112.4 -2.182 . . . . 0.0 107.205 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -8.53 -54.25 0.01 OUTLIER Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 110.467 -3.06 . . . . 0.0 115.606 172.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 19.2 Cg_exo -35.27 -33.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 123.216 2.611 . . . . 0.0 114.512 173.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.511 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -122.91 -19.01 6.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.121 0.486 . . . . 0.0 111.42 177.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.482 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 90.5 m-85 73.04 53.28 0.13 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.162 -174.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -108.78 164.16 5.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 113.628 -1.624 . . . . 0.0 108.086 177.21 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 27.1 p -94.49 139.12 22.24 Favored Pre-proline 0 N--CA 1.424 -1.733 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.638 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 85.4 Cg_endo -78.63 -25.31 6.67 Favored 'Trans proline' 0 CA--C 1.493 -1.545 0 C-N-CA 123.535 2.823 . . . . 0.0 108.822 -166.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 52.9 mtt180 -79.68 -28.86 40.67 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.381 -2.19 . . . . 0.0 113.162 -175.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -157.7 9.8 0.18 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.322 -170.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 49.48 64.24 1.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 167.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.554 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -133.3 147.88 51.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.169 169.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -88.46 6.85 83.13 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.49 -0.862 . . . . 0.0 114.089 -170.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.766 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 69.8 m-85 -83.4 59.46 5.07 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.505 -0.409 . . . . 0.0 111.485 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.783 HG21 HD11 ' A' ' 20' ' ' ILE . 3.5 pt -112.73 141.56 27.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.07 0.462 . . . . 0.0 111.769 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.539 ' HB3' HD13 ' C' ' 60' ' ' ILE . 9.9 pt-20 -129.23 153.71 47.51 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -84.78 143.4 29.14 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.642 HD21 ' HB2' ' A' ' 12' ' ' PHE . 7.9 mt . . . . . 0 C--N 1.311 -1.066 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.899 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.495 0.188 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.34 41.19 31.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.554 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -99.17 21.02 12.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.468 0.651 . . . . 0.0 110.144 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' C' ' 6' ' ' HIS . 6.5 p-80 -93.05 60.9 3.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.074 171.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' C' ' 5' ' ' HIS . 44.9 m80 67.72 95.33 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.191 -167.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -77.32 66.09 3.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.769 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -83.93 141.32 31.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.42 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 61.56 83.89 0.14 Allowed 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.503 0.502 . . . . 0.0 110.615 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.99 147.55 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.362 0.601 . . . . 0.0 110.551 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -145.51 45.47 1.3 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.239 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -98.3 20.5 12.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.292 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.06 146.17 53.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.261 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.44 -10.63 59.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.501 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 48.6 mttm 46.64 -170.62 0.01 OUTLIER 'General case' 0 C--N 1.339 0.117 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.657 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 24.6 ptt? -171.79 111.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.193 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.882 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.4 OUTLIER -104.09 133.07 49.65 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 170.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.608 ' HA ' HG13 ' C' ' 32' ' ' ILE . 26.0 mt-10 -80.45 96.56 6.78 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.614 HG22 HG23 ' C' ' 77' ' ' VAL . 3.0 t -81.63 104.64 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.5 -172.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -93.31 141.78 28.05 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.621 HG22 ' HB ' ' C' ' 82' ' ' ILE . 69.5 t -147.84 118.09 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 118.219 0.463 . . . . 0.0 110.781 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.637 ' HG2' ' OG1' ' C' ' 28' ' ' THR . 73.5 mttt -100.09 115.05 28.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.417 HG21 HG12 ' C' ' 50' ' ' VAL . 0.1 OUTLIER -98.55 -173.24 2.5 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 32.3 mt -82.11 -60.3 2.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.433 0.635 . . . . 0.0 111.021 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -91.01 -18.53 24.46 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.883 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -103.33 -40.33 6.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.798 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 67.25 -177.36 0.2 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.74 0.816 . . . . 0.0 112.564 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.637 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 22.0 m -38.69 101.34 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.591 -175.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -126.67 154.72 43.69 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.332 -1.304 . . . . 0.0 109.547 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 2.4 p -103.03 141.91 35.01 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.489 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 26.8 m-85 -138.08 59.54 1.65 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.247 0.546 . . . . 0.0 109.991 -173.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.608 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.2 mp -54.88 125.46 9.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 123.04 1.4 . . . . 0.0 114.501 -173.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.754 HG21 HD13 ' C' ' 72' ' ' LEU . 15.6 m -132.7 -169.23 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 111.892 -2.413 . . . . 0.0 111.429 -176.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.68 40.85 1.99 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.239 -0.982 . . . . 0.0 114.323 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.882 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 70.07 -28.67 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 168.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -154.48 24.7 0.46 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -76.2 -68.11 0.62 Allowed 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 112.51 -2.132 . . . . 0.0 111.046 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.441 ' O ' HG12 ' C' ' 39' ' ' VAL . 10.9 m120 -132.29 -87.51 0.45 Allowed 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.655 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 82.41 -37.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 O-C-N 124.746 1.279 . . . . 0.0 111.372 -166.033 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.97 -68.17 0.66 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 122.591 1.186 . . . . 0.0 108.653 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.29 -28.0 69.42 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 112.616 -2.084 . . . . 0.0 110.819 173.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.655 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.2 t80 -58.32 -49.52 76.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.89 174.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.519 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 14.9 mtpp -62.97 -41.2 99.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.92 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -61.63 -37.29 83.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.035 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -70.35 -43.2 70.68 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.532 ' O ' HG22 ' C' ' 50' ' ' VAL . 18.2 pt -76.87 -12.13 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.281 -0.262 . . . . 0.0 110.948 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.94 -55.51 3.71 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 -42.82 91.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -21.64 65.64 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.241 0.543 . . . . 0.0 111.276 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.532 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.7 m -112.31 -3.69 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.44 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 32.9 t 65.8 22.42 11.47 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.843 0.83 . . . . 0.0 109.049 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 11.5 mm -131.35 111.76 15.36 Favored Pre-proline 0 N--CA 1.437 -1.095 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.799 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.507 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 7.2 Cg_exo -68.29 151.68 76.3 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.496 2.13 . . . . 0.0 111.445 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.501 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 32.0 t -51.99 -32.65 34.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.572 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.596 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 13.5 pt-20 -66.26 -33.06 74.9 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.815 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.596 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 90.6 mttt -106.56 -1.04 23.4 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.371 0.605 . . . . 0.0 110.518 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.519 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 24.0 tt0 -90.21 123.62 34.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.109 -168.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.476 ' O ' HG23 ' C' ' 85' ' ' VAL . 29.1 mtm105 -121.77 115.4 22.6 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.402 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 53.5 mt -87.94 122.68 31.84 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 122.452 0.301 . . . . 0.0 110.968 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.539 HD13 ' HB3' ' A' ' 38' ' ' GLU . 8.8 mt -114.63 112.07 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 121.494 -0.754 . . . . 0.0 111.39 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.5 ' CG ' HG12 ' C' ' 77' ' ' VAL . 41.0 t80 -116.62 133.12 56.39 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . 0.486 ' HG2' ' CD2' ' C' ' 61' ' ' TYR . 2.3 pt20 39.55 46.14 1.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.142 0.901 . . . . 0.0 112.153 -174.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.71 5.2 63.61 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.864 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -94.85 141.64 28.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.88 98.39 7.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.175 0.512 . . . . 0.0 109.951 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.54 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.0 OUTLIER -90.26 152.09 21.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.228 -176.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -158.14 -166.79 2.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.32 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.621 ' HA ' HG13 ' C' ' 39' ' ' VAL . 5.1 p-10 -62.49 0.54 0.46 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.052 0.941 . . . . 0.0 112.592 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.59 -11.65 0.96 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.376 1.071 . . . . 0.0 112.957 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.548 ' H ' HG11 ' C' ' 39' ' ' VAL . 7.8 mtmp? 84.55 167.43 0.09 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.481 1.112 . . . . 0.0 113.429 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 68.29 83.79 0.16 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.053 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.754 HD13 HG21 ' C' ' 33' ' ' VAL . 13.6 mt -64.47 -32.19 73.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.513 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . 0.428 ' H ' ' HG2' ' C' ' 73' ' ' GLN . 4.6 pt20 -68.83 -29.07 67.33 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.641 -176.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.49 -27.73 67.25 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.54 ' CD1' HD22 ' C' ' 66' ' ' LEU . 30.7 m-85 -82.96 -23.11 33.56 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.5 t30 63.44 36.67 11.2 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.707 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.614 HG23 HG22 ' C' ' 19' ' ' VAL . 20.0 m -85.25 26.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.646 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -86.09 102.36 2.68 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-O 122.926 1.292 . . . . 0.0 113.441 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.89 13.26 56.83 Favored Glycine 0 C--N 1.285 -2.29 0 CA-C-N 112.266 -1.967 . . . . 0.0 114.022 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -133.58 152.53 51.91 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 18.4 m -79.11 126.07 38.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.904 0.859 . . . . 0.0 112.62 -175.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.621 ' HB ' HG22 ' C' ' 21' ' ' VAL . 46.2 mt -71.21 161.68 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.339 168.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.432 ' N ' HG22 ' C' ' 82' ' ' ILE . 45.5 m80 -116.01 113.0 22.63 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 171.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.446 ' CD1' HG11 ' C' ' 50' ' ' VAL . 1.6 mt -85.84 157.86 20.11 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.504 -176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.535 HG13 ' CE1' ' A' ' 14' ' ' HIS . 2.7 t -114.65 147.83 17.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 174.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -126.41 122.43 35.28 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.501 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -93.01 176.73 6.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.828 0.347 . . . . 0.0 111.69 -171.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.37 154.59 42.01 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.89 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.8 149.59 40.59 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.605 2.203 . . . . 0.0 111.381 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.61 135.61 39.53 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.625 2.217 . . . . 0.0 112.325 -173.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -68.35 -25.5 65.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.395 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 6.4 t 35.97 65.32 0.44 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 124.577 1.173 . . . . 0.0 113.303 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -66.32 -46.94 75.15 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.21 113.79 60.98 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.537 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.49 140.4 93.11 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.678 2.252 . . . . 0.0 112.407 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 32.5 t -58.79 125.78 24.91 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.366 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.08 -23.89 2.41 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.67 40.55 2.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.126 0.489 . . . . 0.0 110.916 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 15.9 t -78.49 -20.26 51.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.486 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 68.8 p -74.64 110.24 8.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.539 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.348 -1.251 . . . . 0.0 111.704 178.535 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.8 t -74.43 118.92 17.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.859 0.361 . . . . 0.0 110.202 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.51 89.98 1.89 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.44 18.79 7.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.214 0.53 . . . . 0.0 110.276 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -96.75 141.85 29.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.002 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.84 -24.91 40.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.083 0.468 . . . . 0.0 110.073 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -152.41 74.5 7.35 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.124 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.64 -43.6 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.141 1.894 . . . . 0.0 111.834 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 6.4 p-80 -169.08 136.53 1.55 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.707 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 77.8 Cg_endo -95.54 57.24 0.19 Allowed 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 123.763 2.975 . . . . 0.0 111.799 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.23 16.27 0.29 Allowed Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.76 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 10.9 ptt180 -71.37 106.21 3.81 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.852 0.834 . . . . 0.0 110.907 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.544 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 8.6 m-85 -122.43 174.05 7.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.701 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CB ' HD11 ' A' ' 40' ' ' LEU . 79.1 t80 -142.05 121.27 13.04 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.119 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -100.98 120.29 39.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.812 176.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.521 ' CD2' HG21 ' C' ' 85' ' ' VAL . 62.6 m-70 -74.43 -16.24 60.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.565 -175.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.97 -35.8 72.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.42 ' O ' HG23 ' A' ' 18' ' ' VAL . 88.0 m -91.71 -23.84 19.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.313 0.578 . . . . 0.0 110.319 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.411 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER 56.23 31.42 18.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.421 -173.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 16' ' ' CYS . 39.7 t -136.82 148.31 26.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.763 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 32.3 tt0 -67.19 147.34 53.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.895 0.379 . . . . 0.0 111.326 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.773 ' CD1' HG21 ' A' ' 37' ' ' ILE . 4.2 pt -139.89 168.73 17.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.564 -175.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 94.0 t -126.4 101.29 28.04 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 162.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 6.0 Cg_endo -56.39 174.77 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 125.273 3.982 . . . . 0.0 116.736 -171.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.505 ' HB2' HG13 ' A' ' 28' ' ' ILE . 8.6 mtt180 -107.25 47.2 0.89 Allowed 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.875 175.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 1.6 -61.73 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.941 0 CA-C-N 110.783 -2.917 . . . . 0.0 116.912 175.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 39.2 Cg_exo -30.24 -34.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 124.017 3.145 . . . . 0.0 114.904 175.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.571 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.86 -19.65 9.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 54.7 m-85 68.79 47.62 0.81 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.41 -171.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -101.24 161.47 3.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.237 176.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.9 OUTLIER -97.35 145.54 29.83 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.759 ' HD3' HD12 ' A' ' 20' ' ' ILE . 83.2 Cg_endo -84.26 -15.61 6.44 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 C-N-CA 122.415 2.077 . . . . 0.0 108.864 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.542 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 60.1 mtt-85 -85.12 -21.37 29.3 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.354 -1.748 . . . . 0.0 114.074 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.2 p -149.03 -7.25 0.37 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 58.22 30.81 19.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.803 0.811 . . . . 0.0 111.207 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.7 m -112.47 139.22 48.23 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.583 172.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.38 53.72 4.69 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.419 -173.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.711 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 84.5 m-85 -112.18 46.67 1.13 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.413 0.625 . . . . 0.0 110.011 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.773 HG21 ' CD1' ' A' ' 20' ' ' ILE . 3.4 pt -112.15 138.54 40.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.41 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HB2' HG22 ' C' ' 65' ' ' VAL . 11.2 pt-20 -117.18 141.92 47.68 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -73.6 142.74 46.55 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.161 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 111.547 0.202 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.53 7.91 2.16 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.738 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -154.78 37.39 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.359 0.6 . . . . 0.0 110.8 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -111.88 -61.8 1.66 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -78.97 93.13 5.03 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -76.18 101.84 5.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.452 0.644 . . . . 0.0 111.704 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -80.16 56.42 2.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -148.98 88.34 1.59 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.93 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.87 150.9 3.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.945 0.403 . . . . 0.0 110.659 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -117.15 41.39 2.78 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 122.192 0.996 . . . . 0.0 108.662 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.27 166.46 13.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.388 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 16.8 t70 81.96 -16.4 0.62 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.645 0.778 . . . . 0.0 111.464 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.22 -55.23 11.2 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 71.1 mttt 46.22 -175.27 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.97 -52.02 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.18 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.948 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.8 OUTLIER -102.86 131.03 50.05 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 111.456 -172.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.593 ' HA ' HG13 ' C' ' 32' ' ' ILE . 41.9 tt0 -88.01 94.43 9.79 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 5.6 t -80.75 104.87 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.513 -173.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.728 ' HB3' HG12 ' C' ' 81' ' ' VAL . 1.0 OUTLIER -94.13 141.87 28.05 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 174.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' C' ' 82' ' ' ILE . 78.9 t -150.36 121.32 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.328 0.513 . . . . 0.0 110.585 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 26.2 mtpt -108.36 164.37 12.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.494 0.664 . . . . 0.0 110.669 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 48.7 p -103.95 -162.73 0.92 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.663 167.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.711 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 4.0 mm? -43.53 -42.51 5.01 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 22.6 t70 177.88 -28.57 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.731 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 12.9 p -54.26 -35.08 62.14 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.724 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -138.67 173.82 11.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.628 1.204 . . . . 0.0 113.325 -172.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 61.2 m -172.82 94.89 0.12 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 112.322 -2.217 . . . . 0.0 106.589 176.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -118.95 159.69 23.36 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.869 -1.132 . . . . 0.0 112.215 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 1.4 p -100.66 139.65 36.04 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.947 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.625 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 23.3 m-85 -133.83 55.86 1.88 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.231 -171.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.593 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -54.55 123.11 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 123.38 1.562 . . . . 0.0 113.979 -174.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.453 HG21 HD22 ' C' ' 72' ' ' LEU . 11.2 m -126.87 -175.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 110.961 -2.836 . . . . 0.0 111.196 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.65 52.72 0.8 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.512 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.948 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 71.01 -29.29 0.19 Allowed 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 167.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -162.19 23.83 0.11 Allowed 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -172.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . 0.551 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 16.0 tpt -72.2 -69.24 0.41 Allowed 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 111.754 -2.476 . . . . 0.0 111.435 -171.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.551 ' OD1' ' HG3' ' C' ' 37' ' ' MET . 24.8 m120 -129.18 -82.86 0.57 Allowed 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.09 0.472 . . . . 0.0 111.229 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.709 ' O ' ' HD2' ' C' ' 43' ' ' LYS . 0.4 OUTLIER 74.36 -31.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.744 -165.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' C' ' 43' ' ' LYS . 0.1 OUTLIER -84.15 -67.94 0.75 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.489 1.138 . . . . 0.0 109.661 178.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.17 -25.7 61.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.235 170.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.672 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 1.2 t80 -60.74 -48.63 80.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.425 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.709 ' HD2' ' O ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -53.15 -48.92 67.55 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.862 0.839 . . . . 0.0 109.037 173.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -35.47 74.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.887 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -69.16 -50.95 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.098 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.609 ' O ' HG22 ' C' ' 50' ' ' VAL . 25.5 pt -78.88 -12.44 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.85 -59.3 1.46 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.14 75.34 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.269 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -34.51 72.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.887 0.375 . . . . 0.0 111.113 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.609 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.8 m -100.39 -3.01 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.228 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 26.4 t 69.16 19.75 7.83 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 121.752 0.787 . . . . 0.0 109.287 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.3 mm -128.36 117.67 20.17 Favored Pre-proline 0 N--CA 1.442 -0.836 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.627 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.538 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.0 Cg_exo -65.52 149.37 87.75 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.924 1.749 . . . . 0.0 113.149 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.465 ' CB ' ' HB3' ' C' ' 43' ' ' LYS . 2.2 p -53.37 -29.94 37.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.463 -1.698 . . . . 0.0 113.375 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.8 pt-20 -82.07 -7.47 59.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.65 -176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.57 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 96.0 mttt -125.13 -31.31 3.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.567 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.608 ' OE1' ' HG3' ' C' ' 43' ' ' LYS . 3.3 pt20 -62.6 136.92 58.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.304 0.573 . . . . 0.0 111.185 -174.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -121.49 129.93 53.24 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.798 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' C' ' 66' ' ' LEU . 4.2 mp -91.18 134.57 34.43 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.56 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.3 mt -126.76 115.06 40.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.334 0.588 . . . . 0.0 112.001 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -124.11 116.59 23.01 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.518 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 61.02 34.87 19.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.494 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.16 -7.39 60.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.483 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 10.1 mmm180 -85.39 127.62 34.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -86.11 91.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.084 0.469 . . . . 0.0 110.227 -176.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.691 HD22 ' CD1' ' C' ' 75' ' ' TYR . 1.6 mt -73.24 136.54 44.65 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . 0.493 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 8.5 pt20 -149.89 -168.31 3.07 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.275 -171.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.566 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.8 p-10 -66.42 -0.43 2.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.064 0.946 . . . . 0.0 112.629 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . 0.493 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 9.2 t70 -69.07 2.46 2.74 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.734 0.813 . . . . 0.0 112.62 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.52 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.8 mtpt 72.74 -177.37 0.19 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.155 175.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 70.58 66.84 0.19 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.979 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.533 ' HA ' ' CD2' ' C' ' 75' ' ' TYR . 6.6 mt -64.12 -41.84 97.08 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.549 -175.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . 0.461 ' H ' ' HG2' ' C' ' 73' ' ' GLN . 3.7 pt20 -71.13 -18.27 62.53 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -70.07 -27.69 64.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.691 ' CD1' HD22 ' C' ' 66' ' ' LEU . 22.5 m-85 -74.17 -24.22 59.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 t30 64.09 36.49 9.7 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 123.392 1.568 . . . . 0.0 107.403 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.466 ' CG1' HG22 ' C' ' 19' ' ' VAL . 0.5 OUTLIER -96.41 0.79 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.059 -161.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.578 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -70.41 102.27 1.0 Allowed Glycine 0 N--CA 1.432 -1.591 0 CA-C-O 122.723 1.18 . . . . 0.0 112.824 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.68 13.84 26.83 Favored Glycine 0 C--N 1.283 -2.413 0 CA-C-N 112.24 -1.98 . . . . 0.0 114.325 173.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -124.78 154.36 41.06 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.728 HG12 ' HB3' ' C' ' 20' ' ' LEU . 2.8 m -85.28 131.02 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.093 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.661 HD13 HD12 ' C' ' 66' ' ' LEU . 56.5 mt -83.96 160.56 3.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.246 172.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.446 ' N ' HG22 ' C' ' 82' ' ' ILE . 67.4 m170 -109.22 112.49 24.68 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 166.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.446 HD22 HG12 ' C' ' 21' ' ' VAL . 0.6 OUTLIER -101.15 153.66 19.4 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.426 -0.91 . . . . 0.0 108.618 172.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.521 HG21 ' CD2' ' A' ' 14' ' ' HIS . 17.3 m -127.52 -178.65 2.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.208 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . 0.538 ' HG2' ' H ' ' C' ' 87' ' ' ARG . 25.9 tt0 -77.17 175.71 9.41 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.283 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . 0.538 ' H ' ' HG2' ' C' ' 86' ' ' GLU . 5.0 mtm180 -63.6 166.3 7.03 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.549 0.69 . . . . 0.0 111.058 -175.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' C' ' 89' ' ' PRO . . . -68.47 171.45 5.97 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.051 176.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' C' ' 88' ' ' ALA . 75.6 Cg_exo -53.31 150.63 25.31 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.068 1.845 . . . . 0.0 112.212 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.42 59.14 4.66 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.125 2.55 . . . . 0.0 112.825 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' C' ' 89' ' ' PRO . 2.4 pt20 -76.83 -16.55 59.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.782 177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t 38.04 52.66 1.57 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.095 0.958 . . . . 0.0 112.661 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -70.36 -53.93 14.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.019 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 95.5 mt -134.59 93.5 18.37 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.97 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.65 -23.8 48.77 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.422 2.081 . . . . 0.0 112.181 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 20.3 t -164.33 148.06 9.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.32 35.12 1.85 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.058 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.59 80.87 1.84 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.19 0.519 . . . . 0.0 110.32 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 11.4 t -107.63 -146.37 0.4 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.635 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 24.9 m 65.79 87.13 0.12 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.488 0.661 . . . . 0.0 110.942 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 179.355 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 2.7 p -98.13 -14.06 20.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 110.581 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm -86.27 71.66 10.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.8 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.12 125.63 32.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.726 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.8 150.52 20.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.023 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.46 66.77 9.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.04 0.448 . . . . 0.0 110.335 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -101.35 114.05 65.76 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.928 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.66 143.74 69.33 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.353 2.036 . . . . 0.0 111.936 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.406 ' O ' ' HE1' ' A' ' 11' ' ' TYR . 24.5 m-70 -72.49 -43.96 9.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.54 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.73 101.85 0.81 Allowed 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 122.071 1.847 . . . . 0.0 112.543 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.03 -112.69 0.97 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.012 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 94.5 mtt180 -79.28 87.81 4.96 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.938 -0.631 . . . . 0.0 110.779 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.67 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 14.2 m-85 -115.15 149.45 37.61 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.952 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.544 ' CB ' HD21 ' A' ' 40' ' ' LEU . 71.7 t80 -124.73 120.01 30.57 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.72 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -96.22 121.09 37.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -73.22 -20.22 60.92 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.388 -173.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -71.15 -30.86 66.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.851 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' O ' HG23 ' A' ' 18' ' ' VAL . 53.4 m -90.94 -18.42 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.475 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.8 p 51.49 30.28 6.18 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.888 0.742 . . . . 0.0 110.843 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 16' ' ' CYS . 73.9 t -144.73 145.71 20.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 20' ' ' ILE . 26.3 tt0 -74.96 151.98 38.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.109 0.481 . . . . 0.0 111.779 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.754 HD12 ' HD3' ' A' ' 30' ' ' PRO . 3.7 pt -138.24 168.51 19.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.958 -171.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.46 109.98 36.12 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 159.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.67 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 18.1 Cg_endo -69.94 174.92 8.96 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 124.45 3.433 . . . . 0.0 115.736 -166.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.493 ' HB2' HG13 ' A' ' 28' ' ' ILE . 75.9 mtt180 -106.64 47.69 0.87 Allowed 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.856 -1.975 . . . . 0.0 106.768 174.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -8.34 -55.9 0.01 OUTLIER Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 110.673 -2.967 . . . . 0.0 116.517 174.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 45.8 Cg_exo -34.13 -35.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 123.255 2.637 . . . . 0.0 114.34 175.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.566 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.19 -19.34 10.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.319 0.58 . . . . 0.0 111.839 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 68.41 55.3 0.51 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.991 -169.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -109.63 163.1 6.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.561 175.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -95.19 146.32 31.12 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.754 ' HD3' HD12 ' A' ' 20' ' ' ILE . 52.8 Cg_endo -82.82 -21.88 4.65 Favored 'Trans proline' 0 CA--C 1.504 -0.993 0 C-N-CA 123.202 2.601 . . . . 0.0 108.47 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.4 mtt-85 -79.29 -29.06 42.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.835 -1.984 . . . . 0.0 113.377 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.0 p -147.9 -3.84 0.51 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.69 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 14.7 tt0 60.15 40.51 18.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.067 0.461 . . . . 0.0 111.832 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.4 p -112.59 155.82 23.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.87 44.13 2.09 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.798 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 86.6 m-85 -109.13 47.5 0.92 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.293 0.568 . . . . 0.0 110.158 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.624 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.7 pt -111.86 147.43 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.272 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.532 ' HB2' HG22 ' C' ' 65' ' ' VAL . 12.6 pt-20 -135.57 147.17 48.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.594 0.235 . . . . 0.0 110.804 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.26 144.81 55.72 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 ' CB ' ' A' ' 12' ' ' PHE . 13.5 mt . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.028 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.863 0.363 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.28 7.97 38.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.702 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -97.07 -13.6 22.11 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.121 -0.231 . . . . 0.0 110.994 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -76.73 69.39 3.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.859 0.361 . . . . 0.0 111.827 -176.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -148.11 138.41 22.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.39 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 5.9 t60 53.5 62.6 2.56 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.652 0.595 . . . . 0.0 111.631 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -118.75 -51.18 2.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 62.4 t60 56.22 78.0 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.805 0.691 . . . . 0.0 110.527 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.406 ' C ' ' H ' ' C' ' 12' ' ' ASP . 31.0 m -94.77 169.93 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.955 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 19.4 t70 76.92 -39.51 0.34 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.055 0.942 . . . . 0.0 110.694 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' C' ' 10' ' ' VAL . 22.2 t70 -122.86 112.85 18.36 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.219 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 36.2 t70 58.14 58.98 3.26 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.891 0.853 . . . . 0.0 110.01 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -70.46 -28.6 65.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.39 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -56.31 143.11 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.465 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 50.2 ttm -166.66 112.1 0.79 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.312 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.648 ' HB3' ' CA ' ' C' ' 78' ' ' GLY . 0.9 OUTLIER -101.45 132.12 47.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.584 ' HA ' HG13 ' C' ' 32' ' ' ILE . 30.6 mt-10 -83.87 94.72 8.28 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.554 HG11 ' CZ ' ' C' ' 42' ' ' PHE . 5.4 t -79.23 92.65 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.098 -172.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' C' ' 81' ' ' VAL . 1.5 mp -85.24 133.16 34.18 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' C' ' 82' ' ' ILE . 71.1 t -141.58 116.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 40.7 mtpt -88.29 153.58 21.09 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p -118.86 171.59 8.12 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.397 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 8.5 mt -68.08 -7.34 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.788 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -85.16 8.87 16.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.71 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 16.9 m 71.86 13.27 6.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.641 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.52 -177.73 4.5 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.409 0.623 . . . . 0.0 110.756 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 39.1 m -141.27 113.44 7.98 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.519 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -118.48 149.55 41.09 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.376 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -106.52 141.94 36.99 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.178 0.513 . . . . 0.0 111.777 -174.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.478 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 35.9 m-85 -130.9 60.18 1.66 Allowed 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.722 -174.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.584 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -56.58 121.32 4.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 123.338 1.542 . . . . 0.0 114.48 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.87 -166.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 111.038 -2.801 . . . . 0.0 111.57 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -95.62 -170.82 35.89 Favored Glycine 0 C--N 1.312 -0.758 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.396 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.809 ' O ' ' HB2' ' C' ' 36' ' ' GLN . . . -103.9 83.24 2.09 Favored 'General case' 0 CA--C 1.477 -1.855 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.809 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 23.7 mt-30 108.6 15.88 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 O-C-N 126.599 2.437 . . . . 0.0 107.795 170.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -76.79 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.063 -2.335 . . . . 0.0 111.528 171.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.486 ' CG ' ' HB2' ' C' ' 41' ' ' GLU . 13.0 m120 -123.55 -98.5 0.43 Allowed 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.596 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 84.22 -35.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 123.931 0.892 . . . . 0.0 110.648 -162.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.535 ' HA ' ' CB ' ' C' ' 68' ' ' ASP . 0.0 OUTLIER -81.43 -69.53 0.6 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.3 1.048 . . . . 0.0 108.959 177.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . 0.486 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 43.3 mt-10 -61.12 -28.95 69.47 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.012 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.596 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.1 t80 -61.1 -51.61 68.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.406 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 52.3 mtpt -58.5 -45.53 88.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.445 0.641 . . . . 0.0 110.358 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -59.79 -34.83 73.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.207 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -70.12 -47.76 60.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.789 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.57 ' O ' HG22 ' C' ' 50' ' ' VAL . 24.2 pt -75.04 -16.96 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.971 -0.104 . . . . 0.0 111.133 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -39.92 -61.0 0.91 Allowed 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -176.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.4 77.48 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.371 -0.532 . . . . 0.0 112.376 -173.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -26.73 68.46 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.181 0.515 . . . . 0.0 110.832 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.57 HG22 ' O ' ' C' ' 46' ' ' ILE . 22.2 m -104.66 -0.77 10.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.849 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 55.1 p 66.16 20.27 11.14 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.766 0.826 . . . . 0.0 109.842 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.7 mm -128.82 112.59 18.88 Favored Pre-proline 0 N--CA 1.437 -1.123 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.073 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.586 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.9 Cg_exo -69.29 146.78 64.22 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.471 2.114 . . . . 0.0 111.284 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.452 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 44.2 t -51.95 -25.97 9.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.347 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.5 pt-20 -79.51 -24.52 42.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.706 0.288 . . . . 0.0 111.342 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' C' ' 87' ' ' ARG . 48.2 mtpt -106.79 -16.27 14.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.854 0.359 . . . . 0.0 110.363 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.534 ' OE1' HD11 ' C' ' 46' ' ' ILE . 0.0 OUTLIER -87.25 148.86 24.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.726 -174.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -139.03 132.25 29.84 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.587 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.581 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 52.7 mt -90.67 109.68 20.85 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.598 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.3 mt -106.39 113.73 43.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.263 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.582 ' OH ' ' HD3' ' C' ' 80' ' ' LYS . 50.3 t80 -118.03 127.82 54.17 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . 0.462 ' HG2' ' CD2' ' C' ' 61' ' ' TYR . 3.5 pt20 40.98 46.77 2.5 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.028 0.931 . . . . 0.0 112.244 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.28 5.87 78.26 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.686 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -99.4 134.88 41.62 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 38' ' ' GLU . 2.1 t -88.96 90.07 3.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.078 0.466 . . . . 0.0 109.746 -177.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.597 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -73.91 132.14 42.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -144.83 173.01 12.23 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.201 -171.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.535 ' CB ' ' HA ' ' C' ' 40' ' ' LYS . 5.9 p-10 -70.73 -2.86 16.01 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.896 0.879 . . . . 0.0 113.06 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.25 -15.63 49.53 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.179 -0.326 . . . . 0.0 111.609 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.498 ' HB3' ' OE1' ' C' ' 74' ' ' GLU . 4.0 mtpm? -122.44 -151.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.52 -169.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.504 ' HB2' ' HG3' ' C' ' 74' ' ' GLU . 97.7 mttt -125.25 151.14 46.33 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.838 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.493 HD23 HG23 ' C' ' 39' ' ' VAL . 35.5 mt -57.32 -53.11 61.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . 0.571 ' CB ' ' HG3' ' C' ' 36' ' ' GLN . 53.2 tt0 -71.54 -14.4 62.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.565 -170.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' C' ' 71' ' ' LYS . 46.2 mt-10 -63.09 -29.24 70.65 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 173.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.597 ' CD1' HD22 ' C' ' 66' ' ' LEU . 60.5 m-85 -93.91 -21.24 19.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.2 t30 52.87 52.16 14.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.588 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.441 HG21 HD11 ' C' ' 82' ' ' ILE . 29.9 m -93.27 19.85 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.307 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.648 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -75.18 102.39 1.45 Allowed Glycine 0 CA--C 1.482 -2.01 0 CA-C-O 122.483 1.046 . . . . 0.0 111.713 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.12 14.97 46.65 Favored Glycine 0 C--N 1.281 -2.481 0 CA-C-N 112.562 -1.819 . . . . 0.0 112.107 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . 0.582 ' HD3' ' OH ' ' C' ' 61' ' ' TYR . 81.2 mttt -123.46 142.33 51.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' C' ' 20' ' ' LEU . 16.3 m -82.35 133.91 28.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.907 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' C' ' 21' ' ' VAL . 29.1 mt -92.56 170.19 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.265 175.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.486 ' N ' HG22 ' C' ' 82' ' ' ILE . 70.5 m80 -118.56 114.49 22.88 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.531 HD11 HD12 ' C' ' 46' ' ' ILE . 0.9 OUTLIER -89.79 141.45 28.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.383 0.611 . . . . 0.0 111.743 178.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m -151.83 170.78 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.671 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . 0.507 ' HB2' HD12 ' C' ' 52' ' ' ILE . 32.4 tt0 -110.8 148.37 32.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.374 175.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' C' ' 56' ' ' LYS . 63.8 mtm180 -63.76 166.55 6.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.905 0.859 . . . . 0.0 110.983 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.45 ' HB1' ' HD2' ' C' ' 89' ' ' PRO . . . -73.26 172.5 7.94 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.568 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.45 ' HD2' ' HB1' ' C' ' 88' ' ' ALA . 75.2 Cg_exo -54.39 150.79 32.38 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.767 1.644 . . . . 0.0 111.386 174.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' C' ' 89' ' ' PRO . 3.2 Cg_exo -73.35 30.36 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.956 2.438 . . . . 0.0 113.289 -174.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' C' ' 89' ' ' PRO . 7.2 pt20 -80.61 -26.35 37.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.189 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -82.58 83.52 7.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.943 0.877 . . . . 0.0 110.726 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -146.09 87.05 1.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.071 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 1.5 pt? -124.95 110.88 27.24 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.125 0.488 . . . . 0.0 111.033 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.06 -25.92 82.09 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 123.046 2.497 . . . . 0.0 112.283 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 7.9 p -86.88 28.2 0.92 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.81 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.92 -52.91 6.06 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.844 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 51.96 72.5 0.38 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.9 0.48 . . . . 0.0 111.732 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 39.6 t -75.54 93.1 2.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.093 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 9.3 t 60.64 71.39 0.57 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.655 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.671 -1.072 . . . . 0.0 111.59 178.733 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 111.709 -0.557 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 4.8 p -133.24 153.06 51.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.544 0.211 . . . . 0.0 110.725 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tmm? 71.11 87.78 0.11 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.56 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.47 -37.6 10.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.204 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -87.9 151.32 22.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.015 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.72 11.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 t 56.44 78.86 0.36 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.21 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -71.31 79.37 1.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.78 2.32 . . . . 0.0 111.962 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.468 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 42.3 m-70 64.91 88.71 0.11 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.233 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 7' ' ' HIS . 18.6 Cg_endo -51.25 112.89 0.9 Allowed 'Trans proline' 0 N--CA 1.444 -1.408 0 C-N-CA 124.442 3.428 . . . . 0.0 114.482 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.64 -117.86 1.79 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 172.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 10' ' ' ARG . 10.6 ptt180 -167.79 101.1 0.47 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.471 0.653 . . . . 0.0 111.082 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.686 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 14.3 m-85 -120.17 167.24 12.44 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.401 ' CB ' HD11 ' A' ' 40' ' ' LEU . 65.7 t80 -140.35 114.56 9.15 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.446 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -95.44 114.97 26.79 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.567 174.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -69.9 -18.09 63.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.118 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.545 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 43.9 t -68.66 -35.44 77.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.081 0.467 . . . . 0.0 110.708 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.443 ' O ' HG23 ' A' ' 18' ' ' VAL . 92.6 m -95.16 -15.26 23.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.817 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.5 p 51.57 29.87 5.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.237 1.015 . . . . 0.0 111.582 -173.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 16' ' ' CYS . 97.2 t -139.39 147.25 24.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.761 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.66 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 31.4 tt0 -67.48 149.15 50.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.17 0.509 . . . . 0.0 111.092 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.809 HD11 HG21 ' A' ' 37' ' ' ILE . 3.5 pt -138.68 167.36 21.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.856 -175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 19.4 t -122.64 96.23 45.79 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 164.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.686 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 9.5 Cg_endo -58.36 176.48 0.39 Allowed 'Trans proline' 0 C--N 1.325 -0.697 1 C-N-CA 125.349 4.033 . . . . 0.0 117.776 -167.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.525 ' C ' ' HD2' ' A' ' 25' ' ' PRO . 40.2 mtt180 -112.25 51.42 0.81 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.764 -2.471 . . . . 0.0 106.848 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -7.32 -53.73 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.911 0 CA-C-N 111.705 -2.498 . . . . 0.0 115.965 172.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.525 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 24.1 Cg_exo -31.17 -39.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.398 2.732 . . . . 0.0 114.204 174.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.56 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -120.03 -16.64 8.57 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.296 0.57 . . . . 0.0 111.342 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.473 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 66.3 m-85 70.87 52.26 0.29 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.018 -1.447 . . . . 0.0 109.728 -169.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.56 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -106.38 162.26 5.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.165 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -98.23 149.2 35.49 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 62.2 Cg_endo -83.88 -18.73 5.28 Favored 'Trans proline' 0 CA--C 1.501 -1.135 0 C-N-CA 123.117 2.545 . . . . 0.0 108.59 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.5 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 56.0 mtt180 -88.58 -11.89 44.25 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.07 -1.877 . . . . 0.0 114.192 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 p -156.77 -11.43 0.09 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 61.16 29.48 18.83 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.558 0.694 . . . . 0.0 111.171 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.5 m -107.18 142.94 36.1 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -79.55 38.07 2.08 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.507 -175.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 50.9 m-85 -93.49 39.93 1.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.744 0.307 . . . . 0.0 111.054 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.809 HG21 HD11 ' A' ' 20' ' ' ILE . 6.1 pt -109.87 141.51 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.505 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.2 pt-20 -117.37 144.16 45.23 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 169.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -79.72 129.5 34.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.507 ' HG ' ' OE1' ' C' ' 91' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.909 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.811 0.338 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.08 136.26 33.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.628 0.252 . . . . 0.0 110.713 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -119.48 123.25 43.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.483 . . . . 0.0 110.121 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -65.33 -36.6 84.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.586 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -151.59 -69.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.599 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -133.49 50.7 2.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.957 0.408 . . . . 0.0 110.965 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 83.3 t60 48.85 58.54 5.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.682 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -126.32 90.46 3.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.267 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.33 146.89 11.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.12 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -100.74 -29.3 12.35 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.471 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -104.67 -93.55 0.35 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.398 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 t70 56.0 -154.04 0.33 Allowed 'General case' 0 C--O 1.235 0.316 0 O-C-N 123.604 0.565 . . . . 0.0 110.059 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -86.71 -3.14 59.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.045 0.45 . . . . 0.0 110.463 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -56.8 166.95 0.85 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.925 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 47.0 tpp 61.24 89.53 0.08 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.906 -177.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.757 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -91.69 146.55 23.68 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' C' ' 32' ' ' ILE . 15.1 mt-10 -95.04 91.48 6.37 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 169.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.6 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 4.9 t -78.38 105.21 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.2 -170.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.631 ' C ' ' HA ' ' C' ' 81' ' ' VAL . 0.5 OUTLIER -96.25 142.58 28.23 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 175.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' C' ' 82' ' ' ILE . 54.7 t -148.05 124.53 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.899 0.381 . . . . 0.0 110.628 -173.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.493 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 43.0 mtpt -105.06 141.3 36.87 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 36.3 p -112.02 -179.88 3.81 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.547 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.41 -15.45 62.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.195 0.522 . . . . 0.0 110.854 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -81.48 0.08 39.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.828 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 69.6 m 61.52 22.62 13.04 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.691 0.758 . . . . 0.0 111.573 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -55.67 -56.68 17.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.779 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 51.0 m 54.37 94.33 0.02 OUTLIER 'General case' 0 C--O 1.236 0.344 0 O-C-N 124.284 0.99 . . . . 0.0 110.765 -173.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -127.36 155.83 42.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.814 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.571 HG22 ' CD2' ' C' ' 20' ' ' LEU . 11.8 p -95.49 142.01 28.35 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 121.382 0.611 . . . . 0.0 112.223 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.6 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 25.6 m-85 -132.72 56.17 1.86 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.224 -174.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.592 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -56.87 121.17 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 123.353 1.549 . . . . 0.0 114.412 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.7 m -140.43 -163.06 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 110.777 -2.919 . . . . 0.0 111.307 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.51 165.48 19.24 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.154 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.757 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -68.43 -16.2 63.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.637 0.732 . . . . 0.0 112.16 -175.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -158.8 25.33 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -167.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 51.0 ttm -79.47 -72.64 0.38 Allowed 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 111.699 -2.501 . . . . 0.0 110.928 -176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.528 ' O ' HG12 ' C' ' 39' ' ' VAL . 12.3 m120 -125.51 -99.51 0.4 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.712 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 83.88 -29.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 C-N-CA 125.161 1.385 . . . . 0.0 111.502 -162.094 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.74 -68.13 0.74 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.346 1.07 . . . . 0.0 109.122 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.55 -30.34 69.71 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.949 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.658 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 7.0 t80 -58.34 -51.08 71.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.848 174.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.605 ' HB3' ' OE1' ' C' ' 57' ' ' GLN . 47.8 mtpt -61.24 -47.01 88.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.109 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -56.53 -36.8 69.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.892 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -70.6 -43.79 68.62 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.649 ' O ' HG22 ' C' ' 50' ' ' VAL . 22.1 pt -77.77 -8.51 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -175.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.03 -56.83 1.77 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.74 -36.79 50.37 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.272 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -33.06 71.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.018 0.437 . . . . 0.0 110.9 -177.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.649 HG22 ' O ' ' C' ' 46' ' ' ILE . 34.5 m -105.38 -2.63 9.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.885 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 59.6 p 64.78 21.23 12.33 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 122.003 0.906 . . . . 0.0 109.298 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.2 mm -122.63 117.21 28.98 Favored Pre-proline 0 N--CA 1.439 -0.976 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.302 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.569 ' O ' ' HG3' ' C' ' 57' ' ' GLN . 4.6 Cg_exo -71.76 150.16 55.62 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.961 1.774 . . . . 0.0 112.226 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.632 ' HA ' ' OE1' ' C' ' 57' ' ' GLN . 0.9 OUTLIER -52.12 -25.17 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.096 -176.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.547 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.4 pt-20 -74.67 -26.91 60.17 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.207 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.547 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 47.9 mttm -105.66 -25.01 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.688 0.28 . . . . 0.0 111.526 -173.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.632 ' OE1' ' HA ' ' C' ' 54' ' ' SER . 88.9 mt-30 -56.55 126.17 25.39 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.895 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -122.95 110.14 15.01 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' C' ' 82' ' ' ILE . 1.1 mm? -87.11 112.48 21.96 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.512 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.7 mt -110.33 120.61 61.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 121.809 -0.557 . . . . 0.0 111.024 175.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -128.75 134.61 48.48 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . 0.402 HE21 ' HB2' ' C' ' 62' ' ' GLN . 2.3 pt20 41.97 42.38 2.29 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.987 0.804 . . . . 0.0 111.732 -173.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.98 4.02 61.62 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.593 -0.731 . . . . 0.0 113.608 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -96.15 130.82 43.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.3 99.22 9.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.297 0.57 . . . . 0.0 110.451 -175.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.505 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.2 OUTLIER -86.16 154.66 21.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.054 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -165.91 -169.77 1.59 Allowed 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.958 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.712 ' HA ' HG13 ' C' ' 39' ' ' VAL . 5.1 p-10 -64.94 -1.4 2.0 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.902 0.881 . . . . 0.0 113.123 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.97 -7.2 3.52 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.42 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.8 mttp 88.22 170.57 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.48 1.112 . . . . 0.0 111.827 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.543 ' HB3' ' HG2' ' C' ' 74' ' ' GLU . 13.5 mmmm 71.45 79.52 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.617 177.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.612 HD21 HG23 ' C' ' 39' ' ' VAL . 37.2 mt -68.82 -29.22 67.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.849 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . 0.436 ' HB2' ' HB1' ' C' ' 35' ' ' ALA . 46.8 tt0 -68.52 -27.17 65.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.401 . . . . 0.0 111.364 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . 0.543 ' HG2' ' HB3' ' C' ' 71' ' ' LYS . 58.8 mm-40 -63.48 -27.12 69.06 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.546 ' CD2' ' HA ' ' C' ' 72' ' ' LEU . 7.8 m-85 -90.17 -23.07 21.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 55.31 46.79 22.82 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.198 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.444 HG23 HG22 ' C' ' 19' ' ' VAL . 33.1 m -93.66 4.36 7.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 119.957 -0.697 . . . . 0.0 112.862 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.669 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -56.22 100.37 0.1 Allowed Glycine 0 CA--C 1.491 -1.435 0 CA-C-O 122.918 1.288 . . . . 0.0 113.68 171.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.47 14.8 49.42 Favored Glycine 0 C--N 1.289 -2.076 0 CA-C-N 111.367 -2.417 . . . . 0.0 113.534 173.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -124.37 139.91 53.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.545 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.631 ' HA ' ' C ' ' C' ' 20' ' ' LEU . 22.2 m -80.08 126.48 39.39 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.748 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' C' ' 21' ' ' VAL . 60.9 mt -83.11 167.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.452 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.509 ' N ' HG22 ' C' ' 82' ' ' ILE . 42.9 m80 -114.42 114.63 26.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 171.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.436 HD12 ' N ' ' C' ' 85' ' ' VAL . 15.8 tp -97.23 133.01 42.43 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.203 0.525 . . . . 0.0 110.135 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.436 ' N ' HD12 ' C' ' 84' ' ' LEU . 25.2 m -129.14 172.38 15.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.367 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -70.95 179.94 2.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.879 173.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' C' ' 87' ' ' ARG . 43.0 mtm180 -60.47 165.23 3.83 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.991 0.901 . . . . 0.0 110.781 -175.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.26 146.22 32.31 Favored Pre-proline 0 N--CA 1.425 -1.684 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.56 -175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.55 160.14 37.38 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.242 2.628 . . . . 0.0 111.058 174.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.12 87.36 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.654 2.236 . . . . 0.0 111.746 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . 0.507 ' OE1' ' HG ' ' A' ' 40' ' ' LEU . 16.9 pt20 -124.39 7.71 8.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.752 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 6.0 t -64.29 102.35 0.51 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.04 0.924 . . . . 0.0 110.823 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -109.66 10.43 24.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.898 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.479 HD21 ' O ' ' C' ' 98' ' ' ALA . 42.2 tp -127.66 76.11 77.31 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.787 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -88.28 161.12 6.95 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.602 2.201 . . . . 0.0 113.093 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t 60.61 68.56 0.75 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.355 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.05 -141.09 39.0 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.232 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . 0.479 ' O ' HD21 ' C' ' 94' ' ' LEU . . . 64.13 13.99 8.24 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.028 0.531 . . . . 0.0 111.969 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 12.9 t -85.52 67.17 10.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.499 0.666 . . . . 0.0 109.411 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 16.2 m -136.85 171.26 14.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.349 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.923 -0.932 . . . . 0.0 111.57 177.732 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.966 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 18.0 m -76.63 147.04 37.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 62.26 84.73 0.13 Allowed 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.547 0.529 . . . . 0.0 110.524 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.28 129.8 36.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.964 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -90.08 69.28 7.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.407 0.622 . . . . 0.0 109.628 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.37 -29.29 37.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.462 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.8 t -83.25 142.22 43.64 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.634 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.07 63.94 2.58 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.9 2.4 . . . . 0.0 112.678 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.9 m80 71.5 135.59 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 123.427 0.691 . . . . 0.0 111.188 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HA ' HG11 ' A' ' 21' ' ' VAL . 84.7 Cg_endo -74.32 116.16 4.54 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.058 2.506 . . . . 0.0 113.568 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.88 -116.17 4.15 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -167.48 98.43 0.49 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.19 0.519 . . . . 0.0 111.735 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.738 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.9 m-85 -124.93 151.96 44.73 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 172.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -124.04 118.29 26.64 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.262 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -96.37 117.67 31.32 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.048 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.737 ' CG ' HG13 ' C' ' 85' ' ' VAL . 12.6 p80 -75.07 -10.68 59.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.89 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 49.7 t -71.97 -37.52 69.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.159 0.505 . . . . 0.0 109.727 175.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.3 m -91.0 -27.94 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.182 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.86 32.05 21.39 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.267 -171.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.56 144.45 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -71.83 146.5 47.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.234 0.54 . . . . 0.0 111.093 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.795 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.5 pt -134.04 166.71 28.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.266 -171.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 8' ' ' PRO . 48.3 t -118.44 110.22 39.4 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 158.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.738 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 12.1 Cg_endo -69.28 176.16 6.77 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.441 3.427 . . . . 0.0 114.777 -170.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.678 ' HB2' HG13 ' A' ' 28' ' ' ILE . 40.7 mtt180 -107.02 47.77 0.87 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 113.532 -1.667 . . . . 0.0 106.707 175.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.64 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 1.6 mm? 0.82 -62.62 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.147 0 CA-C-N 111.032 -2.804 . . . . 0.0 117.107 174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 22.1 Cg_exo -35.21 -35.04 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.949 2.433 . . . . 0.0 113.611 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.582 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -112.76 -22.84 10.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.631 -177.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 22.5 m-85 68.48 45.25 1.16 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.026 0.917 . . . . 0.0 110.528 -170.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.678 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -97.53 162.01 2.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.517 172.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.4 t -97.08 146.07 30.69 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.795 ' HD3' HD12 ' A' ' 20' ' ' ILE . 66.9 Cg_endo -79.84 -23.15 7.04 Favored 'Trans proline' 0 CA--C 1.498 -1.315 0 C-N-CA 122.582 2.188 . . . . 0.0 107.785 -174.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.594 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 91.2 mtt-85 -79.21 -35.34 41.84 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 112.683 -2.053 . . . . 0.0 113.556 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.2 p -135.76 -7.74 2.15 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.582 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 11.3 tt0 56.95 31.08 19.17 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.507 0.67 . . . . 0.0 111.511 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.3 m -110.72 145.97 37.11 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.321 170.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.6 52.99 4.81 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.372 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.491 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 72.2 m-85 -109.0 43.86 1.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.551 -0.382 . . . . 0.0 110.684 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.68 HG21 ' CD1' ' A' ' 20' ' ' ILE . 11.7 pt -114.31 139.96 37.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.255 -175.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.06 155.52 30.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.36 127.84 39.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.381 0.61 . . . . 0.0 110.747 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.007 -170.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.2 54.66 0.83 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.876 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 64.41 -91.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 174.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -93.3 82.66 4.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.168 0.508 . . . . 0.0 109.971 -177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -85.89 -4.38 59.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.67 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -79.75 59.26 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.786 0.803 . . . . 0.0 110.257 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -128.88 43.17 3.19 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.623 -1.172 . . . . 0.0 107.942 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -75.92 76.7 2.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.634 -174.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.577 HG22 ' H ' ' C' ' 12' ' ' ASP . 5.0 p -87.86 154.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.7 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . 0.485 ' OD2' ' HE2' ' C' ' 15' ' ' LYS . 5.0 m-20 -120.43 36.57 4.52 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.713 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . 0.577 ' H ' HG22 ' C' ' 10' ' ' VAL . 13.8 m-20 45.3 -102.68 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.016 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -130.72 16.34 5.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.03 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.95 -45.48 81.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.428 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . 0.485 ' HE2' ' OD2' ' C' ' 11' ' ' ASP . 67.3 mttm -59.87 161.47 6.45 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.962 175.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 73.7 mtm 66.32 96.73 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.198 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.856 HD22 ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -98.58 149.05 23.17 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 172.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' C' ' 32' ' ' ILE . 34.2 tt0 -102.17 87.92 3.19 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' C' ' 30' ' ' THR . 2.4 t -77.41 127.05 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.025 -167.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.703 ' HB3' HG12 ' C' ' 81' ' ' VAL . 1.0 OUTLIER -113.05 147.91 36.25 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 170.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' C' ' 82' ' ' ILE . 66.0 t -153.83 114.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -171.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 38.7 mtpt -99.96 172.1 7.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.371 0.605 . . . . 0.0 110.28 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.442 HG23 HD12 ' C' ' 84' ' ' LEU . 6.1 p -116.35 -171.53 2.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.814 172.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 4.3 mm? -42.06 -41.25 2.52 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -177.0 -29.83 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.061 -168.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 17.4 m -47.8 -82.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.827 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -128.13 177.54 6.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -171.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 53.8 m -135.02 111.87 10.13 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.0 -1.909 . . . . 0.0 107.253 170.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -120.49 158.58 26.96 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.15 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 4.2 p -104.26 147.67 27.22 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.527 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 42.1 m-85 -140.96 63.82 1.44 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.487 0.66 . . . . 0.0 110.314 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.59 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.4 mp -54.88 125.4 9.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 123.215 1.483 . . . . 0.0 114.458 -174.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.562 HG21 HD13 ' C' ' 72' ' ' LEU . 15.4 m -131.81 -170.47 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 111.507 -2.588 . . . . 0.0 111.927 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -113.17 40.27 2.57 Favored Glycine 0 C--N 1.317 -0.498 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.706 -175.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.856 ' HA ' HD22 ' C' ' 17' ' ' LEU . . . 68.9 -50.43 0.59 Allowed 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 124.224 1.01 . . . . 0.0 113.529 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -130.72 23.44 5.03 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . 0.412 ' HB2' ' H ' ' C' ' 34' ' ' GLY . 2.1 ttt -66.16 -72.27 0.17 Allowed 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.93 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.602 ' O ' ' HD2' ' C' ' 40' ' ' LYS . 17.9 m120 -129.04 -91.1 0.48 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.613 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.5 OUTLIER 85.19 -40.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 O-C-N 124.5 1.125 . . . . 0.0 110.814 -164.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.602 ' HD2' ' O ' ' C' ' 38' ' ' ASN . 0.0 OUTLIER -74.14 -69.48 0.44 Allowed 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 122.449 1.118 . . . . 0.0 108.594 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.08 -26.52 68.59 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 113.26 -1.791 . . . . 0.0 111.186 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.613 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 5.8 t80 -59.2 -52.65 64.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.753 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.532 ' HD3' ' HB3' ' C' ' 68' ' ' ASP . 7.1 ptmm? -68.58 -38.73 80.94 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.355 0.598 . . . . 0.0 110.974 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' C' ' 54' ' ' SER . 1.3 tm-20 -54.56 -41.52 69.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.138 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -69.67 -51.57 33.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.539 ' O ' HG22 ' C' ' 50' ' ' VAL . 22.5 pt -70.69 -10.01 13.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.341 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.61 -36.63 0.61 Allowed 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.45 -50.57 11.43 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.944 -0.473 . . . . 0.0 111.938 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -28.41 69.47 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.23 0.538 . . . . 0.0 110.79 -176.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.539 HG22 ' O ' ' C' ' 46' ' ' ILE . 6.7 m -96.34 -11.46 8.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.542 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 18.6 m 68.36 19.79 8.82 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 121.55 0.69 . . . . 0.0 109.91 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 3.6 mm -129.35 118.21 19.07 Favored Pre-proline 0 N--CA 1.441 -0.876 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.856 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.467 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 3.9 Cg_exo -67.29 148.5 80.2 Favored 'Trans proline' 0 CA--C 1.514 -0.475 0 C-N-CA 122.27 1.98 . . . . 0.0 111.147 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.455 ' OG ' ' HG3' ' C' ' 43' ' ' LYS . 41.8 t -51.19 -33.26 26.66 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.155 0.285 . . . . 0.0 111.748 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.466 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 8.5 pt-20 -66.42 -30.19 70.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.782 0.325 . . . . 0.0 111.441 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.466 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 55.7 mtpt -101.11 -23.79 14.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.071 0.462 . . . . 0.0 110.281 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.44 ' HB2' HG22 ' C' ' 52' ' ' ILE . 7.1 tt0 -76.19 119.44 20.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.058 -172.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -113.91 123.08 48.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.277 170.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.667 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 19.4 mt -89.79 113.87 25.49 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 37' ' ' ILE . 9.2 mt -108.36 126.44 65.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 121.289 -0.882 . . . . 0.0 111.424 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.509 ' CZ ' ' HB3' ' C' ' 80' ' ' LYS . 31.0 t80 -139.12 127.26 22.52 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 169.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 60.67 35.84 19.7 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.547 0.529 . . . . 0.0 110.549 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 71.33 2.28 47.77 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.596 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -89.0 137.86 31.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.87 88.92 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -76.46 128.11 34.16 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -147.33 177.01 9.56 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.905 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.599 ' CB ' ' HA ' ' C' ' 40' ' ' LYS . 4.0 p-10 -65.69 -1.85 3.11 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.105 0.962 . . . . 0.0 113.469 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -81.48 -13.37 58.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -131.32 -154.44 0.63 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.912 -0.493 . . . . 0.0 112.053 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.403 ' HB2' ' HG2' ' C' ' 74' ' ' GLU . 0.3 OUTLIER -108.82 -179.67 3.93 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 175.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 2.9 mt -86.27 -34.09 20.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.025 0.44 . . . . 0.0 110.809 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.92 -23.72 66.01 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.403 0.681 . . . . 0.0 111.183 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . 0.403 ' HG2' ' HB2' ' C' ' 71' ' ' LYS . 20.0 mm-40 -59.39 -28.81 67.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.655 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.638 ' CD1' HD22 ' C' ' 66' ' ' LEU . 34.0 m-85 -105.16 -16.05 14.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.114 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 55.83 52.49 10.68 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.996 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.515 HG23 HG22 ' C' ' 19' ' ' VAL . 28.2 m -93.08 16.6 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.559 -174.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.654 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -64.41 101.47 0.51 Allowed Glycine 0 CA--C 1.481 -2.033 0 CA-C-O 122.774 1.208 . . . . 0.0 112.785 172.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.34 15.13 56.19 Favored Glycine 0 C--N 1.283 -2.378 0 CA-C-N 111.868 -2.166 . . . . 0.0 112.599 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . 0.509 ' HB3' ' CZ ' ' C' ' 61' ' ' TYR . 73.1 mmtt -116.37 145.32 43.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 118.85 -0.595 . . . . 0.0 109.638 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.703 HG12 ' HB3' ' C' ' 20' ' ' LEU . 3.1 m -86.7 130.17 37.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.379 173.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' C' ' 21' ' ' VAL . 56.3 mt -88.48 169.17 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.869 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.518 ' N ' HG22 ' C' ' 82' ' ' ILE . 58.4 m80 -112.45 121.94 46.27 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.442 HD12 HG23 ' C' ' 23' ' ' THR . 20.6 mt -78.32 152.71 32.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.971 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.737 HG13 ' CG ' ' A' ' 14' ' ' HIS . 5.7 t -143.45 159.51 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.773 -172.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . 0.517 ' O ' HG12 ' C' ' 85' ' ' VAL . 1.5 pm0 -93.17 175.02 6.93 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.403 170.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.34 150.89 45.3 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.219 1.009 . . . . 0.0 111.604 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.72 156.03 55.89 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 113.373 -1.74 . . . . 0.0 111.489 -173.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.4 155.06 32.1 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.741 2.294 . . . . 0.0 111.114 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.9 37.47 0.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.685 2.257 . . . . 0.0 113.668 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -6.88 47.48 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.094 -0.378 . . . . 0.0 110.285 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.0 t -66.38 -4.2 7.6 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.964 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -65.48 -18.51 65.37 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 121.301 0.572 . . . . 0.0 110.087 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 tp -126.12 130.81 23.87 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.162 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.75 103.34 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.316 2.011 . . . . 0.0 111.73 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 30.5 t -68.72 99.37 1.01 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.683 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.32 -118.12 9.04 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.523 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.01 15.68 14.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.548 0.213 . . . . 0.0 111.554 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -66.61 97.64 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.747 0.308 . . . . 0.0 110.455 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 13.3 t 62.38 34.79 15.38 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.103 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.274 -1.292 . . . . 0.0 111.544 179.809 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 42.0 m -86.29 123.56 31.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.792 0.33 . . . . 0.0 110.61 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 tpp -159.31 -59.73 0.07 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.874 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.98 114.12 11.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.562 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 61.95 25.15 15.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.887 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.37 77.62 0.93 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.298 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 m -66.68 116.4 34.33 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.796 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -64.31 -28.12 63.55 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.708 2.272 . . . . 0.0 112.83 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -134.95 127.23 18.17 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.661 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -81.51 37.54 0.69 Allowed 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.409 2.74 . . . . 0.0 112.597 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.52 72.17 0.37 Allowed Glycine 0 CA--C 1.487 -1.689 0 CA-C-O 122.54 1.078 . . . . 0.0 111.518 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.637 ' HD3' ' H ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -72.03 109.27 5.73 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 112.222 -1.989 . . . . 0.0 110.637 -178.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.627 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 5.5 m-85 -118.45 169.8 9.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.264 175.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CB ' HD11 ' A' ' 40' ' ' LEU . 61.9 t80 -138.43 116.11 11.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.595 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -96.36 114.61 26.31 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.808 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.565 ' CD2' HG12 ' C' ' 85' ' ' VAL . 8.9 p80 -73.16 -8.69 56.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.702 0.286 . . . . 0.0 111.406 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 42.6 t -72.6 -32.7 66.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.359 0.6 . . . . 0.0 110.182 173.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.5 m -99.46 -25.9 14.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.391 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER 58.21 31.04 20.3 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.384 -171.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.65 144.75 34.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.5 tt0 -64.28 148.34 50.43 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.158 0.286 . . . . 0.0 110.745 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.711 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.2 pt -140.42 166.98 18.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.51 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 74.9 t -125.6 97.32 36.61 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 164.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.627 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 6.5 Cg_endo -55.94 174.91 0.26 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 125.06 3.84 . . . . 0.0 115.798 -171.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' HB2' HG13 ' A' ' 28' ' ' ILE . 5.3 mtt180 -108.62 49.85 0.8 Allowed 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.156 -1.838 . . . . 0.0 106.937 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.455 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.3 mm? 3.92 -61.98 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.074 0 CA-C-N 110.952 -2.84 . . . . 0.0 117.049 171.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 15.8 Cg_exo -36.96 -33.44 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.69 2.26 . . . . 0.0 113.908 176.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.542 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.93 -22.38 9.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.326 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.461 ' C ' HD11 ' A' ' 37' ' ' ILE . 70.6 m-85 65.28 54.13 1.22 Allowed 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.171 0.986 . . . . 0.0 110.228 -169.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -104.93 161.13 4.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.985 176.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.7 t -96.28 145.84 30.26 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.652 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 81.7 Cg_endo -82.55 -20.52 5.69 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.702 2.268 . . . . 0.0 108.279 -174.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.416 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 18.2 mtt180 -89.37 -15.3 33.65 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 112.952 -1.931 . . . . 0.0 114.694 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.8 p -151.53 -8.09 0.23 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 10.1 tt0 60.79 25.2 15.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 111.586 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 m -103.36 141.89 35.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 169.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.59 30.87 2.49 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.268 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 35.8 m-85 -89.39 52.6 2.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.597 0.713 . . . . 0.0 110.146 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.711 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.6 pt -122.6 134.17 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.598 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HB3' HD13 ' C' ' 60' ' ' ILE . 11.4 pt-20 -119.75 144.03 47.48 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -75.81 138.49 41.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.531 ' HB2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.666 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 48.3 ttp . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.609 0.242 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' C' ' 4' ' ' HIS . . . -101.39 -34.19 9.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' C' ' 3' ' ' ALA . 14.5 m80 70.81 -67.84 0.23 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.439 0.696 . . . . 0.0 111.765 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -115.35 176.16 5.19 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -63.87 -37.58 87.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 19.52 -85.98 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 O-C-N 125.578 1.798 . . . . 0.0 113.9 172.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -144.97 96.19 2.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.422 . . . . 0.0 110.516 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -75.6 94.46 3.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.72 149.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 122.228 1.014 . . . . 0.0 113.223 -169.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -136.65 -63.74 0.61 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.545 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . 0.435 ' OD2' ' HB2' ' C' ' 14' ' ' ASP . 38.4 t70 70.76 127.02 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 124.093 0.871 . . . . 0.0 112.43 169.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.29 59.8 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.578 0.704 . . . . 0.0 110.241 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . 0.435 ' HB2' ' OD2' ' C' ' 12' ' ' ASP . 30.2 t70 -85.38 -16.58 39.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.975 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' C' ' 32' ' ' ILE . 37.3 mttm -71.36 172.39 9.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.169 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 28.1 ttt -140.89 -36.44 0.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.2 mt -109.12 134.76 51.28 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.427 0.632 . . . . 0.0 110.543 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.583 ' HA ' HG13 ' C' ' 32' ' ' ILE . 36.9 mt-10 -89.77 93.33 9.4 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.278 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 2.7 t -77.41 124.11 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -171.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.641 ' C ' ' HA ' ' C' ' 81' ' ' VAL . 0.7 OUTLIER -109.28 146.53 34.13 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 171.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.583 HG22 ' HB ' ' C' ' 82' ' ' ILE . 36.4 t -151.07 125.07 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -172.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.565 ' HE3' HG21 ' C' ' 81' ' ' VAL . 72.2 mttt -110.93 110.98 21.8 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.171 0.51 . . . . 0.0 110.789 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.484 HG23 ' HB2' ' C' ' 84' ' ' LEU . 0.0 OUTLIER -81.8 87.93 6.33 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.614 0.721 . . . . 0.0 110.289 164.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER 62.61 18.81 10.84 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.679 176.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 37.0 t70 76.87 -16.49 0.63 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.363 -1.744 . . . . 0.0 111.2 170.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 37.6 m -62.91 -30.39 71.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.03 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . 0.432 ' OE1' ' HA ' ' C' ' 50' ' ' VAL . 73.8 mt-30 -102.13 -72.0 0.7 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.51 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 71.8 m 53.63 95.2 0.02 OUTLIER 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.15 0.58 . . . . 0.0 111.412 -171.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -135.28 159.04 42.8 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.223 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.541 HG22 ' CD2' ' C' ' 20' ' ' LEU . 8.5 p -96.23 148.55 22.61 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.837 -174.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.591 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 34.3 m-85 -140.21 63.05 1.49 Allowed 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.135 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.583 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.7 mp -59.92 120.18 5.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 123.445 1.593 . . . . 0.0 113.838 -175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.465 ' CG2' HD13 ' C' ' 72' ' ' LEU . 15.5 m -138.12 -172.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 111.016 -2.811 . . . . 0.0 111.565 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.69 175.86 34.51 Favored Glycine 0 C--N 1.308 -0.973 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.954 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.752 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -90.55 50.17 1.79 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -169.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.661 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 1.5 mt-30 139.21 2.22 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 O-C-N 125.189 1.555 . . . . 0.0 109.42 -171.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 22.9 tpp -44.95 -70.49 0.1 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.769 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.432 ' CG ' ' HB2' ' C' ' 41' ' ' GLU . 26.9 m-80 -136.98 -99.09 0.2 Allowed 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 174.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.638 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 94.72 -29.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 125.151 1.532 . . . . 0.0 110.293 -162.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.612 ' HE2' ' O ' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -79.91 -71.11 0.47 Allowed 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . 0.432 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 40.4 mt-10 -63.01 -28.06 69.84 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.851 174.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.638 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 4.7 t80 -58.51 -54.36 47.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.739 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.54 ' HD3' ' HB3' ' C' ' 68' ' ' ASP . 8.9 ptmm? -69.6 -37.19 76.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.483 0.659 . . . . 0.0 111.209 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' C' ' 54' ' ' SER . 1.2 tm-20 -56.07 -44.18 78.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.225 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -69.77 -39.04 76.91 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.544 ' O ' HG22 ' C' ' 50' ' ' VAL . 20.0 pt -83.1 -6.61 10.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -173.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -38.1 -57.48 1.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.97 -36.05 69.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.073 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -20.51 66.45 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.861 0.362 . . . . 0.0 111.455 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.544 HG22 ' O ' ' C' ' 46' ' ' ILE . 14.6 m -111.76 -6.36 11.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.429 176.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 35.7 m 70.33 21.14 5.86 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 123.705 0.628 . . . . 0.0 109.475 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.3 mm -126.03 112.96 24.23 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.131 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.493 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.1 Cg_exo -70.94 145.52 50.56 Favored 'Trans proline' 0 CA--C 1.506 -0.876 0 C-N-CA 122.452 2.101 . . . . 0.0 110.784 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.549 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 1.9 p -54.79 -24.72 23.97 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 123.725 0.64 . . . . 0.0 112.647 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.9 pt-20 -75.12 -33.79 61.61 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.947 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.443 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 38.7 mtpt -98.02 -11.04 23.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.361 0.601 . . . . 0.0 109.503 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.549 ' HB3' ' HA ' ' C' ' 54' ' ' SER . 9.3 tt0 -82.99 119.59 24.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.105 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' C' ' 58' ' ' ARG . 22.2 mtm180 -127.66 126.92 42.85 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 171.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.718 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 22.8 mt -84.85 108.04 17.31 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.443 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.582 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.3 mt -99.95 118.35 46.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.39 173.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -132.37 125.99 32.17 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 171.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 58.37 36.37 25.44 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.209 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 76.63 0.9 69.43 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.489 175.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 16.9 mmm180 -98.13 141.49 30.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -92.72 95.15 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 120.937 0.399 . . . . 0.0 110.399 -176.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -82.96 138.91 33.62 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -147.37 -176.08 5.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.928 0.394 . . . . 0.0 111.446 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.54 ' HB3' ' HD3' ' C' ' 43' ' ' LYS . 2.8 p-10 -69.49 -3.58 15.22 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.593 1.157 . . . . 0.0 113.337 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -75.8 -19.83 58.67 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.612 ' O ' ' HE2' ' C' ' 40' ' ' LYS . 39.5 mtmt -130.56 -147.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -170.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.422 ' HB2' ' HG2' ' C' ' 74' ' ' GLU . 33.8 mmtp -120.35 153.18 36.83 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.795 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.465 HD13 ' CG2' ' C' ' 33' ' ' VAL . 45.4 mt -58.01 -50.73 72.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 7.3 tp60 -68.3 -22.42 64.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.909 0.385 . . . . 0.0 111.444 -174.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' C' ' 71' ' ' LYS . 31.1 mm-40 -60.72 -28.89 69.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.273 0.559 . . . . 0.0 109.947 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.506 ' CD1' HD22 ' C' ' 66' ' ' LEU . 39.5 m-85 -93.72 -19.81 20.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.398 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 t30 59.75 38.5 21.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.41 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.428 HG21 HD11 ' C' ' 82' ' ' ILE . 29.3 m -88.73 22.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -73.98 103.35 1.45 Allowed Glycine 0 N--CA 1.428 -1.876 0 CA-C-O 122.786 1.215 . . . . 0.0 112.787 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.51 12.98 46.14 Favored Glycine 0 C--N 1.284 -2.311 0 CA-C-N 112.185 -2.007 . . . . 0.0 115.157 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -128.37 148.27 50.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.273 0.536 . . . . 0.0 110.561 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.641 ' HA ' ' C ' ' C' ' 20' ' ' LEU . 18.4 m -78.54 120.91 30.43 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-O 122.007 0.908 . . . . 0.0 111.599 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.583 ' HB ' HG22 ' C' ' 21' ' ' VAL . 28.1 mt -76.7 166.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.003 173.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.493 ' N ' HG22 ' C' ' 82' ' ' ILE . 52.7 m170 -118.32 116.21 26.28 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.702 -0.624 . . . . 0.0 109.98 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.545 HD21 HD23 ' C' ' 59' ' ' LEU . 11.4 mt -90.81 157.82 17.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.565 HG12 ' CD2' ' A' ' 14' ' ' HIS . 2.4 m -131.49 161.38 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.987 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -128.07 122.68 32.72 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 167.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -74.53 171.79 13.16 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.136 0.493 . . . . 0.0 110.059 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -126.24 136.89 29.2 Favored Pre-proline 0 N--CA 1.426 -1.656 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.42 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.483 ' HA ' ' HD3' ' C' ' 90' ' ' PRO . 39.3 Cg_exo -63.11 137.42 61.58 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 123.286 2.657 . . . . 0.0 112.328 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' C' ' 89' ' ' PRO . 5.2 Cg_exo -77.82 19.52 0.77 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.961 2.441 . . . . 0.0 112.718 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -96.87 -18.95 19.2 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.168 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.413 HG23 ' O ' ' C' ' 92' ' ' THR . 10.2 t -141.43 108.19 5.38 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.611 0.72 . . . . 0.0 110.319 171.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -88.31 -23.15 23.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.763 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' C' ' 95' ' ' PRO . 93.0 mt -77.4 136.33 64.67 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.428 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 22.7 Cg_exo -62.25 118.64 5.54 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.747 2.298 . . . . 0.0 111.773 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 22.9 t -153.87 99.21 2.26 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.977 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.88 8.68 66.93 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.845 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.9 77.2 1.7 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.031 0.443 . . . . 0.0 110.824 -177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 45.8 m -121.46 2.73 10.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 57.2 m -94.41 37.41 1.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 110.627 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.42 -1.211 . . . . 0.0 111.184 178.702 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 4.2 p -76.8 115.73 16.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.757 0.313 . . . . 0.0 110.79 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -156.29 -36.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.716 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.07 106.28 8.27 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.04 -39.42 4.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.658 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.41 -37.89 88.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.264 0.554 . . . . 0.0 110.498 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.455 ' HB2' ' HA3' ' A' ' 9' ' ' GLY . 49.2 m -145.2 80.47 11.05 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.592 174.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.62 -47.43 16.33 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.23 2.62 . . . . 0.0 114.562 -174.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.627 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 38.3 m80 -86.19 -66.41 0.19 Allowed Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -173.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' A' ' 7' ' ' HIS . 22.3 Cg_endo -84.16 0.66 9.13 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.44 2.093 . . . . 0.0 112.724 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 5' ' ' SER . . . -96.68 1.99 62.05 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.75 -174.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 19.5 mtm180 -97.89 86.68 3.81 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.402 0.62 . . . . 0.0 110.941 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.599 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 14.7 m-85 -125.22 167.39 14.92 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -144.58 121.22 11.13 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.116 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.3 p -91.29 91.89 8.38 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.259 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -56.25 -41.77 76.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.367 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.2 t -55.3 -49.43 72.17 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.427 0.455 . . . . 0.0 112.196 -174.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.54 5.35 44.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.6 0.714 . . . . 0.0 111.559 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.4 p 53.32 58.31 5.36 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.058 1.343 . . . . 0.0 114.266 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -142.77 146.27 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 174.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 28.7 tt0 -89.18 139.42 30.5 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.537 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.972 HD11 HG21 ' A' ' 37' ' ' ILE . 7.0 pt -143.9 168.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -163.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.451 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 42.2 t -118.99 100.78 50.59 Favored Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 114.332 -1.304 . . . . 0.0 107.536 161.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.705 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . 1.2 Cg_endo -53.09 177.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.853 1 C-N-CA 126.078 4.519 . . . . 0.0 118.669 -168.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.522 ' HB2' HG13 ' A' ' 28' ' ' ILE . 62.9 mtt180 -117.94 50.81 1.11 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 111.34 -2.663 . . . . 0.0 107.388 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.433 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.6 mm? -8.71 -57.87 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 127.703 2.401 . . . . 0.0 117.325 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -32.98 -34.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 123.513 2.809 . . . . 0.0 114.378 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.584 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -124.42 -18.48 5.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.536 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.528 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 49.3 m-85 69.98 42.98 0.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.189 -171.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.584 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -91.33 165.19 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.119 174.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.471 ' CB ' HD13 ' A' ' 20' ' ' ILE . 25.2 p -95.49 144.06 27.18 Favored Pre-proline 0 N--CA 1.432 -1.338 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.636 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 44.1 Cg_endo -83.25 -22.55 3.96 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 123.278 2.652 . . . . 0.0 109.151 -168.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.528 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 60.0 mtt180 -81.96 -24.83 35.3 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 112.689 -2.051 . . . . 0.0 113.054 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.08 11.23 0.07 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 49.63 66.86 1.0 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.28 145.77 43.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.452 167.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -85.63 33.68 3.44 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.47 -174.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -108.95 52.03 0.72 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.133 0.492 . . . . 0.0 111.068 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.972 HG21 HD11 ' A' ' 20' ' ' ILE . 3.7 pt -111.58 138.86 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.77 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' HB2' HG22 ' C' ' 65' ' ' VAL . 2.9 pt-20 -116.39 147.71 41.37 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -80.25 122.46 26.91 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.852 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.599 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.35 -82.29 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 O-C-N 124.03 0.831 . . . . 0.0 111.395 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 56.04 78.66 0.19 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.363 0.601 . . . . 0.0 110.509 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -82.46 136.81 34.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.435 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -91.92 27.19 2.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.527 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -143.46 114.56 7.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.159 0.504 . . . . 0.0 109.816 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -122.75 -174.88 3.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.76 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -73.64 93.31 2.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.87 166.59 4.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.753 -174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -146.75 71.52 1.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.707 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . 0.418 ' HA ' ' HB2' ' C' ' 15' ' ' LYS . 41.8 m-20 -79.8 62.65 4.11 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.677 -175.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -99.75 -52.29 3.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.041 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.07 -33.77 13.25 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.429 0.633 . . . . 0.0 109.322 171.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' C' ' 35' ' ' ALA . 61.9 mttm -70.34 176.82 3.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.261 176.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 41.6 tpp 62.75 95.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.687 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.899 HD22 ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -102.09 145.97 28.58 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.524 ' HA ' HG13 ' C' ' 32' ' ' ILE . 43.2 tt0 -97.91 91.88 5.55 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 170.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' C' ' 30' ' ' THR . 4.5 t -76.82 98.68 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.099 -170.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.61 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.4 mt -87.28 132.97 33.75 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' C' ' 82' ' ' ILE . 88.0 t -145.05 120.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.158 0.504 . . . . 0.0 110.322 -173.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.734 ' HG2' ' OG1' ' C' ' 28' ' ' THR . 44.4 mtpt -92.1 144.27 25.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.537 HG22 ' HB2' ' C' ' 84' ' ' LEU . 18.6 p -120.06 114.32 21.82 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' C' ' 25' ' ' ASP . 0.4 OUTLIER 62.7 -47.89 0.19 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 177.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' C' ' 24' ' ' LEU . 31.1 t70 167.38 -27.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.428 0.691 . . . . 0.0 109.511 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -58.3 -72.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.216 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -131.77 -177.65 4.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.768 0.794 . . . . 0.0 112.171 -169.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.734 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 19.9 m -133.59 117.21 16.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.742 -1.572 . . . . 0.0 108.803 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -121.07 150.14 41.65 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.94 0.4 . . . . 0.0 110.885 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.8 p -99.56 144.82 28.2 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.241 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.471 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 34.2 m-85 -132.58 60.18 1.7 Allowed 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.614 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.5 mp -57.96 118.85 2.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 123.06 1.41 . . . . 0.0 114.367 -173.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.474 HG11 ' HD2' ' C' ' 42' ' ' PHE . 16.6 m -138.36 170.51 16.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 111.625 -2.534 . . . . 0.0 112.593 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' C' ' 37' ' ' MET . . . -84.88 50.33 4.38 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.08 -1.418 . . . . 0.0 114.188 -168.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.899 ' HA ' HD22 ' C' ' 17' ' ' LEU . . . 65.39 -48.2 0.37 Allowed 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 124.255 1.022 . . . . 0.0 113.482 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.512 ' HA ' ' HB3' ' C' ' 71' ' ' LYS . 3.9 pt20 -139.82 26.04 2.31 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -164.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . 0.419 ' HB2' ' H ' ' C' ' 34' ' ' GLY . 1.7 tmt? -59.64 -70.99 0.14 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 111.63 -2.532 . . . . 0.0 111.019 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.424 ' O ' ' HB ' ' C' ' 39' ' ' VAL . 13.5 m-80 -144.23 -92.02 0.11 Allowed 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.679 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 96.44 -29.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 O-C-N 125.702 1.876 . . . . 0.0 110.891 -166.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' C' ' 70' ' ' LYS . 0.9 OUTLIER -80.44 -71.39 0.46 Allowed 'General case' 0 N--CA 1.423 -1.813 0 CA-C-O 122.158 0.98 . . . . 0.0 108.859 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.89 -26.59 68.67 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 113.754 -1.567 . . . . 0.0 111.239 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.679 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.6 OUTLIER -59.37 -51.6 69.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.984 174.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.519 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 17.7 mtpp -63.51 -42.06 98.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.96 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -56.14 -37.0 68.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.282 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -69.76 -47.35 63.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.807 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.641 ' O ' HG22 ' C' ' 50' ' ' VAL . 7.4 pt -74.45 -11.46 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.994 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.5 -58.39 2.27 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.64 -37.53 67.96 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.845 -175.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -36.66 83.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.102 0.477 . . . . 0.0 110.648 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.641 HG22 ' O ' ' C' ' 46' ' ' ILE . 24.5 m -98.68 -1.71 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.946 177.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p 60.66 26.58 16.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.014 0.911 . . . . 0.0 109.533 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.3 mm -128.59 113.74 19.36 Favored Pre-proline 0 N--CA 1.434 -1.269 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.099 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 3.7 Cg_exo -69.98 143.65 50.43 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.131 1.888 . . . . 0.0 111.525 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.508 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 35.3 t -51.58 -24.72 5.71 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.331 1.02 . . . . 0.0 112.286 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.48 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.6 pt-20 -72.41 -43.71 63.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.604 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.48 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 96.6 mttt -88.2 -29.13 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.856 0.836 . . . . 0.0 109.382 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.519 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 19.3 tt0 -57.62 131.61 50.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.401 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -136.38 123.76 22.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.876 175.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.523 ' HB3' HG21 ' C' ' 82' ' ' ILE . 46.4 mt -86.73 104.36 16.05 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.098 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.565 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.0 mt -101.94 116.98 46.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.884 -0.51 . . . . 0.0 111.251 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -127.2 113.89 16.94 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 173.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 60.96 43.08 11.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.24 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 72.99 -4.58 22.81 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.142 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -88.32 125.39 34.66 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -87.92 88.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.283 0.564 . . . . 0.0 109.816 -176.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.663 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.5 OUTLIER -68.55 133.69 48.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -142.65 -176.92 5.06 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.641 -170.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.599 ' HA ' HG13 ' C' ' 39' ' ' VAL . 11.4 p-10 -71.88 -0.61 11.76 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.22 1.008 . . . . 0.0 112.627 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -79.89 -21.93 43.42 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.443 ' O ' ' HE3' ' C' ' 40' ' ' LYS . 68.7 mttt -123.93 -148.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -167.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' C' ' 36' ' ' GLN . 0.0 OUTLIER -127.17 163.58 23.54 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 2.9 mm? -66.25 -36.99 84.45 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 118.482 0.583 . . . . 0.0 111.167 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' C' ' 35' ' ' ALA . 35.0 tt0 -70.66 -18.15 62.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.858 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . 0.426 ' HG3' ' HB3' ' C' ' 70' ' ' LYS . 16.9 mm-40 -64.72 -28.84 69.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.464 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.663 ' CD1' HD22 ' C' ' 66' ' ' LEU . 17.8 m-85 -95.54 -22.52 17.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.867 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 t30 63.77 52.35 2.2 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 123.038 1.399 . . . . 0.0 107.76 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.69 -0.86 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 CA-C-N 112.78 -2.009 . . . . 0.0 112.705 -162.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.553 ' CA ' ' HG ' ' C' ' 17' ' ' LEU . . . -47.3 102.45 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.403 0 CA-C-O 122.904 1.28 . . . . 0.0 114.37 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.18 14.29 56.23 Favored Glycine 0 C--N 1.287 -2.188 0 CA-C-N 111.725 -2.237 . . . . 0.0 114.265 170.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -117.23 142.43 47.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.809 0.305 . . . . 0.0 110.25 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.642 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 15.6 m -79.34 124.13 37.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.676 0.751 . . . . 0.0 112.596 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.658 HD13 HD12 ' C' ' 66' ' ' LEU . 25.5 mt -86.87 168.71 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.487 174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.501 ' N ' HG22 ' C' ' 82' ' ' ILE . 46.2 m-70 -119.3 115.65 24.6 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 121.965 -0.459 . . . . 0.0 110.168 174.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.537 ' HB2' HG22 ' C' ' 23' ' ' THR . 11.3 mt -91.52 144.64 25.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.103 0.478 . . . . 0.0 111.235 175.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 31.0 m -142.05 169.39 13.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.837 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.76 150.03 32.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.137 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -71.35 177.2 4.05 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.291 0.567 . . . . 0.0 111.633 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.416 ' HB1' ' HD2' ' C' ' 89' ' ' PRO . . . -60.27 168.7 2.09 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.375 174.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.416 ' HD2' ' HB1' ' C' ' 88' ' ' ALA . 77.2 Cg_exo -53.55 158.39 8.0 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.198 1.932 . . . . 0.0 112.062 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.45 60.49 3.37 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.212 2.608 . . . . 0.0 113.393 -172.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -89.89 -3.34 58.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.811 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -84.82 131.17 34.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.86 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 71.23 -42.8 0.54 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.827 0.851 . . . . 0.0 111.528 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -90.01 116.66 66.9 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.78 110.4 1.45 Allowed 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.404 2.07 . . . . 0.0 112.754 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 23.2 t -76.91 145.81 38.0 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.46 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.64 81.97 1.44 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.272 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 58.6 47.47 13.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.884 0.373 . . . . 0.0 110.576 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 77.9 p 50.65 29.66 4.32 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.918 0.887 . . . . 0.0 112.053 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 15.9 m 60.2 29.03 18.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.995 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.905 -0.942 . . . . 0.0 112.386 177.545 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.7 t -132.31 85.65 2.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.05 0.452 . . . . 0.0 109.872 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -81.48 107.75 14.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.614 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.87 -16.64 37.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.581 0.705 . . . . 0.0 109.639 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.97 -172.07 3.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.148 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.34 58.61 5.06 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 123.604 0.565 . . . . 0.0 110.521 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m 65.72 75.44 0.34 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.126 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.81 -0.92 10.29 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.764 2.31 . . . . 0.0 112.76 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -122.45 128.87 25.29 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.728 0.299 . . . . 0.0 111.066 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.06 50.49 3.13 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.347 2.698 . . . . 0.0 112.553 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.95 3.1 25.72 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.669 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.667 ' HG2' HD12 ' A' ' 40' ' ' LEU . 38.5 ttt180 -114.74 83.4 1.89 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.071 -0.564 . . . . 0.0 110.809 -177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.532 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 8.6 m-85 -117.93 141.21 48.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.955 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.424 ' HB2' HD11 ' A' ' 40' ' ' LEU . 74.4 t80 -112.61 115.69 29.0 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.436 170.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.691 ' HB2' HG22 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -91.11 118.99 30.88 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.094 174.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -80.38 -7.89 59.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.263 -174.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 7.9 t -72.04 -51.52 21.32 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.911 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' HG23 ' A' ' 18' ' ' VAL . 26.9 p -100.94 2.97 41.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.312 0.577 . . . . 0.0 110.324 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p 54.4 45.43 27.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.812 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 16' ' ' CYS . 21.7 t -141.61 147.89 21.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.626 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.58 142.1 42.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.561 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.73 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.9 pt -133.17 167.05 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.703 0.763 . . . . 0.0 112.916 -170.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.9 t -117.79 108.31 42.99 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.303 160.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 19.1 Cg_endo -70.19 176.14 7.5 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 124.404 3.402 . . . . 0.0 116.552 -166.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HB2' HG13 ' A' ' 28' ' ' ILE . 62.6 mtt180 -114.05 49.17 1.02 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 112.924 -1.944 . . . . 0.0 107.802 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.428 HD13 ' CE1' ' A' ' 27' ' ' TYR . 2.6 mm? -0.44 -61.74 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.124 0 CA-C-N 111.308 -2.678 . . . . 0.0 117.763 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -32.38 -36.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.377 2.718 . . . . 0.0 114.397 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.553 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.98 -19.76 9.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.786 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.428 ' CE1' HD13 ' A' ' 24' ' ' LEU . 56.4 m-85 66.91 46.23 1.67 Allowed 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.227 -169.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.553 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -92.09 164.04 2.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 113.82 -1.537 . . . . 0.0 110.341 174.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.435 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -96.41 144.11 27.28 Favored Pre-proline 0 C--N 1.306 -1.303 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.015 177.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.73 ' HD3' HD12 ' A' ' 20' ' ' ILE . 47.5 Cg_endo -84.87 -15.91 5.57 Favored 'Trans proline' 0 CA--C 1.5 -1.212 0 C-N-CA 123.55 2.833 . . . . 0.0 108.627 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 85.7 mtt-85 -91.21 -14.18 31.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.177 -1.829 . . . . 0.0 114.0 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.4 p -163.33 3.77 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HG2' HG21 ' A' ' 28' ' ' ILE . 17.7 tt0 55.41 36.91 28.09 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.542 0.687 . . . . 0.0 112.162 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.449 ' HB3' ' CD2' ' A' ' 36' ' ' PHE . 16.7 m -116.81 136.43 52.96 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.493 172.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.67 28.26 2.46 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.086 -0.578 . . . . 0.0 113.925 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 80.0 m-85 -86.57 44.24 1.14 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.087 0.47 . . . . 0.0 109.799 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.713 HG21 ' CD1' ' A' ' 20' ' ' ILE . 19.6 pt -110.86 132.79 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.104 -176.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' HB3' HD13 ' C' ' 60' ' ' ILE . 10.9 pt-20 -121.7 139.81 53.09 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -76.35 128.64 35.25 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.667 HD12 ' HG2' ' A' ' 10' ' ' ARG . 13.0 mt . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.319 -167.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.43 91.62 4.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.724 0.297 . . . . 0.0 110.682 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 60.34 -161.81 0.27 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.741 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 60.11 46.42 10.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.413 0.625 . . . . 0.0 109.338 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -86.44 14.93 5.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.935 -169.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -56.5 -44.15 80.4 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -120.51 115.82 24.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.042 172.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -86.36 164.41 17.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.15 140.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.149 0.5 . . . . 0.0 110.737 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -124.24 -19.14 5.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.499 0.666 . . . . 0.0 109.419 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -87.07 51.1 2.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.429 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -142.28 155.43 45.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.083 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.43 -26.19 60.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.434 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' C' ' 33' ' ' VAL . 40.9 mttm -82.33 178.16 8.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.739 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' C' ' 35' ' ' ALA . 26.1 ttt -149.1 -36.57 0.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -175.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.759 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -102.08 140.43 36.36 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.786 -179.061 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.588 ' HA ' HG13 ' C' ' 32' ' ' ILE . 4.6 mt-10 -97.21 90.75 5.23 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.966 174.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 24.4 t -78.61 76.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 123.31 1.529 . . . . 0.0 111.019 -169.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.902 ' HB3' HG12 ' C' ' 81' ' ' VAL . 4.3 mt -69.98 140.37 52.94 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.56 HG22 ' HB ' ' C' ' 82' ' ' ILE . 47.4 t -153.44 115.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.986 0.422 . . . . 0.0 110.131 -169.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' C' ' 28' ' ' THR . 34.8 mtpt -98.9 125.44 44.32 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.628 ' O ' HD22 ' C' ' 24' ' ' LEU . 5.7 p -81.97 -60.66 2.15 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.031 0.443 . . . . 0.0 111.467 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.628 HD22 ' O ' ' C' ' 23' ' ' THR . 1.7 mm? -140.17 26.42 2.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.02 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 11.5 t70 84.23 -35.22 0.06 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.082 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 6.1 m -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.758 0.314 . . . . 0.0 111.19 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -92.09 -76.85 0.45 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' C' ' 22' ' ' LYS . 97.5 m 56.67 93.39 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.761 0.315 . . . . 0.0 110.638 -170.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' C' ' 29' ' ' ARG . 66.2 mtt180 -128.09 150.06 50.13 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.094 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.503 ' OG1' HD23 ' C' ' 20' ' ' LEU . 0.2 OUTLIER -97.09 139.94 32.34 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.626 -176.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.605 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 38.0 m-85 -127.0 67.67 1.27 Allowed 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.613 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.588 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -58.78 120.63 4.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 123.384 1.564 . . . . 0.0 114.189 -174.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' C' ' 15' ' ' LYS . 17.8 m -136.99 -170.3 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 110.94 -2.846 . . . . 0.0 110.812 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.447 ' O ' HD22 ' C' ' 17' ' ' LEU . . . -88.93 176.74 44.32 Favored Glycine 0 C--N 1.307 -1.06 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.773 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.759 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -68.73 -17.66 64.09 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 117.818 0.809 . . . . 0.0 112.286 -175.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -163.73 27.07 0.08 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -168.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -55.58 -76.53 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 112.019 -2.355 . . . . 0.0 111.219 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.58 ' O ' HG12 ' C' ' 39' ' ' VAL . 83.8 m-20 -128.79 -84.9 0.57 Allowed 'General case' 0 CA--C 1.494 -1.186 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.355 174.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.723 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 88.12 -28.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 125.594 1.809 . . . . 0.0 111.646 -167.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -72.6 0.5 Allowed 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.013 0.911 . . . . 0.0 109.402 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.2 -27.86 67.5 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.368 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.56 ' HZ ' HG11 ' C' ' 19' ' ' VAL . 0.6 OUTLIER -62.25 -50.32 72.21 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.35 174.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.671 ' HD2' ' O ' ' C' ' 39' ' ' VAL . 0.0 OUTLIER -58.37 -43.16 88.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.089 0.471 . . . . 0.0 110.756 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -57.03 -34.24 68.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.523 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -70.9 -44.51 66.09 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.691 ' O ' HG22 ' C' ' 50' ' ' VAL . 21.5 pt -77.98 -16.77 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.835 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.06 -49.61 2.56 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.06 -42.49 60.12 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.797 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -16.6 63.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.925 0.393 . . . . 0.0 110.976 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.691 HG22 ' O ' ' C' ' 46' ' ' ILE . 29.0 m -112.06 -9.1 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.891 176.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t 70.62 19.79 5.98 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.768 0.794 . . . . 0.0 109.283 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.7 mm -128.48 110.03 19.23 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.873 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.544 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 6.4 Cg_exo -68.37 146.82 70.09 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.173 1.915 . . . . 0.0 111.09 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 41.5 t -54.91 -25.7 30.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.898 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.483 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.7 pt-20 -75.31 -18.01 60.13 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.809 0.338 . . . . 0.0 111.082 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.628 ' O ' ' HG3' ' C' ' 87' ' ' ARG . 98.7 mttt -120.29 -0.95 10.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.401 . . . . 0.0 110.773 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.681 ' OE1' HD11 ' C' ' 46' ' ' ILE . 0.0 OUTLIER -93.1 126.18 38.07 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.335 -175.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.47 ' CD ' ' HG2' ' C' ' 87' ' ' ARG . 66.5 mtp85 -122.35 123.6 41.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.05 173.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.607 ' HB3' HG21 ' C' ' 82' ' ' ILE . 2.1 mm? -92.25 104.49 16.85 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.734 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.613 HG21 ' O ' ' A' ' 37' ' ' ILE . 6.6 mt -101.64 122.93 54.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.893 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.457 ' OH ' ' HD3' ' C' ' 80' ' ' LYS . 29.5 t80 -135.24 131.94 37.24 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 171.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 48.44 38.78 11.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.033 -172.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.88 6.4 63.58 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.848 -0.615 . . . . 0.0 113.169 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' C' ' 64' ' ' ARG . 4.2 mmp_? -98.16 133.52 42.49 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.456 HG11 ' NH2' ' C' ' 58' ' ' ARG . 0.6 OUTLIER -88.17 94.45 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.265 0.555 . . . . 0.0 110.471 -176.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.3 OUTLIER -82.66 156.1 24.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . 0.482 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 16.4 pt20 -169.97 -169.12 0.83 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.601 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.723 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.3 p-10 -62.41 -0.02 0.52 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.771 0.828 . . . . 0.0 112.228 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . 0.482 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 28.9 t70 -63.38 -4.33 2.6 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.016 0.926 . . . . 0.0 112.782 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.476 ' HA ' HG11 ' C' ' 39' ' ' VAL . 51.5 mtmt 83.55 167.89 0.1 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 169.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.435 ' HB3' ' HG3' ' C' ' 74' ' ' GLU . 13.9 mptt 67.35 79.12 0.23 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.939 -178.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 20.8 mt -62.27 -33.23 74.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.648 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -69.36 -19.03 63.84 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 122.696 0.399 . . . . 0.0 112.005 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . 0.435 ' HG3' ' HB3' ' C' ' 71' ' ' LYS . 32.1 mt-10 -73.05 -27.85 61.98 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.535 ' CD1' HD22 ' C' ' 66' ' ' LEU . 15.7 m-85 -87.97 -21.99 24.54 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.4 t30 58.89 40.37 22.73 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.709 174.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.512 HG11 HD11 ' C' ' 82' ' ' ILE . 17.4 m -87.92 10.22 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.84 -171.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -60.91 99.48 0.2 Allowed Glycine 0 CA--C 1.488 -1.6 0 CA-C-O 122.785 1.214 . . . . 0.0 113.226 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . 0.41 ' C ' HD12 ' C' ' 20' ' ' LEU . . . 94.35 15.25 48.17 Favored Glycine 0 C--N 1.284 -2.357 0 CA-C-N 112.091 -2.055 . . . . 0.0 114.132 172.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . 0.457 ' HD3' ' OH ' ' C' ' 61' ' ' TYR . 55.2 mttm -126.75 140.47 52.36 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.902 HG12 ' HB3' ' C' ' 20' ' ' LEU . 33.9 m -75.83 134.02 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.854 0.835 . . . . 0.0 110.732 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.607 HG21 ' HB3' ' C' ' 59' ' ' LEU . 59.4 mt -89.78 169.8 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.969 172.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.524 ' N ' HG22 ' C' ' 82' ' ' ILE . 56.8 m80 -115.95 112.38 21.77 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.474 HD12 ' N ' ' C' ' 85' ' ' VAL . 13.7 tp -97.83 130.63 44.74 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 121.218 0.533 . . . . 0.0 110.296 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.474 ' N ' HD12 ' C' ' 84' ' ' LEU . 30.6 m -131.38 151.81 36.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.978 -176.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . 0.464 ' HB3' HD12 ' C' ' 52' ' ' ILE . 3.2 pt-20 -87.96 143.81 26.89 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.324 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . 0.628 ' HG3' ' O ' ' C' ' 56' ' ' LYS . 54.2 mtt180 -80.76 166.12 21.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.641 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.7 144.44 97.87 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.895 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.9 155.7 62.56 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.101 2.534 . . . . 0.0 112.346 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.08 50.08 2.11 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.906 2.404 . . . . 0.0 113.15 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -100.59 -49.56 4.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.2 t -129.45 150.21 50.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.945 170.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 54.7 t60 60.32 54.85 3.77 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.643 0.735 . . . . 0.0 109.467 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.555 ' H ' HD23 ' C' ' 94' ' ' LEU . 1.3 pt? -109.38 115.58 56.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.231 -175.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.96 -29.55 11.93 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.475 2.117 . . . . 0.0 111.659 176.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 22.6 t -67.44 117.41 9.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.842 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.55 -78.58 1.85 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.517 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 64.29 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.442 0.697 . . . . 0.0 112.174 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 9.7 t 63.48 91.42 0.07 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.392 0.615 . . . . 0.0 110.323 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 8.4 m -87.67 62.2 6.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.136 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.72 -1.044 . . . . 0.0 112.094 177.663 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 112.131 -0.388 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 12.9 p -77.44 95.92 4.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.046 0.45 . . . . 0.0 110.721 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm -160.17 -54.5 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.821 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.12 115.13 4.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.17 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.36 77.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.483 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 66.72 -73.33 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.93 0.769 . . . . 0.0 111.034 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.418 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 58.1 m -151.32 82.04 5.9 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.61 57.59 6.44 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.949 2.433 . . . . 0.0 113.172 -175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.441 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 27.5 t-80 -166.49 -51.57 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.603 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 7' ' ' HIS . 97.1 Cg_endo -95.69 125.12 0.33 Allowed 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 122.497 2.132 . . . . 0.0 111.923 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.629 ' HA3' HG13 ' A' ' 21' ' ' VAL . . . 114.28 5.37 21.37 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 119.506 -1.33 . . . . 0.0 112.289 -176.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -70.96 81.68 0.66 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.483 0.659 . . . . 0.0 110.237 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.691 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.6 m-85 -115.42 166.2 12.14 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.141 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.592 ' HB2' HD11 ' A' ' 40' ' ' LEU . 39.0 t80 -140.64 119.44 12.53 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.317 178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -95.9 107.12 19.35 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.782 177.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.421 ' CE1' HD11 ' C' ' 24' ' ' LEU . 17.9 p80 -62.23 -15.73 48.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.808 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 7.0 t -71.71 -31.12 66.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.645 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.1 m -98.65 -26.14 14.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.156 0.503 . . . . 0.0 110.607 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.37 28.55 15.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.345 -171.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.68 143.53 40.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 36.9 tt0 -71.82 148.39 46.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.11 0.481 . . . . 0.0 110.831 -176.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.727 HD11 HG21 ' A' ' 37' ' ' ILE . 3.6 pt -138.68 167.04 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.719 -170.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.629 HG13 ' HA3' ' A' ' 9' ' ' GLY . 20.9 t -123.36 96.85 43.46 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 163.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.691 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 9.2 Cg_endo -56.0 176.16 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.872 1 C-N-CA 125.328 4.018 . . . . 0.0 116.529 -170.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.74 ' HB2' HG13 ' A' ' 28' ' ' ILE . 24.5 mtt180 -110.25 49.82 0.83 Allowed 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 112.488 -2.142 . . . . 0.0 107.692 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -0.75 -58.25 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 CA-C-N 111.21 -2.723 . . . . 0.0 117.047 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 18.6 Cg_exo -37.15 -31.19 0.12 Allowed 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.88 2.387 . . . . 0.0 114.074 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.554 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -123.69 -19.88 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.357 0.599 . . . . 0.0 111.765 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.436 ' C ' HD11 ' A' ' 37' ' ' ILE . 47.0 m-85 67.34 45.49 1.61 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.28 -171.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.74 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.4 OUTLIER -92.43 160.45 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.723 173.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -96.0 144.64 28.18 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.662 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 96.8 Cg_endo -79.52 -21.55 8.66 Favored 'Trans proline' 0 CA--C 1.497 -1.331 0 C-N-CA 122.672 2.248 . . . . 0.0 108.049 -172.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.1 mtt-85 -79.92 -37.79 33.87 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 112.561 -2.109 . . . . 0.0 113.567 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.0 p -133.75 -6.92 2.81 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.463 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 59.32 30.91 20.71 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.509 0.671 . . . . 0.0 111.661 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 m -111.48 144.24 41.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.467 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.23 41.06 2.6 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.109 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.682 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 60.5 m-85 -96.04 46.02 1.08 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.106 0.479 . . . . 0.0 109.934 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.727 HG21 HD11 ' A' ' 20' ' ' ILE . 3.5 pt -113.31 134.63 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.796 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB3' HD13 ' C' ' 60' ' ' ILE . 0.7 OUTLIER -119.14 141.69 48.6 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -79.9 137.27 36.86 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.455 -175.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.931 0.396 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.79 121.84 3.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.69 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.01 75.09 6.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.354 0.597 . . . . 0.0 110.531 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 t60 54.77 49.07 18.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.257 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -109.39 15.33 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.424 -175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 19.3 m80 -96.63 110.97 23.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.043 0.449 . . . . 0.0 110.641 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -145.5 -172.96 3.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -83.11 -47.66 11.4 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.24 142.41 42.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.442 171.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -104.95 -22.85 13.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.04 0.448 . . . . 0.0 110.028 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -83.47 78.17 9.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.655 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -81.51 74.42 8.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.68 0.753 . . . . 0.0 110.613 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -95.2 -2.7 49.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.764 174.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -68.03 150.79 48.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.173 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.538 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 26.5 ptt? -163.35 122.47 2.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.187 0.518 . . . . 0.0 111.401 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.9 mt -105.04 132.15 51.64 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.562 ' HA ' ' CG1' ' C' ' 32' ' ' ILE . 49.3 mt-10 -81.51 94.39 6.86 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.58 HG22 HG23 ' C' ' 77' ' ' VAL . 9.4 t -80.67 116.53 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.925 -171.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.573 ' CB ' HG12 ' C' ' 81' ' ' VAL . 0.8 OUTLIER -107.5 144.9 33.8 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 175.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' C' ' 28' ' ' THR . 3.5 m -137.02 147.64 26.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.567 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 37.0 mtpt -120.29 123.64 43.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 17.0 p -81.89 179.82 7.67 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.682 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 6.2 mp -67.06 -29.13 68.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.683 0.674 . . . . 0.0 110.134 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.47 -5.91 12.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.783 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 8.7 t 66.21 22.6 10.96 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.539 0.685 . . . . 0.0 110.611 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -47.23 -56.54 6.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.203 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 71.7 m 62.29 96.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.849 0.718 . . . . 0.0 110.615 -174.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -133.11 153.42 51.54 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.425 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.568 HG22 ' CD2' ' C' ' 20' ' ' LEU . 16.3 p -100.11 151.4 21.44 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -170.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.634 ' HE2' HG21 ' C' ' 21' ' ' VAL . 26.8 m-85 -141.43 55.56 1.52 Allowed 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.246 -175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.562 ' CG1' ' HA ' ' C' ' 18' ' ' GLU . 3.0 mp -60.95 120.84 7.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 123.407 1.575 . . . . 0.0 113.801 -174.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' C' ' 16' ' ' MET . 15.6 m -138.03 -168.76 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 110.729 -2.942 . . . . 0.0 111.446 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -76.94 -158.96 9.39 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.052 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.566 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -110.13 23.64 14.06 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 120.9 0.381 . . . . 0.0 111.371 -177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 7.5 tt0 166.19 -17.47 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.418 -163.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -41.25 -64.86 0.5 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.48 1.113 . . . . 0.0 112.262 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.465 ' O ' HG12 ' C' ' 39' ' ' VAL . 66.1 m-20 -131.0 -95.01 0.37 Allowed 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.677 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 86.0 -30.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 O-C-N 125.041 1.463 . . . . 0.0 110.819 -162.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.79 -70.28 0.55 Allowed 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.228 1.013 . . . . 0.0 109.095 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . 0.44 ' HB2' ' CG ' ' C' ' 38' ' ' ASN . 43.7 mt-10 -62.03 -26.66 68.37 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.393 173.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.755 ' O ' HG23 ' C' ' 46' ' ' ILE . 0.2 OUTLIER -56.82 -53.71 54.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.255 172.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.448 ' N ' ' HD1' ' C' ' 42' ' ' PHE . 18.8 mtpp -61.79 -41.89 98.32 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.521 0.677 . . . . 0.0 110.721 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -58.46 -40.28 82.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.662 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -69.92 -44.82 68.87 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.027 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.755 HG23 ' O ' ' C' ' 42' ' ' PHE . 4.3 pt -75.22 -13.23 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.792 -0.185 . . . . 0.0 111.225 -172.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -43.49 -45.64 6.52 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.33 -43.09 34.23 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.892 -0.505 . . . . 0.0 111.804 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -20.28 63.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.516 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.655 HG22 ' O ' ' C' ' 46' ' ' ILE . 31.5 m -112.07 -6.68 11.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 47.6 t 68.85 19.72 8.23 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.724 0.773 . . . . 0.0 109.018 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.64 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 8.6 mm -125.71 112.42 25.06 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.385 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.602 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 4.7 Cg_exo -69.73 146.31 59.97 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.138 1.892 . . . . 0.0 111.494 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 2.3 p -53.0 -24.82 10.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.476 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 12.8 pt-20 -77.27 -32.37 55.56 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.36 0.412 . . . . 0.0 111.894 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' C' ' 86' ' ' GLU . 27.0 mtpp -97.92 -19.93 17.77 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 109.847 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' C' ' 53' ' ' PRO . 25.8 tt0 -66.52 123.26 19.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.92 -170.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.568 ' HD2' ' HG2' ' C' ' 87' ' ' ARG . 43.5 mtp85 -124.93 115.4 20.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.204 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.593 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 51.6 mt -86.96 111.41 20.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.979 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 38' ' ' GLU . 5.6 mt -109.93 113.63 44.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 O-C-N 121.568 -0.707 . . . . 0.0 112.01 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' C' ' 66' ' ' LEU . 21.1 t80 -129.38 126.89 39.86 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 60.5 34.17 20.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.022 0.439 . . . . 0.0 110.379 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.99 5.44 40.09 Favored Glycine 0 N--CA 1.453 -0.211 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.899 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 mmp_? -87.43 133.4 33.74 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.97 87.6 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.261 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.602 ' HB3' ' CD2' ' C' ' 75' ' ' TYR . 0.8 OUTLIER -68.28 141.63 55.81 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' C' ' 69' ' ' ASP . 10.6 pt20 -155.4 -168.97 3.0 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.684 -0.406 . . . . 0.0 109.955 -173.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.677 ' HA ' HG13 ' C' ' 39' ' ' VAL . 8.9 p-10 -67.43 0.24 3.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.608 0.763 . . . . 0.0 112.577 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . 0.441 ' H ' ' HG3' ' C' ' 67' ' ' GLN . 29.1 t70 -64.17 -4.02 3.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.521 0.729 . . . . 0.0 112.846 -174.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.416 ' H ' HG11 ' C' ' 39' ' ' VAL . 49.2 mttp 81.95 177.21 0.08 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.951 0.9 . . . . 0.0 111.865 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.421 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 65.5 mttm 74.66 75.12 0.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.145 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.473 HD12 ' H ' ' C' ' 36' ' ' GLN . 56.6 mt -65.01 -45.39 85.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.292 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -69.55 -25.84 64.2 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . 0.421 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 69.3 mm-40 -67.46 -24.71 65.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.575 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.602 ' CD2' ' HB3' ' C' ' 66' ' ' LEU . 6.9 m-30 -86.42 -10.21 54.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.447 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 1.3 m120 47.89 35.33 4.75 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.328 1.051 . . . . 0.0 113.471 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.58 HG23 HG22 ' C' ' 19' ' ' VAL . 16.5 m -90.55 16.19 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -175.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.556 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -73.18 102.78 1.29 Allowed Glycine 0 N--CA 1.431 -1.658 0 CA-C-O 122.792 1.218 . . . . 0.0 112.082 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.21 14.59 62.01 Favored Glycine 0 C--N 1.283 -2.401 0 CA-C-N 112.052 -2.074 . . . . 0.0 113.045 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -124.23 147.5 48.01 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.573 HG12 ' CB ' ' C' ' 20' ' ' LEU . 34.0 m -84.13 124.26 39.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 121.971 0.891 . . . . 0.0 112.313 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.52 HG22 ' N ' ' C' ' 83' ' ' HIS . 74.0 mt -77.77 171.6 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.433 173.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.52 ' N ' HG22 ' C' ' 82' ' ' ILE . 45.5 m80 -118.85 119.52 34.62 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.465 -0.772 . . . . 0.0 109.775 170.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.468 HD12 ' H ' ' C' ' 85' ' ' VAL . 25.9 tp -100.59 145.14 28.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -171.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.77 HG22 ' H ' ' C' ' 86' ' ' GLU . 2.8 p -153.5 -174.33 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.481 0.658 . . . . 0.0 109.973 171.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . 0.77 ' H ' HG22 ' C' ' 85' ' ' VAL . 4.7 pt-20 -117.98 161.22 20.15 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.858 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . 0.568 ' HG2' ' HD2' ' C' ' 58' ' ' ARG . 29.1 mtm105 -82.38 159.98 22.9 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 171.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -68.74 139.2 90.99 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.601 -175.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.56 ' HB2' ' OE1' ' C' ' 91' ' ' GLN . 38.1 Cg_exo -63.02 162.85 24.46 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 124.146 3.23 . . . . 0.0 112.683 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.95 56.59 2.48 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.335 2.69 . . . . 0.0 113.366 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . 0.56 ' OE1' ' HB2' ' C' ' 89' ' ' PRO . 7.8 pm0 179.18 -26.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.281 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 13.1 t 42.44 42.76 2.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.633 1.173 . . . . 0.0 113.231 169.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 70.15 -63.12 0.41 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.357 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 pp -144.23 137.34 13.91 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.383 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.97 152.16 40.58 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.333 2.022 . . . . 0.0 111.526 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 8.5 t -164.07 149.26 10.49 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.0 -60.42 8.44 Favored Glycine 0 C--O 1.236 0.258 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.849 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 58.32 36.8 25.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.228 0.537 . . . . 0.0 110.962 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 17.2 t -95.27 77.33 3.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.997 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 13.9 m -84.44 53.05 2.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.659 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.315 -1.269 . . . . 0.0 111.17 -178.251 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.1 t -164.33 94.61 0.72 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.003 0.43 . . . . 0.0 110.025 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -77.27 -51.33 11.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.355 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.83 108.55 5.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.923 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -143.39 -63.97 0.39 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.752 -175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.559 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . 55.32 61.79 2.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.206 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -88.69 104.66 7.81 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.62 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 4' ' ' ALA . 97.7 Cg_endo -86.96 178.05 3.78 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.351 2.034 . . . . 0.0 111.52 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.607 ' CB ' ' HG2' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -140.71 93.4 8.55 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.192 173.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 7' ' ' HIS . 19.0 Cg_endo -53.26 -24.43 26.71 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 C-N-CA 123.664 2.91 . . . . 0.0 113.834 173.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.8 34.61 0.02 OUTLIER Glycine 0 CA--C 1.493 -1.295 0 C-N-CA 119.304 -1.427 . . . . 0.0 114.478 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.607 ' HG2' ' CB ' ' A' ' 7' ' ' HIS . 16.7 ptp180 -71.73 97.13 1.71 Allowed 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.353 1.073 . . . . 0.0 109.48 174.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.69 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 8.4 m-85 -116.79 164.59 14.43 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.819 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.611 ' CB ' HD21 ' A' ' 40' ' ' LEU . 54.5 t80 -138.98 112.58 8.3 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.572 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.596 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -91.9 110.52 21.87 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.474 ' CG ' HG13 ' C' ' 85' ' ' VAL . 9.8 p80 -69.15 -17.98 63.89 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -169.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 13.5 p -73.33 -39.11 65.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.255 174.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.7 m -78.19 -29.68 48.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.321 0.581 . . . . 0.0 110.646 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER 58.58 28.8 17.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.694 -176.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.54 146.23 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.69 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 33.1 tt0 -70.06 144.53 52.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.231 0.538 . . . . 0.0 111.034 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.719 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.2 pt -132.08 167.91 25.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.77 -175.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 14.1 t -125.28 95.01 42.17 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 164.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 3.5 Cg_endo -54.28 175.85 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.842 1 C-N-CA 125.423 4.082 . . . . 0.0 116.973 -169.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.709 ' HB2' HG13 ' A' ' 28' ' ' ILE . 37.8 mtt180 -107.5 48.32 0.85 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 112.565 -2.107 . . . . 0.0 107.023 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 0.79 -61.71 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.116 0 CA-C-N 110.811 -2.904 . . . . 0.0 117.253 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -32.18 -36.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 123.553 2.835 . . . . 0.0 113.819 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.531 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -115.68 -22.62 9.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.181 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.513 ' C ' HD11 ' A' ' 37' ' ' ILE . 58.4 m-85 68.1 58.6 0.46 Allowed 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.406 1.098 . . . . 0.0 110.32 -168.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.709 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -110.71 162.57 8.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.304 176.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.5 t -96.16 146.61 31.61 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.624 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 67.6 Cg_endo -81.6 -22.3 5.6 Favored 'Trans proline' 0 CA--C 1.5 -1.224 0 C-N-CA 122.606 2.204 . . . . 0.0 108.031 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.539 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 68.5 mtt-85 -81.7 -25.14 35.73 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 112.892 -1.958 . . . . 0.0 113.752 -177.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.6 p -146.23 -7.25 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.637 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 60.35 32.35 20.65 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.744 0.783 . . . . 0.0 111.033 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.1 m -113.19 146.39 39.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.744 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.57 37.64 2.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.14 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 87.8 m-85 -92.34 38.77 1.01 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.255 0.55 . . . . 0.0 110.041 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.719 HG21 ' CD1' ' A' ' 20' ' ' ILE . 7.1 pt -110.94 133.67 55.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.614 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HB2' HG22 ' C' ' 65' ' ' VAL . 10.5 pt-20 -121.95 136.15 54.91 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 172.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.26 135.9 40.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.219 0.533 . . . . 0.0 109.692 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.611 HD21 ' CB ' ' A' ' 12' ' ' PHE . 8.7 mt . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.328 -171.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' C' ' 7' ' ' HIS . 52.1 mtt . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.511 0.196 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.49 -69.79 0.17 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.536 0.734 . . . . 0.0 112.151 177.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -151.27 120.35 6.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 59.89 -162.43 0.25 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -174.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 57.69 71.19 0.59 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.223 0.535 . . . . 0.0 111.789 171.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . 0.453 ' HA ' ' SD ' ' C' ' 2' ' ' MET . 44.1 m80 -79.27 162.91 25.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.761 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -92.36 18.01 9.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.337 0.589 . . . . 0.0 110.645 -173.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -101.94 11.22 38.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.528 0.68 . . . . 0.0 109.468 173.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.83 156.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.548 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -67.54 -60.39 2.6 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 18.7 t70 176.23 -50.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.09 95.99 2.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.172 164.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -78.64 -2.9 41.3 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.278 -175.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . 0.797 ' HD3' HG22 ' C' ' 32' ' ' ILE . 33.0 mttp 49.51 -165.47 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.067 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . . . . . . . . . 49.9 ttm -170.56 -31.12 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.933 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -104.08 147.87 26.91 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.294 0.569 . . . . 0.0 109.524 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.499 ' HA ' HG13 ' C' ' 32' ' ' ILE . 4.5 mt-10 -106.86 83.55 1.86 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' C' ' 30' ' ' THR . 4.2 t -72.06 143.63 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.441 -166.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 1.018 ' HB3' HG12 ' C' ' 81' ' ' VAL . 7.9 mt -128.65 156.71 43.0 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' C' ' 28' ' ' THR . 21.5 m -145.36 152.89 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.601 ' HG3' ' CB ' ' C' ' 81' ' ' VAL . 35.7 mtpt -138.24 110.44 7.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.952 0.501 . . . . 0.0 109.983 173.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.36 108.69 20.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.869 0.366 . . . . 0.0 111.072 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 mm? 55.97 22.01 5.44 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.541 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . 0.481 ' HA ' ' HE2' ' C' ' 22' ' ' LYS . 34.8 t70 76.5 -22.98 0.25 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.524 173.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 15.1 m -58.63 -44.04 89.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.13 0.491 . . . . 0.0 110.14 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -106.95 171.55 7.3 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.04 0.924 . . . . 0.0 111.576 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.734 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 51.5 m -173.17 103.56 0.13 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 113.087 -1.869 . . . . 0.0 107.846 178.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' C' ' 20' ' ' LEU . 83.8 mtt180 -130.71 168.18 17.6 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.77 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 2.1 p -108.52 148.32 30.43 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.658 ' HE2' HG21 ' C' ' 21' ' ' VAL . 40.6 m-85 -139.73 65.07 1.44 Allowed 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.44 0.638 . . . . 0.0 110.365 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.797 HG22 ' HD3' ' C' ' 15' ' ' LYS . 2.5 mp -55.23 118.45 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 123.214 1.483 . . . . 0.0 113.776 -176.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.41 HG13 ' O ' ' C' ' 31' ' ' PHE . 19.7 m -136.94 -171.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 111.347 -2.661 . . . . 0.0 111.209 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.08 157.18 20.07 Favored Glycine 0 C--N 1.307 -1.082 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.144 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.795 ' HA ' HD21 ' C' ' 17' ' ' LEU . . . -63.42 -18.78 64.08 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -172.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -147.74 22.47 1.13 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -75.53 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.224 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.609 ' O ' HG12 ' C' ' 39' ' ' VAL . 8.1 m120 -128.74 -91.94 0.47 Allowed 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.664 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 82.04 -28.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 125.035 1.459 . . . . 0.0 112.12 -166.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' C' ' 43' ' ' LYS . 0.0 OUTLIER -80.77 -68.96 0.64 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.557 1.17 . . . . 0.0 108.78 174.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.53 -29.62 70.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.476 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.618 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -62.18 -53.21 58.57 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.184 175.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.651 ' HG2' ' O ' ' C' ' 40' ' ' LYS . 3.3 ptmt -67.3 -34.1 76.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.192 0.52 . . . . 0.0 110.136 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.512 ' HA ' ' HB3' ' C' ' 54' ' ' SER . 16.7 tt0 -59.46 -37.01 77.07 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.657 175.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -69.98 -40.73 75.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.925 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.617 ' O ' HG22 ' C' ' 50' ' ' VAL . 18.4 pt -81.46 -7.64 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -174.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.24 -59.76 1.44 Allowed 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.24 -34.54 70.86 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.849 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.04 -28.22 69.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.261 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.617 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.4 m -106.16 -2.75 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 29.0 m 69.53 19.61 7.42 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.536 0.684 . . . . 0.0 109.586 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.6 mm -127.65 117.12 21.08 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.165 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.522 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.0 Cg_exo -68.75 149.8 73.45 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.636 1.558 . . . . 0.0 111.751 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.544 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 29.6 p -53.88 -25.72 21.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.254 -176.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -79.68 -13.6 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -116.24 -33.04 5.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.639 ' OE1' ' HB2' ' C' ' 43' ' ' LYS . 8.7 pt20 -65.33 129.61 40.35 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.985 0.898 . . . . 0.0 111.997 -173.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' C' ' 84' ' ' LEU . 38.5 mmt180 -115.51 116.06 27.55 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.761 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.709 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 11.7 mt -84.23 106.01 15.52 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.346 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.53 HG21 ' O ' ' A' ' 37' ' ' ILE . 26.6 mt -99.1 118.53 45.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.534 -0.729 . . . . 0.0 111.69 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.444 ' OH ' ' HG2' ' C' ' 80' ' ' LYS . 64.5 t80 -135.19 130.2 34.95 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 170.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' C' ' 61' ' ' TYR . 48.1 mt-30 61.8 33.62 17.65 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.053 -174.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 68.3 4.58 37.8 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.43 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -99.17 133.41 43.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -89.99 88.68 2.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.314 0.578 . . . . 0.0 110.013 -175.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.709 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.1 OUTLIER -67.93 155.18 40.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.162 178.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . 0.415 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.5 pt20 -161.95 -167.19 1.6 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.686 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.664 ' HA ' HG13 ' C' ' 39' ' ' VAL . 1.5 p-10 -58.81 -2.48 0.23 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.041 0.936 . . . . 0.0 112.893 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 27.8 t70 -62.25 -9.12 6.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.574 0.75 . . . . 0.0 112.573 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.518 ' H ' HG11 ' C' ' 39' ' ' VAL . 37.5 mtmm 78.81 174.9 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.758 0.823 . . . . 0.0 112.41 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.491 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 32.6 mtmm 78.6 71.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 124.209 0.943 . . . . 0.0 111.362 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 3.5 mm? -62.19 -44.14 97.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' C' ' 35' ' ' ALA . 2.3 pt20 -66.02 -19.47 65.87 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . 0.491 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 36.7 mm-40 -70.52 -28.39 64.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.584 ' CD1' HD22 ' C' ' 66' ' ' LEU . 18.9 m-85 -87.29 -23.51 24.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 60.59 43.66 12.48 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.905 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.563 HG23 HG22 ' C' ' 19' ' ' VAL . 19.6 m -91.3 -8.06 10.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -175.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.714 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -50.03 100.34 0.04 OUTLIER Glycine 0 CA--C 1.493 -1.305 0 CA-C-O 122.914 1.286 . . . . 0.0 113.944 168.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.93 10.38 49.54 Favored Glycine 0 C--N 1.29 -1.993 0 CA-C-N 111.629 -2.286 . . . . 0.0 114.725 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . 0.574 ' C ' ' HB2' ' C' ' 20' ' ' LEU . 0.0 OUTLIER -132.47 148.18 52.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.524 0.662 . . . . 0.0 111.118 -178.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 1.018 HG12 ' HB3' ' C' ' 20' ' ' LEU . 35.6 m -80.52 122.04 35.01 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-O 121.741 0.781 . . . . 0.0 111.934 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.49 HG21 ' HB3' ' C' ' 59' ' ' LEU . 77.6 mt -80.18 160.46 4.15 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.828 174.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.438 ' N ' HG22 ' C' ' 82' ' ' ILE . 54.8 m80 -117.71 114.73 23.77 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 121.657 -0.652 . . . . 0.0 109.989 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' C' ' 58' ' ' ARG . 8.0 mp -90.49 157.34 17.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.474 HG13 ' CG ' ' A' ' 14' ' ' HIS . 4.1 t -117.6 156.63 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.618 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . 0.521 ' H ' ' CD ' ' C' ' 86' ' ' GLU . 0.2 OUTLIER -113.58 122.85 48.46 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.461 179.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . 0.516 ' HE ' ' HA ' ' C' ' 87' ' ' ARG . 1.1 mmp_? -84.08 176.84 8.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 121.643 -0.66 . . . . 0.0 111.891 176.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.88 154.8 57.06 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.834 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.45 157.81 29.84 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.101 2.534 . . . . 0.0 111.917 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.15 55.32 3.45 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.921 2.414 . . . . 0.0 112.5 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -93.16 -68.78 0.78 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.832 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t 46.88 -151.44 0.09 Allowed 'General case' 0 CA--C 1.539 0.542 0 O-C-N 124.28 0.987 . . . . 0.0 111.695 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -66.65 -54.12 26.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.653 0.263 . . . . 0.0 110.497 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.38 104.55 52.96 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.107 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.75 130.29 21.65 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.815 2.343 . . . . 0.0 112.962 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 45.7 t -65.16 -32.06 73.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.64 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.59 -63.01 0.32 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.002 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.34 129.52 50.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.832 0.349 . . . . 0.0 110.434 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 45.3 m -90.68 -54.53 3.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.373 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 44.6 m 51.91 63.41 2.25 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.529 0.518 . . . . 0.0 111.483 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.307 -1.274 . . . . 0.0 111.411 -179.697 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 16.8 m -77.47 130.37 36.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -149.84 160.91 43.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.964 0.411 . . . . 0.0 110.96 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.12 97.87 7.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.817 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.96 56.73 1.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.153 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.25 -5.86 45.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.048 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.0 t -124.35 79.21 60.79 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.908 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.16 -76.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.597 2.198 . . . . 0.0 112.086 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 68.43 130.23 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 O-C-N 123.734 0.646 . . . . 0.0 111.1 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.56 13.46 2.08 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 123.046 2.497 . . . . 0.0 112.37 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.22 7.2 64.11 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.349 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -70.29 95.98 1.07 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.338 0.59 . . . . 0.0 110.526 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.603 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 6.7 m-85 -116.3 166.41 12.08 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.982 171.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 40' ' ' LEU . 60.6 t80 -139.48 123.74 18.01 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.446 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.571 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -98.02 101.05 12.43 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.587 ' HD2' ' OE1' ' A' ' 38' ' ' GLU . 11.9 p80 -52.91 -24.95 10.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.27 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.8 t -67.5 -46.76 71.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.769 0.319 . . . . 0.0 110.443 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.0 m -74.58 -28.24 60.83 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.497 0.665 . . . . 0.0 109.852 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.68 29.6 17.56 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.02 -170.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.03 144.39 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 37.5 tt0 -73.67 148.67 42.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.124 0.488 . . . . 0.0 110.844 -175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.73 HD12 ' HD3' ' A' ' 30' ' ' PRO . 6.2 pt -139.01 168.38 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.265 -172.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.519 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 47.2 t -122.74 101.3 39.8 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 160.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 11' ' ' TYR . 11.1 Cg_endo -54.36 175.32 0.14 Allowed 'Trans proline' 0 C--N 1.328 -0.502 1 C-N-CA 125.582 4.188 . . . . 0.0 116.215 -171.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.492 ' HD3' HD12 ' A' ' 28' ' ' ILE . 29.8 mtt180 -101.82 45.69 0.96 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 112.587 -2.097 . . . . 0.0 107.096 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.48 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -1.98 -59.03 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.861 0 CA-C-N 110.41 -3.086 . . . . 0.0 117.654 175.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.29 44.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.268 1.978 . . . . 0.0 112.857 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.575 ' HB3' HG12 ' A' ' 28' ' ' ILE . 4.8 t70 177.68 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.942 0.897 . . . . 0.0 109.653 -174.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.448 ' CE1' HD13 ' A' ' 24' ' ' LEU . 93.8 m-85 70.69 58.13 0.22 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.328 -173.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.575 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -114.76 163.52 11.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 113.307 -1.77 . . . . 0.0 108.833 175.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.458 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 2.1 t -95.88 144.42 27.79 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.73 ' HD3' HD12 ' A' ' 20' ' ' ILE . 79.6 Cg_endo -81.09 -22.89 5.69 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 C-N-CA 122.807 2.338 . . . . 0.0 108.182 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.517 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 50.2 mtt180 -89.09 -6.31 57.17 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.835 -1.984 . . . . 0.0 114.485 -176.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.7 p -156.06 -14.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 171.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 61.25 22.59 12.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.364 0.602 . . . . 0.0 111.709 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.9 m -96.13 141.55 29.37 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 166.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.56 51.82 4.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.007 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.54 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 39.8 m-85 -107.88 45.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.722 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.9 pt -113.66 143.87 22.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.922 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.587 ' OE1' ' HD2' ' A' ' 14' ' ' HIS . 1.4 pm0 -120.65 149.53 42.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 165.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -81.27 133.82 35.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.62 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.425 -0.797 . . . . 0.0 110.409 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.53 -58.59 0.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.441 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -77.65 126.39 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.252 0.549 . . . . 0.0 110.557 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' C' ' 6' ' ' HIS . 56.4 m80 -135.55 98.4 3.93 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' C' ' 5' ' ' HIS . 25.4 m-70 72.89 -54.41 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.144 0.903 . . . . 0.0 110.748 -173.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . 0.506 ' O ' ' HB2' ' C' ' 8' ' ' HIS . 5.7 t-160 -75.66 142.77 42.49 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 176.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' C' ' 7' ' ' HIS . 28.8 m80 73.41 75.28 0.13 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.689 0.618 . . . . 0.0 110.548 -173.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -77.82 63.72 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.49 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.414 HG22 ' N ' ' C' ' 11' ' ' ASP . 7.6 p -93.1 156.97 3.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.418 0.628 . . . . 0.0 110.863 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . 0.414 ' N ' HG22 ' C' ' 10' ' ' VAL . 24.5 t70 -132.03 66.15 1.56 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.412 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.22 65.2 5.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.064 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 60.7 41.7 14.69 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.507 -172.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -76.92 -56.53 4.51 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.469 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -76.11 -179.05 4.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.838 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.525 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 22.9 mmt 59.6 83.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.54 0.525 . . . . 0.0 110.724 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.726 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.4 OUTLIER -102.18 138.07 39.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.686 178.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' C' ' 32' ' ' ILE . 10.3 mt-10 -85.08 98.55 10.49 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.565 0.698 . . . . 0.0 109.287 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' C' ' 30' ' ' THR . 17.1 t -79.5 83.64 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 122.482 1.134 . . . . 0.0 110.904 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.625 ' HB3' HG12 ' C' ' 81' ' ' VAL . 12.3 mt -75.66 142.58 42.52 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' C' ' 82' ' ' ILE . 82.0 t -156.18 125.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 121.952 0.101 . . . . 0.0 110.889 -171.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.649 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 0.1 OUTLIER -111.97 162.82 14.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.152 0.501 . . . . 0.0 110.901 -178.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.535 HG22 ' O ' ' C' ' 84' ' ' LEU . 11.3 p -132.3 -174.22 3.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.836 176.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.54 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 3.4 mp -65.83 -29.77 70.29 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.142 0.496 . . . . 0.0 110.178 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.42 5.48 3.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.204 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 20.6 t 63.59 18.38 11.05 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.065 0.459 . . . . 0.0 111.484 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -49.95 -65.89 0.49 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.468 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 43.9 m 56.37 90.61 0.04 OUTLIER 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.909 0.862 . . . . 0.0 110.662 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -126.15 151.06 47.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.337 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -99.9 143.41 30.15 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.129 0.49 . . . . 0.0 111.301 -178.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.489 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 29.2 m-85 -126.5 62.82 1.28 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 123.578 0.751 . . . . 0.0 109.766 -175.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.59 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -57.02 121.98 5.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 123.114 1.435 . . . . 0.0 114.745 -172.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' HG ' ' C' ' 72' ' ' LEU . 16.7 m -141.81 167.01 16.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 111.267 -2.697 . . . . 0.0 112.523 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -96.57 52.16 1.53 Allowed Glycine 0 C--N 1.306 -1.089 0 CA-C-N 114.549 -1.205 . . . . 0.0 114.595 -168.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.726 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.61 -44.67 0.52 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 171.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -132.1 26.61 4.56 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -75.37 0.07 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.87 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -146.58 -79.3 0.16 Allowed 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.696 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.4 OUTLIER 90.56 -29.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 125.375 1.672 . . . . 0.0 111.438 -167.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.47 ' HD2' ' HG2' ' C' ' 70' ' ' LYS . 0.1 OUTLIER -84.24 -70.35 0.58 Allowed 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 122.202 1.001 . . . . 0.0 109.14 177.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.04 -26.57 67.72 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.632 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.674 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -56.14 -50.14 71.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.162 171.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.617 ' HG2' ' OE1' ' C' ' 57' ' ' GLN . 43.6 mttp -64.59 -42.32 95.68 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.219 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -56.0 -36.73 68.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.572 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -70.11 -46.71 64.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.755 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.591 HG23 ' O ' ' C' ' 42' ' ' PHE . 8.5 pt -78.1 -13.79 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.792 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.98 -51.2 3.28 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.25 -45.47 69.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -28.07 64.83 Favored 'General case' 0 N--CA 1.424 -1.734 0 C-N-CA 122.868 0.467 . . . . 0.0 112.164 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.528 HG11 ' CD1' ' C' ' 84' ' ' LEU . 27.6 m -106.41 -3.81 9.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.18 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 82.6 p 63.35 23.7 13.87 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 122.054 0.93 . . . . 0.0 109.54 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.1 mm -131.63 120.44 17.71 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.244 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -67.73 152.8 77.29 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.034 1.823 . . . . 0.0 112.588 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.501 ' HA ' ' HG2' ' C' ' 57' ' ' GLN . 29.9 t -50.06 -40.89 46.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.358 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.549 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 15.7 pt-20 -67.12 -17.85 65.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.839 -177.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.549 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 67.7 mttm -121.09 -0.91 9.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -173.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.617 ' OE1' ' HG2' ' C' ' 43' ' ' LYS . 9.3 pt20 -96.07 142.26 28.49 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.626 -0.829 . . . . 0.0 112.863 -175.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.53 ' HG3' ' HG2' ' C' ' 87' ' ' ARG . 98.0 mtt180 -114.94 121.85 44.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.266 173.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 9.0 mp -92.07 107.3 19.11 Favored 'General case' 0 C--O 1.207 -1.164 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.551 HG21 ' O ' ' A' ' 37' ' ' ILE . 2.8 mt -105.2 106.37 20.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 120.973 0.416 . . . . 0.0 111.114 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.442 ' HB2' HG23 ' C' ' 82' ' ' ILE . 53.0 t80 -117.62 114.63 23.68 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.75 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 56.99 41.14 28.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.033 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.7 -15.47 36.34 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.205 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 4.1 tpm_? -81.06 126.87 31.97 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.504 -0.409 . . . . 0.0 110.208 -176.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 38' ' ' GLU . 15.8 t -83.48 90.28 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.973 0.416 . . . . 0.0 109.943 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.6 OUTLIER -75.6 134.14 40.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 6.9 pt20 -135.22 -168.57 2.21 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.161 -171.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.696 ' HA ' HG13 ' C' ' 39' ' ' VAL . 5.7 p-10 -71.13 2.37 4.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.529 0.732 . . . . 0.0 112.296 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . 0.54 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 19.4 t70 -61.11 1.52 0.17 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.455 1.102 . . . . 0.0 113.146 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.472 ' H ' HG11 ' C' ' 39' ' ' VAL . 47.4 mtmt 83.44 158.44 0.12 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 168.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.4 ' HB3' ' HG3' ' C' ' 74' ' ' GLU . 34.6 mmtp 72.2 95.18 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.749 174.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.482 ' HG ' ' CG2' ' C' ' 33' ' ' VAL . 3.6 mm? -62.58 -36.8 83.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.81 177.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -68.95 -19.16 64.16 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -175.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . 0.4 ' HG3' ' HB3' ' C' ' 71' ' ' LYS . 26.8 mt-10 -71.48 -27.87 63.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 174.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.547 ' CD1' HD22 ' C' ' 66' ' ' LEU . 25.4 m-85 -87.78 -22.36 24.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.731 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.1 t30 61.18 40.63 14.49 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.781 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.406 HG23 HG22 ' C' ' 19' ' ' VAL . 26.4 m -92.43 27.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.743 -175.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.569 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.03 101.74 1.61 Allowed Glycine 0 N--CA 1.433 -1.558 0 CA-C-O 122.744 1.191 . . . . 0.0 112.733 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.28 13.7 50.99 Favored Glycine 0 C--N 1.283 -2.366 0 CA-C-N 112.21 -1.995 . . . . 0.0 114.108 172.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -127.01 147.61 50.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.649 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 3.0 m -79.03 127.44 39.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.605 0.717 . . . . 0.0 112.636 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.575 ' HB ' HG22 ' C' ' 21' ' ' VAL . 27.0 mt -88.71 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.301 171.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.537 ' N ' HG22 ' C' ' 82' ' ' ILE . 86.0 t60 -109.82 133.33 53.27 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 121.821 -0.55 . . . . 0.0 110.094 166.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.535 ' O ' HG22 ' C' ' 23' ' ' THR . 5.8 mt -108.8 138.34 45.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.805 0.812 . . . . 0.0 112.244 170.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.741 HG22 ' H ' ' C' ' 86' ' ' GLU . 2.6 p -156.41 -172.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.367 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . 0.741 ' H ' HG22 ' C' ' 85' ' ' VAL . 6.7 pt-20 -97.33 145.95 25.63 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.222 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . 0.53 ' HG2' ' HG3' ' C' ' 58' ' ' ARG . 90.0 mtt180 -73.3 177.28 5.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.603 176.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -66.28 147.56 98.85 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.497 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' C' ' 88' ' ' ALA . 21.7 Cg_exo -67.48 145.09 69.68 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.248 2.632 . . . . 0.0 111.741 173.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.72 77.89 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.6 2.2 . . . . 0.0 111.603 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -71.48 -16.22 62.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.733 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -117.38 21.14 13.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.445 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . 0.404 ' O ' ' HD3' ' C' ' 95' ' ' PRO . 12.7 t-160 68.84 -56.92 0.52 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.659 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -106.02 97.97 17.21 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' C' ' 93' ' ' HIS . 25.3 Cg_exo -60.4 -48.65 10.96 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.768 2.312 . . . . 0.0 112.069 -177.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 13.5 t -178.69 -175.81 0.44 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.71 156.1 9.76 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.564 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -102.53 90.99 4.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.043 0.449 . . . . 0.0 109.856 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -77.1 68.63 3.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.35 0.595 . . . . 0.0 110.525 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 6.3 p -88.15 -175.93 5.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.717 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.258 -1.301 . . . . 0.0 111.255 177.749 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.5 m -79.13 -70.04 0.53 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.542 0.171 . . . . 0.0 110.62 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm 38.08 43.49 0.56 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.012 0.925 . . . . 0.0 112.804 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.63 -26.35 54.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.433 0.635 . . . . 0.0 109.671 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -126.78 82.38 2.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.622 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.52 -42.76 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.259 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 p -112.49 107.42 55.18 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.313 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -66.32 87.1 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.802 2.335 . . . . 0.0 112.055 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -143.42 146.65 36.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.232 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.28 32.86 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.108 2.539 . . . . 0.0 112.516 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.514 ' O ' HG22 ' A' ' 21' ' ' VAL . . . -108.63 1.09 32.29 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.377 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 3.0 mpt_? -90.91 84.47 5.79 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.353 -0.423 . . . . 0.0 110.382 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.631 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 12.3 m-85 -118.04 165.9 13.19 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.326 0.584 . . . . 0.0 109.521 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.419 ' CB ' HD11 ' A' ' 40' ' ' LEU . 74.1 t80 -140.29 118.85 12.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.569 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -98.7 128.55 45.0 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -83.97 -21.32 31.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -167.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 32.0 p -72.36 -31.72 65.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 118.479 0.581 . . . . 0.0 110.016 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.445 ' HB3' HG22 ' A' ' 18' ' ' VAL . 94.5 m -85.64 -20.5 29.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.525 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.8 p 51.22 32.23 7.84 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.116 0.966 . . . . 0.0 112.375 -175.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 16' ' ' CYS . 2.8 m -141.42 157.2 21.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.494 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.628 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 32.8 tt0 -79.01 145.23 34.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.076 0.465 . . . . 0.0 111.196 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.738 HD11 HG21 ' A' ' 37' ' ' ILE . 3.3 pt -134.07 167.17 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.21 -173.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 9' ' ' GLY . 45.3 t -122.76 94.34 47.58 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 163.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.631 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.65 175.35 0.29 Allowed 'Trans proline' 0 C--N 1.325 -0.709 1 C-N-CA 125.537 4.158 . . . . 0.0 116.522 -168.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.663 ' HB2' HG13 ' A' ' 28' ' ' ILE . 36.8 mtt180 -105.74 46.94 0.89 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.702 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -1.46 -60.92 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.932 0 CA-C-N 110.582 -3.008 . . . . 0.0 116.575 174.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.445 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 63.2 Cg_exo -33.58 -31.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.469 2.78 . . . . 0.0 114.55 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.568 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -122.13 -19.08 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.358 0.599 . . . . 0.0 111.745 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.41 ' C ' HD11 ' A' ' 37' ' ' ILE . 50.5 m-85 68.01 58.94 0.46 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.615 -171.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.663 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -111.81 161.38 10.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 113.328 -1.76 . . . . 0.0 108.966 178.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.483 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -95.92 146.38 31.22 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.636 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 83.9 Cg_endo -81.32 -21.03 6.71 Favored 'Trans proline' 0 CA--C 1.5 -1.188 0 C-N-CA 122.668 2.245 . . . . 0.0 108.238 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.493 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 84.5 mtt180 -86.79 -15.1 40.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.032 -1.894 . . . . 0.0 114.398 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.463 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 31.1 p -151.58 -10.69 0.21 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 175.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 60.42 33.6 20.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.559 0.695 . . . . 0.0 111.217 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 m -113.91 146.32 40.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.47 33.15 3.25 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.826 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 97.9 m-85 -87.88 43.45 1.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.2 0.524 . . . . 0.0 110.649 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.738 HG21 HD11 ' A' ' 20' ' ' ILE . 4.6 pt -111.24 135.37 50.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.8 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -117.03 145.01 43.96 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -77.12 135.87 38.59 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.787 -174.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.462 0.172 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.99 144.45 39.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.011 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 74.4 -32.87 0.24 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.19 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -76.1 71.26 2.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.347 0.594 . . . . 0.0 110.404 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -139.76 99.35 3.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.178 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -76.99 71.84 3.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.535 0.683 . . . . 0.0 110.778 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -152.03 128.46 10.65 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -68.45 104.13 1.83 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.086 0.469 . . . . 0.0 111.379 -174.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 m -88.77 142.93 12.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 171.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.67 -60.3 0.26 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.115 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.85 -18.64 36.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.464 0.65 . . . . 0.0 109.51 169.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -97.68 7.39 46.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.622 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.75 -9.14 58.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.159 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . 0.404 ' O ' ' HA2' ' C' ' 34' ' ' GLY . 65.6 mttm -49.93 145.65 5.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.664 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.58 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 45.7 ttm -148.79 118.25 6.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.024 0.44 . . . . 0.0 110.672 -176.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.771 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.2 mt -105.55 137.98 42.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.51 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.541 ' HA ' HG13 ' C' ' 32' ' ' ILE . 32.5 tt0 -84.36 96.75 9.15 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' C' ' 30' ' ' THR . 3.2 t -78.62 104.62 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.189 -172.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.618 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -93.41 145.11 24.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' C' ' 82' ' ' ILE . 68.6 t -151.9 121.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 117.921 0.328 . . . . 0.0 110.957 -171.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.574 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 36.8 mtpt -103.51 122.19 44.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.503 ' O ' HD22 ' C' ' 24' ' ' LEU . 4.5 m -70.01 -62.61 1.32 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.117 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.503 HD22 ' O ' ' C' ' 23' ' ' THR . 0.4 OUTLIER -145.07 27.34 1.29 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.709 0.766 . . . . 0.0 109.841 -178.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 30.0 t70 85.11 -28.06 0.09 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.225 173.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 44.6 t -62.11 -42.71 99.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -106.64 175.94 5.33 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.336 1.065 . . . . 0.0 112.238 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.547 ' OG1' ' HG2' ' C' ' 22' ' ' LYS . 18.4 m -170.79 103.07 0.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.951 -1.931 . . . . 0.0 106.413 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -122.49 153.44 39.17 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.65 -175.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p -101.41 141.29 34.5 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-O 121.219 0.533 . . . . 0.0 112.251 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.509 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 29.4 m-85 -133.81 57.71 1.8 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.663 0.744 . . . . 0.0 109.758 -174.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.541 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.8 mp -57.24 119.19 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 123.362 1.553 . . . . 0.0 114.353 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 17.3 m -143.66 -168.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 110.915 -2.857 . . . . 0.0 111.627 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -96.4 159.11 21.76 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.054 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.771 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -59.65 -31.17 69.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.21 0.529 . . . . 0.0 112.187 -175.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.32 31.7 2.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.486 0.66 . . . . 0.0 109.258 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -74.33 0.14 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.026 -176.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.575 ' O ' HG12 ' C' ' 39' ' ' VAL . 8.5 m120 -128.82 -90.71 0.49 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.711 HG23 HD21 ' C' ' 72' ' ' LEU . 0.3 OUTLIER 81.83 -30.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 124.794 1.309 . . . . 0.0 111.9 -165.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.51 ' HD2' ' HG2' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -80.23 -69.48 0.59 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 122.286 1.041 . . . . 0.0 108.516 176.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.17 -29.26 69.68 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 113.445 -1.707 . . . . 0.0 111.003 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.676 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 3.9 t80 -60.64 -53.49 56.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.523 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.66 ' HB2' ' OE1' ' C' ' 57' ' ' GLN . 0.0 OUTLIER -69.82 -33.64 72.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.99 0.424 . . . . 0.0 110.928 -179.444 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -38.64 87.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.718 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -69.65 -48.59 59.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.194 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.578 ' O ' HG22 ' C' ' 50' ' ' VAL . 17.3 pt -70.49 -12.12 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -173.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.29 -56.28 2.47 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.54 -44.3 87.28 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -176.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -25.27 65.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.338 0.59 . . . . 0.0 111.087 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.578 HG22 ' O ' ' C' ' 46' ' ' ILE . 30.9 m -110.48 -3.31 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.334 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 60.6 p 64.67 22.08 12.53 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.796 0.807 . . . . 0.0 109.49 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 4.7 mm -127.66 115.46 20.97 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.274 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' C' ' 57' ' ' GLN . 4.6 Cg_exo -73.97 147.02 38.13 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 121.936 1.758 . . . . 0.0 111.306 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.439 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 4.0 p -52.55 -24.85 8.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.765 0.826 . . . . 0.0 112.96 -175.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.56 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 8.9 pt-20 -68.68 -41.74 78.81 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.677 0.275 . . . . 0.0 111.493 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.56 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 27.4 mtpp -96.2 -25.08 15.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.574 0.702 . . . . 0.0 109.686 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.66 ' OE1' ' HB2' ' C' ' 43' ' ' LYS . 17.8 tt0 -61.1 118.57 6.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.287 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -123.16 119.11 29.27 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.02 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 6.4 mt -84.79 116.29 23.19 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.542 HG21 ' O ' ' A' ' 37' ' ' ILE . 3.3 mt -114.89 122.04 68.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.831 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -136.32 132.72 36.04 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 57.46 35.39 25.83 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.104 0.478 . . . . 0.0 110.753 -174.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.03 4.93 37.74 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.529 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -91.73 140.08 30.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.71 90.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.481 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.2 OUTLIER -83.03 144.06 30.18 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.144 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -156.89 -167.4 2.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.522 -175.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.658 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.8 p-10 -60.78 0.22 0.23 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.969 1.308 . . . . 0.0 113.368 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 34.0 t70 -60.55 -10.69 5.44 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.506 0.722 . . . . 0.0 112.421 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.522 ' H ' HG11 ' C' ' 39' ' ' VAL . 57.1 mtmt 88.33 -175.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.149 0.98 . . . . 0.0 112.615 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.433 ' HG2' ' C ' ' C' ' 70' ' ' LYS . 16.5 pttp 47.52 84.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.62 1.2 . . . . 0.0 113.06 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.711 HD21 HG23 ' C' ' 39' ' ' VAL . 35.2 mt -64.94 -32.22 73.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.608 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . 0.455 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 10.3 pt20 -67.26 -18.4 65.2 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.01 -28.7 66.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.553 ' CD1' HD22 ' C' ' 66' ' ' LEU . 25.1 m-85 -86.96 -22.48 25.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.621 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.7 t30 62.09 37.11 14.88 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.001 174.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -88.92 18.39 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.053 0.454 . . . . 0.0 111.754 -174.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -73.95 102.81 1.37 Allowed Glycine 0 N--CA 1.427 -1.928 0 CA-C-O 122.779 1.211 . . . . 0.0 111.873 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.36 15.25 60.69 Favored Glycine 0 C--N 1.283 -2.364 0 CA-C-N 112.021 -2.09 . . . . 0.0 112.618 176.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -119.72 145.5 46.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.618 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 34.3 m -83.07 123.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-O 122.111 0.957 . . . . 0.0 111.152 175.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' C' ' 21' ' ' VAL . 57.6 mt -79.07 170.35 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.094 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.531 ' N ' HG22 ' C' ' 82' ' ' ILE . 44.6 m80 -118.26 116.89 27.69 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.425 ' CD1' HG11 ' C' ' 50' ' ' VAL . 9.4 mt -90.63 141.82 28.39 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.257 0.551 . . . . 0.0 111.521 177.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.512 HG21 HD11 ' C' ' 60' ' ' ILE . 31.9 m -142.5 164.48 17.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.677 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -110.93 123.78 50.83 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.302 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -93.62 175.8 6.6 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.637 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.61 162.84 24.14 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.292 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' C' ' 91' ' ' GLN . 45.2 Cg_exo -60.68 159.57 27.9 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.639 2.226 . . . . 0.0 111.522 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.68 41.22 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.074 2.516 . . . . 0.0 112.904 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' C' ' 89' ' ' PRO . 11.5 pt20 -96.75 -29.25 13.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.397 176.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -96.79 85.21 3.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.898 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -87.94 55.77 3.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.145 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mp -118.5 89.68 37.29 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.733 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.35 -36.17 1.02 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.354 2.036 . . . . 0.0 111.594 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 10.5 t 47.53 68.18 0.69 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.667 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.34 -84.59 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.66 72.36 9.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.127 0.489 . . . . 0.0 110.206 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 11.0 p -66.49 -39.57 88.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.742 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 36.7 t -143.52 71.85 1.34 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.239 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.6 -1.111 . . . . 0.0 111.538 179.651 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 30.2 t 69.73 -74.07 0.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.103 0.561 . . . . 0.0 111.213 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm -124.19 -47.72 1.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.712 0.292 . . . . 0.0 110.471 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.74 -77.21 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.226 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -124.59 -42.83 2.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.863 0.363 . . . . 0.0 110.594 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.13 153.77 7.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.007 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.9 m -116.47 94.97 44.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.605 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.62 88.55 0.52 Allowed 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.825 2.35 . . . . 0.0 112.089 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.594 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 27.9 m170 -118.54 -61.27 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.281 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 7' ' ' HIS . 66.7 Cg_endo -82.02 136.49 9.22 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 121.877 1.718 . . . . 0.0 113.619 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.33 -2.62 38.3 Favored Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -102.51 92.02 4.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.648 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 17.9 m-85 -116.2 162.59 17.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 171.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.536 ' CB ' HD11 ' A' ' 40' ' ' LEU . 55.3 t80 -141.01 116.63 10.24 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.394 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -93.83 114.55 26.81 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.434 ' CG ' HG13 ' C' ' 85' ' ' VAL . 19.0 p80 -69.23 -12.81 61.99 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.878 -176.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 38.9 m -71.57 -39.26 70.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 110.705 173.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.1 m -88.35 -27.58 21.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 110.813 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.53 28.48 17.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.696 -170.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.457 HG11 ' CZ ' ' A' ' 31' ' ' ARG . 97.5 t -131.34 144.53 37.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.445 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 25.8 tt0 -74.93 145.83 42.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 110.453 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 37' ' ' ILE . 3.9 pt -135.7 167.84 24.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.343 -170.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 61.3 t -124.59 95.69 42.39 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 164.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 Cg_endo -56.8 176.31 0.23 Allowed 'Trans proline' 0 C--N 1.325 -0.681 1 C-N-CA 125.386 4.057 . . . . 0.0 116.216 -173.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.583 ' HB2' HG13 ' A' ' 28' ' ' ILE . 7.8 mtt180 -112.43 52.19 0.78 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 112.711 -2.041 . . . . 0.0 107.155 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 4.04 -61.4 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.016 0 CA-C-N 111.06 -2.791 . . . . 0.0 117.221 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 13.1 Cg_exo -34.12 -37.42 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.899 2.399 . . . . 0.0 113.701 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.497 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.09 -23.75 9.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.848 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.536 ' C ' HD11 ' A' ' 37' ' ' ILE . 60.4 m-85 65.18 57.41 0.94 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.304 1.049 . . . . 0.0 109.303 -168.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.583 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.4 OUTLIER -105.7 162.61 4.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.521 176.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.475 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.5 t -94.62 145.01 28.87 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.659 ' HD3' HD12 ' A' ' 20' ' ' ILE . 70.3 Cg_endo -83.78 -20.33 4.61 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.938 2.425 . . . . 0.0 108.688 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.487 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 12.5 mtp180 -89.02 -7.91 55.03 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 113.016 -1.902 . . . . 0.0 114.014 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.4 p -162.66 -8.4 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 15.7 tt0 62.31 28.17 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.137 0.494 . . . . 0.0 112.213 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.1 p -99.58 150.86 21.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.8 25.77 7.2 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.711 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' C' ' 24' ' ' LEU . 75.7 m-85 -89.48 48.99 1.67 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.105 0.479 . . . . 0.0 110.551 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.753 HG21 ' CD1' ' A' ' 20' ' ' ILE . 3.5 pt -110.73 138.56 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.485 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' C' ' 65' ' ' VAL . 7.2 pt-20 -123.19 137.67 54.83 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -68.24 140.62 56.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.499 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 91.3 mtp . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.762 0.315 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.77 128.88 38.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.354 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -134.96 -70.48 0.49 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.572 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -136.74 142.29 43.03 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 42.8 t60 62.27 73.81 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.455 0.645 . . . . 0.0 109.353 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -55.15 144.69 23.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.844 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -113.97 62.78 0.66 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.618 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -121.14 140.47 51.94 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 33.5 m -65.71 167.27 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 123.157 0.286 . . . . 0.0 110.671 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 65.96 71.43 0.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.729 0.776 . . . . 0.0 109.517 -174.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' C' ' 13' ' ' ASP . 21.7 m-20 -83.15 -155.4 0.16 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.707 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' C' ' 12' ' ' ASP . 2.0 m-20 80.49 129.9 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.785 0.834 . . . . 0.0 111.37 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -89.39 -37.07 15.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.377 -171.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -68.33 176.56 2.73 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 63.8 ttp 64.06 96.79 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.377 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.696 HD11 ' HA ' ' C' ' 35' ' ' ALA . 1.2 mt -106.25 131.39 53.54 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.066 173.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.62 ' HA ' HG13 ' C' ' 32' ' ' ILE . 33.9 tt0 -82.5 96.24 7.96 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.636 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 2.5 t -80.45 124.57 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -173.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.666 ' CB ' HG12 ' C' ' 81' ' ' VAL . 0.4 OUTLIER -110.45 145.62 37.33 Favored 'General case' 0 N--CA 1.417 -2.075 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 171.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.705 HG22 ' HB ' ' C' ' 82' ' ' ILE . 55.4 t -148.38 126.75 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 117.905 0.321 . . . . 0.0 110.404 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.536 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 42.4 mtmt -111.9 127.13 55.75 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.34 0.59 . . . . 0.0 110.029 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 37.3 p -84.1 -178.68 7.03 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.414 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -63.15 -28.81 70.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.238 0.472 . . . . 0.0 111.101 178.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.77 -3.77 30.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.79 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 68.2 m 63.9 17.63 10.67 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.302 0.641 . . . . 0.0 112.145 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . 0.408 ' O ' ' HB ' ' C' ' 28' ' ' THR . 59.7 mt-30 -46.14 -51.15 14.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.66 177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' C' ' 27' ' ' GLN . 97.3 m 65.28 97.28 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.028 -176.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -122.56 151.81 41.02 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.951 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 3.5 p -99.14 140.2 33.67 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.636 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 24.9 m-85 -136.52 60.78 1.66 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.841 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.62 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.6 mp -57.71 128.88 18.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 122.898 1.332 . . . . 0.0 114.304 -172.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.62 HG11 ' CD2' ' C' ' 42' ' ' PHE . 15.3 m -122.78 -169.88 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 112.053 -2.34 . . . . 0.0 111.546 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -125.57 33.34 3.63 Favored Glycine 0 C--N 1.317 -0.525 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.17 -175.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.696 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 65.72 18.36 11.15 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 167.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.862 ' H ' HD12 ' C' ' 72' ' ' LEU . 10.1 tt0 157.61 -11.85 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.82 0.819 . . . . 0.0 109.163 -166.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.8 tpt -45.4 -73.68 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.844 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.459 ' O ' HG12 ' C' ' 39' ' ' VAL . 77.9 m-20 -141.25 -88.57 0.16 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.694 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.3 OUTLIER 92.84 -30.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 125.297 1.623 . . . . 0.0 111.274 -164.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -66.9 0.78 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 122.393 1.092 . . . . 0.0 108.873 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -61.76 -28.24 69.3 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 113.065 -1.88 . . . . 0.0 111.706 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.62 ' CD2' HG11 ' C' ' 33' ' ' VAL . 0.1 OUTLIER -57.27 -52.87 63.6 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 171.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.453 ' HA ' HG12 ' C' ' 46' ' ' ILE . 24.2 mtpp -67.01 -41.37 86.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.092 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -60.09 -34.71 73.83 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.044 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.6 -48.2 60.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.621 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.639 ' O ' HG22 ' C' ' 50' ' ' VAL . 20.6 pt -74.86 -10.42 13.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.307 -175.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -46.67 -40.64 13.52 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.04 -45.91 19.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -34.13 73.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.104 0.478 . . . . 0.0 110.765 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.639 HG22 ' O ' ' C' ' 46' ' ' ILE . 30.1 m -99.88 -8.12 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.158 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 31.5 m 68.8 20.14 8.15 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 121.837 0.827 . . . . 0.0 109.775 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.2 mm -123.29 110.98 30.41 Favored Pre-proline 0 N--CA 1.44 -0.935 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.72 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.417 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 14.1 Cg_exo -66.39 143.11 68.61 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 122.622 2.214 . . . . 0.0 111.902 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.433 ' OG ' ' HE3' ' C' ' 43' ' ' LYS . 35.2 t -51.13 -28.31 10.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.843 -172.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.45 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 10.8 pt-20 -75.29 -30.96 60.54 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.877 0.37 . . . . 0.0 111.541 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 55.1 mtpt -95.19 -28.83 14.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.827 0.823 . . . . 0.0 109.206 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.43 HE22 HG13 ' C' ' 46' ' ' ILE . 17.1 tt0 -63.67 122.64 16.85 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.124 -176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.431 ' O ' HG23 ' C' ' 85' ' ' VAL . 72.6 mtp85 -120.97 123.76 43.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.756 -0.202 . . . . 0.0 110.462 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 94.1 mt -90.95 124.06 34.92 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 177.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.556 HG21 ' O ' ' A' ' 37' ' ' ILE . 4.6 mt -118.29 125.75 74.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 O-C-N 121.622 -0.674 . . . . 0.0 111.595 172.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.46 ' CD2' HG12 ' C' ' 77' ' ' VAL . 55.1 t80 -138.64 131.87 30.05 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 46.23 40.39 7.43 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.104 0.478 . . . . 0.0 111.357 -170.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.91 5.73 58.39 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.923 -0.58 . . . . 0.0 113.617 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.586 ' HD3' ' N ' ' C' ' 65' ' ' VAL . 0.0 OUTLIER -99.22 131.26 45.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.586 ' N ' ' HD3' ' C' ' 64' ' ' ARG . 2.0 t -82.41 90.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.113 0.482 . . . . 0.0 110.391 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.594 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.4 OUTLIER -71.78 148.1 46.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -158.31 -169.81 2.9 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.835 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.694 ' HA ' HG13 ' C' ' 39' ' ' VAL . 6.7 p-10 -67.04 -2.39 5.37 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.663 0.785 . . . . 0.0 112.233 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 20.9 t70 -68.73 -2.74 9.99 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.082 0.553 . . . . 0.0 111.802 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.54 ' H ' HG11 ' C' ' 39' ' ' VAL . 53.5 mtmt 75.9 -162.47 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.685 178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' C' ' 70' ' ' LYS . 48.5 mttp 77.51 57.18 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.831 0.707 . . . . 0.0 109.659 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.862 HD12 ' H ' ' C' ' 36' ' ' GLN . 22.0 mt -61.72 -56.36 20.46 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.827 -174.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -72.64 -15.86 61.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.073 0.464 . . . . 0.0 111.461 -176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -73.14 -28.93 62.52 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.051 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.594 ' CD1' HD22 ' C' ' 66' ' ' LEU . 24.0 m-85 -75.31 -25.38 57.81 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 61.51 26.39 16.13 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.382 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.46 HG12 ' CD2' ' C' ' 61' ' ' TYR . 31.3 m -83.04 21.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.902 -175.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.647 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.54 98.97 1.43 Allowed Glycine 0 N--CA 1.431 -1.675 0 CA-C-O 122.418 1.01 . . . . 0.0 111.985 177.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.23 14.14 39.84 Favored Glycine 0 C--N 1.285 -2.262 0 CA-C-N 112.382 -1.909 . . . . 0.0 114.541 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -128.68 147.32 50.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.666 HG12 ' CB ' ' C' ' 20' ' ' LEU . 16.6 m -80.19 125.78 39.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 CA-C-O 121.881 0.848 . . . . 0.0 111.637 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.705 ' HB ' HG22 ' C' ' 21' ' ' VAL . 57.5 mt -80.25 171.17 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.8 173.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.546 ' N ' HG22 ' C' ' 82' ' ' ILE . 37.6 m80 -118.22 122.01 41.91 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 122.012 -0.43 . . . . 0.0 109.924 174.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mt -85.75 156.86 20.44 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.439 HG12 ' N ' ' C' ' 86' ' ' GLU . 8.0 t -120.88 161.02 21.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.417 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . 0.439 ' N ' HG12 ' C' ' 85' ' ' VAL . 40.5 tt0 -136.06 127.06 27.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.964 172.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -85.09 162.93 19.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.296 0.569 . . . . 0.0 109.945 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -88.8 141.67 30.05 Favored Pre-proline 0 N--CA 1.438 -1.071 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.029 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.536 ' HB2' ' HG2' ' C' ' 91' ' ' GLN . 23.3 Cg_exo -67.16 149.91 81.92 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.275 2.65 . . . . 0.0 112.119 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.43 -18.79 40.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.696 2.931 . . . . 0.0 114.029 -171.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . 0.536 ' HG2' ' HB2' ' C' ' 89' ' ' PRO . 8.5 pt20 -57.02 -35.79 69.68 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.303 176.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.7 t -108.97 136.05 49.14 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -155.77 76.19 0.93 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.952 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 49.6 tp 58.64 80.3 0.28 Allowed Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.321 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.22 -38.43 66.21 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.769 2.312 . . . . 0.0 111.731 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 34.1 t 57.79 51.65 8.98 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.237 0.541 . . . . 0.0 110.4 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -98.14 -68.84 0.94 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.212 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.6 81.48 1.47 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 38.9 m 71.28 -67.16 0.27 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.885 0.741 . . . . 0.0 111.221 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 21.6 m 59.52 44.23 15.04 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.311 0.576 . . . . 0.0 110.595 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.868 0 CA-C-O 118.635 -1.092 . . . . 0.0 111.895 -178.287 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 18.5 p -59.91 -58.69 7.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.567 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -136.68 124.93 23.15 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.16 138.73 3.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.33 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -89.9 148.17 23.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.849 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 60.46 75.94 0.39 Allowed 'General case' 0 C--O 1.233 0.195 0 O-C-N 123.81 0.694 . . . . 0.0 110.607 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 15.9 m -58.19 137.37 84.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.212 -177.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 9.6 Cg_exo -69.62 93.84 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.735 2.29 . . . . 0.0 112.256 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.496 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 17.9 m-70 -60.81 -55.54 43.75 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 7' ' ' HIS . 43.8 Cg_endo -83.48 22.33 0.94 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.29 1.993 . . . . 0.0 112.409 175.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.18 2.32 8.35 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.635 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HG2' HD23 ' A' ' 40' ' ' LEU . 58.8 ttt180 -75.73 80.81 2.68 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 123.318 0.647 . . . . 0.0 110.587 -178.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.657 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 17.0 m-85 -118.21 164.27 15.42 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.636 0.731 . . . . 0.0 110.752 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.654 ' CB ' HD11 ' A' ' 40' ' ' LEU . 54.9 t80 -140.92 120.28 13.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.877 178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -98.57 121.37 40.42 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.222 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.644 ' CE1' ' HB ' ' C' ' 85' ' ' VAL . 8.9 p80 -76.69 -23.44 53.18 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 24.6 p -71.09 -38.15 72.41 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.272 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.6 m -74.85 -34.81 62.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.084 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.75 32.01 21.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.161 -172.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.5 t -131.65 144.12 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.657 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 38.7 tt0 -74.33 143.28 45.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.116 0.484 . . . . 0.0 110.885 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.74 HD11 HG21 ' A' ' 37' ' ' ILE . 4.0 pt -131.86 168.32 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.216 -169.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.424 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 57.7 t -123.53 98.29 40.95 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 162.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.592 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 6.8 Cg_endo -57.3 175.12 0.39 Allowed 'Trans proline' 0 C--N 1.326 -0.613 1 C-N-CA 125.302 4.001 . . . . 0.0 116.675 -169.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.696 ' HB2' HG13 ' A' ' 28' ' ' ILE . 26.0 mtt180 -107.68 47.38 0.89 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 112.629 -2.078 . . . . 0.0 107.183 176.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -0.07 -61.27 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 110.718 -2.947 . . . . 0.0 116.993 174.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 24' ' ' LEU . 31.2 Cg_exo -30.96 -38.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 123.591 2.861 . . . . 0.0 114.176 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.545 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.48 -18.05 11.59 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.705 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.432 ' C ' HD11 ' A' ' 37' ' ' ILE . 62.8 m-85 67.11 45.93 1.62 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.04 -172.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.696 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -94.07 161.61 2.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.653 174.622 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -96.61 145.73 30.08 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.035 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.656 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 78.7 Cg_endo -80.46 -20.27 8.33 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 122.861 2.374 . . . . 0.0 108.089 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.655 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 95.1 mtt-85 -80.19 -34.77 37.19 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 112.658 -2.065 . . . . 0.0 113.712 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.8 p -137.59 -8.74 1.67 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 61.29 35.42 18.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.474 0.654 . . . . 0.0 111.061 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.8 m -113.09 146.36 39.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.545 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 27' ' ' TYR . . . -84.55 45.86 3.57 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.741 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 57.9 m-85 -102.4 44.38 1.02 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.961 0.41 . . . . 0.0 110.268 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.74 HG21 HD11 ' A' ' 20' ' ' ILE . 5.8 pt -115.27 139.21 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.191 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB2' HG22 ' C' ' 65' ' ' VAL . 12.9 pt-20 -123.86 145.67 48.93 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.34 131.36 39.13 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.654 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.857 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.982 0.42 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.0 107.19 3.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.066 0.46 . . . . 0.0 111.125 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -119.8 32.6 5.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.831 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -93.8 -79.66 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 76.2 m80 48.44 -110.13 0.35 Allowed 'General case' 0 C--O 1.233 0.2 0 O-C-N 123.561 0.538 . . . . 0.0 111.508 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 51.0 m80 50.64 53.07 13.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.255 0.55 . . . . 0.0 111.5 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -117.26 142.97 46.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.584 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -155.25 124.04 6.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.496 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' C' ' 11' ' ' ASP . 9.5 m -122.12 128.57 75.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.324 0.583 . . . . 0.0 109.912 174.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' C' ' 10' ' ' VAL . 38.2 t70 160.95 57.02 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.541 -170.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 34.2 t70 59.12 80.35 0.19 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.419 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -129.7 124.67 34.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.38 -36.23 78.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.186 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' C' ' 35' ' ' ALA . 96.3 mttt -70.14 -174.86 0.86 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.449 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.636 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 50.9 mtm 66.57 83.2 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.073 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.692 HD11 ' HA ' ' C' ' 35' ' ' ALA . 3.7 mt -98.58 132.71 43.77 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.575 ' HA ' HG13 ' C' ' 32' ' ' ILE . 25.6 tt0 -82.23 93.92 7.2 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.631 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 3.1 t -77.06 104.85 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.06 -172.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.651 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.1 mt -92.76 142.27 27.53 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.695 HG22 ' HB ' ' C' ' 82' ' ' ILE . 59.4 t -147.95 128.92 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -174.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.608 ' HE3' HG21 ' C' ' 81' ' ' VAL . 79.2 mttt -114.24 159.81 19.73 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.361 0.601 . . . . 0.0 109.804 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 27.8 p -107.42 -165.84 1.1 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.99 172.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 36' ' ' PHE . 4.4 mm? -44.48 -37.42 3.46 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 15.4 t70 178.29 -31.38 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 29.5 m -42.82 -75.64 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.877 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -128.71 172.9 10.8 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.371 1.081 . . . . 0.0 113.911 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.447 ' OG1' ' HE2' ' C' ' 22' ' ' LYS . 53.7 m -141.84 103.22 4.3 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 112.76 -2.018 . . . . 0.0 107.543 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' C' ' 29' ' ' ARG . 73.1 mtt180 -123.33 161.93 23.71 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.795 -177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.5 p -103.69 143.44 32.78 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.468 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.631 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 27.6 m-85 -137.14 59.0 1.7 Allowed 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.271 -174.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -57.92 124.26 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 123.352 1.548 . . . . 0.0 113.872 -174.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' C' ' 16' ' ' MET . 17.2 m -135.27 -165.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 111.104 -2.771 . . . . 0.0 111.324 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.04 -161.76 37.32 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.741 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.692 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . -100.91 -12.86 18.62 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.577 0.703 . . . . 0.0 111.296 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -166.95 26.57 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -172.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 18.3 ttt -71.95 -73.05 0.2 Allowed 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 111.816 -2.447 . . . . 0.0 110.941 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.605 ' O ' HG12 ' C' ' 39' ' ' VAL . 70.5 m-20 -131.11 -98.18 0.32 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 178.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 86.7 -16.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 125.341 1.651 . . . . 0.0 111.731 -167.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' C' ' 43' ' ' LYS . 0.1 OUTLIER -88.69 -70.79 0.63 Allowed 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.048 0.928 . . . . 0.0 108.965 171.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.12 -29.4 70.31 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.099 173.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.64 ' CD2' ' HA ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -62.08 -54.43 41.41 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.438 175.314 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' C' ' 40' ' ' LYS . 20.0 ptmt -68.25 -33.66 74.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.148 0.499 . . . . 0.0 110.169 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -42.66 82.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.103 176.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -68.71 -43.26 76.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.439 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.603 ' O ' HG22 ' C' ' 50' ' ' VAL . 16.1 pt -78.35 -10.75 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -172.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.65 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -40.2 -61.02 0.95 Allowed 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.75 86.55 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -173.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -32.82 71.15 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.055 0.455 . . . . 0.0 111.049 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.603 HG22 ' O ' ' C' ' 46' ' ' ILE . 24.3 m -103.63 -3.36 9.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.453 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 48.2 t 69.58 20.04 7.2 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.65 0.738 . . . . 0.0 109.318 178.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 7.2 mm -123.38 110.67 30.41 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.174 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.499 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 6.0 Cg_exo -72.8 146.03 41.95 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.371 2.047 . . . . 0.0 111.299 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 8.0 p -54.49 -24.62 21.27 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.608 0.763 . . . . 0.0 112.285 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 15.1 pt-20 -73.6 -26.3 60.74 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -107.66 -26.41 10.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 109.981 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.535 ' OE1' HD11 ' C' ' 46' ' ' ILE . 9.9 tt0 -57.96 118.3 5.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.9 -173.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.413 HH11 HG11 ' C' ' 65' ' ' VAL . 26.1 mmt85 -122.37 118.0 27.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.314 172.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 5.2 mp -84.7 117.87 24.06 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.537 HG21 ' O ' ' A' ' 37' ' ' ILE . 7.0 mt -115.12 118.12 57.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.169 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -132.39 128.15 36.97 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 58.68 38.83 24.95 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.508 0.505 . . . . 0.0 110.627 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.79 4.17 13.15 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.258 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -89.18 133.98 34.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.437 HG22 ' HB2' ' A' ' 38' ' ' GLU . 2.1 t -85.14 89.68 2.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.3 OUTLIER -75.04 130.57 39.54 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -143.11 -172.72 3.74 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.511 -170.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.621 ' HA ' HG13 ' C' ' 39' ' ' VAL . 4.4 p-10 -64.3 -3.06 2.52 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.44 0.696 . . . . 0.0 112.145 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.35 -4.94 16.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.072 0.549 . . . . 0.0 112.293 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 74.44 -158.21 0.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.375 0.67 . . . . 0.0 110.939 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.537 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 54.3 mttp 71.91 54.08 0.19 Allowed 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.552 0.532 . . . . 0.0 110.692 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 60.1 mt -63.43 -44.28 95.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.181 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . 0.439 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 9.3 pt20 -70.08 -20.44 63.21 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.742 0.306 . . . . 0.0 111.466 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . 0.537 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 28.0 mm-40 -71.1 -28.01 64.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.555 ' CD1' HD22 ' C' ' 66' ' ' LEU . 19.3 m-85 -83.7 -24.72 31.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 57.66 37.85 27.48 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.807 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -87.31 20.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.539 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.608 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -77.69 99.93 1.53 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-O 122.767 1.204 . . . . 0.0 112.322 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.88 14.34 43.34 Favored Glycine 0 C--N 1.284 -2.307 0 CA-C-N 112.223 -1.989 . . . . 0.0 113.72 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -124.33 147.49 48.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.651 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 4.5 m -82.05 128.53 38.64 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 CA-C-O 122.055 0.931 . . . . 0.0 111.43 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.695 ' HB ' HG22 ' C' ' 21' ' ' VAL . 54.3 mt -86.9 168.44 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.122 175.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.468 ' N ' HG22 ' C' ' 82' ' ' ILE . 40.7 m80 -117.42 115.03 24.4 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.889 -0.507 . . . . 0.0 110.162 175.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.452 HD13 HG21 ' C' ' 50' ' ' VAL . 13.4 mt -90.67 157.36 17.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.291 0.567 . . . . 0.0 112.379 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.644 ' HB ' ' CE1' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -154.81 154.23 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.917 -175.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . 0.534 ' HB2' ' CD1' ' C' ' 52' ' ' ILE . 44.5 tt0 -112.68 120.57 41.99 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.05 169.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -104.17 177.56 4.81 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.318 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -57.56 148.34 56.27 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.986 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 88' ' ' ALA . 51.3 Cg_exo -58.18 166.55 5.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.212 2.608 . . . . 0.0 112.385 177.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.68 63.15 4.73 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.894 2.396 . . . . 0.0 112.018 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' C' ' 89' ' ' PRO . 7.1 pt20 -96.25 20.93 9.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.652 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.8 t -74.25 139.99 44.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.438 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -83.4 -22.76 32.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.682 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.21 115.23 27.46 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.846 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.09 158.02 31.94 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.658 2.239 . . . . 0.0 111.96 177.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 46.9 t 62.05 58.72 1.8 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.202 0.525 . . . . 0.0 109.874 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.19 64.51 3.44 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.006 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -160.64 179.24 8.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.739 0.304 . . . . 0.0 110.334 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 45.9 m -132.55 65.05 1.59 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.979 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 16.0 m -72.81 131.37 42.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.665 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 118.504 -1.164 . . . . 0.0 111.723 -179.497 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 112.193 -0.363 . . . . 0.0 112.193 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.6 p -72.61 -33.27 66.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.305 0.574 . . . . 0.0 110.091 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.1 mtp -110.96 75.17 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.135 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.21 81.83 8.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.268 0.556 . . . . 0.0 110.48 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -132.06 167.13 20.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.852 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.34 93.73 3.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.286 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 22.9 t -153.08 97.54 2.82 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.855 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.43 -18.19 12.47 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.753 2.302 . . . . 0.0 113.753 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -59.55 -47.15 98.4 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -175.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 5' ' ' SER . 76.2 Cg_endo -85.65 20.45 1.23 Allowed 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 122.225 1.95 . . . . 0.0 112.037 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.48 ' HA3' HG13 ' A' ' 21' ' ' VAL . . . 90.63 109.04 1.42 Allowed Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.132 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 10' ' ' ARG . 1.0 OUTLIER -154.03 80.35 1.13 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.611 -0.794 . . . . 0.0 108.947 178.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.605 ' CD2' ' HG3' ' A' ' 22' ' ' PRO . 5.9 m-85 -116.74 167.53 11.01 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.041 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CB ' HD11 ' A' ' 40' ' ' LEU . 48.8 t80 -140.87 114.39 8.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.28 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.599 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -93.49 118.02 30.81 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.51 177.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' A' ' 36' ' ' PHE . 1.1 p80 -76.68 -20.49 56.56 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.544 -171.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 16.1 p -72.91 -31.61 64.76 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.82 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.2 m -83.43 -30.61 27.16 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.189 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.02 28.29 16.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.409 -171.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.88 144.76 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 11' ' ' TYR . 34.7 tt0 -71.23 146.66 48.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.512 -175.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.7 ' CD1' HG21 ' A' ' 37' ' ' ILE . 2.6 pt -138.62 166.61 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.847 -172.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.482 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 99.1 t -124.08 97.86 39.97 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 163.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 5.6 Cg_endo -57.24 173.76 0.59 Allowed 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 124.912 3.741 . . . . 0.0 116.571 -170.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.501 ' HB2' HG13 ' A' ' 28' ' ' ILE . 15.2 mtt85 -107.35 47.33 0.89 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 112.489 -2.142 . . . . 0.0 107.59 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -6.28 -53.69 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 171.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -35.09 -36.16 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.561 2.174 . . . . 0.0 113.428 171.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.506 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.09 -17.56 10.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.352 177.398 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.423 ' CE1' HD23 ' A' ' 24' ' ' LEU . 74.7 m-85 69.68 50.99 0.47 Allowed 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.603 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.506 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -104.81 159.85 5.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.615 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.493 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 t -95.5 144.56 28.02 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.69 ' CD ' ' HB ' ' A' ' 20' ' ' ILE . 87.2 Cg_endo -81.24 -17.48 9.09 Favored 'Trans proline' 0 CA--C 1.5 -1.179 0 C-N-CA 122.761 2.308 . . . . 0.0 108.24 -173.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.429 ' HG3' ' HG2' ' A' ' 30' ' ' PRO . 60.5 mtt-85 -91.57 -13.81 31.37 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 112.937 -1.938 . . . . 0.0 114.617 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.0 p -153.16 -9.48 0.16 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 60.95 29.18 18.86 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.381 0.61 . . . . 0.0 110.91 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.2 m -109.24 146.97 33.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.487 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.21 28.95 4.46 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.772 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 63.0 m-85 -85.86 47.64 1.48 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.568 -0.372 . . . . 0.0 110.462 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.7 HG21 ' CD1' ' A' ' 20' ' ' ILE . 5.7 pt -115.58 139.0 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.516 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.493 ' HB3' HD13 ' C' ' 60' ' ' ILE . 6.5 pt-20 -123.42 148.28 46.29 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 170.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -80.52 134.24 35.92 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.434 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.547 HD11 ' CB ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.808 -174.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 60.3 ttp . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.77 -73.43 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.915 0.76 . . . . 0.0 111.397 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -167.33 -69.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 24.2 m80 65.77 141.73 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.808 0.692 . . . . 0.0 111.897 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -88.7 100.67 13.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.401 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -72.48 130.0 39.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.635 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -76.55 84.83 3.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.526 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -75.46 124.04 26.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.858 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 p -74.4 146.07 10.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.438 0.637 . . . . 0.0 110.765 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 30.1 t70 177.9 89.45 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.431 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 17.3 t70 69.55 103.6 0.06 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.19 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -95.08 78.53 3.54 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.24 0.543 . . . . 0.0 110.949 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.91 -24.79 64.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 171.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . 0.465 ' HD3' HG22 ' C' ' 32' ' ' ILE . 53.2 mttp -57.38 157.63 6.4 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.51 175.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.658 ' H ' ' HA2' ' C' ' 34' ' ' GLY . 1.9 mpt? -112.24 -51.74 2.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.459 -174.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.877 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.7 OUTLIER -104.71 135.62 45.76 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.643 -171.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.565 ' HA ' HG13 ' C' ' 32' ' ' ILE . 36.4 tt0 -88.91 94.27 9.88 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.3 t -79.48 128.29 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -172.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.595 ' CB ' HG12 ' C' ' 81' ' ' VAL . 0.8 OUTLIER -114.21 150.14 34.74 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.573 HG21 ' HE2' ' C' ' 31' ' ' PHE . 18.5 m -135.32 150.91 29.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.606 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 36.7 mtpt -125.72 96.38 4.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.712 0.291 . . . . 0.0 110.297 174.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.47 HG23 ' O ' ' C' ' 84' ' ' LEU . 0.2 OUTLIER -92.27 167.38 12.05 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 171.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -64.37 -48.97 73.46 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.883 0.373 . . . . 0.0 111.642 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.05 -12.36 38.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.336 0.588 . . . . 0.0 110.228 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -91.96 -23.6 19.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.294 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 67.59 -75.06 0.06 Allowed 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.464 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 78.7 m -157.56 118.18 3.5 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -136.24 154.56 50.88 Favored 'General case' 0 C--O 1.223 -0.333 0 O-C-N 122.288 -0.258 . . . . 0.0 110.31 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.538 HG22 ' CD2' ' C' ' 20' ' ' LEU . 4.1 p -108.79 147.34 32.19 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -171.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.67 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 31.0 m-85 -140.16 65.14 1.43 Allowed 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 123.292 0.637 . . . . 0.0 111.289 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.565 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.7 mp -59.56 122.17 9.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 123.073 1.415 . . . . 0.0 113.81 -175.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.662 HG21 HD13 ' C' ' 72' ' ' LEU . 15.8 m -130.74 -173.71 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 111.723 -2.49 . . . . 0.0 111.461 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.658 ' HA2' ' H ' ' C' ' 16' ' ' MET . . . -120.48 45.61 1.21 Allowed Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.146 -1.026 . . . . 0.0 114.464 -173.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.877 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.16 -36.24 0.3 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 169.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -144.8 20.71 1.64 Allowed 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -172.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 2.0 ttt -66.72 -69.38 0.31 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 112.196 -2.274 . . . . 0.0 110.332 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -142.42 -101.02 0.13 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.655 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.711 HG13 ' HA ' ' C' ' 68' ' ' ASP . 0.4 OUTLIER 101.37 -27.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 125.516 1.76 . . . . 0.0 110.189 -165.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' C' ' 40' ' ' LYS . 0.0 OUTLIER -83.99 -71.14 0.52 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 122.127 0.965 . . . . 0.0 109.056 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' C' ' 40' ' ' LYS . 43.6 mt-10 -63.11 -27.22 69.24 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.721 174.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.742 ' O ' HG23 ' C' ' 46' ' ' ILE . 6.3 t80 -58.95 -52.44 65.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.566 173.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' C' ' 57' ' ' GLN . 51.3 mtpt -61.55 -42.75 99.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.028 0.442 . . . . 0.0 110.642 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -55.6 -40.92 72.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.361 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -68.98 -47.01 66.63 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.971 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.742 HG23 ' O ' ' C' ' 42' ' ' PHE . 4.1 pt -76.01 -13.06 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.415 -173.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.2 -60.6 1.2 Allowed 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.01 93.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.745 0.307 . . . . 0.0 111.699 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -17.69 64.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.475 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.551 HG22 ' O ' ' C' ' 46' ' ' ILE . 17.8 m -113.33 -6.63 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 33.6 t 69.55 22.18 6.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.648 0.737 . . . . 0.0 109.192 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.1 mm -130.06 117.04 17.99 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.635 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.501 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 5.5 Cg_exo -74.99 148.32 35.15 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.962 1.774 . . . . 0.0 111.12 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 35.5 t -55.12 -25.91 34.82 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.153 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.5 pt-20 -68.54 -24.65 64.66 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.653 0.263 . . . . 0.0 111.623 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 95.8 mttt -115.64 -17.76 11.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.446 0.641 . . . . 0.0 110.427 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.453 ' HA ' HG21 ' C' ' 52' ' ' ILE . 23.0 tt0 -66.28 119.35 11.39 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.596 -170.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.42 ' HG3' ' HG3' ' C' ' 87' ' ' ARG . 28.0 mmt180 -114.54 113.66 24.72 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.651 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.756 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 47.7 mt -82.62 105.27 13.53 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.1 mt -102.13 103.62 15.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.611 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -118.6 132.51 56.19 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.628 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 40.64 45.55 2.04 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.985 0.803 . . . . 0.0 111.705 -171.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.95 -6.28 20.83 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.654 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -87.03 129.71 34.78 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 38' ' ' GLU . 1.6 t -87.38 89.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.081 0.467 . . . . 0.0 109.905 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' C' ' 59' ' ' LEU . 0.1 OUTLIER -76.96 155.84 32.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.103 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' C' ' 69' ' ' ASP . 7.7 pt20 -160.16 -169.31 2.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.286 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.711 ' HA ' HG13 ' C' ' 39' ' ' VAL . 1.8 p-10 -61.6 1.34 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.251 1.42 . . . . 0.0 113.116 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' C' ' 67' ' ' GLN . 13.4 t70 -65.29 9.85 0.1 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.155 0.982 . . . . 0.0 113.103 -178.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' C' ' 68' ' ' ASP . 51.4 mttp 84.18 159.69 0.11 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.449 1.1 . . . . 0.0 113.648 170.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.449 ' HB3' ' HG2' ' C' ' 74' ' ' GLU . 95.3 mttt 67.89 89.56 0.1 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.123 -1.399 . . . . 0.0 113.005 173.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.662 HD13 HG21 ' C' ' 33' ' ' VAL . 11.3 mt -63.9 -36.1 82.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.559 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . 0.41 ' HG2' ' H ' ' C' ' 73' ' ' GLN . 4.3 pt20 -66.89 -24.46 66.11 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' C' ' 71' ' ' LYS . 26.1 mm-40 -62.19 -27.78 69.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.241 0.543 . . . . 0.0 109.623 176.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.554 ' CD1' HD22 ' C' ' 66' ' ' LEU . 17.8 m-85 -94.01 -12.24 29.07 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.781 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 3.8 m120 47.83 45.29 18.57 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.417 1.087 . . . . 0.0 113.366 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.455 HG23 HG22 ' C' ' 19' ' ' VAL . 29.5 m -86.68 19.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -74.35 102.41 1.37 Allowed Glycine 0 N--CA 1.429 -1.789 0 CA-C-O 122.989 1.327 . . . . 0.0 112.976 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.26 13.73 53.33 Favored Glycine 0 C--N 1.283 -2.394 0 CA-C-N 111.967 -2.116 . . . . 0.0 114.002 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -127.84 154.7 45.15 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.66 -0.318 . . . . 0.0 110.247 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.606 ' HB ' ' HG3' ' C' ' 22' ' ' LYS . 35.0 m -87.03 122.93 39.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 121.818 0.818 . . . . 0.0 112.157 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . . . . . . . . . 62.3 mt -86.7 135.26 25.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.512 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.414 ' O ' ' HB ' ' C' ' 60' ' ' ILE . 69.5 m80 -93.93 114.62 26.86 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.47 ' O ' HG23 ' C' ' 23' ' ' THR . 2.7 pp -127.37 157.13 40.78 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 118.786 -1.166 . . . . 0.0 113.517 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 m -159.56 -174.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.533 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . 0.413 ' N ' HD12 ' C' ' 52' ' ' ILE . 10.7 pt-20 -106.16 142.81 35.23 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.238 167.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . 0.42 ' HG3' ' HG3' ' C' ' 58' ' ' ARG . 39.3 mtt180 -81.31 176.98 9.28 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 169.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.401 ' HB3' HG21 ' C' ' 92' ' ' THR . . . -56.78 156.27 12.96 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.651 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.09 152.41 18.65 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.624 2.216 . . . . 0.0 112.111 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.23 58.07 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.368 2.712 . . . . 0.0 113.317 -173.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -146.53 20.89 1.34 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.676 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.401 HG21 ' HB3' ' C' ' 88' ' ' ALA . 3.6 t -118.22 111.28 18.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.944 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . 0.4 ' O ' ' HD3' ' C' ' 95' ' ' PRO . 9.7 p-80 -160.81 102.31 1.31 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.37 175.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.43 98.39 43.48 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.257 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' C' ' 93' ' ' HIS . 22.5 Cg_exo -64.36 143.73 83.65 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.588 2.192 . . . . 0.0 111.224 174.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 7.3 m -60.0 -27.52 66.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.043 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -111.74 34.22 5.36 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.248 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.19 -65.36 0.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.894 -0.18 . . . . 0.0 110.772 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 16.6 m 58.51 78.27 0.26 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.736 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 56.4 m 62.04 69.09 0.64 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.847 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.311 -1.272 . . . . 0.0 111.321 179.573 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 41.5 m -88.32 106.32 18.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.924 0.393 . . . . 0.0 110.298 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -65.38 -46.2 81.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 3' ' ' GLU . . . 60.6 89.59 0.07 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.935 0.772 . . . . 0.0 112.372 173.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 13.8 mm-40 72.65 105.17 0.07 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.869 177.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.37 108.85 3.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.146 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 t 61.95 75.07 0.45 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.918 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -85.0 52.33 3.37 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.045 2.497 . . . . 0.0 111.604 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -162.89 155.98 16.68 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.3 70.84 6.6 Favored 'Trans proline' 0 N--CA 1.431 -2.168 0 C-N-CA 122.765 2.31 . . . . 0.0 112.804 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.48 8.46 24.34 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.594 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -121.5 85.53 2.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.892 0.346 . . . . 0.0 110.835 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.478 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 8.2 m-85 -117.99 165.21 13.99 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.34 0.59 . . . . 0.0 109.809 171.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.554 ' HB2' HD11 ' A' ' 40' ' ' LEU . 50.1 t80 -140.26 115.15 9.62 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.491 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.526 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -93.88 108.1 19.92 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.409 ' CD2' HG12 ' C' ' 85' ' ' VAL . 12.6 p80 -64.88 -15.4 61.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.652 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.5 t -72.34 -36.8 68.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.887 0.375 . . . . 0.0 110.478 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.526 ' HB3' HG22 ' A' ' 18' ' ' VAL . 66.0 m -88.77 -23.89 22.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.423 0.63 . . . . 0.0 110.594 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.07 30.61 20.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.272 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 16' ' ' CYS . 2.6 m -138.38 162.95 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.694 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -83.42 145.24 29.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.849 HD12 ' HD3' ' A' ' 30' ' ' PRO . 3.5 pt -137.21 168.42 21.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.094 -171.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.476 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 45.9 t -125.14 99.58 34.09 Favored Pre-proline 0 N--CA 1.445 -0.682 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 162.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HD3' HG13 ' A' ' 20' ' ' ILE . 12.9 Cg_endo -55.37 175.24 0.19 Allowed 'Trans proline' 0 C--N 1.328 -0.538 1 C-N-CA 125.306 4.004 . . . . 0.0 116.257 -173.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.522 ' HB2' HG13 ' A' ' 28' ' ' ILE . 26.0 mtt180 -109.15 48.99 0.84 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.86 -1.973 . . . . 0.0 106.888 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.422 HD13 ' CE1' ' A' ' 27' ' ' TYR . 1.8 mm? 3.05 -61.47 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.362 0 CA-C-N 111.09 -2.777 . . . . 0.0 117.334 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -34.86 -34.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 123.103 2.535 . . . . 0.0 114.42 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.571 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -114.84 -21.83 9.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.937 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.456 ' C ' HD11 ' A' ' 37' ' ' ILE . 77.3 m-85 65.57 57.6 0.86 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.148 0.975 . . . . 0.0 109.795 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -109.19 163.01 6.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 113.492 -1.686 . . . . 0.0 109.542 176.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 1.4 t -95.92 146.15 30.81 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.849 ' HD3' HD12 ' A' ' 20' ' ' ILE . 86.8 Cg_endo -83.32 -20.29 5.02 Favored 'Trans proline' 0 CA--C 1.501 -1.15 0 C-N-CA 122.607 2.205 . . . . 0.0 108.85 -175.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.402 ' H ' ' CD ' ' A' ' 30' ' ' PRO . 63.3 mtt180 -86.16 -14.07 45.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.259 -1.791 . . . . 0.0 114.104 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 p -152.36 -14.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 8.4 tt0 62.72 36.59 13.25 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.028 0.531 . . . . 0.0 112.161 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 98.2 p -108.44 154.18 22.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 166.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.46 33.91 3.79 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.801 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 60.8 m-85 -94.26 47.79 1.21 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.369 . . . . 0.0 111.045 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 20' ' ' ILE . 3.6 pt -114.03 139.55 39.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.779 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.542 ' HB3' HD13 ' C' ' 60' ' ' ILE . 13.1 pt-20 -117.83 143.41 46.31 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -79.13 139.17 38.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.07 0.462 . . . . 0.0 109.836 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.933 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.102 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 5.7 tpt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 120.636 0.255 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.86 133.26 43.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.94 0.4 . . . . 0.0 111.452 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -137.55 38.23 2.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.948 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -85.77 71.46 10.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.229 0.538 . . . . 0.0 110.7 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -146.37 121.98 10.45 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -128.62 104.72 7.82 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.96 0.41 . . . . 0.0 110.896 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -123.01 34.65 5.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.321 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -75.98 83.83 2.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.925 0.393 . . . . 0.0 110.902 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -122.27 146.64 27.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.265 0.555 . . . . 0.0 110.209 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -120.17 -80.83 0.63 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.274 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -114.01 -34.56 5.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 168.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -78.24 74.79 4.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.714 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -70.52 -49.07 52.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.156 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . 0.447 ' HB3' HG22 ' C' ' 32' ' ' ILE . 97.3 mttt -61.11 147.18 44.81 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.891 175.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.579 ' H ' ' HA2' ' C' ' 34' ' ' GLY . 94.1 mmm -112.76 -54.99 2.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.213 -167.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.863 HD11 ' HA ' ' C' ' 35' ' ' ALA . 0.6 OUTLIER -99.95 127.46 46.14 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.859 -171.029 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.613 ' HA ' HG13 ' C' ' 32' ' ' ILE . 40.5 tt0 -84.59 92.64 8.19 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.8 t -76.96 126.24 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.956 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -174.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.622 ' HB2' ' CG1' ' C' ' 81' ' ' VAL . 0.2 OUTLIER -114.21 155.02 26.87 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 170.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.897 ' O ' ' HA ' ' C' ' 28' ' ' THR . 15.7 m -140.82 155.35 22.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.56 ' HG3' ' CG2' ' C' ' 81' ' ' VAL . 45.0 mtmt -134.35 114.18 12.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 169.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.547 ' HB ' ' OE2' ' C' ' 86' ' ' GLU . 65.0 p -83.6 -178.95 7.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.637 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' C' ' 86' ' ' GLU . 12.3 mt -69.93 -24.6 63.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.198 0.523 . . . . 0.0 110.172 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.13 4.38 17.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.131 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 7.1 t 64.96 22.67 12.49 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.163 0.506 . . . . 0.0 111.366 172.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -48.24 -58.12 4.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.292 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.897 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 95.0 m 56.02 96.12 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.516 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -133.93 170.44 15.62 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.205 -0.31 . . . . 0.0 110.674 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.546 HG22 ' CD2' ' C' ' 20' ' ' LEU . 2.6 p -112.09 145.21 40.15 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.639 ' O ' ' HB ' ' C' ' 19' ' ' VAL . 29.5 m-85 -140.85 65.93 1.39 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.177 0.513 . . . . 0.0 110.895 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.613 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.1 mp -60.32 121.7 8.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 123.384 1.564 . . . . 0.0 114.117 -174.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.556 HG11 ' CD2' ' C' ' 42' ' ' PHE . 10.9 m -125.08 -174.17 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 111.036 -2.802 . . . . 0.0 111.348 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.579 ' HA2' ' H ' ' C' ' 16' ' ' MET . . . -126.78 45.6 1.14 Allowed Glycine 0 C--N 1.317 -0.497 0 C-N-CA 119.78 -1.2 . . . . 0.0 114.119 -173.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.863 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 69.81 -26.29 0.15 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 169.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -163.33 25.51 0.09 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . 0.55 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 31.7 tpp -77.14 -68.75 0.58 Allowed 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 112.15 -2.295 . . . . 0.0 109.659 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.557 ' O ' ' HB ' ' C' ' 39' ' ' VAL . 18.2 m120 -142.69 -157.1 0.74 Allowed 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.595 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 2.8 p 159.68 -16.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.41 ' HD3' ' H ' ' C' ' 40' ' ' LYS . 0.0 OUTLIER -86.05 -70.48 0.6 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.248 -1.796 . . . . 0.0 108.24 169.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -62.68 -32.74 73.86 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.142 -1.845 . . . . 0.0 111.207 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.595 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.1 OUTLIER -57.92 -51.69 68.57 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 173.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' C' ' 43' ' ' LYS . 31.3 mtpt -64.11 -39.3 93.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.99 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -56.6 -36.23 69.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.159 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -69.01 -39.79 79.08 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 122.911 0.484 . . . . 0.0 111.342 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.619 HD11 ' OE1' ' C' ' 57' ' ' GLN . 5.7 pt -84.55 -13.15 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.118 -175.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.32 -55.01 2.86 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.02 87.22 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -31.85 71.71 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.295 0.569 . . . . 0.0 110.868 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.547 HG22 ' O ' ' C' ' 46' ' ' ILE . 29.9 m -102.66 -2.06 9.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.033 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 84.3 p 63.12 23.55 13.99 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.812 0.815 . . . . 0.0 109.461 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' C' ' 57' ' ' GLN . 5.6 mm -130.45 115.29 17.2 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.781 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.524 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 4.5 Cg_exo -69.54 147.09 63.52 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.369 2.046 . . . . 0.0 111.061 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -51.37 -25.73 6.56 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.769 0.668 . . . . 0.0 112.059 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' C' ' 53' ' ' PRO . 10.2 pt-20 -70.75 -36.13 72.99 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.631 0.253 . . . . 0.0 111.568 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.428 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 98.4 mttt -98.43 -27.54 14.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.376 0.607 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.619 ' OE1' HD11 ' C' ' 46' ' ' ILE . 6.0 tt0 -68.36 136.44 53.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.239 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . 0.477 ' HB2' HG22 ' C' ' 85' ' ' VAL . 47.2 mtm180 -137.48 137.37 38.62 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.33 172.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.434 ' HB3' HG21 ' C' ' 82' ' ' ILE . 38.6 mt -96.28 123.61 39.98 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.957 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.562 HG21 ' O ' ' A' ' 37' ' ' ILE . 9.9 mt -112.84 122.29 66.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 119.227 0.921 . . . . 0.0 111.374 169.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.662 ' CD2' HG12 ' C' ' 77' ' ' VAL . 36.3 t80 -128.36 119.12 24.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.615 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 58.36 37.4 25.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.117 0.484 . . . . 0.0 110.414 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.46 -4.95 65.78 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.747 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.469 ' HA ' ' NE ' ' C' ' 64' ' ' ARG . 2.5 tpm_? -92.43 126.0 37.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.6 OUTLIER -92.35 90.74 3.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.371 0.605 . . . . 0.0 110.559 -174.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.45 ' CD1' HG11 ' C' ' 77' ' ' VAL . 0.1 OUTLIER -72.6 154.59 40.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.738 -178.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -152.44 -170.47 3.65 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.214 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.568 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.8 p-10 -69.64 -2.37 11.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.174 0.589 . . . . 0.0 112.125 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.91 -9.98 11.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.545 ' HA ' HG11 ' C' ' 39' ' ' VAL . 52.9 mtmt 77.53 -175.51 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.739 0.815 . . . . 0.0 111.888 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.466 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 35.5 mmtp 75.09 69.02 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.634 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 30.7 mt -66.89 -39.75 87.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.563 -176.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -67.81 -19.87 65.12 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 120.793 0.33 . . . . 0.0 111.521 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 17.0 mm-40 -71.05 -27.08 63.39 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.447 ' CD1' HD22 ' C' ' 66' ' ' LEU . 25.2 m-85 -88.28 -25.11 22.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 61.7 t30 60.07 34.24 21.31 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.07 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.662 HG12 ' CD2' ' C' ' 61' ' ' TYR . 17.5 m -83.67 11.92 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -174.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.561 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -71.24 100.81 0.9 Allowed Glycine 0 N--CA 1.431 -1.661 0 CA-C-O 122.634 1.13 . . . . 0.0 113.298 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.5 13.41 28.28 Favored Glycine 0 C--N 1.285 -2.268 0 CA-C-N 112.123 -2.039 . . . . 0.0 115.804 170.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -136.04 148.56 48.41 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.68 0.74 . . . . 0.0 110.507 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.622 ' CG1' ' HB2' ' C' ' 20' ' ' LEU . 27.2 m -74.48 118.94 20.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.535 0 CA-C-O 121.97 0.89 . . . . 0.0 112.502 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' C' ' 59' ' ' LEU . 84.8 mt -70.76 160.6 5.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.929 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.514 173.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.412 ' N ' HG22 ' C' ' 82' ' ' ILE . 66.0 m-70 -115.56 117.65 30.93 Favored 'General case' 0 C--N 1.319 -0.761 0 O-C-N 121.338 -0.851 . . . . 0.0 109.564 173.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.45 ' CD1' ' HB ' ' C' ' 21' ' ' VAL . 10.2 mp -85.29 160.94 19.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.238 0.542 . . . . 0.0 111.699 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' C' ' 58' ' ' ARG . 5.6 m -112.61 134.71 54.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . 0.547 ' OE2' ' HB ' ' C' ' 23' ' ' THR . 30.7 mt-10 -116.47 121.82 42.96 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.788 -177.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -83.41 176.58 8.98 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.32 146.87 88.32 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.96 157.85 36.73 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.073 2.515 . . . . 0.0 111.811 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -48.42 138.99 23.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.449 2.766 . . . . 0.0 112.296 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -77.58 -16.78 58.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.965 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -71.75 147.87 46.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.041 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -85.78 -7.81 58.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.321 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 8.9 tt -67.02 122.76 84.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.002 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.09 110.42 1.01 Allowed 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.717 2.278 . . . . 0.0 112.272 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -73.38 -169.5 0.67 Allowed 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.03 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.04 -111.54 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.734 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . 54.5 39.47 31.11 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.545 0.688 . . . . 0.0 109.986 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 2.6 p -99.16 -173.23 2.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.358 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 13.1 t -72.18 -37.97 69.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.185 0.517 . . . . 0.0 109.644 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.9 -0.945 . . . . 0.0 111.782 179.084 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.4 t -77.37 129.2 35.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.008 0.432 . . . . 0.0 110.706 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt -93.29 -7.74 44.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.303 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.56 82.23 1.58 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.371 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.4 OUTLIER -92.56 141.61 28.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.451 -179.167 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.71 97.11 6.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.927 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.0 p -168.8 122.5 0.71 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.12 -36.42 97.93 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.566 2.178 . . . . 0.0 110.754 173.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -135.92 122.75 14.38 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 169.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.76 40.71 0.82 Allowed 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 123.259 2.639 . . . . 0.0 113.681 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.93 99.68 0.04 OUTLIER Glycine 0 CA--C 1.502 -0.724 0 CA-C-O 121.933 0.741 . . . . 0.0 111.83 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG2' HD12 ' A' ' 40' ' ' LEU . 43.4 ttm180 -161.45 82.04 0.61 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 113.96 -1.12 . . . . 0.0 110.94 -172.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.509 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 6.3 m-85 -116.62 148.69 40.72 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.875 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.507 ' CB ' HD21 ' A' ' 40' ' ' LEU . 37.9 t80 -118.17 116.12 26.18 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.455 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.59 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -92.53 131.73 37.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.53 ' CD2' HG21 ' C' ' 85' ' ' VAL . 72.6 m-70 -85.8 -27.33 25.23 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -169.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.432 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 30.7 p -71.36 -30.63 66.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.319 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.425 ' O ' HG23 ' A' ' 18' ' ' VAL . 84.9 m -83.42 -33.01 25.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.091 0.472 . . . . 0.0 110.211 172.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.0 34.28 24.09 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.114 -173.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 16' ' ' CYS . 18.9 t -138.89 145.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.26 146.36 45.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.18 0.514 . . . . 0.0 112.003 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.804 HD12 ' HD3' ' A' ' 30' ' ' PRO . 2.3 pt -136.14 167.42 24.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.624 -172.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.63 111.39 31.41 Favored Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 159.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.509 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 22.2 Cg_endo -69.04 175.84 6.99 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 124.372 3.381 . . . . 0.0 115.687 -167.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.576 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 13.8 mtt180 -108.77 48.86 0.84 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.859 -1.973 . . . . 0.0 106.798 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.412 HD23 ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -1.05 -58.66 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.057 0 CA-C-N 110.964 -2.835 . . . . 0.0 117.056 171.213 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.435 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 20.0 Cg_exo -37.98 -33.98 0.29 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.706 2.271 . . . . 0.0 113.774 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.557 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.49 -21.0 10.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.777 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 65.49 56.27 0.97 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.356 1.074 . . . . 0.0 109.878 -169.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -109.59 162.85 7.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.38 -1.737 . . . . 0.0 109.606 176.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 1.5 t -97.46 147.53 33.12 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.804 ' HD3' HD12 ' A' ' 20' ' ' ILE . 65.6 Cg_endo -82.56 -19.82 6.08 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.851 2.367 . . . . 0.0 108.046 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.62 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 94.9 mtt-85 -82.69 -24.55 33.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 113.007 -1.906 . . . . 0.0 114.114 -178.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.432 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 28.6 p -147.2 -12.21 0.42 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 8.1 tt0 62.27 29.2 17.33 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.329 0.585 . . . . 0.0 111.02 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 m -106.26 146.76 29.94 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 170.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.27 44.47 3.29 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.572 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 95.4 m-85 -103.95 45.03 0.98 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.52 0.676 . . . . 0.0 109.851 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.671 HG21 ' CD1' ' A' ' 20' ' ' ILE . 10.7 pt -113.41 138.76 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.943 -176.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.499 ' HB3' HD13 ' C' ' 60' ' ' ILE . 13.4 pt-20 -129.57 143.85 51.01 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -79.5 133.39 36.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.024 0.44 . . . . 0.0 110.314 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.507 HD21 ' CB ' ' A' ' 12' ' ' PHE . 8.2 mt . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.708 -170.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.7 -79.97 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.338 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -175.95 -43.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.634 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 32.7 m80 62.52 -166.87 0.21 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.62 0.575 . . . . 0.0 110.371 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 59.67 41.05 19.19 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -73.74 -79.67 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.014 -175.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.434 ' O ' ' HB2' ' C' ' 9' ' ' HIS . 67.4 m-70 46.94 36.57 4.11 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.574 0.547 . . . . 0.0 112.453 173.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' C' ' 8' ' ' HIS . 64.1 m-70 68.42 -51.79 0.55 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.949 0.499 . . . . 0.0 110.757 -170.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.09 151.41 23.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.089 173.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' C' ' 12' ' ' ASP . 3.1 p-10 -57.02 -72.52 0.08 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.824 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' C' ' 11' ' ' ASP . 15.7 t70 176.03 -73.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -172.91 -158.54 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.51 -18.71 61.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 168.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -66.58 -178.58 0.72 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.137 170.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 92.3 mmm 57.31 80.67 0.16 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.175 0.512 . . . . 0.0 110.877 -177.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.777 HD11 ' HA ' ' C' ' 35' ' ' ALA . 5.2 mt -90.37 137.73 32.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.093 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.62 ' HA ' HG13 ' C' ' 32' ' ' ILE . 41.4 tt0 -88.79 89.56 8.04 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.623 ' CG1' ' HB2' ' C' ' 31' ' ' PHE . 7.9 t -74.79 97.29 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.978 -173.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.899 ' HB3' HG12 ' C' ' 81' ' ' VAL . 4.4 mt -88.89 153.14 21.28 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' C' ' 28' ' ' THR . 33.9 m -144.81 147.55 18.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.343 0.257 . . . . 0.0 110.402 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.645 ' HE3' HG21 ' C' ' 81' ' ' VAL . 79.8 mttt -131.17 120.41 23.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.413 HG22 ' O ' ' C' ' 84' ' ' LEU . 3.3 p -102.47 113.85 27.55 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.811 0.339 . . . . 0.0 111.09 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' C' ' 26' ' ' SER . 4.6 mm? 56.05 19.01 3.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.744 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 21.5 t70 71.94 -8.82 1.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.941 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . 0.419 ' H ' ' C ' ' C' ' 24' ' ' LEU . 10.2 m -69.89 -39.19 76.39 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.553 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -110.5 174.06 6.04 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.844 0.83 . . . . 0.0 111.332 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.683 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 53.5 m -167.95 98.59 0.45 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.51 -1.677 . . . . 0.0 108.232 175.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . 0.412 ' O ' HG22 ' C' ' 21' ' ' VAL . 78.4 mtt180 -131.57 172.36 12.32 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.148 -176.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 1.6 p -115.04 151.58 33.98 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.623 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 28.4 m-85 -137.46 58.64 1.7 Allowed 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 124.141 0.977 . . . . 0.0 109.812 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.62 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.4 mp -58.71 123.27 10.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 123.443 1.592 . . . . 0.0 114.38 -172.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.64 HG21 HD13 ' C' ' 72' ' ' LEU . 10.7 m -124.66 -170.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 110.79 -2.913 . . . . 0.0 111.635 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.94 45.42 1.21 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.725 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.777 ' HA ' HD11 ' C' ' 17' ' ' LEU . . . 68.06 17.12 9.51 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 165.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.652 ' HB3' ' O ' ' C' ' 35' ' ' ALA . 3.0 pt20 158.94 -9.08 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.292 0.568 . . . . 0.0 109.718 -162.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . . . . . . . . . 14.2 tpt -39.83 -66.61 0.29 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.855 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.441 ' O ' HG12 ' C' ' 39' ' ' VAL . 26.2 m-80 -148.6 -88.52 0.08 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.692 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.3 OUTLIER 89.29 -27.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 O-C-N 125.393 1.683 . . . . 0.0 111.559 -167.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -70.9 0.52 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.246 1.022 . . . . 0.0 108.873 175.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.46 -27.06 69.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.052 173.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.692 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.4 OUTLIER -56.74 -52.29 65.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.364 173.614 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' C' ' 39' ' ' VAL . 54.7 mtpt -61.02 -43.75 98.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.42 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -54.8 -39.19 68.2 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.306 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -70.23 -43.73 70.0 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.066 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.675 HG23 ' O ' ' C' ' 42' ' ' PHE . 3.9 pt -79.1 -11.66 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 120.458 0.17 . . . . 0.0 110.945 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -42.24 -55.48 3.29 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.793 0.683 . . . . 0.0 112.675 -177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.31 -39.45 74.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -27.96 69.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.053 0.454 . . . . 0.0 111.0 -176.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.592 HG22 ' O ' ' C' ' 46' ' ' ILE . 28.9 m -108.27 -0.9 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.445 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 84.3 p 63.48 23.63 13.75 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.868 0.842 . . . . 0.0 109.464 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 6.0 mm -128.7 114.13 19.23 Favored Pre-proline 0 N--CA 1.439 -1.007 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.721 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.2 145.99 39.94 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.688 2.259 . . . . 0.0 111.929 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . . . . . . . . . 41.1 t -53.08 -25.56 13.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.647 -174.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.54 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.6 pt-20 -70.76 -27.44 63.94 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.726 0.298 . . . . 0.0 111.474 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.54 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 92.8 mttt -109.0 -22.43 12.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.504 0.668 . . . . 0.0 109.936 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.421 ' HA ' HG21 ' C' ' 52' ' ' ILE . 23.6 tt0 -65.03 122.85 17.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.158 -169.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -127.41 115.55 19.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.982 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.658 ' HB3' HG21 ' C' ' 82' ' ' ILE . 5.3 mp -86.04 105.6 16.6 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.556 HG21 ' O ' ' A' ' 37' ' ' ILE . 13.4 mt -99.61 110.98 27.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 121.268 0.556 . . . . 0.0 111.811 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.487 ' CD2' HG12 ' C' ' 77' ' ' VAL . 50.0 t80 -122.12 121.02 35.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.261 173.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 60.31 39.32 19.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.983 0.421 . . . . 0.0 110.752 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.44 -1.45 27.73 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.679 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' C' ' 60' ' ' ILE . 6.2 mmp_? -88.73 140.46 29.42 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.44 87.87 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.297 0.57 . . . . 0.0 110.611 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.603 ' HG ' ' CD1' ' C' ' 75' ' ' TYR . 6.1 mp -65.31 122.55 17.38 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.812 173.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . 0.428 ' HG3' ' HB2' ' C' ' 69' ' ' ASP . 19.1 pt20 -144.19 -170.21 3.3 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.23 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.613 ' HA ' HG13 ' C' ' 39' ' ' VAL . 2.2 p-10 -66.67 0.35 2.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.285 1.034 . . . . 0.0 112.599 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . 0.428 ' HB2' ' HG3' ' C' ' 67' ' ' GLN . 12.7 t70 -62.85 -2.68 1.25 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.516 0.726 . . . . 0.0 112.679 -177.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? 81.71 172.06 0.12 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.12 0.968 . . . . 0.0 112.977 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.488 ' HB3' ' CG ' ' C' ' 74' ' ' GLU . 42.1 mtmt 71.0 86.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.937 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.64 HD13 HG21 ' C' ' 33' ' ' VAL . 41.8 mt -71.68 -49.62 37.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.382 -176.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . 0.513 ' HB3' ' HB1' ' C' ' 35' ' ' ALA . 29.8 pt20 -67.91 -17.08 64.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . 0.488 ' CG ' ' HB3' ' C' ' 71' ' ' LYS . 7.0 mm-40 -63.67 -28.82 70.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 173.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.603 ' CD1' ' HG ' ' C' ' 66' ' ' LEU . 42.1 m-85 -85.11 -23.28 28.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.256 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 64.1 t30 59.72 30.04 19.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.377 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . 0.557 HG11 HD21 ' C' ' 66' ' ' LEU . 18.0 m -85.21 25.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -175.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.567 ' CA ' ' HB3' ' C' ' 17' ' ' LEU . . . -76.33 100.4 1.4 Allowed Glycine 0 N--CA 1.431 -1.65 0 CA-C-O 122.552 1.085 . . . . 0.0 111.929 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.95 13.23 34.63 Favored Glycine 0 C--N 1.284 -2.318 0 CA-C-N 112.364 -1.918 . . . . 0.0 114.278 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . 0.441 ' C ' ' HB2' ' C' ' 20' ' ' LEU . 8.2 mptt -126.19 144.19 50.86 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.142 0.471 . . . . 0.0 110.113 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.899 HG12 ' HB3' ' C' ' 20' ' ' LEU . 35.2 m -80.22 125.5 39.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.809 0.814 . . . . 0.0 111.524 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.658 HG21 ' HB3' ' C' ' 59' ' ' LEU . 42.6 mt -84.99 171.43 1.17 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.813 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.55 ' N ' HG22 ' C' ' 82' ' ' ILE . 49.2 m80 -118.48 113.97 22.14 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 121.759 -0.588 . . . . 0.0 110.131 174.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.475 HD13 ' HB ' ' C' ' 21' ' ' VAL . 8.6 mp -103.32 139.41 38.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.058 0.456 . . . . 0.0 110.756 178.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.53 HG21 ' CD2' ' A' ' 14' ' ' HIS . 7.1 m -148.74 167.81 3.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.734 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . 0.425 ' OE1' ' HB3' ' C' ' 56' ' ' LYS . 0.1 OUTLIER -98.03 147.36 24.59 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.012 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -68.01 179.1 1.58 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.162 0.506 . . . . 0.0 111.429 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.78 155.85 3.75 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.198 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.68 137.48 66.85 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 122.266 1.977 . . . . 0.0 112.45 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.72 51.84 3.96 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 123.287 2.658 . . . . 0.0 113.019 -173.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -88.61 2.91 52.26 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.061 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 12.9 t -144.48 156.74 44.32 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.904 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -134.93 24.49 3.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.116 0.484 . . . . 0.0 110.163 176.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 57.3 mt -97.49 120.74 60.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.402 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.24 133.69 36.22 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.628 2.219 . . . . 0.0 111.715 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 8.9 t -76.11 57.81 1.15 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.072 0.463 . . . . 0.0 110.743 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.36 -103.48 1.51 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.066 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.66 108.45 20.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.646 0.26 . . . . 0.0 110.406 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 8.7 t -81.57 84.65 6.69 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 31.9 t 64.79 79.58 0.25 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.157 -1.357 . . . . 0.0 111.488 178.834 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.776 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.6 m -77.89 77.53 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.361 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptp -118.88 4.72 11.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.832 -174.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.68 53.75 2.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.21 0.529 . . . . 0.0 110.57 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -97.61 -17.7 19.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.986 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.8 119.92 21.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.011 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.5 m -153.69 95.82 2.83 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.431 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.31 65.01 7.98 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.023 2.482 . . . . 0.0 113.015 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -103.64 -46.91 0.16 Allowed Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.15 67.0 4.18 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 121.916 1.744 . . . . 0.0 113.36 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.94 -12.09 2.2 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.568 172.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -154.99 90.22 1.27 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.823 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.567 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.1 m-85 -117.92 145.39 44.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 169.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -119.21 122.04 41.07 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.349 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.671 ' HB2' HG22 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -99.28 130.0 45.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.744 177.434 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -85.11 -26.57 26.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.43 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 26.4 p -70.33 -45.47 66.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.425 -174.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.461 ' O ' HG23 ' A' ' 18' ' ' VAL . 18.6 p -95.05 -0.88 53.24 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.918 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.9 p 50.5 43.18 27.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.586 1.155 . . . . 0.0 113.739 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 16' ' ' CYS . 32.1 t -133.3 144.69 35.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.8 148.27 40.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.739 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.1 pt -140.35 167.57 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.657 0.741 . . . . 0.0 112.93 -167.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.4 t -120.44 106.85 39.67 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 159.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.567 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 25.6 Cg_endo -68.74 175.64 6.97 Favored 'Trans proline' 0 C--N 1.32 -0.921 0 C-N-CA 124.688 3.592 . . . . 0.0 116.546 -166.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HB2' HG13 ' A' ' 28' ' ' ILE . 83.7 mtt180 -108.87 48.48 0.86 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 112.65 -2.068 . . . . 0.0 107.434 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.408 ' CD2' ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -3.28 -59.53 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.85 0 CA-C-N 110.854 -2.885 . . . . 0.0 117.479 173.434 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD2' ' C ' ' A' ' 23' ' ' ARG . 26.8 Cg_exo -37.25 -37.01 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 122.59 2.194 . . . . 0.0 113.53 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.556 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -112.22 -21.49 11.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.704 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 42.2 m-85 68.99 57.41 0.39 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.259 1.028 . . . . 0.0 110.057 -170.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.556 HG12 ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -111.49 163.79 8.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.159 176.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 20' ' ' ILE . 1.5 t -95.72 142.4 24.53 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.739 ' HD3' HD12 ' A' ' 20' ' ' ILE . 91.9 Cg_endo -83.35 -18.82 5.75 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.074 1.85 . . . . 0.0 108.577 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 58.2 mtt180 -95.47 15.96 18.25 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.241 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 31' ' ' ARG . 14.3 p 175.64 -11.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.405 0.441 . . . . 0.0 111.901 172.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 10.4 tt0 63.95 29.71 14.35 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.197 0.522 . . . . 0.0 112.124 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -99.7 148.29 24.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.48 168.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.24 21.98 21.82 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.892 -175.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 74.9 m-85 -86.32 47.73 1.51 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.709 0.29 . . . . 0.0 110.985 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.705 HG21 ' CD1' ' A' ' 20' ' ' ILE . 6.6 pt -110.31 131.59 60.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.191 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.436 ' HB3' HD13 ' C' ' 60' ' ' ILE . 9.3 pt-20 -118.63 145.94 45.05 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -78.79 143.43 36.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.24 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.148 -173.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.03 -61.46 0.45 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.643 0.777 . . . . 0.0 112.403 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -80.19 79.66 6.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 110.799 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -73.92 -47.31 38.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.032 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -169.77 -39.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.819 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -157.57 169.68 24.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -111.94 57.73 0.64 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.133 0.492 . . . . 0.0 111.958 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -99.07 70.02 1.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 165.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 27.2 m -82.46 143.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 122.099 0.952 . . . . 0.0 111.913 -170.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -117.03 7.92 13.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.431 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.46 85.64 5.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.032 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -124.39 -0.44 8.2 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.506 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.73 -36.71 85.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.388 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -51.26 140.78 16.15 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.299 0.571 . . . . 0.0 111.788 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.528 ' HA ' ' HA2' ' C' ' 34' ' ' GLY . 13.4 tmm? -171.82 122.67 0.51 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.931 -173.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.773 ' CD2' ' HA ' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -106.3 142.76 35.45 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 172.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.581 ' HA ' HG13 ' C' ' 32' ' ' ILE . 38.8 tt0 -92.78 91.45 7.48 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 173.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' C' ' 30' ' ' THR . 2.9 t -76.2 103.1 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.757 -169.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.668 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 0.8 OUTLIER -92.31 133.96 35.36 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.329 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.497 HG22 ' HB ' ' C' ' 82' ' ' ILE . 52.1 t -142.38 121.13 8.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -175.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.538 ' HG3' ' HB ' ' C' ' 81' ' ' VAL . 41.9 mtpt -95.7 154.09 17.39 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . 0.41 HG22 HD23 ' C' ' 84' ' ' LEU . 50.9 p -120.21 165.13 15.22 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.662 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.02 -10.09 46.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.137 0.494 . . . . 0.0 110.943 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -75.13 3.04 9.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.233 171.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 50.6 m 74.13 14.58 3.82 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.282 0.633 . . . . 0.0 111.863 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -94.61 -178.12 4.44 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.58 0.705 . . . . 0.0 111.313 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 53.1 m -144.31 117.41 8.91 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.35 178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -129.22 151.45 49.88 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.629 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 4.2 p -104.87 144.12 32.21 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.522 ' HB2' ' CG1' ' C' ' 19' ' ' VAL . 35.8 m-85 -139.09 62.36 1.54 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.82 0.819 . . . . 0.0 110.147 -174.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.581 HG13 ' HA ' ' C' ' 18' ' ' GLU . 3.2 mp -60.25 122.75 11.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 123.221 1.486 . . . . 0.0 114.901 -173.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' C' ' 16' ' ' MET . 19.5 m -140.35 -166.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 111.116 -2.765 . . . . 0.0 112.377 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -80.33 177.84 54.16 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.79 174.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.773 ' HA ' ' CD2' ' C' ' 17' ' ' LEU . . . -79.8 -15.07 58.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.372 0.606 . . . . 0.0 111.476 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -161.93 27.75 0.12 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . 0.434 ' HB2' ' HA3' ' C' ' 34' ' ' GLY . 4.5 ttp -57.69 -75.95 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.394 -174.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.462 ' O ' HG12 ' C' ' 39' ' ' VAL . 11.7 m120 -121.97 -82.33 0.65 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 120.903 0.383 . . . . 0.0 111.401 -177.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.677 ' CA ' ' HB3' ' C' ' 42' ' ' PHE . 0.4 OUTLIER 78.31 -25.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 O-C-N 124.95 1.406 . . . . 0.0 113.068 -173.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.15 -68.87 0.71 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 122.35 1.071 . . . . 0.0 109.075 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -57.77 -32.67 67.72 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.028 -1.896 . . . . 0.0 110.221 171.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.677 ' HB3' ' CA ' ' C' ' 39' ' ' VAL . 0.2 OUTLIER -63.33 -50.46 69.93 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.999 176.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . 0.692 ' HG3' ' OE1' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -59.11 -48.34 81.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.824 0.345 . . . . 0.0 110.278 176.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -57.31 -33.05 67.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.438 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -69.72 -51.12 37.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.284 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.701 HD11 ' OE1' ' C' ' 57' ' ' GLN . 17.7 pt -74.97 -14.31 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.525 -177.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -41.36 -57.09 2.27 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 124.165 0.916 . . . . 0.0 113.293 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.12 87.44 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -57.4 -43.73 83.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.484 0.659 . . . . 0.0 110.485 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.612 HG22 ' O ' ' C' ' 46' ' ' ILE . 27.1 m -88.16 -6.25 10.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.286 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m 67.87 21.1 9.14 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 121.62 0.724 . . . . 0.0 109.409 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 5.5 mm -129.67 111.81 17.6 Favored Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.325 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.55 ' HA ' ' HB1' ' C' ' 47' ' ' ALA . 5.0 Cg_exo -71.39 147.83 53.45 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.84 2.36 . . . . 0.0 111.554 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 37.9 t -51.15 -25.2 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.021 0.928 . . . . 0.0 112.81 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.487 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 11.5 pt-20 -78.14 -21.28 50.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 111.685 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.487 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 46.0 mtpt -112.9 -15.36 12.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.481 . . . . 0.0 110.195 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.701 ' OE1' HD11 ' C' ' 46' ' ' ILE . 9.6 tt0 -75.8 122.71 24.48 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.163 -174.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -121.73 124.2 43.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.743 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.51 HD11 ' HZ1' ' C' ' 43' ' ' LYS . 87.1 mt -88.29 118.23 27.75 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.436 HD13 ' HB3' ' A' ' 38' ' ' GLU . 5.7 mt -114.27 113.12 42.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.047 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -126.15 121.73 33.66 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' C' ' 62' ' ' GLN . 15.1 mt-30 59.95 38.39 20.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.792 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.03 -4.85 36.33 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.013 -0.54 . . . . 0.0 113.532 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -88.04 130.61 34.93 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.63 88.92 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.059 0.456 . . . . 0.0 109.848 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.536 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.3 OUTLIER -74.02 142.79 45.73 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -155.16 -168.65 2.93 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.042 -171.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.675 ' HA ' HG13 ' C' ' 39' ' ' VAL . 4.7 p-10 -60.78 -1.85 0.46 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.087 0.955 . . . . 0.0 113.421 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -68.53 -3.29 11.09 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.181 0.592 . . . . 0.0 112.165 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.506 ' H ' HG11 ' C' ' 39' ' ' VAL . 57.6 mttp 76.63 -165.45 0.06 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.862 0.865 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 mttt 68.69 55.85 0.46 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.463 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.614 HD21 HG23 ' C' ' 39' ' ' VAL . 31.1 mt -61.78 -33.04 73.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -71.72 -18.18 62.16 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 120.746 0.308 . . . . 0.0 111.575 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -76.44 -26.8 55.82 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.555 ' HD2' HD23 ' C' ' 72' ' ' LEU . 16.2 m-85 -82.63 -24.03 34.0 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 58.5 t30 62.88 41.52 8.6 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.596 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.26 -5.25 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-N 112.955 -1.929 . . . . 0.0 112.748 -158.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.692 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -52.58 104.92 0.2 Allowed Glycine 0 CA--C 1.487 -1.666 0 CA-C-O 123.329 1.516 . . . . 0.0 113.769 173.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.97 14.21 59.58 Favored Glycine 0 C--N 1.287 -2.194 0 CA-C-N 111.388 -2.406 . . . . 0.0 113.961 168.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -121.49 138.95 54.07 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.668 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 13.1 m -74.76 127.81 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 122.191 0.996 . . . . 0.0 111.46 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.5 HD13 HD12 ' C' ' 66' ' ' LEU . 12.6 mt -86.25 167.86 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.838 174.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.453 ' N ' HG22 ' C' ' 82' ' ' ILE . 65.2 m80 -118.92 115.3 24.08 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.41 HD23 HG22 ' C' ' 23' ' ' THR . 19.5 tp -92.45 132.79 36.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.276 0.56 . . . . 0.0 111.914 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 m -133.91 170.0 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.342 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . 0.436 ' HB2' HD12 ' C' ' 52' ' ' ILE . 42.7 tt0 -122.89 122.55 38.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.915 0.388 . . . . 0.0 111.27 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -102.91 164.34 11.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' C' ' 89' ' ' PRO . . . -134.02 152.29 78.22 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.948 -173.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 88' ' ' ALA . 36.8 Cg_exo -62.73 141.6 85.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.562 2.175 . . . . 0.0 112.16 175.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.45 65.07 8.05 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.804 2.336 . . . . 0.0 112.229 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -100.97 -20.03 15.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.921 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 14.8 t -152.4 151.36 30.72 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.847 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -87.46 78.91 8.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' C' ' 95' ' ' PRO . 6.1 tt 71.99 120.71 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.35 0 O-C-N 124.009 0.818 . . . . 0.0 110.162 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 34.6 Cg_exo -59.52 103.52 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.624 2.216 . . . . 0.0 112.042 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 25.9 t -62.72 126.45 27.39 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.809 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.93 -134.17 10.36 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.062 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.9 83.02 4.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.997 0.427 . . . . 0.0 110.992 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -77.62 -17.57 57.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.297 0.57 . . . . 0.0 109.939 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 38.9 t -129.86 -53.99 1.14 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.304 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.837 0 CA-C-O 118.569 -1.129 . . . . 0.0 111.46 -178.438 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 111.841 -0.503 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 2.9 p -67.82 108.79 3.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.051 0.453 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 mtm -82.15 -42.1 19.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.103 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 3' ' ' GLU . . . -84.24 79.92 9.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.565 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 2' ' ' ALA . 35.2 tt0 73.43 145.44 0.08 Allowed 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.938 0.774 . . . . 0.0 110.882 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.76 67.77 2.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.259 0.552 . . . . 0.0 110.519 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 23.6 p -79.98 145.71 61.95 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.253 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 31.1 Cg_exo -59.19 139.08 88.67 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.259 1.973 . . . . 0.0 110.951 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -96.33 120.77 61.87 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 121.105 0.479 . . . . 0.0 111.164 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.627 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 70.9 Cg_endo -80.37 153.95 21.28 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.422 2.748 . . . . 0.0 113.827 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.23 -112.89 1.56 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HB3' HD12 ' A' ' 40' ' ' LEU . 77.6 mtp180 -88.13 107.13 18.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.895 0.378 . . . . 0.0 110.587 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.691 ' CG ' ' HG3' ' A' ' 22' ' ' PRO . 9.8 m-85 -116.25 144.82 43.72 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.412 173.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.53 ' CB ' HD21 ' A' ' 40' ' ' LEU . 53.8 t80 -114.24 121.59 44.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.762 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -98.43 119.52 37.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 174.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -76.88 -13.33 60.0 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.468 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 36.3 t -70.89 -42.04 70.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.353 0.597 . . . . 0.0 110.581 175.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -85.21 -27.03 26.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.581 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 1.6 m 58.09 29.5 17.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.214 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.37 144.25 34.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -74.82 147.64 40.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.177 0.513 . . . . 0.0 111.267 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.794 HD12 ' HD3' ' A' ' 30' ' ' PRO . 4.6 pt -133.36 169.7 21.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.841 -169.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.37 108.64 35.61 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 158.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.691 ' HG3' ' CG ' ' A' ' 11' ' ' TYR . 15.0 Cg_endo -69.06 177.49 5.05 Favored 'Trans proline' 0 C--N 1.328 -0.53 0 C-N-CA 125.181 3.921 . . . . 0.0 115.315 -170.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.6 ' HB2' HG13 ' A' ' 28' ' ' ILE . 8.2 mtt180 -112.57 50.46 0.87 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.592 174.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.509 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -0.3 -60.23 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 CA-C-N 111.334 -2.667 . . . . 0.0 116.365 172.316 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 24' ' ' LEU . 27.7 Cg_exo -34.79 -36.4 0.12 Allowed 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 123.045 2.497 . . . . 0.0 114.386 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.533 ' HB3' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -110.35 -22.92 11.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.72 178.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 66.24 49.26 1.51 Allowed 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.642 -168.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.6 HG13 ' HB2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -98.17 162.18 2.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.07 174.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.542 ' SG ' ' HD2' ' A' ' 30' ' ' PRO . 1.8 t -97.63 147.1 32.53 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.794 ' HD3' HD12 ' A' ' 20' ' ' ILE . 66.6 Cg_endo -80.93 -22.84 5.9 Favored 'Trans proline' 0 CA--C 1.499 -1.261 0 C-N-CA 122.897 2.398 . . . . 0.0 108.21 -174.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.516 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 80.1 mtt-85 -81.66 -30.02 32.9 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 112.819 -1.991 . . . . 0.0 113.776 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.4 p -141.6 -7.02 0.99 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.429 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 17.6 tt0 59.47 27.37 16.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.552 0.691 . . . . 0.0 111.219 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -107.71 143.02 36.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.369 171.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.37 33.24 2.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.899 -0.667 . . . . 0.0 114.012 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 13' ' ' CYS . 41.1 m-85 -89.54 45.08 1.25 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.101 0.477 . . . . 0.0 110.423 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.688 HG21 ' CD1' ' A' ' 20' ' ' ILE . 10.4 pt -112.32 132.48 60.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.227 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' C' ' 65' ' ' VAL . 7.5 pt-20 -120.08 136.23 54.66 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.95 137.57 39.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.971 0.415 . . . . 0.0 110.094 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.53 HD21 ' CB ' ' A' ' 12' ' ' PHE . 10.4 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.363 -172.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.04 155.7 17.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.816 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -62.23 -51.52 67.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.213 0.53 . . . . 0.0 109.946 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -117.16 164.71 14.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.311 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -75.49 69.16 2.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.307 0.575 . . . . 0.0 110.463 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -145.13 103.38 3.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.572 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -81.31 -0.59 41.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.966 0.412 . . . . 0.0 111.135 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -138.0 128.79 26.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 170.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 33.5 m -138.98 150.39 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.033 0.444 . . . . 0.0 111.521 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -143.43 17.38 1.86 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.2 44.34 1.01 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.634 -170.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -119.59 69.58 0.84 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -88.63 -45.81 9.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.881 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -67.12 178.78 1.33 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.523 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' C' ' 33' ' ' VAL . 45.5 ttm 65.51 91.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.152 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' C' ' 35' ' ' ALA . 0.0 OUTLIER -108.69 142.53 39.07 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.104 176.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.628 ' HA ' HG13 ' C' ' 32' ' ' ILE . 37.8 mt-10 -85.04 94.69 8.89 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 171.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' C' ' 31' ' ' PHE . 3.5 t -77.9 111.46 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.613 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.665 ' HB2' ' HA ' ' C' ' 81' ' ' VAL . 1.4 mt -100.02 146.97 26.12 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.67 HG21 ' HE2' ' C' ' 31' ' ' PHE . 9.4 m -137.32 153.9 29.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' LYS . . . . . 0.543 ' HG3' ' CG2' ' C' ' 81' ' ' VAL . 41.0 mtmt -125.77 133.18 52.14 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' THR . . . . . . . . . . . . . 3.2 m -78.3 -45.63 22.23 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.121 -172.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.84 -43.17 0.12 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' ASP . . . . . . . . . . . . . 27.2 t70 177.96 -43.26 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.312 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 24.6 t -66.1 -45.69 80.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.483 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -93.32 176.2 6.48 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 122.634 1.207 . . . . 0.0 113.036 -175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' C' ' 21' ' ' VAL . 25.5 m -176.1 104.81 0.07 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 112.068 -2.333 . . . . 0.0 106.817 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -131.21 157.55 42.91 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.442 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . 0.562 HG22 ' CD2' ' C' ' 20' ' ' LEU . 16.8 p -103.76 149.11 25.32 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -172.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' PHE . . . . . 0.67 ' HE2' HG21 ' C' ' 21' ' ' VAL . 27.6 m-85 -140.36 63.11 1.48 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.376 -177.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.628 HG13 ' HA ' ' C' ' 18' ' ' GLU . 2.9 mp -59.17 122.69 9.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 122.973 1.368 . . . . 0.0 114.154 -174.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.639 HG11 ' CD1' ' C' ' 42' ' ' PHE . 13.9 m -135.74 -168.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 111.498 -2.592 . . . . 0.0 112.107 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' C' ' 16' ' ' MET . . . -121.47 38.72 2.56 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.457 -0.878 . . . . 0.0 114.423 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' ALA . . . . . 0.734 ' HB2' HD21 ' C' ' 17' ' ' LEU . . . 71.09 16.99 6.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 163.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.733 ' HB2' ' O ' ' C' ' 35' ' ' ALA . 9.7 tt0 153.43 -7.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.787 0.803 . . . . 0.0 108.933 -166.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' MET . . . . . 0.493 ' HG3' ' OD1' ' C' ' 38' ' ' ASN . 35.8 tpp -47.94 -66.52 0.39 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.296 173.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.493 ' OD1' ' HG3' ' C' ' 37' ' ' MET . 18.3 m120 -139.99 -162.68 1.38 Allowed 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 168.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.643 HG13 ' HA ' ' C' ' 68' ' ' ASP . 8.1 p 173.72 -19.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.538 ' HE2' ' HE2' ' C' ' 70' ' ' LYS . 0.0 OUTLIER -83.05 -70.65 0.54 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.123 173.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -62.77 -32.45 73.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.531 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.639 ' CD1' HG11 ' C' ' 33' ' ' VAL . 5.9 t80 -59.05 -52.17 66.89 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.625 175.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -68.04 -35.67 78.64 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.638 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -56.39 -40.43 74.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.026 0.441 . . . . 0.0 111.133 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -69.56 -41.15 76.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.742 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.625 ' O ' HG22 ' C' ' 50' ' ' VAL . 6.2 pt -76.59 -16.62 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -176.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' C' ' 52' ' ' ILE . . . -39.17 -59.57 1.0 Allowed 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.81 95.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -23.57 67.32 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.177 0.513 . . . . 0.0 111.097 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.628 HG21 ' OE1' ' C' ' 57' ' ' GLN . 26.7 m -108.91 -5.93 10.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.096 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t 69.17 19.63 7.86 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.558 0.694 . . . . 0.0 109.637 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 3.4 mm -129.26 118.4 19.22 Favored Pre-proline 0 N--CA 1.444 -0.761 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.726 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' PRO . . . . . 0.481 ' HB2' ' HG2' ' C' ' 55' ' ' GLU . 5.1 Cg_exo -70.1 146.67 58.75 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.121 1.88 . . . . 0.0 111.188 177.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' SER . . . . . 0.427 ' HA ' ' HB3' ' C' ' 57' ' ' GLN . 8.7 t -53.48 -26.18 19.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.009 -176.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.526 ' HG3' ' HG3' ' C' ' 56' ' ' LYS . 12.7 pt-20 -71.63 -32.45 67.96 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.899 0.38 . . . . 0.0 110.998 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' C' ' 55' ' ' GLU . 57.4 mtpt -99.45 -24.42 14.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.36 0.6 . . . . 0.0 110.123 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.628 ' OE1' HG21 ' C' ' 50' ' ' VAL . 6.2 tt0 -69.2 122.64 19.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.728 -173.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -112.02 122.63 48.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.674 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 95.3 mt -88.46 110.75 21.1 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.463 HG21 ' O ' ' A' ' 37' ' ' ILE . 10.2 mt -108.64 113.88 45.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.95 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -133.54 132.54 41.05 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 59.11 34.21 23.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.401 -173.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 37' ' ' ILE . . . 67.83 2.31 22.58 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.777 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -91.16 136.48 33.06 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -90.64 89.18 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.43 0.633 . . . . 0.0 109.563 -176.332 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.562 HD22 ' CD1' ' C' ' 75' ' ' TYR . 0.3 OUTLIER -73.67 140.94 46.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.918 178.577 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -153.53 -169.31 3.26 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.561 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' ASP . . . . . 0.643 ' HA ' HG13 ' C' ' 39' ' ' VAL . 7.4 p-10 -65.56 -0.43 2.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.268 0.627 . . . . 0.0 112.161 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' C' ' 70' ' ' LYS . 38.4 t70 -58.32 -10.9 2.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.296 1.038 . . . . 0.0 113.367 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.538 ' HE2' ' HE2' ' C' ' 40' ' ' LYS . 89.5 mttt 85.6 175.16 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.285 1.034 . . . . 0.0 113.226 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 64.74 86.02 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.916 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.621 ' HB2' ' C ' ' C' ' 35' ' ' ALA . 57.9 mt -75.42 -34.15 60.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.41 -19.3 65.76 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 120.699 0.285 . . . . 0.0 111.636 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -68.8 -28.41 66.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' TYR . . . . . 0.562 ' CD1' HD22 ' C' ' 66' ' ' LEU . 20.9 m-85 -85.85 -23.26 27.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' ASN . . . . . . . . . . . . . 63.1 t30 61.07 36.52 18.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.848 -1.524 . . . . 0.0 110.852 171.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.04 25.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.711 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.723 ' HA2' ' HB3' ' C' ' 17' ' ' LEU . . . -72.14 95.14 0.65 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-O 122.203 0.89 . . . . 0.0 113.074 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.64 14.77 45.73 Favored Glycine 0 C--N 1.305 -1.179 0 CA-C-N 113.341 -1.429 . . . . 0.0 113.508 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -119.01 149.82 40.99 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.052 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.665 ' HA ' ' HB2' ' C' ' 20' ' ' LEU . 10.5 m -82.68 124.07 39.04 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-O 122.299 1.047 . . . . 0.0 111.177 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' ILE . . . . . 0.481 HG22 ' N ' ' C' ' 83' ' ' HIS . 68.2 mt -81.95 167.3 2.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.925 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' HIS . . . . . 0.481 ' N ' HG22 ' C' ' 82' ' ' ILE . 54.8 m80 -118.71 115.11 23.82 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.446 HD21 HG11 ' C' ' 50' ' ' VAL . 4.3 pp -113.94 151.47 32.24 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.051 -1.059 . . . . 0.0 112.562 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.94 -174.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 113.174 -1.83 . . . . 0.0 110.352 -176.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.88 170.91 9.5 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.239 168.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -77.5 176.91 8.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.078 0.466 . . . . 0.0 111.323 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.85 150.31 77.54 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.557 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.69 135.92 11.82 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.957 1.771 . . . . 0.0 112.365 -175.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -87.8 55.46 2.68 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.943 2.428 . . . . 0.0 111.843 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -67.75 -16.58 64.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.153 0.501 . . . . 0.0 110.814 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -142.74 35.83 1.43 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 172.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' HIS . . . . . . . . . . . . . 45.2 m80 68.15 -78.88 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.572 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 tt -121.41 107.48 36.77 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -64.66 104.23 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.452 2.101 . . . . 0.0 112.25 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' SER . . . . . . . . . . . . . 29.0 t -72.02 -33.72 68.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.115 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.4 84.79 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.429 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.18 71.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.935 0.398 . . . . 0.0 111.2 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' SER . . . . . . . . . . . . . 20.4 m -111.64 19.9 17.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.146 0.498 . . . . 0.0 110.805 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' SER . . . . . . . . . . . . . 18.8 m -98.26 101.16 12.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.983 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.936 0 CA-C-O 118.739 -1.034 . . . . 0.0 111.298 176.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_